"Cmpds","Name","Formula","AllNames","AllReactions","AllPath","AllEnzyme","AllModule","AllBrite","AllDB","OtherCmpds","C","H","O","N","P","S","Cl","I","Br","F","Se","B","Mo","Fe","Co","Mg","Ni","As","PosForm","NegForm","NeutalMass","PosMZ","NegMZ"
"cpd:C00022","Pyruvate;","C3H4O3","Pyruvate; Pyruvic acid; 2-Oxopropanoate; 2-Oxopropanoic acid; Pyroracemic acid","R00006 R00008 R00014 R00195 R00196 R00197 R00198 R00199; R00200 R00203 R00205 R00206 R00207 R00208 R00209 R00210; R00211 R00212 R00213 R00214 R00215 R00216 R00217 R00218; R00219 R00220 R00221 R00223 R00224 R00226 R00237 R00258; R00297 R00324 R00325 R00344 R00350 R00353 R00368 R00369; R00396 R00398 R00400 R00409 R00430 R00452 R00453 R00470; R00471 R00532 R00543 R00562 R00572 R00576 R00585 R00659; R00666 R00673 R00692 R00703 R00704 R00724 R00728 R00750; R00782 R00906 R00907 R00930 R00985 R00986 R01012 R01031; R01032 R01064 R01085 R01138 R01147 R01148 R01196 R01215; R01261 R01286 R01302 R01335 R01344 R01355 R01447 R01576; R01584 R01645 R01647 R01683 R01699 R01712 R01782 R01784; R01811 R01858 R01874 R02050 R02261 R02271 R02293 R02320; R02408 R02628 R02721 R02754 R02953 R02970 R03001 R03037; R03050 R03081 R03105 R03106 R03145 R03277 R03465 R03502; R03528 R03732 R03796 R03854 R04152 R04187 R04672 R04861; R04941 R05136 R05298 R05538 R05544 R05553 R05605 R05636; R05648 R05652 R05861 R06602 R06603 R06913 R06923 R06934; R07399 R07633 R07634 R07685 R07692 R07713 R08166 R08170; R08197 R08200 R08253 R08570 R08648 R08654 R08660 R08667; R08686 R08698 R08714 R09048 R09088 R09238 R09254 R09366; R10147 R10178 R10180 R10283 R10487 R10527 R10539 R10542; R10550 R10552 R10583 R10597 R10616 R10674 R10691 R10866; R10992 R11023 R11038 R11099 R11141 R11213 R11257 R11352; R11463","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Pentose phosphate pathway; Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Alanine, aspartate and glutamate metabolism; Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Valine, leucine and isoleucine biosynthesis; Arginine and proline metabolism; Tyrosine metabolism; Phenylalanine metabolism; Benzoate degradation; Taurine and hypotaurine metabolism; Phosphonate and phosphinate metabolism; D-Alanine metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Thiamine metabolism; Nicotinate and nicotinamide metabolism; Pantothenate and CoA biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Degradation of aromatic compounds; Biosynthesis of amino acids; Vancomycin resistance; Phosphotransferase system (PTS); HIF-1 signaling pathway; AMPK signaling pathway; Insulin secretion; Glucagon signaling pathway; Type II diabetes mellitus; Insulin resistance; Central carbon metabolism in cancer","1.1.1.27; 1.1.1.28; 1.1.1.38; 1.1.1.39; 1.1.1.40; 1.1.1.83; 1.1.2.3; 1.1.2.4; 1.1.2.5; 1.1.99.6; 1.1.99.7; 1.2.1.22; 1.2.1.23; 1.2.1.49; 1.2.1.51; 1.2.3.3; 1.2.3.6; 1.2.3.15; 1.2.4.1; 1.2.5.1; 1.2.7.1; 1.2.7.11; 1.2.7.-; 1.4.1.1; 1.4.1.17; 1.4.3.3; 1.4.3.19; 1.5.1.11; 1.5.1.16; 1.5.1.17; 1.5.1.22; 1.5.1.23; 1.5.1.24; 1.5.1.26; 1.5.1.28; 1.8.1.4; 1.14.11.43; 1.14.11.44; 2.1.3.1; 2.2.1.6; 2.2.1.7; 2.2.1.12; 2.3.1.12; 2.3.1.54; 2.3.1.182; 2.6.1.2; 2.6.1.12; 2.6.1.15; 2.6.1.18; 2.6.1.21; 2.6.1.30; 2.6.1.37; 2.6.1.40; 2.6.1.41; 2.6.1.43; 2.6.1.44; 2.6.1.46; 2.6.1.47; 2.6.1.51; 2.6.1.56; 2.6.1.58; 2.6.1.66; 2.6.1.71; 2.6.1.77; 2.6.1.84; 2.6.1.96; 2.6.1.99; 2.6.1.108; 2.6.1.-; 2.6.3.1; 2.7.1.40; 2.7.1.121; 2.7.3.9; 2.7.9.1; 2.7.9.2; 2.8.1.2; 3.1.3.60; 3.3.2.1; 3.3.2.13; 3.3.2.15; 3.5.99.10; 3.7.1.5; 3.7.1.6; 3.7.1.20; 3.7.1.23; 3.7.1.-; 3.11.1.3; 4.1.1.1; 4.1.1.3; 4.1.1.64; 4.1.1.78; 4.1.1.-; 4.1.2.14; 4.1.2.18; 4.1.2.20; 4.1.2.21; 4.1.2.23; 4.1.2.28; 4.1.2.34; 4.1.2.45; 4.1.2.51; 4.1.2.52; 4.1.2.53; 4.1.2.54; 4.1.2.55; 4.1.2.58; 4.1.2.-; 4.1.3.3; 4.1.3.16; 4.1.3.17; 4.1.3.22; 4.1.3.25; 4.1.3.27; 4.1.3.30; 4.1.3.32; 4.1.3.38; 4.1.3.39; 4.1.3.40; 4.1.3.42; 4.1.3.43; 4.1.3.44; 4.1.3.45; 4.1.3.46; 4.1.99.1; 4.1.99.2; 4.2.1.-; 4.2.99.20; 4.2.99.21; 4.3.1.10; 4.3.1.13; 4.3.1.15; 4.3.1.17; 4.3.1.18; 4.3.1.19; 4.3.3.7; 4.4.1.1; 4.4.1.6; 4.4.1.8; 4.4.1.13; 4.4.1.15; 4.4.1.24; 4.4.1.25; 4.4.1.28; 4.4.1.-; 4.5.1.2; 6.4.1.1","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; C5 isoprenoid biosynthesis, non-mevalonate pathway; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Pyruvate oxidation, pyruvate => acetyl-CoA; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Isoleucine biosynthesis, pyruvate => 2-oxobutanoate; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00022  Pyruvate; 2-Oxopropanoate","CAS: 127-17-3; PubChem: 3324; ChEBI: 15361 32816; ChEMBL: CHEMBL1162144; LIPIDMAPS: LMFA01060077; LipidBank: DFA0385; KNApSAcK: C00001200; PDB-CCD: PYR; 3DMET: B00006; NIKKAJI: J2.015J","cpd:C00022; cpd:C00222; cpd:C00957; cpd:C02055; cpd:C02853; cpd:C12069; cpd:C18618; cpd:C20363",3,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O3","C3H3O3",88.01604399,89.02386902,87.00821896
"cpd:C00024","Acetyl-CoA;","C23H38N7O17P3S","Acetyl-CoA; Acetyl coenzyme A","R00209 R00210 R00211 R00212 R00227 R00228 R00229 R00230; R00233 R00235 R00236 R00237 R00238 R00259 R00271 R00351; R00352 R00353 R00354 R00371 R00391 R00393 R00399 R00454; R00472 R00473 R00487 R00586 R00627 R00693 R00705 R00706; R00742 R00743 R00829 R00927 R00928 R00998 R01023 R01089; R01154 R01160 R01177 R01179 R01196 R01204 R01213 R01323; R01359 R01360 R01556 R01624 R01776 R01806 R01807 R01808; R01850 R01889 R01978 R02058 R02152 R02191 R02232 R02387; R02396 R02481 R02569 R02616 R02772 R02837 R02911 R02955; R03017 R03056 R03064 R03065 R03153 R03168 R03230 R03437; R03455 R03552 R03621 R03668 R03760 R03767 R03778 R03858; R03884 R03903 R03910 R03991 R04000 R04024 R04057 R04192; R04316 R04348 R04364 R04386 R04466 R04484 R04723 R04742; R04747 R04950 R05063 R05188 R05190 R05332 R05336 R05351; R05506 R05508 R05509 R05537 R05586 R05672 R05773 R05870; R05876 R06251 R06307 R06311 R06510 R06635 R06735 R06736; R06978 R06997 R07249 R07252 R07253 R07399 R07815 R07832; R07833 R07891 R07895 R07899 R07937 R07953 R08036 R08091; R08095 R08213 R08248 R08250 R08331 R08332 R08386 R08433; R08530 R08531 R08532 R08619 R08623 R08627 R08631 R08640; R08644 R08680 R08767 R08870 R08871 R08938 R09096 R09317; R09524 R09527 R09622 R09631 R09839 R09842 R09873 R10099; R10100 R10142 R10174 R10200 R10219 R10243 R10253 R10254; R10343 R10473 R10474 R10500 R10514 R10564 R10600 R10614; R10674 R10707 R10745 R10746 R10866 R10893 R11124 R11125; R11182 R11412 R11479","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Synthesis and degradation of ketone bodies; Aflatoxin biosynthesis; Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Lysine biosynthesis; Lysine degradation; Phenylalanine metabolism; Benzoate degradation; Tryptophan metabolism; beta-Alanine metabolism; Taurine and hypotaurine metabolism; Glutathione metabolism; Inositol phosphate metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Ethylbenzene degradation; Butanoate metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Terpenoid backbone biosynthesis; Biosynthesis of type II polyketide backbone; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism; Degradation of aromatic compounds; HIF-1 signaling pathway; AMPK signaling pathway; Cholinergic synapse; Glucagon signaling pathway; Insulin resistance; Bile secretion; Central carbon metabolism in cancer","1.1.1.-; 1.2.1.10; 1.2.1.18; 1.2.1.27; 1.2.1.51; 1.2.3.6; 1.2.4.1; 1.2.7.1; 1.2.7.4; 1.2.7.11; 1.2.7.-; 1.8.1.4; 2.1.1.258; 2.1.3.1; 2.3.1.1; 2.3.1.2; 2.3.1.3; 2.3.1.4; 2.3.1.5; 2.3.1.6; 2.3.1.7; 2.3.1.8; 2.3.1.9; 2.3.1.10; 2.3.1.11; 2.3.1.12; 2.3.1.16; 2.3.1.17; 2.3.1.18; 2.3.1.27; 2.3.1.28; 2.3.1.29; 2.3.1.30; 2.3.1.31; 2.3.1.33; 2.3.1.34; 2.3.1.36; 2.3.1.38; 2.3.1.44; 2.3.1.45; 2.3.1.48; 2.3.1.53; 2.3.1.54; 2.3.1.57; 2.3.1.59; 2.3.1.60; 2.3.1.66; 2.3.1.67; 2.3.1.69; 2.3.1.78; 2.3.1.79; 2.3.1.80; 2.3.1.81; 2.3.1.82; 2.3.1.84; 2.3.1.85; 2.3.1.86; 2.3.1.87; 2.3.1.88; 2.3.1.89; 2.3.1.102; 2.3.1.105; 2.3.1.107; 2.3.1.108; 2.3.1.118; 2.3.1.128; 2.3.1.136; 2.3.1.150; 2.3.1.155; 2.3.1.157; 2.3.1.160; 2.3.1.162; 2.3.1.163; 2.3.1.165; 2.3.1.167; 2.3.1.169; 2.3.1.174; 2.3.1.175; 2.3.1.178; 2.3.1.180; 2.3.1.182; 2.3.1.183; 2.3.1.185; 2.3.1.186; 2.3.1.189; 2.3.1.190; 2.3.1.194; 2.3.1.195; 2.3.1.197; 2.3.1.201; 2.3.1.202; 2.3.1.203; 2.3.1.205; 2.3.1.209; 2.3.1.210; 2.3.1.223; 2.3.1.224; 2.3.1.227; 2.3.1.236; 2.3.1.237; 2.3.1.245; 2.3.1.247; 2.3.1.-; 2.3.3.1; 2.3.3.3; 2.3.3.6; 2.3.3.8; 2.3.3.9; 2.3.3.10; 2.3.3.13; 2.3.3.14; 2.3.3.16; 2.3.3.17; 2.3.3.-; 2.3.-.-; 2.6.1.33; 2.8.3.1; 2.8.3.3; 2.8.3.8; 2.8.3.10; 2.8.3.11; 2.8.3.12; 2.8.3.14; 2.8.3.18; 2.8.3.19; 2.8.3.-; 3.1.2.1; 4.1.1.9; 4.1.2.41; 4.1.3.4; 4.1.3.24; 4.1.3.25; 4.1.3.34; 4.1.3.35; 4.1.3.46; 4.1.3.-; 6.2.1.1; 6.2.1.13; 6.4.1.2","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Fatty acid biosynthesis, initiation; Fatty acid biosynthesis, elongation, mitochondria; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway; Reductive citrate cycle (Arnon-Buchanan cycle); Pyruvate oxidation, pyruvate => acetyl-CoA; Methanogenesis, acetate => methane; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway); Acetyl-CoA pathway, CO2 => acetyl-CoA; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle",NA,"CAS: 72-89-9; PubChem: 3326; ChEBI: 15351; LIPIDMAPS: LMFA07050029; KNApSAcK: C00007259; PDB-CCD: ACO; 3DMET: B04621; NIKKAJI: J192.549K","cpd:C00024; cpd:C02843",23,38,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C23H39O17N7P3S1","C23H37O17N7P3S1",809.125775,810.1336,808.1179499
"cpd:C00031","D-Glucose;","C6H12O6","D-Glucose; Grape sugar; Dextrose; Glucose; D-Glucopyranose","R00010 R00015 R00028 R00049 R00063 R00299 R00300 R00301; R00302 R00303 R00304 R00305 R00306 R00307 R00308 R00327; R00337 R00503 R00534 R00550 R00725 R00801 R00837 R00838; R00839 R00850 R00874 R00952 R00953 R00960 R01006 R01100; R01101 R01139 R01444 R01460 R01498 R01555 R01718 R01790; R01791 R02185 R02558 R02595 R02727 R02738 R02887 R02985; R03075 R03323 R03527 R03604 R03703 R03801 R03802 R03820; R04006 R04094 R04194 R04333 R04409 R04410 R04411 R04498; R04503 R04949 R04998 R05061 R05140 R05141 R05142 R05196; R05804 R05979 R05980 R05981 R06040 R06053 R06056 R06058; R06059 R06067 R06069 R06079 R06087 R06091 R06103 R06104; R06105 R06106 R06107 R06108 R06109 R06112 R06113 R06114; R06115 R06135 R06204 R06620 R07147 R07264 R08404 R08514; R08819 R08823 R08946 R09039 R09723 R09941 R09943 R10411; R10494 R10525 R10530 R10580 R10581 R11215 R11306","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Streptomycin biosynthesis; Neomycin, kanamycin and gentamicin biosynthesis; Indole alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; ABC transporters; Two-component system; Phosphotransferase system (PTS); HIF-1 signaling pathway; FoxO signaling pathway; Meiosis - yeast; AMPK signaling pathway; Taste transduction; Insulin signaling pathway; Insulin secretion; Prolactin signaling pathway; Glucagon signaling pathway; Type II diabetes mellitus; Insulin resistance; Non-alcoholic fatty liver disease (NAFLD); AGE-RAGE signaling pathway in diabetic complications; Carbohydrate digestion and absorption; Bile secretion; Mineral absorption; Biofilm formation - Vibrio cholerae; Central carbon metabolism in cancer","1.1.1.118; 1.1.1.119; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.10; 1.1.5.2; 1.1.5.9; 1.1.99.28; 1.1.99.35; 2.3.1.72; 2.3.1.90; 2.3.1.91; 2.3.1.92; 2.3.1.103; 2.3.1.143; 2.3.1.152; 2.3.1.-; 2.4.1.8; 2.4.1.9; 2.4.1.10; 2.4.1.20; 2.4.1.22; 2.4.1.25; 2.4.1.31; 2.4.1.64; 2.4.1.99; 2.4.1.230; 2.4.1.245; 2.4.1.279; 2.4.1.281; 2.7.1.1; 2.7.1.2; 2.7.1.41; 2.7.1.42; 2.7.1.61; 2.7.1.62; 2.7.1.63; 2.7.1.142; 2.7.1.147; 2.7.1.199; 3.1.1.33; 3.1.3.9; 3.1.3.10; 3.1.3.58; 3.1.4.48; 3.1.6.3; 3.2.1.3; 3.2.1.10; 3.2.1.20; 3.2.1.21; 3.2.1.22; 3.2.1.23; 3.2.1.26; 3.2.1.28; 3.2.1.39; 3.2.1.42; 3.2.1.45; 3.2.1.48; 3.2.1.58; 3.2.1.62; 3.2.1.74; 3.2.1.84; 3.2.1.86; 3.2.1.93; 3.2.1.104; 3.2.1.105; 3.2.1.106; 3.2.1.107; 3.2.1.108; 3.2.1.117; 3.2.1.118; 3.2.1.122; 3.2.1.125; 3.2.1.126; 3.2.1.147; 3.2.1.175; 3.2.1.186; 3.2.1.188; 3.2.1.189; 3.2.1.-; 4.2.99.22; 4.2.99.23; 5.3.1.5",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00031  D-Glucose; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX01 Glucose;       D00009  Glucose (JP17);  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CA Tests for diabetes;      V04CA02 Glucose;       D00009  Glucose (JP17);   V06 GENERAL NUTRIENTS;    V06D OTHER NUTRIENTS;     V06DC Carbohydrates;      V06DC01 Glucose;       D00009  Glucose (JP17); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   32  Nutrients, tonics;    323  Saccharide preparations;     3231  Glucoses;      D00009  Glucose (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glucose;     D00009  Glucose (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00009  [001540] Glucose;  Buffering agent;   D00009  [001540] Glucose;  Sweetening agent;   D00009  [001540] Glucose;  Flavoring substance;   D00009  [001540] Glucose;  Bonding agent;   D00009  [001540] Glucose;  Coating agent;   D00009  [001540] Glucose;  Tonicity agent;   D00009  [001540] Glucose;  Diluting agent;   D00009  [001540] Glucose;   D00009  [999999] Glucose solution;  Soothing agent;   D00009  [001540] Glucose;  Solubilizer;   D00009  [001540] Glucose;  Solubilization agent;   D00009  [001540] Glucose;  Solvent;   D00009  [001540] Glucose; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00009  Glucose;   D00009  Glucose injection; Major components of natural products [BR:br08323];  Crude drugs;   Honey; Honey, purified;    C00031  D-Glucose; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9641  Dextrose and preparations;     C00031  D-Glucose","CAS: 50-99-7 2280-44-6; PubChem: 3333; ChEBI: 4167; ChEMBL: CHEMBL1222250 CHEMBL1614854 CHEMBL423707 CHEMBL98182; KNApSAcK: C00042470; PDB-CCD: BGC GLC; 3DMET: B04623; NIKKAJI: J4.109B","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00033","Acetate;","C2H4O2","Acetate; Acetic acid; Ethanoic acid","R00227 R00229 R00235 R00315 R00316 R00317 R00318 R00319; R00320 R00321 R00322 R00324 R00325 R00326 R00327 R00338; R00362 R00393 R00458 R00488 R00628 R00651 R00669 R00710; R00711 R00743 R00897 R00909 R00928 R01019 R01026 R01156; R01179 R01200 R01241 R01287 R01308 R01323 R01359 R01426; R01649 R01810 R01987 R02026 R02059 R02276 R02333 R02733; R02942 R02955 R03062 R03131 R03132 R03133 R03134 R03145; R03153 R03217 R03482 R03601 R03884 R04000 R04043 R04056; R04057 R04091 R04141 R04146 R04174 R04397 R04449 R04450; R04452 R04490 R04525 R04587 R04727 R04769 R04859 R04945; R05138 R05168 R05219 R05336 R05508 R05509 R05677 R05880; R05917 R06241 R06893 R07183 R07300 R07301 R07342 R07513; R07832 R08090 R08206 R08517 R08518 R08600 R08601 R08874; R08876 R08895 R08901 R08944 R09107 R09475 R09483 R09651; R09721 R09801 R09931 R10248 R10249 R10289 R10305 R10343; R10398 R10401 R10461 R10553 R10600 R10614 R10705 R10839; R10840 R11116 R11283","Glycolysis / Gluconeogenesis; Taurine and hypotaurine metabolism; Phosphonate and phosphinate metabolism; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Pyruvate metabolism; Propanoate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Zeatin biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Cholinergic synapse; Carbohydrate digestion and absorption; Protein digestion and absorption","1.1.1.318; 1.1.1.319; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.-; 1.2.5.1; 1.2.5.2; 1.2.99.6; 1.13.11.50; 1.13.12.4; 1.14.13.54; 1.14.14.32; 2.1.1.152; 2.3.1.187; 2.5.1.47; 2.5.1.48; 2.5.1.49; 2.5.1.50; 2.5.1.51; 2.5.1.52; 2.5.1.53; 2.5.1.65; 2.5.1.118; 2.5.1.119; 2.5.1.134; 2.6.99.3; 2.7.2.1; 2.7.2.12; 2.7.2.15; 2.8.3.1; 2.8.3.3; 2.8.3.8; 2.8.3.10; 2.8.3.11; 2.8.3.12; 2.8.3.14; 2.8.3.18; 2.8.3.19; 2.8.3.-; 3.1.1.2; 3.1.1.6; 3.1.1.7; 3.1.1.8; 3.1.1.33; 3.1.1.41; 3.1.1.47; 3.1.1.53; 3.1.1.54; 3.1.1.55; 3.1.1.56; 3.1.1.58; 3.1.1.66; 3.1.1.71; 3.1.1.80; 3.1.1.94; 3.1.1.-; 3.1.2.1; 3.1.2.16; 3.5.1.4; 3.5.1.14; 3.5.1.15; 3.5.1.16; 3.5.1.17; 3.5.1.21; 3.5.1.25; 3.5.1.29; 3.5.1.33; 3.5.1.41; 3.5.1.47; 3.5.1.48; 3.5.1.51; 3.5.1.62; 3.5.1.63; 3.5.1.66; 3.5.1.76; 3.5.1.85; 3.5.1.89; 3.5.1.103; 3.5.1.104; 3.5.1.108; 3.5.1.112; 3.5.1.113; 3.5.1.114; 3.5.1.-; 3.6.1.7; 3.6.1.20; 3.7.1.1; 3.7.1.6; 3.7.1.-; 3.11.1.2; 4.1.1.88; 4.1.1.89; 4.1.3.4; 4.1.3.6; 4.1.3.22; 4.1.3.26; 6.2.1.1; 6.2.1.13; 6.2.1.22; 6.2.1.35","Methanogenesis, acetate => methane; Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C00033  Acetate; Ethanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00033  Acetic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AD Organic acids;      G01AD02 Acetic acid;       D00010  Acetic acid, glacial (USP);  S SENSORY ORGANS;   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA10 Acetic acid;       D00010  Acetic acid, glacial (USP); USP drug classification [BR:br08302];  Antibacterials;   Antibacterials, Other;    Acetic acid;     D00010  Acetic acid, glacial (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;     2649  Others;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);    266  Emollients;     2661  Organic acids;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);    719  Miscellaneous;     7190  Miscellaneous;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Acetic acid;     D00010  Acetic acid, glacial (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Buffering agent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Flavoring substance;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  pH regulator;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Solubilization agent;   D00010  [001259] Glacial acetic acid;  Solvent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00010  Acetic acid;   D00010  Glacial acetic acid","CAS: 64-19-7; PubChem: 3335; ChEBI: 15366 30089; ChEMBL: CHEMBL539; LIPIDMAPS: LMFA01010002; LipidBank: DFA0002; KNApSAcK: C00001176; PDB-CCD: ACT ACY; 3DMET: B00009; NIKKAJI: J2.355H","cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00098; cpd:C00151; cpd:C00266; cpd:C00405; cpd:C02086; cpd:C05167; cpd:C05234; cpd:C13301; cpd:C13400; cpd:C14860; cpd:C18091; cpd:C18372; cpd:C18568; cpd:C18723; cpd:C18940",2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H5O2","C2H3O2",60.02112937,61.0289544,59.01330434
"cpd:C00036","Oxaloacetate;","C4H4O5","Oxaloacetate; Oxalacetic acid; Oxaloacetic acid; 2-Oxobutanedioic acid; 2-Oxosuccinic acid; keto-Oxaloacetate","R00217 R00338 R00339 R00340 R00341 R00342 R00343 R00344; R00345 R00346 R00347 R00348 R00350 R00351 R00352 R00353; R00354 R00355 R00357 R00359 R00360 R00361 R00362 R00363; R00373 R00400 R00431 R00477 R00493 R00695 R00726 R00930; R00931 R01144 R01257 R01447 R01713 R01731 R03735 R05053; R05758 R07164 R07165 R09683","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Alanine, aspartate and glutamate metabolism; Benzoate degradation; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Two-component system; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Central carbon metabolism in cancer","1.1.1.37; 1.1.1.38; 1.1.1.40; 1.1.1.82; 1.1.1.299; 1.1.5.4; 1.1.99.7; 1.4.1.21; 1.4.3.1; 1.4.3.2; 1.4.3.15; 1.4.3.16; 2.1.3.1; 2.3.3.1; 2.3.3.2; 2.3.3.3; 2.3.3.5; 2.3.3.8; 2.3.3.16; 2.6.1.1; 2.6.1.12; 2.6.1.21; 2.6.1.31; 2.6.1.35; 2.6.1.57; 2.6.1.70; 2.6.1.78; 2.6.1.-; 3.1.1.44; 3.5.1.3; 3.7.1.1; 4.1.1.3; 4.1.1.31; 4.1.1.32; 4.1.1.38; 4.1.1.49; 4.1.3.6; 4.1.3.13; 4.1.3.17; 4.1.3.34; 4.2.1.32; 4.2.1.81; 4.3.1.16; 4.3.1.20; 4.3.1.27; 5.3.2.2; 6.4.1.1","Gluconeogenesis, oxaloacetate => fructose-6P; Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Glyoxylate cycle; CAM (Crassulacean acid metabolism), dark; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Dicarboxylate-hydroxybutyrate cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00036  Oxaloacetate; 2-Oxosuccinate","CAS: 328-42-7; PubChem: 3338; ChEBI: 16452 30744; LIPIDMAPS: LMFA01170120; KNApSAcK: C00001197; PDB-CCD: OAA; 3DMET: B00010; NIKKAJI: J5.675H","cpd:C00036; cpd:C03548; cpd:C03981; cpd:C20341",4,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H5O5","C4H3O5",132.0058732,133.0136983,130.9980482
"cpd:C00068","Thiamin diphosphate;","C12H19N4O7P2S","Thiamin diphosphate; Thiamine diphosphate; Thiamin pyrophosphate; TPP; ThPP","R00014 R00615 R00616 R00617 R00618 R00619 R00621 R00755; R03050 R03270 R03316 R04672 R04673 R06861 R06862 R06863; R07599 R07600 R07601 R07602 R07603 R07604 R10996 R10997; R11319","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Valine, leucine and isoleucine degradation; Pyruvate metabolism; Propanoate metabolism; Thiamine metabolism; Metabolic pathways; Vitamin digestion and absorption","1.2.4.1; 1.2.4.2; 1.2.4.4; 2.2.1.1; 2.2.1.3; 2.2.1.6; 2.7.4.3; 2.7.4.15; 2.7.4.16; 2.7.6.2; 3.6.1.15; 3.6.1.28; 3.6.1.-; 4.1.1.1","Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00068  TPP","PubChem: 3368; ChEBI: 9532; ChEMBL: CHEMBL1236376; KNApSAcK: C00019627; PDB-CCD: TDP TPP; 3DMET: B01146; NIKKAJI: J184.400H J232.214E","cpd:C00068",12,19,7,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C12H20O7N4P2S1","C12H18O7N4P2S1",425.0449691,426.0527942,424.0371441
"cpd:C00074","Phosphoenolpyruvate;","C3H5O6P","Phosphoenolpyruvate; Phosphoenolpyruvic acid; PEP","R00199 R00200 R00206 R00208 R00341 R00345 R00346 R00430; R00431 R00572 R00658 R00659 R00660 R00661 R00724 R00726; R01012 R01138 R01804 R01826 R01858 R02320 R02628 R02769; R03254 R03460 R04435 R06591 R07476 R09760 R09841 R10304; R11439","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Phenylalanine, tyrosine and tryptophan biosynthesis; Phosphonate and phosphinate metabolism; Pyruvate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Phosphotransferase system (PTS); Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Central carbon metabolism in cancer","2.5.1.7; 2.5.1.19; 2.5.1.54; 2.5.1.55; 2.5.1.56; 2.5.1.57; 2.5.1.95; 2.5.1.97; 2.5.1.101; 2.5.1.132; 2.7.1.40; 2.7.1.121; 2.7.3.9; 2.7.9.1; 2.7.9.2; 3.1.3.60; 4.1.1.31; 4.1.1.32; 4.1.1.38; 4.1.1.49; 4.2.1.11; 4.4.1.19; 5.4.2.9","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; CAM (Crassulacean acid metabolism), dark; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Coenzyme M biosynthesis; Dicarboxylate-hydroxybutyrate cycle",NA,"CAS: 138-08-9; PubChem: 3374; ChEBI: 18021 44897; ChEMBL: CHEMBL1235228; KNApSAcK: C00000798; PDB-CCD: PEP; 3DMET: B00019; NIKKAJI: J9.706C","cpd:C00074; cpd:C02798; cpd:C16849",3,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6O6P1","C3H4O6P1",167.9823749,168.9901999,166.9745498
"cpd:C00084","Acetaldehyde;","C2H4O","Acetaldehyde; Ethanal","R00025 R00224 R00228 R00326 R00710 R00711 R00746 R00747; R00748 R00749 R00750 R00751 R00753 R00754 R00755 R00799; R01019 R01066 R01410 R02345 R03723 R05198 R05380 R05381; R05382 R05565 R05567 R05811 R06171 R06973 R07247 R07772; R08195 R08196 R09127 R09156 R09479 R09524 R09552 R09959; R10285 R10936","Glycolysis / Gluconeogenesis; Phenylalanine metabolism; Benzoate degradation; Phosphonate and phosphinate metabolism; Glycerophospholipid metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Chloroalkane and chloroalkene degradation; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Degradation of aromatic compounds","1.1.1.1; 1.1.1.2; 1.1.1.71; 1.1.2.7; 1.1.2.8; 1.1.5.5; 1.1.99.36; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.10; 1.2.1.-; 1.2.5.2; 1.2.99.6; 1.7.3.1; 1.13.12.16; 1.13.12.-; 1.14.15.-; 1.14.99.39; 2.1.1.-; 2.2.1.4; 2.2.1.8; 2.3.1.190; 3.7.1.12; 3.11.1.1; 4.1.1.1; 4.1.1.-; 4.1.2.4; 4.1.2.5; 4.1.2.33; 4.1.2.36; 4.1.2.42; 4.1.2.48; 4.1.2.49; 4.1.2.50; 4.1.3.39; 4.2.1.112; 4.2.1.155; 4.2.3.2; 4.3.1.7; 4.3.3.-; 4.3.99.4","Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA","Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00084  Acetaldehyde","CAS: 75-07-0; PubChem: 3384; ChEBI: 15343; ChEMBL: CHEMBL170365; KNApSAcK: C00007392; PDB-CCD: ACE; 3DMET: B01155; NIKKAJI: J2.388D","cpd:C00084; cpd:C00980; cpd:C01857; cpd:C02998; cpd:C06548; cpd:C11317; cpd:C11623; cpd:C11624; cpd:C11625; cpd:C18675; cpd:C19158; cpd:C20305",2,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H5O1","C2H3O1",44.02621475,45.03403978,43.01838972
"cpd:C00103","D-Glucose 1-phosphate;","C6H13O9P","D-Glucose 1-phosphate; alpha-D-Glucose 1-phosphate; Cori ester; D-Glucose alpha-1-phosphate","R00287 R00289 R00304 R00550 R00803 R00947 R00948 R00949; R00951 R00952 R00953 R00954 R00955 R00956 R00957 R00959; R00960 R01233 R01660 R01821 R02111 R02328 R02888 R03116; R04180 R05512 R06018 R06022 R06034 R06050 R06056 R06058; R06061 R06185 R07265 R08514 R08515 R08639 R09752 R10832; R10987 R11128 R11530","Glycolysis / Gluconeogenesis; Pentose and glucuronate interconversions; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Acarbose and validamycin biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Glucagon signaling pathway","2.4.1.1; 2.4.1.7; 2.4.1.20; 2.4.1.30; 2.4.1.31; 2.4.1.49; 2.4.1.97; 2.4.1.139; 2.4.1.231; 2.4.1.321; 2.4.1.329; 2.4.1.333; 2.4.1.342; 2.7.1.10; 2.7.1.41; 2.7.1.42; 2.7.1.62; 2.7.1.106; 2.7.7.9; 2.7.7.12; 2.7.7.24; 2.7.7.27; 2.7.7.33; 2.7.7.34; 2.7.7.36; 2.7.7.64; 2.7.7.78; 3.1.3.10; 3.1.4.51; 3.6.1.8; 3.6.1.9; 3.6.1.21; 3.6.1.45; 3.6.1.-; 5.4.2.2; 5.4.2.5","Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose; Trehalose biosynthesis, D-glucose 1P => trehalose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P; dTDP-L-rhamnose biosynthesis",NA,"CAS: 59-56-3; PubChem: 3403; ChEBI: 29042; KNApSAcK: C00007482; PDB-CCD: G1P; 3DMET: B04634; NIKKAJI: J40.065C","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C00111","Glycerone phosphate;","C3H7O6P","Glycerone phosphate; Dihydroxyacetone phosphate; 3-Hydroxy-2-oxopropyl phosphate","R00842 R00844 R00846 R00848 R00849 R01010 R01011 R01012; R01013 R01014 R01015 R01016 R01068 R01069 R01070 R01785; R01829 R02262 R02263 R02568 R04292 R05378 R05679 R05680; R08650 R08657 R10673 R10760 R11182","Glycolysis / Gluconeogenesis; Pentose and glucuronate interconversions; Fructose and mannose metabolism; Galactose metabolism; Glycerolipid metabolism; Inositol phosphate metabolism; Glycerophospholipid metabolism; Propanoate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Nicotinate and nicotinamide metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.1.1.8; 1.1.1.94; 1.1.1.261; 1.1.3.21; 1.1.5.3; 2.3.1.42; 2.3.1.245; 2.5.1.72; 2.7.1.29; 2.7.1.121; 3.1.3.1; 3.1.3.2; 4.1.2.2; 4.1.2.13; 4.1.2.17; 4.1.2.19; 4.1.2.29; 4.1.2.40; 4.1.2.56; 4.1.2.57; 4.2.3.3; 5.3.1.1","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Formaldehyde assimilation, xylulose monophosphate pathway; Formaldehyde assimilation, ribulose monophosphate pathway",NA,"CAS: 57-04-5; PubChem: 3411; ChEBI: 16108; ChEMBL: CHEMBL1161998; KNApSAcK: C00007560; PDB-CCD: 13P; 3DMET: B00029; NIKKAJI: J213.543D","cpd:C00111; cpd:C00118; cpd:C00661; cpd:C05217; cpd:C12935; cpd:C19156",3,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O6P1","C3H6O6P1",169.9980249,171.00585,168.9901999
"cpd:C00118","D-Glyceraldehyde 3-phosphate;","C3H7O6P","D-Glyceraldehyde 3-phosphate; (2R)-2-Hydroxy-3-(phosphonooxy)-propanal; Glyceraldehyde 3-phosphate","R00845 R01015 R01058 R01059 R01061 R01063 R01064 R01066; R01067 R01068 R01069 R01070 R01440 R01621 R01641 R01827; R01830 R02340 R02721 R02722 R05465 R05605 R05636 R06861; R07159 R07456 R08575 R10049 R10088 R10089 R10349 R10860; R10935","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Galactose metabolism; Clavulanic acid biosynthesis; Inositol phosphate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Thiamine metabolism; Vitamin B6 metabolism; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.1.1.177; 1.2.1.9; 1.2.1.12; 1.2.1.13; 1.2.1.59; 1.2.1.90; 1.2.7.6; 2.2.1.1; 2.2.1.2; 2.2.1.3; 2.2.1.7; 2.2.1.11; 2.5.1.66; 2.7.1.28; 4.1.2.4; 4.1.2.8; 4.1.2.9; 4.1.2.13; 4.1.2.14; 4.1.2.21; 4.1.2.40; 4.1.2.55; 4.2.1.20; 4.2.3.153; 4.3.3.6; 5.3.1.1","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; C5 isoprenoid biosynthesis, non-mevalonate pathway; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P; Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,"CAS: 591-57-1; PubChem: 3418; ChEBI: 29052; KNApSAcK: C00007564; PDB-CCD: G3H; 3DMET: B01163; NIKKAJI: J228.059K","cpd:C00111; cpd:C00118; cpd:C00661; cpd:C05217; cpd:C12935; cpd:C19156",3,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O6P1","C3H6O6P1",169.9980249,171.00585,168.9901999
"cpd:C00186","(S)-Lactate;","C3H6O3","(S)-Lactate; L-Lactate; L-Lactic acid","R00196 R00319 R00703 R00753 R01446 R01447 R01449 R01450; R05508 R10691 R11074","Glycolysis / Gluconeogenesis; Fructose and mannose metabolism; Pyruvate metabolism; Propanoate metabolism; Styrene degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; cAMP signaling pathway; HIF-1 signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer","1.1.1.27; 1.1.2.3; 1.1.99.7; 1.2.1.22; 1.13.12.4; 2.8.3.1; 3.7.1.-; 4.1.1.101; 4.1.2.36; 5.1.2.1",NA,"Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C00186  L-Lactate; (S)-2-Hydroxypropanoate; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Lactate;     G protein-coupled receptor 81;      C00186  (S)-Lactate","CAS: 79-33-4; PubChem: 3486; ChEBI: 16651 422; ChEMBL: CHEMBL330546; LipidBank: DFA0268; KNApSAcK: C00001191; PDB-CCD: 2OP; 3DMET: B01180; NIKKAJI: J9.134K","cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296",3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O3","C3H5O3",90.03169405,91.03951908,89.02386902
"cpd:C00197","3-Phospho-D-glycerate;","C3H7O7P","3-Phospho-D-glycerate; D-Glycerate 3-phosphate; 3-Phospho-(R)-glycerate; 3-Phosphoglycerate","R00024 R01058 R01511 R01512 R01513 R01514 R01515 R01516; R01517 R01518 R01660 R02188 R03140 R05768 R07159 R08887; R09100 R09663 R10860","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer","1.1.1.95; 1.2.1.9; 1.2.1.90; 1.2.7.6; 2.4.1.217; 2.4.1.266; 2.7.1.31; 2.7.1.106; 2.7.2.3; 2.7.2.10; 2.7.4.17; 3.1.3.38; 3.6.1.7; 4.1.1.39; 5.4.2.11; 5.4.2.12","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Serine biosynthesis, glycerate-3P => serine; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Photorespiration; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"PubChem: 3497; ChEBI: 17794; ChEMBL: CHEMBL1160563; KNApSAcK: C00019551; PDB-CCD: 3PG; 3DMET: B01185; NIKKAJI: J40.061K","cpd:C00197; cpd:C00597; cpd:C00631",3,7,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O7P1","C3H6O7P1",185.9929396,187.0007646,184.9851145
"cpd:C00221","beta-D-Glucose","C6H12O6","beta-D-Glucose","R00026 R01520 R01521 R01522 R01600 R01602 R02187 R03256; R04783 R06077 R06092 R06110 R06144 R09086 R09568 R10035; R10039 R10040 R10236","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.47; 1.1.3.4; 1.1.3.5; 2.3.1.213; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.1.6.3; 3.2.1.21; 3.2.1.23; 3.2.1.85; 4.3.3.5; 5.1.3.3",NA,NA,"CAS: 492-61-5; PubChem: 3521; ChEBI: 15903; ChEMBL: CHEMBL1222250 CHEMBL1614854; PDB-CCD: BGC; 3DMET: B01193; NIKKAJI: J44.213E","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00236","3-Phospho-D-glyceroyl phosphate;","C3H8O10P2","3-Phospho-D-glyceroyl phosphate; 1,3-Bisphospho-D-glycerate; (R)-2-Hydroxy-3-(phosphonooxy)-1-monoanhydride with phosphoric propanoic acid; D-Glycerate 1,3-diphosphate","R01061 R01063 R01512 R01515 R01517 R01660 R01662 R02188","Glycolysis / Gluconeogenesis; Carbon fixation in photosynthetic organisms; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.2.1.12; 1.2.1.13; 1.2.1.59; 2.7.1.106; 2.7.2.3; 2.7.2.10; 2.7.4.17; 3.6.1.7; 5.4.2.4","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P",NA,"CAS: 38168-82-0; PubChem: 3535; ChEBI: 16001; KNApSAcK: C00019552; PDB-CCD: X15; 3DMET: B01197; NIKKAJI: J40.060B","cpd:C00236; cpd:C01159; cpd:C03339",3,8,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H9O10P2","C3H7O10P2",265.9592705,266.9670955,264.9514454
"cpd:C00267","alpha-D-Glucose","C6H12O6","alpha-D-Glucose","R00802 R00878 R00947 R01602 R01678 R01718 R01786 R01787; R01788 R02109 R02189 R03115 R06078 R06080 R06084 R06088; R06098 R06158 R06199 R07265 R09085","Glycolysis / Gluconeogenesis; Fructose and mannose metabolism; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Proximal tubule bicarbonate reclamation","1.1.1.21; 2.4.1.231; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.1.3.9; 3.1.3.10; 3.1.6.3; 3.2.1.3; 3.2.1.10; 3.2.1.20; 3.2.1.23; 3.2.1.26; 3.2.1.33; 3.2.1.48; 3.2.1.58; 3.2.1.108; 5.1.3.3; 5.3.1.5","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Nucleotide sugar biosynthesis, glucose => UDP-glucose",NA,"CAS: 492-62-6; PubChem: 3565; ChEBI: 17925; ChEMBL: CHEMBL1222250 CHEMBL423707 CHEMBL98182; KNApSAcK: C00001122; PDB-CCD: GLC; 3DMET: B01203; NIKKAJI: J44.217H","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00469","Ethanol;","C2H6O","Ethanol; Ethyl alcohol; Methylcarbinol","R00746 R00754 R02359 R02682 R04410 R05198 R09127 R09479; R09552","Glycolysis / Gluconeogenesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Inflammatory mediator regulation of TRP channels; Alcoholism","1.1.1.1; 1.1.1.2; 1.1.1.71; 1.1.2.7; 1.1.2.8; 1.1.5.5; 1.1.99.36; 2.3.1.152; 2.8.1.2; 3.1.1.67; 3.5.1.75",NA,"Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C00469  Ethanol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D08 ANTISEPTICS AND DISINFECTANTS;    D08A ANTISEPTICS AND DISINFECTANTS;     D08AX Other antiseptics and disinfectants;      D08AX08 Ethanol;       D00068  Alcohol (USP);  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB16 Ethanol;       D00068  Alcohol (USP);     V03AZ Nerve depressants;      V03AZ01 Ethanol;       D00068  Alcohol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    261  Antimicrobial agents;     2615  Alcohols;      D00068  Alcohol (USP); Anhydrous ethanol (JP17);  4  Agents affecting cellular function;   42  Antineoplastics;    429  Miscellaneous;     4291  Other Antitumors;      D00068  Alcohol (USP); Anhydrous ethanol (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   54 Disinfectants (incl. special bandages);    D00068  Alcohol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ethanol;     D00068  Alcohol (USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ethanol;     D00068  Alcohol (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00068  [001075] Ethanol;  Solubilizing agent;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Base;   D00068  [001075] Ethanol;  Flavoring substance;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Suspending agent;   D00068  [001075] Ethanol;  Antifoaming agent;   D00068  [001075] Ethanol;  Favoring agent, Fragrance;   D00068  [001075] Ethanol;  Emulsion;   D00068  [001075] Ethanol;  Tenacious agent;   D00068  [001076] Anhydrous ethanol;  Dispersant;   D00068  [001075] Ethanol;  Antiseptic agent;   D00068  [001075] Ethanol;  Preserving agent;   D00068  [001075] Ethanol;  Solubilizer;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Solubilization agent;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Solvent;   D00068  [001075] Ethanol;   D00068  [110749] 55vol% Ethanol;   D00068  [109570] 70vol% Ethanol;   D00068  [110566] Ethanol 50;   D00068  [001076] Anhydrous ethanol;  Fluidizer;   D00068  [001076] Anhydrous ethanol; Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2D6;    Ethanol;     D00068  Alcohol (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00068  Anhydrous ethanol","CAS: 64-17-5; PubChem: 3752; ChEBI: 16236; ChEMBL: CHEMBL545; KNApSAcK: C00019560; PDB-CCD: EOH; 3DMET: B01253; NIKKAJI: J1.930E","cpd:C00469; cpd:C00928; cpd:C02297; cpd:C07447; cpd:C11143; cpd:C11144; cpd:C14704; cpd:C16363",2,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H7O1","C2H5O1",46.04186481,47.04968985,45.03403978
"cpd:C00631","2-Phospho-D-glycerate;","C3H7O7P","2-Phospho-D-glycerate; D-Glycerate 2-phosphate; 2-Phospho-(R)-glycerate","R00658 R01518 R01748 R02664 R08572 R09532","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer","2.7.1.165; 2.7.2.-; 3.1.3.20; 3.1.3.80; 4.2.1.11; 5.4.2.11; 5.4.2.12","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Formaldehyde assimilation, serine pathway",NA,"PubChem: 3904; ChEBI: 17835; KNApSAcK: C00000123; PDB-CCD: 2PG; 3DMET: B01295; NIKKAJI: J71.811D","cpd:C00197; cpd:C00597; cpd:C00631",3,7,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O7P1","C3H6O7P1",185.9929396,187.0007646,184.9851145
"cpd:C00668","alpha-D-Glucose 6-phosphate","C6H13O9P","alpha-D-Glucose 6-phosphate","R00959 R01786 R01788 R02189 R02737 R02738 R02739 R02740; R06102 R06226 R09085","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway","2.4.1.15; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 2.7.1.199; 3.1.3.9; 3.2.1.26; 5.1.3.15; 5.3.1.9; 5.4.2.2; 5.4.2.5","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Pentose phosphate pathway (Pentose phosphate cycle); Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose",NA,"PubChem: 3937; ChEBI: 17665; PDB-CCD: G6P; 3DMET: B01304; NIKKAJI: J40.066A","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C01159","2,3-Bisphospho-D-glycerate;","C3H8O10P2","2,3-Bisphospho-D-glycerate; 2,3-Disphospho-D-glycerate; D-Greenwald ester; DPG","R01516 R01662 R02664 R03298 R09532","Glycolysis / Gluconeogenesis; Metabolic pathways","2.7.2.-; 3.1.3.80; 4.6.1.-; 5.4.2.4; 5.4.2.11",NA,NA,"PubChem: 4387; ChEBI: 17720; PDB-CCD: DG2; 3DMET: B01397; NIKKAJI: J2.731.659J","cpd:C00236; cpd:C01159; cpd:C03339",3,8,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H9O10P2","C3H7O10P2",265.9592705,266.9670955,264.9514454
"cpd:C01172","beta-D-Glucose 6-phosphate","C6H13O9P","beta-D-Glucose 6-phosphate","R01600 R02187 R02728 R02736 R02739 R03321 R05133 R05134; R09086 R10907","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway","1.1.1.49; 1.1.1.363; 1.1.1.388; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.2.1.86; 5.1.3.15; 5.3.1.9; 5.4.2.6","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,"PubChem: 4399; ChEBI: 17719; ChEMBL: CHEMBL257975; PDB-CCD: BG6; 3DMET: B01400; NIKKAJI: J396.144C","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C01451","Salicin;","C13H18O7","Salicin; Salicoside","R03558 R04394","Glycolysis / Gluconeogenesis; Biosynthesis of phenylpropanoids; Phosphotransferase system (PTS); Taste transduction","2.4.1.172; 2.7.1.-",NA,"Major components of natural products [BR:br08323];  Medicinal herbs;   Willow;    C01451  Salicin","CAS: 138-52-3; PubChem: 4628; ChEBI: 17814; ChEMBL: CHEMBL462997; KNApSAcK: C00002672; PDB-CCD: SA0; 3DMET: B01452; NIKKAJI: J5.634K","cpd:C01451; cpd:C16964; cpd:C17599",13,18,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C13H19O7","C13H17O7",286.1052529,287.1130779,285.0974279
"cpd:C05125","2-(alpha-Hydroxyethyl)thiamine diphosphate;","C14H23N4O8P2S","2-(alpha-Hydroxyethyl)thiamine diphosphate; 2-Hydroxyethyl-ThPP","R00014 R00755 R03050 R03270 R04672 R04673","Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Pyruvate metabolism; Metabolic pathways","1.2.4.1; 2.2.1.6; 4.1.1.1",NA,NA,"PubChem: 7546; ChEBI: 978; 3DMET: B04982; NIKKAJI: J683.157E","cpd:C05125",14,23,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C14H24O8N4P2S1","C14H22O8N4P2S1",469.0711839,470.0790089,468.0633589
"cpd:C05345","beta-D-Fructose 6-phosphate","C6H13O9P","beta-D-Fructose 6-phosphate","R00867 R01819 R01827 R01830 R02073 R02703 R02731 R02732; R02740 R03321 R03920 R04779 R04780 R05607 R09031 R09084; R09780 R10987","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.1.1.17; 1.1.1.140; 2.2.1.1; 2.2.1.2; 2.4.1.329; 2.7.1.1; 2.7.1.4; 2.7.1.11; 2.7.1.90; 2.7.1.105; 2.7.1.146; 3.1.3.11; 3.1.3.46; 5.1.3.-; 5.3.1.8; 5.3.1.9; 5.3.1.27","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Gluconeogenesis, oxaloacetate => fructose-6P; Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,"PubChem: 7723; ChEBI: 16084; ChEMBL: CHEMBL604196; KNApSAcK: C00019548; PDB-CCD: F6P; 3DMET: B01846; NIKKAJI: J879.002G","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C05378","beta-D-Fructose 1,6-bisphosphate","C6H14O12P2","beta-D-Fructose 1,6-bisphosphate","R01070 R02071 R02073 R04779 R04780 R09084","Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","2.7.1.11; 2.7.1.56; 2.7.1.90; 2.7.1.146; 3.1.3.11; 4.1.2.13","Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Gluconeogenesis, oxaloacetate => fructose-6P",NA,"PubChem: 7752; ChEBI: 28013; ChEMBL: CHEMBL97893; PDB-CCD: FBP; 3DMET: B01851; NIKKAJI: J322.162H","cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378",6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O12P2","C6H13O12P2",339.9960499,341.0038749,338.9882249
"cpd:C06186","Arbutin;","C12H16O7","Arbutin; Ursin; Uvasol; Hydroquinone-O-beta-D-glucopyranoside","R05132 R05769","Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS)","2.4.1.218; 2.7.1.-",NA,"Target-based classification of compounds [BR:br08010];  Enzymes;   Oxidoreductases;    tyrosinase;     C06186  Arbutin; Major components of natural products [BR:br08323];  Crude drugs;   Bearberry leaf;    C06186  Arbutin;   Uva ursi fluidextract;    C06186  Arbutin;  Medicinal herbs;   Bearberry;    C06186  Arbutin","CAS: 497-76-7; PubChem: 8437; ChEBI: 18305; ChEMBL: CHEMBL232202; KNApSAcK: C00002638; 3DMET: B01987; NIKKAJI: J6.104B","cpd:C03003; cpd:C05995; cpd:C06186; cpd:C12079",12,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H17O7","C12H15O7",272.0896029,273.0974279,271.0817778
"cpd:C06187","Arbutin 6-phosphate;","C12H17O10P","Arbutin 6-phosphate; Arbutin-6P","R05132 R05133","Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS)","2.7.1.-; 3.2.1.86",NA,NA,"PubChem: 8438; ChEBI: 2807; 3DMET: B01988; NIKKAJI: J2.761.841C","cpd:C06187",12,17,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H18O10P1","C12H16O10P1",352.0559337,353.0637588,351.0481087
"cpd:C06188","Salicin 6-phosphate;","C13H19O10P","Salicin 6-phosphate; Salicin-6P","R04394 R05134","Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS)","2.7.1.-; 3.2.1.86",NA,NA,"PubChem: 8439; ChEBI: 9003; PDB-CCD: P53; 3DMET: B01989; NIKKAJI: J2.761.856A","cpd:C06188; cpd:C06436",13,19,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C13H20O10P1","C13H18O10P1",366.0715838,367.0794088,365.0637588
"cpd:C00026","2-Oxoglutarate;","C5H6O5","2-Oxoglutarate; Oxoglutaric acid; 2-Ketoglutaric acid; alpha-Ketoglutaric acid","R00021 R00093 R00114 R00243 R00248 R00250 R00258 R00264; R00265 R00267 R00268 R00269 R00270 R00271 R00272 R00279; R00298 R00355 R00372 R00457 R00474 R00563 R00621 R00667; R00668 R00684 R00694 R00709 R00715 R00716 R00734 R00895; R00896 R00908 R01090 R01148 R01155 R01161 R01197 R01214; R01252 R01339 R01412 R01580 R01582 R01587 R01648 R01684; R01700 R01879 R01939 R01956 R02077 R02160 R02199 R02274; R02283 R02397 R02433 R02444 R02445 R02486 R02619 R02700; R02772 R02773 R03008 R03009 R03053 R03063 R03120 R03126; R03207 R03218 R03219 R03225 R03243 R03248 R03266 R03376; R03451 R03534 R03590 R03640 R03698 R03737 R03806 R03807; R03809 R03812 R03859 R03952 R04028 R04029 R04051 R04073; R04171 R04173 R04188 R04217 R04234 R04269 R04276 R04338; R04438 R04467 R04475 R04529 R05036 R05037 R05039 R05052; R05085 R05097 R05126 R05127 R05228 R05229 R05301 R05302; R05320 R05419 R05466 R05468 R05469 R05493 R05507 R05722; R05723 R05839 R05857 R06322 R06323 R06335 R06336 R06337; R06338 R06423 R06426 R06539 R06540 R06551 R06586 R06631; R06634 R06977 R07184 R07185 R07186 R07187 R07275 R07276; R07277 R07329 R07366 R07367 R07368 R07396 R07613 R07659; R07993 R07996 R07997 R08050 R08081 R08082 R08165 R08198; R08201 R08213 R08254 R08549 R08610 R08611 R08897 R08903; R08931 R08972 R09363 R09402 R09510 R09511 R09572 R09778; R09784 R09785 R09824 R09825 R10056 R10064 R10081 R10086; R10094 R10141 R10143 R10144 R10145 R10157 R10210 R10312; R10413 R10415 R10445 R10446 R10460 R10487 R10522 R10527; R10539 R10542 R10575 R10698 R10723 R10724 R10735 R10740; R10741 R10742 R10845 R10920 R10932 R10991 R11030 R11053; R11118 R11210 R11269 R11270 R11285 R11291 R11297 R11298; R11299 R11337 R11340 R11345 R11395 R11409 R11475 R11549","Citrate cycle (TCA cycle); Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Lysine biosynthesis; Histidine metabolism; Furfural degradation; Taurine and hypotaurine metabolism; D-Glutamine and D-glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; HIF-1 signaling pathway; GABAergic synapse; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Bile secretion; Central carbon metabolism in cancer","1.1.1.41; 1.1.1.42; 1.1.1.95; 1.1.1.286; 1.1.1.399; 1.1.99.2; 1.1.99.24; 1.1.99.39; 1.2.1.3; 1.2.1.26; 1.2.1.52; 1.2.4.2; 1.2.7.3; 1.2.7.11; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.13; 1.4.1.14; 1.4.3.7; 1.4.3.11; 1.4.3.15; 1.4.7.1; 1.5.1.7; 1.5.1.8; 1.5.1.19; 1.8.1.4; 1.13.12.19; 1.14.11.1; 1.14.11.2; 1.14.11.3; 1.14.11.4; 1.14.11.6; 1.14.11.7; 1.14.11.8; 1.14.11.9; 1.14.11.10; 1.14.11.11; 1.14.11.12; 1.14.11.13; 1.14.11.14; 1.14.11.15; 1.14.11.16; 1.14.11.17; 1.14.11.18; 1.14.11.19; 1.14.11.20; 1.14.11.21; 1.14.11.22; 1.14.11.23; 1.14.11.24; 1.14.11.25; 1.14.11.26; 1.14.11.27; 1.14.11.28; 1.14.11.31; 1.14.11.32; 1.14.11.34; 1.14.11.35; 1.14.11.36; 1.14.11.37; 1.14.11.38; 1.14.11.39; 1.14.11.40; 1.14.11.41; 1.14.11.42; 1.14.11.43; 1.14.11.44; 1.14.11.45; 1.14.11.46; 1.14.11.48; 1.14.11.49; 1.14.11.50; 1.14.11.51; 1.14.11.52; 1.14.11.-; 1.14.20.1; 1.14.20.2; 1.14.20.3; 1.14.20.-; 2.2.1.5; 2.2.1.9; 2.3.1.61; 2.3.3.4; 2.3.3.14; 2.6.1.1; 2.6.1.2; 2.6.1.3; 2.6.1.4; 2.6.1.5; 2.6.1.6; 2.6.1.7; 2.6.1.8; 2.6.1.9; 2.6.1.11; 2.6.1.13; 2.6.1.17; 2.6.1.19; 2.6.1.21; 2.6.1.22; 2.6.1.23; 2.6.1.24; 2.6.1.26; 2.6.1.27; 2.6.1.29; 2.6.1.33; 2.6.1.34; 2.6.1.36; 2.6.1.38; 2.6.1.39; 2.6.1.40; 2.6.1.42; 2.6.1.44; 2.6.1.48; 2.6.1.49; 2.6.1.52; 2.6.1.54; 2.6.1.55; 2.6.1.57; 2.6.1.59; 2.6.1.65; 2.6.1.67; 2.6.1.72; 2.6.1.74; 2.6.1.75; 2.6.1.76; 2.6.1.79; 2.6.1.80; 2.6.1.81; 2.6.1.82; 2.6.1.83; 2.6.1.87; 2.6.1.89; 2.6.1.90; 2.6.1.92; 2.6.1.93; 2.6.1.94; 2.6.1.95; 2.6.1.98; 2.6.1.102; 2.6.1.103; 2.6.1.104; 2.6.1.106; 2.6.1.107; 2.6.1.109; 2.6.1.110; 2.6.1.-; 3.5.1.3; 3.5.1.36; 3.5.1.111; 4.1.1.71; 4.2.1.168; 6.4.1.7","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Reductive citrate cycle (Arnon-Buchanan cycle); Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; Photorespiration; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00026  2-Oxoglutarate","CAS: 328-50-7; PubChem: 3328; ChEBI: 16810 30915; ChEMBL: CHEMBL1686; KNApSAcK: C00000769; PDB-CCD: AKG; 3DMET: B00008; NIKKAJI: J11.847H","cpd:C00026; cpd:C00165; cpd:C00641; cpd:C02715; cpd:C03716; cpd:C03957; cpd:C05406; cpd:C06030; cpd:C06316; cpd:C06380; cpd:C06437; cpd:C12248",5,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O5","C5H5O5",146.0215233,147.0293483,145.0136983
"cpd:C00042","Succinate;","C4H6O4","Succinate; Succinic acid; Butanedionic acid; Ethylenesuccinic acid","R00402 R00405 R00406 R00407 R00408 R00409 R00410 R00411; R00412 R00432 R00479 R00499 R00713 R00714 R00727 R00999; R01252 R01288 R01412 R01559 R01780 R01867 R01879 R02084; R02160 R02164 R02397 R02407 R02444 R02445 R02486 R02508; R02603 R02734 R02990 R03008 R03009 R03126 R03154 R03218; R03219 R03260 R03376 R03451 R03590 R03640 R03698 R03737; R03806 R03807 R03809 R03812 R04073 R04276 R04946 R05036; R05037 R05039 R05097 R05126 R05127 R05228 R05229 R05301; R05302 R05320 R05419 R05466 R05468 R05469 R05493 R05588; R05722 R05723 R05857 R06322 R06323 R06335 R06336 R06337; R06338 R06539 R06540 R06551 R06855 R06904 R07184 R07185; R07186 R07187 R07329 R07366 R07367 R07368 R07993 R07996; R07997 R08050 R08081 R08082 R08610 R08611 R08972 R09363; R09402 R09510 R09511 R09572 R09785 R10056 R10081 R10143; R10144 R10145 R10157 R10312 R10343 R10413 R10415 R10445; R10446 R10487 R10522 R10527 R10539 R10542 R10640 R10641; R10660 R10723 R10724 R10735 R10740 R10741 R10742 R10904; R10920 R11030 R11053 R11210 R11340 R11345 R11549","Citrate cycle (TCA cycle); Oxidative phosphorylation; Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Phenylalanine metabolism; Chlorocyclohexane and chlorobenzene degradation; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Nicotinate and nicotinamide metabolism; Sulfur metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Two-component system; cAMP signaling pathway; GABAergic synapse; Glucagon signaling pathway; Central carbon metabolism in cancer","1.2.1.16; 1.2.1.24; 1.2.1.79; 1.3.1.6; 1.3.4.1; 1.3.5.1; 1.3.5.4; 1.3.98.1; 1.3.99.-; 1.14.11.1; 1.14.11.2; 1.14.11.3; 1.14.11.4; 1.14.11.6; 1.14.11.7; 1.14.11.8; 1.14.11.9; 1.14.11.10; 1.14.11.11; 1.14.11.12; 1.14.11.13; 1.14.11.14; 1.14.11.15; 1.14.11.16; 1.14.11.17; 1.14.11.18; 1.14.11.19; 1.14.11.20; 1.14.11.21; 1.14.11.22; 1.14.11.23; 1.14.11.24; 1.14.11.25; 1.14.11.26; 1.14.11.27; 1.14.11.28; 1.14.11.31; 1.14.11.32; 1.14.11.34; 1.14.11.35; 1.14.11.36; 1.14.11.37; 1.14.11.38; 1.14.11.39; 1.14.11.40; 1.14.11.41; 1.14.11.42; 1.14.11.43; 1.14.11.44; 1.14.11.45; 1.14.11.46; 1.14.11.48; 1.14.11.49; 1.14.11.50; 1.14.11.51; 1.14.11.52; 1.14.11.-; 1.14.20.1; 1.14.20.2; 1.14.20.3; 1.14.20.-; 2.5.1.48; 2.5.1.-; 2.8.3.2; 2.8.3.5; 2.8.3.6; 2.8.3.13; 2.8.3.15; 2.8.3.18; 2.8.3.20; 2.8.3.22; 2.8.3.-; 3.1.2.3; 3.1.2.13; 3.5.1.18; 3.5.1.96; 3.7.1.14; 4.1.3.1; 4.1.3.30; 6.2.1.4; 6.2.1.5","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; GABA (gamma-Aminobutyrate) shunt; Succinate dehydrogenase (ubiquinone); Succinate dehydrogenase, prokaryotes; Fumarate reductase, prokaryotes; Reductive citrate cycle (Arnon-Buchanan cycle); Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00042  Succinate; Pharmaceutical additives [BR:br08316];  Flavoring substance;   C00042  [106962] Succinate;  pH regulator;   C00042  [106962] Succinate","CAS: 110-15-6; PubChem: 3344; ChEBI: 15741; ChEMBL: CHEMBL576; LIPIDMAPS: LMFA01170043; KNApSAcK: C00001205; PDB-CCD: SIN; 3DMET: B00012; NIKKAJI: J2.879G","cpd:C00042; cpd:C02170; cpd:C03201; cpd:C07598; cpd:C10900; cpd:C11117; cpd:C14872; cpd:C15607; cpd:C19414; cpd:C20231",4,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O4","C4H5O4",118.0266087,119.0344337,117.0187836
"cpd:C00091","Succinyl-CoA;","C25H40N7O19P3S","Succinyl-CoA; Succinyl coenzyme A","R00265 R00405 R00406 R00407 R00410 R00432 R00727 R00829; R00830 R00832 R00833 R01197 R01559 R01777 R01780 R02084; R02407 R02570 R02990 R03154 R04365 R05587 R05588 R06904; R06908 R08549 R09280 R10343 R10640 R10641 R10904","Citrate cycle (TCA cycle); Valine, leucine and isoleucine degradation; Phenylalanine metabolism; Benzoate degradation; Toluene degradation; Naphthalene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds","1.2.1.52; 1.2.1.76; 1.2.4.2; 1.2.7.3; 1.2.7.11; 1.8.1.4; 2.3.1.16; 2.3.1.37; 2.3.1.46; 2.3.1.61; 2.3.1.109; 2.3.1.117; 2.3.1.174; 2.3.1.-; 2.8.3.2; 2.8.3.5; 2.8.3.6; 2.8.3.13; 2.8.3.15; 2.8.3.18; 2.8.3.20; 2.8.3.22; 2.8.3.-; 3.1.2.3; 5.4.99.2; 6.2.1.4; 6.2.1.5","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Reductive citrate cycle (Arnon-Buchanan cycle); Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",NA,"CAS: 604-98-8; PubChem: 3391; ChEBI: 15380; KNApSAcK: C00019546; PDB-CCD: SCA; 3DMET: B04629; NIKKAJI: J252.493G","cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557",25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O19N7P3S1","C25H39O19N7P3S1",867.1312543,868.1390793,866.1234292
"cpd:C00122","Fumarate;","C4H4O4","Fumarate; Fumaric acid; trans-Butenedioic acid","R00402 R00408 R00412 R00490 R01082 R01083 R01085 R01086; R01087 R01336 R01364 R01867 R02164 R04559 R05598 R06789; R06903 R10660 R10940","Citrate cycle (TCA cycle); Oxidative phosphorylation; Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Phenylalanine metabolism; Pyruvate metabolism; Styrene degradation; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Nicotinate and nicotinamide metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Two-component system; Glucagon signaling pathway; Pathways in cancer; Renal cell carcinoma; Central carbon metabolism in cancer","1.3.1.6; 1.3.4.1; 1.3.5.1; 1.3.5.4; 1.3.98.1; 1.3.99.-; 3.7.1.2; 3.7.1.5; 3.7.1.14; 3.7.1.20; 4.1.99.11; 4.1.99.-; 4.2.1.2; 4.2.99.12; 4.3.1.1; 4.3.2.1; 4.3.2.2; 5.2.1.1; 6.3.2.46","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Urea cycle; Tyrosine degradation, tyrosine => homogentisate; Succinate dehydrogenase (ubiquinone); Succinate dehydrogenase, prokaryotes; Fumarate reductase, prokaryotes; Reductive citrate cycle (Arnon-Buchanan cycle); Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Nicotinate degradation, nicotinate => fumarate","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D05 ANTIPSORIATICS;    D05A ANTIPSORIATICS FOR TOPICAL USE;     D05AX Other antipsoriatics for topical use;      D05AX01 Fumaric acid;       D02308  Fumaric acid (NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02308  [102419] Fumaric acid;  Lubricating agent;   D02308  [102419] Fumaric acid;  Flavoring substance;   D02308  [102419] Fumaric acid;  Bonding agent;   D02308  [102419] Fumaric acid","CAS: 110-17-8; PubChem: 3422; ChEBI: 18012 29806; ChEMBL: CHEMBL503160; KNApSAcK: C00001183 C00033849; PDB-CCD: FUM; 3DMET: B00033; NIKKAJI: J2.880K","cpd:C00122; cpd:C01384; cpd:C02150; cpd:C07780; cpd:C07783; cpd:C12574; cpd:C12896; cpd:C13424; cpd:C13540; cpd:C14029; cpd:C18572",4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H5O4","C4H3O4",116.0109586,117.0187836,115.0031336
"cpd:C00149","(S)-Malate;","C4H6O5","(S)-Malate; L-Malate; L-Apple acid; L-Malic acid; L-2-Hydroxybutanedioic acid; Malate; Malic acid","R00214 R00216 R00342 R00343 R00360 R00361 R00406 R00472; R01082 R01256 R01257 R01447 R03323 R10612 R11074","Citrate cycle (TCA cycle); Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Two-component system; Taste transduction; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Pathways in cancer; Renal cell carcinoma; Central carbon metabolism in cancer","1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.40; 1.1.1.82; 1.1.1.299; 1.1.5.4; 1.1.99.7; 2.3.1.92; 2.3.3.9; 2.8.3.22; 3.1.2.30; 4.1.1.101; 4.2.1.2; 6.2.1.9","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Glyoxylate cycle; CAM (Crassulacean acid metabolism), dark; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C00149  Malate; (S)-2-Hydroxybutanediate","CAS: 97-67-6; PubChem: 3449; ChEBI: 15589 30797; ChEMBL: CHEMBL1234046; KNApSAcK: C00001192; PDB-CCD: LMR; 3DMET: B00042; NIKKAJI: J74.430A","cpd:C00149; cpd:C00497; cpd:C00711; cpd:C03064; cpd:C14873",4,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O5","C4H5O5",134.0215233,135.0293483,133.0136983
"cpd:C00158","Citrate;","C6H8O7","Citrate; Citric acid; 2-Hydroxy-1,2,3-propanetricarboxylic acid; 2-Hydroxytricarballylic acid","R00351 R00352 R00362 R01322 R01323 R01324 R01325 R10090; R10677","Citrate cycle (TCA cycle); Alanine, aspartate and glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Two-component system; Taste transduction; Glucagon signaling pathway; Central carbon metabolism in cancer","2.3.3.1; 2.3.3.3; 2.3.3.8; 2.3.3.16; 2.8.3.10; 4.1.3.6; 4.2.1.3; 6.2.1.18; 6.3.1.17; 6.3.2.38","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00158  Citrate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A09 DIGESTIVES, INCL. ENZYMES;    A09A DIGESTIVES, INCL. ENZYMES;     A09AB Acid preparations;      A09AB04 Citric acid;       D00037  Citric acid, anhydrous (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Anhydrous citric acid;     D00037  Citric acid, anhydrous (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00037  [001216] Anhydrous citric acid;  Solubilizing agent;   D00037  [001216] Anhydrous citric acid;  Buffering agent;   D00037  [001216] Anhydrous citric acid;  Flavoring substance;   D00037  [001216] Anhydrous citric acid;  Coating agent;   D00037  [001216] Anhydrous citric acid;  Bloating agent;   D00037  [001216] Anhydrous citric acid;  pH regulator;   D00037  [001216] Anhydrous citric acid;  Diluting agent;   D00037  [001216] Anhydrous citric acid;  Disintegrant;   D00037  [001216] Anhydrous citric acid;  Disintegrating adjuvant;   D00037  [001216] Anhydrous citric acid;  Solubilization agent;   D00037  [001216] Anhydrous citric acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00037  Anhydrous citric acid","CAS: 77-92-9; PubChem: 3458; ChEBI: 16947 30769; ChEMBL: CHEMBL1261; KNApSAcK: C00007619; PDB-CCD: CIT FLC; 3DMET: B00046; NIKKAJI: J2.824J","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C00311","Isocitrate;","C6H8O7","Isocitrate; Isocitric acid; 1-Hydroxytricarballylic acid; 1-Hydroxypropane-1,2,3-tricarboxylic acid","R00267 R00479 R00709 R01324 R01899 R01900 R01946","Citrate cycle (TCA cycle); Glyoxylate and dicarboxylate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer","1.1.1.41; 1.1.1.42; 1.1.1.286; 2.3.1.126; 4.1.3.1; 4.2.1.3","Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00311  Isocitrate","CAS: 320-77-4; PubChem: 3605; ChEBI: 16087 30887; ChEMBL: CHEMBL539669; 3DMET: B04664; NIKKAJI: J95.796H","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C00417","cis-Aconitate;","C6H6O6","cis-Aconitate; cis-Aconitic acid","R01325 R01900 R02243 R02244","Citrate cycle (TCA cycle); Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism","4.1.1.6; 4.2.1.3; 5.3.3.7","Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00417  cis-Aconitate","CAS: 585-84-2; PubChem: 3707; ChEBI: 16383 32805; ChEMBL: CHEMBL347285; KNApSAcK: C00001177; 3DMET: B00107; NIKKAJI: J37.488A","cpd:C00417; cpd:C02341; cpd:C03360; cpd:C05422",6,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O6","C6H5O6",174.0164379,175.0242629,173.0086129
"cpd:C05379","Oxalosuccinate;","C6H6O7","Oxalosuccinate; Oxalosuccinic acid","R00268 R01899 R08201","Citrate cycle (TCA cycle); Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism","1.1.1.42; 6.4.1.7","Methylaspartate cycle",NA,"CAS: 1948-82-9; PubChem: 7753; ChEBI: 7815; 3DMET: B05012; NIKKAJI: J13.032J","cpd:C05379; cpd:C06675; cpd:C06676",6,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O7","C6H5O7",190.0113525,191.0191776,189.0035275
"cpd:C05381","3-Carboxy-1-hydroxypropyl-ThPP;","C16H25N4O10P2S","3-Carboxy-1-hydroxypropyl-ThPP; Succinate semialdehyde-thiamin diphosphate","R00621 R03316","Citrate cycle (TCA cycle)","1.2.4.2",NA,NA,"PubChem: 7755; ChEBI: 1463; NIKKAJI: J2.755.812G","cpd:C05381",16,25,10,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O10N4P2S1","C16H24O10N4P2S1",527.0766632,528.0844882,526.0688382
"cpd:C00117","D-Ribose 5-phosphate;","C5H11O8P","D-Ribose 5-phosphate; Ribose 5-phosphate","R00182 R00510 R01049 R01050 R01051 R01052 R01053 R01054; R01055 R01056 R01057 R01128 R01270 R01641 R02171 R02345; R06590 R06863 R10088 R10089 R10973 R11553","Pentose phosphate pathway; Purine metabolism; Phosphonate and phosphinate metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Thyroid hormone synthesis","2.2.1.1; 2.2.1.4; 2.7.1.15; 2.7.1.18; 2.7.6.1; 2.7.7.35; 2.7.7.96; 3.1.4.57; 3.2.2.4; 3.2.2.10; 3.2.2.12; 3.2.2.14; 3.6.1.13; 3.6.1.21; 3.6.1.53; 3.6.1.-; 4.2.1.70; 4.3.3.6; 5.3.1.6; 5.4.2.2; 5.4.2.7; 6.3.4.7","Pentose phosphate pathway (Pentose phosphate cycle); PRPP biosynthesis, ribose 5P => PRPP; Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,"CAS: 4300-28-1; PubChem: 3417; ChEBI: 17797 52742; ChEMBL: CHEMBL573025 CHEMBL605020; KNApSAcK: C00007473; PDB-CCD: HSX RP5; 3DMET: B04635; NIKKAJI: J205.693C","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C00119","5-Phospho-alpha-D-ribose 1-diphosphate;","C5H13O14P3","5-Phospho-alpha-D-ribose 1-diphosphate; 5-Phosphoribosyl diphosphate; 5-Phosphoribosyl 1-pyrophosphate; PRPP","R00190 R00966 R01049 R01071 R01072 R01073 R01132 R01229; R01271 R01724 R01870 R02142 R03348 R04068 R04346 R04378; R06836 R08231 R08237 R08238 R08245 R08898 R10095 R10337; R11102 R11280","Pentose phosphate pathway; Purine metabolism; Pyrimidine metabolism; Histidine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Antifolate resistance","2.4.2.7; 2.4.2.8; 2.4.2.9; 2.4.2.10; 2.4.2.12; 2.4.2.14; 2.4.2.17; 2.4.2.18; 2.4.2.19; 2.4.2.20; 2.4.2.22; 2.4.2.45; 2.4.2.49; 2.4.2.54; 2.4.2.-; 2.7.4.23; 2.7.6.1; 6.3.4.8; 6.3.4.21","PRPP biosynthesis, ribose 5P => PRPP; Histidine biosynthesis, PRPP => histidine; Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,"PubChem: 3419; ChEBI: 17111; ChEMBL: CHEMBL606077; KNApSAcK: C00007296; PDB-CCD: PRP; 3DMET: B01164; NIKKAJI: J40.073D","cpd:C00119; cpd:C02884",5,13,14,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H14O14P3","C5H12O14P3",389.9518161,390.9596411,388.9439911
"cpd:C00121","D-Ribose","C5H10O5","D-Ribose","R01051 R01079 R01080 R01081 R01245 R01273 R01677 R01770; R02137 R02143 R02172 R02341 R03885 R07918 R08072 R08073; R08074 R08080 R10046","Pentose phosphate pathway; ABC transporters; Bacterial chemotaxis","1.1.1.115; 2.7.1.15; 3.2.2.1; 3.2.2.2; 3.2.2.3; 3.2.2.7; 3.2.2.8; 3.2.2.13; 3.2.2.25; 5.3.1.20",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00121  D-Ribose","CAS: 50-69-1; PubChem: 3421; ChEBI: 47013; ChEMBL: CHEMBL444125 CHEMBL606078; KNApSAcK: C00034198; PDB-CCD: BDR RIB; 3DMET: B04636; NIKKAJI: J60.867J","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00198","D-Glucono-1,5-lactone;","C6H10O6","D-Glucono-1,5-lactone; Gluconic lactone; Gluconic acid lactone; 1,5-Gluconolactone; delta-Gluconolactone; D-Gluconolactone; Gluconolactone","R00300 R00305 R00874 R01519 R01520 R01521 R01522 R03861; R06620 R07147 R10411","Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.47; 1.1.1.118; 1.1.1.119; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.4; 1.1.3.5; 1.1.5.2; 1.1.5.9; 1.1.99.28; 1.1.99.35; 2.3.1.132; 3.1.1.17",NA,"Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D04332  [102518] Glucono-delta-lactone;  Flavoring substance;   D04332  [102518] Glucono-delta-lactone;  Adhesive;   D04332  [102518] Glucono-delta-lactone;  Tenacious agent;   D04332  [102518] Glucono-delta-lactone;  pH regulator;   D04332  [102518] Glucono-delta-lactone","CAS: 90-80-2; PubChem: 3498; ChEBI: 16217; ChEMBL: CHEMBL1200829; PDB-CCD: LGC; 3DMET: B01186; NIKKAJI: J1.174F","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C00199","D-Ribulose 5-phosphate","C5H11O8P","D-Ribulose 5-phosphate","R01056 R01523 R01524 R01525 R01526 R01528 R01529 R01530; R05338 R07281 R07456 R10221","Pentose phosphate pathway; Pentose and glucuronate interconversions; Lipopolysaccharide biosynthesis; Methane metabolism; Carbon fixation in photosynthetic organisms; Riboflavin metabolism; Vitamin B6 metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.1.1.44; 1.1.1.137; 1.1.1.343; 1.1.1.351; 2.7.1.16; 2.7.1.19; 2.7.1.47; 4.1.2.43; 4.1.99.12; 4.3.3.6; 5.1.3.1; 5.3.1.6; 5.3.1.13","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; CMP-KDO biosynthesis; Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,"CAS: 551-85-9; PubChem: 3499; ChEBI: 17363; PDB-CCD: 5RP; 3DMET: B01187; NIKKAJI: J275.266B","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C00204","2-Dehydro-3-deoxy-D-gluconate;","C6H10O6","2-Dehydro-3-deoxy-D-gluconate; 2-Keto-3-deoxy-D-gluconate","R01538 R01540 R01541 R01542 R01543 R01544 R05606 R08570; R10775","Pentose phosphate pathway; Pentose and glucuronate interconversions; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","1.1.1.125; 1.1.1.126; 1.1.1.127; 2.7.1.45; 2.7.1.178; 4.1.2.51; 4.1.2.55; 4.2.1.7; 4.2.1.8; 4.2.1.39; 4.2.1.140; 4.3.1.9","D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"CAS: 17510-99-5; PubChem: 3504; ChEBI: 17032; PDB-CCD: KDG; 3DMET: B04648","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C00231","D-Xylulose 5-phosphate","C5H11O8P","D-Xylulose 5-phosphate","R01067 R01440 R01529 R01621 R01639 R01641 R01830 R05850; R06861 R09544","Pentose phosphate pathway; Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Thyroid hormone synthesis","1.1.1.301; 2.2.1.1; 2.2.1.3; 2.7.1.17; 4.1.2.9; 5.1.3.1; 5.1.3.4","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Glucuronate pathway (uronate pathway); Ascorbate degradation, ascorbate => D-xylulose-5P",NA,"PubChem: 3530; ChEBI: 16332; KNApSAcK: C00019693; PDB-CCD: 5SP; 3DMET: B01195; NIKKAJI: J652.282C","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C00257","D-Gluconic acid;","C6H12O7","D-Gluconic acid; D-Gluconate; D-gluco-Hexonic acid","R01519 R01538 R01737 R01738 R01739 R01740 R01741 R01742; R10832","Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.69; 1.1.1.215; 1.1.99.3; 2.4.1.321; 2.7.1.12; 3.1.1.17; 4.2.1.39; 4.2.1.140","Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00257  D-Gluconic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Calcium gluconate;     C00257  D-Gluconic acid; Pharmaceutical additives [BR:br08316];  pH regulator;   C00257  [102517] Gluconic acid","CAS: 526-95-4; PubChem: 3556; ChEBI: 18391 33198; ChEMBL: CHEMBL464345; KNApSAcK: C00007303 C00034850; PDB-CCD: GCO; 3DMET: B04655; NIKKAJI: J3.286G","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C00258","D-Glycerate;","C3H6O4","D-Glycerate; Glycerate; (R)-Glycerate; Glyceric acid","R01388 R01392 R01511 R01514 R01745 R01747 R01748 R01749; R01750 R01751 R01752 R08571 R08572 R09645 R09665 R09666; R10324 R10615","Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.26; 1.1.1.29; 1.1.1.60; 1.1.1.79; 1.1.1.81; 1.1.1.92; 1.2.1.3; 1.2.1.89; 1.2.7.5; 1.2.99.8; 2.4.1.268; 2.4.1.269; 2.7.1.31; 2.7.1.165; 3.1.3.20; 3.1.3.38; 3.2.1.170; 4.1.1.73","Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Formaldehyde assimilation, serine pathway; Photorespiration",NA,"CAS: 473-81-4; PubChem: 3557; ChEBI: 16659 32398; KNApSAcK: C00001185; PDB-CCD: DGY; 3DMET: B00076; NIKKAJI: J5.966H","cpd:C00258; cpd:C00603; cpd:C02766; cpd:C13034",3,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O4","C3H5O4",106.0266087,107.0344337,105.0187836
"cpd:C00279","D-Erythrose 4-phosphate","C4H9O7P","D-Erythrose 4-phosphate","R00761 R01067 R01825 R01826 R01827 R01829 R01830 R08575; R09083 R11333","Pentose phosphate pathway; Phenylalanine, tyrosine and tryptophan biosynthesis; Carbon fixation in photosynthetic organisms; Vitamin B6 metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.2.1.72; 1.13.11.79; 2.2.1.1; 2.2.1.2; 2.5.1.54; 4.1.2.13; 4.1.2.22; 5.3.1.34","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P",NA,"CAS: 585-18-2; PubChem: 3574; ChEBI: 48153; ChEMBL: CHEMBL1232448; KNApSAcK: C00007472; PDB-CCD: E4P; 3DMET: B04660; NIKKAJI: J39.057G","cpd:C00279; cpd:C03109; cpd:C03394; cpd:C03604; cpd:C21285; cpd:C21286",4,9,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O7P1","C4H8O7P1",200.0085896,201.0164147,199.0007646
"cpd:C00345","6-Phospho-D-gluconate","C6H13O10P","6-Phospho-D-gluconate","R01528 R01737 R02032 R02034 R02035 R02036 R10221","Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.43; 1.1.1.44; 1.1.1.343; 1.1.1.351; 2.7.1.12; 3.1.1.31; 4.2.1.12","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,"PubChem: 3638; ChEBI: 48928; ChEMBL: CHEMBL1230513; KNApSAcK: C00007481; PDB-CCD: 6PG; 3DMET: B01221; NIKKAJI: J1.343.743B","cpd:C00345; cpd:C04234",6,13,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O10P1","C6H12O10P1",276.0246336,277.0324586,275.0168086
"cpd:C00577","D-Glyceraldehyde","C3H6O3","D-Glyceraldehyde","R01036 R01041 R01059 R01752 R02568 R08570 R08571 R10050; R10324 R10615 R10616","Pentose phosphate pathway; Fructose and mannose metabolism; Galactose metabolism; Glycerolipid metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","1.1.1.2; 1.1.1.21; 1.1.1.72; 1.1.1.372; 1.2.1.3; 1.2.1.89; 1.2.7.5; 1.2.99.8; 2.2.1.11; 2.7.1.28; 4.1.2.13; 4.1.2.51; 4.1.2.55","Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00577  D-Glyceraldehyde","CAS: 453-17-8 367-47-5; PubChem: 3856; ChEBI: 17378; PDB-CCD: 3GR; 3DMET: B00137; NIKKAJI: J5.790H J9.119G","cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296",3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O3","C3H5O3",90.03169405,91.03951908,89.02386902
"cpd:C00620","alpha-D-Ribose 1-phosphate;","C5H11O8P","alpha-D-Ribose 1-phosphate; Ribose 1-phosphate; D-Ribose 1-phosphate","R01057 R01561 R01863 R01876 R01885 R02147 R02294 R02295; R02296 R02297 R02298 R02646 R06837 R08229 R08368 R11535","Pentose phosphate pathway; Purine metabolism","2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.15; 2.4.2.16; 2.4.2.-; 2.7.1.212; 3.6.1.21; 5.4.2.2; 5.4.2.7",NA,NA,"PubChem: 3894; ChEBI: 16300; ChEMBL: CHEMBL603367; PDB-CCD: R1P; 3DMET: B04706; NIKKAJI: J292.493E","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C00672","2-Deoxy-D-ribose 1-phosphate;","C5H11O7P","2-Deoxy-D-ribose 1-phosphate; 2-Deoxy-alpha-D-ribose 1-phosphate","R01570 R01969 R02484 R02557 R02748 R02749 R08230 R10244","Pentose phosphate pathway; Pyrimidine metabolism","2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 5.4.2.7",NA,NA,"CAS: 17210-42-3; PubChem: 3941; ChEBI: 11563 28542; 3DMET: B04713; NIKKAJI: J1.011.725I","cpd:C00653; cpd:C00672; cpd:C00673; cpd:C02270; cpd:C04111; cpd:C11437; cpd:C16637",5,11,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O7P1","C5H10O7P1",214.0242397,215.0320647,213.0164147
"cpd:C00673","2-Deoxy-D-ribose 5-phosphate","C5H11O7P","2-Deoxy-D-ribose 5-phosphate","R01066 R02749 R02750","Pentose phosphate pathway","2.7.1.15; 4.1.2.4; 5.4.2.7",NA,NA,"PubChem: 3942; ChEBI: 16132 55513; PDB-CCD: AAB ORP; 3DMET: B04714; NIKKAJI: J993.340I","cpd:C00653; cpd:C00672; cpd:C00673; cpd:C02270; cpd:C04111; cpd:C11437; cpd:C16637",5,11,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O7P1","C5H10O7P1",214.0242397,215.0320647,213.0164147
"cpd:C01151","D-Ribose 1,5-bisphosphate;","C5H12O11P2","D-Ribose 1,5-bisphosphate; Ribose 1,5-bisphosphate; alpha-D-Ribose 1,5-bisphosphate","R01050 R06836 R06837 R10205 R10555 R10836 R10837 R10838; R11535","Pentose phosphate pathway; Phosphonate and phosphinate metabolism","2.4.2.57; 2.7.1.18; 2.7.1.212; 2.7.4.23; 3.1.4.55; 5.3.1.29",NA,NA,"PubChem: 4380; ChEBI: 17994 68819; PDB-CCD: RI2; 3DMET: B01393; NIKKAJI: J531.560C","cpd:C01095; cpd:C01151; cpd:C01182; cpd:C20986",5,12,11,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O11P2","C5H11O11P2",309.9854852,310.9933102,308.9776602
"cpd:C01218","6-Phospho-2-dehydro-D-gluconate;","C6H11O10P","6-Phospho-2-dehydro-D-gluconate; 2-Dehydro-D-gluconate 6-phosphate","R02032 R02034 R02658","Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments","1.1.1.43; 2.7.1.13",NA,NA,"PubChem: 4440; ChEBI: 2229; 3DMET: B04785; NIKKAJI: J2.731.896G","cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899",6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O10P1","C6H10O10P1",274.0089835,275.0168086,273.0011585
"cpd:C01236","D-Glucono-1,5-lactone 6-phosphate;","C6H11O9P","D-Glucono-1,5-lactone 6-phosphate; 6-Phospho-D-glucono-1,5-lactone","R00835 R02035 R02736 R09550 R10520 R10907","Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.49; 1.1.1.363; 1.1.1.388; 1.1.98.2; 3.1.1.31","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,"PubChem: 4457; ChEBI: 16938; 3DMET: B01420; NIKKAJI: J40.067J","cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668",6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O9P1","C6H10O9P1",258.0140689,259.021894,257.0062439
"cpd:C01801","Deoxyribose;","C5H10O4","Deoxyribose; 2-Deoxy-D-erythro-pentose; Thyminose; 2-Deoxy-D-ribose","R02750","Pentose phosphate pathway","2.7.1.15",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C01801  Deoxyribose","CAS: 533-67-5; PubChem: 4927; ChEBI: 28816; KNApSAcK: C00001115; PDB-CCD: 2DR; 3DMET: B01499; NIKKAJI: J6.332K","cpd:C01801; cpd:C02783; cpd:C04039; cpd:C04272; cpd:C06257; cpd:C08347; cpd:C11497",5,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O4","C5H9O4",134.0579088,135.0657338,133.0500838
"cpd:C03752","2-Amino-2-deoxy-D-gluconate;","C6H13NO6","2-Amino-2-deoxy-D-gluconate; D-Glucosaminate; D-Glucosaminic acid; Glucosaminate","R01544 R01962 R04299 R10407 R10773","Pentose phosphate pathway; Microbial metabolism in diverse environments; Phosphotransferase system (PTS)","1.1.3.-; 2.7.1.203; 4.3.1.9",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C03752  D-Glucosaminic acid","CAS: 3646-68-2; PubChem: 6511; ChEBI: 17784; 3DMET: B04912; NIKKAJI: J205.566J","cpd:C02264; cpd:C03752",6,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O6N1","C6H12O6N1",195.0742871,196.0821122,194.0664621
"cpd:C04442","2-Dehydro-3-deoxy-6-phospho-D-gluconate;","C6H11O9P","2-Dehydro-3-deoxy-6-phospho-D-gluconate; 6-Phospho-2-dehydro-3-deoxy-D-gluconate; 2-Keto-3-deoxy-6-phosphogluconate; 2-Dehydro-3-deoxy-D-gluconate 6-phosphate","R01541 R02036 R05605 R10408","Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","2.7.1.45; 2.7.1.178; 4.1.2.14; 4.1.2.55; 4.2.1.12; 4.3.1.29","Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"PubChem: 7071; ChEBI: 15925; KNApSAcK: C00019434; 3DMET: B04941; NIKKAJI: J40.082C","cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668",6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O9P1","C6H10O9P1",258.0140689,259.021894,257.0062439
"cpd:C05382","Sedoheptulose 7-phosphate;","C7H15O10P","Sedoheptulose 7-phosphate; D-Sedoheptulose 7-phosphate; D-altro-Heptulose 7-phosphate; altro-Heptulose 7-phosphate","R01641 R01827 R01843 R01844 R01845 R05645 R06590 R06863; R08575 R09768 R09769 R11326 R11327","Pentose phosphate pathway; Lipopolysaccharide biosynthesis; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","2.2.1.1; 2.2.1.2; 2.7.1.11; 2.7.1.14; 3.1.3.11; 3.1.3.37; 4.2.3.154; 4.2.3.155; 5.3.1.28","Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; ADP-L-glycero-D-manno-heptose biosynthesis; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P",NA,"PubChem: 7756; ChEBI: 15721; KNApSAcK: C00019575; PDB-CCD: I22; 3DMET: B05013; NIKKAJI: J604.570G","cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956",7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H16O10P1","C7H14O10P1",290.0402837,291.0481087,289.0324586
"cpd:C06019","D-arabino-Hex-3-ulose 6-phosphate;","C6H13O9P","D-arabino-Hex-3-ulose 6-phosphate; D-arabino-3-Hexulose 6-phosphate; D-arabino-6-Phospho-hex-3-ulose","R05338 R05339 R09780","Pentose phosphate pathway; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids","4.1.2.43; 5.3.1.27","Formaldehyde assimilation, ribulose monophosphate pathway; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,"PubChem: 8291; ChEBI: 27973; 3DMET: B01952; NIKKAJI: J2.760.897C","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C06473","2-Keto-D-gluconic acid;","C6H10O7","2-Keto-D-gluconic acid; 2-Dehydro-D-gluconate; 2-Dehydro-D-gluconic acid; alpha-D-arabino-2-Hexulosonic acid","R01739 R01741 R01742 R02658 R02659 R05823 R07153","Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments","1.1.1.215; 1.1.1.274; 1.1.99.3; 1.1.99.4; 2.7.1.13",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C06473  2-Keto-D-gluconic acid","CAS: 669-90-9; PubChem: 8705; ChEBI: 27469; 3DMET: B05206; NIKKAJI: J117.707I","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C20589","D-Glucosaminate-6-phosphate;","C6H14NO9P","D-Glucosaminate-6-phosphate; 2-Amino-2-deoxy-D-gluconate 6-phosphate","R10407 R10408","Pentose phosphate pathway; Microbial metabolism in diverse environments; Phosphotransferase system (PTS)","2.7.1.203; 4.3.1.29",NA,NA,"PubChem: 172232326","cpd:C20589",6,14,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O9N1P1","C6H13O9N1P1",275.040618,276.0484431,274.032793
"cpd:C00029","UDP-glucose;","C15H24N2O17P2","UDP-glucose; UDPglucose; UDP-D-glucose; Uridine diphosphate glucose; UDP-alpha-D-glucose","R00286 R00287 R00289 R00291 R00292 R00293 R00766 R00806; R00836 R00955 R01005 R01240 R01304 R01497 R01722 R01912; R01994 R01995 R02113 R02118 R02158 R02179 R02256 R02380; R02388 R02594 R02689 R02709 R02716 R02737 R02889 R02897; R02932 R02951 R03094 R03118 R03190 R03213 R03267 R03297; R03526 R03547 R03548 R03558 R03565 R03573 R03574 R03588; R03594 R03605 R03625 R03680 R03681 R03686 R03710 R03797; R03996 R04005 R04041 R04071 R04108 R04127 R04179 R04296; R04359 R04377 R04491 R04577 R04579 R04948 R05083 R05164; R05324 R05325 R05769 R05775 R05882 R06047 R06048 R06534; R06535 R06536 R06546 R06547 R06594 R06611 R06795 R06803; R06804 R06805 R06810 R06812 R06813 R06819 R07260 R07266; R07332 R07333 R07338 R07339 R07340 R07426 R07574 R07575; R07718 R07720 R07729 R07740 R07753 R07874 R07875 R07877; R07878 R07879 R07911 R07912 R07913 R07914 R07923 R08006; R08007 R08013 R08021 R08075 R08076 R08128 R08164 R08369; R08533 R08534 R08661 R08668 R08687 R08813 R08814 R08816; R08822 R08830 R08839 R08859 R09641 R09757 R09758 R09759; R09804 R09857 R10037 R10063 R10096 R10262 R10263 R10264; R10265 R10293 R10294 R10295 R10434 R10594 R10607 R10638; R10639 R10807 R10834 R10835 R10850 R10988 R10989 R10990; R11241 R11271 R11272 R11306","Pentose and glucuronate interconversions; Galactose metabolism; Ascorbate and aldarate metabolism; Pyrimidine metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Neomycin, kanamycin and gentamicin biosynthesis; Glycerolipid metabolism; Zeatin biosynthesis; Biosynthesis of ansamycins; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of antibiotics","1.1.1.22; 1.1.1.-; 2.4.1.11; 2.4.1.12; 2.4.1.13; 2.4.1.14; 2.4.1.15; 2.4.1.34; 2.4.1.35; 2.4.1.52; 2.4.1.53; 2.4.1.58; 2.4.1.63; 2.4.1.66; 2.4.1.71; 2.4.1.73; 2.4.1.78; 2.4.1.80; 2.4.1.81; 2.4.1.85; 2.4.1.91; 2.4.1.103; 2.4.1.104; 2.4.1.105; 2.4.1.106; 2.4.1.111; 2.4.1.114; 2.4.1.115; 2.4.1.116; 2.4.1.117; 2.4.1.118; 2.4.1.120; 2.4.1.121; 2.4.1.126; 2.4.1.127; 2.4.1.128; 2.4.1.136; 2.4.1.158; 2.4.1.160; 2.4.1.170; 2.4.1.171; 2.4.1.172; 2.4.1.173; 2.4.1.176; 2.4.1.177; 2.4.1.178; 2.4.1.181; 2.4.1.183; 2.4.1.185; 2.4.1.186; 2.4.1.188; 2.4.1.192; 2.4.1.193; 2.4.1.194; 2.4.1.195; 2.4.1.196; 2.4.1.202; 2.4.1.203; 2.4.1.208; 2.4.1.209; 2.4.1.210; 2.4.1.215; 2.4.1.218; 2.4.1.219; 2.4.1.220; 2.4.1.237; 2.4.1.238; 2.4.1.239; 2.4.1.240; 2.4.1.242; 2.4.1.245; 2.4.1.249; 2.4.1.263; 2.4.1.271; 2.4.1.276; 2.4.1.284; 2.4.1.286; 2.4.1.295; 2.4.1.296; 2.4.1.297; 2.4.1.298; 2.4.1.301; 2.4.1.305; 2.4.1.310; 2.4.1.314; 2.4.1.315; 2.4.1.323; 2.4.1.324; 2.4.1.330; 2.4.1.336; 2.4.1.337; 2.4.1.338; 2.4.1.-; 2.7.7.9; 2.7.7.12; 2.7.7.64; 2.7.8.19; 2.7.8.31; 3.6.1.8; 3.6.1.9; 3.6.1.45; 3.13.1.1; 4.2.1.76; 5.1.3.2","Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00029  UDP-glucose","CAS: 133-89-1; PubChem: 3331; ChEBI: 18066 46229; ChEMBL: CHEMBL1742482 CHEMBL375951; KNApSAcK: C00001514; PDB-CCD: UPG; 3DMET: B04622; NIKKAJI: J9.610E","cpd:C00029; cpd:C00052; cpd:C03733",15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H25O17N2P2","C15H23O17N2P2",566.0550213,567.0628463,565.0471963
"cpd:C00116","Glycerol;","C3H8O3","Glycerol; Glycerin; 1,2,3-Trihydroxypropane; 1,2,3-Propanetriol","R00841 R00847 R00850 R01034 R01036 R01039 R01041 R01043; R01044 R01045 R01047 R01104 R01350 R01351 R01352 R02591; R03331 R03616 R07293 R07298 R07390 R08372 R08658 R10563; R11127","Pentose and glucuronate interconversions; Galactose metabolism; Glycerolipid metabolism; Metabolic pathways; ABC transporters; Retrograde endocannabinoid signaling; Regulation of lipolysis in adipocytes","1.1.1.2; 1.1.1.6; 1.1.1.21; 1.1.1.72; 1.1.1.156; 1.1.1.372; 1.1.99.22; 2.4.1.332; 2.7.1.30; 2.7.1.79; 2.7.1.142; 2.7.8.-; 3.1.1.23; 3.1.1.34; 3.1.1.79; 3.1.3.19; 3.1.3.21; 3.1.4.38; 3.1.4.43; 3.2.1.22; 3.2.1.-; 4.2.1.30","Acylglycerol degradation; D-Galacturonate degradation (fungi), D-galacturonate => glycerol","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00116  Glycerol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AG Enemas;      A06AG04 Glycerol;       D00028  Glycerin (JP17/USP);     A06AX Other drugs for constipation;      A06AX01 Glycerol;       D00028  Glycerin (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    235  Purgatives, clysters;     2357  Glycerins;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN);  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    713  Solvents;     7139  Others;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN);    719  Miscellaneous;     7190  Miscellaneous;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for digestive organs;   18 Enema;    D00028  Glycerin (JP17/USP);  Agents for integumentary system;   55 Chilblain and chap remedies;    D00028  Glycerin (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Glycerin;     D00028  Glycerin (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Glycerin;     D00028  Glycerin (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Plasticizer;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Lubricating agent;   D00028  [001223] Glycerin;  Solubilizing agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Sweetening agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Base;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Flavoring substance;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Bonding agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Suspending agent;   D00028  [001223] Glycerin;  Coating agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Film;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Wetting agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Wetting adjuster;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Sugarcoated agent;   D00028  [001223] Glycerin;  Tonicity agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Flexibilizer;   D00028  [001223] Glycerin;  Emulsion;   D00028  [001223] Glycerin;  Adhesive;   D00028  [001223] Glycerin;  Adhesion-enhancing agent;   D00028  [001223] Glycerin;  Tenacious agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Diluting agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Dispersant;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Disintegrating adjuvant;   D00028  [001223] Glycerin;  Dampproof agent;   D00028  [001223] Glycerin;  Preserving agent;   D00028  [001223] Glycerin;  Solubilizer;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Solubilization agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Solvent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Fluidizer;   D00028  [001224] Concentrated glycerin; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00028  Glycerin;   D00028  Concentrated glycerin; Gastrointestinal agents [br08371.html];  Cathartic agent, antidiarrheal agent, intestinal regulator;   D00028; Animal drugs in Japan [BR:br08331];  93  Agents affecting digestive organs;   937  Clysters;    9371  Glycerine and preparations;     C00116  Glycerine","CAS: 56-81-5; PubChem: 3416; ChEBI: 17754; ChEMBL: CHEMBL692; KNApSAcK: C00001163; PDB-CCD: GOL; 3DMET: B00032; NIKKAJI: J1.916J","cpd:C00116; cpd:C03920; cpd:C10922; cpd:C19239",3,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H9O3","C3H7O3",92.04734412,93.05516915,91.03951908
"cpd:C00167","UDP-glucuronate;","C15H22N2O18P2","UDP-glucuronate; UDPglucuronate; UDP-D-glucuronate; UDP-alpha-D-glucuronate","R00286 R01381 R01383 R01384 R01385 R01386 R01387 R02358; R02389 R02478 R02502 R02902 R03091 R03589 R04352 R04353; R04354 R04607 R04683 R05327 R06827 R06828 R07106 R07335; R07336 R07658 R07932 R08259 R08261 R08262 R08263 R08615; R08817 R08824 R09426 R09427 R09428 R09529 R09635 R09636; R09732","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","1.1.1.22; 1.1.1.305; 2.4.1.17; 2.4.1.135; 2.4.1.189; 2.4.1.190; 2.4.1.191; 2.4.1.212; 2.4.1.225; 2.4.1.226; 2.4.1.253; 2.4.1.254; 2.4.1.262; 2.4.1.264; 2.4.1.-; 2.7.7.44; 2.7.7.64; 4.1.1.35; 5.1.3.6; 5.1.3.12","Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",NA,"PubChem: 3467; ChEBI: 17200; ChEMBL: CHEMBL228057; KNApSAcK: C00007238; PDB-CCD: UGA; 3DMET: B01177; NIKKAJI: J247.699A","cpd:C00167; cpd:C00617; cpd:C02330",15,22,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H23O18N2P2","C15H21O18N2P2",580.0342859,581.0421109,579.0264608
"cpd:C00181","D-Xylose;","C5H10O5","D-Xylose; Wood sugar","R01429 R01430 R01431 R01432 R01433 R04937 R06203 R09477","Pentose and glucuronate interconversions; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters","1.1.1.21; 1.1.1.121; 1.1.1.175; 1.1.1.179; 1.1.1.307; 3.2.1.37; 3.2.1.-; 5.3.1.5",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00181  D-Xylose; Pharmaceutical additives [BR:br08316];  Flavoring substance;   D06346  [101651] D-Xylose","CAS: 58-86-6; PubChem: 3481; ChEBI: 15936 53455; ChEMBL: CHEMBL502135; KNApSAcK: C00007290 C00034344; PDB-CCD: XYP XYS; 3DMET: B04643; NIKKAJI: J2.806A","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00191","D-Glucuronate;","C6H10O7","D-Glucuronate; Glucuronic acid; Glucuronate","R01184 R01476 R01478 R01480 R01481 R01482 R01483 R01484; R04512 R04979 R06143 R07818 R08127 R08260 R08615 R09447; R09533 R10134 R10830 R10842","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Inositol phosphate metabolism; Metabolic pathways","1.1.1.2; 1.1.1.19; 1.1.1.203; 1.13.99.1; 1.-.-.-; 2.4.1.17; 2.7.1.43; 3.1.1.19; 3.1.1.93; 3.2.1.31; 3.2.1.56; 3.2.1.139; 3.2.1.167; 5.3.1.12","Glucuronate pathway (uronate pathway); D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Ascorbate biosynthesis, animals, glucose-1P => ascorbate","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00191  D-Glucuronic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Sodium glucuronate hydrate;     C00191  D-Glucuronate","CAS: 6556-12-3; PubChem: 3491; ChEBI: 15748 4178 47952; ChEMBL: CHEMBL1159524 CHEMBL496672; KNApSAcK: C00001123; PDB-CCD: BDP GCU; 3DMET: B04646; NIKKAJI: J82.112H","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C00259","L-Arabinose;","C5H10O5","L-Arabinose; L-Arabinopyranose","R01754 R01757 R01758 R01759 R01760 R01761 R01762 R04938; R10787","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters","1.1.1.21; 1.1.1.46; 1.1.1.376; 2.7.1.46; 3.2.1.55; 3.2.1.88; 3.2.1.-; 5.3.1.4",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00259  L-Arabinose","CAS: 147-81-9; PubChem: 3558; ChEBI: 17535; ChEMBL: CHEMBL1357418 CHEMBL505348; KNApSAcK: C00041349; PDB-CCD: ARA ARB; 3DMET: B04656; NIKKAJI: J231.471A","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00266","Glycolaldehyde;","C2H4O2","Glycolaldehyde; Hydroxyacetaldehyde","R01333 R01393 R01469 R01781 R01782 R01784 R01785 R03504; R05840 R11037 R11501 R11503","Pentose and glucuronate interconversions; Glyoxylate and dicarboxylate metabolism; Vitamin B6 metabolism; Folate biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments","1.1.1.77; 1.2.1.21; 1.4.3.8; 1.11.1.14; 1.11.1.16; 1.13.11.81; 4.1.1.40; 4.1.2.18; 4.1.2.19; 4.1.2.25; 4.1.2.28",NA,NA,"CAS: 141-46-8; PubChem: 3564; ChEBI: 17071; KNApSAcK: C00007457; 3DMET: B00079; NIKKAJI: J2.537B","cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00098; cpd:C00151; cpd:C00266; cpd:C00405; cpd:C02086; cpd:C05167; cpd:C05234; cpd:C13301; cpd:C13400; cpd:C14860; cpd:C18091; cpd:C18372; cpd:C18568; cpd:C18723; cpd:C18940",2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H5O2","C2H3O2",60.02112937,61.0289544,59.01330434
"cpd:C00309","D-Ribulose;","C5H10O5","D-Ribulose; D-erythro-2-Pentulose; D-Arabinoketose; D-Arabinulose; D-Riboketose","R01081 R01526 R01577 R01892 R01895 R07134 R07144","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.56; 1.1.1.250; 1.1.1.287; 1.1.2.2; 2.7.1.16; 2.7.1.47; 5.3.1.3; 5.3.1.20",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00309  D-Ribulose","CAS: 488-84-6; PubChem: 3603; ChEBI: 17173; ChEMBL: CHEMBL1341376; KNApSAcK: C00001131; 3DMET: B04662; NIKKAJI: J6.034H","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00310","D-Xylulose;","C5H10O5","D-Xylulose; D-threo-Pentulose; D-Lyxulose","R01432 R01639 R01896 R01898 R05604 R07143","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.9; 1.1.1.11; 1.1.1.14; 1.1.1.287; 2.7.1.17; 5.3.1.5; 5.3.1.15","Glucuronate pathway (uronate pathway)","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00310  D-Xylulose","CAS: 551-84-8; PubChem: 3604; ChEBI: 17140; KNApSAcK: C00019684; PDB-CCD: XLF; 3DMET: B04663; NIKKAJI: J14.195J","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00312","L-Xylulose;","C5H10O5","L-Xylulose; L-threo-Pentulose; L-Lyxulose","R01901 R01902 R01903 R01904 R01905 R01906 R05831","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.10; 1.1.1.12; 1.1.1.15; 2.7.1.5; 2.7.1.53; 4.1.1.34; 5.3.1.-","Glucuronate pathway (uronate pathway)","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00312  L-Xylulose","CAS: 527-50-4; PubChem: 3606; ChEBI: 17399; 3DMET: B04665; NIKKAJI: J13.211J","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00333","D-Galacturonate;","C6H10O7","D-Galacturonate; D-Galacturonic acid","R01980 R01981 R01982 R01983 R01984 R04320 R06201 R07413; R07676 R10565 R10841","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters","1.1.1.203; 1.1.1.365; 1.1.1.-; 2.7.1.44; 3.2.1.15; 3.2.1.67; 5.3.1.12","Pectin degradation; D-Galacturonate degradation (fungi), D-galacturonate => glycerol; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00333  D-Galacturonic acid","CAS: 685-73-4; PubChem: 3627; ChEBI: 12952 4153; KNApSAcK: C00001120; PDB-CCD: ADA GTR; 3DMET: B04672; NIKKAJI: J82.118G","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C00379","Xylitol","C5H12O5","Xylitol","R01431 R01896 R01904 R02136 R05831 R07152 R09477","Pentose and glucuronate interconversions; Metabolic pathways; ABC transporters","1.1.1.9; 1.1.1.10; 1.1.1.14; 1.1.1.15; 1.1.1.21; 1.1.1.307; 1.1.3.41; 2.7.1.122","Glucuronate pathway (uronate pathway)","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00379  Xylitol; Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   32  Nutrients, tonics;    323  Saccharide preparations;     3234  Xylitols;      D00061  Xylitol (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00061  [004200] Xylitol;  Sweetening agent;   D00061  [004200] Xylitol;  Flavoring substance;   D00061  [004200] Xylitol;  Tonicity agent;   D00061  [004200] Xylitol;  Diluting agent;   D00061  [004200] Xylitol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00061  Xylitol;   D00061  Xylitol injection; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9643  Xylitol and preparations;     C00379  Xylitol","CAS: 87-99-0; PubChem: 3669; ChEBI: 17151; ChEMBL: CHEMBL1865120 CHEMBL96783; PDB-CCD: XYL; 3DMET: B04675; NIKKAJI: J3.905E","cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942",5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O5","C5H11O5",152.0684735,153.0762985,151.0606485
"cpd:C00433","2,5-Dioxopentanoate;","C5H6O4","2,5-Dioxopentanoate; 2-Oxoglutarate semialdehyde","R00264 R02278 R02279 R02280 R09186 R09253","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Arginine and proline metabolism; Metabolic pathways","1.2.1.3; 1.2.1.26; 3.5.4.22; 4.2.1.41; 4.2.1.43; 4.2.1.141",NA,NA,"PubChem: 3722; ChEBI: 17415; PDB-CCD: DO4; 3DMET: B00112; NIKKAJI: J2.593.782A","cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757",5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O4","C5H5O4",130.0266087,131.0344337,129.0187836
"cpd:C00474","Ribitol;","C5H12O5","Ribitol; Adonitol","R01732 R01892 R01895","Pentose and glucuronate interconversions; Riboflavin metabolism; Metabolic pathways","1.1.1.56; 1.1.2.2; 3.5.99.1",NA,NA,"CAS: 488-81-3; PubChem: 3757; ChEBI: 15963; ChEMBL: CHEMBL1865120; KNApSAcK: C00001171; PDB-CCD: RB0; 3DMET: B04685; NIKKAJI: J6.033J","cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942",5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O5","C5H11O5",152.0684735,153.0762985,151.0606485
"cpd:C00476","D-Lyxose","C5H10O5","D-Lyxose","R01898","Pentose and glucuronate interconversions","5.3.1.15",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00476  D-Lyxose","CAS: 1114-34-7; PubChem: 3759; ChEBI: 16789 82838; ChEMBL: CHEMBL1159661; PDB-CCD: LDY; 3DMET: B04686; NIKKAJI: J82.119E","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00502","D-Xylonate","C5H10O6","D-Xylonate","R02427 R02428 R02429","Pentose and glucuronate interconversions","3.1.1.68; 4.2.1.82",NA,NA,"CAS: 526-91-0; PubChem: 3785; ChEBI: 48093; 3DMET: B04688; NIKKAJI: J387.172J","cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646",5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O6","C5H9O6",166.047738,167.0555631,165.039913
"cpd:C00508","L-Ribulose;","C5H10O5","L-Ribulose; L-erythro-Pentulose; L-Arabinoketose; L-Arabinulose; L-Riboketose","R01761 R02439 R02441","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.13; 2.7.1.16; 5.3.1.4",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00508  L-Ribulose","CAS: 2042-27-5; PubChem: 3791; ChEBI: 16880; KNApSAcK: C00019634; PDB-CCD: 34V RUU; 3DMET: B04690; NIKKAJI: J14.173I","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C00514","D-Mannonate","C6H12O7","D-Mannonate","R02454 R02455 R02456 R05606","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.57; 1.1.1.131; 4.2.1.8","D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P",NA,"CAS: 642-99-9; PubChem: 3797; ChEBI: 17767 33076; ChEMBL: CHEMBL1231941; PDB-CCD: CS2; 3DMET: B04694; NIKKAJI: J13.218G","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C00532","L-Arabitol;","C5H12O5","L-Arabitol; L-Arabinol; L-Arabinitol; L-Lyxitol","R01758 R01759 R01903 R02441","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.12; 1.1.1.13; 1.1.1.21",NA,NA,"CAS: 7643-75-6; PubChem: 3814; ChEBI: 18403; PDB-CCD: SST; 3DMET: B01282; NIKKAJI: J8.955I","cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942",5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O5","C5H11O5",152.0684735,153.0762985,151.0606485
"cpd:C00558","D-Tagaturonate;","C6H10O7","D-Tagaturonate; D-Tagaturonic acid","R01983 R02555","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.58; 5.3.1.12","D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00558  D-Tagaturonic acid","PubChem: 3838; ChEBI: 17886; 3DMET: B04700; NIKKAJI: J1.367.593G","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C00618","3-Dehydro-L-gulonate","C6H10O7","3-Dehydro-L-gulonate","R01905 R02637 R02639 R02640 R07127","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.45; 1.1.1.130; 2.7.1.53; 4.1.1.34","Glucuronate pathway (uronate pathway)",NA,"PubChem: 3892; ChEBI: 16142; 3DMET: B01294; NIKKAJI: J2.729.793E","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C00789","CDP-ribitol;","C14H25N3O15P2","CDP-ribitol; CDP-L-ribitol; CDP 5-ester with D-ribitol","R02921 R04083 R06235","Pentose and glucuronate interconversions; Mannose type O-glycan biosynthesis; Metabolic pathways","2.7.7.40; 2.7.8.14",NA,NA,"CAS: 3506-17-0; PubChem: 4047; ChEBI: 16022; 3DMET: B04723; NIKKAJI: J2.620.993E","cpd:C00789",14,25,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H26O15N3P2","C14H24O15N3P2",537.0760911,538.0839161,536.0682661
"cpd:C00800","L-Gulonate;","C6H12O7","L-Gulonate; L-Gulonic acid; Gulonate; Gulonic acid","R01481 R02640 R02933 R10848","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.2; 1.1.1.19; 1.1.1.45; 1.1.1.380; 3.1.1.17; 3.1.1.25","Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,"CAS: 526-97-6; PubChem: 4058; ChEBI: 13115 16154; PDB-CCD: 2UF; 3DMET: B04727; NIKKAJI: J2.356.740G","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C00817","D-Altronate","C6H12O7","D-Altronate","R01540 R02555","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.58; 4.2.1.7","D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",NA,"PubChem: 4075; ChEBI: 17360 46644; 3DMET: B01337; NIKKAJI: J2.730.724H","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C00905","D-Fructuronate;","C6H10O7","D-Fructuronate; D-Fructuronic acid","R01482 R02454 R10848","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.57; 1.1.1.380; 5.3.1.12","D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00905  D-Fructuronic acid","PubChem: 4160; ChEBI: 4126; 3DMET: B04749; NIKKAJI: J2.372.985G","cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059",6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O7","C6H9O7",194.0426527,195.0504777,193.0348276
"cpd:C01068","D-Ribitol 5-phosphate;","C5H13O8P","D-Ribitol 5-phosphate; Ribitol 5-phosphate; L-Ribitol 1-phosphate","R01524 R01525 R02921","Pentose and glucuronate interconversions; Mannose type O-glycan biosynthesis; Metabolic pathways","1.1.1.137; 2.7.7.40",NA,NA,"PubChem: 4307; ChEBI: 16246; 3DMET: B04762; NIKKAJI: J1.612.794I","cpd:C01068; cpd:C02895; cpd:C03509; cpd:C19674",5,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H14O8P1","C5H12O8P1",232.0348044,233.0426294,231.0269793
"cpd:C01101","L-Ribulose 5-phosphate","C5H11O8P","L-Ribulose 5-phosphate","R02439 R03244 R05850","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments","2.7.1.16; 5.1.3.4; 5.1.3.22; 5.-.-.-","Ascorbate degradation, ascorbate => D-xylulose-5P",NA,"CAS: 2922-69-2; PubChem: 4335; ChEBI: 17666; ChEMBL: CHEMBL1233359; KNApSAcK: C00019543; PDB-CCD: HMS; 3DMET: B01379; NIKKAJI: J974.176C","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C01508","L-Lyxose","C5H10O5","L-Lyxose","R01906","Pentose and glucuronate interconversions","5.3.1.-",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01508  L-Lyxose","CAS: 1949-78-6; PubChem: 4676; ChEBI: 28480 62321; 3DMET: B04799; NIKKAJI: J14.174G","cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382",5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O5","C5H9O5",150.0528234,151.0606485,149.0449984
"cpd:C01904","D-Arabitol;","C5H12O5","D-Arabitol; D-Arabinitol; D-Arabinol; D-Lyxitol","R05604 R07134 R07143 R07144","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.11; 1.1.1.250; 1.1.1.287",NA,NA,"CAS: 488-82-4; PubChem: 5013; ChEBI: 18333; KNApSAcK: C00001156; 3DMET: B04821; NIKKAJI: J12.591A","cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942",5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O5","C5H11O5",152.0684735,153.0762985,151.0606485
"cpd:C02266","D-Xylonolactone;","C5H8O5","D-Xylonolactone; D-Xylono-1,5-lactone","R01429 R01430 R02427","Pentose and glucuronate interconversions","1.1.1.121; 1.1.1.175; 1.1.1.179; 3.1.1.68",NA,NA,"PubChem: 5327; ChEBI: 15867; 3DMET: B01553; NIKKAJI: J2.735.715F","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C02273","Digalacturonate;","C12H18O13","Digalacturonate; Digalacturonic acid","R02360 R07413","Pentose and glucuronate interconversions; Metabolic pathways; ABC transporters","3.2.1.15; 3.2.1.67","Pectin degradation",NA,"CAS: 5894-59-7; PubChem: 5333; ChEBI: 28737 33809; PDB-CCD: AD0; 3DMET: B04846; NIKKAJI: J506.523B","cpd:C00470; cpd:C02273; cpd:C04354",12,18,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H19O13","C12H17O13",370.0747406,371.0825657,369.0669156
"cpd:C02426","L-Glyceraldehyde;","C3H6O3","L-Glyceraldehyde; L-2,3-Dihydroxypropionaldehyde; L-2,3-Dihydroxypropanal; L-Glycerose; L-Aldotriose","R10550 R10563","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.372; 4.1.2.54","D-Galacturonate degradation (fungi), D-galacturonate => glycerol","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C02426  L-Glyceraldehyde","CAS: 497-09-6; PubChem: 5454; ChEBI: 27975; PDB-CCD: GXV; 3DMET: B01571; NIKKAJI: J9.120K","cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296",3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O3","C3H5O3",90.03169405,91.03951908,89.02386902
"cpd:C03291","L-Xylulose 5-phosphate","C5H11O8P","L-Xylulose 5-phosphate","R01901 R03244 R07125","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments","2.7.1.53; 4.1.1.85; 5.1.3.22; 5.-.-.-","Ascorbate degradation, ascorbate => D-xylulose-5P",NA,"PubChem: 6148; ChEBI: 16593; 3DMET: B04887; NIKKAJI: J652.281E","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C03826","2-Dehydro-3-deoxy-D-xylonate;","C5H8O5","2-Dehydro-3-deoxy-D-xylonate; 2-Dehydro-3-deoxy-D-arabinonate; 2-Dehydro-3-deoxy-D-pentonate; (4S)-4,5-Dihydroxy-2-oxopentanoate","R01782 R02429 R03032 R04375 R09186","Pentose and glucuronate interconversions","1.1.1.-; 4.1.2.28; 4.2.1.5; 4.2.1.82; 4.2.1.141",NA,NA,"PubChem: 6569; ChEBI: 1060; NIKKAJI: J1.965.898H","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C04053","5-Dehydro-4-deoxy-D-glucuronate;","C6H8O6","5-Dehydro-4-deoxy-D-glucuronate; 4-Deoxy-L-threo-5-hexosulose uronate","R04382 R04383 R06249 R09831 R10867","Pentose and glucuronate interconversions","3.2.1.179; 3.2.1.180; 4.2.2.6; 5.3.1.17",NA,NA,"PubChem: 6754; ChEBI: 17117 17782; PDB-CCD: D54; 3DMET: B04924; NIKKAJI: J2.745.978A","cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364",6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O6","C6H7O6",176.032088,177.039913,175.0242629
"cpd:C04349","(4S)-4,6-Dihydroxy-2,5-dioxohexanoate;","C6H8O6","(4S)-4,6-Dihydroxy-2,5-dioxohexanoate; 3-Deoxy-D-glycero-2,5-hexodiulosonate; 2,5-Diketo-3-deoxy-D-gluconate","R01542 R04383 R11035","Pentose and glucuronate interconversions","1.1.1.125; 1.1.1.127; 1.1.1.389; 5.3.1.17",NA,NA,"PubChem: 6998; ChEBI: 15623; 3DMET: B00703; NIKKAJI: J2.369.069A","cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364",6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O6","C6H7O6",176.032088,177.039913,175.0242629
"cpd:C04575","(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate;","C6H8O7","(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate; 2,3-Diketo-L-gulonate","R02637 R02639 R04515 R04784 R04785","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism","1.1.1.130; 3.1.1.17; 4.1.1.-",NA,NA,"PubChem: 7176; ChEBI: 15622; LIPIDMAPS: LMFA01060195; 3DMET: B01760; NIKKAJI: J156.563J","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C05385","D-Glucuronate 1-phosphate;","C6H11O10P","D-Glucuronate 1-phosphate; 1-Phospho-alpha-D-glucuronate","R01381 R01476","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","2.7.1.43; 2.7.7.44; 2.7.7.64","Glucuronate pathway (uronate pathway)",NA,"PubChem: 7759; ChEBI: 16787 28547; 3DMET: B05014; NIKKAJI: J294.575D","cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899",6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O10P1","C6H10O10P1",274.0089835,275.0168086,273.0011585
"cpd:C05411","L-Xylonate;","C5H10O6","L-Xylonate; L-Xylonic acid","R04515","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism","4.1.1.-",NA,NA,"PubChem: 7777; ChEBI: 48092; 3DMET: B05019; NIKKAJI: J2.367.490D","cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646",5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O6","C5H9O6",166.047738,167.0555631,165.039913
"cpd:C05412","L-Lyxonate;","C5H10O6","L-Lyxonate; L-Lyxonic acid","R04784","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism","4.1.1.-",NA,NA,"PubChem: 7778; ChEBI: 6268; 3DMET: B05020; NIKKAJI: J237.995C","cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646",5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O6","C5H9O6",166.047738,167.0555631,165.039913
"cpd:C06118","4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate;","C12H16O12","4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate; 4-(4-Deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate; Unsaturated digalacturonate","R02361 R04382","Pentose and glucuronate interconversions","4.2.2.2; 4.2.2.6; 4.2.2.9",NA,NA,"PubChem: 8378; ChEBI: 27450; PDB-CCD: UNF; 3DMET: B01975; NIKKAJI: J2.761.155I","cpd:C03893; cpd:C04733; cpd:C06118",12,16,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H17O12","C12H15O12",352.064176,353.072001,351.0563509
"cpd:C06441","L-Xylulose 1-phosphate","C5H11O8P","L-Xylulose 1-phosphate","R01785 R01902","Pentose and glucuronate interconversions","2.7.1.5; 4.1.2.19",NA,NA,"PubChem: 8675; ChEBI: 28566; 3DMET: B05194; NIKKAJI: J2.765.415K","cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814",5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O8P1","C5H10O8P1",230.0191543,231.0269793,229.0113293
"cpd:C14899","3-Dehydro-L-gulonate 6-phosphate","C6H11O10P","3-Dehydro-L-gulonate 6-phosphate","R07125 R07127 R07677","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments","2.7.1.53; 3.1.1.-; 4.1.1.85","Ascorbate degradation, ascorbate => D-xylulose-5P",NA,"PubChem: 17395897; ChEBI: 49039; NIKKAJI: J2.790.402E","cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899",6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O10P1","C6H10O10P1",274.0089835,275.0168086,273.0011585
"cpd:C15930","L-Galactonate;","C6H12O7","L-Galactonate; L-Galactonic acid","R07676 R07680 R10532 R10565","Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.365; 1.1.1.-; 3.1.1.-; 4.2.1.146","D-Galacturonate degradation (fungi), D-galacturonate => glycerol",NA,"PubChem: 47205248; ChEBI: 37425; PDB-CCD: 2Q2; NIKKAJI: J351.183I","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C20680","2-Dehydro-3-deoxy-L-galactonate;","C6H10O6","2-Dehydro-3-deoxy-L-galactonate; 2-Keto-3-deoxy-L-galactonate; L-threo-3-Deoxy-hexulosonate","R10532 R10550 R10900 R11035","Pentose and glucuronate interconversions; Metabolic pathways","1.1.1.389; 4.1.2.54; 4.2.1.146; 5.5.1.25","D-Galacturonate degradation (fungi), D-galacturonate => glycerol",NA,"PubChem: 172232400","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C00095","D-Fructose;","C6H12O6","D-Fructose; Levulose; Fruit sugar; D-arabino-Hexulose","R00307 R00760 R00801 R00803 R00806 R00865 R00866 R00867; R00868 R00870 R00872 R00873 R00874 R00875 R00876 R00877; R00878 R00879 R01140 R01823 R02120 R02410 R03232 R03635; R03921 R06034 R06036 R06052 R06066 R06087 R06100 R06101; R06208 R08406 R08407 R08548 R08651 R08676 R10817","Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism; Metabolic pathways; Microbial metabolism in diverse environments; ABC transporters; Phosphotransferase system (PTS); Taste transduction; Insulin resistance; Carbohydrate digestion and absorption","1.1.1.11; 1.1.1.14; 1.1.1.15; 1.1.1.67; 1.1.1.124; 1.1.1.138; 1.1.2.2; 1.1.99.11; 1.1.99.28; 2.4.1.4; 2.4.1.5; 2.4.1.7; 2.4.1.13; 2.4.1.125; 2.7.1.1; 2.7.1.3; 2.7.1.4; 2.7.1.61; 2.7.1.202; 3.1.3.68; 3.1.3.-; 3.2.1.10; 3.2.1.20; 3.2.1.26; 3.2.1.48; 3.2.1.80; 5.1.3.30; 5.1.3.31; 5.3.1.5; 5.3.1.7",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00095  D-Fructose; Fruit sugar; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9642  Fructose and preparations;     C00095  D-Fructose","CAS: 57-48-7; PubChem: 3395; ChEBI: 15824 37721; ChEMBL: CHEMBL604608; KNApSAcK: C00033848; PDB-CCD: FRU; 3DMET: B04631; NIKKAJI: J4.580B","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00096","GDP-mannose;","C16H25N5O16P2","GDP-mannose; GDP-D-mannose; GDP-alpha-D-mannose","R00880 R00881 R00883 R00885 R00887 R00888 R00889 R00890; R01009 R03768 R03769 R03829 R03924 R04082 R04331 R04502; R05002 R05768 R07257 R07672 R08858 R08947 R09666 R09667; R09733 R09734","Fructose and mannose metabolism; Ascorbate and aldarate metabolism; N-Glycan biosynthesis; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","1.1.1.132; 2.4.1.32; 2.4.1.48; 2.4.1.54; 2.4.1.83; 2.4.1.110; 2.4.1.132; 2.4.1.142; 2.4.1.217; 2.4.1.246; 2.4.1.251; 2.4.1.252; 2.4.1.269; 2.4.1.270; 2.4.1.-; 2.7.7.13; 2.7.7.22; 2.7.8.9; 3.6.1.21; 3.6.1.-; 4.2.1.47; 5.1.3.18","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"CAS: 3123-67-9; PubChem: 3396; ChEBI: 15820; KNApSAcK: C00007246; PDB-CCD: GDD; 3DMET: B01158; NIKKAJI: J247.698C","cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925",16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O16N5P2","C16H24O16N5P2",605.0771537,606.0849788,604.0693287
"cpd:C00159","D-Mannose;","C6H12O6","D-Mannose; Mannose; Seminose; Carubinose","R00877 R01326 R01327 R01328 R01329 R01330 R01331 R01332; R02630 R05698 R05816 R05982 R05984 R06142 R06149 R06150; R06151 R06207 R06722 R07135 R08405 R08613 R08614 R08717; R08718 R10809 R11398","Fructose and mannose metabolism; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Lysosome","1.1.1.255; 1.1.3.40; 2.4.1.339; 2.7.1.1; 2.7.1.7; 2.7.1.61; 2.7.1.191; 3.1.4.49; 3.2.1.22; 3.2.1.24; 3.2.1.25; 3.2.1.77; 3.2.1.78; 3.2.1.113; 3.2.1.114; 3.2.1.137; 3.2.1.163; 5.3.1.7",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00159  D-Mannose","CAS: 3458-28-4 31103-86-3; PubChem: 3459; ChEBI: 4208; ChEMBL: CHEMBL469448 CHEMBL98182; PDB-CCD: BMA MAN; 3DMET: B04642; NIKKAJI: J82.111J","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00247","L-Sorbose;","C6H12O6","L-Sorbose; L-xylo-Hexulose","R01694 R01695 R01696 R01697 R02925 R04076 R07145 R07346; R09551","Fructose and mannose metabolism","1.1.1.14; 1.1.1.123; 1.1.1.289; 1.1.3.11; 1.1.99.12; 1.1.99.21; 1.1.99.32; 2.7.1.206",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00247  L-Sorbose","CAS: 87-79-6; PubChem: 3546; ChEBI: 48649; PDB-CCD: SOE; 3DMET: B04653; NIKKAJI: J4.280C","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00275","D-Mannose 6-phosphate","C6H13O9P","D-Mannose 6-phosphate","R00772 R01326 R01327 R01330 R01817 R01818 R01819 R02630; R08405 R09645 R11439","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Phosphotransferase system (PTS); Lysosome","1.1.1.224; 2.5.1.132; 2.7.1.1; 2.7.1.7; 2.7.1.61; 2.7.1.191; 3.2.1.170; 5.3.1.8; 5.4.2.8","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"PubChem: 3572; ChEBI: 17369 48066; ChEMBL: CHEMBL402001; PDB-CCD: M6D M6P; 3DMET: B01204; NIKKAJI: J817.412A","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C00325","GDP-L-fucose;","C16H25N5O15P2","GDP-L-fucose; GDP-beta-L-fucose","R01951 R03519 R04081 R04553 R04646 R05106 R05692 R07060; R10439","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","1.1.1.271; 2.4.1.65; 2.4.1.69; 2.4.1.152; 2.4.1.308; 2.7.7.30",NA,NA,"PubChem: 3619; ChEBI: 13332 17009; ChEMBL: CHEMBL1229250; PDB-CCD: GFB; 3DMET: B04668; NIKKAJI: J272.491J","cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192",16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O15N5P2","C16H24O15N5P2",589.0822391,590.0900642,588.0744141
"cpd:C00392","Mannitol;","C6H14O6","Mannitol; D-Mannitol","R00865 R00868 R00870 R02167 R02704 R05698 R07135","Fructose and mannose metabolism; ABC transporters; Phosphotransferase system (PTS)","1.1.1.11; 1.1.1.67; 1.1.1.138; 1.1.1.255; 1.1.2.2; 1.1.3.40; 2.7.1.197; 3.1.3.22",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00392  Mannitol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AD Osmotically acting laxatives;      A06AD16 Mannitol;       D00062  Mannitol (USP);  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05B I.V. SOLUTIONS;     B05BC Solutions producing osmotic diuresis;      B05BC01 Mannitol;       D00062  Mannitol (USP);    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX04 Mannitol;       D00062  Mannitol (USP);  R RESPIRATORY SYSTEM;   R05 COUGH AND COLD PREPARATIONS;    R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;     R05CB Mucolytics;      R05CB16 Mannitol;       D00062  Mannitol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D00062  Mannitol (USP); D-Mannitol (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00062  [009007] D-Mannitol;  Solubilizing agent;   D00062  [009007] D-Mannitol;  Sweetening agent;   D00062  [009007] D-Mannitol;  Base;   D00062  [009007] D-Mannitol;  Flavoring substance;   D00062  [009007] D-Mannitol;  Bonding agent;   D00062  [009007] D-Mannitol;  Suspending agent;   D00062  [009007] D-Mannitol;  Coating agent;   D00062  [009007] D-Mannitol;  Sugarcoated agent;   D00062  [009007] D-Mannitol;  Tonicity agent;   D00062  [009007] D-Mannitol;  Diluting agent;   D00062  [009007] D-Mannitol;  Disintegrant;   D00062  [009007] D-Mannitol;  Solubilization agent;   D00062  [009007] D-Mannitol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00062  D-Mannitol;   D00062  D-Mannitol injection; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00062","CAS: 69-65-8; PubChem: 3682; ChEBI: 16899; ChEMBL: CHEMBL689; KNApSAcK: C00001165; PDB-CCD: MTL; 3DMET: B04676; NIKKAJI: J2.369H","cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862",6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O6","C6H13O6",182.0790382,183.0868632,181.0712131
"cpd:C00424","(S)-Lactaldehyde;","C3H6O2","(S)-Lactaldehyde; L-Lactaldehyde; L-2-Hydroxypropionaldehyde","R01446 R02257 R02258 R02259 R02260 R02261 R02262 R02263; R10715","Fructose and mannose metabolism; Pyruvate metabolism; Propanoate metabolism; Microbial metabolism in diverse environments","1.1.1.6; 1.1.1.55; 1.1.1.77; 1.1.1.283; 1.2.1.22; 1.2.1.49; 4.1.2.17; 4.1.2.19; 4.1.2.53",NA,NA,"CAS: 3913-64-2; PubChem: 3714; ChEBI: 18041; KNApSAcK: C00019649; 3DMET: B01242; NIKKAJI: J2.715D","cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530",3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O2","C3H5O2",74.03677943,75.04460446,73.0289544
"cpd:C00507","L-Rhamnose;","C6H12O5","L-Rhamnose; 6-Deoxy-L-mannose; L-Mannomethylose; L-Rhamnopyranose","R02436 R02437 R02438 R09632 R10098 R10581 R10582 R10788; R10995","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.377; 1.1.1.378; 2.4.1.247; 2.4.1.282; 3.2.1.66; 3.2.1.189; 3.2.1.190; 5.3.1.14",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C00507  L-Rhamnose","CAS: 3615-41-6 73-34-7; PubChem: 3790; ChEBI: 62345 62346; PDB-CCD: RAM RM4; 3DMET: B04689; NIKKAJI: J8.185J","cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058",6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O5","C6H11O5",164.0684735,165.0762985,163.0606485
"cpd:C00636","D-Mannose 1-phosphate;","C6H13O9P","D-Mannose 1-phosphate; alpha-D-Mannose 1-phosphate","R00881 R00883 R00885 R01818 R02677 R09943 R10811 R10829; R11397 R11398 R11429","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of enediyne antibiotics; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.4.1.281; 2.4.1.319; 2.4.1.320; 2.4.1.339; 2.4.1.340; 2.7.7.13; 2.7.7.22; 3.6.1.21; 3.6.1.-; 5.4.2.8","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"PubChem: 3909; ChEBI: 18205 35374; ChEMBL: CHEMBL291890; KNApSAcK: C00007389; PDB-CCD: M1P; 3DMET: B01296; NIKKAJI: J313.724D","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C00644","D-Mannitol 1-phosphate","C6H15O9P","D-Mannitol 1-phosphate","R00758 R01817 R02167 R02703 R02704","Fructose and mannose metabolism; Phosphotransferase system (PTS)","1.1.1.17; 1.1.1.224; 2.7.1.197; 3.1.3.22",NA,NA,"CAS: 15806-48-1; PubChem: 3917; ChEBI: 16298; ChEMBL: CHEMBL1161480; KNApSAcK: C00019638; 3DMET: B04709; NIKKAJI: J923.291E","cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311",6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H16O9P1","C6H14O9P1",262.0453691,263.0531941,261.037544
"cpd:C00665","beta-D-Fructose 2,6-bisphosphate;","C6H14O12P2","beta-D-Fructose 2,6-bisphosphate; D-Fructose 2,6-bisphosphate","R00763 R02730 R02731 R02732","Fructose and mannose metabolism; AMPK signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer","2.7.1.105; 3.1.3.46; 3.1.3.54",NA,NA,"PubChem: 3934; ChEBI: 28602; PDB-CCD: FDP; 3DMET: B01302; NIKKAJI: J470.690K","cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378",6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O12P2","C6H13O12P2",339.9960499,341.0038749,338.9882249
"cpd:C00794","D-Sorbitol;","C6H14O6","D-Sorbitol; D-Glucitol; L-Gulitol; Sorbitol","R00874 R00875 R01697 R01787 R02865 R02866 R02867 R02868; R02925 R02926 R05820 R07346","Fructose and mannose metabolism; Galactose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS)","1.1.1.14; 1.1.1.15; 1.1.1.21; 1.1.1.289; 1.1.99.21; 1.1.99.28; 2.7.1.1; 2.7.1.198; 3.1.3.50; 3.2.1.22",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00794  Sorbitol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AD Osmotically acting laxatives;      A06AD18 Sorbitol;       D00096  D-Sorbitol (JP17);     A06AG Enemas;      A06AG07 Sorbitol;       D00096  D-Sorbitol (JP17);  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX02 Sorbitol;       D00096  D-Sorbitol (JP17);  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CC Tests for bile duct patency;      V04CC01 Sorbitol;       D00096  D-Sorbitol (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   25  Urogenital and anal organ agents;    251  Urinary organ agents;     2519  Others;      D00096  D-Sorbitol (JP17); Sorbitol (NF);  7  Agents not mainly for therapeutic purpose;   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D00096  D-Sorbitol (JP17); Sorbitol (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    D-Sorbitol;     D00096  D-Sorbitol (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Plasticizer;   D00096  [002244] D-Sorbitol;  Sweetening agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Base;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Flavoring substance;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Bonding agent;   D00096  [002244] D-Sorbitol;  Suspending agent;   D00096  [002244] D-Sorbitol;  Coating agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Film;   D00096  [002244] D-Sorbitol;  Wetting agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Tonicity agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Emulsion;   D00096  [002244] D-Sorbitol;  Tenacious agent;   D00096  [002245] D-Sorbitol solution;  Diluting agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Dispersant;   D00096  [002244] D-Sorbitol;  Preserving agent;   D00096  [002244] D-Sorbitol;  Solubilization agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00096  D-Sorbitol;   D00096  D-Sorbitol solution; Gastrointestinal agents [br08371.html];  Cathartic agent, antidiarrheal agent, intestinal regulator;   D00096","CAS: 50-70-4; PubChem: 4052; ChEBI: 17924; ChEMBL: CHEMBL1682; KNApSAcK: C00001173; PDB-CCD: SOR; 3DMET: B04724; NIKKAJI: J2.299C","cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862",6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O6","C6H13O6",182.0790382,183.0868632,181.0712131
"cpd:C00861","L-Rhamnulose;","C6H12O5","L-Rhamnulose; 6-Deoxy-L-fructose","R02437 R03014","Fructose and mannose metabolism; Microbial metabolism in diverse environments","2.7.1.5; 5.3.1.14",NA,NA,"PubChem: 4118; ChEBI: 17897; KNApSAcK: C00019652; 3DMET: B01346; NIKKAJI: J1.739.241G","cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058",6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O5","C6H11O5",164.0684735,165.0762985,163.0606485
"cpd:C00976","GDP-D-mannuronate;","C16H23N5O17P2","GDP-D-mannuronate; GDP-D-mannuronic acid","R00880 R03129 R08692","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism","1.1.1.132; 2.4.1.33",NA,NA,"PubChem: 4225; ChEBI: 85507; PDB-CCD: GDX; 3DMET: B04752; NIKKAJI: J2.731.034F","cpd:C00976",16,23,17,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H24O17N5P2","C16H22O17N5P2",619.0564183,620.0642433,618.0485933
"cpd:C01019","6-Deoxy-L-galactose;","C6H12O5","6-Deoxy-L-galactose; L-Fucose","R03161 R03162 R03163 R04270 R06118 R08926","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Two-component system; Quorum sensing","1.1.1.122; 2.7.1.52; 3.2.1.51; 3.2.1.63; 5.3.1.3; 5.3.1.25",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C01019  L-Fucose","CAS: 2438-80-4; PubChem: 4264; ChEBI: 2181; ChEMBL: CHEMBL469449; KNApSAcK: C00035100; PDB-CCD: FUC FUL; 3DMET: B04756; NIKKAJI: J92.797J","cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058",6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O5","C6H11O5",164.0684735,165.0762985,163.0606485
"cpd:C01094","D-Fructose 1-phosphate","C6H13O9P","D-Fructose 1-phosphate","R00866 R02071 R02568 R03232 R08407 R08548 R10050","Fructose and mannose metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Phosphotransferase system (PTS)","2.2.1.11; 2.7.1.3; 2.7.1.56; 2.7.1.61; 2.7.1.202; 3.1.3.68; 4.1.2.13",NA,NA,"CAS: 15978-08-2; PubChem: 4329; ChEBI: 18105 37515; ChEMBL: CHEMBL605021; KNApSAcK: C00019676; PDB-CCD: F1X; 3DMET: B04765; NIKKAJI: J219.923H","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C01096","Sorbitol 6-phosphate;","C6H15O9P","Sorbitol 6-phosphate; D-Sorbitol 6-phosphate; D-Glucitol 6-phosphate","R00834 R02865 R02866 R02867 R02868 R03234 R05607 R05820; R07133","Fructose and mannose metabolism; Phosphotransferase system (PTS)","1.1.1.140; 1.1.1.200; 1.1.1.-; 2.7.1.1; 2.7.1.198; 3.1.3.50",NA,NA,"CAS: 20479-58-7; PubChem: 4331; ChEBI: 17044; PDB-CCD: S6P; 3DMET: B04766; NIKKAJI: J728.846H","cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311",6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H16O9P1","C6H14O9P1",262.0453691,263.0531941,261.037544
"cpd:C01099","L-Fuculose 1-phosphate","C6H13O8P","L-Fuculose 1-phosphate","R02262 R03241","Fructose and mannose metabolism; Microbial metabolism in diverse environments","2.7.1.51; 4.1.2.17",NA,NA,"PubChem: 4333; ChEBI: 16647 6220; KNApSAcK: C00019651; 3DMET: B01377; NIKKAJI: J1.419.302B","cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369",6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O8P1","C6H12O8P1",244.0348044,245.0426294,243.0269793
"cpd:C01131","L-Rhamnulose 1-phosphate","C6H13O8P","L-Rhamnulose 1-phosphate","R02263 R03014","Fructose and mannose metabolism; Microbial metabolism in diverse environments","2.7.1.5; 4.1.2.19",NA,NA,"CAS: 444-09-7; PubChem: 4362; ChEBI: 17892; KNApSAcK: C00019653; 3DMET: B01389; NIKKAJI: J2.731.617D","cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369",6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O8P1","C6H12O8P1",244.0348044,245.0426294,243.0269793
"cpd:C01222","GDP-4-dehydro-6-deoxy-D-mannose;","C16H23N5O15P2","GDP-4-dehydro-6-deoxy-D-mannose; GDP-4-dehydro-6-deoxy-D-talose; GDP-4-oxo-6-deoxy-D-mannose; GDP-4-dehydro-D-rhamnose; GDP-4-keto-6-deoxy-D-mannose; GDP-4-dehydro-alpha-D-rhamnose; GDP-4-dehydro-6-deoxy-alpha-D-mannose","R00888 R03396 R03397 R03398 R03399 R05692 R07059 R10460; R11409","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","1.1.1.135; 1.1.1.187; 1.1.1.271; 1.1.1.281; 2.6.1.102; 4.2.1.47; 4.2.1.168",NA,NA,"PubChem: 4444; ChEBI: 16955; KNApSAcK: C00007244; 3DMET: B01413; NIKKAJI: J945.361J","cpd:C01222; cpd:C05344; cpd:C14830",16,23,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H24O15N5P2","C16H22O15N5P2",587.0665891,588.0744141,586.058764
"cpd:C01487","D-Allose","C6H12O6","D-Allose","R03576","Fructose and mannose metabolism; Microbial metabolism in diverse environments; ABC transporters","2.7.1.55",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01487  D-Allose","CAS: 2595-97-3; PubChem: 4657; ChEBI: 4093; ChEMBL: CHEMBL1222152; PDB-CCD: AFD ALL; 3DMET: B04798; NIKKAJI: J14.386C","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C01720","L-Fuconate","C6H12O6","L-Fuconate","R03688 R10689","Fructose and mannose metabolism; Microbial metabolism in diverse environments","3.1.1.-; 4.2.1.68",NA,NA,"CAS: 26372-13-4; PubChem: 4857; ChEBI: 17291 21291; PDB-CCD: LFC; NIKKAJI: J1.694.210C","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C01721","L-Fuculose;","C6H12O5","L-Fuculose; 6-Deoxy-L-tagatose","R03163 R03241","Fructose and mannose metabolism; Microbial metabolism in diverse environments","2.7.1.51; 5.3.1.3; 5.3.1.25",NA,NA,"PubChem: 4858; ChEBI: 17617; KNApSAcK: C00019650; PDB-CCD: CVU; 3DMET: B01487; NIKKAJI: J37.412A","cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058",6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O5","C6H11O5",164.0684735,165.0762985,163.0606485
"cpd:C01934","L-Rhamnonate;","C6H12O6","L-Rhamnonate; 6-Deoxy-L-mannonic acid","R03772 R03774","Fructose and mannose metabolism; Microbial metabolism in diverse environments","3.1.1.65; 4.2.1.90",NA,NA,"CAS: 6422-34-0; PubChem: 5039; ChEBI: 17357 21376; 3DMET: B04824; NIKKAJI: J13.859B","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C02431","L-Rhamnofuranose","C6H12O5","L-Rhamnofuranose","R02438 R03942","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.173",NA,NA,"PubChem: 5458; ChEBI: 16935; 3DMET: B04851; NIKKAJI: J2.367.210C","cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058",6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O5","C6H11O5",164.0684735,165.0762985,163.0606485
"cpd:C02888","Sorbose 1-phosphate;","C6H13O9P","Sorbose 1-phosphate; L-Sorbose 1P; L-xylo-Hexulose 1-phosphate; L-Sorbose 1-phosphate","R03234 R04076","Fructose and mannose metabolism; Phosphotransferase system (PTS)","1.1.1.-; 2.7.1.206",NA,NA,"PubChem: 5819; ChEBI: 38342; KNApSAcK: C00019630; 3DMET: B01609; NIKKAJI: J2.743.651J","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C02962","D-Allose 6-phosphate","C6H13O9P","D-Allose 6-phosphate","R03576 R09030","Fructose and mannose metabolism; Microbial metabolism in diverse environments","2.7.1.55; 5.3.1.6",NA,NA,"PubChem: 5878; ChEBI: 17942; PDB-CCD: A6P; NIKKAJI: J2.740.279H","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C02977","GDP-6-deoxy-D-talose;","C16H25N5O15P2","GDP-6-deoxy-D-talose; GDP-6-deoxy-alpha-D-talose","R03396 R03398","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism","1.1.1.135; 1.1.1.187",NA,NA,"PubChem: 5888; ChEBI: 16097; ChEMBL: CHEMBL1208550 CHEMBL609921; 3DMET: B04871; NIKKAJI: J1.849.863D","cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192",16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O15N5P2","C16H24O15N5P2",589.0822391,590.0900642,588.0744141
"cpd:C02985","L-Fucose 1-phosphate;","C6H13O8P","L-Fucose 1-phosphate; 6-Deoxy-L-galactose 1-phosphate; beta-L-Fucose 1-phosphate","R01951 R03161","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","2.7.1.52; 2.7.7.30",NA,NA,"PubChem: 5894; ChEBI: 12387 28319; 3DMET: B04872; NIKKAJI: J840.342B","cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369",6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O8P1","C6H12O8P1",244.0348044,245.0426294,243.0269793
"cpd:C02991","L-Rhamnono-1,4-lactone;","C6H10O5","L-Rhamnono-1,4-lactone; L-Rhamno-1,4-lactone","R03772 R03942 R10788 R10995","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.173; 1.1.1.377; 1.1.1.378; 3.1.1.65",NA,NA,"PubChem: 5900; ChEBI: 17937; 3DMET: B01616; NIKKAJI: J1.153.839H","cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335",6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O5","C6H9O5",162.0528234,163.0606485,161.0449984
"cpd:C03117","GDP-6-deoxy-D-mannose;","C16H25N5O15P2","GDP-6-deoxy-D-mannose; GDP-D-rhamnose; GDP-6-deoxy-alpha-D-mannose; GDP-alpha-D-rhamnose","R03397 R03399","Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism","1.1.1.187; 1.1.1.281",NA,NA,"PubChem: 6011; ChEBI: 17661; ChEMBL: CHEMBL609921; PDB-CCD: GDR; 3DMET: B01633; NIKKAJI: J1.485.223I","cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192",16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O15N5P2","C16H24O15N5P2",589.0822391,590.0900642,588.0744141
"cpd:C03267","beta-D-Fructose 2-phosphate;","C6H13O9P","beta-D-Fructose 2-phosphate; beta-D-Fructofuranose 2-phosphate","R00872 R02730","Fructose and mannose metabolism","3.1.3.54; 3.1.3.-",NA,NA,"PubChem: 6130; ChEBI: 12350; 3DMET: B01644; NIKKAJI: J2.741.446J","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C03827","2-Dehydro-3-deoxy-L-fuconate","C6H10O5","2-Dehydro-3-deoxy-L-fuconate","R03688 R10690","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.-; 4.2.1.68",NA,NA,"PubChem: 6570; ChEBI: 16950; NIKKAJI: J2.751.180E","cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335",6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O5","C6H9O5",162.0528234,163.0606485,161.0449984
"cpd:C03979","2-Dehydro-3-deoxy-L-rhamnonate","C6H10O5","2-Dehydro-3-deoxy-L-rhamnonate","R02261 R03774 R11339","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.401; 4.1.2.53; 4.2.1.90",NA,NA,"PubChem: 6696; ChEBI: 18078; 3DMET: B04919; NIKKAJI: J2.745.065B","cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335",6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O5","C6H9O5",162.0528234,163.0606485,161.0449984
"cpd:C06192","ADP-mannose;","C16H25N5O15P2","ADP-mannose; APD-D-mannose","R02677","Fructose and mannose metabolism","3.6.1.21",NA,NA,"PubChem: 8442; ChEBI: 28845; 3DMET: B01990; NIKKAJI: J811.607E","cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192",16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O15N5P2","C16H24O15N5P2",589.0822391,590.0900642,588.0744141
"cpd:C11516","2-(alpha-D-Mannosyl)-3-phosphoglycerate","C9H17O12P","2-(alpha-D-Mannosyl)-3-phosphoglycerate","R05768 R05790","Fructose and mannose metabolism","2.4.1.217; 3.1.3.70",NA,NA,"PubChem: 13686; ChEBI: 16351; NIKKAJI: J2.774.854F","cpd:C11516; cpd:C16699; cpd:C19791; cpd:C21383",9,17,12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H18O12P1","C9H16O12P1",348.045763,349.053588,347.0379379
"cpd:C11544","2-O-(alpha-D-Mannosyl)-D-glycerate;","C9H16O9","2-O-(alpha-D-Mannosyl)-D-glycerate; alpha-Mannosylglycerate; 2-O-(alpha-D-Mannopyranosyl)-D-glycerate","R05790 R09666 R11169","Fructose and mannose metabolism; Phosphotransferase system (PTS)","2.4.1.269; 2.7.1.195; 3.1.3.70",NA,NA,"PubChem: 13711; ChEBI: 15847; PDB-CCD: 2M8; NIKKAJI: J2.662.226C","cpd:C11544; cpd:C19792; cpd:C20934",9,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H17O9","C9H15O9",268.0794321,269.0872571,267.0716071
"cpd:C18028","L-Fucono-1,5-lactone","C6H10O5","L-Fucono-1,5-lactone","R08926 R10689","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.122; 3.1.1.-",NA,NA,"PubChem: 96024248; ChEBI: 81457","cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335",6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O5","C6H9O5",162.0528234,163.0606485,161.0449984
"cpd:C18096","D-Allulose 6-phosphate","C6H13O9P","D-Allulose 6-phosphate","R09030 R09031","Fructose and mannose metabolism; Microbial metabolism in diverse environments","5.1.3.-; 5.3.1.6",NA,NA,"PubChem: 96024313; ChEBI: 81499; NIKKAJI: J2.640.215H","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C20781","2,4-Diketo-3-deoxy-L-fuconate;","C6H8O5","2,4-Diketo-3-deoxy-L-fuconate; 2,4-Diketo-3-deoxy-L-rhamnonate; 2,4-Didehydro-3-deoxy-L-rhamnonate","R10690 R10691 R11339","Fructose and mannose metabolism; Microbial metabolism in diverse environments","1.1.1.401; 1.1.1.-; 3.7.1.-",NA,NA,"PubChem: 254741248","cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781",6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O5","C6H7O5",160.0371734,161.0449984,159.0293483
"cpd:C00052","UDP-alpha-D-galactose;","C15H24N2O17P2","UDP-alpha-D-galactose; UDP-D-galactose; UDP-galactose; UDP-D-galactopyranose; UDP-alpha-D-galactopyranose","R00291 R00501 R00502 R00503 R00504 R00505 R00506 R00809; R00853 R00854 R00955 R01192 R01205 R01500 R01535 R01928; R01997 R02691 R02791 R03354 R03380 R03486 R03679 R03981; R04016 R04322 R04334 R04431 R04469 R04495 R04531 R04548; R04610 R04631 R04644 R05080 R05107 R05110 R05111 R06808; R09753 R09755 R10240 R10432 R10433 R10436 R10440 R10804; R10865","Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","1.1.1.-; 2.4.1.22; 2.4.1.23; 2.4.1.37; 2.4.1.38; 2.4.1.44; 2.4.1.46; 2.4.1.47; 2.4.1.50; 2.4.1.62; 2.4.1.74; 2.4.1.86; 2.4.1.87; 2.4.1.90; 2.4.1.96; 2.4.1.122; 2.4.1.123; 2.4.1.137; 2.4.1.156; 2.4.1.167; 2.4.1.179; 2.4.1.205; 2.4.1.228; 2.4.1.234; 2.4.1.241; 2.4.1.272; 2.4.1.274; 2.4.1.275; 2.4.1.294; 2.4.1.303; 2.4.1.304; 2.4.1.309; 2.4.1.-; 2.7.7.10; 2.7.7.12; 2.7.7.64; 2.7.8.6; 2.7.8.18; 5.1.3.2; 5.4.99.9","Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",NA,"CAS: 2956-16-3; PubChem: 3354; ChEBI: 18307 67119; ChEMBL: CHEMBL1742482 CHEMBL439009; KNApSAcK: C00007390; PDB-CCD: GDU; 3DMET: B04625; NIKKAJI: J247.696G","cpd:C00029; cpd:C00052; cpd:C03733",15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H25O17N2P2","C15H23O17N2P2",566.0550213,567.0628463,565.0471963
"cpd:C00089","Sucrose;","C12H22O11","Sucrose; Cane sugar; Saccharose; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside","R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807; R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411; R04194 R05140 R07256 R08616 R08676","Galactose metabolism; Starch and sucrose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Taste transduction; Carbohydrate digestion and absorption","1.1.99.13; 2.4.1.4; 2.4.1.5; 2.4.1.7; 2.4.1.9; 2.4.1.10; 2.4.1.13; 2.4.1.82; 2.4.1.99; 2.4.1.125; 2.4.1.166; 2.4.1.167; 2.7.1.211; 3.1.3.24; 3.2.1.10; 3.2.1.20; 3.2.1.22; 3.2.1.26; 3.2.1.48; 5.4.99.11",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00089  Sucrose; Cane sugar; Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00025  Sucrose (JP17/NF); White soft sugar (JP17); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    White soft sugar;     D00025  Sucrose (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Lubricating agent;   D00025  [500313] White soft sugar;  Sweetening agent;   D00025  [110635] Liquid sugar;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Base;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Flavoring substance;   D00025  [110635] Liquid sugar;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Bonding agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Brightening agent;   D00025  [001480] Sucrose;  Coating agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Sugarcoated agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Diluting agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Disintegrant;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Dampproof agent;   D00025  [001480] Sucrose;  Antiseptic agent;   D00025  [500313] White soft sugar;  Solubilizer;   D00025  [500313] White soft sugar;  Solubilization agent;   D00025  [500313] White soft sugar; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    Chemoreception;     taste receptor type 1;      Sucrose;       D00025  Sucrose (JP17/NF); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00025  White soft sugar;   D00025  Sucrose","CAS: 57-50-1; PubChem: 3389; ChEBI: 17992; ChEMBL: CHEMBL253582; KNApSAcK: C00001151; PDB-CCD: SUC; 3DMET: B01156; NIKKAJI: J4.581K","cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336",12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H23O11","C12H21O11",342.1162115,343.1240366,341.1083865
"cpd:C00124","D-Galactose;","C6H12O6","D-Galactose; D-Galactopyranose","R01093 R01094 R01095 R01096 R01097 R01098 R01099 R01100; R01101 R01103 R01104 R01105 R01194 R01329 R01678 R02926; R03355 R03617 R03618 R03634 R04019 R04470 R04633 R05112; R05549 R05961 R05994 R06010 R06070 R06091 R06093 R06094; R06096 R06098 R06099 R06114 R06136 R06142 R06152 R06202; R07807 R08544 R10619 R10622 R11171","Galactose metabolism; Metabolic pathways; Bacterial chemotaxis; Phosphotransferase system (PTS); Carbohydrate digestion and absorption; Mineral absorption","1.1.1.21; 1.1.1.48; 1.1.1.120; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.9; 2.7.1.204; 3.1.3.94; 3.2.1.22; 3.2.1.23; 3.2.1.46; 3.2.1.47; 3.2.1.62; 3.2.1.108; 5.1.3.3","Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00124  D-Galactose","CAS: 59-23-4 10257-28-0; PubChem: 3424; ChEBI: 4139; ChEMBL: CHEMBL195923 CHEMBL300520; KNApSAcK: C00019681; PDB-CCD: GAL GLA; 3DMET: B04637; NIKKAJI: J4.597G","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00137","myo-Inositol;","C6H12O6","myo-Inositol; D-myo-Inositol; 1D-myo-Inositol; L-myo-Inositol; 1L-myo-Inositol; meso-Inositol; Inositol; Dambose; Cyclohexitol; Meat sugar; Bios I","R01183 R01184 R01185 R01186 R01187 R01188 R01189 R01190; R01192 R01193 R01194 R01802 R02411 R03418 R04333 R06042; R06071 R06093 R06214 R07279 R07343","Galactose metabolism; Ascorbate and aldarate metabolism; Streptomycin biosynthesis; Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; ABC transporters; Phosphatidylinositol signaling system","1.1.1.18; 1.13.99.1; 2.1.1.39; 2.1.1.40; 2.1.1.129; 2.3.1.72; 2.4.1.67; 2.4.1.82; 2.4.1.123; 2.7.1.64; 2.7.8.11; 3.1.3.25; 3.1.4.44; 3.2.1.22","Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00137  myo-Inositol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA07 Inositol;       D08079  Inositol (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Inositol;     D08079  Inositol (NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D08079  [001062] Inositol;  Diluting agent;   D08079  [001062] Inositol;  Soothing agent;   D08079  [001062] Inositol","CAS: 87-89-8; PubChem: 3437; ChEBI: 17268; ChEMBL: CHEMBL1222251; KNApSAcK: C00001164; PDB-CCD: INS; 3DMET: B00038; NIKKAJI: J4.282J","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00243","Lactose;","C12H22O11","Lactose; 1-beta-D-Galactopyranosyl-4-D-glucopyranose; beta-D-Gal-(1->4)-D-Glc; Milk sugar","R00503 R01100 R01678 R01680 R04393 R05166","Galactose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Carbohydrate digestion and absorption","1.1.99.13; 2.4.1.22; 2.7.1.207; 3.2.1.23; 3.2.1.108; 3.2.1.140",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00243  Lactose; Milk sugar; Pharmaceutical additives [BR:br08316];  Diluting agent;   D00046  [107790] Anhydrous lactose; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00046  Anhydrous lactose","CAS: 63-42-3; PubChem: 3542; ChEBI: 17716; ChEMBL: CHEMBL417016; KNApSAcK: C00001136; PDB-CCD: LAT LBT; 3DMET: B01199; NIKKAJI: J353.435I","cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336",12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H23O11","C12H21O11",342.1162115,343.1240366,341.1083865
"cpd:C00446","alpha-D-Galactose 1-phosphate;","C6H13O9P","alpha-D-Galactose 1-phosphate; alpha-D-Galactopyranose 1-phosphate","R00502 R00955 R01092 R02329 R05326 R06057 R09632 R10622","Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","2.4.1.211; 2.4.1.247; 2.7.1.6; 2.7.7.10; 2.7.7.12; 2.7.7.32; 2.7.7.64; 3.1.3.94","Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",NA,"CAS: 2255-14-3; PubChem: 3734; ChEBI: 17973; ChEMBL: CHEMBL1159526; KNApSAcK: C00007391; PDB-CCD: GL1; 3DMET: B01244; NIKKAJI: J92.787B","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C00492","Raffinose;","C18H32O16","Raffinose; Melitose; Melitriose; Gossypose; 6G-alpha-D-galactosylsucrose","R00039 R01103 R02410 R02411 R03418 R03634 R08616","Galactose metabolism; ABC transporters","2.4.1.67; 2.4.1.82; 2.4.1.166; 3.2.1.22; 3.2.1.26",NA,NA,"CAS: 512-69-6; PubChem: 3775; ChEBI: 16634; ChEMBL: CHEMBL175500 CHEMBL603717; KNApSAcK: C00001145; PDB-CCD: RAF; 3DMET: B01266; NIKKAJI: J9.760H","cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454",18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H33O16","C18H31O16",504.1690349,505.17686,503.1612099
"cpd:C00795","D-Tagatose;","C6H12O6","D-Tagatose; lyxo-Hexulose","R02927 R02928 R10818","Galactose metabolism","1.1.1.16; 2.7.1.101; 5.1.3.31",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00795  D-Tagatose","CAS: 87-81-0; PubChem: 4053; ChEBI: 4249; PDB-CCD: T6T; 3DMET: B04725; NIKKAJI: J9.874D","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C00880","D-Galactonate;","C6H12O7","D-Galactonate; D-Galactonic acid","R01098 R03033 R03034 R10604","Galactose metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.1.3.9; 3.1.1.25; 4.2.1.6; 4.2.1.140","Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"CAS: 576-36-3; PubChem: 4136; ChEBI: 12931 16534; 3DMET: B04742; NIKKAJI: J82.117I","cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930",6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O7","C6H11O7",196.0583027,197.0661278,195.0504777
"cpd:C00984","alpha-D-Galactose","C6H12O6","alpha-D-Galactose","R01092 R10619","Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways","2.7.1.6; 5.1.3.3","Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CE Tests for liver functional capacity;      V04CE01 Galactose;       D04291  Galactose (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Galactose;     D04291  Galactose (NF)","CAS: 3646-73-9; PubChem: 4231; ChEBI: 28061; ChEMBL: CHEMBL195923; KNApSAcK: C00001119; PDB-CCD: GLA; NIKKAJI: J292.885J","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C01097","D-Tagatose 6-phosphate","C6H13O9P","D-Tagatose 6-phosphate","R02927 R03236 R03237 R03238 R03239 R03240 R05571 R08365","Galactose metabolism; Metabolic pathways","1.1.1.251; 2.7.1.11; 2.7.1.56; 2.7.1.101; 2.7.1.144; 5.3.1.26; 5.3.1.-",NA,NA,"PubChem: 4332; ChEBI: 4251; PDB-CCD: TA6; 3DMET: B04767; NIKKAJI: J2.731.241A","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C01113","D-Galactose 6-phosphate;","C6H13O9P","D-Galactose 6-phosphate; 6-Phospho-D-galactose","R03240 R03255 R03256 R06110 R11171","Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS)","2.7.1.204; 3.2.1.85; 5.3.1.26",NA,NA,"PubChem: 4345; ChEBI: 17733 4141; ChEMBL: CHEMBL1159525; PDB-CCD: BGP; 3DMET: B04769; NIKKAJI: J2.731.379E","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C01132","N-Acetyl-D-galactosamine;","C8H15NO6","N-Acetyl-D-galactosamine; N-Acetyl-D-chondrosamine; 2-Acetamido-2-deoxy-D-galactose","R03492 R04183 R04184 R04586 R05963 R05966 R06001 R06004; R08366 R08967","Galactose metabolism; Phosphotransferase system (PTS)","2.7.1.157; 2.7.1.162; 2.7.1.-; 3.2.1.49; 3.2.1.52",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C01132  N-Acetyl-D-galactosamine","CAS: 14215-68-0 1811-31-0; PubChem: 4363; ChEBI: 28037; ChEMBL: CHEMBL39064 CHEMBL469447; PDB-CCD: A2G NGA; 3DMET: B04773; NIKKAJI: J199.634G J382.936G","cpd:C00140; cpd:C00645; cpd:C01132; cpd:C02711; cpd:C03136; cpd:C03878; cpd:C05021; cpd:C20328; cpd:C21036; cpd:C21039; cpd:C21049; cpd:C21052; cpd:C21061",8,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H16O6N1","C8H14O6N1",221.0899372,222.0977622,220.0821122
"cpd:C01216","2-Dehydro-3-deoxy-D-galactonate","C6H10O6","2-Dehydro-3-deoxy-D-galactonate","R03033 R03387 R10616","Galactose metabolism; Metabolic pathways; Microbial metabolism in diverse environments","2.7.1.58; 2.7.1.178; 4.1.2.51; 4.1.2.55; 4.2.1.6; 4.2.1.140","Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"PubChem: 4438; ChEBI: 17028; 3DMET: B04784; NIKKAJI: J913.056J","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C01235","alpha-D-Galactosyl-(1->3)-1D-myo-inositol;","C12H22O11","alpha-D-Galactosyl-(1->3)-1D-myo-inositol; O-alpha-D-Galactosyl-(1->3)-1D-myo-inositol; 3-O-alpha-D-Galactosyl-1D-myo-inositol; 1-alpha-D-Galactosyl-myo-inositol; Galactinol","R01192 R01194 R02411 R03418","Galactose metabolism","2.4.1.67; 2.4.1.82; 2.4.1.123; 3.2.1.22",NA,NA,"PubChem: 4456; ChEBI: 17505; 3DMET: B01419; NIKKAJI: J475.283J","cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336",12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H23O11","C12H21O11",342.1162115,343.1240366,341.1083865
"cpd:C01286","2-Dehydro-3-deoxy-6-phospho-D-galactonate;","C6H11O9P","2-Dehydro-3-deoxy-6-phospho-D-galactonate; 2-Dehydro-3-deoxy-D-galactonate 6-phosphate","R01064 R03387","Galactose metabolism; Metabolic pathways","2.7.1.58; 2.7.1.178; 4.1.2.21; 4.1.2.55","D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,"PubChem: 4505; ChEBI: 17860; PDB-CCD: KDP; 3DMET: B04789; NIKKAJI: J1.013.608C","cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668",6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O9P1","C6H10O9P1",258.0140689,259.021894,257.0062439
"cpd:C01613","Stachyose","C24H42O21","Stachyose","R03418 R03634 R03635","Galactose metabolism","2.4.1.67; 3.2.1.22; 3.2.1.26",NA,NA,"CAS: 10094-58-3 470-55-3; PubChem: 4765; ChEBI: 17164; ChEMBL: CHEMBL1625803; KNApSAcK: C00001150; 3DMET: B01470; NIKKAJI: J5.938B","cpd:C00182; cpd:C01613; cpd:C02013; cpd:C02052; cpd:C03989; cpd:C04861; cpd:C08242; cpd:C08248",24,42,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H43O21","C24H41O21",666.2218584,667.2296834,665.2140333
"cpd:C01697","Galactitol;","C6H14O6","Galactitol; Dulcitol; Dulcose","R01093 R01095 R02928 R05570","Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS)","1.1.1.16; 1.1.1.21; 2.7.1.200",NA,NA,"CAS: 608-66-2; PubChem: 4837; ChEBI: 16813; ChEMBL: CHEMBL1773904; KNApSAcK: C00001160; 3DMET: B04809; NIKKAJI: J7.011D","cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862",6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O6","C6H13O6",182.0790382,183.0868632,181.0712131
"cpd:C02262","D-Galactosamine;","C6H13NO5","D-Galactosamine; D-Chondrosamine; 2-Amino-2-deoxy-D-galactose","R08367","Galactose metabolism; Phosphotransferase system (PTS)","2.7.1.-",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C02262  D-Galactosamine","CAS: 7535-00-4; PubChem: 5324; ChEBI: 60312; PDB-CCD: 1GN X6X; 3DMET: B04845; NIKKAJI: J16.141A","cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060",6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O5N1","C6H12O5N1",179.0793725,180.0871976,178.0715475
"cpd:C02669","D-Galactono-1,5-lactone","C6H10O6","D-Galactono-1,5-lactone","R01096 R08544 R10604","Galactose metabolism","1.1.1.48; 1.1.1.120; 1.1.1.121; 1.1.1.359; 1.1.1.360",NA,NA,"CAS: 15892-28-1; PubChem: 5640; ChEBI: 15945; PDB-CCD: 149; NIKKAJI: J426.673K","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C03383","D-Galactono-1,4-lactone;","C6H10O6","D-Galactono-1,4-lactone; gamma-D-Galactonolactone","R01094 R01097 R03034","Galactose metabolism; Metabolic pathways","1.1.1.48; 1.1.1.120; 3.1.1.25",NA,NA,"CAS: 2782-07-2; PubChem: 6218; ChEBI: 15895; ChEMBL: CHEMBL466882; 3DMET: B01654; NIKKAJI: J208.533J","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C03733","UDP-alpha-D-galactofuranose;","C15H24N2O17P2","UDP-alpha-D-galactofuranose; UDP-alpha-D-galacto-1,4-furanose; UDP-D-galacto-1,4-furanose","R00505","Galactose metabolism; Amino sugar and nucleotide sugar metabolism","5.4.99.9",NA,NA,"PubChem: 6496; ChEBI: 67118; NIKKAJI: J794.314H","cpd:C00029; cpd:C00052; cpd:C03733",15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H25O17N2P2","C15H23O17N2P2",566.0550213,567.0628463,565.0471963
"cpd:C03785","D-Tagatose 1,6-bisphosphate","C6H14O12P2","D-Tagatose 1,6-bisphosphate","R01069 R03236 R03237 R03238 R03239","Galactose metabolism; Metabolic pathways","2.7.1.11; 2.7.1.56; 2.7.1.144; 4.1.2.40",NA,NA,"PubChem: 6535; ChEBI: 4250; 3DMET: B04913; NIKKAJI: J2.748.254F","cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378",6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O12P2","C6H13O12P2",339.9960499,341.0038749,338.9882249
"cpd:C05396","Lactose 6'-phosphate","C12H23O14P","Lactose 6'-phosphate","R03256 R04393","Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS)","2.7.1.207; 3.2.1.23; 3.2.1.85",NA,NA,"PubChem: 7765; ChEBI: 28339; 3DMET: B05015; NIKKAJI: J2.755.851H","cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237",12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H24O14P1","C12H22O14P1",422.0825424,423.0903674,421.0747174
"cpd:C05399","Melibiitol;","C12H24O11","Melibiitol; 6-O-alpha-D-Galactosyl-D-glucitol","R02926","Galactose metabolism","3.2.1.22",NA,NA,"PubChem: 7766; ChEBI: 27527; 3DMET: B01853; NIKKAJI: J15.208K","cpd:C05399; cpd:C08254; cpd:C13542",12,24,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H25O11","C12H23O11",344.1318616,345.1396866,343.1240366
"cpd:C05400","Epimelibiose;","C12H22O11","Epimelibiose; 6-O-(alpha-D-Galactopyranosyl)-D-mannopyranose","R01329","Galactose metabolism","3.2.1.22",NA,NA,"CAS: 17296-19-4; PubChem: 7767; ChEBI: 4808; 3DMET: B01854; NIKKAJI: J92.817H","cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336",12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H23O11","C12H21O11",342.1162115,343.1240366,341.1083865
"cpd:C05401","3-beta-D-Galactosyl-sn-glycerol;","C9H18O8","3-beta-D-Galactosyl-sn-glycerol; Galactosylglycerol","R01104 R03467 R03616 R04471","Galactose metabolism; Glycerolipid metabolism","3.1.1.26; 3.2.1.22; 3.2.1.-",NA,NA,"PubChem: 7768; ChEBI: 15754; ChEMBL: CHEMBL446492; PDB-CCD: RGG; 3DMET: B05016; NIKKAJI: J362.297E","cpd:C03492; cpd:C05401; cpd:C11546; cpd:C18910",9,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H19O8","C9H17O8",254.1001675,255.1079926,253.0923425
"cpd:C05402","Melibiose;","C12H22O11","Melibiose; 6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose; D-Gal-alpha1->6D-Glucose","R01101 R02410 R05549","Galactose metabolism; ABC transporters","3.2.1.22; 3.2.1.26",NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C05402  Melibiose","CAS: 585-99-9; PubChem: 7769; ChEBI: 28053; ChEMBL: CHEMBL1159652 CHEMBL136400 CHEMBL417686; KNApSAcK: C00001142; PDB-CCD: MLB; 3DMET: B05017; NIKKAJI: J6.735K","cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336",12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H23O11","C12H21O11",342.1162115,343.1240366,341.1083865
"cpd:C05404","D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose;","C18H32O16","D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose; D-Gal-alpha1->6D-Gal-alpha1->6D-Glucose; Manninotriose","R03635 R05549","Galactose metabolism","3.2.1.22; 3.2.1.26",NA,NA,"CAS: 13382-86-0; PubChem: 7771; ChEBI: 27387 31005; 3DMET: B05018; NIKKAJI: J396.387J","cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454",18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H33O16","C18H31O16",504.1690349,505.17686,503.1612099
"cpd:C06311","Galactitol 1-phosphate;","C6H15O9P","Galactitol 1-phosphate; L-Galactitol 1-phosphate; D-Galactitol 6-phosphate","R05147 R05570 R05571","Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS)","1.1.1.251; 2.7.1.200",NA,NA,"PubChem: 8547; ChEBI: 28663; 3DMET: B02007; NIKKAJI: J439.912I","cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311",6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H16O9P1","C6H14O9P1",262.0453691,263.0531941,261.037544
"cpd:C06376","N-Acetyl-D-galactosamine 6-phosphate","C8H16NO9P","N-Acetyl-D-galactosamine 6-phosphate","R05168 R08366","Galactose metabolism; Phosphotransferase system (PTS)","2.7.1.-; 3.5.1.25",NA,NA,"PubChem: 8612; ChEBI: 18207; 3DMET: B05186; NIKKAJI: J2.761.994K","cpd:C00357; cpd:C04256; cpd:C04257; cpd:C04501; cpd:C06376; cpd:C18055; cpd:C18060",8,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H17O9N1P1","C8H15O9N1P1",301.0562681,302.0640931,300.0484431
"cpd:C06377","D-Galactosamine 6-phosphate","C6H14NO8P","D-Galactosamine 6-phosphate","R05168 R08365 R08367","Galactose metabolism; Phosphotransferase system (PTS)","2.7.1.-; 3.5.1.25; 5.3.1.-",NA,NA,"PubChem: 8613; ChEBI: 18232; 3DMET: B05187; NIKKAJI: J2.381.964C","cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214",6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O8N1P1","C6H13O8N1P1",259.0457034,260.0535284,258.0378784
"cpd:C00072","Ascorbate;","C6H8O6","Ascorbate; Ascorbic acid; L-Ascorbate; L-Ascorbic acid; Vitamin C","R00068 R00095 R00640 R00643 R00644 R00645 R00646 R00647; R01108 R02535 R03147 R03186 R03912 R07178 R07179 R07214; R07671 R07679 R08358 R09540 R09739 R10053 R10055","Ascorbate and aldarate metabolism; Glutathione metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Phosphotransferase system (PTS); HIF-1 signaling pathway; Vitamin digestion and absorption","1.1.3.8; 1.3.2.3; 1.3.3.12; 1.6.5.4; 1.8.5.1; 1.10.2.1; 1.10.3.3; 1.11.1.11; 1.14.17.1; 1.14.17.3; 1.14.17.4; 1.14.-.-; 1.16.5.1; 1.23.5.1; 2.7.1.194","Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Ascorbate degradation, ascorbate => D-xylulose-5P","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00072  Ascorbic acid (Vitamin C); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS;     A11GA Ascorbic acid (vitamin C), plain;      A11GA01 Ascorbic acid (vit C);       D00018  Ascorbic acid (JP17/USP/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AD Organic acids;      G01AD03 Ascorbic acid;       D00018  Ascorbic acid (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA15 Ascorbic acid;       D00018  Ascorbic acid (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    314  Vitamin C preparations;     3140  Vitamin C preparations;      D00018  Ascorbic acid (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   38 Vitamin C based drugs;    D00018  Ascorbic acid (JP17/USP/INN);   41 Vitamin EC based drugs;    D00018  Ascorbic acid (JP17/USP/INN);   43 Vitamin containing supplements;    D00018  Ascorbic acid (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Ascorbic acid;     D00018  Ascorbic acid (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00018  [001008] Ascorbic acid;  Buffering agent;   D00018  [001008] Ascorbic acid;  Flavoring substance;   D00018  [001008] Ascorbic acid;  Antioxidant agent;   D00018  [001008] Ascorbic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00018  Ascorbic acid;   D00018  Ascorbic acid powder;   D00018  Ascorbic acid injection; Major components of natural products [BR:br08323];  Medicinal herbs;   Cranberry;    C00072  Ascorbate;   Rose hip;    C00072  Ascorbate; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9624  Vitamin C and preparations;     C00072  Ascorbate","CAS: 50-81-7; PubChem: 3372; ChEBI: 29073 38290; ChEMBL: CHEMBL196; KNApSAcK: C00001179; PDB-CCD: ASC; 3DMET: B01147; NIKKAJI: J2.301I","cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364",6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O6","C6H7O6",176.032088,177.039913,175.0242629
"cpd:C00545","L-Arabinonate","C5H10O6","L-Arabinonate","R02522 R02526","Ascorbate and aldarate metabolism; Metabolic pathways","3.1.1.15; 4.2.1.25",NA,NA,"CAS: 608-53-7; PubChem: 3826; ChEBI: 16501 33510; 3DMET: B04698; NIKKAJI: J7.010F","cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646",5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O6","C5H9O6",166.047738,167.0555631,165.039913
"cpd:C00679","5-Dehydro-4-deoxy-D-glucarate;","C6H8O7","5-Dehydro-4-deoxy-D-glucarate; (2R,3S)-2,3-Dihydroxy-5-oxohexanedioate","R02279 R02752 R02754 R05608 R10847 R11075 R11083","Ascorbate and aldarate metabolism; Metabolic pathways","4.1.2.20; 4.2.1.40; 4.2.1.41; 4.2.1.42; 4.2.1.156; 5.5.1.27",NA,NA,"PubChem: 3948; ChEBI: 16369 42819; PDB-CCD: GLR; 3DMET: B01308; NIKKAJI: J913.057H","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C00684","2-Dehydro-3-deoxy-L-arabinonate;","C5H8O5","2-Dehydro-3-deoxy-L-arabinonate; 2-Dehydro-3-deoxy-L-pentonate","R01784 R02278 R02522","Ascorbate and aldarate metabolism; Metabolic pathways","4.1.2.18; 4.2.1.25; 4.2.1.43",NA,NA,"PubChem: 3953; ChEBI: 17647; 3DMET: B01310; NIKKAJI: J1.965.899F","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C00818","D-Glucarate;","C6H10O8","D-Glucarate; D-Glucaric acid; L-Gularic acid; D-Saccharic acid; D-Glucosaccharic acid; Glucaric acid; Glucarate","R02752 R02899 R02957 R02998 R08056 R09447","Ascorbate and aldarate metabolism; Metabolic pathways","1.2.1.3; 2.3.1.98; 2.3.1.131; 4.2.1.40",NA,NA,"CAS: 87-73-0; PubChem: 4076; ChEBI: 16002 30612; LIPIDMAPS: LMFA01170108; KNApSAcK: C00034205; PDB-CCD: GKR; 3DMET: B04731; NIKKAJI: J9.318A","cpd:C00818; cpd:C00879; cpd:C21064; cpd:C21088; cpd:C21180",6,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O8","C6H9O8",210.0375673,211.0453923,209.0297422
"cpd:C00879","D-Galactarate;","C6H10O8","D-Galactarate; D-Mucic acid; D-Galactaric acid; Galactaric acid; Galactarate; Mucic acid","R01981 R03727 R05608 R11077","Ascorbate and aldarate metabolism","2.3.1.130; 4.2.1.42; 4.2.1.158",NA,NA,"CAS: 526-99-8; PubChem: 4135; ChEBI: 30852; LIPIDMAPS: LMFA01170107; PDB-CCD: GAE; 3DMET: B04741; NIKKAJI: J6.665F","cpd:C00818; cpd:C00879; cpd:C21064; cpd:C21088; cpd:C21180",6,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O8","C6H9O8",210.0375673,211.0453923,209.0297422
"cpd:C01040","L-Gulono-1,4-lactone;","C6H10O6","L-Gulono-1,4-lactone; L-Gulono-gamma-lactone; gamma-Gulonolactone; L-Gulonic acid gamma-lactone; L-Gulonolactone","R02933 R03183 R03184 R10053","Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.20; 1.1.3.8; 3.1.1.17; 3.1.1.25","Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,"CAS: 1128-23-0; PubChem: 4282; ChEBI: 17587; ChEMBL: CHEMBL509311; 3DMET: B01369; NIKKAJI: J208.558E","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C01041","Monodehydroascorbate;","C6H7O6","Monodehydroascorbate; Monodehydroascorbate radical; Ascorbate radical; Semidehydroascorbic acid","R00095 R00645 R03147 R03185 R03186 R09540 R09739","Ascorbate and aldarate metabolism; Metabolic pathways","1.6.5.4; 1.10.2.1; 1.11.1.11; 1.14.-.-; 1.16.5.1",NA,NA,"PubChem: 4283; ChEBI: 16504","cpd:C01041; cpd:C04662; cpd:C04810; cpd:C20954",6,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H8O6","C6H6O6",175.0242629,176.032088,174.0164379
"cpd:C01114","L-Arabinono-1,4-lactone;","C5H8O5","L-Arabinono-1,4-lactone; L-Arabonolactone","R01757 R02526 R10787","Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.46; 1.1.1.376; 3.1.1.15",NA,NA,"CAS: 51532-86-6; PubChem: 4346; ChEBI: 17100; 3DMET: B01385; NIKKAJI: J1.782.210A","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C01115","L-Galactono-1,4-lactone","C6H10O6","L-Galactono-1,4-lactone","R00640 R00643 R03257 R07675 R07680","Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","1.1.1.122; 1.1.1.316; 1.3.2.3; 1.3.3.12; 3.1.1.-","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"CAS: 1668-08-2; PubChem: 4347; ChEBI: 17464; KNApSAcK: C00007388; 3DMET: B04770; NIKKAJI: J630.331E","cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903",6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6","C6H9O6",178.047738,179.0555631,177.039913
"cpd:C01146","2-Hydroxy-3-oxopropanoate;","C3H4O4","2-Hydroxy-3-oxopropanoate; Tartronate semialdehyde","R00013 R01394 R01745 R01747 R02754 R03127 R03277","Ascorbate and aldarate metabolism; Glyoxylate and dicarboxylate metabolism; Metabolic pathways","1.1.1.60; 4.1.1.47; 4.1.1.54; 4.1.2.20; 5.3.1.22",NA,NA,"CAS: 2480-77-5; PubChem: 4376; ChEBI: 16992; 3DMET: B04777; NIKKAJI: J1.397.673B","cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146",3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O4","C3H3O4",104.0109586,105.0187836,103.0031336
"cpd:C01620","Threonate;","C4H8O5","Threonate; L-Threonate; (2R,3S)-2,3,4-Trihydroxybutanoic acid","R00646 R03733","Ascorbate and aldarate metabolism","1.1.1.129",NA,NA,"CAS: 7306-96-9; PubChem: 4772; ChEBI: 15908 49060; LipidBank: DFA0363; PDB-CCD: LTH; 3DMET: B04806; NIKKAJI: J660.315G","cpd:C01620",4,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O5","C4H7O5",136.0371734,137.0449984,135.0293483
"cpd:C01825","L-Galactose","C6H12O6","L-Galactose","R07674 R07675","Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","1.1.1.122; 1.1.1.316; 3.1.3.93","Ascorbate biosynthesis, plants, glucose-6P => ascorbate","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01825  L-Galactose","CAS: 15572-79-9; PubChem: 4948; ChEBI: 42905; PDB-CCD: GIV GXL; 3DMET: B01504; NIKKAJI: J92.789I","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C02280","GDP-L-galactose","C16H25N5O16P2","GDP-L-galactose","R00889 R07673 R07678","Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","2.7.7.69; 5.1.3.18; 5.1.3.-","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"PubChem: 5337; ChEBI: 18038 42660; KNApSAcK: C00007455; PDB-CCD: GDC; 3DMET: B01556; NIKKAJI: J969.615F","cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925",16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O16N5P2","C16H24O16N5P2",605.0771537,606.0849788,604.0693287
"cpd:C02670","D-Glucuronolactone;","C6H8O6","D-Glucuronolactone; Glucurone; D-Glucurono-3,6-lactone; D-Glucurone","R01483 R02957 R03183","Ascorbate and aldarate metabolism; Metabolic pathways","1.1.1.20; 1.2.1.3; 3.1.1.19",NA,"Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glucuronolactone;     D01800  Glucuronolactone (JAN)","CAS: 32449-92-6; PubChem: 5641; ChEBI: 18268; 3DMET: B04859; NIKKAJI: J3.805I","cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364",6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O6","C6H7O6",176.032088,177.039913,175.0242629
"cpd:C03064","3-Dehydro-L-threonate","C4H6O5","3-Dehydro-L-threonate","R03733","Ascorbate and aldarate metabolism","1.1.1.129",NA,NA,"PubChem: 5964; ChEBI: 16943; 3DMET: B01627; NIKKAJI: J2.740.512F","cpd:C00149; cpd:C00497; cpd:C00711; cpd:C03064; cpd:C14873",4,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O5","C4H5O5",134.0215233,135.0293483,133.0136983
"cpd:C03289","L-xylo-Hexulonolactone;","C6H8O6","L-xylo-Hexulonolactone; L-xylo-Hex-2-ulono-1,4-lactone","R00647 R03184","Ascorbate and aldarate metabolism; Metabolic pathways","1.1.3.8","Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,"PubChem: 6146; ChEBI: 73681; 3DMET: B01647; NIKKAJI: J2.741.521K","cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364",6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O6","C6H7O6",176.032088,177.039913,175.0242629
"cpd:C03921","2-Dehydro-3-deoxy-D-glucarate","C6H8O7","2-Dehydro-3-deoxy-D-glucarate","R03277 R08056","Ascorbate and aldarate metabolism","4.1.2.20; 4.2.1.40",NA,NA,"PubChem: 6650; ChEBI: 17305; 3DMET: B01700; NIKKAJI: J790.293J","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C05422","Dehydroascorbate;","C6H6O6","Dehydroascorbate; Dehydroascorbic acid; L-Dehydroascorbate; L-Dehydroascorbic acid","R00068 R00644 R01108 R02535 R03185 R03186 R03912 R04785; R07178 R07179 R07214 R07679 R08358 R10055","Ascorbate and aldarate metabolism; Glutathione metabolism; Metabolic pathways","1.3.2.3; 1.8.5.1; 1.10.3.3; 1.11.1.11; 1.14.17.1; 1.14.17.3; 1.14.17.4; 1.23.5.1; 3.1.1.17",NA,NA,"CAS: 490-83-5; PubChem: 7786; ChEBI: 27956; KNApSAcK: C00007380; 3DMET: B01855; NIKKAJI: J12.580F","cpd:C00417; cpd:C02341; cpd:C03360; cpd:C05422",6,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O6","C6H5O6",174.0164379,175.0242629,173.0086129
"cpd:C15923","L-Gulose","C6H12O6","L-Gulose",NA,"Ascorbate and aldarate metabolism",NA,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C15923  L-Gulose","CAS: 6027-89-0; PubChem: 47205241; ChEBI: 37704; ChEMBL: CHEMBL103010; PDB-CCD: GUP; NIKKAJI: J227.238E","cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066",6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O6","C6H11O6",180.0633881,181.0712131,179.0555631
"cpd:C15924","L-Gulose 1-phosphate","C6H13O9P","L-Gulose 1-phosphate",NA,"Ascorbate and aldarate metabolism",NA,NA,NA,"PubChem: 47205242; ChEBI: 80181; NIKKAJI: J2.796.906B","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C15925","GDP-L-gulose","C16H25N5O16P2","GDP-L-gulose","R07672 R07673","Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism","5.1.3.18; 5.1.3.-",NA,NA,"PubChem: 47205243; ChEBI: 80182; PDB-CCD: GKE; NIKKAJI: J2.221.020C","cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925",16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H26O16N5P2","C16H24O16N5P2",605.0771537,606.0849788,604.0693287
"cpd:C15926","beta-L-Galactose 1-phosphate;","C6H13O9P","beta-L-Galactose 1-phosphate; L-Galactose 1-phosphate","R07674 R07678","Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","2.7.7.69; 3.1.3.93","Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,"PubChem: 47205244; ChEBI: 53072; NIKKAJI: J2.796.938K","cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096",6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O9P1","C6H12O9P1",260.029719,261.037544,259.021894
"cpd:C16186","L-Ascorbate 6-phosphate","C6H9O9P","L-Ascorbate 6-phosphate","R07671 R07677","Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Phosphotransferase system (PTS)","2.7.1.194; 3.1.1.-","Ascorbate degradation, ascorbate => D-xylulose-5P",NA,"PubChem: 47205494; ChEBI: 80368; NIKKAJI: J1.517.171E","cpd:C16186; cpd:C18341",6,9,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H10O9P1","C6H8O9P1",255.9984189,257.0062439,254.9905938
"cpd:C20889","D-Galactaro-1,5-lactone","C6H8O7","D-Galactaro-1,5-lactone","R10841 R10846","Ascorbate and aldarate metabolism","1.1.1.203; 5.4.1.4",NA,NA,"PubChem: 254741352; PDB-CCD: 15L","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C20896","D-Galactaro-1,4-lactone","C6H8O7","D-Galactaro-1,4-lactone","R10846 R10847","Ascorbate and aldarate metabolism","5.4.1.4; 5.5.1.27",NA,NA,"PubChem: 254741359; ChEBI: 85532","cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095",6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O7","C6H7O7",192.0270026,193.0348276,191.0191776
"cpd:C00083","Malonyl-CoA;","C24H38N7O19P3S","Malonyl-CoA; Malonyl coenzyme A","R00233 R00353 R00740 R00742 R00743 R00744 R00989 R01613; R01614 R01626 R02224 R02447 R02482 R02505 R04050 R04356; R04386 R04618 R04709 R05188 R05190 R05331 R06448 R06453; R06458 R06459 R06480 R06481 R06482 R06483 R06510 R06568; R06625 R06635 R06637 R06641 R06643 R06644 R06645 R06796; R06797 R06799 R06800 R06801 R06817 R06821 R07250 R07251; R07253 R07255 R07719 R07721 R07731 R07741 R07754 R07757; R07758 R07884 R07885 R07886 R07910 R07938 R07987 R07988; R07989 R08796 R08797 R08805 R08806 R09090 R09195 R09258; R09419 R09527 R09621 R10171 R10173 R10233 R10234 R10238; R10239 R10485 R10590 R10825 R10960 R10965 R10967 R11124; R11125 R11412 R11435 R11445 R11516","Fatty acid biosynthesis; Fatty acid elongation; Tetracycline biosynthesis; Aflatoxin biosynthesis; Carbapenem biosynthesis; Phenylalanine metabolism; beta-Alanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Pyruvate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of vancomycin group antibiotics; Biosynthesis of type II polyketide backbone; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism; AMPK signaling pathway; Adipocytokine signaling pathway; Glucagon signaling pathway; Insulin resistance","1.2.1.75; 2.1.3.1; 2.3.1.39; 2.3.1.74; 2.3.1.85; 2.3.1.86; 2.3.1.95; 2.3.1.112; 2.3.1.113; 2.3.1.114; 2.3.1.115; 2.3.1.116; 2.3.1.146; 2.3.1.151; 2.3.1.156; 2.3.1.159; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.171; 2.3.1.172; 2.3.1.177; 2.3.1.194; 2.3.1.199; 2.3.1.206; 2.3.1.208; 2.3.1.211; 2.3.1.212; 2.3.1.214; 2.3.1.216; 2.3.1.218; 2.3.1.220; 2.3.1.221; 2.3.1.226; 2.3.1.230; 2.3.1.233; 2.3.1.235; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.246; 2.3.1.253; 2.3.1.260; 2.3.1.-; 2.8.3.3; 4.1.1.9; 6.3.5.-; 6.4.1.2","Fatty acid biosynthesis, initiation; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Fatty acid biosynthesis, elongation, endoplasmic reticulum; Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate; Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin; Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin; Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin; Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide; 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core; 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core; 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA; Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA; Calicheamicin biosynthesis, calicheamicinone => calicheamicin; Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP",NA,"CAS: 524-14-1; PubChem: 3383; ChEBI: 15531; LIPIDMAPS: LMFA07050031; KNApSAcK: C00007260; PDB-CCD: MLC; 3DMET: B04627; NIKKAJI: J203.864A","cpd:C00083",24,38,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C24H39O19N7P3S1","C24H37O19N7P3S1",853.1156042,854.1234292,852.1077792
"cpd:C00154","Palmitoyl-CoA;","C37H66N7O17P3S","Palmitoyl-CoA; Hexadecanoyl-CoA","R01274 R01277 R01278 R01279 R01280 R01281 R01282 R01923; R01952 R02138 R02367 R02375 R04021 R04022 R05918 R07758; R08381 R10484 R10700 R11011 R11012","Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Glycosylphosphatidylinositol (GPI)-anchor biosynthesis; Sphingolipid metabolism; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant hormones; Metabolic pathways; Fatty acid metabolism; Sphingolipid signaling pathway","1.2.1.42; 1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 1.14.19.32; 2.3.1.21; 2.3.1.50; 2.3.1.76; 2.3.1.86; 2.3.1.96; 2.3.1.100; 2.3.1.123; 2.3.1.139; 2.3.1.142; 2.3.1.199; 2.3.1.225; 2.3.1.-; 2.3.-.-; 3.1.2.2; 3.1.2.22; 6.2.1.3","beta-Oxidation, acyl-CoA synthesis; beta-Oxidation; Ceramide biosynthesis; Sphingosine biosynthesis","Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C00154  Hexadecanoyl-CoA","CAS: 1763-10-6; PubChem: 3454; ChEBI: 15525; LIPIDMAPS: LMFA07050002; KNApSAcK: C00007462; PDB-CCD: PKZ; 3DMET: B04641; NIKKAJI: J207.891K","cpd:C00154; cpd:C07296",37,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C37H67O17N7P3S1","C37H65O17N7P3S1",1005.344876,1006.352701,1004.337051
"cpd:C00249","Hexadecanoic acid;","C16H32O2","Hexadecanoic acid; Hexadecanoate; Hexadecylic acid; Palmitic acid; Palmitate; Cetylic acid","R01274 R01280 R01703 R01704 R01705 R01706 R02368 R03049; R08602 R09451","Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Metabolic pathways; Fatty acid metabolism","1.2.1.48; 1.11.1.3; 1.14.-.-; 2.3.1.85; 3.1.1.63; 3.1.1.-; 3.1.2.2; 3.1.2.14; 3.1.2.22; 6.2.1.3","beta-Oxidation, acyl-CoA synthesis","Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C00249  Palmitic acid (16:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00249  Hexadecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C00249  Palmitic acid; Pharmaceutical additives [BR:br08316];  Tenacious agent;   D05341  [104981] Palmitic acid; Major components of natural products [BR:br08323];  Crude drugs;   Burdock fruit;    C00249  Hexadecanoic acid;   Hemp fruit;    C00249  Hexadecanoic acid;  Medicinal herbs;   Hemp;    C00249  Hexadecanoic acid","CAS: 57-10-3; PubChem: 3548; ChEBI: 15756; ChEMBL: CHEMBL82293; LIPIDMAPS: LMFA01010001; LipidBank: DFA0016; KNApSAcK: C00001233 C00030479; PDB-CCD: PLM; 3DMET: B00071; NIKKAJI: J1.378A","cpd:C00249",16,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H33O2","C16H31O2",256.2402303,257.2480553,255.2324052
"cpd:C00712","(9Z)-Octadecenoic acid;","C18H34O2","(9Z)-Octadecenoic acid; (Z)-Octadec-9-enoic acid; Oleate; Oleic acid","R02813 R02814 R08176 R09452 R09462 R09537 R10576","Fatty acid biosynthesis; Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Longevity regulating pathway - worm","1.11.2.3; 1.13.11.77; 1.14.-.-; 3.1.2.2; 3.1.2.14; 3.5.1.99; 4.2.1.53",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C00712  Oleic acid (18:1;9); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C00712  (Z)-Octadec-9-enoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C00712  Oleic acid; Pharmaceutical additives [BR:br08316];  Base;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid;  Suspending agent;   D02315  [002062] Oleic acid;  Dispersant;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid;  Solvent;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid; Major components of natural products [BR:br08323];  Medicinal herbs;   Neem;    C00712  (9Z)-Octadecenoic acid","CAS: 112-80-1; PubChem: 3978; ChEBI: 16196; ChEMBL: CHEMBL8659; LIPIDMAPS: LMFA01030002; LipidBank: DFA0111; KNApSAcK: C00001232; PDB-CCD: OLA; 3DMET: B00158; NIKKAJI: J2.460K","cpd:C00712; cpd:C01712; cpd:C08363; cpd:C08367; cpd:C12103",18,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H35O2","C18H33O2",282.2558803,283.2637054,281.2480553
"cpd:C01530","Octadecanoic acid;","C18H36O2","Octadecanoic acid; Stearate; Stearic acid","R08163 R08174","Fatty acid biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Phototransduction - fly","3.1.2.2; 3.1.2.14",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C01530  Stearic acid (18:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C01530  Octadecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C01530  Stearic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Stearic acid;     D00119  Stearic acid (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00119  [002220] Stearic acid;  Lubricating agent;   D00119  [002220] Stearic acid;  Base;   D00119  [002220] Stearic acid;  Flavoring substance;   D00119  [002220] Stearic acid;  Bonding agent;   D00119  [002220] Stearic acid;  Brightening agent;   D00119  [002220] Stearic acid;  Coating agent;   D00119  [002220] Stearic acid;  Sugarcoated agent;   D00119  [002220] Stearic acid;  Emulsion;   D00119  [002220] Stearic acid;  Diluting agent;   D00119  [002220] Stearic acid;  Dispersant;   D00119  [002220] Stearic acid;  Disintegrating adjuvant;   D00119  [002220] Stearic acid;  Dampproof agent;   D00119  [002220] Stearic acid;  Fluidizer;   D00119  [002220] Stearic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00119  Stearic acid","CAS: 57-11-4; PubChem: 4692; ChEBI: 25629 28842; ChEMBL: CHEMBL46403; LIPIDMAPS: LMFA01010018; LipidBank: DFA0018; KNApSAcK: C00001238 C00032087; PDB-CCD: STE; 3DMET: B01462; NIKKAJI: J1.379J","cpd:C01530; cpd:C20356",18,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H37O2","C18H35O2",284.2715304,285.2793554,283.2637054
"cpd:C01571","Decanoic acid;","C10H20O2","Decanoic acid; Decanoate; Decylic acid; n-Capric acid","R08158","Fatty acid biosynthesis; Metabolic pathways","3.1.2.21",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C01571  Capric acid (10:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C01571  Decanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C01571  Capric acid; Pharmaceutical additives [BR:br08316];  Solubilization agent;   C01571  [511014] Capric acid","CAS: 334-48-5; PubChem: 4728; ChEBI: 27689 30813; ChEMBL: CHEMBL107498; LIPIDMAPS: LMFA01010010; LipidBank: DFA0010; KNApSAcK: C00001213; PDB-CCD: DKA; 3DMET: B01466; NIKKAJI: J2.575E","cpd:C01571; cpd:C02904; cpd:C05546; cpd:C06404; cpd:C12289; cpd:C12292; cpd:C21365",10,20,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H21O2","C10H19O2",172.1463299,173.1541549,171.1385049
"cpd:C02679","Dodecanoic acid;","C12H24O2","Dodecanoic acid; Dodecanoate; Dodecylcarboxylate; Lauric acid","R04014 R11054","Fatty acid biosynthesis; Metabolic pathways","1.14.13.206; 3.1.2.14; 3.1.2.21",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C02679  Lauric acid (12:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C02679  Dodecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C02679  Lauric acid","CAS: 143-07-7; PubChem: 5649; ChEBI: 18262 30805; ChEMBL: CHEMBL108766; LIPIDMAPS: LMFA01010012; LipidBank: DFA0012; KNApSAcK: C00001221; PDB-CCD: DAO; 3DMET: B00483; NIKKAJI: J2.548H","cpd:C02679",12,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H25O2","C12H23O2",200.17763,201.185455,199.169805
"cpd:C06423","Octanoic acid;","C8H16O2","Octanoic acid; Caprylic acid; Octylic acid","R08157 R08509","Fatty acid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways","3.1.2.21",NA,"Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C06423  Caprylate; Octanoate;  Lipids;   Fatty acids;    Saturated fatty acids;     C06423  Caprylic acid (8:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C06423  Octanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C06423  Octanoic acid","CAS: 124-07-2; PubChem: 8658; ChEBI: 28837; ChEMBL: CHEMBL324846; LIPIDMAPS: LMFA01010008; LipidBank: DFA0008; KNApSAcK: C00001231; PDB-CCD: OCA; 3DMET: B02018; NIKKAJI: J2.013C","cpd:C02147; cpd:C06423; cpd:C07185",8,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H17O2","C8H15O2",144.1150298,145.1228548,143.1072047
"cpd:C06424","Tetradecanoic acid;","C14H28O2","Tetradecanoic acid; Tetradecanoate; Myristic acid","R08159","Fatty acid biosynthesis; Metabolic pathways","3.1.2.14",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C06424  Myristic acid (14:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C06424  Tetradecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C06424  Myristic acid; Pharmaceutical additives [BR:br08316];  Base;   C06424  [104368] Myristic acid","CAS: 544-63-8; PubChem: 8659; ChEBI: 28875 30807; ChEMBL: CHEMBL111077; LIPIDMAPS: LMFA01010014; LipidBank: DFA0014; KNApSAcK: C00001228; PDB-CCD: MYR; 3DMET: B02019; NIKKAJI: J4.411C","cpd:C06424",14,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H29O2","C14H27O2",228.2089301,229.2167552,227.2011051
"cpd:C08362","(9Z)-Hexadecenoic acid;","C16H30O2","(9Z)-Hexadecenoic acid; Palmitoleic acid; cis-9-Hexadecenoic acid; (9Z)-Hexadec-9-enoate","R08162 R11202","Fatty acid biosynthesis","3.1.1.98; 3.1.2.14",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C08362  Palmitoleic acid (16:1;9); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C08362  (Z)-Hexadec-9-enoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C08362  Palmitoleic acid","CAS: 373-49-9; PubChem: 10558; ChEBI: 28716; ChEMBL: CHEMBL453509; LIPIDMAPS: LMFA01030056; LipidBank: DFA0095; KNApSAcK: C00001234 C00029354; PDB-CCD: PAM; 3DMET: B02171; NIKKAJI: J12.503B","cpd:C08362",16,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H31O2","C16H29O2",254.2245802,255.2324052,253.2167552
"cpd:C00136","Butanoyl-CoA;","C25H42N7O17P3S","Butanoyl-CoA; Butyryl-CoA","R01171 R01172 R01173 R01174 R01175 R01176 R01177 R01179; R01180 R01181 R01365 R06637 R06645 R08924 R09738 R09958","Fatty acid elongation; Fatty acid degradation; Lysine degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Biosynthesis of type II polyketide backbone; Metabolic pathways; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism","1.2.1.10; 1.2.1.57; 1.2.1.87; 1.3.1.44; 1.3.1.86; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.99.-; 2.3.1.9; 2.3.1.16; 2.3.1.19; 2.3.1.-; 2.3.3.7; 2.8.3.8; 2.8.3.9; 4.1.1.94; 5.4.99.13; 6.2.1.2; 6.4.1.3",NA,NA,"PubChem: 3436; ChEBI: 15517; ChEMBL: CHEMBL1949894; PDB-CCD: BCO; 3DMET: B04638; NIKKAJI: J363.721B","cpd:C00136; cpd:C00630",25,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H43O17N7P3S1","C25H41O17N7P3S1",837.1570751,838.1649001,836.1492501
"cpd:C01832","Lauroyl-CoA;","C33H58N7O17P3S","Lauroyl-CoA; Lauroyl coenzyme A; Dodecanoyl-CoA","R03735 R03856 R03857 R03858 R03859","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.3.2; 2.3.3.4",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C01832  Dodecanoyl-CoA","CAS: 6244-92-4; PubChem: 4951; ChEBI: 15521; ChEMBL: CHEMBL1949898; LIPIDMAPS: LMFA07050005; PDB-CCD: DCC; 3DMET: B04816; NIKKAJI: J710.292E","cpd:C01832",33,58,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H59O17N7P3S1","C33H57O17N7P3S1",949.2822756,950.2901006,948.2744506
"cpd:C01944","Octanoyl-CoA","C29H50N7O17P3S","Octanoyl-CoA","R03776 R03777 R03778 R03779 R10172","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.1.137; 2.3.1.207",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C01944  Octanoyl-CoA","CAS: 1264-52-4; PubChem: 5048; ChEBI: 15533; ChEMBL: CHEMBL1949896; PDB-CCD: CO8; 3DMET: B04826; NIKKAJI: J358.061J","cpd:C01944",29,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C29H51O17N7P3S1","C29H49O17N7P3S1",893.2196753,894.2275004,892.2118503
"cpd:C02593","Tetradecanoyl-CoA;","C35H62N7O17P3S","Tetradecanoyl-CoA; Myristoyl-CoA","R03989 R03990 R03991 R03992 R05321 R05322 R07216 R07217","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 2.3.1.16; 2.3.1.97; 2.3.1.155","beta-Oxidation","Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C02593  Tetradecanoyl-CoA","PubChem: 5585; ChEBI: 15532; ChEMBL: CHEMBL1949899; LIPIDMAPS: LMFA07050008; 3DMET: B04857; NIKKAJI: J589.553G","cpd:C02593",35,62,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C35H63O17N7P3S1","C35H61O17N7P3S1",977.3135757,978.3214008,976.3057507
"cpd:C03221","2-trans-Dodecenoyl-CoA;","C33H56N7O17P3S","2-trans-Dodecenoyl-CoA; (2E)-Dodec-2-enoyl-CoA; (2E)-Dodecenoyl-CoA","R03856 R03857 R04100 R04170","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74; 5.3.3.8",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C03221  (2E)-Dodecenoyl-CoA","PubChem: 6094; ChEBI: 15471; LIPIDMAPS: LMFA07050010; 3DMET: B04884; NIKKAJI: J2.741.386B","cpd:C02944; cpd:C03221",33,56,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H57O17N7P3S1","C33H55O17N7P3S1",947.2666255,948.2744506,946.2588005
"cpd:C05258","(S)-3-Hydroxyhexadecanoyl-CoA","C37H66N7O18P3S","(S)-3-Hydroxyhexadecanoyl-CoA","R04737 R04738","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74","beta-Oxidation",NA,"PubChem: 7645; ChEBI: 27402; 3DMET: B04987; NIKKAJI: J2.755.077K","cpd:C05258",37,66,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C37H67O18N7P3S1","C37H65O18N7P3S1",1021.33979,1022.347616,1020.331965
"cpd:C05259","3-Oxopalmitoyl-CoA;","C37H64N7O18P3S","3-Oxopalmitoyl-CoA; 3-Ketopalmitoyl-CoA; 3-Oxohexadecanoyl-CoA","R03991 R04737","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.16; 2.3.1.155","beta-Oxidation",NA,"PubChem: 7646; ChEBI: 15491; 3DMET: B04988; NIKKAJI: J2.755.078I","cpd:C05259",37,64,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C37H65O18N7P3S1","C37H63O18N7P3S1",1019.32414,1020.331965,1018.316315
"cpd:C05260","(S)-3-Hydroxytetradecanoyl-CoA","C35H62N7O18P3S","(S)-3-Hydroxytetradecanoyl-CoA","R04739 R04740","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74",NA,NA,"PubChem: 7647; ChEBI: 27466; 3DMET: B04989; NIKKAJI: J2.755.089D","cpd:C05260",35,62,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C35H63O18N7P3S1","C35H61O18N7P3S1",993.3084904,994.3163154,992.3006653
"cpd:C05261","3-Oxotetradecanoyl-CoA","C35H60N7O18P3S","3-Oxotetradecanoyl-CoA","R03858 R04739","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.16",NA,NA,"PubChem: 7648; ChEBI: 28726; NIKKAJI: J2.755.090H","cpd:C05261",35,60,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C35H61O18N7P3S1","C35H59O18N7P3S1",991.2928403,992.3006653,990.2850153
"cpd:C05262","(S)-3-Hydroxydodecanoyl-CoA","C33H58N7O18P3S","(S)-3-Hydroxydodecanoyl-CoA","R04170 R04741","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05262  (S)-3-Hydroxydodecanoyl-CoA","PubChem: 7649; ChEBI: 27668; LIPIDMAPS: LMFA07050012; 3DMET: B04990; NIKKAJI: J2.755.091F","cpd:C05262",33,58,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H59O18N7P3S1","C33H57O18N7P3S1",965.2771902,966.2850153,964.2693652
"cpd:C05263","3-Oxododecanoyl-CoA","C33H56N7O18P3S","3-Oxododecanoyl-CoA","R04741 R04742","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.16",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05263  3-Oxododecanoyl-CoA","PubChem: 7650; ChEBI: 27868; LIPIDMAPS: LMFA07050013; 3DMET: B04991; NIKKAJI: J2.755.092D","cpd:C05263",33,56,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H57O18N7P3S1","C33H55O18N7P3S1",963.2615402,964.2693652,962.2537151
"cpd:C05264","(S)-Hydroxydecanoyl-CoA;","C31H54N7O18P3S","(S)-Hydroxydecanoyl-CoA; (S)-3-Hydroxydecanoyl-CoA","R04743 R04744","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05264  (S)-3-Hydroxydecanoyl-CoA","PubChem: 7651; ChEBI: 28325; LIPIDMAPS: LMFA07050014; PDB-CCD: HSC; 3DMET: B04992; NIKKAJI: J2.755.093B","cpd:C05264",31,54,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H55O18N7P3S1","C31H53O18N7P3S1",937.2458901,938.2537151,936.2380651
"cpd:C05265","3-Oxodecanoyl-CoA","C31H52N7O18P3S","3-Oxodecanoyl-CoA","R03778 R04743","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.16",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05265  3-Oxodecanoyl-CoA","PubChem: 7652; ChEBI: 28528; PDB-CCD: ZOZ; 3DMET: B04993; NIKKAJI: J2.755.094K","cpd:C05265; cpd:C11947",31,52,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H53O18N7P3S1","C31H51O18N7P3S1",935.23024,936.2380651,934.222415
"cpd:C05266","(S)-3-Hydroxyoctanoyl-CoA;","C29H50N7O18P3S","(S)-3-Hydroxyoctanoyl-CoA; (S)-3-Hydroxycapryloyl-CoA; (S)-Hydroxyoctanoyl-CoA","R04745 R04746","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74; 5.1.2.3",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05266  (S)-3-Hydroxyoctanoyl-CoA","PubChem: 7653; ChEBI: 28632; LIPIDMAPS: LMFA07050015; 3DMET: B04994; NIKKAJI: J915.535J","cpd:C05266; cpd:C05278",29,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C29H51O18N7P3S1","C29H49O18N7P3S1",909.21459,910.222415,908.2067649
"cpd:C05267","3-Oxooctanoyl-CoA","C29H48N7O18P3S","3-Oxooctanoyl-CoA","R04745 R04747","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.16",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05267  3-Oxooctanoyl-CoA","PubChem: 7654; ChEBI: 28264; LIPIDMAPS: LMFA07050016; 3DMET: B04995; NIKKAJI: J2.755.103C","cpd:C04316; cpd:C05267",29,48,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O18N7P3S1","C29H47O18N7P3S1",907.1989399,908.2067649,906.1911149
"cpd:C05268","(S)-Hydroxyhexanoyl-CoA;","C27H46N7O18P3S","(S)-Hydroxyhexanoyl-CoA; (S)-3-Hydroxyhexanoyl-CoA","R04748 R04749","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05268  (S)-3-Hydroxyhexanoyl-CoA","PubChem: 7655; ChEBI: 28276; LIPIDMAPS: LMFA07050017; PDB-CCD: 3H9; 3DMET: B04996; NIKKAJI: J2.755.104A","cpd:C05268; cpd:C21089",27,46,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O18N7P3S1","C27H45O18N7P3S1",881.1832898,882.1911149,880.1754648
"cpd:C05269","3-Oxohexanoyl-CoA;","C27H44N7O18P3S","3-Oxohexanoyl-CoA; 3-Ketohexanoyl-CoA","R01177 R04748","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.1.1.35; 1.1.1.211; 2.3.1.9; 2.3.1.16",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05269  3-Oxohexanoyl-CoA","CAS: 19774-86-8; PubChem: 7656; ChEBI: 27648; LIPIDMAPS: LMFA07050018; 3DMET: B04997; NIKKAJI: J2.755.105J","cpd:C05269",27,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O18N7P3S1","C27H43O18N7P3S1",879.1676398,880.1754648,878.1598147
"cpd:C05270","Hexanoyl-CoA","C27H46N7O17P3S","Hexanoyl-CoA","R04747 R04751 R06985 R08796 R08797 R10171","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.1.206",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05270  Hexanoyl-CoA","PubChem: 7657; ChEBI: 27540; ChEMBL: CHEMBL1949895; LIPIDMAPS: LMFA07050001; PDB-CCD: HXC; 3DMET: B04998; NIKKAJI: J358.059H","cpd:C05270; cpd:C21400",27,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O17N7P3S1","C27H45O17N7P3S1",865.1883752,866.1962002,864.1805502
"cpd:C05271","trans-Hex-2-enoyl-CoA;","C27H44N7O17P3S","trans-Hex-2-enoyl-CoA; (2E)-Hexenoyl-CoA","R04749 R04751 R06985","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05271  (2E)-Hexenoyl-CoA","PubChem: 7658; ChEBI: 28706; LIPIDMAPS: LMFA07050019; PDB-CCD: TC6; 3DMET: B04999; NIKKAJI: J2.755.178E","cpd:C05271; cpd:C21090",27,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O17N7P3S1","C27H43O17N7P3S1",863.1727252,864.1805502,862.1649001
"cpd:C05272","trans-Hexadec-2-enoyl-CoA;","C37H64N7O17P3S","trans-Hexadec-2-enoyl-CoA; trans-2-Hexadecenoyl-CoA; (2E)-Hexadecenoyl-CoA","R01278 R01279 R01282 R04738","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 4.2.1.17; 4.2.1.74","beta-Oxidation","Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05272  (2E)-Hexadecenoyl-CoA","PubChem: 7659; ChEBI: 28935; LIPIDMAPS: LMFA07050020; 3DMET: B05000; NIKKAJI: J2.755.187D","cpd:C05272; cpd:C20996; cpd:C20997; cpd:C20998; cpd:C21072",37,64,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C37H65O17N7P3S1","C37H63O17N7P3S1",1003.329226,1004.337051,1002.321401
"cpd:C05273","trans-Tetradec-2-enoyl-CoA;","C35H60N7O17P3S","trans-Tetradec-2-enoyl-CoA; (2E)-Tetradecenoyl-CoA","R03989 R03990 R04740","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05273  (2E)-Tetradecenoyl-CoA","PubChem: 7660; ChEBI: 27721; LIPIDMAPS: LMFA07050021; 3DMET: B05001; NIKKAJI: J2.755.213G","cpd:C05273; cpd:C06736; cpd:C06737",35,60,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C35H61O17N7P3S1","C35H59O17N7P3S1",975.2979257,976.3057507,974.2901006
"cpd:C05274","Decanoyl-CoA","C31H54N7O17P3S","Decanoyl-CoA","R04742 R04753 R04754","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05274  Decanoyl-CoA","PubChem: 7661; ChEBI: 28493; ChEMBL: CHEMBL1949897; LIPIDMAPS: LMFA07050022; PDB-CCD: MFK; 3DMET: B05002; NIKKAJI: J362.551F","cpd:C05274",31,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H55O17N7P3S1","C31H53O17N7P3S1",921.2509755,922.2588005,920.2431504
"cpd:C05275","trans-Dec-2-enoyl-CoA;","C31H52N7O17P3S","trans-Dec-2-enoyl-CoA; (2E)-Decenoyl-CoA","R04744 R04753 R04754","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05275  (2E)-Decenoyl-CoA","PubChem: 7662; ChEBI: 10723; LIPIDMAPS: LMFA07050023; 3DMET: B05003; NIKKAJI: J2.755.219F","cpd:C05275; cpd:C16464",31,52,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H53O17N7P3S1","C31H51O17N7P3S1",919.2353254,920.2431504,918.2275004
"cpd:C05276","trans-Oct-2-enoyl-CoA;","C29H48N7O17P3S","trans-Oct-2-enoyl-CoA; (2E)-Octenoyl-CoA","R03776 R03777 R04746","Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism","1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05276  (2E)-Octenoyl-CoA","PubChem: 7663; ChEBI: 27537; LIPIDMAPS: LMFA07050024; 3DMET: B05004; NIKKAJI: J2.755.239K","cpd:C05276",29,48,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O17N7P3S1","C29H47O17N7P3S1",891.2040253,892.2118503,890.1962002
"cpd:C00010","CoA;","C21H36N7O16P3S","CoA; Coenzyme A; CoA-SH","R00091 R00130 R00209 R00210 R00211 R00212 R00227 R00228; R00229 R00230 R00235 R00236 R00238 R00259 R00265 R00271; R00351 R00352 R00371 R00383 R00389 R00390 R00391 R00394; R00395 R00399 R00405 R00407 R00432 R00454 R00468 R00472; R00487 R00521 R00577 R00586 R00627 R00664 R00693 R00705; R00706 R00727 R00740 R00829 R00830 R00832 R00851 R00918; R00920 R00921 R00922 R00925 R00926 R00927 R00931 R00932; R00935 R00982 R00989 R00998 R01013 R01023 R01075 R01089; R01111 R01154 R01160 R01172 R01173 R01174 R01176 R01177; R01180 R01196 R01197 R01199 R01204 R01210 R01213 R01256; R01274 R01277 R01280 R01281 R01300 R01301 R01318 R01319; R01322 R01357 R01358 R01368 R01422 R01461 R01496 R01556; R01558 R01598 R01613 R01614 R01615 R01616 R01617 R01624; R01625 R01626 R01651 R01776 R01777 R01798 R01806 R01807; R01808 R01850 R01889 R01923 R01933 R01941 R01943 R01944; R01945 R01946 R01952 R01978 R01999 R02058 R02081 R02082; R02083 R02138 R02152 R02191 R02193 R02194 R02195 R02220; R02221 R02224 R02241 R02242 R02251 R02255 R02366 R02367; R02375 R02385 R02387 R02396 R02402 R02404 R02405 R02406; R02416 R02447 R02450 R02452 R02453 R02481 R02482 R02505; R02506 R02539 R02543 R02569 R02570 R02571 R02576 R02616; R02617 R02620 R02662 R02694 R02699 R02760 R02764 R02772; R02794 R02837 R02899 R02911 R02986 R03017 R03040 R03056; R03064 R03065 R03109 R03157 R03158 R03168 R03171 R03174; R03209 R03210 R03230 R03352 R03374 R03381 R03383 R03437; R03438 R03455 R03552 R03621 R03631 R03668 R03695 R03718; R03719 R03720 R03727 R03735 R03755 R03756 R03760 R03762; R03767 R03778 R03779 R03838 R03858 R03859 R03861 R03903; R03910 R03932 R03965 R03974 R03991 R03992 R03994 R04021; R04022 R04024 R04030 R04050 R04097 R04150 R04157 R04192; R04205 R04211 R04254 R04316 R04348 R04356 R04361 R04363; R04364 R04365 R04413 R04466 R04480 R04484 R04507 R04546; R04580 R04618 R04709 R04723 R04742 R04747 R04776 R04777; R04811 R04868 R04950 R05063 R05064 R05129 R05163 R05188; R05189 R05190 R05330 R05331 R05332 R05351 R05451 R05452; R05455 R05506 R05537 R05546 R05586 R05587 R05620 R05672; R05714 R05744 R05841 R05870 R05876 R05918 R06251 R06307; R06310 R06311 R06361 R06367 R06368 R06396 R06409 R06410; R06414 R06415 R06448 R06453 R06458 R06459 R06480 R06481; R06482 R06483 R06510 R06515 R06517 R06527 R06544 R06545; R06568 R06569 R06583 R06624 R06625 R06635 R06637 R06641; R06643 R06644 R06645 R06731 R06735 R06736 R06796 R06797; R06799 R06800 R06801 R06806 R06817 R06821 R06872 R06908; R06944 R06978 R06987 R06997 R07160 R07161 R07175 R07249; R07250 R07251 R07252 R07253 R07255 R07262 R07294 R07296; R07382 R07399 R07416 R07432 R07433 R07719 R07721 R07731; R07741 R07754 R07757 R07758 R07815 R07828 R07833 R07873; R07876 R07880 R07881 R07882 R07883 R07884 R07885 R07886; R07887 R07891 R07895 R07899 R07902 R07910 R07926 R07927; R07928 R07929 R07930 R07931 R07937 R07938 R07944 R07953; R07987 R07988 R07989 R08036 R08088 R08091 R08095 R08097; R08117 R08171 R08172 R08174 R08175 R08176 R08177 R08178; R08179 R08180 R08181 R08182 R08183 R08184 R08185 R08186; R08187 R08188 R08189 R08190 R08191 R08192 R08213 R08248; R08250 R08273 R08331 R08332 R08381 R08386 R08423 R08430; R08432 R08433 R08530 R08531 R08532 R08549 R08566 R08567; R08619 R08623 R08627 R08631 R08640 R08644 R08680 R08712; R08713 R08733 R08738 R08743 R08744 R08745 R08767 R08796; R08797 R08805 R08806 R08807 R08808 R08809 R08810 R08870; R08871 R08938 R08983 R09034 R09035 R09036 R09037 R09096; R09097 R09106 R09255 R09256 R09257 R09258 R09279 R09280; R09286 R09317 R09419 R09450 R09470 R09524 R09527 R09528; R09557 R09589 R09621 R09622 R09631 R09643 R09839 R09840; R09842 R09854 R09873 R10003 R10099 R10100 R10104 R10142; R10171 R10172 R10173 R10174 R10200 R10210 R10219 R10233; R10234 R10237 R10238 R10239 R10243 R10253 R10254 R10278; R10473 R10474 R10484 R10485 R10500 R10514 R10516 R10526; R10529 R10589 R10590 R10612 R10681 R10700 R10707 R10745; R10746 R10747 R10758 R10769 R10770 R10771 R10820 R10825; R10866 R10893 R10936 R10947 R10960 R10965 R10967 R10998; R11124 R11125 R11182 R11199 R11200 R11201 R11370 R11390; R11412 R11435 R11445 R11450 R11451 R11479 R11516 R11542; R11550","Fatty acid degradation; Carbapenem biosynthesis; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of antibiotics; Cholinergic synapse; Fat digestion and absorption; Vitamin digestion and absorption","1.1.1.34; 1.1.1.88; 1.1.1.-; 1.2.1.10; 1.2.1.17; 1.2.1.18; 1.2.1.25; 1.2.1.27; 1.2.1.42; 1.2.1.44; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.58; 1.2.1.75; 1.2.1.76; 1.2.1.81; 1.2.1.84; 1.2.1.87; 1.2.1.-; 1.2.3.6; 1.2.4.1; 1.2.4.2; 1.2.7.1; 1.2.7.3; 1.2.7.4; 1.2.7.7; 1.2.7.8; 1.2.7.11; 1.2.7.-; 1.8.1.4; 1.8.1.10; 1.8.1.14; 1.8.4.3; 1.13.11.80; 2.1.1.258; 2.3.1.1; 2.3.1.2; 2.3.1.3; 2.3.1.4; 2.3.1.5; 2.3.1.6; 2.3.1.7; 2.3.1.8; 2.3.1.9; 2.3.1.10; 2.3.1.11; 2.3.1.12; 2.3.1.13; 2.3.1.14; 2.3.1.15; 2.3.1.16; 2.3.1.17; 2.3.1.18; 2.3.1.19; 2.3.1.20; 2.3.1.21; 2.3.1.22; 2.3.1.23; 2.3.1.24; 2.3.1.25; 2.3.1.26; 2.3.1.27; 2.3.1.28; 2.3.1.29; 2.3.1.30; 2.3.1.31; 2.3.1.33; 2.3.1.34; 2.3.1.36; 2.3.1.37; 2.3.1.38; 2.3.1.39; 2.3.1.42; 2.3.1.44; 2.3.1.45; 2.3.1.46; 2.3.1.47; 2.3.1.48; 2.3.1.50; 2.3.1.51; 2.3.1.52; 2.3.1.53; 2.3.1.54; 2.3.1.57; 2.3.1.58; 2.3.1.59; 2.3.1.60; 2.3.1.61; 2.3.1.62; 2.3.1.63; 2.3.1.64; 2.3.1.65; 2.3.1.66; 2.3.1.67; 2.3.1.68; 2.3.1.69; 2.3.1.71; 2.3.1.74; 2.3.1.75; 2.3.1.76; 2.3.1.78; 2.3.1.79; 2.3.1.80; 2.3.1.81; 2.3.1.82; 2.3.1.84; 2.3.1.85; 2.3.1.86; 2.3.1.87; 2.3.1.88; 2.3.1.89; 2.3.1.93; 2.3.1.94; 2.3.1.95; 2.3.1.96; 2.3.1.97; 2.3.1.99; 2.3.1.100; 2.3.1.102; 2.3.1.105; 2.3.1.106; 2.3.1.107; 2.3.1.108; 2.3.1.109; 2.3.1.110; 2.3.1.111; 2.3.1.112; 2.3.1.113; 2.3.1.114; 2.3.1.115; 2.3.1.116; 2.3.1.117; 2.3.1.118; 2.3.1.121; 2.3.1.123; 2.3.1.125; 2.3.1.126; 2.3.1.127; 2.3.1.128; 2.3.1.130; 2.3.1.131; 2.3.1.132; 2.3.1.133; 2.3.1.136; 2.3.1.137; 2.3.1.138; 2.3.1.139; 2.3.1.140; 2.3.1.142; 2.3.1.144; 2.3.1.145; 2.3.1.146; 2.3.1.150; 2.3.1.151; 2.3.1.153; 2.3.1.155; 2.3.1.156; 2.3.1.157; 2.3.1.159; 2.3.1.160; 2.3.1.161; 2.3.1.162; 2.3.1.163; 2.3.1.164; 2.3.1.165; 2.3.1.166; 2.3.1.167; 2.3.1.168; 2.3.1.169; 2.3.1.170; 2.3.1.171; 2.3.1.172; 2.3.1.173; 2.3.1.174; 2.3.1.175; 2.3.1.176; 2.3.1.177; 2.3.1.178; 2.3.1.180; 2.3.1.182; 2.3.1.183; 2.3.1.185; 2.3.1.186; 2.3.1.188; 2.3.1.189; 2.3.1.190; 2.3.1.192; 2.3.1.194; 2.3.1.195; 2.3.1.196; 2.3.1.197; 2.3.1.198; 2.3.1.199; 2.3.1.201; 2.3.1.202; 2.3.1.203; 2.3.1.205; 2.3.1.206; 2.3.1.207; 2.3.1.208; 2.3.1.209; 2.3.1.210; 2.3.1.211; 2.3.1.212; 2.3.1.214; 2.3.1.215; 2.3.1.216; 2.3.1.217; 2.3.1.218; 2.3.1.219; 2.3.1.220; 2.3.1.221; 2.3.1.222; 2.3.1.223; 2.3.1.224; 2.3.1.225; 2.3.1.226; 2.3.1.227; 2.3.1.228; 2.3.1.229; 2.3.1.230; 2.3.1.232; 2.3.1.233; 2.3.1.235; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.245; 2.3.1.246; 2.3.1.248; 2.3.1.249; 2.3.1.250; 2.3.1.252; 2.3.1.253; 2.3.1.260; 2.3.1.-; 2.3.2.-; 2.3.3.1; 2.3.3.2; 2.3.3.3; 2.3.3.4; 2.3.3.5; 2.3.3.6; 2.3.3.7; 2.3.3.8; 2.3.3.9; 2.3.3.10; 2.3.3.11; 2.3.3.12; 2.3.3.13; 2.3.3.14; 2.3.3.16; 2.3.3.17; 2.3.3.-; 2.3.-.-; 2.6.1.33; 2.7.1.24; 2.7.8.7; 2.7.8.-; 2.8.3.-; 3.1.2.1; 3.1.2.2; 3.1.2.3; 3.1.2.4; 3.1.2.5; 3.1.2.10; 3.1.2.11; 3.1.2.17; 3.1.2.18; 3.1.2.19; 3.1.2.20; 3.1.2.22; 3.1.2.23; 3.1.2.25; 3.1.2.27; 3.1.2.28; 3.1.2.29; 3.1.2.30; 3.1.2.32; 3.1.2.-; 3.2.1.-; 3.6.1.-; 4.1.3.36; 4.1.3.-; 4.2.1.155; 4.4.1.26; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.4; 6.2.1.5; 6.2.1.6; 6.2.1.7; 6.2.1.8; 6.2.1.9; 6.2.1.10; 6.2.1.11; 6.2.1.12; 6.2.1.13; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.18; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.34; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.-","Coenzyme A biosynthesis, pantothenate => CoA","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00010  CoA","CAS: 85-61-0; PubChem: 3312; ChEBI: 15346; ChEMBL: CHEMBL1213327 CHEMBL1623949; KNApSAcK: C00007258; PDB-CCD: COA; 3DMET: B04618; NIKKAJI: J192.630F","cpd:C00010",21,36,16,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C21H37O16N7P3S1","C21H35O16N7P3S1",767.1152103,768.1230353,766.1073852
"cpd:C00332","Acetoacetyl-CoA;","C25H40N7O18P3S","Acetoacetyl-CoA; Acetoacetyl coenzyme A; 3-Acetoacetyl-CoA","R00238 R00410 R01357 R01358 R01359 R01365 R01975 R01976; R01977 R01978 R05129 R05576 R09527","Fatty acid degradation; Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism","1.1.1.35; 1.1.1.36; 1.1.1.157; 2.3.1.9; 2.3.1.194; 2.3.3.10; 2.8.3.5; 2.8.3.8; 2.8.3.9; 3.1.2.11; 6.2.1.16","Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,"CAS: 1420-36-6; PubChem: 3626; ChEBI: 15345; LIPIDMAPS: LMFA07050030; KNApSAcK: C00007269; PDB-CCD: CAA; 3DMET: B04671; NIKKAJI: J298.605A","cpd:C00332",25,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O18N7P3S1","C25H39O18N7P3S1",851.1363396,852.1441647,850.1285146
"cpd:C00489","Glutarate;","C5H8O4","Glutarate; Glutaric acid; Pentanedioic acid; 1,3-Propanedicarboxylic acid","R02401 R02402 R07402 R10982","Fatty acid degradation; Lysine degradation","1.2.1.20; 1.2.1.-; 3.5.1.93; 6.2.1.6",NA,"Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00489  Glutarate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0117 Dicarboxylic acids;     C00489  Pentanedioic acid","CAS: 110-94-1; PubChem: 3772; ChEBI: 17859; ChEMBL: CHEMBL1162495; KNApSAcK: C00001184; PDB-CCD: GUA; 3DMET: B01263; NIKKAJI: J40.077G","cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177",5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O4","C5H7O4",132.0422587,133.0500838,131.0344337
"cpd:C00517","Hexadecanal;","C16H32O","Hexadecanal; Palmitaldehyde","R01277 R01704 R02462 R02463 R02464","Fatty acid degradation","1.1.1.164; 1.1.1.192; 1.2.1.42; 1.2.1.48; 1.3.1.27; 4.1.2.27",NA,NA,"CAS: 629-80-1; PubChem: 3800; ChEBI: 17600; ChEMBL: CHEMBL1235338; LIPIDMAPS: LMFA06000088; LipidBank: DLD0088; KNApSAcK: C00007542; 3DMET: B00119; NIKKAJI: J1.704C","cpd:C00517; cpd:C14499",16,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H33O1","C16H31O1",240.2453157,241.2531407,239.2374906
"cpd:C00527","Glutaryl-CoA","C26H42N7O19P3S","Glutaryl-CoA","R01933 R02402 R02487 R02488 R02571 R05579 R05586 R10074","Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics","1.2.4.2; 1.3.8.6; 1.3.99.32; 1.8.1.4; 2.3.1.16; 2.3.1.61; 6.2.1.6","Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,"CAS: 3131-84-8; PubChem: 3810; ChEBI: 15524; PDB-CCD: GRA; 3DMET: B04695; NIKKAJI: J1.748.735C","cpd:C00527; cpd:C18026; cpd:C18324; cpd:C20238",26,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H43O19N7P3S1","C26H41O19N7P3S1",881.1469043,882.1547294,880.1390793
"cpd:C00823","1-Hexadecanol;","C16H34O","1-Hexadecanol; Hexadecanol; Cetyl alcohol; Palmityl alcohol; 16-Hexadecanol","R02462","Fatty acid degradation","1.1.1.164; 1.1.1.192",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA05 Fatty alcohols;    C00823  1-Hexadecanol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00099  [002229] Cetanol;  Surfactant;   D00099  [002229] Cetanol;  Lubricating agent;   D00099  [002229] Cetanol;  Base;   D00099  [002229] Cetanol;  Bonding agent;   D00099  [002229] Cetanol;  Suspending agent;   D00099  [002229] Cetanol;  Brightening agent;   D00099  [002229] Cetanol;  Coating agent;   D00099  [002229] Cetanol;  Emulsion;   D00099  [002229] Cetanol;  Tenacious agent;   D00099  [002229] Cetanol;  Diluting agent;   D00099  [002229] Cetanol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00099  Cetanol","CAS: 36653-82-4; PubChem: 4081; ChEBI: 16125; ChEMBL: CHEMBL706; LIPIDMAPS: LMFA05000061; PDB-CCD: PL3; 3DMET: B00182; NIKKAJI: J3.499A","cpd:C00823",16,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H35O1","C16H33O1",242.2609657,243.2687907,241.2531407
"cpd:C00877","Crotonoyl-CoA;","C25H40N7O17P3S","Crotonoyl-CoA; Crotonyl-CoA; 2-Butenoyl-CoA; trans-But-2-enoyl-CoA; But-2-enoyl-CoA; (E)-But-2-enoyl-CoA","R01171 R01175 R02487 R02488 R03026 R03027 R03028 R03030; R03031 R05595 R07829 R09291 R09738 R10782","Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Aminobenzoate degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism","1.3.1.44; 1.3.1.85; 1.3.1.86; 1.3.3.6; 1.3.8.1; 1.3.8.6; 1.3.8.7; 1.3.99.-; 4.1.1.70; 4.2.1.17; 4.2.1.55; 4.2.1.120; 4.3.1.14; 5.3.3.3; 5.5.1.-","Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,"CAS: 992-67-6; PubChem: 4133; ChEBI: 15473 36926; 3DMET: B04740; NIKKAJI: J1.040.164J J298.590J J808.602H","cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268",25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O17N7P3S1","C25H39O17N7P3S1",835.141425,836.1492501,834.1336
"cpd:C01144","(S)-3-Hydroxybutanoyl-CoA;","C25H42N7O18P3S","(S)-3-Hydroxybutanoyl-CoA; (S)-3-Hydroxybutyryl-CoA","R01975 R01976 R03026 R03276 R07833 R11334","Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Aminobenzoate degradation; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism","1.1.1.35; 1.1.1.157; 2.3.1.-; 4.2.1.17; 5.1.2.3; 5.3.3.20","Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,"PubChem: 4375; ChEBI: 15453; PDB-CCD: 3HC; 3DMET: B04776; NIKKAJI: J2.731.656E","cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287",25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H43O18N7P3S1","C25H41O18N7P3S1",853.1519897,854.1598147,852.1441647
"cpd:C02990","L-Palmitoylcarnitine","C23H45NO4","L-Palmitoylcarnitine","R01923","Fatty acid degradation; Fatty acid metabolism","2.3.1.21",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0707 Fatty acyl carnitines;     C02990  L-Palmitoylcarnitine","CAS: 2364-67-2; PubChem: 5899; ChEBI: 17490; ChEMBL: CHEMBL1398676; LIPIDMAPS: LMFA07070004; 3DMET: B00524; NIKKAJI: J410.749G","cpd:C02990",23,45,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H46O4N1","C23H44O4N1",399.3348589,400.342684,398.3270339
"cpd:C03561","(R)-3-Hydroxybutanoyl-CoA;","C25H42N7O18P3S","(R)-3-Hydroxybutanoyl-CoA; (3R)-3-Hydroxybutanoyl-CoA","R01977 R03027 R03276 R04254","Fatty acid degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Microbial metabolism in diverse environments; Carbon metabolism","1.1.1.36; 2.3.1.-; 4.2.1.55; 5.1.2.3","Ethylmalonyl pathway",NA,"PubChem: 6354; ChEBI: 15452; 3DMET: B04902; NIKKAJI: J2.742.980G","cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287",25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H43O18N7P3S1","C25H41O18N7P3S1",853.1519897,854.1598147,852.1441647
"cpd:C05279","trans,cis-Lauro-2,6-dienoyl-CoA","C33H54N7O17P3S","trans,cis-Lauro-2,6-dienoyl-CoA","R04756","Fatty acid degradation","5.3.3.8",NA,NA,"PubChem: 7666; ChEBI: 28387; 3DMET: B05005; NIKKAJI: J2.755.267F","cpd:C05279; cpd:C05280",33,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H55O17N7P3S1","C33H53O17N7P3S1",945.2509755,946.2588005,944.2431504
"cpd:C05280","cis,cis-3,6-Dodecadienoyl-CoA","C33H54N7O17P3S","cis,cis-3,6-Dodecadienoyl-CoA","R04756","Fatty acid degradation","5.3.3.8",NA,NA,"PubChem: 7667; ChEBI: 28002; 3DMET: B05006; NIKKAJI: J2.755.268D","cpd:C05279; cpd:C05280",33,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C33H55O17N7P3S1","C33H53O17N7P3S1",945.2509755,946.2588005,944.2431504
"cpd:C00164","Acetoacetate;","C4H6O3","Acetoacetate; 3-Oxobutanoic acid; beta-Ketobutyric acid; Acetoacetic acid","R00410 R01357 R01358 R01359 R01360 R01361 R01364 R01365; R01366 R01367 R03225 R05713 R05735 R10564","Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Lysine degradation; Tyrosine metabolism; Propanoate metabolism; Styrene degradation; Butanoate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Two-component system","1.1.1.30; 1.1.99.24; 1.8.1.5; 2.3.1.247; 2.8.3.5; 2.8.3.8; 2.8.3.9; 3.1.2.11; 3.7.1.2; 4.1.1.4; 4.1.3.4; 4.2.1.27; 6.2.1.16; 6.4.1.6","Leucine degradation, leucine => acetoacetate + acetyl-CoA; Tyrosine degradation, tyrosine => homogentisate; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    3-Oxocarboxylic acids;     C00164  Acetoacetate; 3-Oxobutanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C00164  3-Oxobutanoic acid","CAS: 541-50-4; PubChem: 3464; ChEBI: 13705 15344; LIPIDMAPS: LMFA01060003; LipidBank: DFA0387; KNApSAcK: C00007458; PDB-CCD: AAE; 3DMET: B00047; NIKKAJI: J4.508J","cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172",4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3","C4H5O3",102.0316941,103.0395191,101.023869
"cpd:C00207","Acetone;","C3H6O","Acetone; Dimethyl ketone; 2-Propanone","R01366 R01550 R01553 R03796 R05564 R05568 R05735 R08207; R08543 R09002 R09487 R10703 R10704","Synthesis and degradation of ketone bodies; Propanoate metabolism; Metabolic pathways","1.1.1.80; 1.1.1.-; 1.14.13.102; 1.14.13.115; 1.14.13.226; 1.14.15.-; 2.6.3.1; 4.1.1.4; 4.1.2.46; 4.1.99.16; 4.2.3.22; 6.4.1.6","Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone","Pharmaceutical additives [BR:br08316];  Solubilizing agent;   D02311  [001018] Acetone;  Solubilizer;   D02311  [001018] Acetone;  Solubilization agent;   D02311  [001018] Acetone;  Solvent;   D02311  [001018] Acetone","CAS: 67-64-1; PubChem: 3507; ChEBI: 15347; ChEMBL: CHEMBL14253; LIPIDMAPS: LMFA12000057; KNApSAcK: C00048304 C00048954; PDB-CCD: ACN; 3DMET: B00058; NIKKAJI: J2.365E","cpd:C00207; cpd:C00479; cpd:C02001; cpd:C08389; cpd:C11119; cpd:C11506; cpd:C11507; cpd:C14399; cpd:C15508; cpd:C19175; cpd:C19224; cpd:C19282",3,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O1","C3H5O1",58.04186481,59.04968985,57.03403978
"cpd:C00356","(S)-3-Hydroxy-3-methylglutaryl-CoA;","C27H44N7O20P3S","(S)-3-Hydroxy-3-methylglutaryl-CoA; Hydroxymethylglutaryl-CoA; Hydroxymethylglutaroyl coenzyme A; HMG-CoA; 3-Hydroxy-3-methylglutaryl-CoA","R01360 R01978 R02081 R02082 R02083 R02084 R02085","Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Butanoate metabolism; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; HMG-CoA reductase inhibitors","1.1.1.34; 1.1.1.88; 2.3.3.10; 2.8.3.13; 3.1.2.5; 4.1.3.4; 4.2.1.18","Leucine degradation, leucine => acetoacetate + acetyl-CoA; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway",NA,"CAS: 1553-55-5; PubChem: 3649; ChEBI: 15467; ChEMBL: CHEMBL1794644; KNApSAcK: C00007270; PDB-CCD: HMG; 3DMET: B04674","cpd:C00356; cpd:C14145",27,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O20N7P3S1","C27H43O20N7P3S1",911.157469,912.165294,910.149644
"cpd:C01089","(R)-3-Hydroxybutanoate;","C4H8O3","(R)-3-Hydroxybutanoate; (R)-3-Hydroxybutanoic acid; (R)-3-Hydroxybutyric acid; D-beta-Hydroxybutyric acid","R00048 R01361","Synthesis and degradation of ketone bodies; Butanoate metabolism; Metabolic pathways; cAMP signaling pathway","1.1.1.30; 3.1.1.22","Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C01089  (R)-3-Hydroxybutanoate","CAS: 625-72-9; PubChem: 4324; ChEBI: 10983 17066; ChEMBL: CHEMBL1162484; LIPIDMAPS: LMFA01050005 LMFA01050243; LipidBank: DFA0271; PDB-CCD: 3HR; 3DMET: B00239; NIKKAJI: J5.217E","cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297",4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O3","C4H7O3",104.0473441,105.0551691,103.0395191
"cpd:C08281","Docosanoic acid;","C22H44O2","Docosanoic acid; Docosanoate; Behenic acid","R08184 R09454","Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids","1.14.-.-; 3.1.2.-",NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C08281  Behenic acid (22:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C08281  Docosanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C08281  Behenic acid; Pharmaceutical additives [BR:br08316];  Base;   C08281  [122107] Behenic acid","CAS: 112-85-6; PubChem: 10479; ChEBI: 23858 28941; ChEMBL: CHEMBL1173474; LIPIDMAPS: LMFA01010022; LipidBank: DFA0022; KNApSAcK: C00001211; 3DMET: B02157; NIKKAJI: J2.461I","cpd:C08281",22,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H45O2","C22H43O2",340.3341307,341.3419557,339.3263056
"cpd:C08285","10,16-Dihydroxyhexadecanoic acid;","C16H32O4","10,16-Dihydroxyhexadecanoic acid; Hexadecanoic acid, 10,16-dihydroxy-","R09460","Cutin, suberine and wax biosynthesis","1.14.-.-",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C08285  10,16-Dihydroxyhexadecanoic acid","CAS: 3233-90-7; PubChem: 10483; ChEBI: 692; LIPIDMAPS: LMFA01050341; KNApSAcK: C00007440; 3DMET: B05260; NIKKAJI: J1.900.757J","cpd:C08285",16,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H33O4","C16H31O4",288.2300595,289.2378845,287.2222345
"cpd:C18217","16-Feruloyloxypalmitate;","C26H40O6","16-Feruloyloxypalmitate; 16-Feruloyloxypalmitic acid","R09106","Cutin, suberine and wax biosynthesis","2.3.1.188",NA,NA,"PubChem: 103061399; ChEBI: 55330; NIKKAJI: J1.135.019D","cpd:C18217",26,40,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C26H41O6","C26H39O6",448.282489,449.290314,447.274664
"cpd:C18218","16-Hydroxypalmitate;","C16H32O3","16-Hydroxypalmitate; 16-Hydroxypalmitic acid","R09106 R09448 R09451 R09460","Cutin, suberine and wax biosynthesis; Metabolic pathways","1.1.-.-; 1.14.-.-; 2.3.1.188",NA,NA,"PubChem: 103061400; ChEBI: 55328; LIPIDMAPS: LMFA01050051; KNApSAcK: C00007430 C00034997; PDB-CCD: 16Y; NIKKAJI: J11.795A","cpd:C18218",16,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H33O3","C16H31O3",272.2351449,273.2429699,271.2273199
"cpd:C19418","cis-9,10-Epoxystearic acid","C18H34O3","cis-9,10-Epoxystearic acid","R09453 R09462 R09465","Cutin, suberine and wax biosynthesis","1.11.2.3; 1.14.-.-; 3.3.2.-",NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C19418  cis-9,10-Epoxystearic acid","CAS: 2443-39-2; PubChem: 124490090; ChEBI: 82464; ChEMBL: CHEMBL27918","cpd:C00869; cpd:C08365; cpd:C13791; cpd:C19418; cpd:C19616",18,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H35O3","C18H33O3",298.250795,299.25862,297.2429699
"cpd:C19614","16-Oxopalmitate","C16H30O3","16-Oxopalmitate","R09448 R09457","Cutin, suberine and wax biosynthesis; Metabolic pathways","1.1.-.-; 1.2.-.-",NA,NA,"PubChem: 124490282","cpd:C19614",16,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H31O3","C16H29O3",270.2194948,271.2273199,269.2116698
"cpd:C19615","Hexadecanedioate","C16H30O4","Hexadecanedioate","R09457","Cutin, suberine and wax biosynthesis; Metabolic pathways","1.2.-.-",NA,NA,"PubChem: 135626103; ChEBI: 73722; LIPIDMAPS: LMFA01170022; KNApSAcK: C00007429","cpd:C14987; cpd:C19615",16,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H31O4","C16H29O4",286.2144094,287.2222345,285.2065844
"cpd:C19616","18-Hydroxyoleate","C18H34O3","18-Hydroxyoleate","R09452 R09455 R09463","Cutin, suberine and wax biosynthesis","1.1.-.-; 1.11.2.3; 1.14.-.-",NA,NA,"PubChem: 135626104; ChEBI: 78424 79312; LIPIDMAPS: LMFA02000181; KNApSAcK: C00007439","cpd:C00869; cpd:C08365; cpd:C13791; cpd:C19418; cpd:C19616",18,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H35O3","C18H33O3",298.250795,299.25862,297.2429699
"cpd:C19617","18-Oxooleate","C18H32O3","18-Oxooleate","R09455 R09458","Cutin, suberine and wax biosynthesis","1.1.-.-; 1.2.-.-",NA,NA,"PubChem: 135626105; ChEBI: 133357","cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617",18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H33O3","C18H31O3",296.2351449,297.2429699,295.2273199
"cpd:C19618","Octadec-9-ene-1,18-dioic-acid","C18H32O4","Octadec-9-ene-1,18-dioic-acid","R09458","Cutin, suberine and wax biosynthesis","1.2.-.-",NA,NA,"PubChem: 135626106; LIPIDMAPS: LMFA01170055","cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703",18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H33O4","C18H31O4",312.2300595,313.2378845,311.2222345
"cpd:C19620","9,10-Epoxy-18-hydroxystearate","C18H34O4","9,10-Epoxy-18-hydroxystearate","R09453 R09463 R09464","Cutin, suberine and wax biosynthesis","1.11.2.3; 1.14.-.-; 3.3.2.-",NA,NA,"PubChem: 135626108; ChEBI: 133381; KNApSAcK: C00034432","cpd:C07355; cpd:C14828; cpd:C14829; cpd:C19620; cpd:C20702",18,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H35O4","C18H33O4",314.2457096,315.2535346,313.2378845
"cpd:C19621","9,10,18-Trihydroxystearate","C18H36O5","9,10,18-Trihydroxystearate","R09461 R09464","Cutin, suberine and wax biosynthesis","1.14.-.-; 3.3.2.-",NA,NA,"PubChem: 135626109; ChEBI: 133325; LIPIDMAPS: LMFA02000147; KNApSAcK: C00034431","cpd:C16566; cpd:C17989; cpd:C17993; cpd:C19621",18,36,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H37O5","C18H35O5",332.2562743,333.2640993,331.2484492
"cpd:C19622","9,10-Dihydroxystearate","C18H36O4","9,10-Dihydroxystearate","R09461 R09465","Cutin, suberine and wax biosynthesis","1.14.-.-; 3.3.2.-",NA,NA,"PubChem: 135626110; LIPIDMAPS: LMFA02000142","cpd:C08314; cpd:C15988; cpd:C19622",18,36,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H37O4","C18H35O4",316.2613596,317.2691847,315.2535346
"cpd:C19623","22-Hydroxydocosanoate","C22H44O3","22-Hydroxydocosanoate","R09454 R09456","Cutin, suberine and wax biosynthesis","1.1.-.-; 1.14.-.-",NA,NA,"PubChem: 135626111; ChEBI: 76322; LIPIDMAPS: LMFA01050079; KNApSAcK: C00035005","cpd:C03049; cpd:C19623",22,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H45O3","C22H43O3",356.3290453,357.3368703,355.3212202
"cpd:C19624","22-Oxodocosanoate","C22H42O3","22-Oxodocosanoate","R09456 R09459","Cutin, suberine and wax biosynthesis","1.1.-.-; 1.2.-.-",NA,NA,"PubChem: 135626112; ChEBI: 76318","cpd:C19624",22,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H43O3","C22H41O3",354.3133952,355.3212202,353.3055702
"cpd:C19625","Docosanedioate","C22H42O4","Docosanedioate","R09459","Cutin, suberine and wax biosynthesis","1.2.-.-",NA,NA,"PubChem: 135626113; ChEBI: 76319; LIPIDMAPS: LMFA01170037","cpd:C14240; cpd:C19625",22,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H43O4","C22H41O4",370.3083098,371.3161349,369.3004848
"cpd:C00187","Cholesterol;","C27H46O","Cholesterol; Cholest-5-en-3beta-ol","R01451 R01452 R01453 R01454 R01456 R01457 R01459 R01460; R01461 R01462 R01463 R02692 R02723 R02724 R07207 R07218; R08505 R08941 R08977 R09920 R11007 R11008","Steroid biosynthesis; Primary bile acid biosynthesis; Steroid hormone biosynthesis; Insect hormone biosynthesis; Steroid degradation; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways; Microbial metabolism in diverse environments; Ovarian steroidogenesis; Aldosterone synthesis and secretion; Fat digestion and absorption; Bile secretion; Vitamin digestion and absorption; Pathways in cancer; Basal cell carcinoma","1.1.1.145; 1.1.3.6; 1.3.1.21; 1.3.1.72; 1.14.13.-; 1.14.14.23; 1.14.14.25; 1.14.15.6; 1.14.15.15; 1.14.19.21; 1.14.99.38; 2.3.1.26; 2.3.1.73; 2.8.2.2; 2.8.2.14; 3.1.1.13; 3.1.6.2; 3.2.1.104; 5.3.3.1","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone","Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C00187  Cholesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C00187  Cholesterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cholestane;     C00187  Cholesterol; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00187  Cholesterol; Pharmaceutical additives [BR:br08316];  Surfactant;   D00040  [001255] Cholesterol;  Base;   D00040  [001255] Cholesterol;  Diluting agent;   D00040  [001255] Cholesterol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00040  Cholesterol","CAS: 57-88-5; PubChem: 3487; ChEBI: 16113; ChEMBL: CHEMBL112570 CHEMBL1867358; LIPIDMAPS: LMST01010001; LipidBank: SST0005 SST9061; KNApSAcK: C00003648; PDB-CCD: CLR; 3DMET: B01181; NIKKAJI: J2.804E","cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663",27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O1","C27H45O1",386.3548661,387.3626911,385.3470411
"cpd:C00448","trans,trans-Farnesyl diphosphate;","C15H28O7P2","trans,trans-Farnesyl diphosphate; Farnesyl diphosphate; Farnesyl pyrophosphate; 2-trans,6-trans-Farnesyl diphosphate; (2E,6E)-Farnesyl diphosphate","R00702 R02003 R02061 R02303 R02305 R02306 R02307 R02310; R02311 R05555 R05556 R06223 R06447 R06523 R07411 R07630; R07647 R07648 R07649 R07652 R07830 R08144 R08370 R08373; R08374 R08540 R08541 R08542 R08543 R08545 R08546 R08691; R08695 R08696 R08697 R08746 R09064 R09065 R09140 R09245; R09247 R09248 R09249 R09525 R09526 R09558 R09574 R09606; R09614 R09615 R09616 R09617 R09618 R09619 R09620 R09623; R09624 R09626 R09627 R09628 R09629 R09630 R09788 R09789; R09844 R09850 R09886 R09887 R09888 R09889 R09890 R09891; R09892 R09893 R09894 R09895 R09896 R09897 R09898 R09900; R09901 R09902 R09976 R10004 R10005 R10006 R10007 R10008; R10271 R10272 R10273 R10274 R10275 R10493 R10584 R10598; R10599 R10726 R10732 R10733 R10734","Steroid biosynthesis; Terpenoid backbone biosynthesis; Carotenoid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Insect hormone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.5.1.10; 2.5.1.21; 2.5.1.29; 2.5.1.30; 2.5.1.31; 2.5.1.58; 2.5.1.83; 2.5.1.87; 2.5.1.90; 2.5.1.91; 2.5.1.96; 2.5.1.103; 2.5.1.-; 2.7.4.18; 3.1.3.-; 3.1.7.6; 3.1.7.7; 4.1.99.16; 4.2.3.6; 4.2.3.7; 4.2.3.9; 4.2.3.13; 4.2.3.21; 4.2.3.22; 4.2.3.23; 4.2.3.24; 4.2.3.37; 4.2.3.38; 4.2.3.39; 4.2.3.40; 4.2.3.46; 4.2.3.47; 4.2.3.48; 4.2.3.49; 4.2.3.55; 4.2.3.56; 4.2.3.57; 4.2.3.58; 4.2.3.59; 4.2.3.60; 4.2.3.61; 4.2.3.63; 4.2.3.64; 4.2.3.65; 4.2.3.66; 4.2.3.67; 4.2.3.68; 4.2.3.69; 4.2.3.70; 4.2.3.71; 4.2.3.72; 4.2.3.73; 4.2.3.74; 4.2.3.75; 4.2.3.76; 4.2.3.77; 4.2.3.78; 4.2.3.79; 4.2.3.80; 4.2.3.81; 4.2.3.82; 4.2.3.83; 4.2.3.84; 4.2.3.85; 4.2.3.86; 4.2.3.87; 4.2.3.88; 4.2.3.89; 4.2.3.90; 4.2.3.91; 4.2.3.92; 4.2.3.93; 4.2.3.94; 4.2.3.95; 4.2.3.96; 4.2.3.97; 4.2.3.98; 4.2.3.100; 4.2.3.101; 4.2.3.102; 4.2.3.104; 4.2.3.123; 4.2.3.125; 4.2.3.126; 4.2.3.127; 4.2.3.128; 4.2.3.129; 4.2.3.133; 4.2.3.135; 4.2.3.136; 4.2.3.137; 4.2.3.138; 4.2.3.139; 4.2.3.143; 5.5.1.-","C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes; Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C00448  trans,trans-Farnesyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C00448  Farnesyl diphosphate","CAS: 372-97-4; PubChem: 3736; ChEBI: 17407; ChEMBL: CHEMBL69330; LIPIDMAPS: LMPR0103010002; LipidBank: IIP0005; KNApSAcK: C00000907 C00007268; PDB-CCD: FPP; 3DMET: B01245; NIKKAJI: J348.314B","cpd:C00448; cpd:C06111; cpd:C16826; cpd:C19760; cpd:C19853",15,28,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H29O7P2","C15H27O7P2",382.1310272,383.1388523,381.1232022
"cpd:C00751","Squalene;","C30H50","Squalene; Spinacene; Supraene","R02872 R02873 R02874 R02875 R02876 R06223 R07322 R07323; R08535 R09712 R10167 R10169 R11401","Steroid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.3.1.96; 1.14.14.17; 1.17.8.1; 2.1.1.262; 2.5.1.21; 4.2.1.123; 4.2.1.129; 5.4.99.17; 5.4.99.37",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C00751  Squalene; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C00751  Squalene; Pharmaceutical additives [BR:br08316];  Base;   C00751  [508064] Squalene;  Flexibilizer;   C00751  [508064] Squalene;  Emulsion;   C00751  [508064] Squalene;  Solubilizer;   C00751  [508064] Squalene;  Solvent;   C00751  [508064] Squalene","CAS: 111-02-4; PubChem: 4013; ChEBI: 15440; ChEMBL: CHEMBL458402; LIPIDMAPS: LMPR0106010002; LipidBank: SST0122; KNApSAcK: C00003755; PDB-CCD: SQL; 3DMET: B00166; NIKKAJI: J5.103I","cpd:C00751; cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C03685; cpd:C04930; cpd:C04934; cpd:C06310; cpd:C08615; cpd:C08616; cpd:C08618; cpd:C08622; cpd:C08624; cpd:C08625; cpd:C08626; cpd:C08628; cpd:C08634; cpd:C08636; cpd:C08637; cpd:C08789; cpd:C08931; cpd:C08980; cpd:C11523; cpd:C15274; cpd:C16783; cpd:C16958; cpd:C16973; cpd:C17419; cpd:C17421; cpd:C17459; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19732; cpd:C19733; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19834; cpd:C19835; cpd:C19918; cpd:C19942; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C20432; cpd:C20945; cpd:C21116",30,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51","C30H49",410.3912516,411.3990766,409.3834266
"cpd:C01054","(S)-2,3-Epoxysqualene;","C30H50O","(S)-2,3-Epoxysqualene; Squalene 2,3-epoxide; Squalene 2,3-oxide; (S)-Squalene-2,3-epoxide; 2,3-Oxidosqualene; (3S)-2,3-Epoxy-2,3-dihydrosqualene","R02116 R02873 R02874 R03199 R03200 R03201 R06466 R06469; R06471 R08376 R08378 R09476 R09688 R09689 R09700 R09701; R09709 R09710 R09711 R09713 R09743 R09906 R09907 R09908; R09909 R09910 R09911 R09912 R09913 R09914 R09915 R09916; R09917","Steroid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.14.14.17; 4.2.1.124; 4.2.1.125; 4.2.1.128; 5.4.99.7; 5.4.99.8; 5.4.99.31; 5.4.99.32; 5.4.99.33; 5.4.99.34; 5.4.99.35; 5.4.99.36; 5.4.99.38; 5.4.99.39; 5.4.99.40; 5.4.99.41; 5.4.99.46; 5.4.99.47; 5.4.99.48; 5.4.99.49; 5.4.99.50; 5.4.99.51; 5.4.99.52; 5.4.99.53; 5.4.99.54; 5.4.99.55; 5.4.99.56; 5.4.99.57","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C01054  (S)-2,3-Epoxysqualene; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C01054  (S)-2,3-Epoxysqualene","PubChem: 4295; ChEBI: 15441; LIPIDMAPS: LMPR0106010010; KNApSAcK: C00007282; PDB-CCD: 2TX; 3DMET: B01371; NIKKAJI: J39.259F","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C01164","7-Dehydrocholesterol;","C27H44O","7-Dehydrocholesterol; Provitamin D3; Cholesta-5,7-dien-3beta-ol","R01451 R01456 R03311 R07215 R07507 R08132 R11007 R11008","Steroid biosynthesis; Insect hormone biosynthesis; Metabolic pathways","1.3.1.21; 1.3.1.72; 1.14.19.20; 1.14.19.21","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Cholecalciferol biosynthesis","Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C01164  7-Dehydrocholesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C01164  Provitamin D3","CAS: 434-16-2; PubChem: 4391; ChEBI: 17759; ChEMBL: CHEMBL1797131; LIPIDMAPS: LMST01010069; LipidBank: SST0007; KNApSAcK: C00023747; 3DMET: B01398; NIKKAJI: J60.101B","cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711",27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O1","C27H43O1",384.339216,385.3470411,383.331391
"cpd:C01189","Lathosterol;","C27H46O","Lathosterol; 5alpha-Cholest-7-en-3beta-ol","R03353 R04328 R05703 R07215","Steroid biosynthesis; Metabolic pathways","1.1.1.170; 1.1.1.270; 1.3.1.72; 1.14.13.72; 1.14.19.20; 5.3.3.5","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01189  Lathosterol","CAS: 80-99-9; PubChem: 4415; ChEBI: 17168; LIPIDMAPS: LMST01010089; LipidBank: SST9096; KNApSAcK: C00023744; 3DMET: B01406; NIKKAJI: J9.827B","cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663",27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O1","C27H45O1",386.3548661,387.3626911,385.3470411
"cpd:C01561","Calcidiol;","C27H44O2","Calcidiol; 25-Hydroxyvitamin D3; Calcifediol; Calcifediol anhydrous; (3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol","R03610 R03611 R09516 R11458 R11459","Steroid biosynthesis; Metabolic pathways; Tuberculosis","1.14.14.24; 1.14.15.16; 1.14.15.18; 1.14.15.22","Cholecalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C01561  Calcidiol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC06 Calcifediol;       C01561  Calcidiol","CAS: 19356-17-3; PubChem: 4719; ChEBI: 17933; ChEMBL: CHEMBL1040 CHEMBL15596 CHEMBL1599212; LIPIDMAPS: LMST03020246; LipidBank: VVD0273; KNApSAcK: C00040805; PDB-CCD: VDY; 3DMET: B04804; NIKKAJI: J9.697K","cpd:C01561; cpd:C05455; cpd:C15632; cpd:C19662; cpd:C20143; cpd:C21303",27,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O2","C27H43O2",400.3341307,401.3419557,399.3263056
"cpd:C01673","Calcitriol;","C27H44O3","Calcitriol; 1alpha,25-Dihydroxyvitamin D3; (1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol","R03610 R09515 R11459","Steroid biosynthesis; Metabolic pathways; Endocrine and other factor-regulated calcium reabsorption; Mineral absorption; Tuberculosis","1.14.15.16; 1.14.15.18; 1.14.15.22","Cholecalciferol biosynthesis","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Others;     C01673  Calcitriol (Vitamin D); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC04 Calcitriol;       D00129  Calcitriol (JAN/USP/INN);  D DERMATOLOGICALS;   D05 ANTIPSORIATICS;    D05A ANTIPSORIATICS FOR TOPICAL USE;     D05AX Other antipsoriatics for topical use;      D05AX03 Calcitriol;       D00129  Calcitriol (JAN/USP/INN); USP drug classification [BR:br08302];  Dermatological Agents;   Calcitriol;    D00129  Calcitriol (JAN/USP/INN);  Metabolic Bone Disease Agents;   Calcitriol;    D00129  Calcitriol (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    311  Vitamins A and D preparations;     3112  Synthetic vitamin D preparations;      D00129  Calcitriol (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Calcitriol;       D00129  Calcitriol (JAN/USP/INN); Osteoporosis drugs [br08368.html];  D00129; Rx-to-OTC switch list in Japan [br08314.html];  D00129","CAS: 32222-06-3; PubChem: 4817; ChEBI: 17823; ChEMBL: CHEMBL267223 CHEMBL297508 CHEMBL298498 CHEMBL55542 CHEMBL846; LIPIDMAPS: LMST03020258; PDB-CCD: VDX; 3DMET: B01476; NIKKAJI: J17.427K","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C01694","Ergosterol;","C28H44O","Ergosterol; Provitamin D2","R03675 R03677 R05641","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.3.1.71; 4.2.1.62","Ergocalciferol biosynthesis","Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Ergostane derivatives;     C01694  Ergosterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01694  Ergosterol;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C01694  Ergosterol; Major components of natural products [BR:br08323];  Crude drugs;   Polyporus sclerotium;    C01694  Ergosterol","CAS: 57-87-4; PubChem: 4835; ChEBI: 16933; ChEMBL: CHEMBL1232562; LIPIDMAPS: LMST01030093; LipidBank: SST0012 SST9075 VVD0358; KNApSAcK: C00003652 C00023755; PDB-CCD: ERG; 3DMET: B01480; NIKKAJI: J209.317K","cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653",28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O1","C28H43O1",396.339216,397.3470411,395.331391
"cpd:C01724","Lanosterol;","C30H50O","Lanosterol; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol","R03199 R03689 R05640","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.3.1.72; 1.14.13.70; 5.4.99.7","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01724  Lanosterol","CAS: 79-63-0; PubChem: 4861; ChEBI: 16521; ChEMBL: CHEMBL225111; LIPIDMAPS: LMST01010017; LipidBank: SST9081; KNApSAcK: C00003657; PDB-CCD: LAN; 3DMET: B01488; NIKKAJI: J4.237D","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C01753","beta-Sitosterol;","C29H50O","beta-Sitosterol; Sitosterol","R07488 R07489","Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites","1.3.1.-; 1.14.19.41",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C01753  Sitosterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C01753  beta-Sitosterol","CAS: 83-46-5; PubChem: 4886; ChEBI: 27693; ChEMBL: CHEMBL1875388 CHEMBL221542; LIPIDMAPS: LMST01040129; LipidBank: SST0017; KNApSAcK: C00003672 C00023770; 3DMET: B01493; NIKKAJI: J4.633G","cpd:C01753; cpd:C04530; cpd:C08839; cpd:C15915; cpd:C19654",29,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H51O1","C29H49O1",414.3861662,415.3939913,413.3783412
"cpd:C01789","Campesterol","C28H48O","Campesterol","R07427 R07445 R07493","Steroid biosynthesis; Brassinosteroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.-; 1.14.13.-","Castasterone biosynthesis, campesterol => castasterone","Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Campestane derivatives;     C01789  Campesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01789  Campesterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C01789  Campesterol","CAS: 474-62-4; PubChem: 4917; ChEBI: 28623; ChEMBL: CHEMBL1836653 CHEMBL520535; LIPIDMAPS: LMST01030097; LipidBank: SST0036 SST9062; KNApSAcK: C00003647; 3DMET: B01498; NIKKAJI: J5.962E","cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106",28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H49O1","C28H47O1",400.3705162,401.3783412,399.3626911
"cpd:C01802","Desmosterol;","C27H44O","Desmosterol; 24-Dehydrocholesterol; Cholesta-5,24-dien-3beta-ol","R01457 R03723 R03724 R03725 R04763","Steroid biosynthesis; Metabolic pathways","1.3.1.72; 4.1.2.33",NA,"Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C01802  Desmosterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01802  Desmosterol","CAS: 313-04-2; PubChem: 4928; ChEBI: 17737; ChEMBL: CHEMBL455876; LIPIDMAPS: LMST01010016 LMST01010090; LipidBank: SST0008 SST9090; KNApSAcK: C00023743; 3DMET: B01500; NIKKAJI: J5.659F","cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711",27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O1","C27H43O1",384.339216,385.3470411,383.331391
"cpd:C01902","Cycloartenol;","C30H50O","Cycloartenol; 9beta,19-Cyclo-24-lanosten-3beta-ol","R03200 R03765 R05760 R07481","Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.41; 2.1.1.142; 5.4.99.8",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C01902  Cycloartenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cycloartane;     C01902  Cycloartenol","CAS: 469-38-5; PubChem: 5012; ChEBI: 17030; ChEMBL: CHEMBL2007217 CHEMBL225815 CHEMBL393145; LIPIDMAPS: LMST01100008; LipidBank: SST9083; KNApSAcK: C00003650; 3DMET: B01514; NIKKAJI: J11.335B","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C01943","Obtusifoliol;","C30H50O","Obtusifoliol; 4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol; 4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol","R03775 R05731","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.13.70; 5.5.1.9",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01943  Obtusifoliol","CAS: 16910-32-0; PubChem: 5047; ChEBI: 17791; ChEMBL: CHEMBL1978954 CHEMBL481434; LIPIDMAPS: LMST01030101; LipidBank: SST9079; KNApSAcK: C00007368; 3DMET: B01520; NIKKAJI: J69.979I","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C02141","Cycloeucalenol","C30H50O","Cycloeucalenol","R03775 R07482","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.13.72; 5.5.1.9",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C02141  Cycloeucalenol","CAS: 469-39-6; PubChem: 5220; ChEBI: 16653; ChEMBL: CHEMBL225634; LIPIDMAPS: LMST01100011; LipidBank: SST9080; KNApSAcK: C00007367; 3DMET: B01539; NIKKAJI: J11.336K","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C03428","Presqualene diphosphate","C30H52O7P2","Presqualene diphosphate","R00702 R02872 R09793 R10194 R11410","Steroid biosynthesis; Carotenoid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.3.1.96; 1.3.1.97; 2.5.1.21; 2.5.1.96; 2.5.1.103; 4.2.3.156",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C03428  Presqualene diphosphate","PubChem: 6255; ChEBI: 15442; LIPIDMAPS: LMPR0106010003; PDB-CCD: PS7; 3DMET: B01658; NIKKAJI: J816.761C","cpd:C01230; cpd:C03428; cpd:C17434",30,52,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H53O7P2","C30H51O7P2",586.318828,587.326653,585.311003
"cpd:C03845","5alpha-Cholest-8-en-3beta-ol;","C27H46O","5alpha-Cholest-8-en-3beta-ol; Zymostenol; Cholestenol","R03353 R07498","Steroid biosynthesis; Metabolic pathways","1.3.1.72; 5.3.3.5","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,"CAS: 566-97-2; PubChem: 6582; ChEBI: 16608; LIPIDMAPS: LMST01010096; KNApSAcK: C00033775; 3DMET: B01693; NIKKAJI: J488.411F","cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663",27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O1","C27H45O1",386.3548661,387.3626911,385.3470411
"cpd:C04525","Fecosterol;","C28H46O","Fecosterol; 24-Methylene-5alpha-cholest-8-en-3beta-ol","R04427 R07497","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","2.1.1.41","Ergocalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C04525  24-Methylene-5alpha-cholest-8-en-3beta-ol;    ST0103 Ergosterols and C24-methyl derivatives;     C04525  Fecosterol","CAS: 516-86-9; PubChem: 7136; ChEBI: 17038; LIPIDMAPS: LMST01030095; KNApSAcK: C00023751; 3DMET: B01753; NIKKAJI: J16.117I","cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192",28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O1","C28H45O1",398.3548661,399.3626911,397.3470411
"cpd:C05103","4alpha-Methylzymosterol","C28H46O","4alpha-Methylzymosterol","R07495 R07496","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.1.1.270","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05103  4alpha-Methylzymosterol","PubChem: 7531; ChEBI: 1949; LIPIDMAPS: LMST01010202; KNApSAcK: C00023768; 3DMET: B04976; NIKKAJI: J669.213C","cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192",28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O1","C28H45O1",398.3548661,399.3626911,397.3470411
"cpd:C05107","7-Dehydrodesmosterol;","C27H42O","7-Dehydrodesmosterol; Cholesta-5,7,24-triene-3beta-ol","R03724 R04667 R07507","Steroid biosynthesis; Metabolic pathways","1.3.1.72",NA,NA,"CAS: 1715-86-2; PubChem: 7533; ChEBI: 27910; LIPIDMAPS: LMST01010121; 3DMET: B01809; NIKKAJI: J2.754.720F","cpd:C05107; cpd:C15357",27,42,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H43O1","C27H41O1",382.323566,383.331391,381.3157409
"cpd:C05108","14-Demethyllanosterol;","C29H48O","14-Demethyllanosterol; 4,4-Dimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 4,4-Dimethyl-8,24-cholestadienol","R05639 R07499 R07509","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.3.1.70; 1.3.1.72; 1.14.13.72","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05108  14-Demethyllanosterol","CAS: 7448-02-4; PubChem: 7534; ChEBI: 18364; LIPIDMAPS: LMST01010176; KNApSAcK: C00023776; 3DMET: B04978; NIKKAJI: J14.903I","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C05109","24,25-Dihydrolanosterol","C30H52O","24,25-Dihydrolanosterol","R03689 R04670","Steroid biosynthesis","1.3.1.72",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05109  24,25-Dihydrolanosterol","CAS: 79-62-9; PubChem: 7535; ChEBI: 28113; ChEMBL: CHEMBL132906; LIPIDMAPS: LMST01010087; KNApSAcK: C00023781; 3DMET: B01810; NIKKAJI: J40.430F","cpd:C05109; cpd:C06083; cpd:C06309; cpd:C17123",30,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H53O1","C30H51O1",428.4018163,429.4096413,427.3939913
"cpd:C05437","Zymosterol;","C27H44O","Zymosterol; Delta8,24-Cholestadien-3beta-ol; 5alpha-Cholesta-8,24-dien-3beta-ol","R03765 R04427 R04804 R07496 R07498","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.3.1.72; 2.1.1.41; 5.3.3.5","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Ergocalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05437  Zymosterol","CAS: 128-33-6; PubChem: 7800; ChEBI: 18252; LIPIDMAPS: LMST01010066; LipidBank: SST9103; KNApSAcK: C00023749; 3DMET: B01856; NIKKAJI: J10.048J","cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711",27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O1","C27H43O1",384.339216,385.3470411,383.331391
"cpd:C05439","5alpha-Cholesta-7,24-dien-3beta-ol","C27H44O","5alpha-Cholesta-7,24-dien-3beta-ol","R04667 R04804 R05703","Steroid biosynthesis; Metabolic pathways","1.3.1.72; 5.3.3.5",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05439  5alpha-Cholesta-7,24-dien-3beta-ol","CAS: 651-54-7; PubChem: 7801; ChEBI: 16290; LIPIDMAPS: LMST01010206; 3DMET: B05022; NIKKAJI: J530.073H","cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711",27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O1","C27H43O1",384.339216,385.3470411,383.331391
"cpd:C05440","Ergosta-5,7,22,24(28)-tetraen-3beta-ol;","C28H42O","Ergosta-5,7,22,24(28)-tetraen-3beta-ol; Ergosta-5,7,22,24(24(1))-tetraen-3beta-ol; 5,7,22,24(28)-Ergostatetraenol","R04763 R05641 R07506","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.3.1.71; 1.14.19.41","Ergocalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol","PubChem: 7802; ChEBI: 18249; LIPIDMAPS: LMST01031015; KNApSAcK: C00023764; 3DMET: B05023; NIKKAJI: J492.623D","cpd:C05440",28,42,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H43O1","C28H41O1",394.323566,395.331391,393.3157409
"cpd:C05441","Vitamin D2;","C28H44O","Vitamin D2; Ergocalciferol","R03677","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics",NA,"Ergocalciferol biosynthesis","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C05441  Ergocalciferol (Vitamin D2); Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C05441  Vitamin D2; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC01 Ergocalciferol;       D00187  Ergocalciferol (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   39 Vitamin AD based drugs;    D00187  Ergocalciferol (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol or Cholecalciferol;     D00187  Ergocalciferol (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol;     D00187  Ergocalciferol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Ergocalciferol;       D00187  Ergocalciferol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00187  Ergocalciferol","CAS: 50-14-6; PubChem: 7803; ChEBI: 28934; ChEMBL: CHEMBL1436587 CHEMBL1536 CHEMBL50241; LIPIDMAPS: LMST03010000 LMST03010001; LipidBank: VVD0351; PDB-CCD: D2V; 3DMET: B01857; NIKKAJI: J1.907K","cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653",28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O1","C28H43O1",396.339216,397.3470411,395.331391
"cpd:C05442","Stigmasterol","C29H48O","Stigmasterol","R07489","Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites","1.14.19.41",NA,"Compounds with biological roles [BR:br08001];  Steroids;   29-Carbon atoms;    Stigmastane derivatives;     C05442  Stigmasterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C05442  Stigmasterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C05442  Stigmasterol; Major components of natural products [BR:br08323];  Medicinal herbs;   Pumpkin seed;    C05442  Stigmasterol","CAS: 83-48-7; PubChem: 7804; ChEBI: 28824; ChEMBL: CHEMBL186373 CHEMBL400247 CHEMBL66943; LIPIDMAPS: LMST01040123; LipidBank: SST9068; KNApSAcK: C00003674 C00023774; 3DMET: B01858; NIKKAJI: J4.635C","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C05443","Vitamin D3;","C27H44O","Vitamin D3; Cholecalciferol; Calciol","R03311 R03611 R11458","Steroid biosynthesis; Metabolic pathways; Vitamin digestion and absorption; Rheumatoid arthritis","1.14.14.24; 1.14.15.22","Cholecalciferol biosynthesis","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C05443  Cholecalciferol (Vitamin D3); Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C05443  Vitamin D3; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC05 Colecalciferol;       D00188  Cholecalciferol (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   33 Vitamin D based drugs;    D00188  Cholecalciferol (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol or Cholecalciferol;     D00188  Cholecalciferol (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol;     D00188  Cholecalciferol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Colecalciferol;       D00188  Cholecalciferol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00188  Cholecalciferol; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9621  Vitamin A, D and preparations;     C05443  Vitamin D3","CAS: 67-97-0; PubChem: 7805; ChEBI: 28940; ChEMBL: CHEMBL1042 CHEMBL1365250 CHEMBL432780; LIPIDMAPS: LMST03020000 LMST03020001; LipidBank: VVD0237; KNApSAcK: C00041217; 3DMET: B01859; NIKKAJI: J2.367A","cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711",27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O1","C27H43O1",384.339216,385.3470411,383.331391
"cpd:C07712","Secalciferol;","C27H44O3","Secalciferol; 24(R),25-Dihydroxyvitamin D3; (24R),25-Dihydroxyvitamin D3; (3S,5Z,7E,24R)-9,10-Secocholesta-5,7,10-triene-3,24,25-triol","R09516 R11324","Steroid biosynthesis; Metabolic pathways","1.14.15.16; 1.14.15.18",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C07712  Secalciferol","CAS: 55721-11-4; PubChem: 9914; ChEBI: 28818; LIPIDMAPS: LMST03020273; LipidBank: VVD0300; 3DMET: B05256; NIKKAJI: J458.721I","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C08813","Brassicasterol","C28H46O","Brassicasterol","R11097","Steroid biosynthesis; Metabolic pathways","1.14.19.41",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C08813  Brassicasterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C08813  Brassicasterol","CAS: 474-67-9; PubChem: 11006; ChEBI: 3168; LIPIDMAPS: LMST01030098; KNApSAcK: C00003646; 3DMET: B02432; NIKKAJI: J12.044H","cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192",28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O1","C28H45O1",398.3548661,399.3626911,397.3470411
"cpd:C08821","Isofucosterol;","C29H48O","Isofucosterol; Delta5-Avenasterol","R07487 R07488","Steroid biosynthesis; Biosynthesis of secondary metabolites","1.3.1.21; 1.3.1.-",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C08821  Isofucosterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C08821  Isofucosterol","CAS: 481-14-1; PubChem: 11014; ChEBI: 28604; ChEMBL: CHEMBL1836654; LIPIDMAPS: LMST01040145; LipidBank: SST9070; KNApSAcK: C00003656; 3DMET: B02437; NIKKAJI: J12.392G","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C08830","24-Methylenecycloartanol;","C31H52O","24-Methylenecycloartanol; 9,19-Cyclolanostan-3-o1, 24-methylene-, (3beta)-","R07481 R07482","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.13.72; 2.1.1.41",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C08830  24-Methylenecycloartanol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cycloartane;     C08830  24-Methylenecycloartanol","CAS: 1449-09-8; PubChem: 11023; ChEBI: 1307; ChEMBL: CHEMBL376350; KNApSAcK: C00003661; 3DMET: B02440; NIKKAJI: J113.713A","cpd:C08830; cpd:C11513; cpd:C16916; cpd:C17534",31,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C31H53O1","C31H51O1",440.4018163,441.4096413,439.3939913
"cpd:C11455","4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol","C29H46O","4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol","R05639 R05640","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.3.1.70; 1.14.13.70","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C11455  4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol","CAS: 64284-64-6; PubChem: 13626; ChEBI: 17813; ChEMBL: CHEMBL10850; LIPIDMAPS: LMST01010149; 3DMET: B04267; NIKKAJI: J1.007.648J","cpd:C11455; cpd:C11508; cpd:C15783",29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H47O1","C29H45O1",410.3548661,411.3626911,409.3470411
"cpd:C11508","4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol;","C29H46O","4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol; Delta8,14 -Sterol","R05731 R07483","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.70; 1.14.13.70",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C11508  4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol","PubChem: 13678; ChEBI: 30109; LIPIDMAPS: LMST01031020; KNApSAcK: C00007523; 3DMET: B04269; NIKKAJI: J2.774.817A","cpd:C11455; cpd:C11508; cpd:C15783",29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H47O1","C29H45O1",410.3548661,411.3626911,409.3470411
"cpd:C11522","24-Methylenelophenol;","C29H48O","24-Methylenelophenol; 4-alpha-Methyl-5-alpha-ergosta-7,24-dien-3-beta-ol","R05776 R07484 R07490","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.13.72; 2.1.1.143; 5.3.3.5",NA,NA,"PubChem: 13690; ChEBI: 29107; LIPIDMAPS: LMST01030100; LipidBank: SST9077; KNApSAcK: C00007320; 3DMET: B05533; NIKKAJI: J14.185B","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C11523","24-Ethylidenelophenol;","C30H50O","24-Ethylidenelophenol; alpha1-Sitosterol; 4-alpha-Methyl-5-alpha-stigmasta-7,Z-24-dien-3-beta-ol; (Z)-24-Ethylidenelophenol","R05776 R07485","Steroid biosynthesis; Biosynthesis of secondary metabolites","1.14.13.72; 2.1.1.143",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C11523  24-Ethylidene lophenol;     C11523  24-Ethylidene lophenol","CAS: 474-40-8; PubChem: 13691; ChEMBL: CHEMBL1394708; LIPIDMAPS: LMST01040144; LipidBank: SST0116; KNApSAcK: C00007321; 3DMET: B05534; NIKKAJI: J12.662D","cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116",30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H51O1","C30H49O1",426.3861662,427.3939913,425.3783412
"cpd:C15776","4alpha-Methylfecosterol","C29H48O","4alpha-Methylfecosterol","R07483 R07484","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.70; 5.3.3.5",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15776  4alpha-Methylfecosterol","CAS: 17757-07-2; PubChem: 47205102; ChEBI: 80094; LIPIDMAPS: LMST01031019; KNApSAcK: C00007524; NIKKAJI: J126.773F","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C15777","Episterol","C28H46O","Episterol","R07490 R07491 R07497 R07505","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.14.13.72; 1.14.19.20","Ergocalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15777  Episterol","CAS: 474-68-0; PubChem: 47205103; ChEBI: 50586; LIPIDMAPS: LMST01030115; KNApSAcK: C00007272; NIKKAJI: J12.013H","cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192",28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O1","C28H45O1",398.3548661,399.3626911,397.3470411
"cpd:C15778","5,7,24(28)-Ergostatrienol;","C28H44O","5,7,24(28)-Ergostatrienol; Ergosta-5,7,24(28)-trien-3beta-ol","R07505 R07506","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.14.19.20; 1.14.19.41","Ergocalciferol biosynthesis","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15778  5,7,24(28)-Ergostatrienol","PubChem: 47205104; ChEBI: 80095; NIKKAJI: J527.837F","cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653",28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O1","C28H43O1",396.339216,397.3470411,395.331391
"cpd:C15780","5-Dehydroepisterol","C28H44O","5-Dehydroepisterol","R07491 R07492","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.21; 1.14.19.20",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15780  5-Dehydroepisterol","PubChem: 47205105; ChEBI: 52972; LIPIDMAPS: LMST01030135; KNApSAcK: C00007261; NIKKAJI: J527.837F","cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653",28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O1","C28H43O1",396.339216,397.3470411,395.331391
"cpd:C15781","24-Methylenecholesterol","C28H46O","24-Methylenecholesterol","R03725 R07492 R07493 R11096","Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.21; 1.3.1.-",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15781  24-Methylenecholesterol","CAS: 474-63-5; PubChem: 47205106; ChEBI: 19812; ChEMBL: CHEMBL477971; LIPIDMAPS: LMST01030099; KNApSAcK: C00007271; NIKKAJI: J12.062F","cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192",28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O1","C28H45O1",398.3548661,399.3626911,397.3470411
"cpd:C15782","Delta7-Avenasterol;","C29H48O","Delta7-Avenasterol; 7-Dehydroavenasterol","R07485 R07486","Steroid biosynthesis; Biosynthesis of secondary metabolites","1.14.13.72; 1.14.19.20",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C15782  delta7-Avenasterol","PubChem: 47205107; ChEBI: 80096; LIPIDMAPS: LMST01040154; KNApSAcK: C00007322; NIKKAJI: J387.516D","cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193",29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H49O1","C29H47O1",412.3705162,413.3783412,411.3626911
"cpd:C15783","5-Dehydroavenasterol","C29H46O","5-Dehydroavenasterol","R07486 R07487","Steroid biosynthesis; Biosynthesis of secondary metabolites","1.3.1.21; 1.14.19.20",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C15783  5-Dehydroavenasterol","PubChem: 47205108; ChEBI: 80097; LIPIDMAPS: LMST01040155; KNApSAcK: C00007527; NIKKAJI: J707.020I","cpd:C11455; cpd:C11508; cpd:C15783",29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H47O1","C29H45O1",410.3548661,411.3626911,409.3470411
"cpd:C15808","4alpha-Methylzymosterol-4-carboxylate;","C29H46O3","4alpha-Methylzymosterol-4-carboxylate; 4alpha-Carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol","R07494 R07509","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.1.1.170; 1.14.13.72","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,"PubChem: 47205133; ChEBI: 50591; LIPIDMAPS: LMST01010150; PDB-CCD: 4D8; NIKKAJI: J1.817.123F","cpd:C14607; cpd:C15622; cpd:C15808",29,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H47O3","C29H45O3",442.3446953,443.3525204,441.3368703
"cpd:C15816","3-Keto-4-methylzymosterol","C28H44O","3-Keto-4-methylzymosterol","R07494 R07495","Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics","1.1.1.170; 1.1.1.270","Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,"PubChem: 47205141; ChEBI: 50593; LIPIDMAPS: LMST01010167; NIKKAJI: J1.817.124D","cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653",28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O1","C28H43O1",396.339216,397.3470411,395.331391
"cpd:C15915","4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol","C29H50O","4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol","R07499","Steroid biosynthesis","1.3.1.72",NA,NA,"PubChem: 47205233; ChEBI: 87044; LIPIDMAPS: LMST01010225; NIKKAJI: J2.796.893G","cpd:C01753; cpd:C04530; cpd:C08839; cpd:C15915; cpd:C19654",29,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H51O1","C29H49O1",414.3861662,415.3939913,413.3783412
"cpd:C18231","Calcitetrol;","C27H44O4","Calcitetrol; 1alpha,24R,25-Trihydroxyvitamin D3; (1S,3R,5Z,7E,24R,25)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24,25-tetrol","R09515 R11324","Steroid biosynthesis; Metabolic pathways","1.14.15.16; 1.14.15.18",NA,NA,"PubChem: 103061413; ChEBI: 47799; ChEMBL: CHEMBL55281","cpd:C08899; cpd:C16494; cpd:C17003; cpd:C17335; cpd:C18231",27,44,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O4","C27H43O4",432.3239599,433.3317849,431.3161349
"cpd:C21106","24-epi-Campesterol","C28H48O","24-epi-Campesterol","R11096 R11097","Steroid biosynthesis; Metabolic pathways","1.3.1.-; 1.14.19.41",NA,NA,"PubChem: 312642075","cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106",28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H49O1","C28H47O1",400.3705162,401.3783412,399.3626911
"cpd:C00037","Glycine;","C2H5NO2","Glycine; Aminoacetic acid; Gly","R00364 R00365 R00366 R00367 R00368 R00369 R00371 R00372; R00373 R00374 R00395 R00478 R00497 R00565 R00588 R00610; R00611 R00652 R00751 R00775 R00830 R00899 R00945 R01221; R01424 R01723 R01766 R01957 R02452 R02551 R02729 R03121; R03284 R03425 R03579 R03654 R03718 R03956 R03975 R04144; R04486 R04777 R04951 R05055 R05704 R05835 R05841 R06171; R07226 R07463 R08195 R08196 R08252 R08701 R08744 R09099; R09717 R09718 R10060 R10062 R10179 R10685 R10722 R10908; R10994","Primary bile acid biosynthesis; Purine metabolism; Glycine, serine and threonine metabolism; Lysine degradation; Phosphonate and phosphinate metabolism; Cyanoamino acid metabolism; Glutathione metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Thiamine metabolism; Porphyrin and chlorophyll metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Biofilm formation - Escherichia coli; Neuroactive ligand-receptor interaction; Synaptic vesicle cycle; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.1; 1.4.1.10; 1.4.2.1; 1.4.3.3; 1.4.3.19; 1.4.4.2; 1.4.99.5; 1.5.1.22; 1.5.3.1; 1.5.8.3; 1.8.1.4; 1.13.11.78; 1.21.4.2; 2.1.1.20; 2.1.1.156; 2.1.1.162; 2.1.2.1; 2.1.2.4; 2.1.2.10; 2.1.4.1; 2.3.1.13; 2.3.1.29; 2.3.1.37; 2.3.1.65; 2.3.1.71; 2.3.1.192; 2.3.1.-; 2.3.2.15; 2.3.2.-; 2.6.1.4; 2.6.1.35; 2.6.1.44; 2.6.1.45; 2.6.1.60; 2.6.1.63; 2.6.1.73; 2.6.1.96; 2.6.1.-; 3.4.11.1; 3.4.11.2; 3.4.11.23; 3.4.13.-; 3.5.1.24; 3.5.1.32; 3.5.1.58; 3.5.1.71; 3.5.3.2; 4.1.2.5; 4.1.2.26; 4.1.2.42; 4.1.2.48; 4.1.2.49; 4.1.2.-; 4.1.3.14; 4.1.3.41; 6.1.1.14; 6.3.2.3; 6.3.4.13","Formaldehyde assimilation, serine pathway; Photorespiration","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00037  Glycine (Gly);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00037  Glycine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX03 Glycine;       D00011  Glycine (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glycine;     D00011  Glycine (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00011  [102546] Glycine;  Buffering agent;   D00011  [102546] Glycine;  Sweetening agent;   D00011  [102546] Glycine;  Base;   D00011  [102546] Glycine;  Flavoring substance;   D00011  [102546] Glycine;  Suspending agent;   D00011  [102546] Glycine;  pH regulator;   D00011  [102546] Glycine;  Diluting agent;   D00011  [102546] Glycine;  Solubilization agent;   D00011  [102546] Glycine; Target-based classification of drugs [BR:br08310];  Ion channels;   Cys-loop superfamily;    Glycine;     glycine receptor;      Glycine;       D00011  Glycine (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00011  Glycine","CAS: 56-40-6; PubChem: 3339; ChEBI: 15428; ChEMBL: CHEMBL773; KNApSAcK: C00001361; PDB-CCD: GLY; 3DMET: B01136; NIKKAJI: J1.163K","cpd:C00037; cpd:C01837; cpd:C02038; cpd:C02471; cpd:C06808; cpd:C19445",2,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H6O2N1","C2H4O2N1",75.0320284,76.03985344,74.02420337
"cpd:C00245","Taurine;","C2H7NO3S","Taurine; 2-Aminoethanesulfonic acid; Aminoethylsulfonic acid","R01681 R01682 R01683 R01684 R01685 R01686 R01687 R02797; R03720 R03977 R04487 R05320 R05652 R07167 R08745","Primary bile acid biosynthesis; Taurine and hypotaurine metabolism; Sulfur metabolism; Metabolic pathways; ABC transporters; Neuroactive ligand-receptor interaction","1.4.2.-; 1.4.99.2; 1.5.1.23; 1.8.1.3; 1.14.11.17; 2.1.4.1; 2.3.1.65; 2.3.2.2; 2.6.1.55; 2.6.1.77; 3.5.1.24; 3.5.1.74; 4.1.1.15; 4.1.1.29",NA,"Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    391  Liver disease agents;     3919  Others;      D00047  Taurine (JP17/USP/INN); Aminoethylsulfonic acid (JAN); Classification of Japanese OTC drugs [BR:br08313];  Agents for ophthalmologic use;   62 General eye drops;    D00047  Taurine (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Aminoethylsulfonic acid; Taurine;     D00047  Taurine (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00047  [002019] Taurine;  Buffering agent;   D00047  [002019] Taurine;  Flavoring substance;   D00047  [002019] Taurine;  Bonding agent;   D00047  [002019] Taurine;  Tonicity agent;   D00047  [002019] Taurine;  Diluting agent;   D00047  [002019] Taurine;  Antiseptic agent;   D00047  [002019] Taurine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00047  Taurine; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   967  Agents for liver disease and antidotes;    9674  Taurine and preparations;     C00245  Aminoethylsulfonic acid","CAS: 107-35-7; PubChem: 3544; ChEBI: 15891; ChEMBL: CHEMBL239243; KNApSAcK: C00048188; PDB-CCD: TAU; 3DMET: B00069; NIKKAJI: J5.056C","cpd:C00245",2,7,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C2H8O3N1S1","C2H6O3N1S1",125.0146643,126.0224893,124.0068392
"cpd:C00695","Cholic acid;","C24H40O5","Cholic acid; Cholate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid","R02792 R02793 R02794 R02797 R02798 R05835 R07220 R07295; R07296 R11539","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion","1.1.1.159; 1.1.1.176; 2.8.3.25; 3.1.2.27; 3.5.1.24; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C00695  Cholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C00695  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA03 Cholic acid;       D10699  Cholic acid (USAN); Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D10699; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D10699; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D10699; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D10699; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D10699; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D10699; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Cholic acid;     C00695  Cholic acid","CAS: 81-25-4; PubChem: 3963; ChEBI: 16359; ChEMBL: CHEMBL205596; LIPIDMAPS: LMST04010001; LipidBank: BBA0084; PDB-CCD: CHD; 3DMET: B01314; NIKKAJI: J8.604E","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C01301","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al","C27H46O4","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al","R03506 R03507 R08759 R08761","Primary bile acid biosynthesis; Metabolic pathways","1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C01301  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al","CAS: 3836-01-9; PubChem: 4519; ChEBI: 16466; LIPIDMAPS: LMST04030164; LipidBank: BBA0425; 3DMET: B04791; NIKKAJI: J2.732.427D","cpd:C01301; cpd:C04554; cpd:C18043",27,46,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O4","C27H45O4",434.33961,435.347435,433.3317849
"cpd:C01794","Choloyl-CoA;","C45H74N7O20P3S","Choloyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-one-CoA","R02794 R03718 R03719 R03720 R07295 R07296 R11539","Primary bile acid biosynthesis; Metabolic pathways","2.3.1.65; 2.3.1.176; 2.8.3.25; 3.1.2.27; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate",NA,"PubChem: 4921; ChEBI: 15519; 3DMET: B04814; NIKKAJI: J614.038F","cpd:C01794",45,74,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C45H75O20N7P3S1","C45H73O20N7P3S1",1157.39222,1158.400045,1156.384395
"cpd:C01921","Glycocholate;","C26H43NO6","Glycocholate; Glycocholic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine","R03718 R05835","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion","2.3.1.65; 3.5.1.24","Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C01921  Glycocholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C01921  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine;   ST05 Steroid conjugates;    ST0503 Glycine conjugates;     C01921  Glycocholate","CAS: 475-31-0; PubChem: 5027; ChEBI: 17687 29746; ChEMBL: CHEMBL1354821 CHEMBL411070; LIPIDMAPS: LMST05030001; KNApSAcK: C00030410; PDB-CCD: GCH; 3DMET: B04823; NIKKAJI: J12.411G","cpd:C01921",26,43,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C26H44O6N1","C26H42O6N1",465.3090381,466.3168631,464.3012131
"cpd:C02528","Chenodeoxycholate;","C24H40O4","Chenodeoxycholate; Chenodeoxycholic acid; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Chenodiol","R03974 R03975 R03977 R03978 R08743","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion","3.1.2.27; 3.5.1.24; 3.5.1.74; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C02528  Chenodeoxycholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C02528  3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     farnesoid X receptor;      C02528  Chenodeoxycholate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA01 Chenodeoxycholic acid;       D00163  Chenodiol (USAN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    236  Cholagogues;     2362  Bile acids;      D00163  Chenodiol (USAN); Chenodeoxycholic acid (JP17/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00163  Chenodeoxycholic acid; Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D00163; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00163","CAS: 474-25-9; PubChem: 5536; ChEBI: 16755; ChEMBL: CHEMBL240597 CHEMBL73390; LIPIDMAPS: LMST04010032; LipidBank: BBA0032; PDB-CCD: JN3; 3DMET: B01586; NIKKAJI: J2.053B","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C03594","7alpha-Hydroxycholesterol;","C27H46O2","7alpha-Hydroxycholesterol; Cholest-5-ene-3beta,7alpha-diol","R01463 R04263 R04264","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.181; 1.14.14.23","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C03594  7alpha-Hydroxycholesterol","CAS: 566-26-7; PubChem: 6385; ChEBI: 17500; ChEMBL: CHEMBL497207; LIPIDMAPS: LMST01010013; LipidBank: SST9032; PDB-CCD: 5JK; 3DMET: B01674","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C04554","3alpha,7alpha-Dihydroxy-5beta-cholestanate;","C27H46O4","3alpha,7alpha-Dihydroxy-5beta-cholestanate; 3alpha,7alpha-Dihydroxy-5beta-cholestanoate","R04506 R04507 R08738 R08760","Primary bile acid biosynthesis; Metabolic pathways","1.2.1.3; 1.14.15.15; 6.2.1.7; 6.2.1.28","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C04554  3alpha,7alpha-Dihydroxy-5beta-cholestanoic acid","PubChem: 7159; ChEBI: 16577; LIPIDMAPS: LMST04030066; LipidBank: BBA0386; 3DMET: B04947; NIKKAJI: J82.699E","cpd:C01301; cpd:C04554; cpd:C18043",27,46,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O4","C27H45O4",434.33961,435.347435,433.3317849
"cpd:C04722","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate;","C27H46O5","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanate","R03506 R04580 R08733 R08761 R11142","Primary bile acid biosynthesis; Metabolic pathways","1.14.15.15; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C04722  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid","CAS: 547-98-8; PubChem: 7294; ChEBI: 18402 85674; LIPIDMAPS: LMST04030001; LipidBank: BBA0396; 3DMET: B04957; NIKKAJI: J40.090D","cpd:C04722",27,46,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O5","C27H45O5",450.3345246,451.3423496,449.3266995
"cpd:C05122","Taurocholate;","C26H45NO7S","Taurocholate; Taurocholic acid; Cholyltaurine","R02797 R03720","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Taurine and hypotaurine metabolism; Metabolic pathways; Bile secretion","2.3.1.65; 3.5.1.24","Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C05122  Taurocholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05122  Taurocholic acid;   ST05 Steroid conjugates;    ST0504 Taurine conjugates;     C05122  Taurocholate","CAS: 81-24-3; PubChem: 7544; ChEBI: 28865; LIPIDMAPS: LMST05040001; PDB-CCD: TCH; 3DMET: B04981; NIKKAJI: J8.603G","cpd:C05122; cpd:C15516",26,45,7,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H46O7N1S1","C26H44O7N1S1",515.291674,516.299499,514.2838489
"cpd:C05337","Chenodeoxycholoyl-CoA;","C45H74N7O19P3S","Chenodeoxycholoyl-CoA; 3alpha,7alpha-Dihydroxy-5beta-cholanoyl-CoA","R03974 R04546 R04811 R08743 R08744 R08745","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways","2.3.1.65; 2.3.1.176; 3.1.2.27; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7715; ChEBI: 28701; 3DMET: B05010; NIKKAJI: J1.665.314D","cpd:C05337; cpd:C15560; cpd:C17689",45,74,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C45H75O19N7P3S1","C45H73O19N7P3S1",1141.397305,1142.40513,1140.38948
"cpd:C05444","3alpha,7alpha,26-Trihydroxy-5beta-cholestane;","C27H48O3","3alpha,7alpha,26-Trihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,26-triol","R04805 R04806 R08758","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.1; 1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05444  3alpha,7alpha,26-Trihydroxy-5beta-cholestane","PubChem: 7806; ChEBI: 28540; LIPIDMAPS: LMST04030020; LipidBank: BBA0328 SST9002; 3DMET: B05024; NIKKAJI: J676.110K","cpd:C05425; cpd:C05444; cpd:C05454",27,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H49O3","C27H47O3",420.3603454,421.3681704,419.3525204
"cpd:C05445","3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al","C27H46O3","3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al","R04506 R04805 R08758 R08760","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.1; 1.2.1.3; 1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05445  3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al","PubChem: 7807; ChEBI: 27428; LIPIDMAPS: LMST04030162; 3DMET: B05025; NIKKAJI: J2.755.883F","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C05446","3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane;","C27H48O4","3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetraol; 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol","R03507 R04807 R04808 R08759","Primary bile acid biosynthesis; Metabolic pathways","1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05446  3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane","CAS: 862-53-3; PubChem: 7808; ChEBI: 17278; LIPIDMAPS: LMST04030014; LipidBank: BBA0316; 3DMET: B05026; NIKKAJI: J1.513.287F","cpd:C05446",27,48,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H49O4","C27H47O4",436.35526,437.3630851,435.347435
"cpd:C05447","3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA","C48H78N7O19P3S","3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA","R04547 R04809 R08740","Primary bile acid biosynthesis; Metabolic pathways","1.3.99.-; 1.17.99.3; 4.2.1.107","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7809; ChEBI: 27393; LIPIDMAPS: LMST01010220; 3DMET: B05027; NIKKAJI: J2.755.897F","cpd:C05447",48,78,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H79O19N7P3S1","C48H77O19N7P3S1",1181.428605,1182.436431,1180.42078
"cpd:C05448","3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA","C48H80N7O20P3S","3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA","R04809 R04810","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.35; 4.2.1.107","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7810; ChEBI: 27403; 3DMET: B05028; NIKKAJI: J2.755.940I","cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343",48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O20N7P3S1","C48H79O20N7P3S1",1199.43917,1200.446995,1198.431345
"cpd:C05449","3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA","C48H78N7O20P3S","3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA","R04810 R04811","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.35; 2.3.1.176","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7811; ChEBI: 28533; LIPIDMAPS: LMST01010219; 3DMET: B05029; NIKKAJI: J2.755.941G","cpd:C05449; cpd:C05460",48,78,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H79O20N7P3S1","C48H77O20N7P3S1",1197.42352,1198.431345,1196.415695
"cpd:C05450","3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA;","C48H80N7O21P3S","3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA; 3alpha,7alpha,12alpha,24zeta-Tetrahydroxy-5beta-cholestanoyl-CoA","R04812 R04813","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.35; 4.2.1.107","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7812; ChEBI: 27458; LIPIDMAPS: LMST01010215; 3DMET: B05030; NIKKAJI: J2.755.944A","cpd:C05450; cpd:C15614",48,80,21,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O21N7P3S1","C48H79O21N7P3S1",1215.434085,1216.44191,1214.42626
"cpd:C05451","7alpha-Hydroxy-5beta-cholestan-3-one;","C27H46O2","7alpha-Hydroxy-5beta-cholestan-3-one; 5beta-Cholestan-7alpha-ol-3-one","R04817 R04818 R04819","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.50; 1.3.1.3","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05451  7alpha-Hydroxy-5beta-cholestan-3-one","PubChem: 7813; ChEBI: 2290; LIPIDMAPS: LMST04030112; LipidBank: BBA0438; 3DMET: B05031; NIKKAJI: J2.755.945J","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C05452","3alpha,7alpha-Dihydroxy-5beta-cholestane;","C27H48O2","3alpha,7alpha-Dihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha-diol","R04806 R04818 R04819 R07204","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.50; 1.14.13.96; 1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05452  3alpha,7alpha-Dihydroxy-5beta-cholestane","PubChem: 7814; ChEBI: 28047; LIPIDMAPS: LMST04030109; LipidBank: BBA0435; 3DMET: B05032; NIKKAJI: J608.249A","cpd:C05424; cpd:C05452; cpd:C10818",27,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H49O2","C27H47O2",404.3654308,405.3732558,403.3576058
"cpd:C05453","7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one;","C27H46O3","7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one; 5beta-Cholesten-7alpha,12alpha-diol-3-one","R04823 R04824 R04825","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.50; 1.3.1.3","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7815; ChEBI: 2288; LIPIDMAPS: LMST04030113; LipidBank: BBA0439; 3DMET: B05033; NIKKAJI: J2.755.946H","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C05454","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane;","C27H48O3","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,12alpha-triol; 3alpha,7alpha,12alpha-Trihydroxycoprostane","R04807 R04824 R04825 R07204 R11142","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.50; 1.14.13.96; 1.14.15.15","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05454  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane","CAS: 547-96-6; PubChem: 7816; ChEBI: 16496; LIPIDMAPS: LMST04030035; LipidBank: BBA0347 SST9020; 3DMET: B01860; NIKKAJI: J40.089K","cpd:C05425; cpd:C05444; cpd:C05454",27,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H49O3","C27H47O3",420.3603454,421.3681704,419.3525204
"cpd:C05455","7alpha-Hydroxycholest-4-en-3-one","C27H44O2","7alpha-Hydroxycholest-4-en-3-one","R04263 R04264 R04817 R04826","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.181; 1.3.1.3; 1.14.18.8","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05455  7alpha-Hydroxycholest-4-en-3-one","CAS: 3862-25-7; PubChem: 7817; ChEBI: 17899; LIPIDMAPS: LMST04030123; LipidBank: BBA0449; 3DMET: B05034; NIKKAJI: J602.383E","cpd:C01561; cpd:C05455; cpd:C15632; cpd:C19662; cpd:C20143; cpd:C21303",27,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O2","C27H43O2",400.3341307,401.3419557,399.3263056
"cpd:C05460","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA","C48H78N7O20P3S","3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA","R04592 R04813 R08735","Primary bile acid biosynthesis; Metabolic pathways","1.3.99.-; 1.17.99.3; 4.2.1.107","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7820; ChEBI: 27505; LIPIDMAPS: LMST01010217; 3DMET: B05037; NIKKAJI: J2.755.972G","cpd:C05449; cpd:C05460",48,78,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H79O20N7P3S1","C48H77O20N7P3S1",1197.42352,1198.431345,1196.415695
"cpd:C05465","Taurochenodeoxycholate;","C26H45NO6S","Taurochenodeoxycholate; Taurochenodeoxycholic acid; Chenodeoxycholoyltaurine","R03977 R07205 R08745","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Bile secretion","1.14.13.97; 2.3.1.65; 3.5.1.24; 3.5.1.74",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05465  Taurochenodeoxycholic acid;   ST05 Steroid conjugates;    ST0504 Taurine conjugates;     C05465  Taurochenodeoxycholate","CAS: 516-35-8; PubChem: 7825; ChEBI: 16525 9407; ChEMBL: CHEMBL185878 CHEMBL55965 CHEMBL73668; LIPIDMAPS: LMST05040005; PDB-CCD: TUD; 3DMET: B05042; NIKKAJI: J13.987D","cpd:C05463; cpd:C05465; cpd:C16868",26,45,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H46O6N1S1","C26H44O6N1S1",499.2967593,500.3045844,498.2889343
"cpd:C05466","Glycochenodeoxycholate;","C26H43NO5","Glycochenodeoxycholate; Glycochenodeoxycholic acid; Chenodeoxyglycocholate","R03975 R07289 R08744","Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Bile secretion","2.3.1.65; 2.8.2.34; 3.5.1.24",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05466  Glycochenodeoxycholic acid","CAS: 640-79-9; PubChem: 7826; ChEBI: 36274; ChEMBL: CHEMBL1552 CHEMBL55736 CHEMBL75793; LIPIDMAPS: LMST05030008; PDB-CCD: CHO; 3DMET: B05043; NIKKAJI: J22.601G","cpd:C05464; cpd:C05466",26,43,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C26H44O5N1","C26H42O5N1",449.3141235,450.3219485,448.3062985
"cpd:C05467","3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA;","C48H78N7O21P3S","3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA","R03719 R04812","Primary bile acid biosynthesis; Metabolic pathways","1.1.1.35; 2.3.1.176","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 7827; ChEBI: 27379; LIPIDMAPS: LMST01010216; 3DMET: B05044; NIKKAJI: J2.755.975A","cpd:C05467",48,78,21,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H79O21N7P3S1","C48H77O21N7P3S1",1213.418435,1214.42626,1212.41061
"cpd:C05468","5beta-Cyprinolsulfate","C27H48O8S","5beta-Cyprinolsulfate","R04808","Primary bile acid biosynthesis",NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST05 Steroid conjugates;    ST0502 Sulfates;     C05468  5beta-Cyprinolsulfate","PubChem: 7828; ChEBI: 2149; LIPIDMAPS: LMST05020004; 3DMET: B05045; NIKKAJI: J2.755.981F","cpd:C05468",27,48,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H49O8S1","C27H47O8S1",532.3069897,533.3148147,531.2991646
"cpd:C06341","7alpha,27-Dihydroxycholesterol;","C27H46O3","7alpha,27-Dihydroxycholesterol; Cholest-5-ene-3beta,7alpha,26-triol; Cholest-5-ene-3beta,7alpha,27-triol","R07372 R08724","Primary bile acid biosynthesis","1.1.1.181; 1.14.14.23; 1.14.14.29",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C06341  7-alpha,27-Dihydroxycholesterol","CAS: 4725-24-0; PubChem: 8577; ChEBI: 18431; LIPIDMAPS: LMST04030081; 3DMET: B05185; NIKKAJI: J575.886F","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C13550","Cerebrosterol;","C27H46O2","Cerebrosterol; 24-Hydroxycholesterol; Cholest-5-ene-3,24-diol; (24S)-24-Hydroxycholesterol; (24S)-Cholest-5-ene-3beta,24-diol","R07207 R07208","Primary bile acid biosynthesis","1.14.14.25; 1.14.14.26",NA,"Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C13550  Cerebrosterol;     liver X receptor beta;      C13550  Cerebrosterol Agonist","CAS: 474-73-7; PubChem: 7846926; ChEBI: 34310; ChEMBL: CHEMBL171804; LIPIDMAPS: LMST01010019; LipidBank: SST0080; NIKKAJI: J637.349F","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C15518","(24S)-Cholest-5-ene-3beta,7alpha,24-triol;","C27H46O3","(24S)-Cholest-5-ene-3beta,7alpha,24-triol; 5-Cholesten-3beta,7alpha,24(S)-triol","R07208 R08721","Primary bile acid biosynthesis","1.1.1.181; 1.14.14.26",NA,NA,"PubChem: 17396510; ChEBI: 37640; LIPIDMAPS: LMST04030168; NIKKAJI: J1.343.556A","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C15519","25-Hydroxycholesterol;","C27H46O2","25-Hydroxycholesterol; Cholest-5-ene-3beta,25-diol","R07209 R07218","Primary bile acid biosynthesis","1.14.14.29; 1.14.99.38",NA,NA,"CAS: 2140-46-7; PubChem: 17396511; ChEBI: 42977; ChEMBL: CHEMBL169046; LIPIDMAPS: LMST01010018; LipidBank: SST0081 SST9041; PDB-CCD: HC3; NIKKAJI: J80.397I","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C15520","Cholest-5-ene-3beta,7alpha,25-triol;","C27H46O3","Cholest-5-ene-3beta,7alpha,25-triol; 7alpha,25-Dihydroxycholesterol; 5-Cholesten-3beta,7alpha,25-triol; 3beta,7alpha,25-Trihydroxycholest-5-ene","R07209 R08723","Primary bile acid biosynthesis","1.1.1.181; 1.14.14.29",NA,NA,"PubChem: 17396512; ChEBI: 37623; LIPIDMAPS: LMST04030166; NIKKAJI: J652.922D","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C15610","Cholest-5-ene-3beta,26-diol;","C27H46O2","Cholest-5-ene-3beta,26-diol; Cholest-5-ene-3beta,27-diol; 26-Hydroxycholesterol; 27-Hydroxycholesterol","R07372 R08505 R08506 R08507 R08508 R08726","Primary bile acid biosynthesis; Biosynthesis of alkaloids derived from terpenoid and polyketide","1.14.14.23; 1.14.14.29; 1.14.15.15",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C15610  27-Hydroxycholesterol; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C15610  Cholest-5-ene-3beta,26-diol;     liver X receptor beta;      C15610  Cholest-5-ene-3beta,26-diol","CAS: 13095-61-9; PubChem: 17396601; ChEBI: 17703; ChEMBL: CHEMBL162044 CHEMBL353882; LIPIDMAPS: LMST01010057; NIKKAJI: J533.768B","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C15613","(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA","C48H80N7O20P3S","(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA","R07374 R08733 R08734","Primary bile acid biosynthesis; Metabolic pathways","1.17.99.3; 5.1.99.4; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 17396604; ChEBI: 37642; NIKKAJI: J2.795.088D","cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343",48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O20N7P3S1","C48H79O20N7P3S1",1199.43917,1200.446995,1198.431345
"cpd:C17331","7alpha,24-Dihydroxy-4-cholesten-3-one","C27H44O3","7alpha,24-Dihydroxy-4-cholesten-3-one","R08721","Primary bile acid biosynthesis","1.1.1.181",NA,NA,"PubChem: 96023693; ChEBI: 48701; LIPIDMAPS: LMST04030170; NIKKAJI: J2.806.270B","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C17332","7alpha,25-Dihydroxy-4-cholesten-3-one","C27H44O3","7alpha,25-Dihydroxy-4-cholesten-3-one","R08723","Primary bile acid biosynthesis","1.1.1.181",NA,NA,"PubChem: 96023694; ChEBI: 81013; LIPIDMAPS: LMST04030107; NIKKAJI: J674.519I","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C17333","3beta-Hydroxy-5-cholestenoate;","C27H44O3","3beta-Hydroxy-5-cholestenoate; 3beta-Hydroxycholest-5-en-27-oic acid","R08726 R08727","Primary bile acid biosynthesis","1.14.14.29",NA,NA,"CAS: 6561-58-6; PubChem: 96023695; ChEBI: 81014; NIKKAJI: J676.103H","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C17335","3beta,7alpha-Dihydroxy-5-cholestenoate;","C27H44O4","3beta,7alpha-Dihydroxy-5-cholestenoate; 3beta,7alpha-Dihydroxy-5-cholesten-26-oic acid","R08727 R08728","Primary bile acid biosynthesis","1.1.1.181; 1.14.14.29",NA,NA,"CAS: 115538-84-6; PubChem: 96023696; ChEBI: 81015; NIKKAJI: J676.104F","cpd:C08899; cpd:C16494; cpd:C17003; cpd:C17335; cpd:C18231",27,44,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O4","C27H43O4",432.3239599,433.3317849,431.3161349
"cpd:C17336","7alpha,26-Dihydroxy-4-cholesten-3-one","C27H44O3","7alpha,26-Dihydroxy-4-cholesten-3-one","R08724 R08725","Primary bile acid biosynthesis","1.1.1.181",NA,NA,"CAS: 4675-38-1; PubChem: 96023697; ChEBI: 48825; LIPIDMAPS: LMST04030157; NIKKAJI: J676.106B","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C17337","7alpha-Hydroxy-3-oxo-4-cholestenoate","C27H42O4","7alpha-Hydroxy-3-oxo-4-cholestenoate","R08725 R08728","Primary bile acid biosynthesis","1.1.1.181",NA,NA,"CAS: 115538-85-7; PubChem: 96023698; NIKKAJI: J676.107K","cpd:C04715; cpd:C08891; cpd:C08902; cpd:C08909; cpd:C16498; cpd:C17337; cpd:C17891",27,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H43O4","C27H41O4",430.3083098,431.3161349,429.3004848
"cpd:C17339","4-Cholesten-7alpha,12alpha-diol-3-one;","C27H44O3","4-Cholesten-7alpha,12alpha-diol-3-one; 7alpha,12alpha-Dihydroxy-4-cholesten-3-one","R04823 R04826 R04827","Primary bile acid biosynthesis; Metabolic pathways","1.3.1.3; 1.3.99.5; 1.14.18.8","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"CAS: 1254-03-1; PubChem: 96023699; ChEBI: 28477; LIPIDMAPS: LMST04030114; NIKKAJI: J1.513.288D","cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650",27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H45O3","C27H43O3",416.3290453,417.3368703,415.3212202
"cpd:C17343","(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA","C48H80N7O20P3S","(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA","R08734 R08735","Primary bile acid biosynthesis; Metabolic pathways","1.17.99.3; 5.1.99.4","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 96023700; ChEBI: 81017; NIKKAJI: J2.806.271K","cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343",48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O20N7P3S1","C48H79O20N7P3S1",1199.43917,1200.446995,1198.431345
"cpd:C17345","(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA","C48H80N7O19P3S","(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA","R08738 R08739","Primary bile acid biosynthesis; Metabolic pathways","5.1.99.4; 6.2.1.7","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 96023701; ChEBI: 81018; NIKKAJI: J2.806.273G","cpd:C04644; cpd:C17345; cpd:C17346",48,80,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O19N7P3S1","C48H79O19N7P3S1",1183.444256,1184.452081,1182.436431
"cpd:C17346","(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA","C48H80N7O19P3S","(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA","R08739 R08740","Primary bile acid biosynthesis; Metabolic pathways","1.17.99.3; 5.1.99.4","Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,"PubChem: 96023702; ChEBI: 81019; NIKKAJI: J2.806.274E","cpd:C04644; cpd:C17345; cpd:C17346",48,80,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C48H81O19N7P3S1","C48H79O19N7P3S1",1183.444256,1184.452081,1182.436431
"cpd:C03990","Lithocholic acid;","C24H40O3","Lithocholic acid; Lithocholate; 3alpha-Hydroxy-5beta-cholanate; 3alpha-Hydroxy-5beta-cholanic acid","R03978 R04139 R07203 R07206 R11145 R11539","Secondary bile acid biosynthesis; Bile secretion","1.1.1.52; 1.1.1.392; 1.14.13.94; 1.14.13.97; 2.8.3.25",NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C03990  Lithocholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C03990  3alpha-Hydroxy-5beta-cholanic acid","CAS: 434-13-9; PubChem: 6705; ChEBI: 16325; ChEMBL: CHEMBL137446 CHEMBL1478 CHEMBL160837 CHEMBL1997202 CHEMBL369963; LIPIDMAPS: LMST04010003; LipidBank: BBA0003; PDB-CCD: 4OA; 3DMET: B01708; NIKKAJI: J1.532F","cpd:C03990; cpd:C17658",24,40,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O3","C24H39O3",376.2977451,377.3055702,375.2899201
"cpd:C04483","Deoxycholic acid;","C24H40O4","Deoxycholic acid; Deoxycholate; 3alpha,12alpha-Dihydroxy-5beta-cholanate; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid","R04486 R04487 R05836 R07220 R07295","Secondary bile acid biosynthesis; Bile secretion","2.8.3.25; 3.5.1.24",NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C04483  Deoxycholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C04483  3alpha,12alpha-Dihydroxy-5beta-cholanic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AX Other dermatologicals;      D11AX24 Deoxycholic acid;       D10781  Deoxycholic acid (USAN/INN); New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D10781; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D10781","CAS: 83-44-3; PubChem: 7102; ChEBI: 28834; ChEMBL: CHEMBL1253841 CHEMBL134680 CHEMBL406393; LIPIDMAPS: LMST04010040; LipidBank: BBA0040; KNApSAcK: C00030117; PDB-CCD: DXC; 3DMET: B04945; NIKKAJI: J3.873C","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C07880","Ursodiol;","C24H40O4","Ursodiol; Ursodeoxycholic acid; Ursodeoxycholate; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C07880  Ursodiol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C07880  Ursodeoxycholic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA02 Ursodeoxycholic acid;       D00734  Ursodiol (USP); USP drug classification [BR:br08302];  Gastrointestinal Agents;   Gastrointestinal Agents, Other;    Ursodiol;     D00734  Ursodiol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    236  Cholagogues;     2362  Bile acids;      D00734  Ursodiol (USP); Ursodeoxycholic acid (JP17/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for digestive organs;   11 Stomachics;    D00734  Ursodiol (USP);   13 Digestives;    D00734  Ursodiol (USP);   14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators;    D00734  Ursodiol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Ursodeoxycholic acid;     D00734  Ursodiol (USP); Pharmaceutical additives [BR:br08316];  Solubilizer;   D00734  [001070] Ursodeoxycholic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00734  Ursodeoxycholic acid;   D00734  Ursodeoxycholic acid tablets;   D00734  Ursodeoxycholic acid granules; Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D00734; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00734; Animal drugs in Japan [BR:br08331];  93  Agents affecting digestive organs;   935  Cholagogues;    9351  Bile acid, derivatives preparations;     C07880  Ursodeoxycholic acid","CAS: 128-13-2; PubChem: 10082; ChEBI: 9907; ChEMBL: CHEMBL118093 CHEMBL1551 CHEMBL163550 CHEMBL311521 CHEMBL73390; LIPIDMAPS: LMST04010033; LipidBank: BBA0033; KNApSAcK: C00032464; 3DMET: B02140; NIKKAJI: J2.520H","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C15515","Murideoxycholic acid;","C24H40O4","Murideoxycholic acid; Murideoxycholate; 6beta-Hydroxylithocholate; 3alpha,6beta-Dihydroxy-5beta-cholanic acid","R07203","Secondary bile acid biosynthesis","1.14.13.94",NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C15515  Murideoxycholate","PubChem: 17396507; ChEBI: 52030; ChEMBL: CHEMBL272620 CHEMBL345642; LIPIDMAPS: LMST04010025; LipidBank: BBA0025; NIKKAJI: J472.757F","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C15517","Hyodeoxycholate;","C24H40O4","Hyodeoxycholate; Hyodesoxycholic acid; 6alpha-Hydroxylithocholate; Iodeoxycholic acid; 3alpha,6alpha-Dihydroxy-5beta-cholanic acid","R07206","Secondary bile acid biosynthesis","1.14.13.97",NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C15517  Hyodeoxycholate","CAS: 83-49-8; PubChem: 17396509; ChEBI: 52023; ChEMBL: CHEMBL135587 CHEMBL272621 CHEMBL74719; LIPIDMAPS: LMST04010024; LipidBank: BBA0024; KNApSAcK: C00030498; NIKKAJI: J4.636A","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17644","Ursocholate;","C24H40O5","Ursocholate; Ursocholic acid; 3alpha,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7beta,12alpha-Trihydroxy-5beta-cholanic acid; 7beta-Hydroxyisocholic acid; 7-Epicholic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 2955-27-3; PubChem: 96023988; ChEBI: 81240; ChEMBL: CHEMBL1254416; LIPIDMAPS: LMST04010088; NIKKAJI: J363.683F","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17646","12-Epideoxycholic acid;","C24H40O4","12-Epideoxycholic acid; 12-Epideoxycholate",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 96023990; ChEBI: 81242; ChEMBL: CHEMBL157202 CHEMBL410872; LIPIDMAPS: LMST04010041; NIKKAJI: J39.832B","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17647","alpha-Muricholate;","C24H40O5","alpha-Muricholate; alpha-Muricholic acid; 5beta-Cholanic acid-3alpha,6beta,7alpha-triol; 3alpha,6beta,7alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 2393-58-0; PubChem: 96023991; ChEBI: 134116 81243; ChEMBL: CHEMBL1997972; LIPIDMAPS: LMST04010066; NIKKAJI: J367.449E","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17649","Hyocholate;","C24H40O5","Hyocholate; Hyocholic acid; Iocholic acid; gamma-Muricholate; alpha-Hyocholic acid; 3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid; 6alpha-Hydroxychenodeoxycholic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 547-75-1; PubChem: 96023992; ChEBI: 81244; ChEMBL: CHEMBL156391 CHEMBL1908063 CHEMBL1997972 CHEMBL360867; LIPIDMAPS: LMST04010064; NIKKAJI: J15.782A","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17650","Vulpecholate;","C24H40O5","Vulpecholate; Vulpecholic acid; 1alpha,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 107368-95-6; PubChem: 96023993; ChEBI: 81245; LIPIDMAPS: LMST04010057","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17651","alpha-Phocaecholic acid;","C24H40O6","alpha-Phocaecholic acid; 3alpha,7alpha,12alpha,23R-Tetrahydroxycholanic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 6879-45-4; PubChem: 96023994; ChEBI: 81246; LIPIDMAPS: LMST04010254","cpd:C17651",24,40,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O6","C24H39O6",424.282489,425.290314,423.274664
"cpd:C17654","beta-Phocaecholate;","C24H40O5","beta-Phocaecholate; beta-Phocaecholic acid; (23R)-Hydroxychenodeoxycholate",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 105369-89-9; PubChem: 96023997; ChEBI: 81249; ChEMBL: CHEMBL186681; LIPIDMAPS: LMST04010102; NIKKAJI: J91.793A","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17657","Bitocholate;","C24H40O5","Bitocholate; Bitocholic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 96024000; ChEBI: 81252; LIPIDMAPS: LMST04010113","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17658","Isolithocholate;","C24H40O3","Isolithocholate; Isolithocholic acid; beta-Lithocholic acid; beta-Lithocholanic acid; 3-Epilithocholic acid; 3beta-Hydroxy-5beta-cholan-24-oic acid; 3beta-Hydroxy-5beta-cholan-24-oic acid","R11144 R11146","Secondary bile acid biosynthesis","1.1.1.391; 1.1.1.393",NA,NA,"CAS: 1534-35-6; PubChem: 96024001; ChEBI: 81253; ChEMBL: CHEMBL1997202 CHEMBL318229 CHEMBL349105; LIPIDMAPS: LMST04010004; NIKKAJI: J363.671B","cpd:C03990; cpd:C17658",24,40,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O3","C24H39O3",376.2977451,377.3055702,375.2899201
"cpd:C17660","Isochenodeoxycholate;","C24H40O4","Isochenodeoxycholate; Isochenodeoxycholic acid; 3beta,7alpha-Dihydroxy-5beta-cholanic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 566-24-5; PubChem: 96024003; ChEBI: 88102; LIPIDMAPS: LMST04010034; NIKKAJI: J21.478G","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17662","Isoursodeoxycholate;","C24H40O4","Isoursodeoxycholate; Isoursodeoxycholic acid; 3beta,7beta-Dihydroxy-5beta-cholanoic acid; 3beta,7beta-Dihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17662  Isoursodeoxycholate","CAS: 78919-26-3; PubChem: 96024005; ChEBI: 43419; LIPIDMAPS: LMST04010035; PDB-CCD: IU5; NIKKAJI: J21.479E","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17664","Allochenodeoxycholate;","C24H40O4","Allochenodeoxycholate; Allochenodeoxycholic acid; 3alpha,7alpha-Dihydroxy-5alpha-cholanoic acid",NA,"Secondary bile acid biosynthesis",NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17664  Allochenodeoxycholate","PubChem: 96024007; ChEBI: 81258; ChEMBL: CHEMBL73390; LIPIDMAPS: LMST04010036; NIKKAJI: J14.876H","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17667","Avicholate;","C24H40O5","Avicholate; Avicholic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 96024010; ChEBI: 81261; LIPIDMAPS: LMST04010107; NIKKAJI: J1.772.832F","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17668","Haemulcholate;","C24H40O5","Haemulcholate; Hemulcholic acid; 3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 14959-83-2; PubChem: 96024011; ChEBI: 81262; LIPIDMAPS: LMST04010101","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17687","Allodeoxycholate;","C24H40O4","Allodeoxycholate; 5alpha-Deoxycholic acid; 3alpha,12alpha-Dihydroxy-5alpha-cholanoic acid",NA,"Secondary bile acid biosynthesis",NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17687  Allodeoxycholate","PubChem: 96024028; ChEBI: 81276; ChEMBL: CHEMBL1253841; LIPIDMAPS: LMST04010044; NIKKAJI: J15.089D","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C17689","Ursodeoxycholoyl-CoA;","C45H74N7O19P3S","Ursodeoxycholoyl-CoA; 3alpha,7beta-Dihydroxy-5beta-cholanoyl-CoA",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 96024029; ChEBI: 81277","cpd:C05337; cpd:C15560; cpd:C17689",45,74,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C45H75O19N7P3S1","C45H73O19N7P3S1",1141.397305,1142.40513,1140.38948
"cpd:C17726","beta-Muricholate;","C24H40O5","beta-Muricholate; beta-Muricholic acid; 3alpha,6beta,7beta-Trihydroxy-5beta-cholan-24-oic acid; 5beta-Cholanic acid-3alpha,6beta,7beta-triol",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 2393-59-1; PubChem: 96024056; ChEBI: 134119 81298; ChEMBL: CHEMBL1997972; LIPIDMAPS: LMST04010067; NIKKAJI: J367.450I","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17727","omega-Muricholate;","C24H40O5","omega-Muricholate; omega-Muricholic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 96024057; ChEBI: 81299; ChEMBL: CHEMBL159119 CHEMBL1997972; LIPIDMAPS: LMST04010065; NIKKAJI: J472.758D","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C17737","Allocholic acid;","C24H40O5","Allocholic acid; Allocholate; 3alpha,7alpha,12alpha-Trihydroxy-5alpha-cholanoic acid",NA,"Secondary bile acid biosynthesis",NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17737  Allocholic acid","CAS: 2464-18-8; PubChem: 96024066; ChEBI: 81308; LIPIDMAPS: LMST04010092; NIKKAJI: J14.831H","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C20865","3beta,12alpha-Dihydroxy-5beta-cholanoate;","C24H40O4","3beta,12alpha-Dihydroxy-5beta-cholanoate; 3beta,12alpha-Dihydroxy-5beta-cholanoic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"CAS: 570-63-8; PubChem: 254741331","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C20866","Alloavicholate;","C24H40O5","Alloavicholate; Alloavicholic acid; 3alpha,7alpha,16alpha-Trihydroxy-5alpha-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 254741332","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C20867","Avideoxycholate;","C24H40O4","Avideoxycholate; Avideoxycholic acid; 3alpha,16alpha-Dihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 254741333","cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867",24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O4","C24H39O4",392.2926598,393.3004848,391.2848347
"cpd:C20868","Cygnocholate;","C24H40O5","Cygnocholate; Cygnocholic acid; 3alpha,7alpha,15alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,"Secondary bile acid biosynthesis",NA,NA,NA,"PubChem: 254741334","cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868",24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O5","C24H39O5",408.2875744,409.2953994,407.2797494
"cpd:C00082","L-Tyrosine;","C9H11NO3","L-Tyrosine; (S)-3-(p-Hydroxyphenyl)alanine; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; Tyrosine","R00031 R00728 R00729 R00730 R00731 R00732 R00733 R00734; R00735 R00736 R00737 R00739 R01795 R01815 R02078 R02918; R03539 R04730 R05671 R06626 R06751 R07211 R07212 R08825; R09254 R09521 R09830 R10059 R10246 R10671 R10964 R10968; R11366","Ubiquinone and other terpenoid-quinone biosynthesis; Puromycin biosynthesis; Monobactam biosynthesis; Tyrosine metabolism; Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Novobiocin biosynthesis; Cyanoamino acid metabolism; Methane metabolism; Thiamine metabolism; Phenylpropanoid biosynthesis; Isoquinoline alkaloid biosynthesis; Betalain biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Dopaminergic synapse; Melanogenesis; Prolactin signaling pathway; Protein digestion and absorption; Parkinson's disease; Cocaine addiction; Amphetamine addiction; Alcoholism; Central carbon metabolism in cancer","1.3.1.43; 1.3.1.78; 1.3.1.79; 1.4.1.20; 1.4.3.2; 1.10.3.1; 1.11.1.8; 1.14.14.36; 1.14.16.1; 1.14.16.2; 1.14.18.1; 1.21.1.1; 2.1.1.304; 2.5.1.122; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.57; 2.6.1.58; 2.6.1.103; 4.1.1.25; 4.1.1.28; 4.1.99.2; 4.1.99.19; 4.3.1.23; 4.3.1.25; 5.4.3.6; 6.1.1.1; 6.3.2.24; 6.3.2.25","Tyrosine biosynthesis, chorismate => tyrosine; Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine; Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline; Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine; Tyrosine degradation, tyrosine => homogentisate; Cyanogenic glycoside biosynthesis, tyrosine => dhurrin; C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP; Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(2-chloro-3-hydroxy-4-methoxyphenyl)-3-hydroxypropanoyl-PCP","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00082  Tyrosine (Tyr); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00022  L-Tyrosine","CAS: 60-18-4; PubChem: 3382; ChEBI: 17895; ChEMBL: CHEMBL925; KNApSAcK: C00001397; PDB-CCD: TYR; 3DMET: B01154; NIKKAJI: J9.173A","cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308",9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H12O3N1","C9H10O3N1",181.0738932,182.0817182,180.0660682
"cpd:C00156","4-Hydroxybenzoate;","C7H6O3","4-Hydroxybenzoate; Hydroxybenzoic acid; 4-Hydroxybenzoic acid; Hydroxybenzenecarboxylic acid","R01238 R01293 R01294 R01295 R01296 R01297 R01298 R01299; R01300 R01301 R01302 R01303 R01304 R01305 R01306 R01307; R01308 R05000 R05603 R05615 R05616 R06889 R07273 R09039; R09040 R09105 R11102","Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine metabolism; Benzoate degradation; Bisphenol degradation; Toluene degradation; Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Benzoic acid family","1.2.1.7; 1.2.1.28; 1.2.1.64; 1.2.1.96; 1.13.11.41; 1.13.-.-; 1.14.13.2; 1.14.13.12; 1.14.13.33; 1.14.13.64; 1.14.99.15; 1.14.99.-; 2.4.1.194; 2.4.2.54; 2.5.1.39; 2.5.1.93; 3.1.1.-; 3.1.2.23; 3.2.1.-; 3.8.1.6; 4.1.1.61; 4.1.3.40; 6.2.1.27; 6.4.1.-","Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone; Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone",NA,"CAS: 99-96-7; PubChem: 3456; ChEBI: 17879 30763; ChEMBL: CHEMBL441343; KNApSAcK: C00000856; PDB-CCD: PHB; 3DMET: B00045; NIKKAJI: J43.201F","cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248",7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H7O3","C7H5O3",138.0316941,139.0395191,137.023869
"cpd:C00223","p-Coumaroyl-CoA;","C30H42N7O18P3S","p-Coumaroyl-CoA; 4-Coumaroyl-CoA; 4-Hydroxycinnamoyl-CoA","R01613 R01614 R01615 R01616 R01617 R02416 R06544 R06545; R06568 R06806 R07432 R07436 R07880 R07882 R07883 R07927; R07929 R08767 R08796 R08805 R08807 R08809 R08815 R08983; R09256 R10233 R10234 R10237 R10529 R11200","Ubiquinone and other terpenoid-quinone biosynthesis; Arginine and proline metabolism; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds","1.2.1.44; 1.14.13.11; 1.14.13.-; 2.3.1.64; 2.3.1.74; 2.3.1.95; 2.3.1.133; 2.3.1.153; 2.3.1.170; 2.3.1.173; 2.3.1.211; 2.3.1.212; 2.3.1.215; 2.3.1.218; 2.3.1.219; 2.3.1.229; 2.3.1.249; 2.3.1.-; 6.2.1.12","Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin","Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C00223  p-Coumaroyl-CoA","CAS: 119785-99-8; PubChem: 3523; ChEBI: 15499; ChEMBL: CHEMBL250086; KNApSAcK: C00007280; PDB-CCD: WCA; 3DMET: B04651; NIKKAJI: J796.717I","cpd:C00223; cpd:C07118",30,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C30H43O18N7P3S1","C30H41O18N7P3S1",913.1519897,914.1598147,912.1441647
"cpd:C00251","Chorismate;","C10H10O6","Chorismate; Chorismic acid; (3R,4R)-3-[(1-Carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylate","R00985 R00986 R01302 R01714 R01715 R01716 R01717 R05552; R06603 R08956 R10583 R10597 R10666","Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine, tyrosine and tryptophan biosynthesis; Folate biosynthesis; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","2.6.1.85; 2.6.1.86; 3.3.2.13; 4.1.3.27; 4.1.3.40; 4.1.3.45; 4.2.1.151; 4.2.3.5; 5.4.4.2; 5.4.99.5","Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; Tryptophan biosynthesis, chorismate => tryptophan; Phenylalanine biosynthesis, chorismate => phenylalanine; Tyrosine biosynthesis, chorismate => tyrosine; Menaquinone biosynthesis, chorismate => menaquinone; Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone; C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,"CAS: 617-12-9; PubChem: 3550; ChEBI: 17333; KNApSAcK: C00000733; PDB-CCD: ISJ; 3DMET: B01200; NIKKAJI: J7.035A","cpd:C00251; cpd:C00254; cpd:C00885; cpd:C03721; cpd:C11631",10,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H11O6","C10H9O6",226.047738,227.0555631,225.039913
"cpd:C00341","Geranyl diphosphate","C10H20O7P2","Geranyl diphosphate","R01658 R02003 R02004 R02006 R02007 R02009 R02010 R02011; R02013 R05765 R05766 R06120 R06421 R07631 R07632 R08393; R08394 R08395 R08396 R08397 R08398 R08399 R08528 R09040; R09250 R09940 R09961 R09962 R09963 R09964 R09965 R09966; R09968 R09969 R09970 R09971 R09972 R09974 R09975 R10176; R10509 R10969 R11086 R11087 R11551","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Monoterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.1.1.255; 2.5.1.1; 2.5.1.10; 2.5.1.68; 2.5.1.84; 2.5.1.93; 2.5.1.102; 2.5.1.123; 2.5.1.124; 2.5.1.125; 3.1.7.3; 3.1.7.11; 3.6.1.68; 4.2.3.10; 4.2.3.11; 4.2.3.15; 4.2.3.16; 4.2.3.20; 4.2.3.25; 4.2.3.26; 4.2.3.105; 4.2.3.106; 4.2.3.107; 4.2.3.108; 4.2.3.109; 4.2.3.110; 4.2.3.111; 4.2.3.112; 4.2.3.113; 4.2.3.114; 4.2.3.115; 4.2.3.116; 4.2.3.117; 4.2.3.119; 4.2.3.120; 4.2.3.121; 4.2.3.122; 4.2.3.-; 5.5.1.8; 5.5.1.22","C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C00341  Geranyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C00341  Geranyl diphosphate","PubChem: 3634; ChEBI: 17211; ChEMBL: CHEMBL41342; LIPIDMAPS: LMPR0102010001; LipidBank: IIP0003; KNApSAcK: C00000846; PDB-CCD: GPP; 3DMET: B00091; NIKKAJI: J1.452.575K J39.583H","cpd:C00341; cpd:C02569; cpd:C03190; cpd:C05308; cpd:C18051; cpd:C18052; cpd:C20664",10,20,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H21O7P2","C10H19O7P2",314.068427,315.076252,313.0606019
"cpd:C00353","Geranylgeranyl diphosphate;","C20H36O7P2","Geranylgeranyl diphosphate; Geranylgeranyl pyrophosphate; all-trans-Geranylgeranyl diphosphate; all-trans-Geranylgeranyl pyrophosphate; (2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate","R02061 R02063 R02064 R02065 R02068 R04158 R04520 R06298; R06305 R06312 R06321 R07475 R07916 R08754 R08992 R08993; R09123 R09246 R09251 R09685 R09714 R09715 R09730 R09874; R09967 R10177 R10349 R10533 R10708 R10763 R10896 R10897; R10898 R10899 R11514 R11517","Ubiquinone and other terpenoid-quinone biosynthesis; Indole diterpene alkaloid biosynthesis; Terpenoid backbone biosynthesis; Diterpenoid biosynthesis; Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.3.1.83; 1.3.1.-; 2.5.1.29; 2.5.1.32; 2.5.1.41; 2.5.1.42; 2.5.1.81; 2.5.1.82; 2.5.1.85; 2.5.1.89; 2.5.1.99; 2.5.1.116; 2.5.1.133; 3.1.7.5; 3.1.7.10; 4.2.1.133; 4.2.3.8; 4.2.3.17; 4.2.3.41; 4.2.3.43; 4.2.3.144; 4.2.3.146; 4.2.3.148; 4.2.3.149; 4.2.3.150; 4.2.3.151; 5.5.1.12; 5.5.1.13; 5.5.1.14; 5.5.1.15; 5.5.1.16","beta-Carotene biosynthesis, GGAP => beta-carotene; Tocopherol/tocotorienol biosynthesis; C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes; Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline; Terpentecin biosynthesis, GGAP => terpentecin","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C00353  Geranylgeranyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C00353  Geranylgeranyl diphosphate","CAS: 6699-20-3; PubChem: 3646; ChEBI: 48861; ChEMBL: CHEMBL1229266; LipidBank: IIP0006; KNApSAcK: C00000908; PDB-CCD: GRG; 3DMET: B01223; NIKKAJI: J39.582J","cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836",20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H37O7P2","C20H35O7P2",450.1936275,451.2014525,449.1858025
"cpd:C00423","trans-Cinnamate;","C9H8O2","trans-Cinnamate; trans-Cinnamic acid; (E)-Cinnamate; (2E)-3-Phenylprop-2-enoate","R00697 R01426 R02252 R02253 R02254 R02255 R02256 R06745; R06781 R06783 R07796 R08422 R08423 R11070","Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds","1.3.1.31; 1.14.12.19; 1.14.13.11; 1.14.13.14; 2.4.1.177; 2.8.3.17; 4.1.1.102; 4.3.1.24; 4.3.1.25; 6.2.1.12","Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin; Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA","Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C00423  trans-Cinnamate","CAS: 140-10-3; PubChem: 3713; ChEBI: 15669 35697; ChEMBL: CHEMBL27246; KNApSAcK: C00000170 C00029961; PDB-CCD: TCA; 3DMET: B00108; NIKKAJI: J2.024I","cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268",9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H9O2","C9H7O2",148.0524295,149.0602545,147.0446045
"cpd:C00544","Homogentisate;","C8H8O4","Homogentisate; Homogentisic acid; 2,5-Dihydroxyphenylacetic acid; 2,5-Dihydroxyphenylacetate","R02514 R02515 R02516 R02517 R02518 R02519 R02520 R02521; R05450 R07500 R08782 R10708","Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments","1.13.11.5; 1.13.11.27; 1.13.12.-; 1.14.13.18; 1.14.13.63; 1.14.13.-; 2.5.1.115; 2.5.1.116; 2.5.1.117; 4.1.1.-","Tyrosine degradation, tyrosine => homogentisate","Major components of natural products [BR:br08323];  Crude drugs;   Pinellia tuber;    C00544  Homogentisate","CAS: 451-13-8; PubChem: 3825; ChEBI: 16169 44747; KNApSAcK: C00007309; PDB-CCD: OMD; 3DMET: B00126; NIKKAJI: J5.750I","cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272",8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H9O4","C8H7O4",168.0422587,169.0500838,167.0344337
"cpd:C00811","4-Coumarate;","C9H8O3","4-Coumarate; p-Coumaric acid; trans-4-Hydroxycinnamate; trans-p-Hydroxycinnamate; 4-Hydroxycinnamic acid; 4-Hydroxycinnamate","R00737 R01308 R01616 R02253 R02950 R02951 R02952 R07826; R08023 R08534 R08766","Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds","1.14.13.11; 1.14.13.-; 1.14.18.1; 2.4.1.126; 4.1.1.102; 4.2.1.-; 4.3.1.23; 4.3.1.25; 6.2.1.12","Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin","Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C00811  4-Coumarate","CAS: 7400-08-0 501-98-4; PubChem: 4069; ChEBI: 32374; ChEMBL: CHEMBL66879; KNApSAcK: C00000152 C00000580 C00026316; PDB-CCD: HC4; 3DMET: B01335; NIKKAJI: J6.196D J8.929J","cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345",9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H9O3","C9H7O3",164.0473441,165.0551691,163.0395191
"cpd:C00885","Isochorismate;","C10H10O6","Isochorismate; Isochorismic acid","R01717 R03037 R06602 R08165","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of phenylpropanoids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.2.1.9; 3.3.2.1; 4.2.99.21; 5.4.4.2","Menaquinone biosynthesis, chorismate => menaquinone",NA,"CAS: 22642-82-6; PubChem: 4141; ChEBI: 17582 29780; KNApSAcK: C00000734; PDB-CCD: ISC; 3DMET: B01348; NIKKAJI: J389.211E","cpd:C00251; cpd:C00254; cpd:C00885; cpd:C03721; cpd:C11631",10,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H11O6","C10H9O6",226.047738,227.0555631,225.039913
"cpd:C01179","3-(4-Hydroxyphenyl)pyruvate;","C9H8O4","3-(4-Hydroxyphenyl)pyruvate; 4-Hydroxyphenylpyruvate; p-Hydroxyphenylpyruvic acid","R00042 R00729 R00734 R01728 R01730 R02521 R03336 R03337; R03338 R03339 R03341 R03342 R05778 R06626 R06632 R06757; R09254 R09396 R09830","Ubiquinone and other terpenoid-quinone biosynthesis; Monobactam biosynthesis; Tyrosine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Novobiocin biosynthesis; Methane metabolism; Isoquinoline alkaloid biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.222; 1.1.1.237; 1.2.3.13; 1.3.1.12; 1.3.1.13; 1.4.1.20; 1.4.3.2; 1.13.11.27; 1.13.11.46; 2.5.1.77; 2.5.1.111; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.57; 2.6.1.58; 2.6.1.103; 4.1.1.80; 5.3.2.1","Tyrosine biosynthesis, chorismate => tyrosine; Tyrosine degradation, tyrosine => homogentisate; F420 biosynthesis",NA,"CAS: 156-39-8; PubChem: 4406; ChEBI: 15999 36242; ChEMBL: CHEMBL607712; KNApSAcK: C00007512; PDB-CCD: ENO; 3DMET: B00254; NIKKAJI: J101.877I","cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346",9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H9O4","C9H7O4",180.0422587,181.0500838,179.0344337
"cpd:C01230","all-trans-Hexaprenyl diphosphate","C30H52O7P2","all-trans-Hexaprenyl diphosphate","R05612 R05613 R05616 R09245 R09246","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39; 2.5.1.82; 2.5.1.83; 2.5.1.-",NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C01230  all-trans-Hexaprenyl diphosphate","PubChem: 4452; ChEBI: 17528; LIPIDMAPS: LMPR03030005; 3DMET: B01417","cpd:C01230; cpd:C03428; cpd:C17434",30,52,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H53O7P2","C30H51O7P2",586.318828,587.326653,585.311003
"cpd:C01967","Ubiquinone-9;","C54H82O4","Ubiquinone-9; Ubiquinone-45; Coenzyme Q(9)","R07235","Ubiquinone and other terpenoid-quinone biosynthesis","2.1.1.64",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C01967  Ubiquinone-9","CAS: 303-97-9; PubChem: 5068; ChEBI: 18160; LIPIDMAPS: LMPR02010004; LipidBank: VCQ0002; KNApSAcK: C00007442; 3DMET: B01523; NIKKAJI: J11.404I","cpd:C01967",54,82,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C54H83O4","C54H81O4",794.6213111,795.6291362,793.6134861
"cpd:C02059","Phylloquinone;","C31H46O2","Phylloquinone; Vitamin K1; Phytonadione; 2-Methyl-3-phytyl-1,4-naphthoquinone","R03510 R03511 R03816 R06859 R10728","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption","1.6.5.2; 1.14.13.194; 1.14.99.20; 1.17.4.4; 2.1.1.163",NA,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C02059  Phylloquinone (Vitamin K1); Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C02059  Phylloquinone (Vitamin K1); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B02 ANTIHEMORRHAGICS;    B02B VITAMIN K AND OTHER HEMOSTATICS;     B02BA Vitamin K;      B02BA01 Phytomenadione;       D00148  Phytonadione (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    316  Vitamin K preparations;     3160  Vitamin K preparations;      D00148  Phytonadione (JP17/USP); Phytomenadione (INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Phytonadione;     D00148  Phytonadione (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Phylloquinone;     C02059  Phylloquinone; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00148  Phytonadione","CAS: 84-80-0; PubChem: 5148; ChEBI: 18067; ChEMBL: CHEMBL520156; LIPIDMAPS: LMPR02030028; LipidBank: VVK0001; KNApSAcK: C00002868; 3DMET: B04836; NIKKAJI: J3.883K","cpd:C02059",31,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C31H47O2","C31H45O2",450.3497807,451.3576058,449.3419557
"cpd:C02477","alpha-Tocopherol;","C29H50O2","alpha-Tocopherol; Vitamin E","R07236 R07508","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption","2.1.1.95","Tocopherol/tocotorienol biosynthesis","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C02477  alpha-Tocopherol (Vitamin E); Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C02477  alpha-Tocopherol; Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   34 Vitamin E based drugs;    C02477  alpha-Tocopherol; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Tocopherol;     C02477  alpha-Tocopherol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C02477  [001439] Tocopherol;  Antioxidant agent;   C02477  [001439] Tocopherol","CAS: 59-02-9; PubChem: 5492; ChEBI: 18145; ChEMBL: CHEMBL47; LIPIDMAPS: LMPR02020000 LMPR02020001; LipidBank: VVE0002 VVE0003; KNApSAcK: C00007366; PDB-CCD: VIV; 3DMET: B01577; NIKKAJI: J24.260H","cpd:C02477; cpd:C04814",29,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H51O2","C29H49O2",430.3810809,431.3889059,429.3732558
"cpd:C02483","gamma-Tocopherol","C28H48O2","gamma-Tocopherol","R07236 R07502","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.95; 5.5.1.24","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C02483  gamma-Tocopherol","CAS: 54-28-4; PubChem: 5496; ChEBI: 18185; LIPIDMAPS: LMPR02020060 LMPR02020065; LipidBank: VVE0006; KNApSAcK: C00029470; 3DMET: B01578; NIKKAJI: J213.540J","cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883",28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H49O2","C28H47O2",416.3654308,417.3732558,415.3576058
"cpd:C02730","2-Succinylbenzoate;","C11H10O5","2-Succinylbenzoate; o-Succinylbenzoate; Succinylbenzoate","R04030 R04031 R05454","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","4.2.1.113; 6.2.1.26","Menaquinone biosynthesis, chorismate => menaquinone",NA,"PubChem: 5692; ChEBI: 18325 44788; KNApSAcK: C00000743; PDB-CCD: OSB; 3DMET: B00493; NIKKAJI: J387.833C","cpd:C02730; cpd:C09271; cpd:C10496; cpd:C12264; cpd:C14106; cpd:C14107; cpd:C17479; cpd:C17480",11,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H11O5","C11H9O5",222.0528234,223.0606485,221.0449984
"cpd:C02949","4-Hydroxybenzoyl-CoA","C28H40N7O18P3S","4-Hydroxybenzoyl-CoA","R01300 R01301 R04101 R05316 R08118 R08767","Ubiquinone and other terpenoid-quinone biosynthesis; Benzoate degradation; Fluorobenzoate degradation; Aminobenzoate degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds","1.3.7.9; 3.1.2.23; 3.8.1.7; 6.2.1.27",NA,NA,"PubChem: 5868; ChEBI: 15500; PDB-CCD: BCA; NIKKAJI: J727.498J","cpd:C02949; cpd:C05195; cpd:C19684; cpd:C20394",28,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C28H41O18N7P3S1","C28H39O18N7P3S1",887.1363396,888.1441647,886.1285146
"cpd:C03160","2-Succinylbenzoyl-CoA;","C32H44N7O20P3S","2-Succinylbenzoyl-CoA; o-Succinylbenzoyl-CoA; Succinylbenzoyl-CoA; 4-(2-Carboxyphenyl)-4-oxobutanoyl-CoA","R04030 R04150 R05455 R07263","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","4.1.3.36; 6.2.1.26","Menaquinone biosynthesis, chorismate => menaquinone",NA,"PubChem: 6045; ChEBI: 15509; 3DMET: B04881; NIKKAJI: J1.968.559D","cpd:C03160; cpd:C09820",32,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C32H45O20N7P3S1","C32H43O20N7P3S1",971.157469,972.165294,970.149644
"cpd:C03313","Phylloquinol;","C31H48O2","Phylloquinol; Vitamin K1 hydroquinone; Phytonadiol","R03816 R04994 R05144","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.6.5.2; 2.1.1.329; 4.1.1.90",NA,NA,"CAS: 572-96-3; PubChem: 6166; ChEBI: 28433; LIPIDMAPS: LMPR02030030; NIKKAJI: J188.437I","cpd:C03313; cpd:C07373",31,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C31H49O2","C31H47O2",452.3654308,453.3732558,451.3576058
"cpd:C03657","1,4-Dihydroxy-2-naphthoate;","C11H8O4","1,4-Dihydroxy-2-naphthoate; 1,4-Dihydroxy-2-naphthoic acid","R04150 R05617 R06858 R07262 R10757","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.5.1.74; 2.5.1.-; 3.1.2.28; 4.1.3.36","Menaquinone biosynthesis, chorismate => menaquinone",NA,"CAS: 31519-22-9; PubChem: 6435; ChEBI: 18094; ChEMBL: CHEMBL1232286; KNApSAcK: C00000736; PDB-CCD: DNA; 3DMET: B00613; NIKKAJI: J27.838F","cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018",11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H9O4","C11H7O4",204.0422587,205.0500838,203.0344337
"cpd:C03672","3-(4-Hydroxyphenyl)lactate;","C9H10O4","3-(4-Hydroxyphenyl)lactate; 4-Hydroxyphenyllactate; p-Hydroxyphenyllactate; 2-Hydroxy-3-(4-hydroxyphenyl)propanoate","R03336 R03338 R08766","Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Biosynthesis of secondary metabolites","1.1.1.222; 1.1.1.237; 4.2.1.-",NA,NA,"PubChem: 6448; ChEBI: 17385 36659; ChEMBL: CHEMBL1162489; 3DMET: B04909; NIKKAJI: J70.493H","cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085",9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H11O4","C9H9O4",182.0579088,183.0657338,181.0500838
"cpd:C03885","3-Nonaprenyl-4-hydroxybenzoate;","C52H78O3","3-Nonaprenyl-4-hydroxybenzoate; Nonaprenyl-4-hydroxybenzoate","R07273","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39",NA,NA,"PubChem: 6618; ChEBI: 18162 84501; NIKKAJI: J2.744.423G","cpd:C03885",52,78,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C52H79O3","C52H77O3",750.5950964,751.6029214,749.5872713
"cpd:C03993","4-(beta-D-Glucosyloxy)benzoate;","C13H16O8","4-(beta-D-Glucosyloxy)benzoate; 4-Hydroxybenzoate-O-glucoside","R01304 R09039","Ubiquinone and other terpenoid-quinone biosynthesis","2.4.1.194; 3.2.1.-",NA,NA,"PubChem: 6706; ChEBI: 11935 16741; NIKKAJI: J589.936B","cpd:C03993; cpd:C11755; cpd:C14295; cpd:C20691",13,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C13H17O8","C13H15O8",300.0845175,301.0923425,299.0766924
"cpd:C04145","all-trans-Nonaprenyl diphosphate;","C45H76O7P2","all-trans-Nonaprenyl diphosphate; Solanesyl pyrophosphate; Solanesyl diphosphate","R07267 R07273 R08747 R08782 R09250 R09251","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39; 2.5.1.84; 2.5.1.85; 2.5.1.117; 2.5.1.-",NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04145  all-trans-Nonaprenyl diphosphate","PubChem: 6830; ChEBI: 18144; LIPIDMAPS: LMPR03030007; KNApSAcK: C00007289; 3DMET: B01720; NIKKAJI: J435.278E","cpd:C04145; cpd:C17438",45,76,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C45H77O7P2","C45H75O7P2",790.5066288,791.5144538,789.4988038
"cpd:C04146","all-trans-Octaprenyl diphosphate;","C40H68O7P2","all-trans-Octaprenyl diphosphate; Farnesylfarnesylgeraniol","R05611 R05615 R05617 R07267 R09248","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39; 2.5.1.74; 2.5.1.84; 2.5.1.85; 2.5.1.90; 2.5.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C04146  all-trans-Octaprenyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04146  all-trans-Octaprenyl diphosphate","PubChem: 6831; ChEBI: 16275; LIPIDMAPS: LMPR01070226; PDB-CCD: OTP; 3DMET: B01721; NIKKAJI: J2.167.537G","cpd:C03427; cpd:C04146; cpd:C17437",40,68,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C40H69O7P2","C40H67O7P2",722.4440285,723.4518536,721.4362035
"cpd:C05200","3-Hexaprenyl-4,5-dihydroxybenzoate","C37H54O4","3-Hexaprenyl-4,5-dihydroxybenzoate","R04711 R06865","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.114",NA,NA,"PubChem: 7605; ChEBI: 18081; LIPIDMAPS: LMPR02010043; 3DMET: B00760; NIKKAJI: J2.754.909H","cpd:C05200",37,54,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C37H55O4","C37H53O4",562.4022102,563.4100353,561.3943852
"cpd:C05313","3-Hexaprenyl-4-hydroxy-5-methoxybenzoate","C38H56O4","3-Hexaprenyl-4-hydroxy-5-methoxybenzoate","R04711 R06866","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.114",NA,NA,"PubChem: 7695; ChEBI: 16835; LIPIDMAPS: LMPR02010044; 3DMET: B00764; NIKKAJI: J2.755.454G","cpd:C05313; cpd:C05805",38,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C38H57O4","C38H55O4",576.4178603,577.4256853,575.4100353
"cpd:C05427","Phytyl diphosphate","C20H42O7P2","Phytyl diphosphate","R02063 R04795 R06284 R06858 R07500 R08756 R09067","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites","1.3.1.83; 1.3.1.-; 2.5.1.62; 2.5.1.115; 2.5.1.-","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C05427  Phytyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C05427  Phytyl diphosphate","PubChem: 7791; ChEBI: 75837; LIPIDMAPS: LMPR0104010008 LMPR0104010017; LipidBank: IIP0039; KNApSAcK: C00007255; 3DMET: B05021; NIKKAJI: J841.050J","cpd:C05427",20,42,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H43O7P2","C20H41O7P2",456.2405777,457.2484027,455.2327527
"cpd:C05802","2-Hexaprenyl-6-methoxyphenol","C37H56O2","2-Hexaprenyl-6-methoxyphenol","R04981 R04982 R06866","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.-",NA,NA,"PubChem: 8097; ChEBI: 1109; LIPIDMAPS: LMPR02010042; 3DMET: B00844; NIKKAJI: J2.759.730K","cpd:C05802",37,56,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C37H57O2","C37H55O2",532.428031,533.4358561,531.420206
"cpd:C05803","2-Hexaprenyl-6-methoxy-1,4-benzoquinone","C37H54O3","2-Hexaprenyl-6-methoxy-1,4-benzoquinone","R04982 R04983","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.201",NA,NA,"PubChem: 8098; ChEBI: 27752; 3DMET: B00845; NIKKAJI: J2.759.731I","cpd:C05803; cpd:C13425",37,54,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C37H55O3","C37H53O3",546.4072956,547.4151206,545.3994706
"cpd:C05804","2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone","C38H56O3","2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone","R04983 R04984","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.201",NA,NA,"PubChem: 8099; ChEBI: 28711; 3DMET: B00846; NIKKAJI: J93.211F","cpd:C05804",38,56,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C38H57O3","C38H55O3",560.4229457,561.4307707,559.4151206
"cpd:C05805","2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone","C38H56O4","2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone","R02175 R04984","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.64",NA,NA,"PubChem: 8100; ChEBI: 28753; 3DMET: B00847; NIKKAJI: J2.068.755J","cpd:C05313; cpd:C05805",38,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C38H57O4","C38H55O4",576.4178603,577.4256853,575.4100353
"cpd:C05809","3-Octaprenyl-4-hydroxybenzoate;","C47H70O3","3-Octaprenyl-4-hydroxybenzoate; 4-Hydroxy-3-octaprenylbenzoate","R04986 R05615","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39; 4.1.1.98",NA,NA,"PubChem: 8104; ChEBI: 50116; 3DMET: B00848; NIKKAJI: J2.759.756D","cpd:C05809; cpd:C05813",47,70,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C47H71O3","C47H69O3",682.5324961,683.5403211,681.5246711
"cpd:C05810","2-Octaprenylphenol","C46H70O","2-Octaprenylphenol","R04986 R04987","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 4.1.1.98",NA,NA,"CAS: 42187-47-3; PubChem: 8105; ChEBI: 40407; PDB-CCD: 8PP; 3DMET: B00849; NIKKAJI: J2.759.758K","cpd:C05810",46,70,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C46H71O1","C46H69O1",638.5426669,639.5504919,637.5348418
"cpd:C05811","2-Octaprenyl-6-hydroxyphenol;","C46H70O2","2-Octaprenyl-6-hydroxyphenol; 3-Octaprenylcatechol","R04987 R04988","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.222",NA,NA,"PubChem: 8106; ChEBI: 1233; 3DMET: B00850; NIKKAJI: J2.759.759I","cpd:C05811",46,70,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C46H71O2","C46H69O2",654.5375815,655.5454065,653.5297565
"cpd:C05812","2-Octaprenyl-6-methoxyphenol","C47H72O2","2-Octaprenyl-6-methoxyphenol","R04988 R04989","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.222",NA,NA,"PubChem: 8107; ChEBI: 1235; 3DMET: B00851; NIKKAJI: J2.759.762I","cpd:C05812",47,72,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C47H73O2","C47H71O2",668.5532316,669.5610566,667.5454065
"cpd:C05813","2-Octaprenyl-6-methoxy-1,4-benzoquinone","C47H70O3","2-Octaprenyl-6-methoxy-1,4-benzoquinone","R04989 R04990","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.201",NA,NA,"PubChem: 8108; ChEBI: 28423; 3DMET: B00852; NIKKAJI: J2.759.805F","cpd:C05809; cpd:C05813",47,70,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C47H71O3","C47H69O3",682.5324961,683.5403211,681.5246711
"cpd:C05814","2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone","C48H72O3","2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone","R04990 R06146","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.201",NA,NA,"PubChem: 8109; ChEBI: 28636; 3DMET: B00853; NIKKAJI: J28.579J","cpd:C05814",48,72,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C48H73O3","C48H71O3",696.5481462,697.5559712,695.5403211
"cpd:C05815","2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone","C48H72O4","2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone","R05614 R06146","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.-; 2.1.1.64",NA,NA,"PubChem: 8110; ChEBI: 27688; 3DMET: B00854; NIKKAJI: J2.759.807B","cpd:C05815",48,72,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C48H73O4","C48H71O4",712.5430608,713.5508858,711.5352358
"cpd:C05817","(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate;","C11H12O6","(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate; (1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate; SHCHC","R04031 R08166","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","4.2.1.113; 4.2.99.20","Menaquinone biosynthesis, chorismate => menaquinone",NA,"PubChem: 8112; ChEBI: 39564; PDB-CCD: 164; 3DMET: B05119; NIKKAJI: J2.759.808K","cpd:C05817; cpd:C08566",11,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H13O6","C11H11O6",240.0633881,241.0712131,239.0555631
"cpd:C05849","Vitamin K1 epoxide;","C31H46O3","Vitamin K1 epoxide; (2,3-Epoxyphytyl)menaquinone; 2,3-Epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone; 2,3-Epoxyphylloquinone; 1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dione; Phylloquinone oxide; Phylloquinone epoxide; Phylloquinone-2,3-epoxide; Vitamin K1 2,3-epoxide; Vitamin K1 oxide","R03510 R03511 R03512 R05144 R05830","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.99.20; 1.17.4.4; 1.17.4.5; 4.1.1.90",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C05849  Vitamin K epoxide","CAS: 25486-55-9; PubChem: 8142; ChEBI: 28371; ChEMBL: CHEMBL299632; 3DMET: B05123; NIKKAJI: J16.897A","cpd:C05849; cpd:C20806",31,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C31H47O3","C31H45O3",466.3446953,467.3525204,465.3368703
"cpd:C06986","Spirodilactone","C11H8O4","Spirodilactone","R05454 R05455","Ubiquinone and other terpenoid-quinone biosynthesis",NA,NA,NA,"PubChem: 9200; ChEBI: 9239; 3DMET: B05236; NIKKAJI: J1.968.558F","cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018",11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H9O4","C11H7O4",204.0422587,205.0500838,203.0344337
"cpd:C10793","Geranylhydroquinone","C16H22O2","Geranylhydroquinone","R09041 R09042 R09045","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.116",NA,NA,"CAS: 10457-66-6; PubChem: 12976; ChEBI: 24233; ChEMBL: CHEMBL459815; KNApSAcK: C00002650; 3DMET: B04127; NIKKAJI: J40.428D","cpd:C10793; cpd:C18947",16,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H23O2","C16H21O2",246.1619799,247.169805,245.1541549
"cpd:C13309","2-Phytyl-1,4-naphthoquinone;","C30H44O2","2-Phytyl-1,4-naphthoquinone; Demethylphylloquinone","R06858 R06859 R11061","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","1.6.5.12; 2.1.1.163; 2.5.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C13309  2-Demethylphylloquinone","PubChem: 586053; ChEBI: 31087; 3DMET: B05649; NIKKAJI: J1.722.871D","cpd:C13309",30,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C30H45O2","C30H43O2",436.3341307,437.3419557,435.3263056
"cpd:C13425","3-Hexaprenyl-4-hydroxybenzoate;","C37H54O3","3-Hexaprenyl-4-hydroxybenzoate; 3-Hexaprenyl-4-hydroxybenzoic acid","R05616 R06865","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.39",NA,NA,"PubChem: 586167; ChEBI: 31116; LIPIDMAPS: LMPR02010045; 3DMET: B04571; NIKKAJI: J669.042D","cpd:C05803; cpd:C13425",37,54,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C37H55O3","C37H53O3",546.4072956,547.4151206,545.3994706
"cpd:C14151","delta-Tocopherol","C27H46O2","delta-Tocopherol","R07503 R07504","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.95; 5.5.1.24","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14151  delta-Tocopherol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C14151  [109575] d-delta-Tocopherol;  Antioxidant agent;   C14151  [109575] d-delta-Tocopherol","CAS: 119-13-1; PubChem: 7846963; ChEBI: 47772; ChEMBL: CHEMBL1451395; LIPIDMAPS: LMPR02020061 LMPR02020066; LipidBank: VVE0007; KNApSAcK: C00007363; NIKKAJI: J5.309K","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C14152","beta-Tocopherol","C28H48O2","beta-Tocopherol","R07504 R07508","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.95","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14152  beta-Tocopherol","CAS: 148-03-8; PubChem: 7846964; ChEBI: 47771; LipidBank: VVE0005; KNApSAcK: C00007364; NIKKAJI: J1.604.281A","cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883",28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H49O2","C28H47O2",416.3654308,417.3732558,415.3576058
"cpd:C14153","alpha-Tocotrienol","C29H44O2","alpha-Tocotrienol","R10491","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.95","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14153  alpha-Tocotrienol","CAS: 1721-51-3; PubChem: 7846965; ChEBI: 33270; ChEMBL: CHEMBL120276; LIPIDMAPS: LMPR02020054; LipidBank: VVE0018; KNApSAcK: C00035044; NIKKAJI: J152.078D","cpd:C14153; cpd:C14287",29,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C29H45O2","C29H43O2",424.3341307,425.3419557,423.3263056
"cpd:C14154","beta-Tocotrienol","C28H42O2","beta-Tocotrienol","R10492","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.95","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14154  beta-Tocotrienol","CAS: 490-23-3; PubChem: 7846966; ChEBI: 33275; LIPIDMAPS: LMPR02020055; LipidBank: VVE0019; KNApSAcK: C00035060; NIKKAJI: J37.066E","cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738",28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H43O2","C28H41O2",410.3184806,411.3263056,409.3106556
"cpd:C14155","gamma-Tocotrienol","C28H42O2","gamma-Tocotrienol","R10491 R10624","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.95; 5.5.1.24","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14155  gamma-Tocotrienol","PubChem: 7846967; ChEBI: 33277; ChEMBL: CHEMBL120697; LIPIDMAPS: LMPR02020057; LipidBank: VVE0020; KNApSAcK: C00035101; NIKKAJI: J13.903C","cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738",28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H43O2","C28H41O2",410.3184806,411.3263056,409.3106556
"cpd:C14156","delta-Tocotrienol","C27H40O2","delta-Tocotrienol","R10492 R10623","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.95; 5.5.1.24","Tocopherol/tocotorienol biosynthesis","Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14156  delta-Tocotrienol","CAS: 25612-59-3; PubChem: 7846968; ChEBI: 33276; ChEMBL: CHEMBL121305; LIPIDMAPS: LMPR02020056; LipidBank: VVE0021; KNApSAcK: C00035077; NIKKAJI: J17.358D","cpd:C14156; cpd:C20737",27,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H41O2","C27H39O2",396.3028305,397.3106556,395.2950055
"cpd:C15547","1,4-Dihydroxy-2-naphthoyl-CoA","C32H42N7O19P3S","1,4-Dihydroxy-2-naphthoyl-CoA","R07262 R07263","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","3.1.2.28; 4.1.3.36","Menaquinone biosynthesis, chorismate => menaquinone",NA,"PubChem: 17396539; ChEBI: 52668; NIKKAJI: J1.968.560H","cpd:C15547",32,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C32H43O19N7P3S1","C32H41O19N7P3S1",953.1469043,954.1547294,952.1390793
"cpd:C15882","2-Methyl-6-phytylquinol;","C27H46O2","2-Methyl-6-phytylquinol; 2-Methyl-6-phytyl-1,4-hydroquinone; 2-Methyl-6-phytylbenzene-1,4-diol; 2-Methyl-6-phytyl-1,4-benzoquinol","R07500 R07501 R07503","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.295; 2.5.1.115; 5.5.1.24","Tocopherol/tocotorienol biosynthesis",NA,"PubChem: 47205202; ChEBI: 75406 75920; KNApSAcK: C00007590; NIKKAJI: J1.989.063E","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C15883","2,3-Dimethyl-5-phytylquinol;","C28H48O2","2,3-Dimethyl-5-phytylquinol; 2,3-Dimethyl-5-phytyl-1,4-hydroquinone; 2,3-Dimethyl-6-phytylbenzene-1,4-diol","R07501 R07502","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.295; 5.5.1.24","Tocopherol/tocotorienol biosynthesis",NA,"PubChem: 47205203; ChEBI: 75407; KNApSAcK: C00007591; NIKKAJI: J1.039.810J","cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883",28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H49O2","C28H47O2",416.3654308,417.3732558,415.3576058
"cpd:C16519","2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate;","C14H16O9","2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate; 5-Enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate","R08165 R08166","Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites","2.2.1.9; 4.2.99.20","Menaquinone biosynthesis, chorismate => menaquinone",NA,"PubChem: 51090848; ChEBI: 50271; NIKKAJI: J2.532.457I","cpd:C09919; cpd:C16519",14,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H17O9","C14H15O9",328.0794321,329.0872571,327.0716071
"cpd:C16695","Plastoquinol-9;","C53H82O2","Plastoquinol-9; Plastoquinol A","R08409 R10709","Ubiquinone and other terpenoid-quinone biosynthesis","1.10.9.1; 2.1.1.295",NA,NA,"PubChem: 51091017; ChEBI: 28026; NIKKAJI: J1.914.166G","cpd:C16695",53,82,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C53H83O2","C53H81O2",750.6314819,751.6393069,749.6236568
"cpd:C16999","Futalosine","C19H18N4O7","Futalosine","R08587 R10695","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","3.2.2.26; 3.5.4.40",NA,NA,"PubChem: 96023485; ChEBI: 51310; NIKKAJI: J1.114.779H","cpd:C16999",19,18,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H19O7N4","C19H17O7N4",414.1175489,415.125374,413.1097239
"cpd:C17010","Dehypoxanthine futalosine","C14H16O7","Dehypoxanthine futalosine","R08587 R08588 R10668","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.21.98.1; 3.2.2.26; 3.2.2.30",NA,NA,"PubChem: 96023493; ChEBI: 51312; NIKKAJI: J2.695.784B","cpd:C08564; cpd:C17010",14,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H17O7","C14H15O7",296.0896029,297.0974279,295.0817778
"cpd:C17017","Cyclic dehypoxanthine futalosine","C14H14O7","Cyclic dehypoxanthine futalosine","R08588 R08589","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.-.-; 1.21.98.1",NA,NA,"PubChem: 96023498; ChEBI: 64252; NIKKAJI: J2.695.783D","cpd:C17017",14,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H15O7","C14H13O7",294.0739528,295.0817778,293.0661278
"cpd:C17018","1,4-Dihydroxy-6-naphthoate","C11H8O4","1,4-Dihydroxy-6-naphthoate","R08589 R08596","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.-.-",NA,NA,"PubChem: 96023499; ChEBI: 64254 64284; NIKKAJI: J2.695.785K","cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018",11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H9O4","C11H7O4",204.0422587,205.0500838,203.0344337
"cpd:C17412","Shikonin","C16H16O5","Shikonin","R09044","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites",NA,NA,"Phytochemical compounds [BR:br08003];  Others;   Naphthoquinones;    alpha-Naphthoquinones;     C17412  Shikonin; Major components of natural products [BR:br08323];  Crude drugs;   Lithospermum root;    C17412  Shikonin","CAS: 517-89-5; PubChem: 96023762; ChEBI: 81068; ChEMBL: CHEMBL9470; KNApSAcK: C00000859; NIKKAJI: J13.981E","cpd:C09471; cpd:C10292; cpd:C12435; cpd:C16187; cpd:C17412",16,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H17O5","C16H15O5",288.0997736,289.1075986,287.0919486
"cpd:C17432","all-trans-Decaprenyl diphosphate","C50H84O7P2","all-trans-Decaprenyl diphosphate","R08747 R09249","Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.91; 2.5.1.-",NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C17432  all-trans-Decaprenyl diphosphate","PubChem: 96023782; ChEBI: 61011","cpd:C04509; cpd:C17432; cpd:C18321",50,84,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C50H85O7P2","C50H83O7P2",858.569229,859.5770541,857.561404
"cpd:C17568","Ubiquinone-6;","C39H58O4","Ubiquinone-6; Coenzyme Q6","R02175","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.64",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C17568  Ubiquinone-6","CAS: 1065-31-2; PubChem: 96023913; ChEBI: 52971; LIPIDMAPS: LMPR02010002; NIKKAJI: J14.035J","cpd:C17568",39,58,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C39H59O4","C39H57O4",590.4335103,591.4413354,589.4256853
"cpd:C17569","Ubiquinone-8;","C49H74O4","Ubiquinone-8; Coenzyme Q8","R05614","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.64",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C17569  Ubiquinone-8","CAS: 2394-68-5; PubChem: 96023914; ChEBI: 61683; LIPIDMAPS: LMPR02010005; PDB-CCD: UQ8; NIKKAJI: J34.208D","cpd:C17569",49,74,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C49H75O4","C49H73O4",726.5587109,727.5665359,725.5508858
"cpd:C17570","2-Methyl-6-solanyl-1,4-benzoquinol;","C52H80O2","2-Methyl-6-solanyl-1,4-benzoquinol; 2-Methyl-6-nonaprenyl-benzene-1,4-diol; 2-Methyl-6-all-trans-nonaprenylbenzene-1,4-diol; 2-Methyl-6-solanesylbenzene-1,4-diol; MSBQ","R08782 R10709","Ubiquinone and other terpenoid-quinone biosynthesis","2.1.1.295; 2.5.1.117",NA,NA,"PubChem: 96023915; ChEBI: 81191","cpd:C17570",52,80,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C52H81O2","C52H79O2",736.6158318,737.6236568,735.6080068
"cpd:C18131","Geranyl-hydroxybenzoate","C17H22O3","Geranyl-hydroxybenzoate","R09040 R09041","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.93",NA,NA,"PubChem: 96024348; ChEBI: 61122; ChEMBL: CHEMBL482787; KNApSAcK: C00000852; NIKKAJI: J796.688A J909.752J","cpd:C09171; cpd:C14660; cpd:C18131",17,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H23O3","C17H21O3",274.1568946,275.1647196,273.1490695
"cpd:C18132","3''-Hydroxy-geranylhydroquinone","C16H22O3","3''-Hydroxy-geranylhydroquinone","R09042 R09043","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","1.14.13.116",NA,NA,"PubChem: 96024349; ChEBI: 61158; NIKKAJI: J1.266.490G","cpd:C09170; cpd:C13235; cpd:C18132; cpd:C18497; cpd:C19051",16,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H23O3","C16H21O3",262.1568946,263.1647196,261.1490695
"cpd:C18133","Deoxyshikonin","C16H16O4","Deoxyshikonin","R09043 R09044","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites",NA,NA,NA,"PubChem: 96024350; ChEBI: 81530; ChEMBL: CHEMBL486627; NIKKAJI: J19.312G","cpd:C04547; cpd:C08109; cpd:C09014; cpd:C09644; cpd:C10340; cpd:C10372; cpd:C10540; cpd:C13705; cpd:C16225; cpd:C18133; cpd:C18417; cpd:C18420",16,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H17O4","C16H15O4",272.104859,273.112684,271.097034
"cpd:C18134","Dihydroechinofuran","C16H18O3","Dihydroechinofuran","R09046","Ubiquinone and other terpenoid-quinone biosynthesis",NA,NA,NA,"PubChem: 96024351; ChEBI: 81531; NIKKAJI: J460.241B","cpd:C06687; cpd:C09936; cpd:C10271; cpd:C10610; cpd:C11697; cpd:C11819; cpd:C18134; cpd:C19076",16,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H19O3","C16H17O3",258.1255944,259.1334195,257.1177694
"cpd:C18135","Dihydroshikonofuran","C16H20O3","Dihydroshikonofuran","R09045 R09046","Ubiquinone and other terpenoid-quinone biosynthesis",NA,NA,NA,"PubChem: 96024352; ChEBI: 81532","cpd:C09695; cpd:C11494; cpd:C11495; cpd:C17744; cpd:C18135",16,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H21O3","C16H19O3",260.1412445,261.1490695,259.1334195
"cpd:C20737","6-Geranylgeranyl-2-methylbenzene-1,4-diol","C27H40O2","6-Geranylgeranyl-2-methylbenzene-1,4-diol","R10623 R10708 R10710","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.295; 2.5.1.116; 5.5.1.24","Tocopherol/tocotorienol biosynthesis",NA,"PubChem: 254741205","cpd:C14156; cpd:C20737",27,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H41O2","C27H39O2",396.3028305,397.3106556,395.2950055
"cpd:C20738","6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol","C28H42O2","6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol","R10624 R10710","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.1.1.295; 5.5.1.24","Tocopherol/tocotorienol biosynthesis",NA,"PubChem: 254741206","cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738",28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C28H43O2","C28H41O2",410.3184806,411.3263056,409.3106556
"cpd:C20772","3-[(1-Carboxyvinyl)oxy]benzoate;","C10H8O5","3-[(1-Carboxyvinyl)oxy]benzoate; 3-[(1-Carboxyethenyl)oxy]benzoic acid","R10666 R10667","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.120; 4.2.1.151",NA,NA,"PubChem: 254741239","cpd:C05155; cpd:C09265; cpd:C16196; cpd:C20772",10,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H9O5","C10H7O5",208.0371734,209.0449984,207.0293483
"cpd:C20773","6-Amino-6-deoxyfutalosine","C19H19N5O6","6-Amino-6-deoxyfutalosine","R10667 R10668 R10695","Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites","2.5.1.120; 3.2.2.30; 3.5.4.40",NA,NA,"PubChem: 254741240","cpd:C20773",19,19,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H20O6N5","C19H18O6N5",413.1335334,414.1413584,412.1257083
"cpd:C00280","Androstenedione;","C19H26O2","Androstenedione; Androst-4-ene-3,17-dione; 4-Androstene-3,17-dione","R01833 R01834 R01835 R01836 R01837 R01838 R01840 R01842; R02725 R08205 R08206 R08518 R09884 R09919 R09955 R10242; R10515","Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Endocrine resistance; Ovarian steroidogenesis; Prolactin signaling pathway; Pathways in cancer; Prostate cancer","1.1.1.51; 1.1.1.64; 1.1.1.145; 1.1.1.239; 1.3.1.3; 1.3.1.22; 1.3.99.4; 1.3.99.5; 1.14.13.54; 1.14.14.1; 1.14.14.14; 1.14.14.32; 1.14.15.4; 1.14.99.12; 5.3.3.1","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00280  Androstenedione;  Hormones and transmitters;   Steroid hormones;    Androgens;     C00280  Androstenedione; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00280  Androst-4-ene-3,17-dione; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Androstane;     C00280  Androstenedione; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00051  Androstenedione (JAN)","CAS: 63-05-8; PubChem: 3575; ChEBI: 16422; ChEMBL: CHEMBL274826; LIPIDMAPS: LMST02020007; LipidBank: SST0028; KNApSAcK: C00003644; PDB-CCD: ASD; 3DMET: B01205; NIKKAJI: J38.388K","cpd:C00280; cpd:C14483; cpd:C14502; cpd:C15293; cpd:C15315; cpd:C20217; cpd:C20252",19,26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O2","C19H25O2",286.1932801,287.2011051,285.185455
"cpd:C00410","Progesterone;","C21H30O2","Progesterone; 4-Pregnene-3,20-dione","R02207 R02208 R02209 R02210 R02211 R02212 R02213 R02214; R02215 R02216 R02218 R02219 R09587","Steroid hormone biosynthesis; Metabolic pathways; Oocyte meiosis; Ovarian steroidogenesis; Progesterone-mediated oocyte maturation; Prolactin signaling pathway; Aldosterone synthesis and secretion; Pathways in cancer; Prostate cancer; Breast cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists; Progesterone, androgen and estrogen receptor agonists/antagonists","1.1.1.145; 1.1.1.149; 1.3.1.3; 1.3.1.22; 1.3.99.6; 1.14.13.54; 1.14.14.16; 1.14.14.19; 1.14.15.4; 1.14.15.8; 1.14.99.4; 1.14.99.14; 5.3.3.1","Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone; C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone; C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00410  Progesterone;  Hormones and transmitters;   Steroid hormones;    Progestagens;     C00410  Progesterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03D PROGESTOGENS;     G03DA Pregnen (4) derivatives;      G03DA04 Progesterone;       D00066  Progesterone (JP17/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Progestins;    Progesterone;     D00066  Progesterone (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2477  Progesterones;      D00066  Progesterone (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     progesterone receptor;      Progesterone;       D00066  Progesterone (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C19;    Progesterone;     D00066  Progesterone (JP17/USP/INN);   CYP3A4;    Progesterone;     D00066  Progesterone (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00066  Progesterone;   D00066  Progesterone injection; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00066;  Other gynecological agents;   D00066; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   941  Hormone preparations (except posterior-pituitary hormone and preparations);    9415  Luteinizing hormone and preparations;     C00410  Progesterone","CAS: 57-83-0; PubChem: 3700; ChEBI: 17026; ChEMBL: CHEMBL103; LIPIDMAPS: LMST02030159; KNApSAcK: C00034649; PDB-CCD: STR; 3DMET: B01238; NIKKAJI: J2.329I","cpd:C00410; cpd:C06392; cpd:C06972; cpd:C07578; cpd:C08998; cpd:C14661; cpd:C15158; cpd:C15260; cpd:C15342; cpd:C15402; cpd:C15468",21,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O2","C21H29O2",314.2245802,315.2324052,313.2167552
"cpd:C00468","Estrone;","C18H22O2","Estrone; 3-Hydroxy-1,3,5(10)-estratrien-17-one","R02347 R02349 R02350 R02351 R02352 R02353 R02354 R02355; R02356 R02358 R03980 R10515","Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis; Prolactin signaling pathway; Progesterone, androgen and estrogen receptor agonists/antagonists","1.1.1.51; 1.1.1.62; 1.1.1.148; 1.14.13.-; 1.14.14.1; 1.14.14.14; 2.4.1.17; 2.8.2.4; 2.8.2.15; 3.1.6.1","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C00468  Estrone;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C00468  Estrone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C00468  Estrone; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Estrane;     C00468  Estrone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA07 Estrone;       D00067  Estrone (JAN/USP/INN);     G03CC Estrogens, combinations with other drugs;      G03CC04 Estrone;       D00067  Estrone (JAN/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Estrogens;    Estrone;     D00067  Estrone (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estrone;       D00067  Estrone (JAN/USP/INN);     estrogen receptor 2;      Estrone;       D00067  Estrone (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   ABCG2;    Estrone;     D00067  Estrone (JAN/USP/INN); Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00067  Estrone (JAN/USP/INN)","CAS: 53-16-7; PubChem: 3751; ChEBI: 17263; ChEMBL: CHEMBL1405; LIPIDMAPS: LMST02010004; LipidBank: SST0015 SST0067; KNApSAcK: C00003663; PDB-CCD: J3Z; 3DMET: B01252; NIKKAJI: J9.114F","cpd:C00468; cpd:C13101; cpd:C14261; cpd:C14485; cpd:C14590; cpd:C15215; cpd:C18422; cpd:C20436",18,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H23O2","C18H21O2",270.1619799,271.169805,269.1541549
"cpd:C00523","Androsterone;","C19H30O2","Androsterone; 3alpha-Hydroxy-5alpha-androstan-17-one","R02476 R02477 R02478","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.209; 1.1.1.213; 2.4.1.17",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00523  Androsterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00523  3alpha-Hydroxy-5alpha-androstan-17-one","CAS: 53-41-8; PubChem: 3806; ChEBI: 16032; ChEMBL: CHEMBL41708 CHEMBL87285; LIPIDMAPS: LMST02020001; PDB-CCD: AOI; 3DMET: B01279; NIKKAJI: J4.145I","cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442",19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H31O2","C19H29O2",290.2245802,291.2324052,289.2167552
"cpd:C00535","Testosterone;","C19H28O2","Testosterone; 17beta-Hydroxy-4-androsten-3-one","R01836 R01838 R02497 R02498 R02499 R02501 R02502 R02503; R10511 R11349","Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Endocrine resistance; Ovarian steroidogenesis; Pathways in cancer; Prostate cancer; Progesterone, androgen and estrogen receptor agonists/antagonists","1.1.1.51; 1.1.1.64; 1.1.1.145; 1.1.1.239; 1.3.1.3; 1.3.1.22; 1.14.14.1; 1.14.14.14; 1.14.15.19; 2.4.1.17; 5.3.3.1",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00535  Testosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C00535  Testosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00535  17beta-Hydroxy-4-androsten-3-one; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Androstane;     C00535  Testosterone; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      C00535  Testosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03B ANDROGENS;     G03BA 3-oxoandrosten (4) derivatives;      G03BA03 Testosterone;       D00075  Testosterone (JAN/USP); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Androgens;    Testosterone;     D00075  Testosterone (JAN/USP); Classification of Japanese OTC drugs [BR:br08313];  Agents for  urogenital organs and anus;   31 Other drugs for  urogenital organs and anus;    D00075  Testosterone (JAN/USP);  Agents for integumentary system;   61 Other agents for integumentary system;    D00075  Testosterone (JAN/USP); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Testosterone;     D00075  Testosterone (JAN/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Testosterone;       D00075  Testosterone (JAN/USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Testosterone;     D00075  Testosterone (JAN/USP);   CYP3A5;    Testosterone;     D00075  Testosterone (JAN/USP);   CYP3A7;    Testosterone;     D00075  Testosterone (JAN/USP);  Transporter inhibitors;   SLC22A2;    Testosterone;     D00075  Testosterone (JAN/USP); Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00075  Testosterone (JAN/USP); Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00075","CAS: 58-22-0; PubChem: 3817; ChEBI: 17347; ChEMBL: CHEMBL386630 CHEMBL67934; LIPIDMAPS: LMST02020002; KNApSAcK: C00003675; PDB-CCD: TES; 3DMET: B01283; NIKKAJI: J4.590J","cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395",19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O2","C19H27O2",288.2089301,289.2167552,287.2011051
"cpd:C00674","5alpha-Androstane-3,17-dione;","C19H28O2","5alpha-Androstane-3,17-dione; Androstanedione","R01834 R02476 R02477 R09956 R10242","Steroid hormone biosynthesis; Steroid degradation; Microbial metabolism in diverse environments","1.1.1.50; 1.1.1.51; 1.1.1.209; 1.1.1.213; 1.3.1.22; 1.3.99.5",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00674  5alpha-Androstane-3,17-dione","CAS: 846-46-8; PubChem: 3943; ChEBI: 15994; ChEMBL: CHEMBL1253; LIPIDMAPS: LMST02020085; PDB-CCD: 5SD; 3DMET: B04715; NIKKAJI: J38.549B","cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395",19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O2","C19H27O2",288.2089301,289.2167552,287.2011051
"cpd:C00735","Cortisol;","C21H30O5","Cortisol; Hydrocortisone; 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione; Kendall's compound F; Reichstein's substance M","R02834 R02836 R02837 R02838 R02839 R02840 R02841 R02843; R08995","Steroid hormone biosynthesis; Metabolic pathways; Neuroactive ligand-receptor interaction; Aldosterone-regulated sodium reabsorption; Bile secretion; Pathways in cancer; Prostate cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists","1.1.1.145; 1.1.1.146; 1.1.1.-; 1.3.1.3; 1.14.14.16; 1.14.15.4; 2.3.1.27; 2.8.2.18; 5.3.3.1","C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00735  Cortisol;  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C00735  Cortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C00735  Cortisol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AC Corticosteroids for local oral treatment;      A01AC03 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07E INTESTINAL ANTIINFLAMMATORY AGENTS;     A07EA Corticosteroids acting locally;      A07EA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  C CARDIOVASCULAR SYSTEM;   C05 VASOPROTECTIVES;    C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;     C05AA Corticosteroids;      C05AA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  D DERMATOLOGICALS;   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;    D07A CORTICOSTEROIDS, PLAIN;     D07AA Corticosteroids, weak (group I);      D07AA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);    D07X CORTICOSTEROIDS, OTHER COMBINATIONS;     D07XA Corticosteroids, weak, other combinations;      D07XA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AB Glucocorticoids;      H02AB09 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01B ANTIINFLAMMATORY AGENTS;     S01BA Corticosteroids, plain;      S01BA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);    S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;     S01CB Corticosteroids/antiinfectives/mydriatics in combination;      S01CB03 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);   S02 OTOLOGICALS;    S02B CORTICOSTEROIDS;     S02BA Corticosteroids;      S02BA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);  Inflammatory Bowel Disease Agents;   Glucocorticoids;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    245  Adrenal hormone preparations;     2452  Cortisones;      D00088  Hydrocortisone (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D00088  Hydrocortisone (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);  Second-class OTC drugs;   Inorganic and organic chemicals;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);   CYP3A5;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);   CYP3A7;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00088  Hydrocortisone; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00088; Dermatological agents [br08370.html];  Topical steroids;   D00088; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00088; Rx-to-OTC switch list in the USA [br08315.html];  D00088","CAS: 50-23-7; PubChem: 3998; ChEBI: 17650; ChEMBL: CHEMBL1092578 CHEMBL196519 CHEMBL389621; LIPIDMAPS: LMST02030001; LipidBank: SST0244; PDB-CCD: HCY; 3DMET: B01319; NIKKAJI: J1.908I","cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034",21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O5","C21H29O5",362.2093241,363.2171491,361.201499
"cpd:C00762","Cortisone;","C21H28O5","Cortisone; 17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione; Kendall's compound E; Reichstein's substance Fa","R02834 R02836 R02892 R02893","Steroid hormone biosynthesis; Metabolic pathways; Aldosterone-regulated sodium reabsorption; Pathways in cancer; Prostate cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists","1.1.1.146; 1.1.1.-; 1.3.1.3; 1.3.1.22","C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00762  Cortisone;  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C00762  Cortisone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C00762  Cortisone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AB Glucocorticoids;      H02AB10 Cortisone;       D07749  Cortisone (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01B ANTIINFLAMMATORY AGENTS;     S01BA Corticosteroids, plain;      S01BA03 Cortisone;       D07749  Cortisone (INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);   Cortisone;    D07749  Cortisone (INN);  Inflammatory Bowel Disease Agents;   Glucocorticoids;    Cortisone;     D07749  Cortisone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Cortisone;       D07749  Cortisone (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Cortisone;     D07749  Cortisone (INN);   CYP3A5;    Cortisone;     D07749  Cortisone (INN)","CAS: 53-06-5; PubChem: 4024; ChEBI: 16962; ChEMBL: CHEMBL1499 CHEMBL536; LIPIDMAPS: LMST02030090; LipidBank: SST0042; 3DMET: B01327; NIKKAJI: J4.139D","cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039",21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H29O5","C21H27O5",360.193674,361.201499,359.185849
"cpd:C00951","Estradiol-17beta;","C18H24O2","Estradiol-17beta; Estradiol; beta-Estradiol","R00535 R02352 R02353 R03086 R03087 R03088 R03089 R03090; R03091 R10511","Steroid hormone biosynthesis; Metabolic pathways; Endocrine resistance; Ovarian steroidogenesis; Estrogen signaling pathway; Prolactin signaling pathway; Endocrine and other factor-regulated calcium reabsorption; Pathways in cancer; Prostate cancer; Breast cancer; Progesterone, androgen and estrogen receptor agonists/antagonists","1.1.1.51; 1.1.1.62; 1.14.14.1; 1.14.14.14; 1.14.99.11; 2.4.1.17; 2.8.2.15",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C00951  Estradiol-17beta;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C00951  Estradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C00951  Estradiol-17beta; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1, 2;      C00951  Estradiol-17beta; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA03 Estradiol;       D00105  Estradiol (JAN/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Estrogens;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2473  Estradiols;      D00105  Estradiol (JAN/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Drugs for women;   51 Other drugs for women;    D00105  Estradiol (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Estradiol;     D00105  Estradiol (JAN/USP/INN);  Second-class OTC drugs;   Inorganic and organic chemicals;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estradiol;       D00105  Estradiol (JAN/USP/INN);     estrogen receptor 2;      Estradiol;       D00105  Estradiol (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Estradiol;     D00105  Estradiol (JAN/USP/INN);   CYP1B1;    Estradiol;     D00105  Estradiol (JAN/USP/INN);   CYP3A4;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Osteoporosis drugs [br08368.html];  D00105; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00105","CAS: 50-28-2; PubChem: 4202; ChEBI: 16469; ChEMBL: CHEMBL135; LIPIDMAPS: LMST02010001; LipidBank: SST0013 SST0064; PDB-CCD: EST; 3DMET: B01357; NIKKAJI: J4.100I","cpd:C00951; cpd:C02537; cpd:C14500; cpd:C15129; cpd:C15261",18,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O2","C18H23O2",272.17763,273.185455,271.169805
"cpd:C01124","18-Hydroxycorticosterone","C21H30O5","18-Hydroxycorticosterone","R03262 R03263","Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion","1.14.15.4; 1.14.15.5","C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C01124  18-Hydroxycorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C01124  18-Hydroxycorticosterone","CAS: 561-65-9; PubChem: 4355; ChEBI: 16485; LIPIDMAPS: LMST02030091; 3DMET: B04772; NIKKAJI: J188.422K","cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034",21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O5","C21H29O5",362.2093241,363.2171491,361.201499
"cpd:C01176","17alpha-Hydroxyprogesterone;","C21H30O3","17alpha-Hydroxyprogesterone; 17alpha-Hydroxy-4-pregnene-3,20-dione; Pregn-4-ene-3,20-dione-17-ol; 17alpha-Hydroxy-progesterone","R02211 R03325 R03326 R03327 R03329 R08206 R08518","Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis","1.1.1.145; 1.1.1.149; 1.14.13.54; 1.14.14.16; 1.14.14.19; 1.14.14.32; 1.14.15.4; 5.3.3.1","C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Progestagens;     C01176  17alpha-Hydroxyprogesterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03D PROGESTOGENS;     G03DA Pregnen (4) derivatives;      G03DA03 Hydroxyprogesterone;       D08052  Hydroxyprogesterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     progesterone receptor;      Hydroxyprogesterone;       D08052  Hydroxyprogesterone (INN)","CAS: 68-96-2; PubChem: 4403; ChEBI: 17252; ChEMBL: CHEMBL1062; LIPIDMAPS: LMST02030161; PDB-CCD: 3QZ; 3DMET: B01402; NIKKAJI: J4.862C","cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218",21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O3","C21H29O3",330.2194948,331.2273199,329.2116698
"cpd:C01227","Dehydroepiandrosterone;","C19H28O2","Dehydroepiandrosterone; 3beta-Hydroxyandrost-5-en-17-one; Dehydroisoandrosterone; DHA; DHEA","R01837 R03404 R03405 R03406 R03407 R03408 R08517 R08961; R09957","Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Ovarian steroidogenesis; Pathways in cancer; Prostate cancer","1.1.1.51; 1.1.1.145; 1.14.13.-; 1.14.14.1; 1.14.14.23; 1.14.14.32; 2.8.2.2; 3.1.6.2; 5.3.3.1","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C01227  Dehydroepiandrosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C01227  Dehydroepiandrosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C01227  3beta-Hydroxyandrost-5-en-17-one; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A14 ANABOLIC AGENTS FOR SYSTEMIC USE;    A14A ANABOLIC STEROIDS;     A14AA Androstan derivatives;      A14AA07 Prasterone;       D08409  Prasterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Prasterone;       D08409  Prasterone (INN)","CAS: 53-43-0; PubChem: 4449; ChEBI: 28689; ChEMBL: CHEMBL309821 CHEMBL363554 CHEMBL90593; LIPIDMAPS: LMST02020021; LipidBank: SST0185; PDB-CCD: AND; 3DMET: B01415; NIKKAJI: J4.147E","cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395",19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O2","C19H27O2",288.2089301,289.2167552,287.2011051
"cpd:C01780","Aldosterone;","C21H28O5","Aldosterone; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al","R03263 R03713 R03714 R08949 R08953","Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion; Aldosterone-regulated sodium reabsorption; Glucocorticoid and meneralocorticoid receptor agonists/antagonists","1.3.1.3; 1.14.15.4; 1.14.15.5","C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C01780  Aldosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C01780  Aldosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AA Mineralocorticoids;      H02AA01 Aldosterone;       D10528  Aldosterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     mineralocorticoid receptor;      Aldosterone;       D10528  Aldosterone (INN)","CAS: 52-39-1; PubChem: 4910; ChEBI: 27584; ChEMBL: CHEMBL273453; LIPIDMAPS: LMST02030026; PDB-CCD: AS4; 3DMET: B01497; NIKKAJI: J4.130K","cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039",21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H29O5","C21H27O5",360.193674,361.201499,359.185849
"cpd:C01953","Pregnenolone;","C21H32O2","Pregnenolone; 5-Pregnen-3beta-ol-20-one; 3beta-Hydroxypregn-5-en-20-one","R02216 R02724 R03783 R03784 R03933 R08942 R08943 R08978","Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis; Aldosterone synthesis and secretion","1.1.1.145; 1.14.14.16; 1.14.14.19; 1.14.14.29; 1.14.15.6; 2.8.2.2; 2.8.2.14; 3.1.6.2; 5.3.3.1","Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone; C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C01953  Pregnenolone;  Hormones and transmitters;   Steroid hormones;    Progestagens;     C01953  Pregnenolone; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived by amination reactions;    Steroidal alkaloids;     D00143  Pregnenolone (JAN/INN)","CAS: 145-13-1; PubChem: 5056; ChEBI: 16581; ChEMBL: CHEMBL253363 CHEMBL77462; LIPIDMAPS: LMST02030088; KNApSAcK: C00047082 C00049664; PDB-CCD: PLO; 3DMET: B04827; NIKKAJI: J11.381F","cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219",21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O2","C21H31O2",316.2402303,317.2480553,315.2324052
"cpd:C02140","Corticosterone;","C21H30O4","Corticosterone; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; Kendall's compound B; Reichstein's substance H","R03262 R03847 R03848 R03849 R03850 R03851","Steroid hormone biosynthesis; Metabolic pathways; Regulation of lipolysis in adipocytes; Aldosterone synthesis and secretion; Prion diseases","1.1.1.146; 1.1.1.-; 1.3.1.3; 1.14.14.16; 1.14.15.4; 1.14.15.5","C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C02140  Corticosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C02140  Corticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C02140  Corticosterone","CAS: 50-22-6; PubChem: 5219; ChEBI: 16827; ChEMBL: CHEMBL110739 CHEMBL1513569; LIPIDMAPS: LMST02030186; LipidBank: SST0168; PDB-CCD: C0R; 3DMET: B01538; NIKKAJI: J5.239F","cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365",21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O4","C21H29O4",346.2144094,347.2222345,345.2065844
"cpd:C02373","4-Methylpentanal;","C6H12O","4-Methylpentanal; Isocaproaldehyde; Isohexanal","R02724 R03933 R04676","Steroid hormone biosynthesis","1.14.15.6",NA,NA,"CAS: 1119-16-0; PubChem: 5415; ChEBI: 17998; PDB-CCD: MOP; 3DMET: B00433; NIKKAJI: J49.658H","cpd:C00854; cpd:C01952; cpd:C02373; cpd:C02837; cpd:C02893; cpd:C05328; cpd:C08492; cpd:C19263; cpd:C19350; cpd:C19543; cpd:C19809; cpd:C21098",6,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O1","C6H11O1",100.088815,101.09664,99.08098997
"cpd:C02537","Estradiol-17alpha;","C18H24O2","Estradiol-17alpha; 17alpha-Estradiol","R02347 R02349","Steroid hormone biosynthesis","1.1.1.148",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C02537  Estradiol-17alpha; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C02537  Estradiol-17alpha","CAS: 57-91-0; PubChem: 5544; ChEBI: 17160; ChEMBL: CHEMBL286452; LIPIDMAPS: LMST02010029; 3DMET: B01587; NIKKAJI: J4.586A","cpd:C00951; cpd:C02537; cpd:C14500; cpd:C15129; cpd:C15261",18,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O2","C18H23O2",272.17763,273.185455,271.169805
"cpd:C02538","Estrone 3-sulfate","C18H22O5S","Estrone 3-sulfate","R02350 R03980","Steroid hormone biosynthesis; Bile secretion","2.8.2.4; 2.8.2.15; 3.1.6.1",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Estrogens;     C02538  Estrone 3-sulfate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C02538  Estrone 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C02538  Estrone 3-sulfate","CAS: 481-97-0; PubChem: 5545; ChEBI: 17474; ChEMBL: CHEMBL494753; LIPIDMAPS: LMST02010043; 3DMET: B04855; NIKKAJI: J5.782G","cpd:C02538",18,22,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C18H23O5S1","C18H21O5S1",350.118795,351.12662,349.1109699
"cpd:C03205","11-Deoxycorticosterone;","C21H30O3","11-Deoxycorticosterone; Deoxycorticosterone; Cortexone; 21-Hydroxy-4-pregnene-3,20-dione; Desoxycortone; DOC","R02213 R03851 R04163 R04165 R08949 R08954","Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion","1.1.1.145; 1.3.1.22; 1.14.14.16; 1.14.15.4; 5.3.1.21; 5.3.3.1","C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C03205  11-Deoxycorticosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C03205  11-Deoxycorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C03205  11-Deoxycorticosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AA Mineralocorticoids;      H02AA03 Desoxycortone;       D07792  Desoxycortone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     mineralocorticoid receptor;      Desoxycortone;       D07792  Desoxycortone (INN)","CAS: 64-85-7; PubChem: 6081; ChEBI: 16973; ChEMBL: CHEMBL1498; LIPIDMAPS: LMST02030087; LipidBank: SST0186; PDB-CCD: 1CA; 3DMET: B01638; NIKKAJI: J1.407I","cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218",21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O3","C21H29O3",330.2194948,331.2273199,329.2116698
"cpd:C03681","5alpha-Pregnane-3,20-dione;","C21H32O2","5alpha-Pregnane-3,20-dione; 5alpha-Dihydroprogesterone","R02208 R07138 R08957 R08958","Steroid hormone biosynthesis","1.1.1.149; 1.1.1.213; 1.1.1.278; 1.3.1.22",NA,NA,"CAS: 566-65-4; PubChem: 6456; ChEBI: 28952; ChEMBL: CHEMBL407717 CHEMBL40910; LIPIDMAPS: LMST02030170; 3DMET: B01685; NIKKAJI: J6.519F","cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219",21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O2","C21H31O2",316.2402303,317.2480553,315.2324052
"cpd:C03747","11alpha-Hydroxyprogesterone","C21H30O3","11alpha-Hydroxyprogesterone","R02214","Steroid hormone biosynthesis","1.14.99.14",NA,NA,"CAS: 80-75-1; PubChem: 6508; ChEBI: 16076; ChEMBL: CHEMBL1563246 CHEMBL1908051; LIPIDMAPS: LMST02030184; 3DMET: B04911; NIKKAJI: J121.148J","cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218",21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O3","C21H29O3",330.2194948,331.2273199,329.2116698
"cpd:C03772","5beta-Androstane-3,17-dione","C19H28O2","5beta-Androstane-3,17-dione","R01835 R04309 R04310","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.152; 1.3.1.3",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C03772  5beta-Androstane-3,17-dione; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03772  5beta-Androstane-3,17-dione","CAS: 1229-12-5; PubChem: 6526; ChEBI: 16985; ChEMBL: CHEMBL1230988; LIPIDMAPS: LMST02020058; PDB-CCD: ANO; 3DMET: B01689; NIKKAJI: J38.550F","cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395",19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O2","C19H27O2",288.2089301,289.2167552,287.2011051
"cpd:C03852","Androstan-3alpha,17beta-diol;","C19H32O2","Androstan-3alpha,17beta-diol; 5alpha-Androstan-3alpha,17beta-diol","R04330 R08963","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.53",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03852  Androstan-3alpha,17beta-diol","PubChem: 6589; ChEBI: 18011; ChEMBL: CHEMBL410494; 3DMET: B04916; NIKKAJI: J58.218B","cpd:C01090; cpd:C02159; cpd:C03050; cpd:C03051; cpd:C03176; cpd:C03852; cpd:C07632; cpd:C10800; cpd:C12525; cpd:C14960; cpd:C14975; cpd:C15288",19,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H33O2","C19H31O2",292.2402303,293.2480553,291.2324052
"cpd:C03917","Dihydrotestosterone;","C19H30O2","Dihydrotestosterone; 17beta-Hydroxyandrostan-3-one; Androstanolone; 17beta-Hydroxy-5alpha-androstan-3-one","R02497 R04330 R04344 R08963","Steroid hormone biosynthesis; Pathways in cancer; Prostate cancer","1.1.1.50; 1.1.1.53; 1.1.1.210; 1.3.1.22",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C03917  Dihydrotestosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C03917  Dihydrotestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03917  17beta-Hydroxy-5alpha-androstan-3-one; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A14 ANABOLIC AGENTS FOR SYSTEMIC USE;    A14A ANABOLIC STEROIDS;     A14AA Androstan derivatives;      A14AA01 Androstanolone;       D07456  Androstanolone (INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03B ANDROGENS;     G03BB 5-androstanon (3) derivatives;      G03BB02 Androstanolone;       D07456  Androstanolone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Androstanolone;       D07456  Androstanolone (INN)","CAS: 521-18-6; PubChem: 6646; ChEBI: 16330; ChEMBL: CHEMBL27769 CHEMBL358627; LIPIDMAPS: LMST02020042 LMST02020107; LipidBank: SST0297; PDB-CCD: DHT; 3DMET: B01699; NIKKAJI: J39.503J","cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442",19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H31O2","C19H29O2",290.2245802,291.2324052,289.2167552
"cpd:C03935","6beta-Hydroxy-17beta-estradiol;","C18H24O3","6beta-Hydroxy-17beta-estradiol; 6beta-Hydroxyestradiol-17beta","R03086","Steroid hormone biosynthesis","1.14.99.11",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C03935  6beta-Hydroxyestradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C03935  6beta-Hydroxyestradiol-17beta","PubChem: 6661; ChEBI: 16784; ChEMBL: CHEMBL390714; LIPIDMAPS: LMST02010031; 3DMET: B01701; NIKKAJI: J824.125B","cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415",18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O3","C18H23O3",288.1725446,289.1803697,287.1647196
"cpd:C04042","20alpha-Hydroxy-4-pregnen-3-one;","C21H32O2","20alpha-Hydroxy-4-pregnen-3-one; 20alpha-Hydroxypregn-4-en-3-one; 20alpha-Hydroxyprogesterone; (S)-20-Hydroxypregn-4-en-3-one","R02207 R02209","Steroid hormone biosynthesis","1.1.1.149",NA,NA,"CAS: 145-14-2; PubChem: 6743; ChEBI: 28453; ChEMBL: CHEMBL137320 CHEMBL1583424; LIPIDMAPS: LMST02030169; 3DMET: B04922; NIKKAJI: J6.126C","cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219",21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O2","C21H31O2",316.2402303,317.2480553,315.2324052
"cpd:C04295","Androstenediol;","C19H30O2","Androstenediol; Androst-5-ene-3beta,17beta-diol; 3beta,17beta-Dihydroxyandrost-5-ene; 3beta,17beta-Dihydroxy-5-androstene","R02499 R03406 R03407","Steroid hormone biosynthesis; Ovarian steroidogenesis","1.1.1.51; 1.1.1.145; 5.3.3.1",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C04295  Androstenediol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04295  3beta,17beta-Dihydroxyandrost-5-ene","CAS: 521-17-5; PubChem: 6955; ChEBI: 2710; ChEMBL: CHEMBL317104 CHEMBL440283 CHEMBL77135; LIPIDMAPS: LMST02020005; PDB-CCD: B81; 3DMET: B01731; NIKKAJI: J6.611G","cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442",19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H31O2","C19H29O2",290.2245802,291.2324052,289.2167552
"cpd:C04373","Etiocholanolone;","C19H30O2","Etiocholanolone; 3alpha-Hydroxy-5beta-androstan-17-one; Etiocholan-3alpha-ol-17-one; 3alpha-Hydroxyetiocholan-17-one","R04309 R04310 R04352","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.152; 2.4.1.17",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C04373  Etiocholanolone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04373  3alpha-Hydroxy-5beta-androstan-17-one","CAS: 53-42-9; PubChem: 7015; ChEBI: 28195; ChEMBL: CHEMBL1257060 CHEMBL1405827 CHEMBL289067 CHEMBL85799; LIPIDMAPS: LMST02020059; PDB-CCD: AE2; 3DMET: B01736; NIKKAJI: J4.146G","cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442",19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H31O2","C19H29O2",290.2245802,291.2324052,289.2167552
"cpd:C04518","17alpha,20alpha-Dihydroxypregn-4-en-3-one","C21H32O3","17alpha,20alpha-Dihydroxypregn-4-en-3-one","R03325","Steroid hormone biosynthesis","1.1.1.149",NA,NA,"CAS: 652-69-7; PubChem: 7131; ChEBI: 16418; LIPIDMAPS: LMST02030183; 3DMET: B01751; NIKKAJI: J396.241E","cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040",21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O3","C21H31O3",332.2351449,333.2429699,331.2273199
"cpd:C04555","Dehydroepiandrosterone sulfate;","C19H28O5S","Dehydroepiandrosterone sulfate; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; DHEA sulfate","R03404 R03405","Steroid hormone biosynthesis; Bile secretion","2.8.2.2; 3.1.6.2",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C04555  Dehydroepiandrosterone sulfate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate","CAS: 651-48-9; PubChem: 7160; ChEBI: 16814; ChEMBL: CHEMBL259898; LIPIDMAPS: LMST05020010; 3DMET: B01756; NIKKAJI: J412.303D","cpd:C04555",19,28,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O5S1","C19H27O5S1",368.1657452,369.1735702,367.1579201
"cpd:C04676","Testololactone;","C19H26O3","Testololactone; 3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone","R01833 R03641 R08205","Steroid hormone biosynthesis","1.14.13.54; 1.14.99.12; 3.1.1.37",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04676  3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone","CAS: 4416-57-3; PubChem: 7257; ChEBI: 18084; LIPIDMAPS: LMST02020061; 3DMET: B01773; NIKKAJI: J39.509I","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05138","17alpha-Hydroxypregnenolone","C21H32O3","17alpha-Hydroxypregnenolone","R03327 R03783 R04675 R04676 R08517","Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis","1.1.1.145; 1.14.14.16; 1.14.14.19; 1.14.14.32; 1.14.15.6; 5.3.3.1","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Progestagens;     C05138  17alpha-Hydroxypregnenolone","CAS: 387-79-1; PubChem: 7557; ChEBI: 28750; ChEMBL: CHEMBL408706; LIPIDMAPS: LMST02030089; PDB-CCD: LZZ; 3DMET: B04983; NIKKAJI: J22.718H","cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040",21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O3","C21H31O3",332.2351449,333.2429699,331.2273199
"cpd:C05139","16alpha-Hydroxydehydroepiandrosterone;","C19H28O3","16alpha-Hydroxydehydroepiandrosterone; 5-Androstene-3beta,16alpha-diol-17-one","R03408 R04678","Steroid hormone biosynthesis","1.1.1.145; 1.14.13.-; 1.14.14.1; 5.3.3.1",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05139  16alpha-Hydroxydehydroepiandrosterone","CAS: 1232-73-1; PubChem: 7558; ChEBI: 27771; LIPIDMAPS: LMST02020064; 3DMET: B01812; NIKKAJI: J14.213A","cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296",19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O3","C19H27O3",304.2038448,305.2116698,303.1960197
"cpd:C05140","16alpha-Hydroxyandrost-4-ene-3,17-dione;","C19H26O3","16alpha-Hydroxyandrost-4-ene-3,17-dione; 4-Androsten-16alpha-ol-3,17-dione","R04678","Steroid hormone biosynthesis","1.1.1.145; 5.3.3.1",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05140  16alpha-Hydroxyandrost-4-ene-3,17-dione","CAS: 63-02-5; PubChem: 7559; ChEBI: 27582; ChEMBL: CHEMBL143789 CHEMBL1908014; LIPIDMAPS: LMST02020065; 3DMET: B01813; NIKKAJI: J337.168I","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05141","Estriol;","C18H24O3","Estriol; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol","R03089 R04681 R04682 R04683","Steroid hormone biosynthesis; Metabolic pathways; Progesterone, androgen and estrogen receptor agonists/antagonists","1.1.1.62; 1.14.14.1; 2.4.1.17",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05141  Estriol;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C05141  Estriol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05141  Estriol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA04 Estriol;       D00185  Estriol (JP17/USP);     G03CC Estrogens, combinations with other drugs;      G03CC06 Estriol;       D00185  Estriol (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2475  Estriols;      D00185  Estriol (JP17/USP);   25  Urogenital and anal organ agents;    252  Genital organ agents;     2529  Others;      D00185  Estriol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estriol;       D00185  Estriol (JP17/USP);     estrogen receptor 2;      Estriol;       D00185  Estriol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00185  Estriol;   D00185  Estriol tablets;   D00185  Estriol injection (aqueous suspension); Osteoporosis drugs [br08368.html];  D00185; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00185; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   941  Hormone preparations (except posterior-pituitary hormone and preparations);    9414  Follicle stimulating hormone and preparations;     C05141  Estriol","CAS: 50-27-1; PubChem: 7560; ChEBI: 27974; ChEMBL: CHEMBL193482; LIPIDMAPS: LMST02010003; LipidBank: SST0014; PDB-CCD: ESL; 3DMET: B01814; NIKKAJI: J4.099A","cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415",18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O3","C18H23O3",288.1725446,289.1803697,287.1647196
"cpd:C05284","11beta-Hydroxyandrost-4-ene-3,17-dione;","C19H26O3","11beta-Hydroxyandrost-4-ene-3,17-dione; Androst-4-ene-3,17-dione-11beta-ol; 4-Androsten-11beta-ol-3,17-dione","R02725 R04758 R08945 R08980 R08995","Steroid hormone biosynthesis","1.1.1.62; 1.1.1.146; 1.1.1.-; 1.14.15.4",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05284  11beta-Hydroxyandrost-4-ene-3,17-dione","CAS: 382-44-5; PubChem: 7671; ChEBI: 27967; ChEMBL: CHEMBL347785; LIPIDMAPS: LMST02020066; 3DMET: B01832; NIKKAJI: J104.102I","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05285","Adrenosterone","C19H24O3","Adrenosterone","R04758","Steroid hormone biosynthesis","1.1.1.146; 1.1.1.-",NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C05285  Adrenosterone","CAS: 382-45-6; PubChem: 7672; ChEBI: 2495; ChEMBL: CHEMBL485683; LipidBank: SST0128; 3DMET: B01833; NIKKAJI: J5.714B","cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982",19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H25O3","C19H23O3",300.1725446,301.1803697,299.1647196
"cpd:C05290","19-Hydroxyandrost-4-ene-3,17-dione;","C19H26O3","19-Hydroxyandrost-4-ene-3,17-dione; 19-Hydroxyandrostenedione","R01840 R04759","Steroid hormone biosynthesis; Metabolic pathways","1.14.14.14","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05290  19-Hydroxyandrost-4-ene-3,17-dione","CAS: 510-64-5; PubChem: 7675; ChEBI: 27576; ChEMBL: CHEMBL1385863; LIPIDMAPS: LMST02020067; 3DMET: B01834; NIKKAJI: J117.011B","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05291","7alpha-Hydroxytestosterone","C19H28O3","7alpha-Hydroxytestosterone","R02503 R04760","Steroid hormone biosynthesis","1.14.14.1",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C05291  7alpha-Hydroxytestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05291  7alpha-Hydroxytestosterone","CAS: 62-83-9; PubChem: 7676; ChEBI: 2295; LIPIDMAPS: LMST02020068; 3DMET: B05007; NIKKAJI: J239.114G","cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296",19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O3","C19H27O3",304.2038448,305.2116698,303.1960197
"cpd:C05293","5beta-Dihydrotestosterone","C19H30O2","5beta-Dihydrotestosterone","R02498","Steroid hormone biosynthesis","1.3.1.3",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05293  5beta-Dihydrotestosterone","CAS: 571-22-2; PubChem: 7677; ChEBI: 2150; ChEMBL: CHEMBL1872046 CHEMBL373357; LIPIDMAPS: LMST02020069; PDB-CCD: BDT; 3DMET: B01835; NIKKAJI: J16.844K","cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442",19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H31O2","C19H29O2",290.2245802,291.2324052,289.2167552
"cpd:C05294","19-Hydroxytestosterone;","C19H28O3","19-Hydroxytestosterone; 17beta,19-Dihydroxyandrost-4-en-3-one","R02501 R04761","Steroid hormone biosynthesis; Metabolic pathways","1.14.14.14",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C05294  19-Hydroxytestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05294  17beta,19-Dihydroxyandrost-4-en-3-one","PubChem: 7678; ChEBI: 798; LIPIDMAPS: LMST02020070; 3DMET: B01836; NIKKAJI: J426.714A","cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296",19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O3","C19H27O3",304.2038448,305.2116698,303.1960197
"cpd:C05295","19-Oxotestosterone","C19H26O3","19-Oxotestosterone","R03087 R04761","Steroid hormone biosynthesis; Metabolic pathways","1.14.14.14",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05295  19-Oxotestosterone","PubChem: 7679; ChEBI: 75308; NIKKAJI: J1.968.925E","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05296","7alpha-Hydroxyandrost-4-ene-3,17-dione;","C19H26O3","7alpha-Hydroxyandrost-4-ene-3,17-dione; 7alpha-Hydroxyandrostenedione","R01842 R04760","Steroid hormone biosynthesis","1.14.14.1",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05296  7alpha-Hydroxyandrost-4-ene-3,17-dione","PubChem: 7680; ChEBI: 27768; LIPIDMAPS: LMST02020071; 3DMET: B01837; NIKKAJI: J337.164F","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05297","19-Oxoandrost-4-ene-3,17-dione;","C19H24O3","19-Oxoandrost-4-ene-3,17-dione; 19-Oxoandrostenedione","R02351 R04759","Steroid hormone biosynthesis; Metabolic pathways","1.14.14.14","C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05297  19-Oxoandrost-4-ene-3,17-dione","PubChem: 7681; ChEBI: 799; ChEMBL: CHEMBL1545651; LIPIDMAPS: LMST02020083; 3DMET: B05008; NIKKAJI: J101.998H","cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982",19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H25O3","C19H23O3",300.1725446,301.1803697,299.1647196
"cpd:C05298","2-Hydroxyestrone","C18H22O3","2-Hydroxyestrone","R02354 R02355 R04762","Steroid hormone biosynthesis","1.14.14.1; 2.1.1.6",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05298  2-Hydroxyestrone","CAS: 362-06-1; PubChem: 7682; ChEBI: 1156; ChEMBL: CHEMBL1627343; LIPIDMAPS: LMST02010032; 3DMET: B01838; NIKKAJI: J108.087C","cpd:C05298; cpd:C05300; cpd:C06490; cpd:C07621; cpd:C14383; cpd:C14496; cpd:C18506",18,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H23O3","C18H21O3",286.1568946,287.1647196,285.1490695
"cpd:C05299","2-Methoxyestrone","C19H24O3","2-Methoxyestrone","R00536 R04353 R04762","Steroid hormone biosynthesis","2.1.1.6; 2.4.1.17; 2.8.2.15",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05299  2-Methoxyestrone","CAS: 362-08-3; PubChem: 7683; ChEBI: 1189; ChEMBL: CHEMBL425194; LIPIDMAPS: LMST02010033; 3DMET: B01839; NIKKAJI: J101.999F","cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982",19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H25O3","C19H23O3",300.1725446,301.1803697,299.1647196
"cpd:C05300","16alpha-Hydroxyestrone","C18H22O3","16alpha-Hydroxyestrone","R02356 R04681 R04682","Steroid hormone biosynthesis; Metabolic pathways","1.1.1.62; 1.14.13.-; 1.14.14.1",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Estrogens;     C05300  16alpha-Hydroxyestrone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05300  16alpha-Hydroxyestrone","CAS: 566-76-7; PubChem: 7684; ChEBI: 776; LIPIDMAPS: LMST02010041; PDB-CCD: J2Z; 3DMET: B01840; NIKKAJI: J130.683I","cpd:C05298; cpd:C05300; cpd:C06490; cpd:C07621; cpd:C14383; cpd:C14496; cpd:C18506",18,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H23O3","C18H21O3",286.1568946,287.1647196,285.1490695
"cpd:C05301","2-Hydroxyestradiol;","C18H24O3","2-Hydroxyestradiol; 2-Hydroxyestradiol-17beta; 2-OH-Estradiol","R03088 R03090 R04764","Steroid hormone biosynthesis; Ovarian steroidogenesis","1.14.14.1; 2.1.1.6",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05301  2-Hydroxyestradiol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05301  2-Hydroxyestradiol-17beta","CAS: 362-05-0; PubChem: 7685; ChEBI: 28744; ChEMBL: CHEMBL467987; LIPIDMAPS: LMST02010027; PDB-CCD: ECS; NIKKAJI: J108.138A","cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415",18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O3","C18H23O3",288.1725446,289.1803697,287.1647196
"cpd:C05302","2-Methoxy-17beta-estradiol;","C19H26O3","2-Methoxy-17beta-estradiol; 2-Methoxyestradiol-17beta","R00537 R04354 R04764","Steroid hormone biosynthesis","2.1.1.6; 2.4.1.17; 2.8.2.15",NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05302  2-Methoxyestradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05302  2-Methoxyestradiol-17beta","CAS: 362-07-2; PubChem: 7686; ChEBI: 28955; ChEMBL: CHEMBL1627340 CHEMBL299613; LIPIDMAPS: LMST02010035; PDB-CCD: ESM; 3DMET: B01841; NIKKAJI: J104.105C","cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693",19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O3","C19H25O3",302.1881947,303.1960197,301.1803697
"cpd:C05469","17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione;","C21H30O5","17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione; 5beta-Pregnane-17alpha,21-diol-3,11,20-trione; 4,5beta-Dihydrocortisone","R02893 R04829 R04830","Steroid hormone biosynthesis","1.1.1.50; 1.3.1.3",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05469  4,5beta-Dihydrocortisone","CAS: 68-54-2; PubChem: 7829; ChEBI: 18093; LIPIDMAPS: LMST02030095; 3DMET: B01861; NIKKAJI: J789.264K","cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034",21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O5","C21H29O5",362.2093241,363.2171491,361.201499
"cpd:C05470","Tetrahydrocortisone;","C21H32O5","Tetrahydrocortisone; Urocortisone","R04829 R04830 R04831","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.53",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05470  Tetrahydrocortisone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05470  Urocortisone","CAS: 53-05-4; PubChem: 7830; ChEBI: 9901; ChEMBL: CHEMBL1908043; LIPIDMAPS: LMST02030098; 3DMET: B05046; NIKKAJI: J4.138F","cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044",21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O5","C21H31O5",364.2249741,365.2327992,363.2171491
"cpd:C05471","11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione;","C21H32O5","11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione; 5beta-Pregnane-11beta,17alpha,21-triol-3,20-dione","R02841 R04832 R04833","Steroid hormone biosynthesis","1.1.1.50; 1.3.1.3",NA,NA,"CAS: 1482-50-4; PubChem: 7831; ChEBI: 732; LIPIDMAPS: LMST02030204; LipidBank: SST0243; 3DMET: B01862; NIKKAJI: J39.546C","cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044",21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O5","C21H31O5",364.2249741,365.2327992,363.2171491
"cpd:C05472","Urocortisol;","C21H34O5","Urocortisol; Tetrahydrocortisol; 5beta-Pregnane-3alpha,11beta,17alpha,21-tetrol-20-one","R04832 R04833 R04834","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.53",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05472  Urocortisol","CAS: 53-02-1; PubChem: 7832; ChEBI: 28320; ChEMBL: CHEMBL1908047; LIPIDMAPS: LMST02030143; 3DMET: B05047; NIKKAJI: J39.547A","cpd:C05472; cpd:C05481",21,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O5","C21H33O5",366.2406242,367.2484492,365.2327992
"cpd:C05473","11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al","C21H30O5","11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al","R03713 R03714 R04835 R04836","Steroid hormone biosynthesis","1.1.1.50; 1.3.1.3",NA,NA,"PubChem: 7833; ChEBI: 86389; LIPIDMAPS: LMST02030187; 3DMET: B05048; NIKKAJI: J2.755.992A","cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034",21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O5","C21H29O5",362.2093241,363.2171491,361.201499
"cpd:C05474","3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al","C21H32O5","3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al","R04835 R04836","Steroid hormone biosynthesis","1.1.1.50",NA,NA,"PubChem: 7834; ChEBI: 1684; LIPIDMAPS: LMST02030197; 3DMET: B05049; NIKKAJI: J2.755.993J","cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044",21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O5","C21H31O5",364.2249741,365.2327992,363.2171491
"cpd:C05475","11beta,21-Dihydroxy-5beta-pregnane-3,20-dione;","C21H32O4","11beta,21-Dihydroxy-5beta-pregnane-3,20-dione; 5beta-Pregnane-11beta,21-diol-3,20-dione","R03850 R04837 R04838","Steroid hormone biosynthesis","1.1.1.50; 1.3.1.3",NA,NA,"CAS: 566-01-8; PubChem: 7835; ChEBI: 86381; LIPIDMAPS: LMST02030188; 3DMET: B05050; NIKKAJI: J401.582G","cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685",21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O4","C21H31O4",348.2300595,349.2378845,347.2222345
"cpd:C05476","Tetrahydrocorticosterone","C21H34O4","Tetrahydrocorticosterone","R04837 R04838 R04840","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.146; 1.1.1.-",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05476  Tetrahydrocorticosterone","CAS: 68-42-8; PubChem: 7836; ChEBI: 9481; LIPIDMAPS: LMST02030100; 3DMET: B01863; NIKKAJI: J4.858E","cpd:C05476; cpd:C05483; cpd:C14594; cpd:C15368; cpd:C15403; cpd:C17496",21,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O4","C21H33O4",350.2457096,351.2535346,349.2378845
"cpd:C05477","21-Hydroxy-5beta-pregnane-3,11,20-trione","C21H30O4","21-Hydroxy-5beta-pregnane-3,11,20-trione","R04842 R04843 R08994","Steroid hormone biosynthesis","1.1.1.50",NA,NA,"PubChem: 7837; ChEBI: 1298; LIPIDMAPS: LMST02030196; 3DMET: B05051; NIKKAJI: J2.755.994H","cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365",21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O4","C21H29O4",346.2144094,347.2222345,345.2065844
"cpd:C05478","3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione;","C21H32O4","3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione; 5beta-Pregnane-3alpha,21-diol-11,20-dione","R04840 R04842 R04843 R04844","Steroid hormone biosynthesis","1.1.1.50; 1.1.1.53; 1.1.1.146; 1.1.1.-",NA,NA,"CAS: 566-03-0; PubChem: 7838; ChEBI: 1690; LIPIDMAPS: LMST02030199; 3DMET: B05052; NIKKAJI: J188.431J","cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685",21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O4","C21H31O4",348.2300595,349.2378845,347.2222345
"cpd:C05479","5beta-Pregnane-3,20-dione","C21H32O2","5beta-Pregnane-3,20-dione","R02215 R02219 R04845 R04846 R06166","Steroid hormone biosynthesis; Metabolic pathways","1.1.1.50; 1.1.1.277; 1.3.1.3; 1.3.99.6",NA,NA,"CAS: 128-23-4; PubChem: 7839; ChEBI: 30154; ChEMBL: CHEMBL486954; LIPIDMAPS: LMST02030146; LipidBank: SST0097; PDB-CCD: CI2; 3DMET: B05053; NIKKAJI: J6.569B","cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219",21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O2","C21H31O2",316.2402303,317.2480553,315.2324052
"cpd:C05480","Pregnanolone;","C21H34O2","Pregnanolone; 3alpha-Hydroxy-5beta-pregnan-20-one","R04845 R04846 R04847","Steroid hormone biosynthesis; Metabolic pathways","1.1.1.50; 1.1.1.53",NA,NA,"CAS: 128-20-1; PubChem: 7840; ChEBI: 1712; ChEMBL: CHEMBL210952; LIPIDMAPS: LMST02030175; LipidBank: SST0098; 3DMET: B05054; NIKKAJI: J6.567F","cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041",21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O2","C21H33O2",318.2558803,319.2637054,317.2480553
"cpd:C05481","Cortolone","C21H34O5","Cortolone","R04831","Steroid hormone biosynthesis","1.1.1.53",NA,NA,"CAS: 516-42-7; PubChem: 7841; ChEBI: 3899; ChEMBL: CHEMBL1908042; 3DMET: B05055; NIKKAJI: J6.310J","cpd:C05472; cpd:C05481",21,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O5","C21H33O5",366.2406242,367.2484492,365.2327992
"cpd:C05482","Cortol","C21H36O5","Cortol","R04834","Steroid hormone biosynthesis","1.1.1.53",NA,NA,"CAS: 516-38-1; PubChem: 7842; ChEBI: 3898; ChEMBL: CHEMBL1908046; 3DMET: B05056; NIKKAJI: J6.307J","cpd:C05482; cpd:C06872; cpd:C11717",21,36,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H37O5","C21H35O5",368.2562743,369.2640993,367.2484492
"cpd:C05483","3alpha,20alpha,21-Trihydroxy-5beta-pregnan-11-one","C21H34O4","3alpha,20alpha,21-Trihydroxy-5beta-pregnan-11-one","R04844","Steroid hormone biosynthesis","1.1.1.53",NA,NA,"PubChem: 7843; ChEBI: 1689; 3DMET: B05057; NIKKAJI: J2.755.996D","cpd:C05476; cpd:C05483; cpd:C14594; cpd:C15368; cpd:C15403; cpd:C17496",21,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O4","C21H33O4",350.2457096,351.2535346,349.2378845
"cpd:C05484","Pregnanediol;","C21H36O2","Pregnanediol; 5beta-Pregnane-3alpha,20alpha-diol; Pregnandiol; Diol","R04847","Steroid hormone biosynthesis; Metabolic pathways","1.1.1.53",NA,NA,"CAS: 80-92-2; PubChem: 7844; ChEBI: 8387; ChEMBL: CHEMBL269897; LIPIDMAPS: LMST02030202; 3DMET: B05058; NIKKAJI: J4.884D","cpd:C05484; cpd:C10809; cpd:C14878; cpd:C14982; cpd:C15047; cpd:C15198; cpd:C18042",21,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H37O2","C21H35O2",320.2715304,321.2793554,319.2637054
"cpd:C05485","21-Hydroxypregnenolone","C21H32O3","21-Hydroxypregnenolone","R03784 R04163","Steroid hormone biosynthesis","1.1.1.145; 1.14.14.16; 5.3.3.1",NA,NA,"CAS: 1164-98-3; PubChem: 7845; ChEBI: 28043; ChEMBL: CHEMBL1908012; LIPIDMAPS: LMST02030167; 3DMET: B05059; NIKKAJI: J924.614B","cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040",21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O3","C21H31O3",332.2351449,333.2429699,331.2273199
"cpd:C05487","17alpha,21-Dihydroxypregnenolone","C21H32O4","17alpha,21-Dihydroxypregnenolone","R04675 R04849 R04850","Steroid hormone biosynthesis","1.1.1.145; 1.14.14.16; 1.14.15.4; 5.3.3.1",NA,NA,"CAS: 1167-48-2; PubChem: 7846; ChEBI: 27832; LIPIDMAPS: LMST02030141; 3DMET: B05060; NIKKAJI: J2.756.013J","cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685",21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O4","C21H31O4",348.2300595,349.2378845,347.2222345
"cpd:C05488","11-Deoxycortisol;","C21H30O4","11-Deoxycortisol; Cortodoxone","R02843 R03326 R04849","Steroid hormone biosynthesis; Metabolic pathways","1.1.1.145; 1.14.14.16; 1.14.15.4; 5.3.3.1","C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05488  11-Deoxycortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05488  11-Deoxycortisol; Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Cortodoxone;       D03595  Cortodoxone (USAN)","CAS: 152-58-9; PubChem: 7847; ChEBI: 28324; ChEMBL: CHEMBL253144; LIPIDMAPS: LMST02030086; 3DMET: B01864; NIKKAJI: J5.867J","cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365",21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O4","C21H29O4",346.2144094,347.2222345,345.2065844
"cpd:C05489","11beta,17alpha,21-Trihydroxypregnenolone","C21H32O5","11beta,17alpha,21-Trihydroxypregnenolone","R02840 R04850","Steroid hormone biosynthesis","1.1.1.145; 1.14.15.4; 5.3.3.1",NA,NA,"PubChem: 7848; ChEBI: 27783; LIPIDMAPS: LMST02030166; 3DMET: B05061; NIKKAJI: J2.756.014H","cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044",21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O5","C21H31O5",364.2249741,365.2327992,363.2171491
"cpd:C05490","11-Dehydrocorticosterone","C21H28O4","11-Dehydrocorticosterone","R03847 R03848 R08994","Steroid hormone biosynthesis","1.1.1.146; 1.1.1.-",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C05490  11-Dehydrocorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05490  11-Dehydrocorticosterone","CAS: 72-23-1; PubChem: 7849; ChEBI: 78600; LIPIDMAPS: LMST02030192; 3DMET: B05062; NIKKAJI: J5.250G","cpd:C05490; cpd:C14478; cpd:C15135; cpd:C15208",21,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H29O4","C21H27O4",344.1987594,345.2065844,343.1909343
"cpd:C05497","21-Deoxycortisol;","C21H30O4","21-Deoxycortisol; 4-Pregnene-11beta,17alpha-diol-3,20-dione; 11beta,17alpha-Dihydroxyprogesterone","R02838 R03329 R04852","Steroid hormone biosynthesis","1.14.14.16; 1.14.14.19; 1.14.15.4",NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05497  21-Deoxycortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05497  21-Deoxycortisol","CAS: 641-77-0; PubChem: 7850; ChEBI: 28697; ChEMBL: CHEMBL1527439; LIPIDMAPS: LMST02030195; 3DMET: B05063; NIKKAJI: J205.915K","cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365",21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O4","C21H29O4",346.2144094,347.2222345,345.2065844
"cpd:C05498","11beta-Hydroxyprogesterone","C21H30O3","11beta-Hydroxyprogesterone","R02218 R03849 R04852","Steroid hormone biosynthesis","1.14.14.16; 1.14.14.19; 1.14.15.4",NA,NA,"CAS: 600-57-7; PubChem: 7851; ChEBI: 28247; ChEMBL: CHEMBL345682; LIPIDMAPS: LMST02030168; 3DMET: B05064; NIKKAJI: J66.993H","cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218",21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O3","C21H29O3",330.2194948,331.2273199,329.2116698
"cpd:C05499","17alpha,20alpha-Dihydroxycholesterol","C27H46O3","17alpha,20alpha-Dihydroxycholesterol","R04676 R04853","Steroid hormone biosynthesis","1.14.14.19; 1.14.15.6",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05499  17alpha,20alpha-Dihydroxycholesterol","PubChem: 7852; ChEBI: 783; LIPIDMAPS: LMST04030176; 3DMET: B05065; NIKKAJI: J2.756.020B","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C05500","20alpha-Hydroxycholesterol;","C27H46O2","20alpha-Hydroxycholesterol; 20-Hydroxycholesterol","R01454 R04853 R04854","Steroid hormone biosynthesis; Metabolic pathways","1.14.14.19; 1.14.15.6","Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05500  20alpha-Hydroxycholesterol","CAS: 516-72-3; PubChem: 7853; ChEBI: 1296; ChEMBL: CHEMBL173898; LIPIDMAPS: LMST01010201; PDB-CCD: HCD; 3DMET: B01865; NIKKAJI: J631.217I","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C05501","20alpha,22beta-Dihydroxycholesterol;","C27H46O3","20alpha,22beta-Dihydroxycholesterol; (22R)-20alpha,22-Dihydroxycholesterol","R03933 R04854 R04855","Steroid hormone biosynthesis; Metabolic pathways","1.14.15.6","Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05501  20alpha,22beta-Dihydroxycholesterol","PubChem: 7854; ChEBI: 1294; ChEMBL: CHEMBL560194; LIPIDMAPS: LMST01010200; PDB-CCD: 2DC; 3DMET: B05066; NIKKAJI: J401.177E","cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520",27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O3","C27H45O3",418.3446953,419.3525204,417.3368703
"cpd:C05502","22(R)-Hydroxycholesterol;","C27H46O2","22(R)-Hydroxycholesterol; (22R)-22-Hydroxycholesterol; 22beta-Hydroxycholesterol","R02723 R04855","Steroid hormone biosynthesis; Metabolic pathways","1.14.15.6","Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05502  22beta-Hydroxycholesterol; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C05502  22(R)-Hydroxycholesterol;     liver X receptor beta;      C05502 22beta-Hydroxycholesterol","CAS: 17954-98-2; PubChem: 7855; ChEBI: 67237; ChEMBL: CHEMBL422904 CHEMBL59549; LIPIDMAPS: LMST01010086; LipidBank: SST9039; PDB-CCD: HC9; 3DMET: B01866; NIKKAJI: J14.202F","cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992",27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O2","C27H45O2",402.3497807,403.3576058,401.3419557
"cpd:C05503","Estradiol-17beta 3-glucuronide;","C24H32O8","Estradiol-17beta 3-glucuronide; 17beta-Estradiol 3-(beta-D-glucuronide)","R03091","Steroid hormone biosynthesis; Bile secretion","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05503  17beta-Estradiol 3-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C05503  17beta-Estradiol 3-(beta-D-glucuronide)","PubChem: 7856; ChEBI: 36489; LIPIDMAPS: LMST05010007; 3DMET: B01867; NIKKAJI: J506.208J","cpd:C04300; cpd:C05503; cpd:C09121; cpd:C11237",24,32,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H33O8","C24H31O8",448.209718,449.217543,447.201893
"cpd:C05504","16-Glucuronide-estriol;","C24H32O9","16-Glucuronide-estriol; 16alpha,17beta-Estriol 16-(beta-D-glucuronide)","R04683","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide)","CAS: 1852-50-2; PubChem: 7857; ChEBI: 766; LIPIDMAPS: LMST05010008; 3DMET: B01868; NIKKAJI: J459.851B","cpd:C05504; cpd:C11288; cpd:C11346; cpd:C16859",24,32,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H33O9","C24H31O9",464.2046326,465.2124576,463.1968076
"cpd:C08357","Estradiol-17beta 3-sulfate","C18H24O5S","Estradiol-17beta 3-sulfate","R00535","Steroid hormone biosynthesis; Bile secretion","2.8.2.15",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08357  Estradiol-17beta 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08357  Estradiol-17beta 3-sulfate","PubChem: 10554; ChEBI: 4866; ChEMBL: CHEMBL1628111; LIPIDMAPS: LMST05020005; 3DMET: B02168; NIKKAJI: J464.382H","cpd:C08357",18,24,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C18H25O5S1","C18H23O5S1",352.134445,353.1422701,351.12662
"cpd:C08358","2-Methoxyestrone 3-sulfate","C19H24O6S","2-Methoxyestrone 3-sulfate","R00536","Steroid hormone biosynthesis","2.8.2.15",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08358  2-Methoxyestrone 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08358  2-Methoxyestrone 3-sulfate","PubChem: 10555; ChEBI: 1191; LIPIDMAPS: LMST05020006; 3DMET: B02169; NIKKAJI: J2.765.944F","cpd:C08358",19,24,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C19H25O6S1","C19H23O6S1",380.1293597,381.1371847,379.1215346
"cpd:C08359","2-Methoxyestradiol-17beta 3-sulfate","C19H26O6S","2-Methoxyestradiol-17beta 3-sulfate","R00537","Steroid hormone biosynthesis","2.8.2.15",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08359  2-Methoxyestradiol-17beta 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08359  2-Methoxyestradiol-17beta 3-sulfate","PubChem: 10556; ChEBI: 1188; LIPIDMAPS: LMST05020007; 3DMET: B02170; NIKKAJI: J2.765.948I","cpd:C08359",19,26,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C19H27O6S1","C19H25O6S1",382.1450097,383.1528348,381.1371847
"cpd:C11131","2-Methoxy-estradiol-17beta 3-glucuronide","C25H34O9","2-Methoxy-estradiol-17beta 3-glucuronide","R04354","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11131  2-Methoxy-estradiol-17beta 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11131  2-Methoxy-estradiol-17beta 3-glucuronide","PubChem: 13313; ChEBI: 36491; LIPIDMAPS: LMST05010009; 3DMET: B04205; NIKKAJI: J506.208J","cpd:C08746; cpd:C08755; cpd:C08783; cpd:C11131",25,34,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C25H35O9","C25H33O9",478.2202827,479.2281077,477.2124576
"cpd:C11132","2-Methoxyestrone 3-glucuronide","C25H32O9","2-Methoxyestrone 3-glucuronide","R04353","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11132  2-Methoxyestrone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11132  2-Methoxyestrone 3-glucuronide","CAS: 25577-70-2; PubChem: 13314; ChEBI: 37450; LIPIDMAPS: LMST05010010; 3DMET: B04206; NIKKAJI: J2.773.451K","cpd:C11132",25,32,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C25H33O9","C25H31O9",476.2046326,477.2124576,475.1968076
"cpd:C11133","Estrone glucuronide;","C24H30O8","Estrone glucuronide; Estrone 3-glucuronide; Estrone beta-D-glucuronide","R02358","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11133  Estrone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11133  Estrone 3-glucuronide","CAS: 2479-90-5; PubChem: 13315; ChEBI: 28919; LIPIDMAPS: LMST05010011; PDB-CCD: E3G; 3DMET: B04207; NIKKAJI: J468.255F","cpd:C10894; cpd:C11133",24,30,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H31O8","C24H29O8",446.1940679,447.201893,445.1862429
"cpd:C11134","Testosterone glucuronide;","C25H36O8","Testosterone glucuronide; Testosterone 17beta-(beta-D-glucuronide)","R02502","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C11134  Testosterone 17beta-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11134  Testosterone glucuronide","CAS: 1180-25-2; PubChem: 13316; ChEBI: 28835; LIPIDMAPS: LMST05010012; 3DMET: B04208; NIKKAJI: J752.948A","cpd:C11134",25,36,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C25H37O8","C25H35O8",464.2410181,465.2488431,463.2331931
"cpd:C11135","Androsterone glucuronide;","C25H38O8","Androsterone glucuronide; Androsterone 3-glucuronide","R02478","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C11135  Androsterone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11135  Androsterone 3-glucuronide","CAS: 1852-43-3; PubChem: 13317; ChEBI: 28832; LIPIDMAPS: LMST05010013; 3DMET: B04209; NIKKAJI: J448.218B","cpd:C11135; cpd:C11136",25,38,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C25H39O8","C25H37O8",466.2566682,467.2644932,465.2488431
"cpd:C11136","Etiocholan-3alpha-ol-17-one 3-glucuronide","C25H38O8","Etiocholan-3alpha-ol-17-one 3-glucuronide","R04352","Steroid hormone biosynthesis","2.4.1.17",NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11136  Etiocholan-3alpha-ol-17-one 3-glucuronide","CAS: 3602-09-3; PubChem: 13318; ChEBI: 37451; LIPIDMAPS: LMST05010014; 3DMET: B04210; NIKKAJI: J1.437.459K","cpd:C11135; cpd:C11136",25,38,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C25H39O8","C25H37O8",466.2566682,467.2644932,465.2488431
"cpd:C13712","Allopregnanolone;","C21H34O2","Allopregnanolone; 3alpha-Hydroxy-5alpha-pregnan-20-one; 3alpha-OH DHP","R08957 R08959","Steroid hormone biosynthesis","1.1.1.149; 1.1.1.213",NA,NA,"CAS: 516-54-1; PubChem: 586301; ChEMBL: CHEMBL207538 CHEMBL38856 CHEMBL435035; LIPIDMAPS: LMST02030130 LMST02030156; NIKKAJI: J6.315K","cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041",21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O2","C21H33O2",318.2558803,319.2637054,317.2480553
"cpd:C13713","Allotetrahydrodeoxycorticosterone;","C21H34O3","Allotetrahydrodeoxycorticosterone; 5alpha-THDOC; 3alpha,21-Dihydroxy-5alpha-pregnan-20-one","R08955","Steroid hormone biosynthesis","1.1.1.213",NA,NA,"CAS: 567-02-2; PubChem: 586302; ChEBI: 34461; ChEMBL: CHEMBL1256760 CHEMBL288464 CHEMBL76857; LIPIDMAPS: LMST05030013; NIKKAJI: J188.433F","cpd:C13713; cpd:C14608; cpd:C14609; cpd:C14978; cpd:C15137; cpd:C15139; cpd:C15391",21,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O3","C21H33O3",334.250795,335.25862,333.2429699
"cpd:C18038","7alpha-Hydroxypregnenolone;","C21H32O3","7alpha-Hydroxypregnenolone; 3beta,7alpha-Dihydroxy-5-pregnen-20-one","R08943","Steroid hormone biosynthesis","1.14.14.29",NA,NA,"PubChem: 96024258; ChEBI: 81467; NIKKAJI: J704.244B","cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040",21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O3","C21H31O3",332.2351449,333.2429699,331.2273199
"cpd:C18039","Aldosterone hemiacetal;","C21H28O5","Aldosterone hemiacetal; 11beta,18-Epoxy-18,21-dihydroxypregn-4-ene-3,20-dione","R08953","Steroid hormone biosynthesis",NA,NA,NA,"CAS: 6251-69-0; PubChem: 96024259; ChEBI: 30834; LIPIDMAPS: LMST02030145","cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039",21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H29O5","C21H27O5",360.193674,361.201499,359.185849
"cpd:C18040","5alpha-Dihydrodeoxycorticosterone;","C21H32O3","5alpha-Dihydrodeoxycorticosterone; 5alpha-Pregnan-21-ol-3,20-dione; Allopregnane-21-ol-3,20-dione","R08954 R08955","Steroid hormone biosynthesis","1.1.1.213; 1.3.1.22",NA,NA,"CAS: 298-36-2; PubChem: 96024260; ChEBI: 81468; ChEMBL: CHEMBL40713; NIKKAJI: J322.211J","cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040",21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O3","C21H31O3",332.2351449,333.2429699,331.2273199
"cpd:C18041","5alpha-Pregnan-20alpha-ol-3-one;","C21H34O2","5alpha-Pregnan-20alpha-ol-3-one; Allopregnan-20alpha-ol-3-one","R08958 R08960","Steroid hormone biosynthesis","1.1.1.149; 1.1.1.213",NA,NA,"CAS: 516-59-6; PubChem: 96024261; ChEBI: 81469","cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041",21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H35O2","C21H33O2",318.2558803,319.2637054,317.2480553
"cpd:C18042","5alpha-Pregnane-3alpha,20alpha-diol;","C21H36O2","5alpha-Pregnane-3alpha,20alpha-diol; Allopregnane-3alpha,20alpha-diol","R08959 R08960","Steroid hormone biosynthesis","1.1.1.149; 1.1.1.213",NA,NA,"CAS: 566-58-5; PubChem: 96024262; ChEBI: 81470; ChEMBL: CHEMBL1790205","cpd:C05484; cpd:C10809; cpd:C14878; cpd:C14982; cpd:C15047; cpd:C15198; cpd:C18042",21,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H37O2","C21H35O2",320.2715304,321.2793554,319.2637054
"cpd:C18043","Cholesterol sulfate;","C27H46O4S","Cholesterol sulfate; Cholest-5-en-3beta-ol sulfate","R08941 R08977","Steroid hormone biosynthesis","2.8.2.2; 2.8.2.14; 3.1.6.2",NA,NA,"CAS: 1256-86-6; PubChem: 96024263; ChEBI: 41321; LIPIDMAPS: LMST05020016; PDB-CCD: C3S; NIKKAJI: J324.075D","cpd:C18043",27,46,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H47O4S1","C27H45O4S1",466.3116811,467.3195062,465.3038561
"cpd:C18044","3beta-Hydroxypregn-5-en-20-one sulfate;","C21H32O5S","3beta-Hydroxypregn-5-en-20-one sulfate; Pregnenolone sulfate","R08942 R08978","Steroid hormone biosynthesis","2.8.2.2; 2.8.2.14; 3.1.6.2",NA,NA,"CAS: 1247-64-9; PubChem: 96024264; ChEBI: 35420; ChEMBL: CHEMBL1179605 CHEMBL1330831; LIPIDMAPS: LMST05020014; NIKKAJI: J468.821J","cpd:C18044",21,32,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C21H33O5S1","C21H31O5S1",396.1970453,397.2048703,395.1892203
"cpd:C18045","7alpha-Hydroxydehydroepiandrosterone;","C19H28O3","7alpha-Hydroxydehydroepiandrosterone; 7alpha-OH-DHEA; 3beta,7alpha-Dihydroxy-5-androstene-17-one","R08961","Steroid hormone biosynthesis","1.14.14.23",NA,NA,"CAS: 53-00-9; PubChem: 96024265; ChEBI: 81471; ChEMBL: CHEMBL1079392; LIPIDMAPS: LMST02020101; NIKKAJI: J575.713D","cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296",19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O3","C19H27O3",304.2038448,305.2116698,303.1960197
"cpd:C18075","11beta,17beta-Dihydroxy-4-androsten-3-one;","C19H28O3","11beta,17beta-Dihydroxy-4-androsten-3-one; 11beta-Hydroxytestosterone","R08945 R08980","Steroid hormone biosynthesis","1.1.1.62",NA,NA,"CAS: 1816-85-9; PubChem: 96024292; ChEBI: 81481; ChEMBL: CHEMBL486718; NIKKAJI: J337.158A","cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296",19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H29O3","C19H27O3",304.2038448,305.2116698,303.1960197
"cpd:C00002","ATP;","C10H16N5O13P3","ATP; Adenosine 5'-triphosphate","R00002 R00076 R00085 R00086 R00087 R00088 R00089 R00104; R00105 R00124 R00126 R00127 R00128 R00129 R00130 R00137; R00139 R00140 R00141 R00149 R00150 R00156 R00158 R00161; R00162 R00174 R00177 R00184 R00185 R00189 R00199 R00200; R00206 R00229 R00235 R00239 R00241 R00251 R00253 R00257; R00283 R00299 R00315 R00316 R00330 R00331 R00332 R00334; R00341 R00344 R00352 R00381 R00389 R00390 R00405 R00429; R00435 R00436 R00480 R00482 R00483 R00497 R00509 R00512; R00513 R00518 R00529 R00549 R00554 R00570 R00571 R00573; R00575 R00578 R00616 R00617 R00619 R00686 R00722 R00735; R00742 R00756 R00760 R00774 R00847 R00866 R00867 R00894; R00910 R00912 R00920 R00925 R00942 R00943 R00948 R00949; R00964 R00982 R01011 R01021 R01049 R01050 R01051 R01053; R01059 R01071 R01074 R01075 R01092 R01121 R01131 R01137; R01150 R01164 R01176 R01201 R01228 R01230 R01231 R01256; R01280 R01300 R01322 R01326 R01353 R01354 R01357 R01395; R01406 R01407 R01417 R01422 R01441 R01468 R01476 R01490; R01492 R01495 R01504 R01512 R01514 R01523 R01526 R01541; R01547 R01558 R01567 R01573 R01585 R01598 R01600 R01616; R01618 R01639 R01654 R01665 R01666 R01688 R01723 R01724; R01737 R01754 R01771 R01786 R01843 R01844 R01857 R01859; R01881 R01888 R01901 R01902 R01909 R01917 R01926 R01943; R01954 R01961 R01967 R01980 R01991 R02014 R02071 R02089; R02090 R02093 R02094 R02098 R02099 R02134 R02136 R02184; R02194 R02221 R02225 R02226 R02227 R02237 R02238 R02240; R02245 R02255 R02301 R02303 R02324 R02326 R02331 R02402; R02404 R02412 R02430 R02439 R02451 R02473 R02493 R02539; R02575 R02584 R02625 R02626 R02649 R02650 R02658 R02664; R02699 R02705 R02711 R02718 R02732 R02741 R02750 R02757; R02758 R02783 R02786 R02788 R02794 R02848 R02865 R02884; R02903 R02918 R02927 R02929 R02971 R02976 R02980 R02986; R03005 R03014 R03018 R03035 R03038 R03095 R03098 R03150; R03157 R03161 R03182 R03187 R03193 R03209 R03236 R03241; R03245 R03258 R03272 R03274 R03286 R03298 R03315 R03347; R03361 R03362 R03383 R03384 R03387 R03395 R03428 R03429; R03433 R03449 R03469 R03471 R03473 R03478 R03479 R03494; R03503 R03516 R03530 R03576 R03595 R03607 R03613 R03631; R03632 R03646 R03647 R03648 R03650 R03651 R03652 R03654; R03655 R03656 R03657 R03658 R03659 R03660 R03661 R03662; R03663 R03664 R03665 R03691 R03744 R03754 R03766 R03770; R03780 R03785 R03819 R03822 R03840 R03876 R03877 R03905; R03920 R03932 R03939 R03944 R04002 R04023 R04030 R04036; R04068 R04126 R04138 R04143 R04144 R04157 R04208 R04212; R04230 R04235 R04241 R04267 R04274 R04275 R04358 R04369; R04385 R04388 R04391 R04401 R04403 R04448 R04449 R04463; R04504 R04507 R04509 R04545 R04555 R04562 R04563 R04573; R04580 R04582 R04589 R04591 R04604 R04617 R04657 R04730; R04771 R04773 R04779 R04870 R04928 R04929 R05030 R05185; R05186 R05193 R05197 R05202 R05220 R05221 R05224 R05225; R05227 R05451 R05452 R05453 R05467 R05496 R05537 R05577; R05578 R05620 R05625 R05626 R05634 R05644 R05646 R05661; R05668 R05735 R05744 R05795 R05799 R05800 R05801 R05802; R05803 R05806 R05815 R06176 R06282 R06367 R06368 R06396; R06409 R06410 R06515 R06529 R06531 R06583 R06588 R06731; R06746 R06751 R06777 R06778 R06836 R06944 R06974 R06975; R06976 R07127 R07268 R07279 R07302 R07325 R07404 R07414; R07416 R07459 R07640 R07641 R07642 R07643 R07644 R07646; R07770 R07828 R07887 R08051 R08088 R08117 R08124 R08154; R08201 R08217 R08218 R08223 R08232 R08233 R08241 R08242; R08244 R08323 R08352 R08353 R08354 R08355 R08572 R08576; R08578 R08700 R08733 R08738 R08743 R08844 R08855 R08872; R08905 R08906 R08924 R08962 R08964 R08967 R08968 R09047; R09053 R09060 R09087 R09195 R09279 R09286 R09378 R09379; R09382 R09386 R09401 R09475 R09588 R09589 R09590 R09591; R09592 R09593 R09594 R09595 R09596 R09597 R09598 R09599; R09640 R09675 R09726 R09729 R09767 R09770 R09775 R09776; R09879 R09880 R09945 R09946 R09978 R10003 R10011 R10065; R10090 R10091 R10093 R10185 R10288 R10342 R10453 R10462; R10463 R10470 R10495 R10496 R10531 R10541 R10548 R10556; R10561 R10657 R10661 R10677 R10678 R10679 R10693 R10758; R10767 R10768 R10769 R10770 R10771 R10772 R10779 R10780; R10820 R10821 R10880 R10892 R10901 R10902 R10909 R10910; R10929 R10930 R10940 R10941 R10942 R10943 R10944 R10948; R10951 R10953 R10970 R10993 R10994 R11024 R11039 R11064; R11084 R11085 R11090 R11143 R11183 R11184 R11185 R11207; R11234 R11279 R11367 R11370 R11392 R11400 R11406 R11460; R11461 R11515 R11531 R11536 R11537 R11538 R11553 R11554","Oxidative phosphorylation; Photosynthesis; Purine metabolism; Puromycin biosynthesis; Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Bacterial secretion system; Calcium signaling pathway; HIF-1 signaling pathway; Neuroactive ligand-receptor interaction; Lysosome; Platelet activation; NOD-like receptor signaling pathway; Synaptic vesicle cycle; Taste transduction; Inflammatory mediator regulation of TRP channels; Insulin secretion; Prolactin signaling pathway; Renin secretion; Type II diabetes mellitus; Parkinson's disease; Pertussis; Hypertrophic cardiomyopathy (HCM)","1.2.1.30; 1.2.1.31; 1.3.7.7; 1.3.7.8; 1.3.7.14; 1.3.7.15; 1.13.12.7; 1.17.4.2; 1.18.6.1; 1.19.6.1; 1.-.-.-; 2.1.2.-; 2.3.3.8; 2.4.2.17; 2.4.2.52; 2.5.1.6; 2.5.1.17; 2.5.1.112; 2.7.1.1; 2.7.1.2; 2.7.1.3; 2.7.1.4; 2.7.1.5; 2.7.1.6; 2.7.1.7; 2.7.1.8; 2.7.1.10; 2.7.1.11; 2.7.1.12; 2.7.1.13; 2.7.1.14; 2.7.1.15; 2.7.1.16; 2.7.1.17; 2.7.1.18; 2.7.1.19; 2.7.1.20; 2.7.1.21; 2.7.1.22; 2.7.1.23; 2.7.1.24; 2.7.1.25; 2.7.1.26; 2.7.1.27; 2.7.1.28; 2.7.1.29; 2.7.1.30; 2.7.1.31; 2.7.1.32; 2.7.1.33; 2.7.1.34; 2.7.1.35; 2.7.1.36; 2.7.1.39; 2.7.1.40; 2.7.1.43; 2.7.1.44; 2.7.1.45; 2.7.1.46; 2.7.1.47; 2.7.1.48; 2.7.1.49; 2.7.1.50; 2.7.1.51; 2.7.1.52; 2.7.1.53; 2.7.1.54; 2.7.1.55; 2.7.1.56; 2.7.1.58; 2.7.1.59; 2.7.1.60; 2.7.1.64; 2.7.1.65; 2.7.1.66; 2.7.1.67; 2.7.1.68; 2.7.1.71; 2.7.1.72; 2.7.1.73; 2.7.1.74; 2.7.1.76; 2.7.1.78; 2.7.1.82; 2.7.1.83; 2.7.1.84; 2.7.1.85; 2.7.1.86; 2.7.1.87; 2.7.1.88; 2.7.1.89; 2.7.1.91; 2.7.1.92; 2.7.1.93; 2.7.1.94; 2.7.1.95; 2.7.1.100; 2.7.1.101; 2.7.1.102; 2.7.1.103; 2.7.1.105; 2.7.1.107; 2.7.1.113; 2.7.1.119; 2.7.1.122; 2.7.1.127; 2.7.1.130; 2.7.1.134; 2.7.1.136; 2.7.1.137; 2.7.1.138; 2.7.1.140; 2.7.1.144; 2.7.1.145; 2.7.1.148; 2.7.1.149; 2.7.1.150; 2.7.1.151; 2.7.1.153; 2.7.1.154; 2.7.1.156; 2.7.1.157; 2.7.1.158; 2.7.1.159; 2.7.1.162; 2.7.1.163; 2.7.1.164; 2.7.1.165; 2.7.1.166; 2.7.1.167; 2.7.1.168; 2.7.1.169; 2.7.1.170; 2.7.1.173; 2.7.1.175; 2.7.1.176; 2.7.1.177; 2.7.1.178; 2.7.1.179; 2.7.1.181; 2.7.1.183; 2.7.1.184; 2.7.1.185; 2.7.1.186; 2.7.1.187; 2.7.1.188; 2.7.1.189; 2.7.1.209; 2.7.1.210; 2.7.1.213; 2.7.1.214; 2.7.1.215; 2.7.1.-; 2.7.2.1; 2.7.2.2; 2.7.2.3; 2.7.2.4; 2.7.2.6; 2.7.2.7; 2.7.2.8; 2.7.2.11; 2.7.2.13; 2.7.2.14; 2.7.2.15; 2.7.2.-; 2.7.3.1; 2.7.3.2; 2.7.3.3; 2.7.3.4; 2.7.3.5; 2.7.3.6; 2.7.3.7; 2.7.3.8; 2.7.3.10; 2.7.4.1; 2.7.4.2; 2.7.4.3; 2.7.4.4; 2.7.4.6; 2.7.4.7; 2.7.4.8; 2.7.4.9; 2.7.4.11; 2.7.4.12; 2.7.4.13; 2.7.4.14; 2.7.4.15; 2.7.4.16; 2.7.4.18; 2.7.4.19; 2.7.4.21; 2.7.4.22; 2.7.4.23; 2.7.4.24; 2.7.4.25; 2.7.4.26; 2.7.4.31; 2.7.4.-; 2.7.6.1; 2.7.6.2; 2.7.6.3; 2.7.6.4; 2.7.6.5; 2.7.7.1; 2.7.7.2; 2.7.7.3; 2.7.7.4; 2.7.7.6; 2.7.7.18; 2.7.7.19; 2.7.7.27; 2.7.7.42; 2.7.7.46; 2.7.7.47; 2.7.7.48; 2.7.7.53; 2.7.7.58; 2.7.7.70; 2.7.7.72; 2.7.7.73; 2.7.7.75; 2.7.7.80; 2.7.7.84; 2.7.7.85; 2.7.7.86; 2.7.7.87; 2.7.7.94; 2.7.7.96; 2.7.7.97; 2.7.8.37; 2.7.9.1; 2.7.9.2; 2.7.9.3; 2.7.9.-; 2.7.10.1; 2.7.10.2; 2.7.11.1; 2.7.11.2; 2.7.11.3; 2.7.11.4; 2.7.11.5; 2.7.11.6; 2.7.11.7; 2.7.11.8; 2.7.11.9; 2.7.11.10; 2.7.11.11; 2.7.11.12; 2.7.11.13; 2.7.11.14; 2.7.11.15; 2.7.11.17; 2.7.11.18; 2.7.11.19; 2.7.11.21; 2.7.11.22; 2.7.11.23; 2.7.11.24; 2.7.11.25; 2.7.11.26; 2.7.11.27; 2.7.11.28; 2.7.11.29; 2.7.11.30; 2.7.11.31; 2.7.12.1; 2.7.12.2; 2.7.13.1; 2.7.13.2; 2.7.14.1; 2.8.1.13; 3.5.2.9; 3.5.2.14; 3.5.4.17; 3.5.4.18; 3.6.1.3; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.14; 3.6.1.15; 3.6.1.17; 3.6.1.61; 3.6.3.1; 3.6.3.2; 3.6.3.3; 3.6.3.4; 3.6.3.5; 3.6.3.6; 3.6.3.7; 3.6.3.8; 3.6.3.9; 3.6.3.10; 3.6.3.11; 3.6.3.12; 3.6.3.14; 3.6.3.15; 3.6.3.16; 3.6.3.17; 3.6.3.18; 3.6.3.19; 3.6.3.20; 3.6.3.21; 3.6.3.22; 3.6.3.23; 3.6.3.24; 3.6.3.25; 3.6.3.26; 3.6.3.27; 3.6.3.28; 3.6.3.29; 3.6.3.30; 3.6.3.31; 3.6.3.32; 3.6.3.33; 3.6.3.34; 3.6.3.35; 3.6.3.36; 3.6.3.37; 3.6.3.38; 3.6.3.39; 3.6.3.40; 3.6.3.41; 3.6.3.42; 3.6.3.43; 3.6.3.44; 3.6.3.46; 3.6.3.47; 3.6.3.48; 3.6.3.49; 3.6.3.50; 3.6.3.51; 3.6.3.52; 3.6.3.53; 3.6.3.54; 3.6.3.55; 3.6.4.1; 3.6.4.2; 3.6.4.3; 3.6.4.4; 3.6.4.5; 3.6.4.6; 3.6.4.7; 3.6.4.8; 3.6.4.9; 3.6.4.10; 3.6.4.11; 3.6.4.12; 3.6.4.13; 4.1.1.33; 4.1.1.49; 4.1.1.99; 4.2.1.93; 4.6.1.1; 4.6.1.-; 5.1.1.11; 6.1.1.1; 6.1.1.2; 6.1.1.3; 6.1.1.4; 6.1.1.5; 6.1.1.6; 6.1.1.7; 6.1.1.9; 6.1.1.10; 6.1.1.11; 6.1.1.12; 6.1.1.13; 6.1.1.14; 6.1.1.15; 6.1.1.16; 6.1.1.17; 6.1.1.18; 6.1.1.19; 6.1.1.20; 6.1.1.21; 6.1.1.22; 6.1.1.23; 6.1.1.24; 6.1.1.26; 6.1.1.27; 6.1.2.1; 6.1.2.2; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.5; 6.2.1.6; 6.2.1.7; 6.2.1.8; 6.2.1.9; 6.2.1.11; 6.2.1.12; 6.2.1.13; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.18; 6.2.1.19; 6.2.1.20; 6.2.1.22; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.34; 6.2.1.35; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.39; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.46; 6.2.1.-; 6.3.1.1; 6.3.1.2; 6.3.1.4; 6.3.1.5; 6.3.1.6; 6.3.1.7; 6.3.1.8; 6.3.1.9; 6.3.1.10; 6.3.1.11; 6.3.1.12; 6.3.1.13; 6.3.1.14; 6.3.1.15; 6.3.1.17; 6.3.1.18; 6.3.1.19; 6.3.1.20; 6.3.2.1; 6.3.2.2; 6.3.2.3; 6.3.2.4; 6.3.2.5; 6.3.2.6; 6.3.2.7; 6.3.2.8; 6.3.2.9; 6.3.2.10; 6.3.2.11; 6.3.2.12; 6.3.2.13; 6.3.2.14; 6.3.2.16; 6.3.2.17; 6.3.2.18; 6.3.2.20; 6.3.2.23; 6.3.2.24; 6.3.2.25; 6.3.2.26; 6.3.2.29; 6.3.2.30; 6.3.2.32; 6.3.2.33; 6.3.2.35; 6.3.2.36; 6.3.2.37; 6.3.2.38; 6.3.2.39; 6.3.2.40; 6.3.2.41; 6.3.2.42; 6.3.2.43; 6.3.2.44; 6.3.2.45; 6.3.2.46; 6.3.2.47; 6.3.2.48; 6.3.2.49; 6.3.2.-; 6.3.3.1; 6.3.3.2; 6.3.3.3; 6.3.3.4; 6.3.3.5; 6.3.3.6; 6.3.4.2; 6.3.4.3; 6.3.4.5; 6.3.4.6; 6.3.4.7; 6.3.4.8; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.12; 6.3.4.13; 6.3.4.14; 6.3.4.15; 6.3.4.16; 6.3.4.17; 6.3.4.18; 6.3.4.19; 6.3.4.20; 6.3.4.21; 6.3.4.22; 6.3.4.23; 6.3.4.24; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-; 6.4.1.1; 6.4.1.2; 6.4.1.3; 6.4.1.4; 6.4.1.5; 6.4.1.6; 6.4.1.7; 6.4.1.8; 6.5.1.1; 6.5.1.3; 6.5.1.4; 6.5.1.6; 6.5.1.7; 6.6.1.1; 6.6.1.2","Adenine ribonucleotide biosynthesis, IMP => ADP,ATP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00002  ATP;  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00002  ATP; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D08646  Triphosadenine (DCF); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Adenosinetriphosphoric acid;     D08646  Triphosadenine (DCF)","CAS: 56-65-5; PubChem: 3304; ChEBI: 15422; ChEMBL: CHEMBL14249 CHEMBL605638; KNApSAcK: C00001491; PDB-CCD: ATP; 3DMET: B01125; NIKKAJI: J10.680A","cpd:C00002; cpd:C00286; cpd:C01806; cpd:C19969",10,16,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O13N5P3","C10H15O13N5P3",506.9957466,508.0035716,505.9879216
"cpd:C00003","NAD+;","C21H28N7O14P2","NAD+; NAD; Nicotinamide adenine dinucleotide; DPN; Diphosphopyridine nucleotide; Nadide; beta-NAD+","R00023 R00090 R00091 R00092 R00093 R00094 R00095 R00097; R00099 R00100 R00101 R00102 R00103 R00104 R00112 R00118; R00137 R00143 R00145 R00189 R00203 R00209 R00214 R00215; R00228 R00243 R00245 R00257 R00281 R00286 R00300 R00342; R00365 R00368 R00382 R00384 R00396 R00398 R00402 R00421; R00445 R00446 R00501 R00519 R00538 R00555 R00562 R00581; R00604 R00605 R00623 R00624 R00631 R00675 R00688 R00700; R00703 R00704 R00705 R00707 R00709 R00710 R00713 R00715; R00717 R00732 R00754 R00758 R00787 R00794 R00812 R00813; R00818 R00823 R00842 R00868 R00875 R00880 R00892 R00904; R00906 R00922 R00935 R00936 R00937 R00977 R00994 R01000; R01033 R01034 R01036 R01061 R01088 R01093 R01094 R01130; R01142 R01158 R01163 R01171 R01172 R01183 R01202 R01210; R01211 R01218 R01221 R01246 R01248 R01258 R01277 R01293; R01296 R01297 R01308 R01333 R01337 R01361 R01370 R01388; R01403 R01414 R01419 R01426 R01429 R01434 R01446 R01451; R01465 R01486 R01487 R01505 R01513 R01520 R01524 R01542; R01574 R01604 R01608 R01629 R01633 R01636 R01644 R01651; R01681 R01683 R01689 R01698 R01704 R01707 R01728 R01735; R01738 R01745 R01749 R01752 R01757 R01758 R01763 R01768; R01773 R01778 R01781 R01793 R01825 R01836 R01837 R01869; R01872 R01895 R01896 R01903 R01921 R01932 R01933 R01934; R01937 R01971 R01975 R01981 R01998 R02000 R02032 R02039; R02047 R02081 R02103 R02123 R02124 R02163 R02196 R02201; R02207 R02216 R02229 R02235 R02246 R02252 R02257 R02258; R02313 R02343 R02344 R02347 R02352 R02354 R02377 R02383; R02391 R02395 R02401 R02434 R02441 R02450 R02454 R02455; R02462 R02471 R02476 R02492 R02499 R02514 R02515 R02527; R02531 R02536 R02544 R02545 R02549 R02553 R02555 R02559; R02561 R02565 R02580 R02589 R02611 R02618 R02637 R02640; R02651 R02655 R02678 R02679 R02683 R02695 R02698 R02703; R02762 R02766 R02792 R02819 R02823 R02830 R02834 R02840; R02847 R02855 R02878 R02896 R02928 R02935 R02940 R02941; R02944 R02945 R02946 R02957 R02964 R02968 R02969 R02988; R02993 R02994 R03012 R03021 R03022 R03023 R03043 R03048; R03080 R03082 R03088 R03102 R03104 R03119 R03171 R03176; R03177 R03191 R03198 R03226 R03251 R03261 R03278 R03279; R03283 R03290 R03291 R03299 R03300 R03306 R03317 R03327; R03336 R03337 R03349 R03369 R03373 R03381 R03385 R03391; R03396 R03397 R03406 R03431 R03439 R03447 R03475 R03476; R03497 R03506 R03543 R03544 R03559 R03577 R03582 R03584; R03591 R03614 R03630 R03637 R03643 R03707 R03709 R03732; R03733 R03745 R03759 R03761 R03763 R03787 R03790 R03792; R03815 R03816 R03826 R03847 R03863 R03869 R03882 R03886; R03889 R03913 R03942 R03945 R03947 R03963 R03964 R03998; R04046 R04049 R04065 R04066 R04074 R04088 R04102 R04115; R04123 R04130 R04139 R04142 R04151 R04163 R04176 R04185; R04198 R04200 R04203 R04210 R04228 R04236 R04263 R04278; R04304 R04307 R04309 R04330 R04339 R04366 R04375 R04412; R04418 R04426 R04429 R04444 R04483 R04501 R04506 R04517; R04524 R04556 R04598 R04600 R04678 R04681 R04687 R04724; R04737 R04739 R04741 R04743 R04745 R04748 R04805 R04810; R04812 R04818 R04824 R04829 R04831 R04832 R04834 R04835; R04837 R04842 R04844 R04845 R04847 R04849 R04862 R04876; R04880 R04882 R04888 R04891 R04903 R04916 R04955 R04958; R04961 R04966 R04969 R04996 R05049 R05050 R05051 R05066; R05119 R05147 R05148 R05154 R05156 R05157 R05158 R05217; R05232 R05233 R05234 R05235 R05236 R05239 R05240 R05241; R05243 R05247 R05261 R05263 R05266 R05271 R05272 R05273; R05274 R05275 R05281 R05282 R05283 R05286 R05288 R05290; R05292 R05294 R05305 R05307 R05309 R05310 R05311 R05312; R05313 R05314 R05315 R05321 R05322 R05347 R05348 R05349; R05351 R05352 R05353 R05354 R05355 R05395 R05397 R05399; R05414 R05417 R05418 R05422 R05423 R05425 R05426 R05428; R05429 R05430 R05431 R05434 R05435 R05437 R05439 R05440; R05442 R05443 R05444 R05448 R05450 R05487 R05515 R05537; R05571 R05575 R05581 R05582 R05604 R05607 R05621 R05632; R05643 R05649 R05653 R05654 R05655 R05665 R05668 R05678; R05679 R05681 R05683 R05685 R05689 R05690 R05693 R05699; R05700 R05705 R05715 R05724 R05729 R05730 R05733 R05734; R05746 R05812 R05831 R05837 R05843 R05875 R06117 R06180; R06289 R06357 R06366 R06376 R06377 R06378 R06379 R06382; R06383 R06384 R06385 R06398 R06399 R06406 R06407 R06408; R06413 R06438 R06594 R06621 R06782 R06783 R06784 R06785; R06786 R06787 R06831 R06832 R06847 R06848 R06856 R06857; R06883 R06884 R06888 R06891 R06894 R06909 R06910 R06914; R06915 R06916 R06917 R06918 R06919 R06926 R06927 R06928; R06930 R06931 R06935 R06936 R06937 R06939 R06941 R06945; R06954 R06980 R06983 R07058 R07104 R07105 R07133 R07134; R07135 R07136 R07141 R07145 R07148 R07156 R07164 R07168; R07171 R07188 R07194 R07326 R07345 R07349 R07351 R07354; R07358 R07410 R07417 R07428 R07441 R07477 R07478 R07530; R07558 R07559 R07561 R07562 R07568 R07569 R07570 R07572; R07618 R07658 R07665 R07667 R07675 R07703 R07704 R07705; R07706 R07709 R07765 R07781 R07799 R07851 R07890 R07894; R07898 R07936 R07952 R07954 R07955 R07957 R07959 R07961; R07963 R07965 R07967 R07969 R07971 R07973 R07975 R07985; R08017 R08018 R08042 R08043 R08044 R08045 R08046 R08047; R08086 R08087 R08094 R08096 R08100 R08101 R08103 R08104; R08105 R08108 R08109 R08110 R08111 R08112 R08113 R08140; R08141 R08146 R08198 R08214 R08215 R08240 R08281 R08282; R08306 R08307 R08310 R08382 R08385 R08536 R08544 R08549; R08550 R08557 R08569 R08590 R08621 R08625 R08629 R08636; R08642 R08646 R08709 R08721 R08723 R08724 R08728 R08764; R08767 R08846 R08892 R08914 R08916 R08918 R08919 R08926; R08945 R09055 R09069 R09078 R09097 R09129 R09130 R09132; R09137 R09141 R09148 R09151 R09152 R09159 R09160 R09162; R09165 R09183 R09201 R09204 R09209 R09213 R09219 R09223; R09224 R09227 R09228 R09230 R09231 R09232 R09233 R09235; R09236 R09288 R09312 R09375 R09385 R09388 R09447 R09472; R09477 R09478 R09484 R09498 R09508 R09513 R09514 R09524; R09544 R09545 R09561 R09567 R09586 R09662 R09747 R09748; R09750 R09783 R09786 R09805 R09830 R09859 R09860 R09920; R09922 R09923 R09924 R09925 R09951 R09953 R09956 R09957; R09981 R09984 R09986 R09988 R10012 R10021 R10042 R10043; R10048 R10052 R10054 R10057 R10106 R10107 R10108 R10113; R10125 R10126 R10128 R10129 R10131 R10140 R10146 R10156; R10161 R10163 R10189 R10190 R10217 R10218 R10221 R10222; R10301 R10308 R10310 R10311 R10325 R10332 R10412 R10419; R10420 R10422 R10428 R10459 R10467 R10502 R10504 R10505; R10517 R10519 R10520 R10565 R10592 R10629 R10633 R10634; R10635 R10685 R10690 R10702 R10703 R10715 R10717 R10718; R10719 R10783 R10785 R10790 R10798 R10800 R10841 R10842; R10848 R10860 R10861 R10907 R10916 R10917 R10918 R10981; R10985 R10986 R10995 R11007 R11026 R11031 R11035 R11036; R11056 R11067 R11091 R11092 R11093 R11121 R11144 R11147; R11149 R11150 R11151 R11153 R11155 R11156 R11158 R11197; R11231 R11243 R11265 R11290 R11336 R11337 R11338 R11339; R11342 R11346 R11347 R11350 R11355 R11356 R11357 R11373; R11374 R11382 R11384 R11424 R11448 R11471 R11472 R11504; R11505 R11578","Oxidative phosphorylation; Thiamine metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; AMPK signaling pathway; Longevity regulating pathway; Longevity regulating pathway - worm; Aldosterone synthesis and secretion; Vitamin digestion and absorption","1.1.1.1; 1.1.1.3; 1.1.1.4; 1.1.1.6; 1.1.1.7; 1.1.1.8; 1.1.1.9; 1.1.1.11; 1.1.1.12; 1.1.1.13; 1.1.1.14; 1.1.1.15; 1.1.1.16; 1.1.1.17; 1.1.1.18; 1.1.1.21; 1.1.1.22; 1.1.1.23; 1.1.1.24; 1.1.1.26; 1.1.1.27; 1.1.1.28; 1.1.1.29; 1.1.1.30; 1.1.1.31; 1.1.1.32; 1.1.1.35; 1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.41; 1.1.1.43; 1.1.1.45; 1.1.1.46; 1.1.1.47; 1.1.1.48; 1.1.1.50; 1.1.1.51; 1.1.1.52; 1.1.1.53; 1.1.1.56; 1.1.1.57; 1.1.1.58; 1.1.1.59; 1.1.1.60; 1.1.1.61; 1.1.1.62; 1.1.1.66; 1.1.1.67; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.73; 1.1.1.75; 1.1.1.76; 1.1.1.77; 1.1.1.78; 1.1.1.79; 1.1.1.81; 1.1.1.83; 1.1.1.84; 1.1.1.85; 1.1.1.87; 1.1.1.88; 1.1.1.90; 1.1.1.92; 1.1.1.93; 1.1.1.94; 1.1.1.95; 1.1.1.96; 1.1.1.98; 1.1.1.99; 1.1.1.103; 1.1.1.104; 1.1.1.105; 1.1.1.106; 1.1.1.107; 1.1.1.108; 1.1.1.110; 1.1.1.111; 1.1.1.112; 1.1.1.114; 1.1.1.116; 1.1.1.117; 1.1.1.118; 1.1.1.121; 1.1.1.122; 1.1.1.125; 1.1.1.127; 1.1.1.129; 1.1.1.130; 1.1.1.131; 1.1.1.132; 1.1.1.135; 1.1.1.136; 1.1.1.137; 1.1.1.140; 1.1.1.141; 1.1.1.143; 1.1.1.144; 1.1.1.145; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.150; 1.1.1.152; 1.1.1.154; 1.1.1.157; 1.1.1.159; 1.1.1.163; 1.1.1.164; 1.1.1.165; 1.1.1.166; 1.1.1.167; 1.1.1.170; 1.1.1.172; 1.1.1.173; 1.1.1.174; 1.1.1.175; 1.1.1.178; 1.1.1.181; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.190; 1.1.1.192; 1.1.1.196; 1.1.1.198; 1.1.1.199; 1.1.1.202; 1.1.1.203; 1.1.1.205; 1.1.1.209; 1.1.1.211; 1.1.1.212; 1.1.1.213; 1.1.1.218; 1.1.1.221; 1.1.1.222; 1.1.1.223; 1.1.1.226; 1.1.1.227; 1.1.1.228; 1.1.1.232; 1.1.1.233; 1.1.1.237; 1.1.1.239; 1.1.1.240; 1.1.1.241; 1.1.1.244; 1.1.1.245; 1.1.1.250; 1.1.1.251; 1.1.1.254; 1.1.1.255; 1.1.1.256; 1.1.1.257; 1.1.1.258; 1.1.1.259; 1.1.1.260; 1.1.1.261; 1.1.1.262; 1.1.1.264; 1.1.1.265; 1.1.1.268; 1.1.1.269; 1.1.1.275; 1.1.1.281; 1.1.1.282; 1.1.1.284; 1.1.1.285; 1.1.1.286; 1.1.1.288; 1.1.1.290; 1.1.1.291; 1.1.1.294; 1.1.1.295; 1.1.1.296; 1.1.1.297; 1.1.1.299; 1.1.1.301; 1.1.1.302; 1.1.1.303; 1.1.1.304; 1.1.1.305; 1.1.1.306; 1.1.1.307; 1.1.1.308; 1.1.1.309; 1.1.1.310; 1.1.1.311; 1.1.1.312; 1.1.1.315; 1.1.1.316; 1.1.1.322; 1.1.1.323; 1.1.1.326; 1.1.1.327; 1.1.1.328; 1.1.1.329; 1.1.1.331; 1.1.1.332; 1.1.1.333; 1.1.1.335; 1.1.1.336; 1.1.1.337; 1.1.1.339; 1.1.1.340; 1.1.1.343; 1.1.1.344; 1.1.1.345; 1.1.1.347; 1.1.1.350; 1.1.1.351; 1.1.1.352; 1.1.1.354; 1.1.1.356; 1.1.1.357; 1.1.1.359; 1.1.1.361; 1.1.1.363; 1.1.1.364; 1.1.1.366; 1.1.1.368; 1.1.1.369; 1.1.1.370; 1.1.1.373; 1.1.1.374; 1.1.1.375; 1.1.1.376; 1.1.1.378; 1.1.1.379; 1.1.1.380; 1.1.1.382; 1.1.1.383; 1.1.1.385; 1.1.1.386; 1.1.1.387; 1.1.1.388; 1.1.1.389; 1.1.1.390; 1.1.1.391; 1.1.1.394; 1.1.1.396; 1.1.1.397; 1.1.1.399; 1.1.1.400; 1.1.1.401; 1.1.1.403; 1.1.1.-; 1.1.-.-; 1.2.1.2; 1.2.1.3; 1.2.1.5; 1.2.1.8; 1.2.1.10; 1.2.1.12; 1.2.1.15; 1.2.1.16; 1.2.1.18; 1.2.1.19; 1.2.1.20; 1.2.1.21; 1.2.1.22; 1.2.1.23; 1.2.1.24; 1.2.1.25; 1.2.1.27; 1.2.1.28; 1.2.1.29; 1.2.1.31; 1.2.1.32; 1.2.1.33; 1.2.1.36; 1.2.1.39; 1.2.1.42; 1.2.1.46; 1.2.1.47; 1.2.1.48; 1.2.1.53; 1.2.1.54; 1.2.1.57; 1.2.1.58; 1.2.1.59; 1.2.1.60; 1.2.1.61; 1.2.1.62; 1.2.1.64; 1.2.1.65; 1.2.1.67; 1.2.1.68; 1.2.1.69; 1.2.1.71; 1.2.1.72; 1.2.1.73; 1.2.1.74; 1.2.1.78; 1.2.1.80; 1.2.1.82; 1.2.1.85; 1.2.1.86; 1.2.1.87; 1.2.1.88; 1.2.1.90; 1.2.1.92; 1.2.1.98; 1.2.1.-; 1.2.3.9; 1.2.4.1; 1.2.4.2; 1.2.4.-; 1.3.1.1; 1.3.1.5; 1.3.1.6; 1.3.1.7; 1.3.1.9; 1.3.1.11; 1.3.1.12; 1.3.1.14; 1.3.1.18; 1.3.1.19; 1.3.1.21; 1.3.1.24; 1.3.1.25; 1.3.1.28; 1.3.1.29; 1.3.1.31; 1.3.1.32; 1.3.1.41; 1.3.1.43; 1.3.1.44; 1.3.1.47; 1.3.1.48; 1.3.1.49; 1.3.1.53; 1.3.1.56; 1.3.1.58; 1.3.1.60; 1.3.1.62; 1.3.1.64; 1.3.1.65; 1.3.1.66; 1.3.1.67; 1.3.1.68; 1.3.1.74; 1.3.1.76; 1.3.1.77; 1.3.1.79; 1.3.1.87; 1.3.1.95; 1.3.1.98; 1.3.1.101; 1.3.1.105; 1.3.1.106; 1.3.1.107; 1.3.1.-; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.11; 1.4.1.12; 1.4.1.14; 1.4.1.15; 1.4.1.18; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.23; 1.4.1.24; 1.4.1.-; 1.4.4.2; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.7; 1.5.1.9; 1.5.1.11; 1.5.1.15; 1.5.1.17; 1.5.1.18; 1.5.1.20; 1.5.1.22; 1.5.1.23; 1.5.1.25; 1.5.1.26; 1.5.1.28; 1.5.1.34; 1.5.1.36; 1.5.1.37; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.44; 1.5.1.45; 1.5.1.47; 1.5.1.49; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.2; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.3; 1.6.3.4; 1.6.3.5; 1.6.5.2; 1.6.5.3; 1.6.5.4; 1.6.5.7; 1.6.5.8; 1.6.5.9; 1.6.5.11; 1.6.5.-; 1.6.6.9; 1.6.99.3; 1.7.1.1; 1.7.1.2; 1.7.1.4; 1.7.1.5; 1.7.1.9; 1.7.1.10; 1.7.1.12; 1.7.1.14; 1.7.1.15; 1.7.1.-; 1.7.99.1; 1.8.1.3; 1.8.1.4; 1.8.1.6; 1.8.1.7; 1.8.1.8; 1.8.1.11; 1.8.1.15; 1.8.1.16; 1.8.1.17; 1.8.1.18; 1.11.1.1; 1.12.1.2; 1.12.1.4; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.17; 1.13.12.-; 1.14.12.1; 1.14.12.3; 1.14.12.4; 1.14.12.7; 1.14.12.8; 1.14.12.9; 1.14.12.10; 1.14.12.11; 1.14.12.12; 1.14.12.13; 1.14.12.14; 1.14.12.15; 1.14.12.16; 1.14.12.17; 1.14.12.18; 1.14.12.19; 1.14.12.22; 1.14.12.23; 1.14.12.24; 1.14.12.25; 1.14.12.-; 1.14.13.1; 1.14.13.4; 1.14.13.5; 1.14.13.6; 1.14.13.10; 1.14.13.18; 1.14.13.19; 1.14.13.24; 1.14.13.25; 1.14.13.27; 1.14.13.29; 1.14.13.33; 1.14.13.40; 1.14.13.44; 1.14.13.61; 1.14.13.62; 1.14.13.63; 1.14.13.64; 1.14.13.69; 1.14.13.72; 1.14.13.82; 1.14.13.83; 1.14.13.107; 1.14.13.111; 1.14.13.113; 1.14.13.114; 1.14.13.127; 1.14.13.128; 1.14.13.129; 1.14.13.130; 1.14.13.131; 1.14.13.135; 1.14.13.141; 1.14.13.142; 1.14.13.151; 1.14.13.162; 1.14.13.163; 1.14.13.165; 1.14.13.172; 1.14.13.178; 1.14.13.179; 1.14.13.182; 1.14.13.196; 1.14.13.209; 1.14.13.210; 1.14.13.211; 1.14.13.212; 1.14.13.215; 1.14.13.216; 1.14.13.217; 1.14.13.218; 1.14.13.220; 1.14.13.222; 1.14.13.223; 1.14.13.224; 1.14.13.227; 1.14.13.230; 1.14.13.-; 1.14.14.1; 1.14.14.9; 1.14.15.3; 1.14.18.1; 1.14.19.21; 1.14.99.2; 1.14.-.-; 1.16.1.2; 1.16.1.3; 1.16.1.4; 1.16.1.7; 1.17.1.1; 1.17.1.4; 1.17.1.8; 1.18.1.1; 1.18.1.3; 1.18.1.4; 1.18.1.5; 1.20.1.1; 1.-.-.-; 2.1.2.10; 2.3.1.12; 2.3.1.61; 2.3.1.190; 2.3.1.-; 2.4.2.30; 2.4.2.31; 2.4.2.36; 2.4.2.37; 2.5.1.46; 2.7.1.23; 2.7.7.1; 2.7.7.18; 3.1.3.-; 3.2.2.5; 3.2.2.6; 3.5.1.-; 3.6.1.9; 3.6.1.22; 4.3.1.22; 5.3.3.1; 6.3.1.5; 6.3.5.1; 6.5.1.2; 6.5.1.6","NAD biosynthesis, aspartate => NAD; NADH:ubiquinone oxidoreductase, mitochondria; NADH:quinone oxidoreductase, prokaryotes; NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00003  NAD; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA01 Nicotinamide;       D00002  Nadide (JAN/USAN/INN)","CAS: 53-84-9; PubChem: 3305; ChEBI: 15846; ChEMBL: CHEMBL1454168; KNApSAcK: C00007256; PDB-CCD: NAD NAJ; 3DMET: B01126; NIKKAJI: J136.554A","cpd:C00003",21,28,14,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H29O14N7P2","C21H27O14N7P2",664.1169476,665.1247726,663.1091226
"cpd:C00004","NADH;","C21H29N7O14P2","NADH; DPNH; Reduced nicotinamide adenine dinucleotide","R00023 R00090 R00091 R00092 R00093 R00094 R00095 R00097; R00099 R00100 R00101 R00105 R00112 R00129 R00143 R00145; R00203 R00209 R00214 R00215 R00228 R00243 R00245 R00281; R00286 R00300 R00342 R00365 R00368 R00384 R00396 R00398; R00402 R00421 R00445 R00446 R00501 R00519 R00538 R00562; R00581 R00604 R00605 R00623 R00624 R00631 R00675 R00688; R00700 R00703 R00704 R00705 R00707 R00709 R00710 R00713; R00715 R00717 R00732 R00754 R00758 R00787 R00794 R00812; R00813 R00818 R00823 R00842 R00868 R00875 R00880 R00892; R00904 R00906 R00922 R00935 R00936 R00937 R00977 R00994; R01000 R01033 R01034 R01036 R01061 R01088 R01093 R01094; R01130 R01142 R01158 R01163 R01171 R01172 R01183 R01202; R01210 R01211 R01218 R01221 R01246 R01248 R01258 R01277; R01293 R01296 R01297 R01308 R01333 R01337 R01361 R01370; R01388 R01403 R01414 R01419 R01426 R01429 R01434 R01446; R01451 R01465 R01486 R01487 R01505 R01513 R01520 R01524; R01542 R01574 R01604 R01608 R01629 R01633 R01636 R01644; R01651 R01681 R01683 R01689 R01698 R01704 R01707 R01728; R01735 R01738 R01745 R01749 R01752 R01757 R01758 R01763; R01768 R01773 R01778 R01781 R01793 R01825 R01836 R01837; R01869 R01872 R01895 R01896 R01903 R01921 R01932 R01933; R01934 R01937 R01971 R01975 R01981 R01998 R02000 R02032; R02039 R02047 R02081 R02103 R02123 R02124 R02163 R02196; R02201 R02207 R02216 R02229 R02235 R02246 R02252 R02257; R02258 R02313 R02343 R02344 R02347 R02352 R02354 R02377; R02383 R02391 R02395 R02401 R02434 R02441 R02450 R02454; R02455 R02462 R02471 R02476 R02492 R02499 R02514 R02515; R02527 R02531 R02536 R02544 R02545 R02549 R02553 R02555; R02559 R02561 R02565 R02580 R02589 R02611 R02618 R02637; R02640 R02651 R02655 R02678 R02679 R02683 R02695 R02698; R02703 R02762 R02766 R02792 R02819 R02823 R02830 R02834; R02840 R02847 R02855 R02878 R02896 R02928 R02935 R02940; R02941 R02944 R02945 R02946 R02957 R02964 R02968 R02969; R02988 R02993 R02994 R03012 R03021 R03022 R03023 R03043; R03048 R03080 R03082 R03088 R03102 R03104 R03119 R03171; R03176 R03177 R03191 R03198 R03226 R03251 R03261 R03278; R03279 R03283 R03290 R03291 R03299 R03300 R03306 R03317; R03327 R03336 R03337 R03349 R03369 R03373 R03381 R03385; R03391 R03396 R03397 R03406 R03431 R03439 R03475 R03476; R03497 R03506 R03543 R03544 R03559 R03577 R03582 R03584; R03591 R03614 R03630 R03637 R03643 R03707 R03709 R03732; R03733 R03745 R03759 R03761 R03763 R03787 R03790 R03792; R03815 R03816 R03826 R03847 R03863 R03869 R03882 R03886; R03889 R03913 R03942 R03945 R03947 R03963 R03964 R03998; R04046 R04049 R04065 R04066 R04088 R04102 R04115 R04123; R04130 R04139 R04142 R04151 R04163 R04185 R04198 R04200; R04203 R04210 R04228 R04236 R04263 R04278 R04304 R04307; R04309 R04330 R04339 R04366 R04375 R04412 R04418 R04426; R04429 R04444 R04483 R04501 R04506 R04517 R04524 R04556; R04598 R04600 R04678 R04681 R04687 R04724 R04737 R04739; R04741 R04743 R04745 R04748 R04805 R04810 R04812 R04818; R04824 R04829 R04831 R04832 R04834 R04835 R04837 R04842; R04844 R04845 R04847 R04849 R04862 R04876 R04880 R04882; R04888 R04891 R04903 R04916 R04955 R04958 R04961 R04966; R04969 R04996 R05049 R05050 R05051 R05066 R05119 R05147; R05148 R05154 R05156 R05157 R05158 R05217 R05232 R05233; R05234 R05235 R05236 R05239 R05240 R05241 R05243 R05247; R05261 R05263 R05266 R05271 R05272 R05273 R05274 R05275; R05281 R05282 R05283 R05286 R05288 R05290 R05292 R05294; R05305 R05307 R05309 R05310 R05311 R05312 R05313 R05314; R05315 R05321 R05322 R05347 R05348 R05349 R05351 R05352; R05353 R05354 R05355 R05395 R05397 R05399 R05414 R05417; R05418 R05422 R05423 R05425 R05426 R05428 R05429 R05430; R05431 R05434 R05435 R05437 R05439 R05440 R05442 R05443; R05444 R05448 R05450 R05487 R05515 R05537 R05571 R05575; R05581 R05582 R05604 R05607 R05621 R05632 R05643 R05649; R05653 R05654 R05655 R05665 R05668 R05678 R05679 R05681; R05683 R05685 R05689 R05690 R05693 R05699 R05700 R05705; R05715 R05724 R05729 R05730 R05733 R05734 R05746 R05812; R05831 R05837 R05843 R05875 R06117 R06180 R06289 R06357; R06366 R06376 R06377 R06378 R06379 R06382 R06383 R06384; R06385 R06398 R06399 R06406 R06407 R06408 R06413 R06438; R06594 R06621 R06782 R06783 R06784 R06785 R06786 R06787; R06831 R06832 R06847 R06848 R06856 R06857 R06883 R06884; R06888 R06891 R06894 R06909 R06910 R06914 R06915 R06916; R06917 R06918 R06919 R06926 R06927 R06928 R06930 R06931; R06935 R06936 R06937 R06939 R06941 R06945 R06954 R06980; R06983 R07058 R07104 R07105 R07133 R07134 R07135 R07136; R07141 R07145 R07148 R07156 R07164 R07168 R07171 R07188; R07194 R07326 R07345 R07349 R07351 R07354 R07358 R07410; R07417 R07428 R07441 R07477 R07478 R07530 R07558 R07559; R07561 R07562 R07568 R07569 R07570 R07572 R07618 R07658; R07665 R07667 R07675 R07703 R07704 R07705 R07706 R07709; R07765 R07781 R07799 R07851 R07890 R07894 R07898 R07936; R07952 R07954 R07955 R07957 R07959 R07961 R07963 R07965; R07967 R07969 R07971 R07973 R07975 R07985 R08017 R08018; R08042 R08043 R08044 R08045 R08046 R08047 R08086 R08087; R08094 R08096 R08100 R08101 R08103 R08104 R08105 R08108; R08109 R08110 R08111 R08112 R08113 R08140 R08141 R08146; R08198 R08214 R08215 R08240 R08281 R08282 R08306 R08307; R08310 R08382 R08385 R08536 R08544 R08549 R08550 R08557; R08569 R08590 R08621 R08625 R08629 R08636 R08642 R08646; R08709 R08721 R08723 R08724 R08728 R08764 R08767 R08846; R08892 R08914 R08916 R08918 R08919 R08926 R08945 R09055; R09069 R09078 R09097 R09129 R09130 R09132 R09137 R09141; R09148 R09151 R09152 R09159 R09160 R09162 R09165 R09183; R09201 R09204 R09209 R09213 R09219 R09223 R09224 R09227; R09228 R09230 R09231 R09232 R09233 R09235 R09236 R09288; R09312 R09375 R09385 R09388 R09447 R09472 R09477 R09478; R09484 R09498 R09508 R09513 R09514 R09524 R09544 R09545; R09561 R09567 R09586 R09662 R09747 R09748 R09750 R09783; R09786 R09805 R09830 R09859 R09860 R09920 R09922 R09923; R09924 R09925 R09951 R09953 R09956 R09957 R09981 R09984; R09986 R09988 R10012 R10021 R10042 R10043 R10048 R10052; R10054 R10057 R10106 R10107 R10108 R10113 R10125 R10126; R10128 R10129 R10131 R10140 R10146 R10156 R10161 R10163; R10189 R10190 R10217 R10218 R10221 R10222 R10267 R10301; R10308 R10310 R10311 R10325 R10332 R10412 R10419 R10420; R10422 R10428 R10459 R10467 R10502 R10504 R10505 R10517; R10519 R10520 R10565 R10592 R10690 R10702 R10703 R10715; R10717 R10718 R10719 R10783 R10785 R10790 R10798 R10800; R10841 R10842 R10848 R10860 R10861 R10907 R10916 R10917; R10918 R10981 R10985 R10986 R10995 R11007 R11026 R11031; R11035 R11036 R11056 R11067 R11091 R11092 R11093 R11104; R11121 R11144 R11147 R11149 R11150 R11151 R11153 R11155; R11156 R11158 R11197 R11231 R11243 R11265 R11290 R11336; R11337 R11338 R11339 R11342 R11346 R11347 R11350 R11355; R11356 R11357 R11373 R11374 R11382 R11384 R11424 R11448; R11471 R11472 R11578","Oxidative phosphorylation; Metabolic pathways; Calcium signaling pathway; Aldosterone synthesis and secretion","1.1.1.1; 1.1.1.3; 1.1.1.4; 1.1.1.6; 1.1.1.7; 1.1.1.8; 1.1.1.9; 1.1.1.11; 1.1.1.12; 1.1.1.13; 1.1.1.14; 1.1.1.15; 1.1.1.16; 1.1.1.17; 1.1.1.18; 1.1.1.21; 1.1.1.22; 1.1.1.23; 1.1.1.24; 1.1.1.26; 1.1.1.27; 1.1.1.28; 1.1.1.29; 1.1.1.30; 1.1.1.31; 1.1.1.32; 1.1.1.35; 1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.41; 1.1.1.43; 1.1.1.45; 1.1.1.46; 1.1.1.47; 1.1.1.48; 1.1.1.50; 1.1.1.51; 1.1.1.52; 1.1.1.53; 1.1.1.56; 1.1.1.57; 1.1.1.58; 1.1.1.59; 1.1.1.60; 1.1.1.61; 1.1.1.62; 1.1.1.66; 1.1.1.67; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.73; 1.1.1.75; 1.1.1.76; 1.1.1.77; 1.1.1.78; 1.1.1.79; 1.1.1.81; 1.1.1.83; 1.1.1.84; 1.1.1.85; 1.1.1.87; 1.1.1.88; 1.1.1.90; 1.1.1.92; 1.1.1.93; 1.1.1.94; 1.1.1.95; 1.1.1.96; 1.1.1.98; 1.1.1.99; 1.1.1.103; 1.1.1.104; 1.1.1.105; 1.1.1.106; 1.1.1.107; 1.1.1.108; 1.1.1.110; 1.1.1.111; 1.1.1.112; 1.1.1.114; 1.1.1.116; 1.1.1.117; 1.1.1.118; 1.1.1.121; 1.1.1.122; 1.1.1.125; 1.1.1.127; 1.1.1.129; 1.1.1.130; 1.1.1.131; 1.1.1.132; 1.1.1.135; 1.1.1.136; 1.1.1.137; 1.1.1.140; 1.1.1.141; 1.1.1.143; 1.1.1.144; 1.1.1.145; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.150; 1.1.1.152; 1.1.1.154; 1.1.1.157; 1.1.1.159; 1.1.1.163; 1.1.1.164; 1.1.1.165; 1.1.1.166; 1.1.1.167; 1.1.1.170; 1.1.1.172; 1.1.1.173; 1.1.1.174; 1.1.1.175; 1.1.1.178; 1.1.1.181; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.190; 1.1.1.192; 1.1.1.196; 1.1.1.198; 1.1.1.199; 1.1.1.202; 1.1.1.203; 1.1.1.205; 1.1.1.209; 1.1.1.211; 1.1.1.212; 1.1.1.213; 1.1.1.218; 1.1.1.221; 1.1.1.222; 1.1.1.223; 1.1.1.226; 1.1.1.227; 1.1.1.228; 1.1.1.232; 1.1.1.233; 1.1.1.237; 1.1.1.239; 1.1.1.240; 1.1.1.241; 1.1.1.244; 1.1.1.245; 1.1.1.250; 1.1.1.251; 1.1.1.254; 1.1.1.255; 1.1.1.256; 1.1.1.257; 1.1.1.258; 1.1.1.259; 1.1.1.260; 1.1.1.261; 1.1.1.262; 1.1.1.264; 1.1.1.265; 1.1.1.268; 1.1.1.269; 1.1.1.275; 1.1.1.281; 1.1.1.282; 1.1.1.284; 1.1.1.285; 1.1.1.286; 1.1.1.288; 1.1.1.290; 1.1.1.291; 1.1.1.294; 1.1.1.295; 1.1.1.296; 1.1.1.297; 1.1.1.299; 1.1.1.301; 1.1.1.302; 1.1.1.303; 1.1.1.304; 1.1.1.305; 1.1.1.306; 1.1.1.307; 1.1.1.308; 1.1.1.309; 1.1.1.310; 1.1.1.311; 1.1.1.312; 1.1.1.315; 1.1.1.316; 1.1.1.322; 1.1.1.323; 1.1.1.326; 1.1.1.327; 1.1.1.328; 1.1.1.329; 1.1.1.331; 1.1.1.332; 1.1.1.333; 1.1.1.335; 1.1.1.336; 1.1.1.337; 1.1.1.339; 1.1.1.340; 1.1.1.343; 1.1.1.344; 1.1.1.345; 1.1.1.347; 1.1.1.350; 1.1.1.351; 1.1.1.352; 1.1.1.354; 1.1.1.356; 1.1.1.357; 1.1.1.359; 1.1.1.361; 1.1.1.363; 1.1.1.364; 1.1.1.366; 1.1.1.368; 1.1.1.369; 1.1.1.370; 1.1.1.373; 1.1.1.374; 1.1.1.375; 1.1.1.376; 1.1.1.378; 1.1.1.379; 1.1.1.380; 1.1.1.382; 1.1.1.383; 1.1.1.385; 1.1.1.386; 1.1.1.387; 1.1.1.388; 1.1.1.389; 1.1.1.390; 1.1.1.391; 1.1.1.394; 1.1.1.396; 1.1.1.397; 1.1.1.399; 1.1.1.400; 1.1.1.401; 1.1.1.403; 1.1.1.-; 1.1.-.-; 1.2.1.2; 1.2.1.3; 1.2.1.5; 1.2.1.8; 1.2.1.10; 1.2.1.12; 1.2.1.15; 1.2.1.16; 1.2.1.18; 1.2.1.19; 1.2.1.20; 1.2.1.21; 1.2.1.22; 1.2.1.23; 1.2.1.24; 1.2.1.25; 1.2.1.27; 1.2.1.28; 1.2.1.29; 1.2.1.31; 1.2.1.32; 1.2.1.33; 1.2.1.36; 1.2.1.39; 1.2.1.42; 1.2.1.46; 1.2.1.47; 1.2.1.48; 1.2.1.53; 1.2.1.54; 1.2.1.57; 1.2.1.58; 1.2.1.59; 1.2.1.60; 1.2.1.61; 1.2.1.62; 1.2.1.64; 1.2.1.65; 1.2.1.67; 1.2.1.68; 1.2.1.69; 1.2.1.71; 1.2.1.72; 1.2.1.73; 1.2.1.74; 1.2.1.78; 1.2.1.80; 1.2.1.82; 1.2.1.85; 1.2.1.86; 1.2.1.87; 1.2.1.88; 1.2.1.90; 1.2.1.92; 1.2.1.98; 1.2.1.-; 1.2.3.9; 1.2.4.1; 1.2.4.2; 1.2.4.-; 1.3.1.1; 1.3.1.5; 1.3.1.6; 1.3.1.7; 1.3.1.9; 1.3.1.11; 1.3.1.12; 1.3.1.14; 1.3.1.18; 1.3.1.19; 1.3.1.21; 1.3.1.24; 1.3.1.25; 1.3.1.28; 1.3.1.29; 1.3.1.31; 1.3.1.32; 1.3.1.41; 1.3.1.43; 1.3.1.44; 1.3.1.47; 1.3.1.48; 1.3.1.49; 1.3.1.53; 1.3.1.56; 1.3.1.58; 1.3.1.60; 1.3.1.62; 1.3.1.64; 1.3.1.65; 1.3.1.66; 1.3.1.67; 1.3.1.68; 1.3.1.74; 1.3.1.76; 1.3.1.77; 1.3.1.79; 1.3.1.87; 1.3.1.95; 1.3.1.98; 1.3.1.101; 1.3.1.105; 1.3.1.106; 1.3.1.107; 1.3.1.-; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.11; 1.4.1.12; 1.4.1.14; 1.4.1.15; 1.4.1.18; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.23; 1.4.1.24; 1.4.1.-; 1.4.4.2; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.7; 1.5.1.9; 1.5.1.11; 1.5.1.15; 1.5.1.17; 1.5.1.18; 1.5.1.20; 1.5.1.22; 1.5.1.23; 1.5.1.25; 1.5.1.26; 1.5.1.28; 1.5.1.34; 1.5.1.36; 1.5.1.37; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.44; 1.5.1.45; 1.5.1.47; 1.5.1.49; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.2; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.3; 1.6.3.4; 1.6.5.2; 1.6.5.3; 1.6.5.4; 1.6.5.7; 1.6.5.8; 1.6.5.9; 1.6.5.11; 1.6.5.-; 1.6.6.9; 1.6.99.3; 1.7.1.1; 1.7.1.2; 1.7.1.4; 1.7.1.5; 1.7.1.9; 1.7.1.10; 1.7.1.12; 1.7.1.14; 1.7.1.15; 1.7.1.-; 1.7.99.1; 1.8.1.3; 1.8.1.4; 1.8.1.6; 1.8.1.7; 1.8.1.8; 1.8.1.11; 1.8.1.15; 1.8.1.16; 1.8.1.17; 1.8.1.18; 1.11.1.1; 1.12.1.2; 1.12.1.4; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.17; 1.13.12.-; 1.14.12.1; 1.14.12.3; 1.14.12.4; 1.14.12.7; 1.14.12.8; 1.14.12.9; 1.14.12.10; 1.14.12.11; 1.14.12.12; 1.14.12.13; 1.14.12.14; 1.14.12.15; 1.14.12.16; 1.14.12.17; 1.14.12.18; 1.14.12.19; 1.14.12.22; 1.14.12.23; 1.14.12.24; 1.14.12.25; 1.14.12.-; 1.14.13.1; 1.14.13.4; 1.14.13.5; 1.14.13.6; 1.14.13.10; 1.14.13.18; 1.14.13.19; 1.14.13.24; 1.14.13.25; 1.14.13.27; 1.14.13.29; 1.14.13.33; 1.14.13.40; 1.14.13.44; 1.14.13.61; 1.14.13.62; 1.14.13.63; 1.14.13.64; 1.14.13.69; 1.14.13.72; 1.14.13.82; 1.14.13.83; 1.14.13.107; 1.14.13.111; 1.14.13.113; 1.14.13.114; 1.14.13.127; 1.14.13.128; 1.14.13.129; 1.14.13.130; 1.14.13.131; 1.14.13.135; 1.14.13.141; 1.14.13.142; 1.14.13.151; 1.14.13.162; 1.14.13.163; 1.14.13.165; 1.14.13.172; 1.14.13.178; 1.14.13.179; 1.14.13.182; 1.14.13.196; 1.14.13.209; 1.14.13.210; 1.14.13.211; 1.14.13.212; 1.14.13.215; 1.14.13.216; 1.14.13.217; 1.14.13.218; 1.14.13.220; 1.14.13.222; 1.14.13.223; 1.14.13.224; 1.14.13.227; 1.14.13.230; 1.14.13.-; 1.14.14.1; 1.14.14.9; 1.14.15.3; 1.14.18.1; 1.14.19.21; 1.14.99.2; 1.14.-.-; 1.16.1.2; 1.16.1.3; 1.16.1.4; 1.16.1.7; 1.17.1.1; 1.17.1.4; 1.17.1.8; 1.18.1.1; 1.18.1.3; 1.18.1.4; 1.18.1.5; 1.20.1.1; 1.-.-.-; 2.1.2.10; 2.3.1.12; 2.3.1.61; 2.3.1.190; 2.3.1.-; 2.5.1.46; 2.7.1.86; 3.6.1.22; 4.2.1.93; 4.2.1.136; 4.3.1.22; 5.3.3.1","NADH:ubiquinone oxidoreductase, mitochondria; NADH:quinone oxidoreductase, prokaryotes; NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria",NA,"CAS: 58-68-4; PubChem: 3306; ChEBI: 16908; KNApSAcK: C00019343; PDB-CCD: NAI; 3DMET: B01127; NIKKAJI: J213.546I","cpd:C00004; cpd:C20744; cpd:C21423; cpd:C21424",21,29,14,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H30O14N7P2","C21H28O14N7P2",665.1247726,666.1325977,664.1169476
"cpd:C00008","ADP;","C10H15N5O10P2","ADP; Adenosine 5'-diphosphate","R00002 R00076 R00086 R00104 R00105 R00122 R00123 R00124; R00125 R00126 R00127 R00129 R00130 R00139 R00140 R00141; R00149 R00150 R00156 R00157 R00158 R00162 R00174 R00185; R00187 R00200 R00229 R00239 R00241 R00251 R00253 R00283; R00299 R00315 R00330 R00331 R00332 R00333 R00334 R00341; R00344 R00352 R00405 R00437 R00480 R00482 R00497 R00509; R00512 R00513 R00518 R00530 R00549 R00554 R00570 R00571; R00573 R00575 R00616 R00617 R00722 R00742 R00756 R00760; R00774 R00847 R00866 R00867 R00894 R00910 R00912 R00920; R00942 R00943 R00949 R00964 R01011 R01021 R01050 R01051; R01052 R01053 R01059 R01092 R01121 R01131 R01137 R01150; R01164 R01201 R01228 R01256 R01322 R01326 R01353 R01395; R01417 R01441 R01468 R01476 R01495 R01512 R01514 R01523; R01526 R01541 R01547 R01567 R01568 R01573 R01585 R01600; R01639 R01654 R01665 R01666 R01688 R01724 R01737 R01754; R01771 R01786 R01843 R01844 R01857 R01859 R01881 R01888; R01901 R01902 R01909 R01917 R01926 R01961 R01967 R01980; R01991 R02017 R02071 R02089 R02090 R02093 R02094 R02098; R02099 R02134 R02136 R02184 R02225 R02227 R02237 R02238; R02240 R02245 R02301 R02303 R02324 R02326 R02331 R02402; R02404 R02412 R02420 R02421 R02430 R02439 R02451 R02493; R02575 R02584 R02625 R02626 R02649 R02650 R02658 R02664; R02705 R02732 R02741 R02750 R02757 R02758 R02783 R02786; R02788 R02848 R02865 R02884 R02903 R02927 R02929 R02971; R02976 R02980 R03014 R03018 R03095 R03142 R03150 R03157; R03161 R03182 R03187 R03193 R03236 R03241 R03245 R03272; R03274 R03286 R03298 R03315 R03347 R03361 R03362 R03384; R03387 R03395 R03428 R03429 R03433 R03449 R03469 R03471; R03474 R03478 R03479 R03494 R03516 R03530 R03576 R03607; R03632 R03691 R03744 R03754 R03766 R03770 R03780 R03785; R03819 R03822 R03840 R03877 R03905 R03920 R03939 R03944; R04002 R04023 R04068 R04126 R04138 R04143 R04144 R04208; R04212 R04235 R04241 R04267 R04275 R04358 R04369 R04385; R04388 R04391 R04401 R04403 R04448 R04463 R04504 R04509; R04545 R04555 R04573 R04589 R04591 R04617 R04657 R04730; R04779 R04928 R05030 R05185 R05186 R05197 R05202 R05221; R05224 R05225 R05227 R05328 R05453 R05496 R05626 R05634; R05646 R05661 R05795 R05799 R05800 R05801 R05802 R05803; R05804 R05805 R05806 R05815 R06282 R06367 R06396 R06529; R06531 R06588 R06836 R06974 R06975 R06976 R07127 R07279; R07302 R07404 R07414 R07641 R07642 R07828 R08052 R08124; R08154 R08201 R08217 R08223 R08232 R08233 R08241 R08242; R08323 R08352 R08353 R08354 R08355 R08515 R08572 R08676; R08844 R08855 R08905 R08906 R08924 R08946 R08962 R08964; R08967 R08968 R09053 R09060 R09084 R09085 R09086 R09087; R09378 R09401 R09588 R09590 R09592 R09593 R09594 R09595; R09596 R09598 R09599 R09640 R09665 R09729 R09767 R09770; R09775 R09776 R09880 R09945 R09946 R09978 R10065 R10093; R10267 R10268 R10288 R10470 R10531 R10548 R10561 R10657; R10677 R10678 R10679 R10693 R10758 R10772 R10779 R10780; R10821 R10822 R10892 R10901 R10902 R10929 R10930 R10941; R10942 R10943 R10944 R10948 R10951 R10953 R10970 R10993; R10994 R11024 R11039 R11064 R11085 R11090 R11183 R11184; R11185 R11207 R11234 R11319 R11400 R11406 R11460 R11461; R11530 R11531 R11535 R11536","Oxidative phosphorylation; Photosynthesis; Purine metabolism; Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; FoxO signaling pathway; Neuroactive ligand-receptor interaction; Lysosome; AMPK signaling pathway; Platelet activation; Taste transduction; Renin secretion; Parkinson's disease","1.3.7.7; 1.3.7.8; 1.3.7.14; 1.3.7.15; 1.17.4.1; 1.18.6.1; 1.19.6.1; 2.1.2.-; 2.3.3.8; 2.4.1.13; 2.4.1.21; 2.4.1.113; 2.4.1.213; 2.4.1.242; 2.4.1.245; 2.4.1.268; 2.4.1.342; 2.5.1.112; 2.7.1.1; 2.7.1.2; 2.7.1.3; 2.7.1.4; 2.7.1.5; 2.7.1.6; 2.7.1.7; 2.7.1.8; 2.7.1.10; 2.7.1.11; 2.7.1.12; 2.7.1.13; 2.7.1.14; 2.7.1.15; 2.7.1.16; 2.7.1.17; 2.7.1.18; 2.7.1.19; 2.7.1.20; 2.7.1.21; 2.7.1.22; 2.7.1.23; 2.7.1.24; 2.7.1.25; 2.7.1.26; 2.7.1.27; 2.7.1.28; 2.7.1.29; 2.7.1.30; 2.7.1.31; 2.7.1.32; 2.7.1.33; 2.7.1.34; 2.7.1.35; 2.7.1.36; 2.7.1.39; 2.7.1.40; 2.7.1.43; 2.7.1.44; 2.7.1.45; 2.7.1.46; 2.7.1.47; 2.7.1.48; 2.7.1.49; 2.7.1.50; 2.7.1.51; 2.7.1.52; 2.7.1.53; 2.7.1.54; 2.7.1.55; 2.7.1.56; 2.7.1.58; 2.7.1.59; 2.7.1.60; 2.7.1.64; 2.7.1.65; 2.7.1.66; 2.7.1.67; 2.7.1.68; 2.7.1.71; 2.7.1.72; 2.7.1.73; 2.7.1.74; 2.7.1.76; 2.7.1.78; 2.7.1.82; 2.7.1.83; 2.7.1.84; 2.7.1.85; 2.7.1.86; 2.7.1.87; 2.7.1.88; 2.7.1.89; 2.7.1.91; 2.7.1.92; 2.7.1.93; 2.7.1.94; 2.7.1.95; 2.7.1.100; 2.7.1.101; 2.7.1.102; 2.7.1.103; 2.7.1.105; 2.7.1.107; 2.7.1.113; 2.7.1.118; 2.7.1.119; 2.7.1.122; 2.7.1.127; 2.7.1.130; 2.7.1.134; 2.7.1.136; 2.7.1.137; 2.7.1.138; 2.7.1.140; 2.7.1.144; 2.7.1.145; 2.7.1.146; 2.7.1.147; 2.7.1.148; 2.7.1.149; 2.7.1.150; 2.7.1.151; 2.7.1.153; 2.7.1.154; 2.7.1.156; 2.7.1.157; 2.7.1.158; 2.7.1.159; 2.7.1.162; 2.7.1.163; 2.7.1.164; 2.7.1.165; 2.7.1.166; 2.7.1.167; 2.7.1.168; 2.7.1.169; 2.7.1.170; 2.7.1.173; 2.7.1.175; 2.7.1.176; 2.7.1.177; 2.7.1.178; 2.7.1.179; 2.7.1.181; 2.7.1.183; 2.7.1.184; 2.7.1.185; 2.7.1.186; 2.7.1.187; 2.7.1.188; 2.7.1.189; 2.7.1.209; 2.7.1.210; 2.7.1.212; 2.7.1.213; 2.7.1.214; 2.7.1.215; 2.7.1.-; 2.7.2.1; 2.7.2.2; 2.7.2.3; 2.7.2.4; 2.7.2.6; 2.7.2.7; 2.7.2.8; 2.7.2.11; 2.7.2.13; 2.7.2.14; 2.7.2.15; 2.7.2.-; 2.7.3.1; 2.7.3.2; 2.7.3.3; 2.7.3.4; 2.7.3.5; 2.7.3.6; 2.7.3.7; 2.7.3.8; 2.7.3.10; 2.7.4.1; 2.7.4.2; 2.7.4.3; 2.7.4.4; 2.7.4.6; 2.7.4.7; 2.7.4.8; 2.7.4.9; 2.7.4.10; 2.7.4.11; 2.7.4.12; 2.7.4.13; 2.7.4.14; 2.7.4.15; 2.7.4.16; 2.7.4.18; 2.7.4.19; 2.7.4.21; 2.7.4.22; 2.7.4.23; 2.7.4.24; 2.7.4.25; 2.7.4.26; 2.7.4.31; 2.7.4.-; 2.7.7.5; 2.7.7.8; 2.7.7.35; 2.7.7.36; 2.7.7.53; 2.7.7.89; 2.7.10.1; 2.7.10.2; 2.7.11.1; 2.7.11.2; 2.7.11.3; 2.7.11.4; 2.7.11.5; 2.7.11.6; 2.7.11.7; 2.7.11.8; 2.7.11.9; 2.7.11.10; 2.7.11.11; 2.7.11.12; 2.7.11.13; 2.7.11.14; 2.7.11.15; 2.7.11.17; 2.7.11.18; 2.7.11.19; 2.7.11.21; 2.7.11.22; 2.7.11.23; 2.7.11.24; 2.7.11.25; 2.7.11.26; 2.7.11.27; 2.7.11.28; 2.7.11.29; 2.7.11.30; 2.7.11.31; 2.7.12.1; 2.7.12.2; 2.7.13.1; 2.7.13.2; 2.7.14.1; 3.5.2.9; 3.5.2.14; 3.5.4.7; 3.5.4.17; 3.6.1.3; 3.6.1.5; 3.6.1.8; 3.6.1.15; 3.6.1.29; 3.6.1.41; 3.6.1.61; 3.6.3.1; 3.6.3.2; 3.6.3.3; 3.6.3.4; 3.6.3.5; 3.6.3.6; 3.6.3.7; 3.6.3.8; 3.6.3.9; 3.6.3.10; 3.6.3.11; 3.6.3.12; 3.6.3.14; 3.6.3.15; 3.6.3.16; 3.6.3.17; 3.6.3.18; 3.6.3.19; 3.6.3.20; 3.6.3.21; 3.6.3.22; 3.6.3.23; 3.6.3.24; 3.6.3.25; 3.6.3.26; 3.6.3.27; 3.6.3.28; 3.6.3.29; 3.6.3.30; 3.6.3.31; 3.6.3.32; 3.6.3.33; 3.6.3.34; 3.6.3.35; 3.6.3.36; 3.6.3.37; 3.6.3.38; 3.6.3.39; 3.6.3.40; 3.6.3.41; 3.6.3.42; 3.6.3.43; 3.6.3.44; 3.6.3.46; 3.6.3.47; 3.6.3.48; 3.6.3.49; 3.6.3.50; 3.6.3.51; 3.6.3.52; 3.6.3.53; 3.6.3.54; 3.6.3.55; 3.6.4.1; 3.6.4.2; 3.6.4.3; 3.6.4.4; 3.6.4.5; 3.6.4.6; 3.6.4.7; 3.6.4.8; 3.6.4.9; 3.6.4.10; 3.6.4.11; 3.6.4.12; 3.6.4.13; 4.1.1.33; 4.1.1.49; 4.1.1.99; 4.2.1.93; 4.2.1.136; 4.6.1.-; 6.1.2.1; 6.2.1.5; 6.2.1.6; 6.2.1.9; 6.2.1.13; 6.2.1.18; 6.2.1.39; 6.2.1.-; 6.3.1.2; 6.3.1.4; 6.3.1.6; 6.3.1.8; 6.3.1.9; 6.3.1.10; 6.3.1.11; 6.3.1.12; 6.3.1.17; 6.3.1.18; 6.3.1.19; 6.3.2.2; 6.3.2.3; 6.3.2.4; 6.3.2.6; 6.3.2.7; 6.3.2.8; 6.3.2.9; 6.3.2.10; 6.3.2.11; 6.3.2.12; 6.3.2.13; 6.3.2.16; 6.3.2.17; 6.3.2.18; 6.3.2.20; 6.3.2.23; 6.3.2.25; 6.3.2.29; 6.3.2.30; 6.3.2.32; 6.3.2.33; 6.3.2.35; 6.3.2.37; 6.3.2.41; 6.3.2.42; 6.3.2.43; 6.3.2.44; 6.3.2.45; 6.3.2.47; 6.3.2.48; 6.3.2.49; 6.3.2.-; 6.3.3.1; 6.3.3.2; 6.3.3.3; 6.3.3.5; 6.3.4.2; 6.3.4.3; 6.3.4.6; 6.3.4.7; 6.3.4.8; 6.3.4.12; 6.3.4.13; 6.3.4.14; 6.3.4.16; 6.3.4.17; 6.3.4.18; 6.3.4.20; 6.3.4.21; 6.3.4.23; 6.3.4.24; 6.3.5.3; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-; 6.4.1.1; 6.4.1.2; 6.4.1.3; 6.4.1.4; 6.4.1.5; 6.4.1.7; 6.4.1.8; 6.5.1.7; 6.6.1.1; 6.6.1.2","Adenine ribonucleotide biosynthesis, IMP => ADP,ATP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00008  ADP","CAS: 58-64-0; PubChem: 3310; ChEBI: 16761; ChEMBL: CHEMBL14830; KNApSAcK: C00019353; PDB-CCD: ADP; 3DMET: B01130; NIKKAJI: J10.683F","cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850",10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O10N5P2","C10H14O10N5P2",427.0294157,428.0372407,426.0215907
"cpd:C00061","FMN;","C17H21N4O9P","FMN; Riboflavin-5-phosphate; Flavin mononucleotide","R00025 R00160 R00161 R00548 R00549 R00550 R05218 R05705; R05706 R07210 R07664 R08574 R08908 R09313 R09314 R09559; R09798 R09819 R09936 R09937 R10203 R10206 R10551 R11161; R11162 R11163 R11164 R11404 R11454 R11455 R11456 R11457","Oxidative phosphorylation; Riboflavin metabolism; Biosynthesis of type II polyketide products; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption","1.1.99.31; 1.3.99.24; 1.5.1.36; 1.5.1.38; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.-; 1.13.12.16; 1.14.14.3; 1.14.14.5; 1.14.14.10; 1.14.14.12; 1.14.14.13; 1.14.14.21; 1.14.14.22; 1.14.14.30; 1.14.14.33; 1.14.14.34; 1.14.14.35; 1.14.14.-; 1.14.99.46; 1.16.8.1; 2.7.1.26; 2.7.1.42; 2.7.1.161; 2.7.7.2; 3.1.3.2; 3.1.3.102; 3.6.1.9; 3.6.1.18","Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00061  FMN","CAS: 146-17-8; PubChem: 3361; ChEBI: 17621; ChEMBL: CHEMBL1201794; KNApSAcK: C00019686; PDB-CCD: FMN; 3DMET: B04626; NIKKAJI: J30.175B","cpd:C00061",17,21,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H22O9N4P1","C17H20O9N4P1",456.1046153,457.1124403,455.0967902
"cpd:C00005","NADPH;","C21H30N7O17P3","NADPH; TPNH; Reduced nicotinamide adenine dinucleotide phosphate","R00105 R00106 R00107 R00108 R00109 R00111 R00112 R00113; R00114 R00115 R00134 R00146 R00205 R00210 R00216 R00248; R00264 R00265 R00267 R00282 R00301 R00343 R00385 R00387; R00448 R00452 R00465 R00468 R00557 R00558 R00563 R00625; R00634 R00666 R00676 R00706 R00708 R00711 R00714 R00716; R00733 R00740 R00744 R00746 R00789 R00796 R00814 R00815; R00825 R00828 R00834 R00835 R00844 R00845 R00858 R00870; R00871 R00900 R00918 R00919 R00939 R00940 R00941 R00978; R00980 R01039 R01041 R01058 R01063 R01079 R01095 R01096; R01097 R01134 R01143 R01173 R01195 R01212 R01220 R01224; R01249 R01251 R01260 R01278 R01294 R01295 R01298 R01299; R01338 R01371 R01392 R01404 R01415 R01420 R01430 R01431; R01452 R01453 R01456 R01457 R01463 R01481 R01488 R01490; R01521 R01525 R01528 R01543 R01550 R01575 R01584 R01607; R01615 R01628 R01630 R01694 R01708 R01720 R01730 R01739; R01740 R01747 R01750 R01759 R01775 R01779 R01787 R01794; R01812 R01813 R01817 R01835 R01838 R01866 R01899 R01904; R01938 R01941 R01960 R01976 R01977 R01986 R02002 R02016; R02034 R02063 R02082 R02177 R02178 R02193 R02203 R02208; R02209 R02210 R02219 R02220 R02224 R02231 R02236 R02247; R02253 R02254 R02259 R02260 R02291 R02315 R02339 R02349; R02353 R02355 R02356 R02364 R02393 R02413 R02417 R02442; R02449 R02456 R02463 R02468 R02469 R02470 R02472 R02477; R02497 R02498 R02506 R02516 R02517 R02518 R02528 R02537; R02548 R02554 R02562 R02566 R02577 R02581 R02593 R02600; R02609 R02610 R02620 R02639 R02680 R02684 R02697 R02736; R02742 R02755 R02756 R02767 R02776 R02777 R02793 R02799; R02800 R02807 R02820 R02829 R02832 R02836 R02841 R02856; R02872 R02874 R02892 R02893 R02906 R02915 R02936 R02954; R02975 R02978 R02983 R02989 R02995 R02999 R03006 R03044; R03051 R03054 R03089 R03090 R03103 R03114 R03123 R03124; R03155 R03183 R03192 R03203 R03227 R03234 R03264 R03281; R03292 R03293 R03302 R03313 R03322 R03325 R03338 R03339; R03344 R03357 R03386 R03388 R03392 R03398 R03399 R03401; R03407 R03408 R03440 R03443 R03452 R03458 R03463 R03495; R03498 R03520 R03545 R03555 R03556 R03557 R03560 R03562; R03566 R03568 R03572 R03581 R03583 R03585 R03586 R03592; R03596 R03608 R03611 R03615 R03636 R03638 R03639 R03667; R03689 R03712 R03713 R03716 R03728 R03753 R03764 R03776; R03821 R03827 R03834 R03842 R03845 R03848 R03850 R03856; R03860 R03864 R03866 R03879 R03883 R03900 R03914 R03918; R03930 R03962 R03982 R03989 R03997 R03999 R04047 R04059; R04060 R04099 R04105 R04106 R04109 R04136 R04186 R04199; R04201 R04229 R04256 R04264 R04265 R04279 R04285 R04303; R04310 R04319 R04328 R04340 R04342 R04344 R04360 R04370; R04387 R04390 R04400 R04419 R04430 R04439 R04440 R04445; R04453 R04518 R04523 R04533 R04534 R04536 R04543 R04552; R04557 R04566 R04570 R04599 R04601 R04623 R04670 R04675; R04682 R04688 R04690 R04694 R04695 R04696 R04697 R04699; R04700 R04702 R04708 R04725 R04753 R04758 R04789 R04790; R04817 R04819 R04823 R04825 R04830 R04833 R04836 R04838; R04840 R04843 R04846 R04853 R04883 R04889 R04892 R04901; R04902 R04910 R04917 R04919 R04940 R04953 R04956 R04959; R04962 R04964 R04967 R04970 R04980 R04984 R04987 R04989; R05038 R05068 R05099 R05102 R05124 R05150 R05182 R05188; R05189 R05190 R05210 R05215 R05231 R05244 R05249 R05250; R05258 R05262 R05264 R05270 R05276 R05289 R05291 R05293; R05308 R05350 R05396 R05400 R05401 R05432 R05433 R05436; R05438 R05441 R05462 R05463 R05471 R05521 R05522 R05526; R05576 R05622 R05623 R05639 R05640 R05641 R05663 R05664; R05680 R05682 R05684 R05686 R05687 R05688 R05691 R05692; R05694 R05701 R05702 R05703 R05706 R05707 R05711 R05713; R05714 R05716 R05725 R05727 R05731 R05732 R05736 R05737; R05738 R05741 R05823 R05827 R05828 R05832 R05833 R05847; R05848 R05855 R05866 R05874 R05877 R05878 R05879 R06119; R06126 R06146 R06166 R06223 R06265 R06266 R06267 R06272; R06286 R06290 R06291 R06292 R06293 R06294 R06295 R06296; R06297 R06308 R06309 R06351 R06354 R06386 R06387 R06388; R06389 R06400 R06417 R06419 R06420 R06434 R06436 R06448; R06449 R06453 R06454 R06458 R06459 R06462 R06463 R06464; R06465 R06467 R06468 R06470 R06472 R06473 R06474 R06475; R06480 R06481 R06482 R06483 R06532 R06533 R06537 R06538; R06541 R06542 R06543 R06560 R06561 R06562 R06563 R06568; R06569 R06570 R06571 R06572 R06573 R06582 R06606 R06607; R06610 R06613 R06615 R06622 R06629 R06642 R06677 R06682; R06683 R06688 R06689 R06690 R06691 R06692 R06704 R06734; R06792 R06846 R06851 R06890 R06892 R06896 R06985 R07000; R07001 R07015 R07016 R07020 R07021 R07022 R07041 R07046; R07048 R07050 R07051 R07052 R07054 R07055 R07056 R07060; R07066 R07068 R07075 R07079 R07080 R07081 R07085 R07087; R07088 R07089 R07090 R07098 R07099 R07107 R07112 R07137; R07138 R07140 R07142 R07143 R07144 R07147 R07149 R07150; R07162 R07165 R07169 R07172 R07175 R07181 R07191 R07192; R07193 R07195 R07196 R07197 R07198 R07201 R07202 R07203; R07204 R07205 R07206 R07207 R07208 R07216 R07217 R07241; R07251 R07253 R07328 R07346 R07350 R07352 R07355 R07356; R07357 R07359 R07369 R07370 R07371 R07373 R07403 R07407; R07418 R07421 R07422 R07423 R07429 R07430 R07437 R07440; R07442 R07445 R07447 R07452 R07453 R07454 R07470 R07474; R07483 R07488 R07489 R07493 R07494 R07495 R07498 R07499; R07506 R07507 R07509 R07605 R07666 R07676 R07710 R07711; R07714 R07715 R07727 R07728 R07737 R07739 R07745 R07746; R07747 R07748 R07751 R07752 R07759 R07761 R07763 R07776; R07777 R07778 R07779 R07786 R07787 R07791 R07792 R07836; R07837 R07939 R07956 R07958 R07960 R07962 R07964 R07966; R07968 R07970 R07972 R07974 R07976 R07998 R07999 R08002; R08014 R08015 R08016 R08019 R08032 R08059 R08083 R08084; R08085 R08148 R08160 R08168 R08194 R08203 R08204 R08205; R08206 R08207 R08208 R08226 R08266 R08267 R08270 R08271; R08274 R08275 R08283 R08285 R08294 R08303 R08304 R08312; R08313 R08325 R08326 R08327 R08356 R08357 R08379 R08380; R08383 R08390 R08391 R08392 R08442 R08492 R08494 R08499; R08510 R08539 R08551 R08558 R08561 R08562 R08563 R08573; R08604 R08607 R08651 R08652 R08653 R08655 R08659 R08663; R08664 R08665 R08666 R08670 R08672 R08673 R08674 R08675; R08684 R08685 R08705 R08710 R08711 R08725 R08726 R08727; R08754 R08755 R08756 R08768 R08775 R08784 R08790 R08815; R08838 R08851 R08852 R08853 R08854 R08861 R08878 R08879; R08880 R08912 R08913 R08915 R08917 R08922 R08923 R08925; R08935 R08943 R08954 R08955 R08957 R08958 R08959 R08960; R08961 R08963 R08980 R09002 R09042 R09070 R09079 R09080; R09122 R09131 R09133 R09138 R09190 R09193 R09194 R09198; R09234 R09240 R09241 R09242 R09243 R09262 R09263 R09264; R09275 R09280 R09281 R09289 R09291 R09306 R09309 R09329; R09353 R09372 R09376 R09389 R09390 R09393 R09403 R09404; R09405 R09406 R09407 R09408 R09416 R09418 R09420 R09421; R09423 R09424 R09425 R09441 R09442 R09446 R09449 R09451; R09452 R09453 R09454 R09460 R09461 R09470 R09485 R09512; R09520 R09521 R09522 R09541 R09546 R09547 R09548 R09549; R09554 R09555 R09557 R09573 R09575 R09576 R09577 R09578; R09579 R09580 R09583 R09584 R09602 R09738 R09749 R09756; R09777 R09806 R09812 R09813 R09814 R09815 R09816 R09817; R09818 R09820 R09838 R09861 R09862 R09863 R09864 R09865; R09866 R09867 R09868 R09921 R09926 R09927 R09928 R09929; R09930 R09931 R09932 R09933 R09934 R09935 R09954 R09985; R09987 R09989 R09990 R10023 R10024 R10025 R10026 R10027; R10028 R10031 R10032 R10036 R10038 R10044 R10045 R10058; R10059 R10066 R10067 R10068 R10069 R10072 R10073 R10075; R10076 R10077 R10080 R10104 R10105 R10114 R10116 R10118; R10120 R10122 R10127 R10130 R10132 R10154 R10155 R10159; R10181 R10194 R10225 R10226 R10227 R10228 R10229 R10242; R10248 R10249 R10258 R10260 R10268 R10288 R10289 R10309; R10313 R10314 R10315 R10316 R10317 R10318 R10319 R10320; R10321 R10323 R10326 R10350 R10351 R10356 R10357 R10358; R10359 R10361 R10362 R10366 R10367 R10368 R10371 R10373; R10376 R10379 R10381 R10399 R10400 R10414 R10416 R10417; R10418 R10421 R10423 R10429 R10438 R10476 R10477 R10478; R10479 R10512 R10518 R10528 R10540 R10549 R10562 R10563; R10573 R10591 R10593 R10615 R10626 R10627 R10628 R10637; R10656 R10662 R10663 R10664 R10665 R10670 R10671 R10672; R10692 R10694 R10704 R10725 R10727 R10728 R10730 R10786; R10787 R10788 R10789 R10791 R10793 R10794 R10795 R10799; R10801 R10826 R10828 R10851 R10852 R10862 R10875 R10877; R10878 R10879 R10882 R10919 R10921 R10922 R10923 R10924; R10925 R10931 R10954 R10982 R10984 R10999 R11000 R11008; R11019 R11032 R11051 R11054 R11061 R11096 R11097 R11107; R11124 R11125 R11132 R11134 R11135 R11145 R11146 R11152; R11157 R11195 R11198 R11211 R11212 R11222 R11226 R11232; R11266 R11276 R11277 R11341 R11358 R11359 R11360 R11361; R11383 R11385 R11405 R11425 R11426 R11427 R11435 R11445; R11446 R11447 R11449 R11450 R11451 R11474 R11477 R11485; R11500 R11518 R11525 R11526","Photosynthesis; Glutathione metabolism; Metabolic pathways; Thyroid hormone synthesis; Aldosterone synthesis and secretion","1.1.1.1; 1.1.1.2; 1.1.1.3; 1.1.1.10; 1.1.1.19; 1.1.1.20; 1.1.1.21; 1.1.1.25; 1.1.1.33; 1.1.1.34; 1.1.1.36; 1.1.1.40; 1.1.1.42; 1.1.1.43; 1.1.1.44; 1.1.1.47; 1.1.1.48; 1.1.1.49; 1.1.1.50; 1.1.1.51; 1.1.1.54; 1.1.1.55; 1.1.1.60; 1.1.1.62; 1.1.1.64; 1.1.1.65; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.79; 1.1.1.80; 1.1.1.81; 1.1.1.82; 1.1.1.86; 1.1.1.91; 1.1.1.92; 1.1.1.94; 1.1.1.97; 1.1.1.100; 1.1.1.101; 1.1.1.102; 1.1.1.104; 1.1.1.111; 1.1.1.112; 1.1.1.113; 1.1.1.115; 1.1.1.117; 1.1.1.119; 1.1.1.120; 1.1.1.123; 1.1.1.124; 1.1.1.126; 1.1.1.130; 1.1.1.131; 1.1.1.133; 1.1.1.134; 1.1.1.135; 1.1.1.137; 1.1.1.138; 1.1.1.142; 1.1.1.145; 1.1.1.146; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.151; 1.1.1.153; 1.1.1.154; 1.1.1.156; 1.1.1.157; 1.1.1.160; 1.1.1.162; 1.1.1.168; 1.1.1.169; 1.1.1.170; 1.1.1.176; 1.1.1.177; 1.1.1.179; 1.1.1.181; 1.1.1.183; 1.1.1.184; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.188; 1.1.1.189; 1.1.1.191; 1.1.1.193; 1.1.1.194; 1.1.1.195; 1.1.1.196; 1.1.1.197; 1.1.1.200; 1.1.1.201; 1.1.1.206; 1.1.1.207; 1.1.1.208; 1.1.1.209; 1.1.1.210; 1.1.1.213; 1.1.1.214; 1.1.1.215; 1.1.1.216; 1.1.1.217; 1.1.1.218; 1.1.1.219; 1.1.1.220; 1.1.1.222; 1.1.1.224; 1.1.1.225; 1.1.1.229; 1.1.1.230; 1.1.1.231; 1.1.1.232; 1.1.1.234; 1.1.1.235; 1.1.1.236; 1.1.1.237; 1.1.1.238; 1.1.1.243; 1.1.1.247; 1.1.1.248; 1.1.1.252; 1.1.1.256; 1.1.1.261; 1.1.1.263; 1.1.1.264; 1.1.1.265; 1.1.1.266; 1.1.1.267; 1.1.1.270; 1.1.1.271; 1.1.1.272; 1.1.1.273; 1.1.1.274; 1.1.1.276; 1.1.1.277; 1.1.1.278; 1.1.1.279; 1.1.1.280; 1.1.1.281; 1.1.1.282; 1.1.1.283; 1.1.1.284; 1.1.1.285; 1.1.1.287; 1.1.1.289; 1.1.1.292; 1.1.1.294; 1.1.1.295; 1.1.1.298; 1.1.1.299; 1.1.1.300; 1.1.1.302; 1.1.1.307; 1.1.1.312; 1.1.1.313; 1.1.1.314; 1.1.1.317; 1.1.1.318; 1.1.1.319; 1.1.1.320; 1.1.1.321; 1.1.1.322; 1.1.1.323; 1.1.1.324; 1.1.1.325; 1.1.1.328; 1.1.1.329; 1.1.1.330; 1.1.1.334; 1.1.1.338; 1.1.1.341; 1.1.1.342; 1.1.1.344; 1.1.1.346; 1.1.1.348; 1.1.1.349; 1.1.1.351; 1.1.1.353; 1.1.1.355; 1.1.1.356; 1.1.1.357; 1.1.1.358; 1.1.1.359; 1.1.1.360; 1.1.1.362; 1.1.1.363; 1.1.1.364; 1.1.1.365; 1.1.1.367; 1.1.1.371; 1.1.1.372; 1.1.1.375; 1.1.1.376; 1.1.1.377; 1.1.1.378; 1.1.1.381; 1.1.1.383; 1.1.1.384; 1.1.1.386; 1.1.1.392; 1.1.1.393; 1.1.1.402; 1.1.1.-; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.7; 1.2.1.8; 1.2.1.9; 1.2.1.11; 1.2.1.13; 1.2.1.15; 1.2.1.16; 1.2.1.17; 1.2.1.18; 1.2.1.26; 1.2.1.28; 1.2.1.30; 1.2.1.31; 1.2.1.38; 1.2.1.41; 1.2.1.43; 1.2.1.44; 1.2.1.49; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.59; 1.2.1.63; 1.2.1.68; 1.2.1.70; 1.2.1.75; 1.2.1.76; 1.2.1.77; 1.2.1.79; 1.2.1.80; 1.2.1.81; 1.2.1.83; 1.2.1.84; 1.2.1.88; 1.2.1.89; 1.2.1.90; 1.2.1.91; 1.2.1.92; 1.2.1.96; 1.2.1.-; 1.3.1.2; 1.3.1.3; 1.3.1.5; 1.3.1.8; 1.3.1.10; 1.3.1.13; 1.3.1.15; 1.3.1.16; 1.3.1.17; 1.3.1.20; 1.3.1.21; 1.3.1.22; 1.3.1.24; 1.3.1.27; 1.3.1.32; 1.3.1.33; 1.3.1.34; 1.3.1.36; 1.3.1.37; 1.3.1.38; 1.3.1.39; 1.3.1.40; 1.3.1.42; 1.3.1.45; 1.3.1.46; 1.3.1.47; 1.3.1.48; 1.3.1.51; 1.3.1.54; 1.3.1.57; 1.3.1.67; 1.3.1.69; 1.3.1.70; 1.3.1.71; 1.3.1.72; 1.3.1.73; 1.3.1.74; 1.3.1.75; 1.3.1.77; 1.3.1.78; 1.3.1.79; 1.3.1.81; 1.3.1.82; 1.3.1.83; 1.3.1.84; 1.3.1.85; 1.3.1.86; 1.3.1.92; 1.3.1.93; 1.3.1.96; 1.3.1.97; 1.3.1.98; 1.3.1.101; 1.3.1.102; 1.3.1.103; 1.3.1.104; 1.3.1.105; 1.3.1.107; 1.3.1.111; 1.3.1.112; 1.3.1.-; 1.3.3.9; 1.3.99.6; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.12; 1.4.1.13; 1.4.1.15; 1.4.1.16; 1.4.1.17; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.-; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.5; 1.5.1.6; 1.5.1.8; 1.5.1.10; 1.5.1.16; 1.5.1.19; 1.5.1.20; 1.5.1.21; 1.5.1.24; 1.5.1.25; 1.5.1.27; 1.5.1.30; 1.5.1.31; 1.5.1.32; 1.5.1.33; 1.5.1.34; 1.5.1.38; 1.5.1.39; 1.5.1.40; 1.5.1.41; 1.5.1.43; 1.5.1.45; 1.5.1.46; 1.5.1.47; 1.5.1.48; 1.5.1.49; 1.5.1.50; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.4; 1.6.2.5; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.5.2; 1.6.5.5; 1.6.5.6; 1.6.5.10; 1.6.5.12; 1.6.99.1; 1.7.1.2; 1.7.1.3; 1.7.1.4; 1.7.1.6; 1.7.1.7; 1.7.1.9; 1.7.1.11; 1.7.1.12; 1.7.1.13; 1.7.1.14; 1.7.1.-; 1.8.1.2; 1.8.1.5; 1.8.1.7; 1.8.1.8; 1.8.1.9; 1.8.1.10; 1.8.1.12; 1.8.1.13; 1.8.1.14; 1.8.1.15; 1.8.1.18; 1.8.1.19; 1.10.1.1; 1.11.1.2; 1.12.1.3; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.-; 1.14.12.1; 1.14.12.4; 1.14.12.5; 1.14.12.10; 1.14.12.17; 1.14.12.18; 1.14.12.22; 1.14.12.-; 1.14.13.2; 1.14.13.7; 1.14.13.8; 1.14.13.9; 1.14.13.11; 1.14.13.12; 1.14.13.14; 1.14.13.16; 1.14.13.18; 1.14.13.19; 1.14.13.20; 1.14.13.21; 1.14.13.22; 1.14.13.23; 1.14.13.25; 1.14.13.27; 1.14.13.28; 1.14.13.30; 1.14.13.31; 1.14.13.32; 1.14.13.33; 1.14.13.34; 1.14.13.35; 1.14.13.36; 1.14.13.37; 1.14.13.38; 1.14.13.39; 1.14.13.40; 1.14.13.43; 1.14.13.46; 1.14.13.47; 1.14.13.48; 1.14.13.49; 1.14.13.50; 1.14.13.51; 1.14.13.52; 1.14.13.53; 1.14.13.54; 1.14.13.55; 1.14.13.56; 1.14.13.57; 1.14.13.58; 1.14.13.59; 1.14.13.63; 1.14.13.64; 1.14.13.66; 1.14.13.67; 1.14.13.70; 1.14.13.71; 1.14.13.72; 1.14.13.73; 1.14.13.74; 1.14.13.75; 1.14.13.76; 1.14.13.77; 1.14.13.78; 1.14.13.79; 1.14.13.80; 1.14.13.81; 1.14.13.84; 1.14.13.85; 1.14.13.87; 1.14.13.88; 1.14.13.89; 1.14.13.91; 1.14.13.92; 1.14.13.93; 1.14.13.94; 1.14.13.96; 1.14.13.97; 1.14.13.101; 1.14.13.102; 1.14.13.103; 1.14.13.104; 1.14.13.105; 1.14.13.106; 1.14.13.107; 1.14.13.108; 1.14.13.109; 1.14.13.110; 1.14.13.112; 1.14.13.115; 1.14.13.116; 1.14.13.117; 1.14.13.118; 1.14.13.119; 1.14.13.120; 1.14.13.121; 1.14.13.122; 1.14.13.123; 1.14.13.124; 1.14.13.125; 1.14.13.128; 1.14.13.133; 1.14.13.134; 1.14.13.135; 1.14.13.136; 1.14.13.137; 1.14.13.138; 1.14.13.139; 1.14.13.140; 1.14.13.143; 1.14.13.144; 1.14.13.145; 1.14.13.146; 1.14.13.147; 1.14.13.148; 1.14.13.149; 1.14.13.150; 1.14.13.153; 1.14.13.154; 1.14.13.156; 1.14.13.157; 1.14.13.158; 1.14.13.160; 1.14.13.161; 1.14.13.165; 1.14.13.167; 1.14.13.168; 1.14.13.170; 1.14.13.171; 1.14.13.172; 1.14.13.173; 1.14.13.174; 1.14.13.175; 1.14.13.176; 1.14.13.177; 1.14.13.178; 1.14.13.179; 1.14.13.180; 1.14.13.181; 1.14.13.183; 1.14.13.184; 1.14.13.185; 1.14.13.186; 1.14.13.187; 1.14.13.188; 1.14.13.189; 1.14.13.190; 1.14.13.194; 1.14.13.195; 1.14.13.196; 1.14.13.197; 1.14.13.198; 1.14.13.199; 1.14.13.200; 1.14.13.201; 1.14.13.202; 1.14.13.203; 1.14.13.204; 1.14.13.206; 1.14.13.208; 1.14.13.210; 1.14.13.211; 1.14.13.213; 1.14.13.214; 1.14.13.216; 1.14.13.217; 1.14.13.219; 1.14.13.221; 1.14.13.222; 1.14.13.224; 1.14.13.225; 1.14.13.226; 1.14.13.228; 1.14.13.229; 1.14.13.231; 1.14.13.232; 1.14.13.233; 1.14.13.234; 1.14.13.-; 1.14.14.1; 1.14.14.16; 1.14.14.17; 1.14.14.19; 1.14.14.23; 1.14.14.24; 1.14.14.25; 1.14.14.26; 1.14.14.29; 1.14.14.36; 1.14.15.3; 1.14.16.-; 1.14.19.21; 1.14.19.41; 1.14.19.48; 1.14.21.1; 1.14.21.2; 1.14.21.3; 1.14.21.4; 1.14.21.5; 1.14.21.7; 1.14.21.8; 1.14.21.9; 1.14.21.10; 1.14.21.11; 1.14.21.12; 1.14.21.-; 1.14.99.2; 1.14.99.34; 1.14.-.-; 1.16.1.1; 1.16.1.5; 1.16.1.6; 1.16.1.8; 1.16.1.9; 1.17.1.1; 1.17.1.3; 1.17.1.5; 1.17.1.8; 1.18.1.2; 1.18.1.4; 1.18.1.6; 1.19.1.1; 1.21.1.1; 1.21.1.2; 1.23.1.1; 1.23.1.2; 1.23.1.3; 1.23.1.4; 1.23.1.-; 1.-.-.-; 2.1.1.147; 2.1.1.148; 2.3.1.85; 2.3.1.86; 2.3.1.94; 2.3.1.111; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.252; 2.3.1.-; 2.5.1.21; 2.7.1.86; 4.1.1.-; 4.1.99.5; 4.2.1.93; 4.2.1.136; 4.2.1.-; 5.3.3.1",NA,NA,"CAS: 2646-71-1; PubChem: 3307; ChEBI: 16474; ChEMBL: CHEMBL1163090 CHEMBL1594246 CHEMBL407009; PDB-CCD: NDP; 3DMET: B01128; NIKKAJI: J208.978E","cpd:C00005; cpd:C20745",21,30,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H31O17N7P3","C21H29O17N7P3",745.0911035,746.0989286,744.0832785
"cpd:C00006","NADP+;","C21H29N7O17P3","NADP+; NADP; Nicotinamide adenine dinucleotide phosphate; beta-Nicotinamide adenine dinucleotide phosphate; TPN; Triphosphopyridine nucleotide; beta-NADP+","R00104 R00106 R00107 R00108 R00109 R00111 R00112 R00113; R00114 R00115 R00118 R00119 R00134 R00146 R00205 R00210; R00216 R00248 R00264 R00265 R00267 R00282 R00301 R00343; R00385 R00387 R00448 R00452 R00465 R00468 R00557 R00558; R00563 R00625 R00634 R00666 R00676 R00706 R00708 R00711; R00714 R00716 R00733 R00740 R00744 R00746 R00789 R00796; R00814 R00815 R00825 R00828 R00834 R00835 R00844 R00845; R00858 R00870 R00871 R00900 R00918 R00919 R00939 R00940; R00941 R00978 R00980 R01039 R01041 R01058 R01063 R01079; R01095 R01096 R01097 R01134 R01143 R01173 R01195 R01212; R01220 R01224 R01249 R01251 R01260 R01278 R01294 R01295; R01298 R01299 R01338 R01371 R01392 R01404 R01415 R01420; R01430 R01431 R01452 R01453 R01456 R01457 R01463 R01481; R01488 R01490 R01521 R01525 R01528 R01543 R01550 R01575; R01584 R01607 R01615 R01628 R01630 R01694 R01708 R01720; R01730 R01739 R01740 R01747 R01750 R01759 R01775 R01779; R01787 R01794 R01812 R01813 R01817 R01835 R01838 R01866; R01899 R01904 R01938 R01941 R01960 R01976 R01977 R01986; R02002 R02016 R02034 R02063 R02082 R02177 R02178 R02193; R02203 R02208 R02209 R02210 R02219 R02220 R02224 R02231; R02236 R02247 R02253 R02254 R02259 R02260 R02291 R02315; R02339 R02349 R02353 R02355 R02356 R02364 R02393 R02413; R02417 R02442 R02449 R02456 R02463 R02468 R02469 R02470; R02472 R02477 R02497 R02498 R02506 R02516 R02517 R02518; R02528 R02537 R02548 R02554 R02562 R02566 R02577 R02581; R02593 R02600 R02609 R02610 R02620 R02639 R02680 R02684; R02697 R02736 R02742 R02755 R02756 R02767 R02776 R02777; R02793 R02799 R02800 R02807 R02820 R02829 R02832 R02836; R02841 R02856 R02872 R02874 R02892 R02893 R02906 R02915; R02936 R02954 R02975 R02978 R02983 R02989 R02995 R02999; R03006 R03044 R03051 R03054 R03089 R03090 R03103 R03114; R03123 R03124 R03155 R03183 R03192 R03203 R03227 R03234; R03264 R03281 R03292 R03293 R03302 R03313 R03322 R03325; R03338 R03339 R03344 R03357 R03386 R03388 R03392 R03398; R03399 R03401 R03407 R03408 R03440 R03443 R03452 R03458; R03463 R03495 R03498 R03520 R03545 R03555 R03556 R03557; R03560 R03562 R03566 R03568 R03572 R03581 R03583 R03585; R03586 R03592 R03596 R03608 R03611 R03615 R03636 R03638; R03639 R03667 R03689 R03712 R03713 R03716 R03728 R03753; R03764 R03776 R03821 R03827 R03834 R03842 R03845 R03848; R03850 R03856 R03860 R03864 R03866 R03879 R03883 R03900; R03914 R03918 R03930 R03962 R03982 R03989 R03997 R03999; R04047 R04059 R04060 R04099 R04105 R04106 R04109 R04136; R04186 R04199 R04201 R04229 R04256 R04264 R04265 R04279; R04285 R04303 R04310 R04319 R04328 R04340 R04342 R04344; R04360 R04370 R04387 R04390 R04400 R04419 R04430 R04439; R04440 R04445 R04453 R04518 R04523 R04533 R04534 R04536; R04543 R04552 R04557 R04566 R04570 R04599 R04601 R04623; R04670 R04675 R04682 R04688 R04690 R04694 R04695 R04696; R04697 R04699 R04700 R04702 R04708 R04725 R04753 R04758; R04789 R04790 R04817 R04819 R04823 R04825 R04830 R04833; R04836 R04838 R04840 R04843 R04846 R04853 R04883 R04889; R04892 R04901 R04902 R04910 R04917 R04919 R04940 R04953; R04956 R04959 R04962 R04964 R04967 R04970 R04980 R04984; R04987 R04989 R05038 R05068 R05099 R05102 R05124 R05150; R05182 R05188 R05189 R05190 R05210 R05215 R05231 R05244; R05249 R05250 R05258 R05262 R05264 R05270 R05276 R05289; R05291 R05293 R05308 R05350 R05396 R05400 R05401 R05432; R05433 R05436 R05438 R05441 R05462 R05463 R05471 R05521; R05522 R05526 R05576 R05622 R05623 R05639 R05640 R05641; R05663 R05664 R05680 R05682 R05684 R05686 R05687 R05688; R05691 R05692 R05694 R05701 R05702 R05703 R05706 R05707; R05711 R05713 R05714 R05716 R05725 R05727 R05731 R05732; R05736 R05737 R05738 R05741 R05823 R05827 R05828 R05832; R05833 R05847 R05848 R05855 R05866 R05874 R05877 R05878; R05879 R06119 R06126 R06146 R06166 R06223 R06265 R06266; R06267 R06272 R06286 R06290 R06291 R06292 R06293 R06294; R06295 R06296 R06297 R06308 R06309 R06351 R06354 R06386; R06387 R06388 R06389 R06400 R06417 R06419 R06420 R06434; R06436 R06448 R06449 R06453 R06454 R06458 R06459 R06462; R06463 R06464 R06465 R06467 R06468 R06470 R06472 R06473; R06474 R06475 R06480 R06481 R06482 R06483 R06532 R06533; R06537 R06538 R06541 R06542 R06543 R06560 R06561 R06562; R06563 R06568 R06569 R06570 R06571 R06572 R06573 R06582; R06606 R06607 R06610 R06613 R06615 R06622 R06629 R06642; R06677 R06682 R06683 R06688 R06689 R06690 R06691 R06692; R06704 R06734 R06792 R06846 R06851 R06890 R06892 R06896; R06985 R07000 R07001 R07015 R07016 R07020 R07021 R07022; R07041 R07046 R07048 R07050 R07051 R07052 R07054 R07055; R07056 R07060 R07066 R07068 R07075 R07079 R07080 R07081; R07085 R07087 R07088 R07089 R07090 R07098 R07099 R07107; R07112 R07137 R07138 R07140 R07142 R07143 R07144 R07147; R07149 R07150 R07162 R07165 R07169 R07172 R07175 R07181; R07191 R07192 R07193 R07195 R07196 R07197 R07198 R07201; R07202 R07203 R07204 R07205 R07206 R07207 R07208 R07216; R07217 R07241 R07251 R07253 R07328 R07346 R07350 R07352; R07355 R07356 R07357 R07359 R07369 R07370 R07371 R07373; R07403 R07407 R07418 R07421 R07422 R07423 R07429 R07430; R07437 R07440 R07442 R07445 R07447 R07452 R07453 R07454; R07470 R07474 R07483 R07488 R07489 R07493 R07494 R07495; R07498 R07499 R07506 R07507 R07509 R07605 R07666 R07676; R07710 R07711 R07714 R07715 R07727 R07728 R07737 R07739; R07745 R07746 R07747 R07748 R07751 R07752 R07759 R07761; R07763 R07776 R07777 R07778 R07779 R07786 R07787 R07791; R07792 R07836 R07837 R07939 R07956 R07958 R07960 R07962; R07964 R07966 R07968 R07970 R07972 R07974 R07976 R07998; R07999 R08002 R08014 R08015 R08016 R08019 R08032 R08059; R08083 R08084 R08085 R08148 R08160 R08168 R08194 R08203; R08204 R08205 R08206 R08207 R08208 R08226 R08266 R08267; R08270 R08271 R08274 R08275 R08283 R08285 R08294 R08303; R08304 R08312 R08313 R08325 R08326 R08327 R08356 R08357; R08379 R08380 R08383 R08390 R08391 R08392 R08442 R08492; R08494 R08499 R08510 R08539 R08551 R08558 R08561 R08562; R08563 R08573 R08604 R08607 R08651 R08652 R08653 R08655; R08659 R08663 R08664 R08665 R08666 R08670 R08672 R08673; R08674 R08675 R08684 R08685 R08705 R08710 R08711 R08725; R08726 R08727 R08754 R08755 R08756 R08768 R08775 R08784; R08790 R08815 R08838 R08851 R08852 R08853 R08854 R08861; R08878 R08879 R08880 R08912 R08913 R08915 R08917 R08922; R08923 R08925 R08935 R08943 R08954 R08955 R08957 R08958; R08959 R08960 R08961 R08963 R08980 R09002 R09042 R09070; R09079 R09080 R09122 R09131 R09133 R09138 R09190 R09193; R09194 R09198 R09234 R09240 R09241 R09242 R09243 R09262; R09263 R09264 R09275 R09280 R09281 R09289 R09291 R09306; R09309 R09329 R09353 R09372 R09376 R09389 R09390 R09393; R09403 R09404 R09405 R09406 R09407 R09408 R09416 R09418; R09420 R09421 R09423 R09424 R09425 R09441 R09442 R09446; R09449 R09451 R09452 R09453 R09454 R09460 R09461 R09470; R09485 R09512 R09520 R09521 R09522 R09541 R09546 R09547; R09548 R09549 R09554 R09555 R09557 R09573 R09575 R09576; R09577 R09578 R09579 R09580 R09583 R09584 R09602 R09738; R09749 R09756 R09777 R09806 R09812 R09813 R09814 R09815; R09816 R09817 R09818 R09820 R09838 R09861 R09862 R09863; R09864 R09865 R09866 R09867 R09868 R09921 R09926 R09927; R09928 R09929 R09930 R09931 R09932 R09933 R09934 R09935; R09954 R09985 R09987 R09989 R09990 R10023 R10024 R10025; R10026 R10027 R10028 R10031 R10032 R10036 R10038 R10044; R10045 R10058 R10059 R10066 R10067 R10068 R10069 R10072; R10073 R10075 R10076 R10077 R10080 R10104 R10105 R10114; R10116 R10118 R10120 R10122 R10127 R10130 R10132 R10154; R10155 R10159 R10181 R10194 R10225 R10226 R10227 R10228; R10229 R10242 R10248 R10249 R10258 R10260 R10289 R10309; R10313 R10314 R10315 R10316 R10317 R10318 R10319 R10320; R10321 R10323 R10326 R10350 R10351 R10356 R10357 R10358; R10359 R10361 R10362 R10366 R10367 R10368 R10371 R10373; R10376 R10379 R10381 R10399 R10400 R10414 R10416 R10417; R10418 R10421 R10423 R10429 R10438 R10476 R10477 R10478; R10479 R10512 R10518 R10528 R10540 R10549 R10562 R10563; R10573 R10591 R10593 R10615 R10626 R10627 R10628 R10631; R10636 R10637 R10656 R10662 R10663 R10664 R10665 R10670; R10671 R10672 R10692 R10694 R10704 R10725 R10727 R10728; R10730 R10786 R10787 R10788 R10789 R10791 R10793 R10794; R10795 R10799 R10801 R10826 R10828 R10851 R10852 R10862; R10875 R10877 R10878 R10879 R10882 R10919 R10921 R10922; R10923 R10924 R10925 R10931 R10954 R10982 R10984 R10999; R11000 R11008 R11019 R11032 R11051 R11054 R11061 R11096; R11097 R11107 R11124 R11125 R11132 R11134 R11135 R11145; R11146 R11152 R11157 R11195 R11198 R11211 R11212 R11222; R11226 R11232 R11266 R11276 R11277 R11341 R11358 R11359; R11360 R11361 R11383 R11385 R11405 R11425 R11426 R11427; R11435 R11445 R11446 R11447 R11449 R11450 R11451 R11474; R11477 R11485 R11500 R11518 R11525 R11526","Photosynthesis; Glutathione metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Thyroid hormone synthesis; Aldosterone synthesis and secretion","1.1.1.1; 1.1.1.2; 1.1.1.3; 1.1.1.10; 1.1.1.19; 1.1.1.20; 1.1.1.21; 1.1.1.25; 1.1.1.33; 1.1.1.34; 1.1.1.36; 1.1.1.40; 1.1.1.42; 1.1.1.43; 1.1.1.44; 1.1.1.47; 1.1.1.48; 1.1.1.49; 1.1.1.50; 1.1.1.51; 1.1.1.54; 1.1.1.55; 1.1.1.60; 1.1.1.62; 1.1.1.64; 1.1.1.65; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.79; 1.1.1.80; 1.1.1.81; 1.1.1.82; 1.1.1.86; 1.1.1.91; 1.1.1.92; 1.1.1.94; 1.1.1.97; 1.1.1.100; 1.1.1.101; 1.1.1.102; 1.1.1.104; 1.1.1.111; 1.1.1.112; 1.1.1.113; 1.1.1.115; 1.1.1.117; 1.1.1.119; 1.1.1.120; 1.1.1.123; 1.1.1.124; 1.1.1.126; 1.1.1.130; 1.1.1.131; 1.1.1.133; 1.1.1.134; 1.1.1.135; 1.1.1.137; 1.1.1.138; 1.1.1.142; 1.1.1.145; 1.1.1.146; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.151; 1.1.1.153; 1.1.1.154; 1.1.1.156; 1.1.1.157; 1.1.1.160; 1.1.1.162; 1.1.1.168; 1.1.1.169; 1.1.1.170; 1.1.1.176; 1.1.1.177; 1.1.1.179; 1.1.1.181; 1.1.1.183; 1.1.1.184; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.188; 1.1.1.189; 1.1.1.191; 1.1.1.193; 1.1.1.194; 1.1.1.195; 1.1.1.196; 1.1.1.197; 1.1.1.200; 1.1.1.201; 1.1.1.206; 1.1.1.207; 1.1.1.208; 1.1.1.209; 1.1.1.210; 1.1.1.213; 1.1.1.214; 1.1.1.215; 1.1.1.216; 1.1.1.217; 1.1.1.218; 1.1.1.219; 1.1.1.220; 1.1.1.222; 1.1.1.224; 1.1.1.225; 1.1.1.229; 1.1.1.230; 1.1.1.231; 1.1.1.232; 1.1.1.234; 1.1.1.235; 1.1.1.236; 1.1.1.237; 1.1.1.238; 1.1.1.243; 1.1.1.247; 1.1.1.248; 1.1.1.252; 1.1.1.256; 1.1.1.261; 1.1.1.263; 1.1.1.264; 1.1.1.265; 1.1.1.266; 1.1.1.267; 1.1.1.270; 1.1.1.271; 1.1.1.272; 1.1.1.273; 1.1.1.274; 1.1.1.276; 1.1.1.277; 1.1.1.278; 1.1.1.279; 1.1.1.280; 1.1.1.281; 1.1.1.282; 1.1.1.283; 1.1.1.284; 1.1.1.285; 1.1.1.287; 1.1.1.289; 1.1.1.292; 1.1.1.294; 1.1.1.295; 1.1.1.298; 1.1.1.299; 1.1.1.300; 1.1.1.302; 1.1.1.307; 1.1.1.312; 1.1.1.313; 1.1.1.314; 1.1.1.317; 1.1.1.318; 1.1.1.319; 1.1.1.320; 1.1.1.321; 1.1.1.322; 1.1.1.323; 1.1.1.324; 1.1.1.325; 1.1.1.328; 1.1.1.329; 1.1.1.330; 1.1.1.334; 1.1.1.338; 1.1.1.341; 1.1.1.342; 1.1.1.344; 1.1.1.346; 1.1.1.348; 1.1.1.349; 1.1.1.351; 1.1.1.353; 1.1.1.355; 1.1.1.356; 1.1.1.357; 1.1.1.358; 1.1.1.359; 1.1.1.360; 1.1.1.362; 1.1.1.363; 1.1.1.364; 1.1.1.365; 1.1.1.367; 1.1.1.371; 1.1.1.372; 1.1.1.375; 1.1.1.376; 1.1.1.377; 1.1.1.378; 1.1.1.381; 1.1.1.383; 1.1.1.384; 1.1.1.386; 1.1.1.392; 1.1.1.393; 1.1.1.402; 1.1.1.-; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.7; 1.2.1.8; 1.2.1.9; 1.2.1.11; 1.2.1.13; 1.2.1.15; 1.2.1.16; 1.2.1.17; 1.2.1.18; 1.2.1.26; 1.2.1.28; 1.2.1.30; 1.2.1.31; 1.2.1.38; 1.2.1.41; 1.2.1.43; 1.2.1.44; 1.2.1.49; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.59; 1.2.1.63; 1.2.1.68; 1.2.1.70; 1.2.1.75; 1.2.1.76; 1.2.1.77; 1.2.1.79; 1.2.1.80; 1.2.1.81; 1.2.1.83; 1.2.1.84; 1.2.1.88; 1.2.1.89; 1.2.1.90; 1.2.1.91; 1.2.1.92; 1.2.1.96; 1.2.1.-; 1.3.1.2; 1.3.1.3; 1.3.1.5; 1.3.1.8; 1.3.1.10; 1.3.1.13; 1.3.1.15; 1.3.1.16; 1.3.1.17; 1.3.1.20; 1.3.1.21; 1.3.1.22; 1.3.1.24; 1.3.1.27; 1.3.1.32; 1.3.1.33; 1.3.1.34; 1.3.1.36; 1.3.1.37; 1.3.1.38; 1.3.1.39; 1.3.1.40; 1.3.1.42; 1.3.1.45; 1.3.1.46; 1.3.1.47; 1.3.1.48; 1.3.1.51; 1.3.1.54; 1.3.1.57; 1.3.1.67; 1.3.1.69; 1.3.1.70; 1.3.1.71; 1.3.1.72; 1.3.1.73; 1.3.1.74; 1.3.1.75; 1.3.1.77; 1.3.1.78; 1.3.1.79; 1.3.1.81; 1.3.1.82; 1.3.1.83; 1.3.1.84; 1.3.1.85; 1.3.1.86; 1.3.1.92; 1.3.1.93; 1.3.1.96; 1.3.1.97; 1.3.1.98; 1.3.1.101; 1.3.1.102; 1.3.1.103; 1.3.1.104; 1.3.1.105; 1.3.1.107; 1.3.1.111; 1.3.1.112; 1.3.1.-; 1.3.3.9; 1.3.99.6; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.12; 1.4.1.13; 1.4.1.15; 1.4.1.16; 1.4.1.17; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.-; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.5; 1.5.1.6; 1.5.1.8; 1.5.1.10; 1.5.1.16; 1.5.1.19; 1.5.1.20; 1.5.1.21; 1.5.1.24; 1.5.1.25; 1.5.1.27; 1.5.1.30; 1.5.1.31; 1.5.1.32; 1.5.1.33; 1.5.1.34; 1.5.1.38; 1.5.1.39; 1.5.1.40; 1.5.1.41; 1.5.1.43; 1.5.1.45; 1.5.1.46; 1.5.1.47; 1.5.1.48; 1.5.1.49; 1.5.1.50; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.4; 1.6.2.5; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.5; 1.6.5.2; 1.6.5.5; 1.6.5.6; 1.6.5.10; 1.6.5.12; 1.6.99.1; 1.7.1.2; 1.7.1.3; 1.7.1.4; 1.7.1.6; 1.7.1.7; 1.7.1.9; 1.7.1.11; 1.7.1.12; 1.7.1.13; 1.7.1.14; 1.7.1.-; 1.8.1.2; 1.8.1.5; 1.8.1.7; 1.8.1.8; 1.8.1.9; 1.8.1.10; 1.8.1.12; 1.8.1.13; 1.8.1.14; 1.8.1.15; 1.8.1.18; 1.8.1.19; 1.10.1.1; 1.11.1.2; 1.12.1.3; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.-; 1.14.12.1; 1.14.12.4; 1.14.12.5; 1.14.12.10; 1.14.12.17; 1.14.12.18; 1.14.12.22; 1.14.12.-; 1.14.13.2; 1.14.13.7; 1.14.13.8; 1.14.13.9; 1.14.13.11; 1.14.13.12; 1.14.13.14; 1.14.13.16; 1.14.13.18; 1.14.13.19; 1.14.13.20; 1.14.13.21; 1.14.13.22; 1.14.13.23; 1.14.13.25; 1.14.13.27; 1.14.13.28; 1.14.13.30; 1.14.13.31; 1.14.13.32; 1.14.13.33; 1.14.13.34; 1.14.13.35; 1.14.13.36; 1.14.13.37; 1.14.13.38; 1.14.13.39; 1.14.13.40; 1.14.13.43; 1.14.13.46; 1.14.13.47; 1.14.13.48; 1.14.13.49; 1.14.13.50; 1.14.13.51; 1.14.13.52; 1.14.13.53; 1.14.13.54; 1.14.13.55; 1.14.13.56; 1.14.13.57; 1.14.13.58; 1.14.13.59; 1.14.13.63; 1.14.13.64; 1.14.13.66; 1.14.13.67; 1.14.13.70; 1.14.13.71; 1.14.13.72; 1.14.13.73; 1.14.13.74; 1.14.13.75; 1.14.13.76; 1.14.13.77; 1.14.13.78; 1.14.13.79; 1.14.13.80; 1.14.13.81; 1.14.13.84; 1.14.13.85; 1.14.13.87; 1.14.13.88; 1.14.13.89; 1.14.13.91; 1.14.13.92; 1.14.13.93; 1.14.13.94; 1.14.13.96; 1.14.13.97; 1.14.13.101; 1.14.13.102; 1.14.13.103; 1.14.13.104; 1.14.13.105; 1.14.13.106; 1.14.13.107; 1.14.13.108; 1.14.13.109; 1.14.13.110; 1.14.13.112; 1.14.13.115; 1.14.13.116; 1.14.13.117; 1.14.13.118; 1.14.13.119; 1.14.13.120; 1.14.13.121; 1.14.13.122; 1.14.13.123; 1.14.13.124; 1.14.13.125; 1.14.13.128; 1.14.13.133; 1.14.13.134; 1.14.13.135; 1.14.13.136; 1.14.13.137; 1.14.13.138; 1.14.13.139; 1.14.13.140; 1.14.13.143; 1.14.13.144; 1.14.13.145; 1.14.13.146; 1.14.13.147; 1.14.13.148; 1.14.13.149; 1.14.13.150; 1.14.13.153; 1.14.13.154; 1.14.13.156; 1.14.13.157; 1.14.13.158; 1.14.13.160; 1.14.13.161; 1.14.13.165; 1.14.13.167; 1.14.13.168; 1.14.13.170; 1.14.13.171; 1.14.13.172; 1.14.13.173; 1.14.13.174; 1.14.13.175; 1.14.13.176; 1.14.13.177; 1.14.13.178; 1.14.13.179; 1.14.13.180; 1.14.13.181; 1.14.13.183; 1.14.13.184; 1.14.13.185; 1.14.13.186; 1.14.13.187; 1.14.13.188; 1.14.13.189; 1.14.13.190; 1.14.13.194; 1.14.13.195; 1.14.13.196; 1.14.13.197; 1.14.13.198; 1.14.13.199; 1.14.13.200; 1.14.13.201; 1.14.13.202; 1.14.13.203; 1.14.13.204; 1.14.13.206; 1.14.13.208; 1.14.13.210; 1.14.13.211; 1.14.13.213; 1.14.13.214; 1.14.13.216; 1.14.13.217; 1.14.13.219; 1.14.13.221; 1.14.13.222; 1.14.13.224; 1.14.13.225; 1.14.13.226; 1.14.13.228; 1.14.13.229; 1.14.13.231; 1.14.13.232; 1.14.13.233; 1.14.13.234; 1.14.13.-; 1.14.14.1; 1.14.14.16; 1.14.14.17; 1.14.14.19; 1.14.14.23; 1.14.14.24; 1.14.14.25; 1.14.14.26; 1.14.14.29; 1.14.14.36; 1.14.15.3; 1.14.16.-; 1.14.19.21; 1.14.19.41; 1.14.19.48; 1.14.21.1; 1.14.21.2; 1.14.21.3; 1.14.21.4; 1.14.21.5; 1.14.21.7; 1.14.21.8; 1.14.21.9; 1.14.21.10; 1.14.21.11; 1.14.21.12; 1.14.21.-; 1.14.99.2; 1.14.99.34; 1.14.-.-; 1.16.1.1; 1.16.1.5; 1.16.1.6; 1.16.1.8; 1.16.1.9; 1.17.1.1; 1.17.1.3; 1.17.1.5; 1.17.1.8; 1.18.1.2; 1.18.1.4; 1.18.1.6; 1.19.1.1; 1.21.1.1; 1.21.1.2; 1.23.1.1; 1.23.1.2; 1.23.1.3; 1.23.1.4; 1.23.1.-; 1.-.-.-; 2.1.1.147; 2.1.1.148; 2.3.1.85; 2.3.1.86; 2.3.1.94; 2.3.1.111; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.252; 2.3.1.-; 2.4.99.20; 2.5.1.21; 2.7.1.23; 3.1.3.-; 4.1.1.-; 4.1.99.5; 4.2.1.-; 5.3.3.1",NA,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00006  NADP","CAS: 53-59-8; PubChem: 3308; ChEBI: 18009; ChEMBL: CHEMBL1623886 CHEMBL295069; PDB-CCD: NAP; 3DMET: B01129; NIKKAJI: J247.824B","cpd:C00006",21,29,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H30O17N7P3","C21H28O17N7P3",744.0832785,745.0911035,743.0754535
"cpd:C02185","Plastoquinol-1","C13H18O2","Plastoquinol-1",NA,"Photosynthesis; Metabolic pathways",NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C02185  Plastoquinol-1","PubChem: 5256; ChEBI: 16323; LIPIDMAPS: LMPR02010037; 3DMET: B04841; NIKKAJI: J2.735.622B","cpd:C01588; cpd:C02185; cpd:C07122; cpd:C11200; cpd:C18326; cpd:C18718; cpd:C19256; cpd:C19442",13,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C13H19O2","C13H17O2",206.1306798,207.1385049,205.1228548
"cpd:C00025","L-Glutamate;","C5H9NO4","L-Glutamate; L-Glutamic acid; L-Glutaminic acid; Glutamate","R00021 R00093 R00114 R00239 R00241 R00243 R00245 R00248; R00250 R00251 R00253 R00254 R00256 R00257 R00258 R00259; R00260 R00261 R00262 R00263 R00355 R00372 R00411 R00457; R00494 R00525 R00573 R00575 R00578 R00609 R00667 R00668; R00684 R00694 R00707 R00708 R00734 R00768 R00894 R00895; R00908 R00942 R00986 R01072 R01090 R01155 R01161 R01214; R01231 R01339 R01585 R01586 R01648 R01654 R01684 R01716; R01939 R01956 R02040 R02077 R02199 R02237 R02274 R02282; R02283 R02285 R02287 R02313 R02315 R02433 R02619 R02700; R02772 R02773 R02929 R02930 R03053 R03120 R03189 R03207; R03243 R03248 R03266 R03651 R03905 R03916 R03952 R03970; R03971 R04028 R04029 R04051 R04171 R04173 R04188 R04212; R04217 R04234 R04241 R04242 R04269 R04338 R04438 R04463; R04467 R04475 R04529 R04558 R04776 R05052 R05085 R05197; R05207 R05224 R05225 R05507 R05578 R05815 R06423 R06426; R06586 R06631 R06634 R06977 R07275 R07276 R07277 R07396; R07414 R07419 R07456 R07613 R07643 R07659 R08244 R08855; R08897 R08903 R08905 R08906 R08931 R08956 R09195 R09399; R09400 R09401 R09495 R09594 R09598 R09599 R09778 R09824; R09825 R09875 R10064 R10086 R10089 R10094 R10141 R10153; R10460 R10677 R10678 R10679 R10687 R10688 R10693 R10698; R10772 R10845 R10902 R10929 R10932 R10991 R10993 R11021; R11118 R11269 R11270 R11285 R11291 R11297 R11298 R11299; R11395 R11409 R11475 R11515 R11561","Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Carbapenem biosynthesis; Histidine metabolism; Taurine and hypotaurine metabolism; D-Glutamine and D-glutamate metabolism; Glutathione metabolism; Neomycin, kanamycin and gentamicin biosynthesis; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Porphyrin and chlorophyll metabolism; Nitrogen metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Two-component system; FoxO signaling pathway; Phospholipase D signaling pathway; Neuroactive ligand-receptor interaction; Gap junction; Circadian entrainment; Long-term potentiation; Synaptic vesicle cycle; Retrograde endocannabinoid signaling; Glutamatergic synapse; GABAergic synapse; Long-term depression; Taste transduction; Proximal tubule bicarbonate reclamation; Protein digestion and absorption; Amyotrophic lateral sclerosis (ALS); Huntington's disease; Cocaine addiction; Amphetamine addiction; Nicotine addiction; Alcoholism; Central carbon metabolism in cancer","1.2.1.88; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.13; 1.4.1.14; 1.4.3.11; 1.4.7.1; 1.5.1.9; 1.5.1.10; 1.5.3.18; 1.5.99.5; 2.1.1.21; 2.1.2.5; 2.3.1.1; 2.3.1.14; 2.3.1.35; 2.3.2.2; 2.3.2.-; 2.4.2.14; 2.4.2.-; 2.6.1.1; 2.6.1.2; 2.6.1.3; 2.6.1.4; 2.6.1.5; 2.6.1.6; 2.6.1.7; 2.6.1.8; 2.6.1.9; 2.6.1.11; 2.6.1.13; 2.6.1.16; 2.6.1.17; 2.6.1.19; 2.6.1.22; 2.6.1.23; 2.6.1.24; 2.6.1.26; 2.6.1.27; 2.6.1.29; 2.6.1.33; 2.6.1.34; 2.6.1.36; 2.6.1.38; 2.6.1.39; 2.6.1.40; 2.6.1.42; 2.6.1.44; 2.6.1.48; 2.6.1.49; 2.6.1.52; 2.6.1.55; 2.6.1.57; 2.6.1.59; 2.6.1.65; 2.6.1.67; 2.6.1.72; 2.6.1.75; 2.6.1.76; 2.6.1.79; 2.6.1.80; 2.6.1.81; 2.6.1.82; 2.6.1.83; 2.6.1.85; 2.6.1.86; 2.6.1.87; 2.6.1.89; 2.6.1.90; 2.6.1.92; 2.6.1.93; 2.6.1.94; 2.6.1.95; 2.6.1.98; 2.6.1.102; 2.6.1.103; 2.6.1.104; 2.6.1.106; 2.6.1.107; 2.6.1.109; 2.6.1.110; 2.6.1.-; 2.7.2.11; 2.7.2.13; 3.4.17.21; 3.4.19.9; 3.4.19.13; 3.4.19.14; 3.5.1.2; 3.5.1.38; 3.5.1.55; 3.5.1.65; 3.5.1.68; 3.5.1.87; 3.5.1.94; 3.5.1.96; 3.5.1.118; 3.5.1.123; 3.5.2.9; 3.5.3.8; 4.1.1.15; 4.1.3.27; 4.1.3.-; 4.2.1.168; 4.3.3.6; 5.1.1.3; 5.4.3.9; 5.4.99.1; 6.1.1.17; 6.1.1.24; 6.2.1.39; 6.3.1.2; 6.3.1.6; 6.3.1.11; 6.3.1.17; 6.3.1.18; 6.3.2.2; 6.3.2.12; 6.3.2.17; 6.3.2.18; 6.3.2.31; 6.3.2.32; 6.3.2.33; 6.3.2.34; 6.3.2.41; 6.3.2.42; 6.3.2.-; 6.3.4.2; 6.3.4.12; 6.3.4.24; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-","Proline biosynthesis, glutamate => proline; GABA (gamma-Aminobutyrate) shunt; Ornithine biosynthesis, glutamate => ornithine; Histidine degradation, histidine => N-formiminoglutamate => glutamate; Glutathione biosynthesis, glutamate => glutathione; Heme biosynthesis, glutamate => protoheme/siroheme; Photorespiration; Methylaspartate cycle; Ornithine biosynthesis, mediated by LysW, glutamate => ornithine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00025  Glutamic acid (Glu);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00025  Glutamate; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glutamic acid;     D00007  Glutamic acid (USP); Pharmaceutical additives [BR:br08316];  Buffering agent;   D00007  [003613] L-Glutamic acid;  Flavoring substance;   D00007  [003613] L-Glutamic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00007  L-Glutamic acid","CAS: 56-86-0; PubChem: 3327; ChEBI: 16015; ChEMBL: CHEMBL575060; KNApSAcK: C00001358; PDB-CCD: GGL GLU; 3DMET: B00007; NIKKAJI: J9.171E","cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269",5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H10O4N1","C5H8O4N1",147.0531578,148.0609828,146.0453327
"cpd:C00049","L-Aspartate;","C4H7NO4","L-Aspartate; L-Aspartic acid; 2-Aminosuccinic acid; L-Asp","R00355 R00357 R00373 R00397 R00400 R00480 R00481 R00482; R00483 R00484 R00485 R00486 R00487 R00488 R00489 R00490; R00491 R00493 R00526 R00546 R00578 R00695 R00777 R01135; R01397 R01713 R01731 R01954 R03421 R03647 R04591 R05577; R07164 R07165 R07407 R07410 R08478 R09592 R09805","Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Histidine metabolism; beta-Alanine metabolism; Cyanoamino acid metabolism; Carbon fixation in photosynthetic organisms; Nicotinate and nicotinamide metabolism; Pantothenate and CoA biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Two-component system; Bacterial chemotaxis; Neuroactive ligand-receptor interaction; Protein digestion and absorption; Central carbon metabolism in cancer","1.2.1.-; 1.4.1.21; 1.4.3.2; 1.4.3.16; 2.1.3.2; 2.3.1.17; 2.6.1.1; 2.6.1.12; 2.6.1.31; 2.6.1.35; 2.6.1.57; 2.6.1.70; 2.6.1.78; 2.6.1.-; 2.7.2.4; 3.5.1.1; 3.5.1.7; 3.5.1.8; 3.5.1.15; 3.5.1.26; 3.5.1.38; 3.5.3.14; 3.5.5.4; 4.1.1.11; 4.1.1.12; 4.1.1.15; 4.3.1.1; 5.1.1.13; 6.1.1.12; 6.1.1.23; 6.3.1.1; 6.3.1.4; 6.3.2.6; 6.3.2.29; 6.3.4.4; 6.3.4.5; 6.3.5.4","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Urea cycle; Ectoine biosynthesis, aspartate => ectoine; NAD biosynthesis, aspartate => NAD; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00049  Aspartic acid (Asp);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00049  Aspartate; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Aspartic acid;     D00013  Aspartic acid (USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00013  [003608] L-Aspartic acid;  Solubilizing agent;   D00013  [003608] L-Aspartic acid;  Flavoring substance;   D00013  [003608] L-Aspartic acid;  Diluting agent;   D00013  [003608] L-Aspartic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00013  L-Aspartic acid","CAS: 56-84-8; PubChem: 3351; ChEBI: 17053; ChEMBL: CHEMBL274323; KNApSAcK: C00001342; PDB-CCD: ASP IAS; 3DMET: B00015; NIKKAJI: J9.169C","cpd:C00049; cpd:C00402; cpd:C16433; cpd:C19710; cpd:C19911",4,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H8O4N1","C4H6O4N1",133.0375077,134.0453327,132.0296827
"cpd:C00062","L-Arginine;","C6H14N4O2","L-Arginine; (S)-2-Amino-5-guanidinovaleric acid; L-Arg","R00551 R00552 R00554 R00557 R00558 R00559 R00562 R00563; R00565 R00566 R00567 R00735 R00832 R00912 R01086 R01686; R01886 R01989 R03477 R03646 R05465 R05547 R08197 R09363; R09593 R09785 R10081 R10106 R10107 R10880 R11031 R11032; R11033 R11085","Arginine biosynthesis; Monobactam biosynthesis; Arginine and proline metabolism; Clavulanic acid biosynthesis; D-Arginine and D-ornithine metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Amyotrophic lateral sclerosis (ALS); Salmonella infection; Chagas disease (American trypanosomiasis); Amoebiasis; Central carbon metabolism in cancer","1.4.1.-; 1.5.1.11; 1.5.1.19; 1.13.12.1; 1.14.11.34; 1.14.11.41; 1.14.13.39; 1.14.13.165; 2.1.4.1; 2.1.4.2; 2.3.1.109; 2.5.1.66; 2.6.1.84; 2.7.3.3; 3.2.2.19; 3.5.3.1; 3.5.3.6; 4.1.1.19; 4.3.2.1; 5.1.1.9; 6.1.1.19; 6.3.2.11; 6.3.2.24; 6.3.2.30; 6.3.2.48","Urea cycle; Creatine pathway; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine; Polyamine biosynthesis, arginine => ornithine => putrescine; Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate; Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A; Cycloserine biosynthesis, arginine/serine => cycloserine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00062  Arginine (Arg); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Arginine;     D02982  Arginine (USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02982  [003610] L-Arginine;  Solubilizing agent;   D02982  [003610] L-Arginine;  Buffering agent;   D02982  [003610] L-Arginine;  Solubilization agent;   D02982  [003610] L-Arginine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D02982  L-Arginine","CAS: 74-79-3; PubChem: 3362; ChEBI: 16467; ChEMBL: CHEMBL1485; KNApSAcK: C00001340; PDB-CCD: ARG GND; 3DMET: B01143; NIKKAJI: J9.182K","cpd:C00062; cpd:C00792; cpd:C02385",6,14,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O2N4","C6H13O2N4",174.1116757,175.1195007,173.1038507
"cpd:C00064","L-Glutamine;","C5H10N2O3","L-Glutamine; L-2-Aminoglutaramic acid","R00021 R00093 R00114 R00253 R00256 R00257 R00573 R00575; R00576 R00577 R00578 R00579 R00768 R00986 R01072 R01149; R01231 R01375 R01716 R02576 R02781 R02895 R03652 R03905; R04011 R04212 R04463 R04558 R05224 R05225 R05815 R07456; R08244 R08855 R08890 R08891 R08956 R09195 R09598 R09599; R10089 R11515","Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; D-Glutamine and D-glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Nitrogen metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids; ABC transporters; Two-component system; Glutamatergic synapse; GABAergic synapse; Proximal tubule bicarbonate reclamation; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.13; 1.4.1.14; 1.4.7.1; 2.3.1.14; 2.3.1.68; 2.3.2.1; 2.3.2.14; 2.4.2.14; 2.4.2.-; 2.6.1.15; 2.6.1.16; 2.6.1.50; 2.6.1.64; 2.6.1.85; 2.6.1.86; 2.6.1.100; 2.6.1.101; 3.5.1.2; 3.5.1.38; 4.1.3.27; 4.1.3.-; 4.3.3.6; 5.1.1.10; 6.1.1.18; 6.3.1.2; 6.3.4.2; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00064  Glutamine (Gln); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA03 Glutamine;       D00015  Glutamine (USP); USP drug classification [BR:br08302];  Gastrointestinal Agents;   Gastrointestinal Agents, Other;    Glutamine;     D00015  Glutamine (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    232  Peptic ulcer agents;     2322  Glutamines;      D00015  Glutamine (USP); L-Glutamine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Glutamine;     D00015  Glutamine (USP); Pharmaceutical additives [BR:br08316];  Diluting agent;   D00015  [003612] L-Glutamine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00015  L-Glutamine; Gastrointestinal agents [br08371.html];  Antiulcer agent;   D00015; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D00015; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D00015; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00015","CAS: 56-85-9; PubChem: 3364; ChEBI: 18050; ChEMBL: CHEMBL930; KNApSAcK: C00001359; PDB-CCD: GLN; 3DMET: B00017; NIKKAJI: J9.170G","cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029",5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O3N2","C5H9O3N2",146.0691422,147.0769672,145.0613172
"cpd:C00077","L-Ornithine;","C5H12N2O2","L-Ornithine; (S)-2,5-Diaminovaleric acid; (S)-2,5-Diaminopentanoic acid; (S)-2,5-Diaminopentanoate","R00551 R00565 R00664 R00665 R00666 R00667 R00668 R00669; R00670 R00671 R00672 R01343 R01398 R01686 R01989 R02282; R03477 R05547 R10466 R10789 R10790 R10933","Arginine biosynthesis; Arginine and proline metabolism; D-Arginine and D-ornithine metabolism; Glutathione metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters","1.5.1.24; 1.14.13.195; 1.14.13.196; 2.1.3.3; 2.1.4.1; 2.1.4.2; 2.3.1.35; 2.3.1.127; 2.6.1.13; 3.5.1.14; 3.5.1.16; 3.5.1.20; 3.5.3.1; 3.5.3.25; 4.1.1.17; 4.3.1.12; 5.1.1.9; 5.1.1.10; 5.1.1.12","Ornithine biosynthesis, glutamate => ornithine; Urea cycle; Polyamine biosynthesis, arginine => ornithine => putrescine; Ornithine biosynthesis, mediated by LysW, glutamate => ornithine; Cycloserine biosynthesis, arginine/serine => cycloserine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00077  L-Ornithine","CAS: 70-26-8; PubChem: 3377; ChEBI: 15729; ChEMBL: CHEMBL446143; KNApSAcK: C00001384; PDB-CCD: ORN; 3DMET: B00020; NIKKAJI: J9.177D","cpd:C00077; cpd:C00515; cpd:C01602; cpd:C03943; cpd:C11320; cpd:C16550; cpd:C16555",5,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O2N2","C5H11O2N2",132.0898776,133.0977027,131.0820526
"cpd:C00086","Urea;","CH4N2O","Urea; Carbamide","R00131 R00551 R00774 R00775 R00776 R00777 R00778 R00913; R01157 R01418 R01566 R01589 R01990 R02422 R02458 R03250; R03870 R05357 R07629 R10347 R10778","Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Arginine and proline metabolism; Biotin metabolism; Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments; ABC transporters; Epithelial cell signaling in Helicobacter pylori infection","3.5.1.5; 3.5.1.84; 3.5.1.95; 3.5.2.1; 3.5.3.1; 3.5.3.2; 3.5.3.3; 3.5.3.4; 3.5.3.7; 3.5.3.10; 3.5.3.11; 3.5.3.14; 3.5.3.16; 3.5.3.17; 3.5.3.20; 3.5.3.22; 3.5.3.24; 4.2.1.69; 4.3.2.3; 6.3.4.6","Urea cycle; Purine degradation, xanthine => urea","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05B I.V. SOLUTIONS;     B05BC Solutions producing osmotic diuresis;      B05BC02 Carbamide;       D00023  Urea (JP17/USP);  D DERMATOLOGICALS;   D02 EMOLLIENTS AND PROTECTIVES;    D02A EMOLLIENTS AND PROTECTIVES;     D02AE Carbamide products;      D02AE01 Carbamide;       D00023  Urea (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    266  Emollients;     2669  Others;      D00023  Urea (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   59 Skin emollient (incl. pus extrusion);    D00023  Urea (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Urea;     D00023  Urea (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00023  [002286] Urea;  Wetting agent;   D00023  [002286] Urea;  Wetting adjuster;   D00023  [002286] Urea;  Tenacious agent;   D00023  [002286] Urea;  Diluting agent;   D00023  [120238] Purified urea;  Solubilization agent;   D00023  [002286] Urea; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00023  Urea; Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00023","CAS: 57-13-6; PubChem: 3386; ChEBI: 16199; ChEMBL: CHEMBL985; KNApSAcK: C00007314; PDB-CCD: URE; 3DMET: B00021; NIKKAJI: J2.322A","cpd:C00086; cpd:C19568; cpd:C20306",1,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C1H5O1N2","C1H3O1N2",60.03236276,61.04018779,59.02453773
"cpd:C00169","Carbamoyl phosphate","CH4NO5P","Carbamoyl phosphate","R00149 R00150 R00575 R01395 R01396 R01397 R01398 R01399; R01400 R02937 R04281 R05230 R06772 R07245 R07641 R08937; R09853 R09858 R10541 R10767 R10768 R11279","Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; Nitrogen metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids","2.1.3.2; 2.1.3.3; 2.1.3.5; 2.1.3.6; 2.1.3.7; 2.1.3.8; 2.1.3.9; 2.1.3.11; 2.1.3.12; 2.1.3.-; 2.7.2.2; 6.1.2.2; 6.3.4.16; 6.3.5.5","Urea cycle; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,"CAS: 590-55-6; PubChem: 3469; ChEBI: 17672; ChEMBL: CHEMBL369105; KNApSAcK: C00007513; PDB-CCD: CP; 3DMET: B00050; NIKKAJI: J39.574I","cpd:C00169",1,4,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C1H5O5N1P1","C1H3O5N1P1",140.9827092,141.9905343,139.9748842
"cpd:C00327","L-Citrulline;","C6H13N3O3","L-Citrulline; 2-Amino-5-ureidovaleric acid; Citrulline","R00111 R00552 R00557 R00665 R01398 R01954 R02513 R09107; R10106 R10108","Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.14.13.39; 1.14.13.165; 2.1.3.3; 3.5.1.16; 3.5.1.20; 3.5.3.6; 3.5.3.18; 6.3.4.5","Urea cycle","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00327  L-Citrulline","CAS: 372-75-8; PubChem: 3621; ChEBI: 16349; ChEMBL: CHEMBL444814; KNApSAcK: C00001348; PDB-CCD: CIR; 3DMET: B01217; NIKKAJI: J5.711H","cpd:C00327",6,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O3N3","C6H12O3N3",175.0956913,176.1035163,174.0878663
"cpd:C00437","N-Acetylornithine;","C7H14N2O3","N-Acetylornithine; N2-Acetyl-L-ornithine","R00669 R02282 R02283 R07245","Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.1.3.9; 2.3.1.35; 2.6.1.11; 3.5.1.14; 3.5.1.16","Ornithine biosynthesis, glutamate => ornithine",NA,"CAS: 6205-08-9; PubChem: 3726; ChEBI: 16543; PDB-CCD: AOR; 3DMET: B00114; NIKKAJI: J37.495D","cpd:C00437; cpd:C01047",7,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H15O3N2","C7H13O3N2",174.1004423,175.1082674,173.0926173
"cpd:C00624","N-Acetyl-L-glutamate;","C7H11NO5","N-Acetyl-L-glutamate; N-Acetyl-L-glutamic acid","R00259 R02282 R02649","Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.3.1.1; 2.3.1.35; 2.7.2.8","Ornithine biosynthesis, glutamate => ornithine",NA,"CAS: 1188-37-0; PubChem: 3897; ChEBI: 17533 44337; ChEMBL: CHEMBL1234751; PDB-CCD: NLG; 3DMET: B00147; NIKKAJI: J37.497K","cpd:C00624; cpd:C03871; cpd:C12109",7,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H12O5N1","C7H10O5N1",189.0637225,190.0715475,188.0558974
"cpd:C01010","Urea-1-carboxylate;","C2H4N2O3","Urea-1-carboxylate; Allophanate; Allophanic acid","R00005 R00774 R05563","Arginine biosynthesis; Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments","3.5.1.54; 3.5.1.84; 6.3.4.6",NA,NA,"CAS: 625-78-5; PubChem: 4255; ChEBI: 15832 9889; 3DMET: B00219; NIKKAJI: J38.544A","cpd:C01010",2,4,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H5O3N2","C2H3O3N2",104.022192,105.030017,103.014367
"cpd:C01250","N-Acetyl-L-glutamate 5-semialdehyde;","C7H11NO4","N-Acetyl-L-glutamate 5-semialdehyde; 2-Acetamido-5-oxopentanoate","R02283 R03443","Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.2.1.38; 2.6.1.11","Ornithine biosynthesis, glutamate => ornithine",NA,"PubChem: 4470; ChEBI: 16319 29123; 3DMET: B00264; NIKKAJI: J37.498I","cpd:C01250; cpd:C12121; cpd:C17366; cpd:C21248",7,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H12O4N1","C7H10O4N1",173.0688078,174.0766329,172.0609828
"cpd:C03406","N-(L-Arginino)succinate;","C10H18N4O6","N-(L-Arginino)succinate; 2-(Nomega-L-Arginino)succinate; L-Argininosuccinate; L-Argininosuccinic acid; L-Arginosuccinic acid","R01086 R01954","Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","4.3.2.1; 6.3.4.5","Urea cycle","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C03406  L-Argininosuccinate","CAS: 2387-71-5; PubChem: 6235; ChEBI: 15682; KNApSAcK: C00019688; 3DMET: B04894; NIKKAJI: J37.380J","cpd:C03406",10,18,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O6N4","C10H17O6N4",290.1226343,291.1304593,289.1148093
"cpd:C04133","N-Acetyl-L-glutamate 5-phosphate;","C7H12NO8P","N-Acetyl-L-glutamate 5-phosphate; N-Acetyl-L-glutamyl 5-phosphate","R02649 R03443","Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.2.1.38; 2.7.2.8","Ornithine biosynthesis, glutamate => ornithine",NA,"PubChem: 6819; ChEBI: 16878; PDB-CCD: X2W; 3DMET: B00683; NIKKAJI: J37.496B","cpd:C00350; cpd:C04133",7,12,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O8N1P1","C7H11O8N1P1",269.0300533,270.0378784,268.0222283
"cpd:C15532","N-Acetyl-L-citrulline","C8H15N3O4","N-Acetyl-L-citrulline","R07245 R09107","Arginine biosynthesis; Metabolic pathways","2.1.3.9; 3.5.1.16",NA,NA,"PubChem: 17396524; ChEBI: 49002; PDB-CCD: OLN; NIKKAJI: J2.794.851K","cpd:C15532",8,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H16O4N3","C8H14O4N3",217.106256,218.114081,216.0984309
"cpd:C00020","AMP;","C10H14N5O7P","AMP; Adenosine 5'-monophosphate; Adenylic acid; Adenylate; 5'-AMP; 5'-Adenylic acid; 5'-Adenosine monophosphate; Adenosine 5'-phosphate","R00085 R00087 R00103 R00122 R00127 R00157 R00160 R00181; R00182 R00183 R00184 R00185 R00187 R00188 R00189 R00190; R00191 R00199 R00206 R00235 R00236 R00257 R00322 R00333; R00381 R00382 R00389 R00390 R00429 R00436 R00483 R00531; R00542 R00578 R00619 R00686 R00735 R00860 R00925 R00926; R00951 R00982 R01049 R01054 R01075 R01083 R01176 R01230; R01231 R01280 R01300 R01357 R01406 R01407 R01422 R01423; R01490 R01558 R01568 R01571 R01598 R01616 R01723 R01885; R01943 R01954 R02194 R02221 R02255 R02473 R02539 R02677; R02699 R02711 R02718 R02794 R02918 R02986 R03004 R03036; R03038 R03209 R03258 R03383 R03503 R03570 R03595 R03613; R03631 R03646 R03647 R03648 R03650 R03651 R03652 R03654; R03655 R03656 R03657 R03658 R03659 R03660 R03661 R03662; R03663 R03664 R03665 R03762 R03876 R03932 R04030 R04036; R04038 R04157 R04230 R04274 R04449 R04507 R04562 R04563; R04580 R04582 R04604 R04773 R04863 R04870 R04927 R05145; R05193 R05451 R05452 R05467 R05537 R05577 R05578 R05620; R05625 R05717 R05735 R05804 R05805 R06368 R06409 R06410; R06515 R06583 R06731 R06746 R06751 R06777 R06778 R06944; R07176 R07325 R07416 R07461 R07636 R07640 R07644 R07646; R07771 R07887 R08088 R08117 R08218 R08244 R08553 R08576; R08578 R08700 R08733 R08738 R08743 R08872 R09084 R09085; R09086 R09195 R09279 R09286 R09379 R09475 R09589 R09591; R09597 R09735 R09881 R09882 R10003 R10090 R10091 R10267; R10268 R10453 R10495 R10496 R10543 R10544 R10556 R10613; R10648 R10661 R10711 R10767 R10768 R10769 R10770 R10771; R10820 R10822 R10836 R10880 R10940 R11084 R11104 R11143; R11279 R11319 R11367 R11370 R11392 R11515 R11535","Purine metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Antifolate resistance; cGMP-PKG signaling pathway; cAMP signaling pathway; FoxO signaling pathway; mTOR signaling pathway; PI3K-Akt signaling pathway; AMPK signaling pathway; Longevity regulating pathway; Olfactory transduction; Taste transduction; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Parkinson's disease; Morphine addiction","1.2.1.30; 1.2.1.31; 1.8.4.9; 1.8.4.10; 1.8.99.2; 1.13.12.7; 2.3.1.234; 2.4.2.7; 2.4.2.8; 2.4.2.57; 2.5.1.27; 2.7.1.20; 2.7.1.74; 2.7.1.114; 2.7.1.118; 2.7.1.146; 2.7.1.147; 2.7.1.180; 2.7.1.212; 2.7.4.3; 2.7.4.10; 2.7.6.1; 2.7.6.2; 2.7.6.3; 2.7.6.4; 2.7.6.5; 2.7.9.1; 2.7.9.2; 2.7.9.3; 2.7.9.-; 2.8.1.11; 2.8.1.13; 2.8.1.-; 2.10.1.1; 3.1.3.5; 3.1.3.7; 3.1.3.97; 3.1.4.17; 3.1.4.53; 3.2.2.4; 3.5.4.6; 3.5.4.17; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.13; 3.6.1.17; 3.6.1.18; 3.6.1.20; 3.6.1.21; 3.6.1.22; 3.6.1.29; 3.6.1.53; 3.6.1.60; 3.6.1.61; 3.6.1.-; 3.6.2.1; 4.2.1.136; 4.3.2.2; 4.6.1.15; 5.1.1.11; 6.1.1.1; 6.1.1.2; 6.1.1.3; 6.1.1.4; 6.1.1.5; 6.1.1.6; 6.1.1.7; 6.1.1.9; 6.1.1.10; 6.1.1.11; 6.1.1.12; 6.1.1.13; 6.1.1.14; 6.1.1.15; 6.1.1.16; 6.1.1.17; 6.1.1.18; 6.1.1.19; 6.1.1.20; 6.1.1.21; 6.1.1.22; 6.1.1.23; 6.1.1.24; 6.1.1.26; 6.1.1.27; 6.1.2.2; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.7; 6.2.1.8; 6.2.1.11; 6.2.1.12; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.19; 6.2.1.20; 6.2.1.22; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.35; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.46; 6.2.1.-; 6.3.1.1; 6.3.1.5; 6.3.1.7; 6.3.1.13; 6.3.1.14; 6.3.1.15; 6.3.1.20; 6.3.2.1; 6.3.2.5; 6.3.2.14; 6.3.2.18; 6.3.2.24; 6.3.2.26; 6.3.2.36; 6.3.2.38; 6.3.2.39; 6.3.2.40; 6.3.2.46; 6.3.3.4; 6.3.3.6; 6.3.4.5; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.15; 6.3.4.19; 6.3.4.22; 6.3.5.1; 6.3.5.2; 6.3.5.4; 6.3.5.-; 6.4.1.6; 6.5.1.1; 6.5.1.2; 6.5.1.3; 6.5.1.4; 6.5.1.6; 6.5.1.7","Adenine ribonucleotide biosynthesis, IMP => ADP,ATP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00020  AMP; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D02769  Adenosine phosphate (USAN/INN)","CAS: 61-19-8; PubChem: 3322; ChEBI: 16027; ChEMBL: CHEMBL603764 CHEMBL752; KNApSAcK: C00019347; PDB-CCD: A AMP AP7; 3DMET: B01133; NIKKAJI: J4.814C","cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648",10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O7N5P1","C10H13O7N5P1",347.0630848,348.0709098,346.0552598
"cpd:C00035","GDP;","C10H15N5O11P2","GDP; Guanosine 5'-diphosphate; Guanosine diphosphate","R00328 R00330 R00332 R00335 R00336 R00337 R00394 R00430; R00431 R00432 R00439 R00517 R00883 R00887 R00890 R00968; R01009 R01135 R01517 R02019 R02168 R02405 R02890 R03129; R03378 R03519 R03768 R03769 R03829 R04081 R04082 R04331; R04502 R04553 R04646 R05002 R05106 R05768 R06558 R07257; R07678 R08692 R08858 R08947 R09399 R09400 R09666 R09667; R09733 R09734 R09752 R10439 R11203 R11229 R11497","Purine metabolism; Metabolic pathways; RNA transport; Ras signaling pathway; Rap1 signaling pathway; Endocytosis","1.17.4.1; 2.4.1.29; 2.4.1.32; 2.4.1.33; 2.4.1.36; 2.4.1.48; 2.4.1.54; 2.4.1.65; 2.4.1.69; 2.4.1.83; 2.4.1.110; 2.4.1.132; 2.4.1.142; 2.4.1.152; 2.4.1.217; 2.4.1.246; 2.4.1.251; 2.4.1.252; 2.4.1.269; 2.4.1.270; 2.4.1.308; 2.4.1.-; 2.5.1.135; 2.7.1.40; 2.7.1.48; 2.7.1.81; 2.7.1.156; 2.7.1.190; 2.7.2.10; 2.7.4.6; 2.7.4.8; 2.7.7.8; 2.7.7.22; 2.7.7.69; 2.7.7.78; 2.7.7.88; 3.1.7.2; 3.2.1.42; 3.6.1.5; 3.6.1.6; 3.6.1.42; 3.6.5.1; 3.6.5.2; 3.6.5.3; 3.6.5.4; 3.6.5.5; 3.6.5.6; 4.1.1.32; 6.2.1.4; 6.2.1.10; 6.3.2.31; 6.3.2.34; 6.3.4.4","Guanine ribonucleotide biosynthesis IMP => GDP,GTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00035  GDP","CAS: 146-91-8; PubChem: 3337; ChEBI: 17552; ChEMBL: CHEMBL384759; PDB-CCD: GDP; 3DMET: B01135; NIKKAJI: J40.056D","cpd:C00035; cpd:C20176",10,15,11,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O11N5P2","C10H14O11N5P2",443.0243303,444.0321553,442.0165053
"cpd:C00044","GTP;","C10H16N5O14P3","GTP; Guanosine 5'-triphosphate","R00012 R00330 R00335 R00394 R00424 R00425 R00426 R00428; R00429 R00430 R00431 R00432 R00434 R00441 R00517 R00885; R00954 R00968 R01135 R01232 R01517 R01951 R02020 R02405; R03318 R03378 R03828 R05222 R06558 R07306 R08057 R09394; R09397 R09399 R09400 R09772 R10348 R10462 R10537 R10823; R11229 R11402","Purine metabolism; Riboflavin metabolism; Folate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biofilm formation - Pseudomonas aeruginosa; RNA transport; Ras signaling pathway; Rap1 signaling pathway; Sulfur relay system; Endocytosis; Biofilm formation - Vibrio cholerae","1.17.4.2; 2.7.1.40; 2.7.1.48; 2.7.1.81; 2.7.1.156; 2.7.1.190; 2.7.2.10; 2.7.4.6; 2.7.6.5; 2.7.7.6; 2.7.7.13; 2.7.7.28; 2.7.7.30; 2.7.7.34; 2.7.7.45; 2.7.7.48; 2.7.7.50; 2.7.7.62; 2.7.7.65; 2.7.7.68; 2.7.7.71; 2.7.7.86; 2.7.7.91; 3.5.4.16; 3.5.4.25; 3.5.4.29; 3.5.4.39; 3.6.1.5; 3.6.1.8; 3.6.1.17; 3.6.1.-; 3.6.5.1; 3.6.5.2; 3.6.5.3; 3.6.5.4; 3.6.5.5; 3.6.5.6; 4.1.1.32; 4.1.99.22; 4.6.1.1; 4.6.1.2; 6.2.1.4; 6.2.1.10; 6.3.2.31; 6.3.2.34; 6.3.4.4; 6.5.1.5; 6.5.1.7","Guanine ribonucleotide biosynthesis IMP => GDP,GTP; Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD; Tetrahydrofolate biosynthesis, GTP => THF","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00044  GTP","CAS: 86-01-1; PubChem: 3346; ChEBI: 15996; ChEMBL: CHEMBL1233147; KNApSAcK: C00007223; PDB-CCD: GTP; 3DMET: B01137; NIKKAJI: J40.055F","cpd:C00044; cpd:C19967; cpd:C21310",10,16,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O14N5P3","C10H15O14N5P3",522.9906612,523.9984862,521.9828362
"cpd:C00048","Glyoxylate;","C2H2O3","Glyoxylate; Glyoxalate; Glyoxylic acid","R00013 R00364 R00365 R00366 R00369 R00372 R00373 R00465; R00466 R00468 R00469 R00470 R00471 R00472 R00473 R00474; R00475 R00476 R00477 R00478 R00479 R00588 R00652 R00717; R00776 R00932 R00934 R01180 R01957 R03040 R03121 R03874; R05418 R05419 R05493 R05862 R05863 R07982 R08702 R09144; R09151 R09717 R09718 R09798 R10179 R10245 R10283 R10908; R11351 R11454 R11455 R11456 R11486","Purine metabolism; Caffeine metabolism; Glycine, serine and threonine metabolism; Arginine and proline metabolism; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.26; 1.1.1.29; 1.1.1.79; 1.1.3.15; 1.1.99.14; 1.2.1.17; 1.2.3.5; 1.2.3.15; 1.4.1.1; 1.4.1.10; 1.4.2.1; 1.4.3.3; 1.4.3.19; 1.5.3.23; 1.5.3.-; 1.14.11.-; 1.14.12.11; 1.14.13.-; 1.14.14.10; 1.14.14.33; 2.2.1.5; 2.3.3.7; 2.3.3.9; 2.3.3.11; 2.3.3.12; 2.6.1.4; 2.6.1.35; 2.6.1.44; 2.6.1.45; 2.6.1.60; 2.6.1.63; 2.6.1.73; 2.6.1.96; 2.6.1.-; 3.5.1.116; 4.1.1.47; 4.1.3.1; 4.1.3.13; 4.1.3.14; 4.1.3.16; 4.1.3.24; 4.1.3.41; 4.1.3.42; 4.3.2.3; 4.3.2.5","Glyoxylate cycle; Formaldehyde assimilation, serine pathway; Ethylmalonyl pathway; 3-Hydroxypropionate bi-cycle; Photorespiration; Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00048  Glyoxylate; Oxoacetate","CAS: 298-12-4; PubChem: 3350; ChEBI: 16891; ChEMBL: CHEMBL1162545; KNApSAcK: C00001186; PDB-CCD: GLV; 3DMET: B00014; NIKKAJI: J38.150K","cpd:C00048; cpd:C05718",2,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H3O3","C2H1O3",74.00039392,75.00821896,72.99256889
"cpd:C00053","3'-Phosphoadenylyl sulfate;","C10H15N5O13P2S","3'-Phosphoadenylyl sulfate; 3'-Phosphoadenosine 5'-phosphosulfate; 3'-Phospho-5'-adenylyl sulfate; PAPS","R00507 R00508 R00509 R00535 R00536 R00537 R00629 R01027; R01236 R01242 R01861 R02021 R02122 R02159 R02180 R02181; R02350 R02586 R02632 R02633 R02809 R02839 R03138 R03214; R03289 R03405 R03553 R03700 R03946 R03987 R04017 R04213; R04476 R04643 R05105 R05798 R06122 R06279 R06809 R07287; R07288 R07289 R07797 R07798 R08167 R08662 R08669 R08671; R08688 R08699 R08977 R08978 R09444 R10655 R10751 R10805; R10868 R10869 R10873 R10971","Purine metabolism; Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Sulfur metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.8.4.8; 2.7.1.25; 2.8.2.1; 2.8.2.2; 2.8.2.3; 2.8.2.4; 2.8.2.5; 2.8.2.6; 2.8.2.7; 2.8.2.8; 2.8.2.9; 2.8.2.10; 2.8.2.11; 2.8.2.13; 2.8.2.14; 2.8.2.15; 2.8.2.16; 2.8.2.17; 2.8.2.18; 2.8.2.19; 2.8.2.20; 2.8.2.21; 2.8.2.23; 2.8.2.24; 2.8.2.25; 2.8.2.26; 2.8.2.27; 2.8.2.28; 2.8.2.29; 2.8.2.30; 2.8.2.31; 2.8.2.32; 2.8.2.33; 2.8.2.34; 2.8.2.35; 2.8.2.36; 2.8.2.37; 2.8.2.-; 3.1.3.7; 3.6.2.2","Assimilatory sulfate reduction, sulfate => H2S","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00053  PAPS","CAS: 482-67-7; PubChem: 3355; ChEBI: 17980; KNApSAcK: C00007446; PDB-CCD: PPS; 3DMET: B01139; NIKKAJI: J372.802A","cpd:C00053; cpd:C03568",10,15,13,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O13N5P2S1","C10H14O13N5P2S1",506.9862307,507.9940558,505.9784057
"cpd:C00054","Adenosine 3',5'-bisphosphate;","C10H15N5O10P2","Adenosine 3',5'-bisphosphate; PAP; 3'-Phosphoadenylate; Phosphoadenosine phosphate","R00188 R00507 R00535 R00536 R00537 R00629 R01027 R01236; R01242 R01625 R01861 R02021 R02122 R02159 R02180 R02181; R02350 R02586 R02632 R02633 R02809 R02839 R03138 R03214; R03289 R03405 R03553 R03700 R03946 R03987 R04017 R04213; R04476 R04643 R04940 R05105 R05798 R06122 R06279 R06809; R07287 R07288 R07289 R07797 R07798 R08167 R08662 R08669; R08671 R08688 R08699 R08977 R08978 R09444 R10655 R10747; R10751 R10805 R10868 R10869 R10873 R10971","Purine metabolism; Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Pantothenate and CoA biosynthesis; Sulfur metabolism","1.8.4.8; 2.7.8.7; 2.7.8.-; 2.8.2.1; 2.8.2.2; 2.8.2.3; 2.8.2.4; 2.8.2.5; 2.8.2.6; 2.8.2.7; 2.8.2.8; 2.8.2.9; 2.8.2.10; 2.8.2.11; 2.8.2.13; 2.8.2.14; 2.8.2.15; 2.8.2.16; 2.8.2.17; 2.8.2.18; 2.8.2.19; 2.8.2.20; 2.8.2.21; 2.8.2.23; 2.8.2.24; 2.8.2.25; 2.8.2.26; 2.8.2.27; 2.8.2.28; 2.8.2.29; 2.8.2.30; 2.8.2.31; 2.8.2.32; 2.8.2.33; 2.8.2.34; 2.8.2.35; 2.8.2.36; 2.8.2.37; 2.8.2.-; 3.1.3.7; 3.1.3.97; 3.6.1.-; 3.6.2.2",NA,NA,"CAS: 1053-73-2; PubChem: 3356; ChEBI: 17985; ChEMBL: CHEMBL574817; KNApSAcK: C00019352; PDB-CCD: A3P; 3DMET: B01140; NIKKAJI: J14.396K","cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850",10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O10N5P2","C10H14O10N5P2",427.0294157,428.0372407,426.0215907
"cpd:C00081","ITP;","C10H15N4O14P3","ITP; Inosine 5'-triphosphate; Inosine triphosphate; Inosine tripolyphosphate","R00088 R00719 R00720 R00722 R00723 R00724 R00725 R00726; R00727 R00770 R00876 R00962 R00970 R01327 R01964 R02406; R02849 R02867 R03239","Purine metabolism","2.7.1.1; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 3.5.4.17; 3.5.4.18; 3.6.1.5; 3.6.1.8; 3.6.1.14; 3.6.1.-; 4.1.1.32; 6.2.1.4",NA,NA,"CAS: 132-06-9; PubChem: 3381; ChEBI: 16039; ChEMBL: CHEMBL1233686; PDB-CCD: ITT; 3DMET: B01153; NIKKAJI: J38.562J","cpd:C00081; cpd:C01348",10,15,14,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O14N4P3","C10H14O14N4P3",507.9797622,508.9875872,506.9719371
"cpd:C00104","IDP;","C10H14N4O11P2","IDP; Inosine 5'-diphosphate; Inosine diphosphate","R00123 R00719 R00722 R00724 R00725 R00726 R00727 R00770; R00876 R00961 R00962 R00970 R01327 R01964 R02406 R02849; R02867 R03239","Purine metabolism","2.7.1.1; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 3.5.4.7; 3.5.4.17; 3.6.1.5; 3.6.1.6; 3.6.1.64; 4.1.1.32; 6.2.1.4",NA,NA,"CAS: 86-04-4; PubChem: 3404; ChEBI: 17808; PDB-CCD: IDP; 3DMET: B01160; NIKKAJI: J38.561A","cpd:C00104; cpd:C01347",10,14,11,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O11N4P2","C10H13O11N4P2",428.0134313,429.0212563,427.0056062
"cpd:C00130","IMP;","C10H13N4O8P","IMP; Inosinic acid; Inosine monophosphate; Inosine 5'-monophosphate; Inosine 5'-phosphate; 5'-Inosinate; 5'-Inosinic acid; 5'-Inosine monophosphate; 5'-IMP","R00181 R00720 R00961 R01126 R01127 R01128 R01130 R01131; R01132 R01134 R01135 R01690","Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Antifolate resistance; Taste transduction","1.1.1.205; 1.7.1.7; 2.1.2.3; 2.4.2.8; 2.7.1.73; 3.1.3.5; 3.1.3.99; 3.2.2.12; 3.5.4.6; 3.5.4.10; 3.5.4.17; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.20; 3.6.1.64; 3.6.1.-; 6.3.4.4","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Adenine ribonucleotide biosynthesis, IMP => ADP,ATP; Guanine ribonucleotide biosynthesis IMP => GDP,GTP",NA,"CAS: 131-99-7; PubChem: 3430; ChEBI: 17202; ChEMBL: CHEMBL1207374 CHEMBL603339; KNApSAcK: C00007224; PDB-CCD: IMP; 3DMET: B01168; NIKKAJI: J9.493E","cpd:C00130; cpd:C16618; cpd:C20451; cpd:C20458",10,13,8,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O8N4P1","C10H12O8N4P1",348.0471004,349.0549254,347.0392754
"cpd:C00131","dATP;","C10H16N5O12P3","dATP; 2'-Deoxyadenosine 5'-triphosphate; Deoxyadenosine 5'-triphosphate; Deoxyadenosine triphosphate","R00375 R01137 R01138 R01139 R01140 R01330 R01548 R01549; R01965 R02014 R02850 R02868 R03904","Purine metabolism; Metabolic pathways","1.17.4.2; 2.6.99.1; 2.7.1.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.7.7",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00131  dATP","CAS: 1927-31-7; PubChem: 3431; ChEBI: 16284; ChEMBL: CHEMBL335538; PDB-CCD: DTP; 3DMET: B01169; NIKKAJI: J90.479A","cpd:C00131; cpd:C13742",10,16,12,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O12N5P3","C10H15O12N5P3",491.000832,492.008657,489.9930069
"cpd:C00144","GMP;","C10H14N5O8P","GMP; Guanosine 5'-phosphate; Guanosine monophosphate; Guanosine 5'-monophosphate; Guanylic acid","R00328 R00332 R00426 R00881 R01134 R01227 R01228 R01229; R01230 R01231 R01232 R01233 R01234 R03924 R05223 R09398; R10537 R10823 R11174","Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Antifolate resistance; cGMP-PKG signaling pathway; Olfactory transduction; Taste transduction; Phototransduction","1.7.1.7; 2.4.2.7; 2.4.2.8; 2.4.2.22; 2.7.1.73; 2.7.4.8; 2.7.8.9; 2.7.8.26; 2.7.8.28; 3.1.3.5; 3.1.4.17; 3.1.4.35; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.17; 3.6.1.21; 3.6.1.42; 3.6.1.-; 6.3.5.2; 6.5.1.5; 6.5.1.7","Guanine ribonucleotide biosynthesis IMP => GDP,GTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00144  GMP","CAS: 85-32-5; PubChem: 3444; ChEBI: 17345; ChEMBL: CHEMBL281820 CHEMBL283807; KNApSAcK: C00019635; PDB-CCD: 5GP G; 3DMET: B01172; NIKKAJI: J10.615A","cpd:C00144; cpd:C01977; cpd:C06193; cpd:C18239; cpd:C19968",10,14,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O8N5P1","C10H13O8N5P1",363.0579994,364.0658245,362.0501744
"cpd:C00147","Adenine;","C5H5N5","Adenine; 6-Aminopurine","R00182 R00190 R00194 R01244 R01245 R01401 R01402 R01561; R02557 R05708 R09675 R10185 R10668 R10836 R11113","Purine metabolism; Zeatin biosynthesis; Metabolic pathways","1.5.99.12; 2.4.2.1; 2.4.2.7; 2.4.2.8; 2.4.2.28; 2.4.2.52; 2.4.2.57; 2.7.8.37; 3.2.2.1; 3.2.2.4; 3.2.2.7; 3.2.2.8; 3.2.2.9; 3.2.2.16; 3.2.2.30; 3.5.4.2",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Purines;     C00147  Adenine (Ade); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   41  Cellular function activating agents;    419  Miscellaneous;     4191  Adenines;      D00034  Adenine (JAN/USP)","CAS: 73-24-5; PubChem: 3447; ChEBI: 16708; ChEMBL: CHEMBL226345; KNApSAcK: C00001490; PDB-CCD: ADE; 3DMET: B00041; NIKKAJI: J5.257D","cpd:C00147; cpd:C00242; cpd:C07648; cpd:C20155",5,5,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H6N5","C5H4N5",135.0544952,136.0623202,134.0466702
"cpd:C00206","dADP;","C10H15N5O9P2","dADP; 2'-Deoxyadenosine 5'-diphosphate","R01137 R01138 R01139 R01140 R01330 R01547 R01548 R01549; R01965 R02017 R02850 R02868","Purine metabolism; Metabolic pathways","1.17.4.1; 2.7.1.1; 2.7.1.40; 2.7.1.48; 2.7.4.3; 2.7.4.6; 2.7.4.11",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00206  dADP","CAS: 2793-06-8; PubChem: 3506; ChEBI: 16174; PDB-CCD: DAT; 3DMET: B01188; NIKKAJI: J247.700I","cpd:C00206; cpd:C13743",10,15,9,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O9N5P2","C10H14O9N5P2",411.0345011,412.0423261,410.026676
"cpd:C00212","Adenosine","C10H13N5O4","Adenosine","R00183 R00185 R00192 R01245 R01560 R01561 R01562 R01571; R04936 R05695 R05696","Purine metabolism; Metabolic pathways; cGMP-PKG signaling pathway; cAMP signaling pathway; Sphingolipid signaling pathway; Neuroactive ligand-receptor interaction; Vascular smooth muscle contraction; Regulation of lipolysis in adipocytes; Renin secretion; Parkinson's disease; Morphine addiction; Alcoholism","1.1.3.39; 2.4.2.1; 2.7.1.20; 2.7.1.74; 2.7.1.114; 3.1.3.5; 3.1.3.6; 3.2.2.1; 3.2.2.7; 3.2.2.8; 3.3.1.1; 3.5.4.4",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00212  Adenosine (A); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D00045  Adenosine (JAN/USP); Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D00045  Adenosine (JAN/USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A2a receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A2b receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A3 receptor;      Adenosine;       D00045  Adenosine (JAN/USP); New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D00045","CAS: 58-61-7; PubChem: 3512; ChEBI: 16335; ChEMBL: CHEMBL477; KNApSAcK: C00007444; PDB-CCD: ADN; 3DMET: B01189; NIKKAJI: J4.501B","cpd:C00212; cpd:C00330; cpd:C07195; cpd:C07210",10,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O4N5","C10H12O4N5",267.0967539,268.104579,266.0889289
"cpd:C00224","Adenylyl sulfate;","C10H14N5O10PS","Adenylyl sulfate; Adenosine 5'-phosphosulfate; APS; 5'-Adenylyl sulfate","R00508 R00509 R00529 R00530 R00531 R00860 R01618 R01619; R05717 R07176 R08553","Purine metabolism; Monobactam biosynthesis; Sulfur metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics","1.8.4.9; 1.8.4.10; 1.8.99.2; 2.7.1.25; 2.7.7.4; 2.7.7.5; 2.7.7.51; 2.7.7.53; 3.1.3.7; 3.6.2.1","Assimilatory sulfate reduction, sulfate => H2S; Dissimilatory sulfate reduction, sulfate => H2S",NA,"CAS: 485-84-7; PubChem: 3524; ChEBI: 17709; ChEMBL: CHEMBL572546; KNApSAcK: C00007445; PDB-CCD: ADX; 3DMET: B01194; NIKKAJI: J37.502K","cpd:C00224",10,14,10,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O10N5P1S1","C10H13O10N5P1S1",427.0198998,428.0277249,426.0120748
"cpd:C00242","Guanine;","C5H5N5O","Guanine; 2-Amino-6-hydroxypurine","R01229 R01676 R01677 R01969 R02147 R03789 R10209","Purine metabolism; Metabolic pathways","2.4.2.1; 2.4.2.4; 2.4.2.7; 2.4.2.8; 2.4.2.15; 2.4.2.22; 2.4.2.29; 3.2.2.1; 3.2.2.8; 3.5.4.3",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Purines;     C00242  Guanine (Gua)","CAS: 73-40-5; PubChem: 3541; ChEBI: 16235; ChEMBL: CHEMBL219568; KNApSAcK: C00001501; PDB-CCD: GUN; 3DMET: B00067; NIKKAJI: J9.344K","cpd:C00242",5,5,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H6O1N5","C5H4O1N5",151.0494098,152.0572348,150.0415848
"cpd:C00262","Hypoxanthine;","C5H4N4O","Hypoxanthine; Purine-6-ol","R01128 R01132 R01244 R01768 R01769 R01770 R01863 R02748; R08587 R09668","Purine metabolism; Metabolic pathways","1.17.1.4; 1.17.3.2; 2.4.2.1; 2.4.2.4; 2.4.2.8; 2.4.2.15; 2.4.2.44; 3.2.2.1; 3.2.2.2; 3.2.2.8; 3.2.2.12; 3.2.2.26; 3.5.4.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00262  Hypoxanthine","CAS: 68-94-0; PubChem: 3560; ChEBI: 17368; ChEMBL: CHEMBL1427; KNApSAcK: C00001502; PDB-CCD: HPA; 3DMET: B00078; NIKKAJI: J1.934H","cpd:C00262",5,4,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H5O1N4","C5H3O1N4",136.0385108,137.0463358,135.0306857
"cpd:C00286","dGTP;","C10H16N5O13P3","dGTP; 2'-Deoxyguanosine 5'-triphosphate; Deoxyguanosine 5'-triphosphate; Deoxyguanosine triphosphate","R00376 R01855 R01856 R01857 R01858 R01880 R02020 R02091; R07278","Purine metabolism; Metabolic pathways","1.17.4.2; 2.6.99.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.7.7; 3.1.5.1; 3.6.1.-",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00286  dGTP","CAS: 2564-35-4; PubChem: 3581; ChEBI: 16497; ChEMBL: CHEMBL477486; KNApSAcK: C00019346; PDB-CCD: DGT; 3DMET: B01207; NIKKAJI: J192.065K","cpd:C00002; cpd:C00286; cpd:C01806; cpd:C19969",10,16,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O13N5P3","C10H15O13N5P3",506.9957466,508.0035716,505.9879216
"cpd:C00294","Inosine","C10H12N4O5","Inosine","R00055 R01126 R01131 R01560 R01770 R01863 R05821","Purine metabolism; Metabolic pathways","1.1.3.28; 2.4.2.1; 2.4.2.15; 2.7.1.73; 3.1.3.5; 3.1.3.99; 3.2.2.1; 3.2.2.2; 3.2.2.8; 3.5.4.4",NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06B CHEMOTHERAPEUTICS FOR TOPICAL USE;     D06BB Antivirals;      D06BB05 Inosine;       D00054  Inosine (JAN/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AX Other antiinfectives and antiseptics;      G01AX02 Inosine;       D00054  Inosine (JAN/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA10 Inosine;       D00054  Inosine (JAN/INN)","CAS: 58-63-9; PubChem: 3588; ChEBI: 17596; ChEMBL: CHEMBL1556; KNApSAcK: C00019692; PDB-CCD: NOS; 3DMET: B01208; NIKKAJI: J1.388I","cpd:C00294; cpd:C07771",10,12,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O5N4","C10H11O5N4",268.0807695,269.0885945,267.0729445
"cpd:C00301","ADP-ribose;","C15H23N5O14P2","ADP-ribose; ADP-D-ribose; Adenosine diphosphate ribose","R00102 R01052 R01054 R01885 R01886 R03446 R07626 R10630; R11553","Purine metabolism","2.7.7.35; 2.7.7.96; 3.2.2.5; 3.2.2.6; 3.2.2.19; 3.2.2.24; 3.5.1.-; 3.6.1.13; 3.6.1.21; 3.6.1.53; 3.6.1.-",NA,NA,"PubChem: 3595; ChEBI: 16960; ChEMBL: CHEMBL1161865; PDB-CCD: APR; 3DMET: B01211; NIKKAJI: J17.074G","cpd:C00301; cpd:C01882; cpd:C02741",15,23,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C15H24O14N5P2","C15H22O14N5P2",559.0716744,560.0794995,558.0638494
"cpd:C00330","Deoxyguanosine;","C10H13N5O4","Deoxyguanosine; 2'-Deoxyguanosine","R01856 R01967 R01968 R01969","Purine metabolism; Metabolic pathways","2.4.2.1; 2.4.2.4; 2.7.1.113; 3.1.3.5; 3.1.3.89; 3.1.5.1",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00330  Deoxyguanosine (dG)","CAS: 961-07-9; PubChem: 3624; ChEBI: 17172; ChEMBL: CHEMBL1415372 CHEMBL68908; PDB-CCD: GNG; 3DMET: B01219; NIKKAJI: J13.863K","cpd:C00212; cpd:C00330; cpd:C07195; cpd:C07210",10,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O4N5","C10H12O4N5",267.0967539,268.104579,266.0889289
"cpd:C00360","dAMP;","C10H14N5O6P","dAMP; 2'-Deoxyadenosine 5'-phosphate; 2'-Deoxyadenosine 5'-monophosphate; Deoxyadenylic acid; Deoxyadenosine monophosphate","R01547 R02088 R02089","Purine metabolism; Metabolic pathways","2.7.1.76; 2.7.4.3; 2.7.4.11; 3.1.3.5; 3.1.3.89",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00360  dAMP","CAS: 653-63-4; PubChem: 3651; ChEBI: 17713; ChEMBL: CHEMBL1206239; PDB-CCD: D5M DA; 3DMET: B01226; NIKKAJI: J205.943F","cpd:C00360; cpd:C00821; cpd:C05924",10,14,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O6N5P1","C10H13O6N5P1",331.0681702,332.0759952,330.0603452
"cpd:C00361","dGDP;","C10H15N5O10P2","dGDP; 2'-Deoxyguanosine 5'-diphosphate","R01857 R01858 R01880 R02019 R02090 R02091","Purine metabolism; Metabolic pathways","1.17.4.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.4.8; 2.7.4.12",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00361  dGDP","PubChem: 3652; ChEBI: 28862; PDB-CCD: DGI; 3DMET: B01227; NIKKAJI: J366.498H","cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850",10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O10N5P2","C10H14O10N5P2",427.0294157,428.0372407,426.0215907
"cpd:C00362","dGMP;","C10H14N5O7P","dGMP; 2'-Deoxyguanosine 5'-monophosphate; 2'-Deoxyguanosine 5'-phosphate; Deoxyguanylic acid; Deoxyguanosine monophosphate","R01855 R01967 R01968 R02090","Purine metabolism; Metabolic pathways","2.7.1.113; 2.7.4.8; 2.7.4.12; 3.1.3.5; 3.1.3.89; 3.6.1.-",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00362  dGMP","CAS: 902-04-5; PubChem: 3653; ChEBI: 16192; ChEMBL: CHEMBL477487; KNApSAcK: C00019356; PDB-CCD: DG DGP; 3DMET: B01228; NIKKAJI: J195.198J","cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648",10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O7N5P1","C10H13O7N5P1",347.0630848,348.0709098,346.0552598
"cpd:C00366","Urate;","C5H4N4O3","Urate; Uric acid","R02103 R02106 R02107 R02646 R09514 R09876 R10920","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Bile secretion","1.7.3.3; 1.14.11.48; 1.14.13.113; 1.17.1.4; 1.17.3.2; 2.4.2.16; 3.5.4.32","Purine degradation, xanthine => urea",NA,"CAS: 69-93-2; PubChem: 3657; ChEBI: 17775; ChEMBL: CHEMBL792; KNApSAcK: C00007301; PDB-CCD: 8HX URC; 3DMET: B00094; NIKKAJI: J2.372H","cpd:C00366",5,4,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H5O3N4","C5H3O3N4",168.02834,169.036165,167.020515
"cpd:C00385","Xanthine","C5H4N4O2","Xanthine","R01676 R01768 R01769 R02103 R02107 R02141 R02142 R02143; R02297 R07965 R07966 R07967 R07968 R07969 R07970 R08410; R10920","Purine metabolism; Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.14.11.48; 1.14.13.128; 1.14.13.178; 1.14.13.179; 1.17.1.4; 1.17.3.2; 2.4.2.1; 2.4.2.8; 2.4.2.22; 2.4.2.-; 3.2.2.1; 3.5.2.-; 3.5.4.3","Purine degradation, xanthine => urea","Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00385  Xanthine","CAS: 69-89-6; PubChem: 3675; ChEBI: 17712 48517; ChEMBL: CHEMBL1424; KNApSAcK: C00019660; PDB-CCD: XAN; 3DMET: B00099; NIKKAJI: J2.371J","cpd:C00385; cpd:C07599; cpd:C16613",5,4,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H5O2N4","C5H3O2N4",152.0334254,153.0412504,151.0256004
"cpd:C00387","Guanosine","C10H13N5O5","Guanosine","R01227 R01228 R01677 R02145 R02147 R02148","Purine metabolism; Metabolic pathways","2.4.2.1; 2.4.2.15; 2.7.1.73; 3.1.3.5; 3.1.3.6; 3.2.2.1; 3.2.2.8; 3.5.4.15",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00387  Guanosine (G)","CAS: 118-00-3; PubChem: 3677; ChEBI: 16750; ChEMBL: CHEMBL375655; KNApSAcK: C00019679; PDB-CCD: GMP; 3DMET: B01233; NIKKAJI: J10.076E","cpd:C00387; cpd:C08432",10,13,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O5N5","C10H12O5N5",283.0916685,284.0994936,282.0838435
"cpd:C00499","Allantoate;","C4H8N4O4","Allantoate; Allantoic acid","R02422 R02423 R02425","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","3.5.2.5; 3.5.3.4; 3.5.3.9","Purine degradation, xanthine => urea",NA,"CAS: 99-16-1; PubChem: 3782; ChEBI: 17536 30837; KNApSAcK: C00007470; PDB-CCD: 1AL; 3DMET: B01270; NIKKAJI: J11.619J","cpd:C00499",4,8,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O4N4","C4H7O4N4",176.0545548,177.0623798,175.0467297
"cpd:C00559","Deoxyadenosine;","C10H13N5O3","Deoxyadenosine; 2'-Deoxyadenosine","R02088 R02089 R02556 R02557","Purine metabolism; Metabolic pathways","2.4.2.1; 2.7.1.76; 3.1.3.5; 3.1.3.89; 3.5.4.4",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00559  Deoxyadenosine (dA)","CAS: 958-09-8; PubChem: 3839; ChEBI: 17256; ChEMBL: CHEMBL449329; KNApSAcK: C00019281; PDB-CCD: 3D1; 3DMET: B01287; NIKKAJI: J80.042B","cpd:C00559; cpd:C05198; cpd:C08431",10,13,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O3N5","C10H12O3N5",251.1018393,252.1096643,250.0940143
"cpd:C00575","3',5'-Cyclic AMP;","C10H12N5O6P","3',5'-Cyclic AMP; Cyclic adenylic acid; Cyclic AMP; Adenosine 3',5'-phosphate; Adenosine 3',5'-cyclic phosphate; cAMP","R00089 R00191","Purine metabolism; Endocrine resistance; Biofilm formation - Pseudomonas aeruginosa; Biofilm formation - Escherichia coli; MAPK signaling pathway; Ras signaling pathway; Rap1 signaling pathway; Calcium signaling pathway; cGMP-PKG signaling pathway; cAMP signaling pathway; Chemokine signaling pathway; Phospholipase D signaling pathway; Cell cycle - yeast; Meiosis - yeast; Oocyte meiosis; Longevity regulating pathway; Longevity regulating pathway - multiple species; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; Hedgehog signaling pathway; Apelin signaling pathway; Gap junction; Platelet activation; Leukocyte transendothelial migration; Circadian rhythm; Circadian entrainment; Long-term potentiation; Retrograde endocannabinoid signaling; Glutamatergic synapse; Cholinergic synapse; Serotonergic synapse; GABAergic synapse; Dopaminergic synapse; Olfactory transduction; Taste transduction; Inflammatory mediator regulation of TRP channels; Insulin signaling pathway; Insulin secretion; GnRH signaling pathway; Ovarian steroidogenesis; Progesterone-mediated oocyte maturation; Estrogen signaling pathway; Melanogenesis; Thyroid hormone synthesis; Thyroid hormone signaling pathway; Oxytocin signaling pathway; Glucagon signaling pathway; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Aldosterone-regulated sodium reabsorption; Endocrine and other factor-regulated calcium reabsorption; Vasopressin-regulated water reabsorption; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Bile secretion; Parkinson's disease; Prion diseases; Cocaine addiction; Amphetamine addiction; Morphine addiction; Alcoholism; Vibrio cholerae infection; Biofilm formation - Vibrio cholerae; Pertussis; Chagas disease (American trypanosomiasis); Amoebiasis; HTLV-I infection; Pathways in cancer; Dilated cardiomyopathy","3.1.4.17; 3.1.4.53; 4.6.1.1",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    3',5'-Cyclic nuclcleotides;     C00575  3',5'-Cyclic AMP","CAS: 60-92-4; PubChem: 3854; ChEBI: 17489; ChEMBL: CHEMBL316966; KNApSAcK: C00001497; PDB-CCD: CMP; 3DMET: B01289; NIKKAJI: J4.811I","cpd:C00575; cpd:C00895; cpd:C02353; cpd:C02507; cpd:C20935",10,12,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O6N5P1","C10H11O6N5P1",329.0525201,330.0603452,328.0446951
"cpd:C00603","(-)-Ureidoglycolate;","C3H6N2O4","(-)-Ureidoglycolate; (S)-Ureidoglycolate","R00469 R00776 R02422 R02935 R02936 R05554","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.1.1.154; 1.1.1.350; 3.5.1.116; 3.5.3.4; 3.5.3.26; 4.3.2.3",NA,NA,"PubChem: 3878; ChEBI: 15412; KNApSAcK: C00007466; PDB-CCD: UGC; 3DMET: B01292; NIKKAJI: J1.344.912K","cpd:C00603; cpd:C02766",3,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O4N2","C3H5O4N2",134.0327567,135.0405817,133.0249316
"cpd:C00655","Xanthosine 5'-phosphate;","C10H13N4O9P","Xanthosine 5'-phosphate; Xanthylic acid; XMP; (9-D-Ribosylxanthine)-5'-phosphate","R01130 R01230 R01231 R02142 R02719 R02720 R02805","Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites","1.1.1.205; 2.4.2.8; 2.4.2.22; 3.1.3.5; 3.6.1.17; 3.6.1.66; 3.6.1.-; 6.3.5.2","Guanine ribonucleotide biosynthesis IMP => GDP,GTP","Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00655  Xanthosine 5'-phosphate","CAS: 523-98-8; PubChem: 3925; ChEBI: 15652; ChEMBL: CHEMBL1206243; KNApSAcK: C00007396; PDB-CCD: XMP; 3DMET: B01300; NIKKAJI: J29.066A","cpd:C00655",10,13,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O9N4P1","C10H12O9N4P1",364.042015,365.04984,363.03419
"cpd:C00700","XTP;","C10H15N4O15P3","XTP; Xanthosine 5'-triphosphate","R02720 R02805","Purine metabolism","3.6.1.17; 3.6.1.66; 3.6.1.-",NA,NA,"CAS: 6253-56-1; PubChem: 3968; ChEBI: 10049; 3DMET: B01316; NIKKAJI: J276.384B","cpd:C00700",10,15,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O15N4P3","C10H14O15N4P3",523.9746768,524.9825018,522.9668518
"cpd:C00802","Oxalureate;","C3H4N2O4","Oxalureate; Oxaluric acid; Monooxalylurea; Oxalurate","R02935 R02936 R02937 R10908","Purine metabolism; Microbial metabolism in diverse environments","1.1.1.154; 1.1.1.350; 2.1.3.5; 2.6.1.-",NA,NA,"CAS: 585-05-7; PubChem: 4060; ChEBI: 16582; KNApSAcK: C00007463; 3DMET: B01334; NIKKAJI: J2.677H","cpd:C00802",3,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O4N2","C3H3O4N2",132.0171066,133.0249316,131.0092816
"cpd:C00942","3',5'-Cyclic GMP;","C10H12N5O7P","3',5'-Cyclic GMP; Guanosine 3',5'-cyclic monophosphate; Guanosine 3',5'-cyclic phosphate; Cyclic GMP; cGMP","R00434 R01234","Purine metabolism; cGMP-PKG signaling pathway; Vascular smooth muscle contraction; Gap junction; Platelet activation; Circadian entrainment; Long-term depression; Olfactory transduction; Phototransduction; Oxytocin signaling pathway; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Salivary secretion; Bile secretion","3.1.4.17; 3.1.4.35; 4.6.1.1; 4.6.1.2",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    3',5'-Cyclic nuclcleotides;     C00942  3',5'-Cyclic GMP","CAS: 7665-99-8; PubChem: 4194; ChEBI: 16356; ChEMBL: CHEMBL395336 CHEMBL68554; KNApSAcK: C00019673; PDB-CCD: 35G PCG; 3DMET: B01354; NIKKAJI: J8.958C","cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344",10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O7N5P1","C10H11O7N5P1",345.0474347,346.0552598,344.0396097
"cpd:C01228","Guanosine 3',5'-bis(diphosphate);","C10H17N5O17P4","Guanosine 3',5'-bis(diphosphate); Guanosine 3'-diphosphate 5'-diphosphate; Guanosine 5'-diphosphate,3'-diphosphate","R00336 R03409","Purine metabolism; Biofilm formation - Escherichia coli","3.1.7.2; 3.6.1.11; 3.6.1.40",NA,NA,"PubChem: 4450; ChEBI: 17633; PDB-CCD: G4P; 3DMET: B01416; NIKKAJI: J40.058K","cpd:C01228",10,17,17,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H18O17N5P4","C10H16O17N5P4",602.9569921,603.9648171,601.9491671
"cpd:C01260","P1,P4-Bis(5'-adenosyl)tetraphosphate;","C20H28N10O19P4","P1,P4-Bis(5'-adenosyl)tetraphosphate; AppppA","R00125 R00126 R00184 R01618","Purine metabolism","2.7.7.53; 3.6.1.17; 3.6.1.41; 3.6.1.61",NA,NA,"PubChem: 4479; ChEBI: 17422; ChEMBL: CHEMBL339385; PDB-CCD: B4P; 3DMET: B01424; NIKKAJI: J313.703A","cpd:C01260; cpd:C20935",20,28,19,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H29O19N10P4","C20H27O19N10P4",836.0482667,837.0560917,835.0404417
"cpd:C01261","P1,P4-Bis(5'-guanosyl) tetraphosphate;","C20H28N10O21P4","P1,P4-Bis(5'-guanosyl) tetraphosphate; GppppG; Bis(5'-guanosyl) tetraphosphate","R00012 R01232","Purine metabolism","2.7.7.45; 3.6.1.17",NA,NA,"PubChem: 4480; ChEBI: 15883; ChEMBL: CHEMBL448348; 3DMET: B01425; NIKKAJI: J398.256D","cpd:C01261",20,28,21,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H29O21N10P4","C20H27O21N10P4",868.038096,869.045921,867.0302709
"cpd:C01344","dIDP;","C10H14N4O10P2","dIDP; 2'-Deoxyinosine-5'-diphosphate; 2'-Deoxyinosine 5'-diphosphate","R03530 R10235","Purine metabolism","2.7.4.6; 3.6.1.64",NA,NA,"PubChem: 4549; ChEBI: 28823; 3DMET: B01439; NIKKAJI: J2.732.433I","cpd:C01344; cpd:C16616",10,14,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O10N4P2","C10H13O10N4P2",412.0185167,413.0263417,411.0106916
"cpd:C01345","dITP;","C10H15N4O13P3","dITP; 2'-Deoxyinosine-5'-triphosphate; 2'-Deoxyinosine 5'-triphosphate","R03530 R03531","Purine metabolism","2.7.4.6; 3.6.1.66; 3.6.1.-",NA,NA,"PubChem: 4550; ChEBI: 28807; 3DMET: B01440; NIKKAJI: J322.120B","cpd:C01345; cpd:C16617",10,15,13,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O13N4P3","C10H14O13N4P3",491.9848476,492.9926726,490.9770225
"cpd:C01367","3'-AMP;","C10H14N5O7P","3'-AMP; 3'-Adenylic acid; 3'-Adenosine monophosphate; Adenosine-3'-monophosphate; Adenosine 3'-phosphate; AMP 3'-phosphate","R01562 R03537","Purine metabolism","3.1.3.6; 3.1.4.16",NA,NA,"CAS: 84-21-9; PubChem: 4566; ChEBI: 28931; ChEMBL: CHEMBL576739; KNApSAcK: C00019350; PDB-CCD: 3AM; 3DMET: B01442; NIKKAJI: J36.734F","cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648",10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O7N5P1","C10H13O7N5P1",347.0630848,348.0709098,346.0552598
"cpd:C01762","Xanthosine","C10H12N4O6","Xanthosine","R02143 R02145 R02297 R02719 R07917","Purine metabolism; Caffeine metabolism; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.158; 2.4.2.1; 2.4.2.-; 3.1.3.5; 3.2.2.1; 3.5.4.15",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C01762  Xanthosine","CAS: 146-80-5; PubChem: 4895; ChEBI: 18107; ChEMBL: CHEMBL402439 CHEMBL605888; KNApSAcK: C00007222; PDB-CCD: 4UO; 3DMET: B01495; NIKKAJI: J9.367J","cpd:C01762",10,12,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O6N4","C10H11O6N4",284.0756841,285.0835092,283.0678591
"cpd:C02091","(S)-Ureidoglycine","C3H7N3O3","(S)-Ureidoglycine","R02423 R05554 R10908","Purine metabolism; Microbial metabolism in diverse environments","2.6.1.-; 3.5.3.9; 3.5.3.26",NA,NA,"PubChem: 5176; ChEBI: 16282 59945; KNApSAcK: C00007467; PDB-CCD: UGY; 3DMET: B00388; NIKKAJI: J2.735.485H","cpd:C02091; cpd:C06382",3,7,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O3N3","C3H6O3N3",133.0487411,134.0565661,132.0409161
"cpd:C02348","(R)(-)-Allantoin;","C4H6N4O3","(R)(-)-Allantoin; (R)-Allantoin","R03925 R06063 R06605","Purine metabolism; Microbial metabolism in diverse environments","5.1.99.3",NA,NA,"PubChem: 5396; ChEBI: 15677; 3DMET: B01563; NIKKAJI: J732.397B","cpd:C01551; cpd:C02348; cpd:C02350; cpd:C06805",4,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3N4","C4H5O3N4",158.0439901,159.0518151,157.036165
"cpd:C02350","(S)-Allantoin;","C4H6N4O3","(S)-Allantoin; (S)(+)-Allantoin","R02425 R03925 R06064 R06604","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","3.5.2.5; 4.1.1.97; 5.1.99.3","Purine degradation, xanthine => urea",NA,"PubChem: 5397; ChEBI: 15678; ChEMBL: CHEMBL1230080; PDB-CCD: 3AL; 3DMET: B00428; NIKKAJI: J732.396D","cpd:C01551; cpd:C02348; cpd:C02350; cpd:C06805",4,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3N4","C4H5O3N4",158.0439901,159.0518151,157.036165
"cpd:C02353","2',3'-Cyclic AMP","C10H12N5O6P","2',3'-Cyclic AMP","R03537","Purine metabolism","3.1.4.16",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02353  2',3'-Cyclic AMP","PubChem: 5400; ChEBI: 27844; PDB-CCD: ACK; 3DMET: B01564; NIKKAJI: J205.905C","cpd:C00575; cpd:C00895; cpd:C02353; cpd:C02507; cpd:C20935",10,12,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O6N5P1","C10H11O6N5P1",329.0525201,330.0603452,328.0446951
"cpd:C02718","N-Formiminoglycine;","C3H6N2O2","N-Formiminoglycine; Formiminoglycine; N-Formimidoylglycine","R02729 R04026","Purine metabolism","2.1.2.4; 3.5.2.-",NA,NA,"CAS: 2140-03-6; PubChem: 5681; ChEBI: 18415; 3DMET: B00489; NIKKAJI: J2.359.626A","cpd:C02718; cpd:C06682; cpd:C08057",3,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O2N2","C3H5O2N2",102.0429274,103.0507525,101.0351024
"cpd:C03090","5-Phosphoribosylamine;","C5H12NO7P","5-Phosphoribosylamine; 5-Phospho-beta-D-ribosylamine; 5-Phospho-D-ribosylamine; 5-Phosphoribosyl-1-amine","R01053 R01072 R04144","Purine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.4.2.14; 6.3.4.7; 6.3.4.13","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"PubChem: 5988; ChEBI: 37737; KNApSAcK: C00007377; PDB-CCD: GRF; 3DMET: B01631; NIKKAJI: J40.074B","cpd:C03090",5,12,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O7N1P1","C5H11O7N1P1",229.0351387,230.0429638,228.0273137
"cpd:C03373","Aminoimidazole ribotide;","C8H14N3O7P","Aminoimidazole ribotide; AIR; 1-(5'-Phosphoribosyl)-5-aminoimidazole; 5'-Phosphoribosyl-5-aminoimidazole; 1-(5-Phospho-D-ribosyl)-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole","R03472 R04208 R04209 R07404","Purine metabolism; Thiamine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","4.1.1.21; 4.1.99.17; 6.3.3.1; 6.3.4.18","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",NA,"CAS: 25635-88-5; PubChem: 6208; ChEBI: 28843; KNApSAcK: C00019655; PDB-CCD: AIR; 3DMET: B01653; NIKKAJI: J17.002J","cpd:C03373",8,14,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H15O7N3P1","C8H13O7N3P1",295.0569368,296.0647618,294.0491118
"cpd:C03483","Adenosine tetraphosphate;","C10H17N5O16P4","Adenosine tetraphosphate; Adenosine 5'-tetraphosphate","R00128 R09882","Purine metabolism","3.6.1.14; 3.6.1.60",NA,NA,"PubChem: 6295; ChEBI: 18334; PDB-CCD: AQP; 3DMET: B01663","cpd:C03483",10,17,16,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H18O16N5P4","C10H16O16N5P4",586.9620775,587.9699025,585.9542524
"cpd:C03614","Inosine 5'-tetraphosphate","C10H16N4O17P4","Inosine 5'-tetraphosphate","R00723","Purine metabolism","3.6.1.14",NA,NA,"PubChem: 6400; ChEBI: 28505; 3DMET: B01675; NIKKAJI: J952.101A","cpd:C03614",10,16,17,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O17N4P4","C10H15O17N4P4",587.9460931,588.9539181,586.938268
"cpd:C03794","N6-(1,2-Dicarboxyethyl)-AMP;","C14H18N5O11P","N6-(1,2-Dicarboxyethyl)-AMP; N6-(1,2-Dicarboxyethyl)AMP; Adenylosuccinate; Adenylosuccinic acid","R01083 R01135","Purine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways","4.3.2.2; 6.3.4.4","Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",NA,"CAS: 19046-78-7; PubChem: 6543; ChEBI: 15919; KNApSAcK: C00007229; PDB-CCD: 2SA; 3DMET: B04914; NIKKAJI: J37.503I","cpd:C03794",14,18,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H19O11N5P1","C14H17O11N5P1",463.0740434,464.0818684,462.0662184
"cpd:C03838","5'-Phosphoribosylglycinamide;","C7H15N2O8P","5'-Phosphoribosylglycinamide; GAR; N1-(5-Phospho-D-ribosyl)glycinamide; Glycinamide ribonucleotide","R04144 R04325 R04326 R06974","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.1.2.2; 2.1.2.-; 6.3.4.13","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"CAS: 10074-18-7; PubChem: 6578; ChEBI: 18349; KNApSAcK: C00007395; PDB-CCD: GAR; 3DMET: B04915; NIKKAJI: J372.863C","cpd:C03838",7,15,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H16O8N2P1","C7H14O8N2P1",286.0566024,287.0644275,285.0487774
"cpd:C04051","5-Amino-4-imidazolecarboxyamide","C4H6N4O","5-Amino-4-imidazolecarboxyamide","R04378","Purine metabolism","2.4.2.7",NA,NA,"PubChem: 6752; ChEBI: 2030; ChEMBL: CHEMBL1610; PDB-CCD: 5AC; 3DMET: B00671; NIKKAJI: J37.792I","cpd:C04051",4,6,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O1N4","C4H5O1N4",126.0541608,127.0619859,125.0463358
"cpd:C04376","5'-Phosphoribosyl-N-formylglycinamide;","C8H15N2O9P","5'-Phosphoribosyl-N-formylglycinamide; N-Formyl-GAR; N-Formylglycinamide ribonucleotide; N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide","R04325 R04326 R04463 R06974","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.1.2.2; 2.1.2.-; 6.3.5.3","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"CAS: 349-34-8; PubChem: 7017; ChEBI: 18272 42411; KNApSAcK: C00019642; PDB-CCD: FGR; 3DMET: B04939; NIKKAJI: J40.075K","cpd:C04376",8,15,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H16O9N2P1","C8H14O9N2P1",314.0515171,315.0593421,313.043692
"cpd:C04392","P1,P4-Bis(5'-xanthosyl) tetraphosphate;","C20H26N8O23P4","P1,P4-Bis(5'-xanthosyl) tetraphosphate; XppppX","R02805","Purine metabolism","3.6.1.17",NA,NA,"PubChem: 7032; ChEBI: 28400; 3DMET: B01739; NIKKAJI: J2.750.452C","cpd:C04392",20,26,23,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H27O23N8P4","C20H25O23N8P4",870.0061271,871.0139521,868.9983021
"cpd:C04494","Guanosine 3'-diphosphate 5'-triphosphate;","C10H18N5O20P5","Guanosine 3'-diphosphate 5'-triphosphate; Guanosine 5'-triphosphate,3'-diphosphate","R00429 R03409","Purine metabolism; Biofilm formation - Escherichia coli","2.7.6.5; 3.6.1.11; 3.6.1.40",NA,NA,"CAS: 38918-96-6; PubChem: 7111; ChEBI: 16690; PDB-CCD: 0O2; 3DMET: B01748; NIKKAJI: J40.057B","cpd:C04494",10,18,20,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O20N5P5","C10H17O20N5P5",682.923323,683.931148,681.915498
"cpd:C04640","2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine;","C8H16N3O8P","2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine; 1-(5'-Phosphoribosyl)-N-formylglycinamidine; 5'-Phosphoribosyl-N-formylglycinamidine; 5'-Phosphoribosylformylglycinamidine; 2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine","R04208 R04463","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","6.3.3.1; 6.3.5.3","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"PubChem: 7229; ChEBI: 18413; 3DMET: B01768; NIKKAJI: J2.752.466D","cpd:C04640",8,16,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H17O8N3P1","C8H15O8N3P1",313.0675015,314.0753265,312.0596765
"cpd:C04677","1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide;","C9H15N4O8P","1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide; 5'-Phosphoribosyl-5-amino-4-imidazolecarboxamide; 5'-Phospho-ribosyl-5-amino-4-imidazole carboxamide; AICAR; 5-Aminoimidazole-4-carboxamide ribotide; 5-Phosphoribosyl-4-carbamoyl-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide","R04378 R04558 R04559 R04560 R06975","Purine metabolism; Histidine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; AMPK signaling pathway","2.1.2.3; 2.4.2.7; 2.4.2.-; 4.1.3.-; 4.3.2.2; 6.3.4.23","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"CAS: 3031-94-5; PubChem: 7258; ChEBI: 18406; ChEMBL: CHEMBL483849; KNApSAcK: C00007383; PDB-CCD: AMZ; 3DMET: B01774; NIKKAJI: J7.665A","cpd:C04677",9,15,8,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H16O8N4P1","C9H14O8N4P1",338.0627505,339.0705755,337.0549254
"cpd:C04734","1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide;","C10H15N4O9P","1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide; 5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide; 5-Formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide; 5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide; FAICAR","R01127 R04560 R06975","Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","2.1.2.3; 3.5.4.10; 6.3.4.23","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"PubChem: 7305; ChEBI: 18381; ChEMBL: CHEMBL521310; PDB-CCD: FAI; 3DMET: B01781; NIKKAJI: J602.393B","cpd:C04734",10,15,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O9N4P1","C10H14O9N4P1",366.0576651,367.0654901,365.04984
"cpd:C04751","1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate;","C9H14N3O9P","1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-5-amino-4-carboxyimidazole; 5'-Phosphoribosyl-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-4-carboxy-5-aminoimidazole; 5'-Phosphoribosyl-4-carboxy-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate","R04209 R04591 R07405","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","4.1.1.21; 5.4.99.18; 6.3.2.6","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"PubChem: 7321; ChEBI: 28413; PDB-CCD: C2R; 3DMET: B01784; NIKKAJI: J38.129B","cpd:C04751; cpd:C15667",9,14,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O9N3P1","C9H13O9N3P1",339.046766,340.0545911,338.038941
"cpd:C04823","1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole;","C13H19N4O12P","1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; 1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole; 5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; (S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate; SAICAR","R04559 R04591","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","4.3.2.2; 6.3.2.6","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"CAS: 3031-95-6; PubChem: 7384; ChEBI: 18319; 3DMET: B04963; NIKKAJI: J7.666J","cpd:C04823",13,19,12,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C13H20O12N4P1","C13H18O12N4P1",454.0737091,455.0815341,453.065884
"cpd:C05239","5-Aminoimidazole;","C3H5N3","5-Aminoimidazole; Aminoimidazole; 4-Aminoimidazole","R04731 R04732","Purine metabolism","3.5.4.8; 4.1.1.-",NA,NA,"CAS: 4919-03-3; PubChem: 7633; ChEBI: 16607; 3DMET: B00762; NIKKAJI: J507.002C","cpd:C05239; cpd:C07455",3,5,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6N3","C3H4N3",83.04834717,84.05617221,82.04052214
"cpd:C05512","Deoxyinosine","C10H12N4O4","Deoxyinosine","R02556 R02748","Purine metabolism; Metabolic pathways","2.4.2.1; 2.4.2.4; 3.5.4.4",NA,NA,"CAS: 890-38-0; PubChem: 7859; ChEBI: 28997; ChEMBL: CHEMBL1229971; PDB-CCD: 2ND; 3DMET: B01869; NIKKAJI: J128.131C","cpd:C00343; cpd:C01736; cpd:C05512; cpd:C15586; cpd:C21102",10,12,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O4N4","C10H11O4N4",252.0858549,253.0936799,251.0780299
"cpd:C05513","Urate-3-ribonucleoside;","C10H12N4O7","Urate-3-ribonucleoside; Uric acid ribonucleoside","R02646","Purine metabolism","2.4.2.16",NA,NA,"PubChem: 7860; ChEBI: 50547; NIKKAJI: J2.328.067A","cpd:C05513",10,12,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O7N4","C10H11O7N4",300.0705987,301.0784238,299.0627737
"cpd:C05515","5-Ureido-4-imidazole carboxylate;","C5H6N4O3","5-Ureido-4-imidazole carboxylate; 4-Ureido-5-imidazolecarboxylic acid","R02141 R04857","Purine metabolism","3.5.2.-; 3.5.3.-",NA,NA,"PubChem: 7861; ChEBI: 27580; 3DMET: B00782; NIKKAJI: J805.606D","cpd:C05515",5,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O3N4","C5H5O3N4",170.0439901,171.0518151,169.036165
"cpd:C05516","5-Amino-4-imidazole carboxylate;","C4H5N3O2","5-Amino-4-imidazole carboxylate; 4-Amino-5-imidazolecarboxylic acid","R04732 R04857","Purine metabolism","3.5.3.-; 4.1.1.-",NA,NA,"PubChem: 7862; ChEBI: 28280; 3DMET: B00783; NIKKAJI: J2.361.602E","cpd:C05516; cpd:C16621",4,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H6O2N3","C4H4O2N3",127.0381764,128.0460014,126.0303514
"cpd:C05993","Acetyl adenylate;","C12H16N5O8P","Acetyl adenylate; 5'-Acetylphosphoadenosine","R00236 R00316 R00322","Purine metabolism; Pyruvate metabolism","3.6.1.20; 6.2.1.1",NA,NA,"CAS: 13015-87-7; PubChem: 8267; ChEBI: 37666; PDB-CCD: 6R9; 3DMET: B01944; NIKKAJI: J227.896K","cpd:C05993",12,16,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H17O8N5P1","C12H15O8N5P1",389.0736495,390.0814745,388.0658245
"cpd:C06193","Guanosine 3'-phosphate;","C10H14N5O8P","Guanosine 3'-phosphate; 3'-GMP; 3'-Guanylic acid; Guo-3'-P; Gp","R02148 R05135","Purine metabolism","3.1.3.6; 3.1.4.16",NA,NA,"CAS: 117-68-0; PubChem: 8443; ChEBI: 28072; PDB-CCD: 3GP; 3DMET: B01991; NIKKAJI: J10.077C","cpd:C00144; cpd:C01977; cpd:C06193; cpd:C18239; cpd:C19968",10,14,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O8N5P1","C10H13O8N5P1",363.0579994,364.0658245,362.0501744
"cpd:C06194","2',3'-Cyclic GMP","C10H12N5O7P","2',3'-Cyclic GMP","R05135","Purine metabolism","3.1.4.16",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C06194  2',3'-Cyclic GMP","PubChem: 8444; ChEBI: 28181; 3DMET: B01992; NIKKAJI: J205.906A","cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344",10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O7N5P1","C10H11O7N5P1",345.0474347,346.0552598,344.0396097
"cpd:C06195","Imidazolone;","C3H4N2O","Imidazolone; 4-Imidazolone; Imidazol-4-one","R04026 R04731","Purine metabolism","3.5.2.-; 3.5.4.8",NA,NA,"PubChem: 8445; ChEBI: 28470 51023; 3DMET: B00917; NIKKAJI: J776.713G","cpd:C06195; cpd:C20382",3,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O1N2","C3H3O1N2",84.03236276,85.04018779,83.02453773
"cpd:C06196","2'-Deoxyinosine 5'-phosphate;","C10H13N4O7P","2'-Deoxyinosine 5'-phosphate; dIMP","R03531 R10235","Purine metabolism","3.6.1.64; 3.6.1.66; 3.6.1.-",NA,NA,"PubChem: 8446; ChEBI: 28806; PDB-CCD: DI; NIKKAJI: J205.494I","cpd:C04646; cpd:C05325; cpd:C06196",10,13,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O7N4P1","C10H12O7N4P1",332.0521858,333.0600108,331.0443607
"cpd:C06197","P1,P3-Bis(5'-adenosyl) triphosphate;","C20H27N10O16P3","P1,P3-Bis(5'-adenosyl) triphosphate; ApppA; Adenosine 5'-triphosphate 5'-adenosine","R00187","Purine metabolism","3.6.1.29",NA,NA,"CAS: 5959-90-0; PubChem: 8447; ChEBI: 27775; ChEMBL: CHEMBL407938; PDB-CCD: BA3; 3DMET: B01993; NIKKAJI: J398.258K","cpd:C04307; cpd:C06197",20,27,16,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H28O16N10P3","C20H26O16N10P3",756.0819358,757.0897609,755.0741108
"cpd:C06433","5'-Benzoylphosphoadenosine","C17H18N5O8P","5'-Benzoylphosphoadenosine","R01423","Purine metabolism","3.6.1.20",NA,NA,"PubChem: 8667; ChEBI: 1955; PDB-CCD: OOB; 3DMET: B02024; NIKKAJI: J396.565A","cpd:C06433",17,18,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H19O8N5P1","C17H17O8N5P1",451.0892996,452.0971246,450.0814745
"cpd:C06435","5'-Butyrylphosphoinosine;","C14H19N4O9P","5'-Butyrylphosphoinosine; Inosine 5'-phosphobutyrate","R01690","Purine metabolism","3.6.1.20",NA,NA,"PubChem: 8669; ChEBI: 1956; 3DMET: B02025; NIKKAJI: J2.767.314G","cpd:C06435",14,19,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C14H20O9N4P1","C14H18O9N4P1",418.0889652,419.0967902,417.0811402
"cpd:C11821","5-Hydroxyisourate","C5H4N4O4","5-Hydroxyisourate","R02106 R06063 R06064 R06601 R09514","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.7.3.3; 1.14.13.113; 3.5.2.17","Purine degradation, xanthine => urea",NA,"PubChem: 13985; ChEBI: 18072; KNApSAcK: C00007531; 3DMET: B05546; NIKKAJI: J861.998K","cpd:C11821",5,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H5O4N4","C5H3O4N4",184.0232546,185.0310797,183.0154296
"cpd:C12248","5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate;","C5H6N4O5","5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate; 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline","R06601 R06604 R06605","Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","3.5.2.17; 4.1.1.97","Purine degradation, xanthine => urea",NA,"PubChem: 14393; ChEBI: 31132; KNApSAcK: C00007532; 3DMET: B05622; NIKKAJI: J861.997B","cpd:C12248",5,6,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O5N4","C5H5O5N4",202.0338193,203.0416443,201.0259943
"cpd:C15667","5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole","C9H14N3O9P","5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole","R07404 R07405","Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","5.4.99.18; 6.3.4.18","Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,"PubChem: 47204994; ChEBI: 48000; NIKKAJI: J2.795.736F","cpd:C04751; cpd:C15667",9,14,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O9N3P1","C9H13O9N3P1",339.046766,340.0545911,338.038941
"cpd:C01610","Puromycin","C22H29N7O5","Puromycin","R03633 R05677","Puromycin biosynthesis; Biosynthesis of antibiotics","2.1.1.38",NA,"Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    Others;     Aminonucleoside;      Puromycin;       D05653  Puromycin (USAN)","CAS: 53-79-2; PubChem: 4763; ChEBI: 17939; ChEMBL: CHEMBL2009976 CHEMBL469912; KNApSAcK: C00001507; PDB-CCD: PUY; 3DMET: B01469; NIKKAJI: J2.310H","cpd:C01610; cpd:C11618",22,29,5,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H30O5N7","C22H28O5N7",471.2230171,472.2308421,470.215192
"cpd:C07024","3'-Keto-3'-deoxy-ATP","C10H14N5O13P3","3'-Keto-3'-deoxy-ATP","R05668 R05669","Puromycin biosynthesis; Biosynthesis of antibiotics","1.-.-.-; 3.-.-.-",NA,NA,"PubChem: 9236; ChEBI: 27782; 3DMET: B02104; NIKKAJI: J1.012.248A","cpd:C07024",10,14,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O13N5P3","C10H13O13N5P3",504.9800965,505.9879216,503.9722715
"cpd:C07025","3'-Keto-3'-deoxy-AMP","C10H12N5O7P","3'-Keto-3'-deoxy-AMP","R05669 R05670","Puromycin biosynthesis; Biosynthesis of antibiotics","2.-.-.-; 3.-.-.-",NA,NA,"PubChem: 9237; ChEBI: 28722; 3DMET: B02105; NIKKAJI: J2.764.870C","cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344",10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H13O7N5P1","C10H11O7N5P1",345.0474347,346.0552598,344.0396097
"cpd:C07026","3'-Amino-3'-deoxy-AMP","C10H15N6O6P","3'-Amino-3'-deoxy-AMP","R05670 R05671","Puromycin biosynthesis; Biosynthesis of antibiotics","2.-.-.-",NA,NA,"PubChem: 9238; ChEBI: 27488; PDB-CCD: 8AN; 3DMET: B05237; NIKKAJI: J1.219.758F","cpd:C01655; cpd:C03851; cpd:C07026",10,15,6,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O6N6P1","C10H14O6N6P1",346.0790692,347.0868943,345.0712442
"cpd:C07027","N6,N6,O-Tridemethylpuromycin-5'-phosphate","C19H24N7O8P","N6,N6,O-Tridemethylpuromycin-5'-phosphate","R05671 R05672","Puromycin biosynthesis; Biosynthesis of antibiotics","2.3.-.-",NA,NA,"PubChem: 9239; ChEBI: 27830; 3DMET: B05238; NIKKAJI: J2.764.875D","cpd:C07027",19,24,8,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H25O8N7P1","C19H23O8N7P1",509.1423978,510.1502228,508.1345727
"cpd:C07028","N-Acetyl-N6,N6,O-tridemethylpuromycin-5'-phosphate","C21H26N7O9P","N-Acetyl-N6,N6,O-tridemethylpuromycin-5'-phosphate","R05672 R05673","Puromycin biosynthesis; Biosynthesis of antibiotics","2.3.-.-; 2.-.-.-",NA,NA,"PubChem: 9240; ChEBI: 28337; 3DMET: B05239; NIKKAJI: J2.764.876B","cpd:C07028",21,26,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C21H27O9N7P1","C21H25O9N7P1",551.1529624,552.1607875,550.1451374
"cpd:C07029","N-Acetyl-N6,O-didemethylpuromycin-5'-phosphate","C22H28N7O9P","N-Acetyl-N6,O-didemethylpuromycin-5'-phosphate","R05673 R05674","Puromycin biosynthesis; Biosynthesis of antibiotics","2.-.-.-",NA,NA,"PubChem: 9241; ChEBI: 28060; 3DMET: B05240; NIKKAJI: J2.764.877K","cpd:C07029",22,28,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H29O9N7P1","C22H27O9N7P1",565.1686125,566.1764375,564.1607875
"cpd:C07030","N-Acetyl-O-demethylpuromycin-5'-phosphate","C23H30N7O9P","N-Acetyl-O-demethylpuromycin-5'-phosphate","R05674 R05675","Puromycin biosynthesis; Biosynthesis of antibiotics","2.-.-.-",NA,NA,"PubChem: 9242; ChEBI: 27883; 3DMET: B05241; NIKKAJI: J2.764.879G","cpd:C07030",23,30,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H31O9N7P1","C23H29O9N7P1",579.1842626,580.1920876,578.1764375
"cpd:C07031","N-Acetyl-O-demethylpuromycin","C23H29N7O6","N-Acetyl-O-demethylpuromycin","R05675 R05676","Puromycin biosynthesis; Biosynthesis of antibiotics","2.1.1.38",NA,NA,"PubChem: 9243; ChEBI: 28682; 3DMET: B05242; NIKKAJI: J2.764.882G","cpd:C07031",23,29,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H30O6N7","C23H28O6N7",499.2179317,500.2257567,498.2101067
"cpd:C07032","N-Acetylpuromycin","C24H31N7O6","N-Acetylpuromycin","R05676 R05677","Puromycin biosynthesis; Biosynthesis of antibiotics","2.1.1.38",NA,NA,"PubChem: 9244; ChEBI: 28588; 3DMET: B05243; NIKKAJI: J2.764.883E","cpd:C07032",24,31,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C24H32O6N7","C24H30O6N7",513.2335817,514.2414068,512.2257567
"cpd:C07130","Theophylline;","C7H8N4O2","Theophylline; 1,3-Dimethylxanthine","R07971 R07972 R07973 R07974 R07975 R07976 R08410","Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07130  Theophylline; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07130  Theophylline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;     R03DA Xanthines;      R03DA04 Theophylline;       D00371  Theophylline (JP17); USP drug classification [BR:br08302];  Respiratory Tract/Pulmonary Agents;   Phosphodiesterase Inhibitors, Airways Disease;    Theophylline;     D00371  Theophylline (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   22  Respiratory organ agents;    225  Bronchodilators;     2251  Xanthines;      D00371  Theophylline (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for respiratory organs;   26 Antitussives and expectorants;    D00371  Theophylline (JP17); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Theophylline;     D00371  Theophylline (JP17); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Theophylline;       D00371  Theophylline (JP17);     adenosine A2a receptor;      Theophylline;       D00371  Theophylline (JP17);  Enzymes;   Hydrolases;    phosphodiesterase (PDE);     Theophylline;      D00371  Theophylline (JP17); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Theophylline;     D00371  Theophylline (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00371  Theophylline; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Others;    Purine alkaloids;     D00371  Theophylline (JP15); Respiratory agents [br08372.html];  Bronchodilator;   D00371","CAS: 58-55-9; PubChem: 9340; ChEBI: 28177; ChEMBL: CHEMBL190; KNApSAcK: C00001510; PDB-CCD: TEP; 3DMET: B02107; NIKKAJI: J2.333G","cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663",7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O2N4","C7H7O2N4",180.0647255,181.0725505,179.0569005
"cpd:C07480","Theobromine;","C7H8N4O2","Theobromine; 3,7-Dimethylxanthine","R07919 R07920 R07955 R07956 R07961 R07962 R07963 R07964; R07978","Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179; 1.17.3.2; 2.1.1.159; 2.1.1.160",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07480  Theobromine; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07480  Theobromine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C03 DIURETICS;    C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES;     C03BD Xanthine derivatives;      C03BD01 Theobromine;       C07480  Theobromine;  R RESPIRATORY SYSTEM;   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;     R03DA Xanthines;      R03DA07 Theobromine;       C07480  Theobromine; Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Theobromine;     C07480  Theobromine","CAS: 83-67-0; PubChem: 9683; ChEBI: 28946; ChEMBL: CHEMBL1114; KNApSAcK: C00001509; PDB-CCD: 37T; 3DMET: B02123; NIKKAJI: J3.874A","cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663",7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O2N4","C7H7O2N4",180.0647255,181.0725505,179.0569005
"cpd:C07481","Caffeine;","C8H10N4O2","Caffeine; 1,3,7-Trimethylxanthine","R07920 R07921 R07939 R07954 R07955 R07956 R07971 R07972; R07980","Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.14.1; 1.17.5.2; 1.17.5.-; 2.1.1.160",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07481  Caffeine; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07481  Caffeine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS;     N06BC Xanthine derivatives;      N06BC01 Caffeine;       D00528  Caffeine (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    211  Cardiotonics;     2115  Caffeines;      D00528  Caffeine (USP); Anhydrous caffeine (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for nervous and sensory systems;   05 Alertness drug;    D00528  Caffeine (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Anhydrous caffeine;     D00528  Caffeine (USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Caffeine;       D00528  Caffeine (USP);     adenosine A2a receptor;      Caffeine;       D00528  Caffeine (USP);     adenosine A2b receptor;      Caffeine;       D00528  Caffeine (USP);  Enzymes;   Hydrolases;    phosphodiesterase (PDE);     Caffeine;      D00528  Caffeine (USP); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Caffeine;     D00528  Caffeine (USP);  CYP substrates;   CYP1A2;    Caffeine;     D00528  Caffeine (USP);   CYP3A4;    Caffeine;     D00528  Caffeine (USP);   CYP3A5;    Caffeine;     D00528  Caffeine (USP);   CYP3A7;    Caffeine;     D00528  Caffeine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00528  Anhydrous caffeine; Major components of natural products [BR:br08323];  Medicinal herbs;   Guarana;    C07481  Caffeine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Others;    Purine alkaloids;     D00528  Anhydrous caffeine (JP15); Caffeine (USP); Rx-to-OTC switch list in the USA [br08315.html];  D00528","CAS: 58-08-2; PubChem: 9684; ChEBI: 27732; ChEMBL: CHEMBL113; KNApSAcK: C00001492; PDB-CCD: CFF; 3DMET: B02124; NIKKAJI: J2.330B","cpd:C04087; cpd:C07481; cpd:C13403",8,10,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H11O2N4","C8H9O2N4",194.0803756,195.0882006,193.0725505
"cpd:C13747","1,7-Dimethylxanthine;","C7H8N4O2","1,7-Dimethylxanthine; Paraxanthine","R07921 R07922 R07939 R07940 R07943 R07945 R07954 R07957; R07958 R07959 R07960 R07977","Caffeine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.13.-; 1.14.14.1; 1.17.3.2; 2.1.1.160; 2.3.1.5",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C13747  1,7-Dimethylxanthine; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Adenosine;     adenosine A1 receptor;      C13747  1,7-Dimethylxanthine;     adenosine A2a receptor;      C13747  1,7-Dimethylxanthine;     adenosine A2b receptor;      C13747  1,7-Dimethylxanthine","CAS: 611-59-6; PubChem: 586336; ChEBI: 25858; ChEMBL: CHEMBL1158; KNApSAcK: C00039930; 3DMET: B04575; NIKKAJI: J2.991B","cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663",7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O2N4","C7H7O2N4",180.0647255,181.0725505,179.0569005
"cpd:C16352","7-Methylxanthosine","C11H15N4O6","7-Methylxanthosine","R07917 R07918","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","2.1.1.158; 3.2.2.25",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16352  7-Methylxanthosine","PubChem: 47205660; ChEBI: 49310; NIKKAJI: J466.510D","cpd:C16352",11,15,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H16O6N4","C11H14O6N4",299.0991592,300.1069843,298.0913342
"cpd:C16353","7-Methylxanthine","C6H6N4O2","7-Methylxanthine","R07918 R07919 R07922 R07957 R07958 R07961 R07962 R07965; R07966 R07979","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.14.13.128; 1.14.13.178; 1.14.13.179; 1.17.3.2; 2.1.1.159; 2.1.1.160; 3.2.2.25",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16353  7-Methylxanthine","CAS: 552-62-5; PubChem: 47205661; ChEBI: 48991; ChEMBL: CHEMBL321248; KNApSAcK: C00007326; NIKKAJI: J1.614D","cpd:C16353; cpd:C16357; cpd:C16358",6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O2N4","C6H5O2N4",166.0490755,167.0569005,165.0412504
"cpd:C16355","7-Methyluric acid","C6H6N4O3","7-Methyluric acid","R07979","Caffeine metabolism","1.17.3.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16355  7-Methyluric acid","CAS: 612-37-3; PubChem: 47205663; ChEBI: 80470; ChEMBL: CHEMBL34869; NIKKAJI: J252.499F","cpd:C16355; cpd:C16359; cpd:C19268",6,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O3N4","C6H5O3N4",182.0439901,183.0518151,181.036165
"cpd:C16356","1,7-Dimethyluric acid","C7H8N4O3","1,7-Dimethyluric acid","R07945 R07977","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.13.-; 1.14.14.1; 1.17.3.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16356  1,7-Dimethyluric acid","CAS: 33868-03-0; PubChem: 47205664; ChEBI: 68449; ChEMBL: CHEMBL794; NIKKAJI: J308.550C","cpd:C16356; cpd:C16360",7,8,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O3N4","C7H7O3N4",196.0596401,197.0674652,195.0518151
"cpd:C16357","3-Methylxanthine","C6H6N4O2","3-Methylxanthine","R07963 R07964 R07967 R07968 R07973 R07974","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16357  3-Methylxanthine","CAS: 1076-22-8; PubChem: 47205665; ChEBI: 62207 62208; ChEMBL: CHEMBL619; KNApSAcK: C00043196; NIKKAJI: J3.360J","cpd:C16353; cpd:C16357; cpd:C16358",6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O2N4","C6H5O2N4",166.0490755,167.0569005,165.0412504
"cpd:C16358","1-Methylxanthine","C6H6N4O2","1-Methylxanthine","R07942 R07943 R07959 R07960 R07969 R07970 R07975 R07976","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments","1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.14.1; 1.17.3.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16358  1-Methylxanthine","CAS: 6136-37-4; PubChem: 47205666; ChEBI: 68444; ChEMBL: CHEMBL1250; NIKKAJI: J2.241A","cpd:C16353; cpd:C16357; cpd:C16358",6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O2N4","C6H5O2N4",166.0490755,167.0569005,165.0412504
"cpd:C16359","1-Methyluric acid","C6H6N4O3","1-Methyluric acid","R07942","Caffeine metabolism","1.17.3.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16359  1-Methyluric acid","CAS: 708-79-2; PubChem: 47205667; ChEBI: 68441; ChEMBL: CHEMBL793; NIKKAJI: J94.928K","cpd:C16355; cpd:C16359; cpd:C19268",6,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H7O3N4","C6H5O3N4",182.0439901,183.0518151,181.036165
"cpd:C16360","3,7-Dimethyluric acid","C7H8N4O3","3,7-Dimethyluric acid","R07978","Caffeine metabolism","1.17.3.2",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16360  3,7-Dimethyluric acid","CAS: 13087-49-5; PubChem: 47205668; ChEBI: 68531; ChEMBL: CHEMBL430928; NIKKAJI: J367.208E","cpd:C16356; cpd:C16360",7,8,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O3N4","C7H7O3N4",196.0596401,197.0674652,195.0518151
"cpd:C16361","1,3,7-Trimethyluric acid;","C8H10N4O3","1,3,7-Trimethyluric acid; 1,3,7-Trimethylurate","R07980 R07981 R11153","Caffeine metabolism; Microbial metabolism in diverse environments","1.7.3.3; 1.14.13.212; 1.17.5.2; 1.17.5.-",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16361  1,3,7-Trimethyluric acid","CAS: 5415-44-1; PubChem: 47205669; ChEBI: 691622; ChEMBL: CHEMBL1767; NIKKAJI: J2.233K","cpd:C16361",8,10,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H11O3N4","C8H9O3N4",210.0752902,211.0831152,209.0674652
"cpd:C16362","3,6,8-Trimethylallantoin","C7H12N4O3","3,6,8-Trimethylallantoin","R07981 R07982","Caffeine metabolism; Microbial metabolism in diverse environments","1.7.3.3",NA,NA,"CAS: 42794-72-9; PubChem: 47205670; ChEBI: 80471; NIKKAJI: J2.802.445B","cpd:C03022; cpd:C16362; cpd:C19092",7,12,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O3N4","C7H11O3N4",200.0909403,201.0987653,199.0831152
"cpd:C16363","N-Methylurea;","C2H6N2O","N-Methylurea; Methylurea","R07982","Caffeine metabolism; Microbial metabolism in diverse environments",NA,NA,NA,"CAS: 598-50-5; PubChem: 47205671; ChEBI: 44383; PDB-CCD: NMU; NIKKAJI: J2.718I","cpd:C02297; cpd:C07447; cpd:C14704; cpd:C16363",2,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H7O1N2","C2H5O1N2",74.04801282,75.05583785,73.04018779
"cpd:C16364","N,N'-Dimethylurea;","C3H8N2O","N,N'-Dimethylurea; 1,3-Dimethylurea","R07982","Caffeine metabolism; Microbial metabolism in diverse environments",NA,NA,NA,"CAS: 96-31-1; PubChem: 47205672; ChEBI: 80472; PDB-CCD: MMU; NIKKAJI: J4.720A","cpd:C16364; cpd:C19281; cpd:C19779",3,8,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H9O1N2","C3H7O1N2",88.06366289,89.07148792,87.05583785
"cpd:C16365","5-Acetylamino-6-formylamino-3-methyluracil;","C8H10N4O4","5-Acetylamino-6-formylamino-3-methyluracil; AFMU","R07940 R07941","Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites","2.3.1.5",NA,NA,"CAS: 85438-96-6; PubChem: 47205673; ChEBI: 32643; NIKKAJI: J425.388D","cpd:C16365; cpd:C21144",8,10,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H11O4N4","C8H9O4N4",226.0702048,227.0780299,225.0623798
"cpd:C16366","5-Acetylamino-6-amino-3-methyluracil;","C7H10N4O3","5-Acetylamino-6-amino-3-methyluracil; AAMU","R07941","Caffeine metabolism",NA,NA,NA,"CAS: 19893-78-8; PubChem: 47205674; ChEBI: 80473; ChEMBL: CHEMBL1899490; NIKKAJI: J128.135F","cpd:C16366; cpd:C18498",7,10,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H11O3N4","C7H9O3N4",198.0752902,199.0831152,197.0674652
"cpd:C00015","UDP;","C9H14N2O12P2","UDP; Uridine 5'-diphosphate","R00155 R00156 R00157 R00158 R00159 R00292 R00414 R00417; R00438 R00503 R00506 R00516 R00659 R00766 R00769 R00806; R00809 R00836 R00853 R00854 R00967 R01005 R01008 R01192; R01205 R01240 R01304 R01383 R01472 R01474 R01497 R01500; R01722 R01912 R01928 R01994 R01995 R01996 R01997 R02018; R02113 R02118 R02119 R02158 R02179 R02183 R02256 R02335; R02358 R02380 R02388 R02389 R02478 R02502 R02594 R02654; R02689 R02691 R02707 R02709 R02716 R02717 R02737 R02789; R02790 R02791 R02889 R02897 R02902 R02932 R02951 R03078; R03079 R03091 R03094 R03118 R03190 R03213 R03238 R03267; R03268 R03297 R03354 R03380 R03486 R03490 R03513 R03514; R03526 R03547 R03548 R03558 R03565 R03573 R03574 R03588; R03589 R03594 R03605 R03625 R03679 R03680 R03681 R03686; R03710 R03797 R03880 R03928 R03981 R03996 R04005 R04016; R04041 R04071 R04108 R04127 R04182 R04296 R04322 R04334; R04335 R04343 R04352 R04353 R04354 R04359 R04377 R04423; R04431 R04451 R04469 R04477 R04491 R04493 R04494 R04495; R04526 R04531 R04548 R04575 R04577 R04579 R04584 R04603; R04606 R04607 R04610 R04615 R04619 R04631 R04636 R04642; R04644 R04645 R04653 R04654 R04659 R04662 R04665 R04683; R04900 R04948 R05032 R05080 R05083 R05107 R05108 R05109; R05110 R05111 R05164 R05191 R05324 R05325 R05327 R05566; R05631 R05662 R05769 R05882 R06047 R06048 R06534 R06535; R06536 R06546 R06547 R06611 R06795 R06802 R06803 R06804; R06805 R06808 R06810 R06811 R06812 R06813 R06814 R06818; R06819 R06820 R06826 R06827 R06828 R06829 R06867 R07106; R07258 R07259 R07260 R07266 R07332 R07333 R07334 R07335; R07336 R07337 R07338 R07339 R07340 R07397 R07426 R07574; R07575 R07661 R07718 R07720 R07729 R07740 R07753 R07874; R07875 R07877 R07878 R07879 R07903 R07911 R07912 R07913; R07914 R07923 R07932 R08006 R08007 R08013 R08021 R08022; R08075 R08076 R08128 R08164 R08259 R08261 R08262 R08263; R08369 R08533 R08534 R08615 R08661 R08668 R08687 R08813; R08814 R08816 R08817 R08822 R08824 R08830 R08839 R08859; R08894 R08900 R09426 R09427 R09428 R09529 R09634 R09635; R09636 R09676 R09677 R09732 R09753 R09754 R09755 R09757; R09758 R09759 R09802 R09803 R09804 R09834 R09857 R10037; R10063 R10096 R10187 R10188 R10240 R10256 R10257 R10262; R10263 R10264 R10265 R10290 R10291 R10292 R10293 R10294; R10295 R10424 R10425 R10426 R10427 R10432 R10433 R10434; R10435 R10436 R10440 R10594 R10596 R10607 R10609 R10620; R10638 R10639 R10804 R10807 R10834 R10835 R10850 R10865; R10988 R10989 R10990 R11115 R11224 R11241 R11271 R11272; R11278 R11282 R11289 R11306","Pyrimidine metabolism; Zeatin biosynthesis; Metabolic pathways; Neuroactive ligand-receptor interaction","1.17.4.1; 2.4.1.11; 2.4.1.12; 2.4.1.13; 2.4.1.14; 2.4.1.15; 2.4.1.16; 2.4.1.17; 2.4.1.22; 2.4.1.23; 2.4.1.34; 2.4.1.35; 2.4.1.37; 2.4.1.38; 2.4.1.39; 2.4.1.40; 2.4.1.41; 2.4.1.43; 2.4.1.44; 2.4.1.46; 2.4.1.47; 2.4.1.50; 2.4.1.52; 2.4.1.53; 2.4.1.56; 2.4.1.58; 2.4.1.62; 2.4.1.63; 2.4.1.66; 2.4.1.70; 2.4.1.71; 2.4.1.73; 2.4.1.74; 2.4.1.78; 2.4.1.79; 2.4.1.80; 2.4.1.81; 2.4.1.85; 2.4.1.86; 2.4.1.87; 2.4.1.88; 2.4.1.90; 2.4.1.91; 2.4.1.92; 2.4.1.94; 2.4.1.96; 2.4.1.102; 2.4.1.103; 2.4.1.104; 2.4.1.105; 2.4.1.106; 2.4.1.111; 2.4.1.114; 2.4.1.115; 2.4.1.116; 2.4.1.117; 2.4.1.118; 2.4.1.120; 2.4.1.121; 2.4.1.122; 2.4.1.123; 2.4.1.126; 2.4.1.127; 2.4.1.128; 2.4.1.135; 2.4.1.136; 2.4.1.137; 2.4.1.138; 2.4.1.141; 2.4.1.143; 2.4.1.144; 2.4.1.145; 2.4.1.146; 2.4.1.147; 2.4.1.148; 2.4.1.149; 2.4.1.150; 2.4.1.153; 2.4.1.155; 2.4.1.156; 2.4.1.158; 2.4.1.159; 2.4.1.160; 2.4.1.164; 2.4.1.165; 2.4.1.167; 2.4.1.170; 2.4.1.171; 2.4.1.172; 2.4.1.173; 2.4.1.175; 2.4.1.176; 2.4.1.177; 2.4.1.178; 2.4.1.179; 2.4.1.180; 2.4.1.181; 2.4.1.182; 2.4.1.183; 2.4.1.185; 2.4.1.186; 2.4.1.187; 2.4.1.188; 2.4.1.189; 2.4.1.190; 2.4.1.191; 2.4.1.192; 2.4.1.193; 2.4.1.194; 2.4.1.195; 2.4.1.196; 2.4.1.198; 2.4.1.201; 2.4.1.202; 2.4.1.203; 2.4.1.205; 2.4.1.206; 2.4.1.208; 2.4.1.209; 2.4.1.210; 2.4.1.212; 2.4.1.215; 2.4.1.218; 2.4.1.219; 2.4.1.220; 2.4.1.223; 2.4.1.224; 2.4.1.225; 2.4.1.226; 2.4.1.227; 2.4.1.228; 2.4.1.234; 2.4.1.236; 2.4.1.237; 2.4.1.238; 2.4.1.239; 2.4.1.240; 2.4.1.241; 2.4.1.242; 2.4.1.245; 2.4.1.249; 2.4.1.250; 2.4.1.253; 2.4.1.254; 2.4.1.255; 2.4.1.262; 2.4.1.263; 2.4.1.264; 2.4.1.271; 2.4.1.272; 2.4.1.273; 2.4.1.274; 2.4.1.275; 2.4.1.276; 2.4.1.283; 2.4.1.284; 2.4.1.285; 2.4.1.286; 2.4.1.290; 2.4.1.294; 2.4.1.295; 2.4.1.296; 2.4.1.297; 2.4.1.298; 2.4.1.301; 2.4.1.303; 2.4.1.304; 2.4.1.305; 2.4.1.306; 2.4.1.309; 2.4.1.310; 2.4.1.312; 2.4.1.313; 2.4.1.314; 2.4.1.315; 2.4.1.323; 2.4.1.324; 2.4.1.330; 2.4.1.335; 2.4.1.336; 2.4.1.337; 2.4.1.338; 2.4.1.-; 2.4.2.24; 2.4.2.25; 2.4.2.32; 2.4.2.34; 2.4.2.35; 2.4.2.40; 2.4.2.50; 2.4.2.51; 2.4.2.53; 2.4.2.56; 2.4.2.-; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.4; 2.7.4.6; 2.7.4.10; 2.7.4.14; 2.7.4.22; 2.7.7.8; 3.2.1.183; 3.2.1.184; 3.2.1.-; 3.6.1.5; 3.6.1.6; 3.6.1.39; 3.6.1.57; 5.1.3.14","Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00015  UDP","CAS: 58-98-0; PubChem: 3317; ChEBI: 17659; ChEMBL: CHEMBL130266 CHEMBL605272; KNApSAcK: C00007313; PDB-CCD: UDP; 3DMET: B01132; NIKKAJI: J4.595K","cpd:C00015",9,14,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O12N2P2","C9H13O12N2P2",404.0021979,405.0100229,402.9943729
"cpd:C00055","CMP;","C9H14N3O8P","CMP; Cytidine-5'-monophosphate; Cytidylic acid","R00510 R00511 R00512 R00513 R00514 R00515 R00516 R00517; R00855 R00962 R01321 R01503 R01548 R01797 R01800 R01801; R01802 R01891 R01929 R02030 R02057 R02091 R02096 R02371; R02372 R02563 R02598 R03110 R03468 R03488 R03489 R04042; R04083 R04231 R04321 R04532 R04564 R04583 R04590 R04596; R04630 R04632 R04635 R04647 R04648 R04649 R04656 R04658; R04660 R04661 R04920 R04921 R04922 R05074 R05113 R05114; R05116 R05580 R05637 R05794 R06285 R06364 R07384 R07389; R08887 R09538 R09670 R09763 R09764 R09765 R09766 R10255; R10441 R10464 R10837 R11558","Pyrimidine metabolism; Metabolic pathways","2.4.2.57; 2.4.99.1; 2.4.99.2; 2.4.99.4; 2.4.99.5; 2.4.99.6; 2.4.99.7; 2.4.99.8; 2.4.99.9; 2.4.99.10; 2.4.99.12; 2.4.99.13; 2.4.99.14; 2.4.99.15; 2.4.99.-; 2.7.1.48; 2.7.1.213; 2.7.4.14; 2.7.4.25; 2.7.8.1; 2.7.8.2; 2.7.8.3; 2.7.8.4; 2.7.8.5; 2.7.8.8; 2.7.8.10; 2.7.8.11; 2.7.8.12; 2.7.8.14; 2.7.8.22; 2.7.8.24; 2.7.8.34; 2.7.8.38; 2.7.8.39; 2.7.8.41; 2.7.8.44; 2.7.8.-; 3.1.3.5; 3.1.3.91; 3.1.4.40; 3.2.2.10; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.16; 3.6.1.26; 3.6.1.53; 3.6.1.65; 4.6.1.12; 6.3.2.5",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00055  CMP","CAS: 63-37-6; PubChem: 3357; ChEBI: 17361; ChEMBL: CHEMBL307679; PDB-CCD: C C5P; 3DMET: B01141; NIKKAJI: J60.869F","cpd:C00055; cpd:C03104; cpd:C05822; cpd:C17325; cpd:C19722",9,14,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O8N3P1","C9H13O8N3P1",323.0518514,324.0596765,322.0440264
"cpd:C00063","CTP;","C9H16N3O14P3","CTP; Cytidine 5'-triphosphate; Cytidine triphosphate","R00442 R00515 R00568 R00569 R00570 R00571 R00572 R00573; R00574 R00767 R00856 R00956 R01018 R01117 R01799 R01890; R02022 R02038 R02590 R02599 R02921 R03237 R03351 R03375; R04215 R04231 R04247 R05633 R08574 R08867 R08966 R09382; R09383 R09384 R09669 R09843 R09849 R09850 R09944 R10182; R10659 R11396 R11441","Pyrimidine metabolism; Mannose type O-glycan biosynthesis; Metabolic pathways","1.17.4.2; 2.7.1.11; 2.7.1.40; 2.7.1.108; 2.7.1.161; 2.7.1.174; 2.7.1.182; 2.7.1.-; 2.7.4.6; 2.7.7.6; 2.7.7.14; 2.7.7.15; 2.7.7.33; 2.7.7.38; 2.7.7.39; 2.7.7.40; 2.7.7.41; 2.7.7.43; 2.7.7.48; 2.7.7.57; 2.7.7.60; 2.7.7.67; 2.7.7.72; 2.7.7.74; 2.7.7.81; 2.7.7.82; 2.7.7.90; 2.7.7.92; 2.7.7.93; 3.5.4.13; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.65; 4.6.1.6; 6.3.2.5; 6.3.4.2","Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP; Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00063  CTP;  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00063  CTP","CAS: 65-47-4; PubChem: 3363; ChEBI: 17677; ChEMBL: CHEMBL223533; KNApSAcK: C00019639; PDB-CCD: CTP; 3DMET: B01144; NIKKAJI: J213.552C","cpd:C00063",9,16,14,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H17O14N3P3","C9H15O14N3P3",482.9845132,483.9923382,481.9766882
"cpd:C00075","UTP;","C9H15N2O15P3","UTP; Uridine 5'-triphosphate; Uridine triphosphate","R00156 R00157 R00159 R00289 R00416 R00443 R00502 R00516; R00568 R00571 R00573 R00659 R00662 R00769 R00967 R00969; R01381 R01471 R02023 R02634 R03077 R03238 R04733 R08845; R10183 R11025","Pyrimidine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction","1.17.4.2; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.4.10; 2.7.7.6; 2.7.7.9; 2.7.7.10; 2.7.7.11; 2.7.7.23; 2.7.7.44; 2.7.7.48; 2.7.7.52; 2.7.7.59; 2.7.7.64; 2.7.7.83; 2.7.7.-; 3.5.4.13; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.17; 3.6.1.39; 6.3.4.2","Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00075  UTP","CAS: 63-39-8; PubChem: 3375; ChEBI: 15713; ChEMBL: CHEMBL336296 CHEMBL605653; PDB-CCD: UTP; 3DMET: B01149; NIKKAJI: J4.827E","cpd:C00075",9,15,15,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H16O15N2P3","C9H14O15N2P3",483.9685288,484.9763538,482.9607037
"cpd:C00099","beta-Alanine;","C3H7NO2","beta-Alanine; 3-Aminopropionic acid; 3-Aminopropanoate","R00489 R00904 R00905 R00906 R00907 R00908 R00909 R00910; R00911 R00912 R00913 R00914 R00915 R00916 R00917 R01164; R01166 R02473 R02474 R02741 R03286 R03288 R03935 R09379; R09648 R10821","Pyrimidine metabolism; beta-Alanine metabolism; Propanoate metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction; Protein digestion and absorption","1.2.1.3; 1.2.1.5; 1.2.1.19; 1.5.1.26; 2.6.1.18; 2.6.1.19; 2.6.1.55; 2.8.3.-; 3.4.13.4; 3.4.13.5; 3.4.13.18; 3.4.13.20; 3.5.1.6; 3.5.1.21; 3.5.1.22; 3.5.1.100; 3.5.3.17; 4.1.1.11; 4.1.1.15; 6.3.2.1; 6.3.2.11; 6.3.2.23; 6.3.2.36; 6.3.2.44","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate; Pantothenate biosynthesis, valine/L-aspartate => pantothenate","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00099  beta-Alanine;   Amines;    Biogenic amines;     C00099  beta-Alanine","CAS: 107-95-9; PubChem: 3399; ChEBI: 16958; ChEMBL: CHEMBL297569; KNApSAcK: C00001333; PDB-CCD: BAL; 3DMET: B00025; NIKKAJI: J4.070C","cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488",3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1","C3H6O2N1",89.04767847,90.0555035,88.03985344
"cpd:C00105","UMP;","C9H13N2O9P","UMP; Uridylic acid; Uridine monophosphate; Uridine 5'-monophosphate; 5'Uridylic acid","R00155 R00158 R00287 R00504 R00662 R00963 R00964 R00965; R00966 R00967 R00968 R00969 R00970 R01007 R01535 R01549; R01880 R02097 R02327 R02332 R03986 R04179 R04291 R04549; R05629 R05630 R05969 R08856 R09641 R09642 R10137 R10184; R10465 R10838 R11053","Pyrimidine metabolism; Peptidoglycan biosynthesis; Metabolic pathways","1.14.11.49; 2.4.2.9; 2.4.2.57; 2.7.1.48; 2.7.1.213; 2.7.4.4; 2.7.4.14; 2.7.4.22; 2.7.8.6; 2.7.8.13; 2.7.8.15; 2.7.8.17; 2.7.8.18; 2.7.8.19; 2.7.8.31; 2.7.8.32; 2.7.8.33; 2.7.8.35; 2.7.8.36; 2.7.8.40; 3.1.3.5; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.9; 3.6.1.17; 3.6.1.45; 3.6.1.54; 4.1.1.23","Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP; Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00105  UMP","CAS: 58-97-9; PubChem: 3405; ChEBI: 16695; ChEMBL: CHEMBL214393; KNApSAcK: C00007311; PDB-CCD: U U5P; 3DMET: B01161; NIKKAJI: J4.594B","cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031",9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O9N2P1","C9H12O9N2P1",324.035867,325.043692,323.028042
"cpd:C00106","Uracil","C4H4N2O2","Uracil","R00966 R00973 R00974 R00975 R00976 R00977 R00978 R01055; R01080 R01876 R02484 R02486 R03131 R09936 R10838","Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways","1.3.1.1; 1.3.1.2; 1.3.3.7; 1.14.11.10; 1.14.99.46; 1.17.99.4; 2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 2.4.2.9; 2.4.2.57; 2.5.1.53; 3.2.2.3; 3.5.4.1; 4.1.1.66; 4.2.1.70","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate","Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00106  Uracil (Ura)","CAS: 66-22-8; PubChem: 3406; ChEBI: 17568; ChEMBL: CHEMBL566; KNApSAcK: C00001513; PDB-CCD: URA; 3DMET: B00026; NIKKAJI: J4.842I","cpd:C00106; cpd:C16734; cpd:C18474",4,4,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H5O2N2","C4H3O2N2",112.0272774,113.0351024,111.0194523
"cpd:C00112","CDP;","C9H15N3O11P2","CDP; Cytidine 5'-diphosphate; Cytidine diphosphate","R00440 R00512 R00514 R00569 R00570 R00572 R00767 R01018; R02024 R03237 R04581 R08574 R09849 R09850 R09944 R10659","Pyrimidine metabolism; Metabolic pathways","1.17.4.1; 2.4.1.60; 2.7.1.11; 2.7.1.40; 2.7.1.108; 2.7.1.161; 2.7.1.174; 2.7.1.182; 2.7.1.-; 2.7.4.6; 2.7.4.14; 2.7.4.25; 2.7.7.8; 3.6.1.5","Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP; Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00112  CDP","CAS: 63-38-7; PubChem: 3412; ChEBI: 17239; ChEMBL: CHEMBL425252 CHEMBL610634; PDB-CCD: CDP; 3DMET: B01162; NIKKAJI: J150.290E","cpd:C00112",9,15,11,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H16O11N3P2","C9H14O11N3P2",403.0181823,404.0260073,402.0103573
"cpd:C00178","Thymine;","C5H6N2O2","Thymine; 5-Methyluracil","R01411 R01412 R01413 R01414 R01415 R01570 R02806 R09937; R11026","Pyrimidine metabolism; Metabolic pathways","1.3.1.1; 1.3.1.2; 1.14.11.6; 1.14.99.46; 1.17.99.4; 2.4.2.2; 2.4.2.4; 2.4.2.6; 3.5.4.1","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate","Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00178  Thymine (Thy)","CAS: 65-71-4; PubChem: 3478; ChEBI: 17821; ChEMBL: CHEMBL993; KNApSAcK: C00001511; PDB-CCD: TDR; 3DMET: B00051; NIKKAJI: J2.357D","cpd:C00178; cpd:C02835",5,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O2N2","C5H5O2N2",126.0429274,127.0507525,125.0351024
"cpd:C00214","Thymidine;","C10H14N2O5","Thymidine; Deoxythymidine","R01567 R01568 R01569 R01570 R01571 R02806","Pyrimidine metabolism; Metabolic pathways","2.4.2.2; 2.4.2.4; 2.4.2.6; 2.7.1.21; 2.7.1.114; 2.7.1.118; 3.1.3.5; 3.1.3.35; 3.1.3.89",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00214  Deoxythymidine (dT)","CAS: 50-89-5; PubChem: 3514; ChEBI: 17748; ChEMBL: CHEMBL52609; KNApSAcK: C00019698; PDB-CCD: THM; 3DMET: B01191; NIKKAJI: J4.548I","cpd:C00214; cpd:C19431",10,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H15O5N2","C10H13O5N2",242.0902716,243.0980966,241.0824465
"cpd:C00222","3-Oxopropanoate;","C3H4O3","3-Oxopropanoate; Malonate semialdehyde","R00705 R00706 R00740 R00907 R00908 R01604 R01607 R01608; R01609 R01611 R05371 R05372 R05378 R06973 R09289 R09983; R10947","Pyrimidine metabolism; beta-Alanine metabolism; Inositol phosphate metabolism; Chloroalkane and chloroalkene degradation; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","1.1.1.59; 1.1.1.298; 1.1.1.-; 1.2.1.15; 1.2.1.18; 1.2.1.27; 1.2.1.75; 1.7.3.5; 2.6.1.18; 2.6.1.19; 2.6.1.55; 3.5.1.-; 3.8.1.-; 4.1.1.-; 4.1.2.29; 4.2.1.27; 4.2.1.155","Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    3-Oxocarboxylic acids;     C00222  3-Oxopropanoate","PubChem: 3522; ChEBI: 17960 33190; 3DMET: B00062; NIKKAJI: J7.174I","cpd:C00022; cpd:C00222; cpd:C00957; cpd:C02055; cpd:C02853; cpd:C12069; cpd:C18618; cpd:C20363",3,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O3","C3H3O3",88.01604399,89.02386902,87.00821896
"cpd:C00239","dCMP;","C9H14N3O7P","dCMP; Deoxycytidylic acid; Deoxycytidine monophosphate; Deoxycytidylate; 2'-Deoxycytidine 5'-monophosphate","R01663 R01664 R01665 R01666 R01667 R01668 R01669 R01670; R02321","Pyrimidine metabolism; Metabolic pathways","2.1.1.54; 2.1.2.8; 2.7.1.74; 2.7.1.213; 2.7.4.14; 2.7.4.25; 3.1.3.5; 3.1.3.89; 3.5.4.12; 3.6.1.12; 3.6.1.65",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00239  dCMP","CAS: 1032-65-1; PubChem: 3538; ChEBI: 15918; ChEMBL: CHEMBL374699; PDB-CCD: DC DCM DNR; 3DMET: B01198; NIKKAJI: J14.407J","cpd:C00239; cpd:C00856",9,14,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O7N3P1","C9H13O7N3P1",307.0569368,308.0647618,306.0491118
"cpd:C00295","Orotate;","C5H4N2O4","Orotate; Orotic acid; Uracil-6-carboxylic acid","R01866 R01867 R01868 R01869 R01870","Pyrimidine metabolism; Metabolic pathways","1.3.1.14; 1.3.1.15; 1.3.5.2; 1.3.98.1; 2.4.2.10","Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP","Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Orotic acid;     D00055  Orotic acid (JAN)","CAS: 65-86-1; PubChem: 3589; ChEBI: 16742; ChEMBL: CHEMBL1235017; KNApSAcK: C00007300 C00019689; PDB-CCD: ORO; 3DMET: B00083; NIKKAJI: J2.359K","cpd:C00295; cpd:C03030",5,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H5O4N2","C5H3O4N2",156.0171066,157.0249316,155.0092816
"cpd:C00299","Uridine","C9H12N2O6","Uridine","R00963 R00964 R00967 R00968 R00970 R01080 R01549 R01876; R01877 R01878 R01879 R01880 R02097 R02327 R02332","Pyrimidine metabolism; Metabolic pathways","1.14.11.3; 2.4.2.2; 2.4.2.3; 2.7.1.48; 2.7.1.213; 3.1.3.5; 3.1.3.6; 3.2.2.3; 3.5.4.5",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00299  Uridine (U)","CAS: 58-96-8; PubChem: 3593; ChEBI: 16704; ChEMBL: CHEMBL100259; KNApSAcK: C00019674; PDB-CCD: URI; 3DMET: B01210; NIKKAJI: J4.593D","cpd:C00299; cpd:C02067; cpd:C16745",9,12,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H13O6N2","C9H11O6N2",244.0695361,245.0773611,243.0617111
"cpd:C00337","(S)-Dihydroorotate;","C5H6N2O4","(S)-Dihydroorotate; (S)-4,5-Dihydroorotate; L-Dihydroorotate; L-Dihydroorotic acid; Dihydro-L-orotic acid","R01866 R01867 R01868 R01869 R01993","Pyrimidine metabolism; Metabolic pathways","1.3.1.14; 1.3.1.15; 1.3.5.2; 1.3.98.1; 3.5.2.3","Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,"CAS: 5988-19-2; PubChem: 3630; ChEBI: 17025; KNApSAcK: C00007302; PDB-CCD: DOR; 3DMET: B01220; NIKKAJI: J236.345C","cpd:C00337; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757",5,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O4N2","C5H5O4N2",158.0327567,159.0405817,157.0249316
"cpd:C00363","dTDP;","C10H16N2O11P2","dTDP; Deoxythymidine 5'-diphosphate","R02092 R02093 R02094 R02095 R02096 R02097 R04222 R05530; R05531 R06443 R06450 R06451 R06452 R06455 R06457 R06460; R06461 R06484 R06485 R06486 R06487 R06488 R06489 R06490; R06491 R06492 R06493 R06494 R06495 R06496 R06497 R06498; R06499 R06506 R06659 R06660 R06662 R06664 R06666 R06667; R06668 R06684 R06716 R06717 R06718 R06767 R06770 R06773; R08857 R09331 R09332 R09345 R09351 R09352 R10175 R10303; R10595 R10833 R10874 R10876 R10955 R11122 R11417 R11418; R11420 R11421 R11422 R11423","Pyrimidine metabolism; Metabolic pathways","2.4.1.277; 2.4.1.278; 2.4.1.289; 2.4.1.302; 2.4.1.311; 2.4.1.316; 2.4.1.317; 2.4.1.318; 2.4.1.322; 2.4.1.325; 2.4.1.326; 2.4.1.327; 2.4.1.328; 2.4.1.331; 2.4.1.-; 2.4.2.27; 2.4.2.-; 2.4.-.-; 2.7.1.48; 2.7.4.6; 2.7.4.9; 2.7.4.12; 3.6.1.5; 3.6.1.39","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00363  dTDP","CAS: 491-97-4; PubChem: 3654; ChEBI: 18075; ChEMBL: CHEMBL259724; KNApSAcK: C00019696; PDB-CCD: TYD; 3DMET: B01229; NIKKAJI: J247.693B","cpd:C00363",10,16,11,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O11N2P2","C10H15O11N2P2",402.0229333,403.0307584,401.0151083
"cpd:C00364","dTMP;","C10H15N2O8P","dTMP; Thymidine 5'-phosphate; Deoxythymidine 5'-phosphate; Thymidylic acid; 5'-Thymidylic acid; Thymidine monophosphate; Deoxythymidylic acid; Thymidylate","R01567 R01568 R01569 R01571 R02092 R02094 R02101 R06613; R11323","Pyrimidine metabolism; Metabolic pathways; Antifolate resistance","2.1.1.45; 2.1.1.148; 2.7.1.21; 2.7.1.114; 2.7.1.118; 2.7.4.9; 2.7.4.12; 3.1.3.5; 3.1.3.35; 3.1.3.89; 3.6.1.5; 3.6.1.9","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00364  dTMP","CAS: 365-07-1; PubChem: 3655; ChEBI: 17013; ChEMBL: CHEMBL394429; KNApSAcK: C00019637; PDB-CCD: DT TMP; 3DMET: B01230; NIKKAJI: J150.344H","cpd:C00364",10,15,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H16O8N2P1","C10H14O8N2P1",322.0566024,323.0644275,321.0487774
"cpd:C00365","dUMP;","C9H13N2O8P","dUMP; Deoxyuridylic acid; Deoxyuridine monophosphate; Deoxyuridine 5'-phosphate; 2'-Deoxyuridine 5'-phosphate","R01663 R02098 R02099 R02100 R02101 R02102 R06613 R07307","Pyrimidine metabolism; Metabolic pathways; Antifolate resistance","2.1.1.45; 2.1.1.148; 2.7.1.21; 2.7.4.4; 2.7.4.9; 3.1.3.5; 3.1.3.89; 3.5.4.12; 3.5.4.30; 3.6.1.23; 3.6.1.-","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00365  dUMP","CAS: 964-26-1; PubChem: 3656; ChEBI: 17622; ChEMBL: CHEMBL211312; KNApSAcK: C00019282; PDB-CCD: DU UMP; 3DMET: B01231; NIKKAJI: J298.569A","cpd:C00365; cpd:C17322",9,13,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O8N2P1","C9H12O8N2P1",308.0409524,309.0487774,307.0331274
"cpd:C00380","Cytosine","C4H5N3O","Cytosine","R00510 R00974 R02137 R02296 R10837","Pyrimidine metabolism; Metabolic pathways","2.4.2.2; 2.4.2.57; 3.2.2.8; 3.2.2.10; 3.5.4.1",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00380  Cytosine (Cyt)","CAS: 71-30-7; PubChem: 3670; ChEBI: 16040; ChEMBL: CHEMBL15913; KNApSAcK: C00001498; PDB-CCD: CYT; 3DMET: B00097; NIKKAJI: J9.343B","cpd:C00380",4,5,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H6O1N3","C4H4O1N3",111.0432618,112.0510868,110.0354368
"cpd:C00383","Malonate;","C3H4O4","Malonate; Malonic acid; Propanedioic acid","R00743 R01604 R01607 R07629 R08944 R09483","Pyrimidine metabolism; beta-Alanine metabolism","1.2.1.15; 2.3.1.187; 2.8.3.3; 3.5.1.95; 4.1.1.88; 4.1.1.89",NA,"Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00383  Malonate; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C00383  [120347] Malonate","CAS: 141-82-2; PubChem: 3673; ChEBI: 15792 30794; ChEMBL: CHEMBL7942; LIPIDMAPS: LMFA01170041; KNApSAcK: C00001193; PDB-CCD: MLA MLI; 3DMET: B00098; NIKKAJI: J2.541K","cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146",3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O4","C3H3O4",104.0109586,105.0187836,103.0031336
"cpd:C00429","5,6-Dihydrouracil;","C4H6N2O2","5,6-Dihydrouracil; Dihydro-2,4(1H,3H)-pyrimidinedione; Dihydrouracile; Dihydrouracil; 5,6-Dihydro-2,4-dihydroxypyrimidine; Hydrouracil; 2,4-Dioxotetrahydropyrimidine","R00975 R00977 R00978 R02269 R04346","Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways","1.3.1.1; 1.3.1.2; 1.3.3.7; 2.4.2.20; 3.5.2.2","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,"CAS: 504-07-4; PubChem: 3718; ChEBI: 15901; PDB-CCD: DUC; 3DMET: B00109; NIKKAJI: J11.667J","cpd:C00429; cpd:C02065; cpd:C02248; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C08311; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C21440",4,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O2N2","C4H5O2N2",114.0429274,115.0507525,113.0351024
"cpd:C00438","N-Carbamoyl-L-aspartate","C5H8N2O5","N-Carbamoyl-L-aspartate","R00484 R01397 R01993 R02284","Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways","2.1.3.2; 3.5.1.7; 3.5.2.3; 3.5.2.4","Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,"PubChem: 3727; ChEBI: 15859; KNApSAcK: C00007265; PDB-CCD: NCD; 3DMET: B00115; NIKKAJI: J39.568D","cpd:C00438; cpd:C04209",5,8,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5N2","C5H7O5N2",176.0433214,177.0511464,175.0354963
"cpd:C00458","dCTP;","C9H16N3O13P3","dCTP; Deoxycytidine 5'-triphosphate; Deoxycytidine triphosphate; 2'-Deoxycytidine 5'-triphosphate","R00377 R01668 R02022 R02325 R02326 R02327 R02371 R07307","Pyrimidine metabolism; Metabolic pathways","1.17.4.2; 2.7.1.48; 2.7.4.6; 2.7.7.7; 3.5.4.13; 3.5.4.30; 3.6.1.12; 3.6.1.65","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00458  dCTP","CAS: 2056-98-6; PubChem: 3742; ChEBI: 16311; ChEMBL: CHEMBL560403; PDB-CCD: DCP; 3DMET: B01248; NIKKAJI: J247.702E","cpd:C00458",9,16,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H17O13N3P3","C9H15O13N3P3",466.9895986,467.9974236,465.9817735
"cpd:C00459","dTTP;","C10H17N2O14P3","dTTP; Deoxythymidine triphosphate; Deoxythymidine 5'-triphosphate; TTP","R00378 R02093 R02095 R02096 R02097 R02328 R02329 R11323","Pyrimidine metabolism; Metabolic pathways","2.7.1.48; 2.7.4.6; 2.7.7.7; 2.7.7.24; 2.7.7.32; 3.6.1.5; 3.6.1.9; 3.6.1.39","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00459  dTTP","PubChem: 3743; ChEBI: 18077; ChEMBL: CHEMBL363559; PDB-CCD: TTP; 3DMET: B01249; NIKKAJI: J193.870C","cpd:C00459",10,17,14,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H18O14N2P3","C10H16O14N2P3",481.9892642,482.9970893,480.9814392
"cpd:C00460","dUTP;","C9H15N2O14P3","dUTP; 2'-Deoxyuridine 5'-triphosphate","R02023 R02100 R02325 R02330 R02331 R02332 R02372","Pyrimidine metabolism; Metabolic pathways","1.17.4.2; 2.7.1.48; 2.7.4.6; 3.5.4.13; 3.6.1.23; 3.6.1.39; 3.6.1.-","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00460  dUTP","PubChem: 3744; ChEBI: 17625; ChEMBL: CHEMBL374361; KNApSAcK: C00019636; PDB-CCD: DUT; 3DMET: B01250; NIKKAJI: J315.490D","cpd:C00460",9,15,14,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H16O14N2P3","C9H14O14N2P3",467.9736142,468.9814392,466.9657891
"cpd:C00475","Cytidine","C9H13N3O5","Cytidine","R00511 R00513 R00516 R00517 R00962 R01548 R01878 R02091; R02096 R02137 R02296 R02370 R02371 R02372","Pyrimidine metabolism; Metabolic pathways","2.4.2.2; 2.7.1.48; 2.7.1.213; 3.1.3.5; 3.1.3.6; 3.1.3.91; 3.2.2.8; 3.5.4.5",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00475  Cytidine (C)","CAS: 65-46-3; PubChem: 3758; ChEBI: 17562; ChEMBL: CHEMBL136152 CHEMBL95606; KNApSAcK: C00042440; PDB-CCD: CTN; 3DMET: B01256; NIKKAJI: J4.837B","cpd:C00475; cpd:C02961; cpd:C05711",9,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O5N3","C9H12O5N3",243.0855205,244.0933456,242.0776955
"cpd:C00526","Deoxyuridine;","C9H12N2O5","Deoxyuridine; 2-Deoxyuridine; 2'-Deoxyuridine","R01879 R02099 R02102 R02484 R02485 R02486","Pyrimidine metabolism","1.14.11.3; 1.14.11.10; 2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 2.7.1.21; 3.1.3.5; 3.1.3.89; 3.5.4.5",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00526  Deoxyuridine (dU)","CAS: 951-78-0; PubChem: 3809; ChEBI: 16450; ChEMBL: CHEMBL353955; KNApSAcK: C00019697; PDB-CCD: DUR; 3DMET: B01281; NIKKAJI: J7.186B","cpd:C00526",9,12,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H13O5N2","C9H11O5N2",228.0746215,229.0824465,227.0667965
"cpd:C00705","dCDP;","C9H15N3O10P2","dCDP; 2'-Deoxycytidine diphosphate; 2'-Deoxycytidine 5'-diphosphate","R01665 R01667 R02024 R02326 R02327 R02371","Pyrimidine metabolism; Metabolic pathways","1.17.4.1; 2.7.1.48; 2.7.4.6; 2.7.4.14; 2.7.4.25; 3.6.1.12","Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP","Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00705  dCDP","CAS: 800-73-7; PubChem: 3972; ChEBI: 28846; PDB-CCD: YYY; 3DMET: B01317; NIKKAJI: J247.701G","cpd:C00705",9,15,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H16O10N3P2","C9H14O10N3P2",387.0232677,388.0310927,386.0154427
"cpd:C00813","Barbiturate;","C4H4N2O3","Barbiturate; Barbituric acid; Malonylurea","R00976 R02139","Pyrimidine metabolism","1.17.99.4; 3.5.2.1",NA,NA,"CAS: 67-52-7; PubChem: 4071; ChEBI: 16294 29745; ChEMBL: CHEMBL574699; PDB-CCD: BR8; 3DMET: B01336; NIKKAJI: J348D","cpd:C00813; cpd:C11116",4,4,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H5O3N2","C4H3O3N2",128.022192,129.030017,127.014367
"cpd:C00881","Deoxycytidine;","C9H13N3O4","Deoxycytidine; 2'-Deoxycytidine","R01664 R01666 R02321 R02485","Pyrimidine metabolism","2.7.1.74; 2.7.1.213; 3.1.3.5; 3.1.3.89; 3.5.4.5",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00881  Deoxycytidine (dC)","CAS: 951-77-9; PubChem: 4137; ChEBI: 15698; ChEMBL: CHEMBL66115; PDB-CCD: DCZ; 3DMET: B01347; NIKKAJI: J14.406A","cpd:C00881",9,13,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O4N3","C9H12O4N3",227.0906059,228.0984309,226.0827809
"cpd:C01013","3-Hydroxypropanoate;","C3H6O3","3-Hydroxypropanoate; 3-Hydroxypropanoic acid; 3-Hydroxypropionate; 3-Hydroxypropionic acid; Hydracrylic acid","R01608 R03157 R03158 R09286 R09289","Pyrimidine metabolism; beta-Alanine metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","1.1.1.59; 1.1.1.298; 1.1.1.-; 3.1.2.4; 6.2.1.36; 6.2.1.-","Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C01013  3-Hydroxypropanoate","CAS: 503-66-2; PubChem: 4258; ChEBI: 16510 33404; ChEMBL: CHEMBL1205969; LipidBank: DFA0269; PDB-CCD: 3OH; 3DMET: B00221; NIKKAJI: J6.213H","cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296",3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O3","C3H5O3",90.03169405,91.03951908,89.02386902
"cpd:C01103","Orotidine 5'-phosphate;","C10H13N2O11P","Orotidine 5'-phosphate; Orotidylic acid","R00965 R01870","Pyrimidine metabolism; Metabolic pathways","2.4.2.10; 4.1.1.23","Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,"CAS: 2149-82-8; PubChem: 4337; ChEBI: 15842; ChEMBL: CHEMBL1207358 CHEMBL610606; PDB-CCD: OMP; 3DMET: B01381; NIKKAJI: J13.801K","cpd:C01103",10,13,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O11N2P1","C10H12O11N2P1",368.0256962,369.0335213,367.0178712
"cpd:C01168","Pseudouridine 5'-phosphate","C9H13N2O9P","Pseudouridine 5'-phosphate","R01055 R03315 R11180","Pyrimidine metabolism","2.7.1.83; 3.1.3.96; 4.2.1.70",NA,NA,"CAS: 1157-60-4; PubChem: 4395; ChEBI: 18116; PDB-CCD: PSU; 3DMET: B01399; NIKKAJI: J2.731.765K","cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031",9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O9N2P1","C9H12O9N2P1",324.035867,325.043692,323.028042
"cpd:C01205","(R)-3-Amino-2-methylpropanoate;","C4H9NO2","(R)-3-Amino-2-methylpropanoate; (R)-3-Aminoisobutyrate; D-3-Aminoisobutanoate; (R)-beta-Aminoisobutyrate","R02050 R04666","Pyrimidine metabolism; Valine, leucine and isoleucine degradation; Metabolic pathways","2.6.1.40; 3.5.1.6","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,"PubChem: 4429; ChEBI: 16320; LIPIDMAPS: LMFA01100049; NIKKAJI: J36.420G","cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514",4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1","C4H8O2N1",103.0633285,104.0711536,102.0555035
"cpd:C01346","dUDP;","C9H14N2O11P2","dUDP; 2'-Deoxyuridine 5'-diphosphate","R02018 R02098 R02330 R02331 R02332 R02372","Pyrimidine metabolism; Metabolic pathways","1.17.4.1; 2.7.1.48; 2.7.4.4; 2.7.4.6; 2.7.4.9; 3.6.1.39",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C01346  dUDP","CAS: 4208-67-7; PubChem: 4551; ChEBI: 28850; ChEMBL: CHEMBL9519; PDB-CCD: DUD; 3DMET: B01441; NIKKAJI: J699.272B","cpd:C01346",9,14,11,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O11N2P2","C9H13O11N2P2",388.0072833,389.0151083,386.9994582
"cpd:C01368","3'-UMP;","C9H13N2O9P","3'-UMP; Uridine 3'-monophosphate; Uridine 3'-phosphate","R01877 R03538","Pyrimidine metabolism","3.1.3.6; 3.1.4.16",NA,NA,"CAS: 35170-03-7; PubChem: 4567; ChEBI: 28895; ChEMBL: CHEMBL460741; PDB-CCD: U3P; 3DMET: B01443; NIKKAJI: J150.311A","cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031",9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O9N2P1","C9H12O9N2P1",324.035867,325.043692,323.028042
"cpd:C01563","Carbamate;","CH3NO2","Carbamate; Carbamic acid; Aminoformic acid","R01395 R03546 R07316 R09947 R09949 R09980 R10949","Pyrimidine metabolism; Nitrogen metabolism","2.7.2.2; 3.5.1.110; 4.2.1.104; 6.3.5.5",NA,NA,"CAS: 463-77-4 302-11-4; PubChem: 4721; ChEBI: 28616; ChEMBL: CHEMBL125278; PDB-CCD: OUT; 3DMET: B00320; NIKKAJI: J39.572B","cpd:C01563; cpd:C19275",1,3,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C1H4O2N1","C1H2O2N1",61.01637834,62.02420337,60.00855331
"cpd:C02067","Pseudouridine","C9H12N2O6","Pseudouridine","R03315 R11180","Pyrimidine metabolism","2.7.1.83; 3.1.3.96",NA,NA,"CAS: 1445-07-4; PubChem: 5155; ChEBI: 17802; ChEMBL: CHEMBL603512; KNApSAcK: C00001508; 3DMET: B01529; NIKKAJI: J20.385H","cpd:C00299; cpd:C02067; cpd:C16745",9,12,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H13O6N2","C9H11O6N2",244.0695361,245.0773611,243.0617111
"cpd:C02170","Methylmalonate;","C4H6O4","Methylmalonate; Methylmalonic acid","R02764 R03383 R03869 R03870 R03871 R03872 R10778","Pyrimidine metabolism; Valine, leucine and isoleucine degradation; Propanoate metabolism","1.2.1.3; 1.2.3.1; 3.1.2.17; 3.5.1.95; 3.5.2.1; 6.2.1.-",NA,NA,"CAS: 516-05-2; PubChem: 5245; ChEBI: 17453 30860; ChEMBL: CHEMBL1232416; LIPIDMAPS: LMFA01170118; PDB-CCD: DXX; 3DMET: B00395; NIKKAJI: J6.302I","cpd:C00042; cpd:C02170; cpd:C03201; cpd:C07598; cpd:C10900; cpd:C11117; cpd:C14872; cpd:C15607; cpd:C19414; cpd:C20231",4,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O4","C4H5O4",118.0266087,119.0344337,117.0187836
"cpd:C02354","2',3'-Cyclic CMP","C9H12N3O7P","2',3'-Cyclic CMP","R03929","Pyrimidine metabolism","3.1.4.16",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02354  2',3'-Cyclic CMP","PubChem: 5401; ChEBI: 27652; 3DMET: B01565; NIKKAJI: J32.847B","cpd:C00941; cpd:C02072; cpd:C02354",9,12,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H13O7N3P1","C9H11O7N3P1",305.0412867,306.0491118,304.0334617
"cpd:C02355","2',3'-Cyclic UMP","C9H11N2O8P","2',3'-Cyclic UMP","R03538","Pyrimidine metabolism","3.1.4.16",NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02355  2',3'-Cyclic UMP","PubChem: 5402; ChEBI: 28637; 3DMET: B01566; NIKKAJI: J380.961G","cpd:C00549; cpd:C02355",9,11,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H12O8N2P1","C9H10O8N2P1",306.0253023,307.0331274,305.0174773
"cpd:C02376","5-Methylcytosine","C5H7N3O","5-Methylcytosine","R01411","Pyrimidine metabolism","3.5.4.1",NA,NA,"CAS: 554-01-8; PubChem: 5418; ChEBI: 27551; PDB-CCD: 17E; 3DMET: B00435; NIKKAJI: J9.416A","cpd:C02376",5,7,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H8O1N3","C5H6O1N3",125.0589119,126.0667369,124.0510868
"cpd:C02642","3-Ureidopropionate;","C4H8N2O3","3-Ureidopropionate; 3-Ureidopropanoate; beta-Ureidopropionic acid; N-Carbamoyl-beta-alanine","R00905 R02269","Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways","3.5.1.6; 3.5.2.2","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,"CAS: 462-88-4; PubChem: 5621; ChEBI: 18261; ChEMBL: CHEMBL20962; PDB-CCD: URP; 3DMET: B00472; NIKKAJI: J39.569B","cpd:C00152; cpd:C01043; cpd:C01905; cpd:C02037; cpd:C02642; cpd:C16438; cpd:C19258; cpd:C19301",4,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O3N2","C4H7O3N2",132.0534921,133.0613172,131.0456671
"cpd:C03997","5-Hydroxymethyldeoxycytidylate;","C10H16N3O8P","5-Hydroxymethyldeoxycytidylate; 5-Hydroxymethyldeoxycytidylic acid; 2'-Deoxy-5-hydroxymethylcytidine 5'-phosphate","R00140 R01669","Pyrimidine metabolism","2.1.2.8; 2.7.4.12",NA,NA,"CAS: 13009-95-5; PubChem: 6710; ChEBI: 16952; PDB-CCD: 5HC; 3DMET: B01709; NIKKAJI: J2.745.326K","cpd:C03997; cpd:C04155; cpd:C11478; cpd:C21031",10,16,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O8N3P1","C10H15O8N3P1",337.0675015,338.0753265,336.0596765
"cpd:C05281","5-Methylbarbiturate;","C5H6N2O3","5-Methylbarbiturate; 5-Methylbarbituric acid","R01413 R03870 R10777","Pyrimidine metabolism","1.17.99.4; 3.5.2.1",NA,NA,"CAS: 2417-22-3; PubChem: 7668; ChEBI: 28492; NIKKAJI: J497.987G","cpd:C02144; cpd:C03088; cpd:C05133; cpd:C05281",5,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O3N2","C5H5O3N2",142.0378421,143.0456671,141.030017
"cpd:C05822","3'-CMP;","C9H14N3O8P","3'-CMP; Cytidine 3'-phosphate","R02370 R03929","Pyrimidine metabolism","3.1.3.6; 3.1.4.16",NA,NA,"CAS: 84-52-6; PubChem: 8117; ChEBI: 53013; ChEMBL: CHEMBL258728; PDB-CCD: C3P; 3DMET: B01898; NIKKAJI: J60.869F","cpd:C00055; cpd:C03104; cpd:C05822; cpd:C17325; cpd:C19722",9,14,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O8N3P1","C9H13O8N3P1",323.0518514,324.0596765,322.0440264
"cpd:C06198","P1,P4-Bis(5'-uridyl) tetraphosphate;","C18H26N4O23P4","P1,P4-Bis(5'-uridyl) tetraphosphate; UppppU","R00969","Pyrimidine metabolism","3.6.1.17",NA,NA,"PubChem: 8448; ChEBI: 27791; ChEMBL: CHEMBL221326; 3DMET: B01994; NIKKAJI: J1.474.025B","cpd:C06198",18,26,23,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H27O23N4P4","C18H25O23N4P4",789.9938311,791.0016561,788.9860061
"cpd:C11038","2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate","C10H17N3O11P2","2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate","R00139 R00140","Pyrimidine metabolism","2.7.4.6; 2.7.4.12",NA,NA,"PubChem: 13221; ChEBI: 835; 3DMET: B04201; NIKKAJI: J2.787.088K","cpd:C11038",10,17,11,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H18O11N3P2","C10H16O11N3P2",417.0338324,418.0416574,416.0260073
"cpd:C11039","2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate","C10H18N3O14P3","2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate","R00139 R11029","Pyrimidine metabolism","2.7.4.6; 2.7.7.7",NA,NA,"PubChem: 13222; ChEBI: 836; 3DMET: B04202; NIKKAJI: J1.301.486H","cpd:C11039",10,18,14,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O14N3P3","C10H17O14N3P3",497.0001633,498.0079883,495.9923382
"cpd:C15607","3-Oxo-3-ureidopropanoate;","C4H6N2O4","3-Oxo-3-ureidopropanoate; Malonuric acid","R02139 R07629","Pyrimidine metabolism","3.5.1.95; 3.5.2.1",NA,NA,"PubChem: 47204992; ChEBI: 49049; NIKKAJI: J657.734B","cpd:C11117; cpd:C15607; cpd:C20231",4,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O4N2","C4H5O4N2",146.0327567,147.0405817,145.0249316
"cpd:C20231","(Z)-3-Ureidoacrylate peracid;","C4H6N2O4","(Z)-3-Ureidoacrylate peracid; Ureidoperacrylic acid","R09936 R09947 R09948 R09981","Pyrimidine metabolism; Metabolic pathways","1.14.99.46; 3.5.1.110",NA,NA,"PubChem: 163311974","cpd:C11117; cpd:C15607; cpd:C20231",4,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O4N2","C4H5O4N2",146.0327567,147.0405817,145.0249316
"cpd:C20249","(Z)-3-Peroxyaminoacrylate","C3H5NO3","(Z)-3-Peroxyaminoacrylate","R09947 R09948 R09982","Pyrimidine metabolism; Metabolic pathways","3.5.1.110",NA,NA,"PubChem: 163311992","cpd:C02193; cpd:C11822; cpd:C20249",3,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6O3N1","C3H4O3N1",103.026943,104.0347681,102.019118
"cpd:C20253","Aminoacrylate;","C3H5NO2","Aminoacrylate; (Z)-3-Aminoacrylate","R09980 R09982 R09983","Pyrimidine metabolism; Metabolic pathways","3.5.1.110; 3.5.1.-",NA,NA,"PubChem: 163311996","cpd:C02218; cpd:C04313; cpd:C06695; cpd:C20253; cpd:C20904",3,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6O2N1","C3H4O2N1",87.0320284,88.03985344,86.02420337
"cpd:C20254","Ureidoacrylate;","C4H6N2O3","Ureidoacrylate; (Z)-3-Ureidoacrylate","R09980 R09981","Pyrimidine metabolism","3.5.1.110",NA,NA,"PubChem: 163311997","cpd:C00107; cpd:C00211; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C02189; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06395; cpd:C06396; cpd:C16116; cpd:C20254; cpd:C21172",4,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3N2","C4H5O3N2",130.0378421,131.0456671,129.030017
"cpd:C20846","3-Oxo-3-ureidoisobutyrate","C5H8N2O4","3-Oxo-3-ureidoisobutyrate","R10777 R10778","Pyrimidine metabolism","3.5.1.95; 3.5.2.1",NA,NA,"PubChem: 254741312","cpd:C03409; cpd:C08298; cpd:C19483; cpd:C20232; cpd:C20846",5,8,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O4N2","C5H7O4N2",160.0484067,161.0562318,159.0405817
"cpd:C21028","(R)-5,6-Dihydrothymine;","C5H8N2O2","(R)-5,6-Dihydrothymine; (5R)-Dihydrothymine","R01415 R03055 R11026","Pyrimidine metabolism; Metabolic pathways","1.3.1.1; 1.3.1.2; 3.5.2.2","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,"CAS: 86387-01-1; PubChem: 254816253","cpd:C00906; cpd:C03800; cpd:C05715; cpd:C05717; cpd:C21028",5,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O2N2","C5H7O2N2",128.0585775,129.0664025,127.0507525
"cpd:C21029","(R)-3-Ureidoisobutyrate;","C5H10N2O3","(R)-3-Ureidoisobutyrate; (R)-N-Carbamyl-beta-aminoisobutyrate","R03055 R04666","Pyrimidine metabolism; Metabolic pathways","3.5.1.6; 3.5.2.2","Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,"PubChem: 254816254","cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029",5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O3N2","C5H9O3N2",146.0691422,147.0769672,145.0613172
"cpd:C00041","L-Alanine;","C3H7NO2","L-Alanine; L-2-Aminopropionic acid; L-alpha-Alanine","R00258 R00369 R00396 R00397 R00398 R00400 R00401 R00453; R00576 R00585 R00692 R00863 R00907 R00987 R01215 R01261; R01712 R02050 R02271 R02293 R02668 R02970 R03001 R03038; R03193 R03210 R03502 R03599 R03854 R03936 R04112 R04152; R04187 R05652 R07460 R08197 R08714 R08872 R09048 R09254; R10124 R10178 R10180 R10992 R11038 R11064 R11528","Alanine, aspartate and glutamate metabolism; Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Selenocompound metabolism; D-Alanine metabolism; Carbon fixation in photosynthetic organisms; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Sulfur relay system; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.1; 1.5.1.17; 2.3.1.47; 2.6.1.2; 2.6.1.12; 2.6.1.15; 2.6.1.18; 2.6.1.30; 2.6.1.37; 2.6.1.40; 2.6.1.41; 2.6.1.43; 2.6.1.44; 2.6.1.46; 2.6.1.47; 2.6.1.51; 2.6.1.56; 2.6.1.58; 2.6.1.66; 2.6.1.71; 2.6.1.77; 2.6.1.84; 2.6.1.96; 2.6.1.99; 2.6.1.108; 2.6.1.-; 2.8.1.7; 3.5.1.28; 3.7.1.3; 4.1.1.12; 4.1.1.64; 4.4.1.16; 5.1.1.1; 6.1.1.7; 6.3.2.8; 6.3.2.49","C4-dicarboxylic acid cycle, NAD - malic enzyme type","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00041  Alanine (Ala); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Alanine;     D00012  Alanine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00012  [003609] L-Alanine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00012  L-Alanine","CAS: 56-41-7; PubChem: 3343; ChEBI: 16977; ChEMBL: CHEMBL279597; KNApSAcK: C00001332; PDB-CCD: ALA; 3DMET: B00011; NIKKAJI: J9.168E","cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488",3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1","C3H6O2N1",89.04767847,90.0555035,88.03985344
"cpd:C00152","L-Asparagine;","C4H8N2O3","L-Asparagine; 2-Aminosuccinamic acid","R00482 R00483 R00485 R00578 R01266 R01267 R01346 R01485; R03648 R10446","Alanine, aspartate and glutamate metabolism; Cyanoamino acid metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.14.11.39; 2.3.2.7; 2.6.1.14; 3.2.2.11; 3.5.1.1; 3.5.1.38; 3.5.5.4; 4.2.1.65; 6.1.1.22; 6.3.1.1; 6.3.1.4; 6.3.5.4",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00152  Asparagine (Asn)","CAS: 70-47-3; PubChem: 3452; ChEBI: 17196; ChEMBL: CHEMBL58832; KNApSAcK: C00001341 C00034027; PDB-CCD: 41Q ASN; 3DMET: B00043; NIKKAJI: J9.178B","cpd:C00152; cpd:C01043; cpd:C01905; cpd:C02037; cpd:C02642; cpd:C16438; cpd:C19258; cpd:C19301",4,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O3N2","C4H7O3N2",132.0534921,133.0613172,131.0456671
"cpd:C00232","Succinate semialdehyde;","C4H6O3","Succinate semialdehyde; Succinic semialdehyde; 4-Oxobutanoate","R00272 R00713 R00714 R01644 R01645 R01647 R01648 R01649; R01650 R08461 R09280 R09281 R09472 R10101 R10178 R10179","Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Vitamin B6 metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Quorum sensing","1.1.1.61; 1.1.1.-; 1.2.1.16; 1.2.1.24; 1.2.1.76; 1.2.1.79; 1.5.3.21; 1.14.13.163; 2.6.1.19; 2.6.1.96; 3.5.1.29; 4.1.1.71; 4.1.2.52","GABA (gamma-Aminobutyrate) shunt; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde; Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    4-Oxocarboxylic acid;     C00232  Succinate semialdehyde; 4-Oxobutanoate","CAS: 692-29-5; PubChem: 3531; ChEBI: 16265; LIPIDMAPS: LMFA06000118; KNApSAcK: C00019682; PDB-CCD: SSN; 3DMET: B00065; NIKKAJI: J61.361D","cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172",4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3","C4H5O3",102.0316941,103.0395191,101.023869
"cpd:C00334","4-Aminobutanoate;","C4H9NO2","4-Aminobutanoate; 4-Aminobutanoic acid; 4-Aminobutyrate; 4-Aminobutyric acid; gamma-Aminobutyric acid; GABA","R00261 R01648 R01986 R01987 R01989 R01990 R01991 R01992; R02549 R07419 R08461 R10102 R10178 R10179","Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; beta-Alanine metabolism; Butanoate metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Quorum sensing; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Synaptic vesicle cycle; Retrograde endocannabinoid signaling; GABAergic synapse; Taste transduction; Estrogen signaling pathway; Morphine addiction; Nicotine addiction","1.2.1.3; 1.2.1.19; 1.2.1.-; 1.5.3.19; 2.1.4.1; 2.6.1.19; 2.6.1.96; 3.4.13.18; 3.4.13.20; 3.5.1.63; 3.5.1.94; 3.5.3.7; 4.1.1.15; 6.3.2.11","GABA (gamma-Aminobutyrate) shunt; GABA biosynthesis, eukaryotes, putrescine => GABA; GABA biosynthesis, prokaryotes, putrescine => GABA","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00334  gamma-Aminobutyric acid;   Amines;    Biogenic amines;     C00334  gamma-Aminobutyric acid (GABA);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00334  GABA; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C00334  4-Aminobutanoic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AG Fatty acid derivatives;      N03AG03 Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D00058  gamma-Aminobutyric acid (JAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    GABA;     GABAB-receptor;      Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN);  Ion channels;   Cys-loop superfamily;    GABA-A;     GABAA-receptor (benzodiazepine binding site);      Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN); Neurological agents [br08367.html];  Antiepileptic agents;   D00058","CAS: 56-12-2; PubChem: 3628; ChEBI: 16865 30566; ChEMBL: CHEMBL96; LIPIDMAPS: LMFA01100039; KNApSAcK: C00001337; PDB-CCD: ABU; 3DMET: B00090; NIKKAJI: J1.375G","cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514",4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1","C4H8O2N1",103.0633285,104.0711536,102.0555035
"cpd:C00352","D-Glucosamine 6-phosphate;","C6H14NO8P","D-Glucosamine 6-phosphate; D-Glucosamine phosphate","R00765 R00768 R01961 R01964 R01965 R02058 R02059 R02060; R02631","Alanine, aspartate and glutamate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of antibiotics; Phosphotransferase system (PTS); Insulin resistance","2.3.1.4; 2.6.1.16; 2.7.1.1; 2.7.1.8; 2.7.1.-; 3.5.1.25; 3.5.99.6; 5.4.2.10",NA,NA,"CAS: 3616-42-0; PubChem: 3645; ChEBI: 15873 47987; KNApSAcK: C00019580; PDB-CCD: 4R1 GLP; 3DMET: B01222; NIKKAJI: J79.822C","cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214",6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O8N1P1","C6H13O8N1P1",259.0457034,260.0535284,258.0378784
"cpd:C00402","D-Aspartate;","C4H7NO4","D-Aspartate; D-Aspartic acid","R00359 R00491 R02182 R05053 R09590","Alanine, aspartate and glutamate metabolism","1.4.3.1; 1.4.3.15; 2.6.1.21; 3.5.1.83; 5.1.1.13; 6.3.1.12",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00402  D-Aspartic acid","CAS: 1783-96-6; PubChem: 3692; ChEBI: 17364; ChEMBL: CHEMBL29757; PDB-CCD: DAS; 3DMET: B01235; NIKKAJI: J9.205C","cpd:C00049; cpd:C00402; cpd:C16433; cpd:C19710; cpd:C19911",4,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H8O4N1","C4H6O4N1",133.0375077,134.0453327,132.0296827
"cpd:C00940","2-Oxoglutaramate;","C5H7NO4","2-Oxoglutaramate; 2-Oxoglutaramic acid; alpha-Ketoglutaramate; 2-Ketoglutaramate","R00269 R00576 R01375 R02781 R08890 R08891","Alanine, aspartate and glutamate metabolism","2.6.1.15; 2.6.1.50; 2.6.1.64; 2.6.1.100; 2.6.1.101; 3.5.1.3; 3.5.1.111",NA,NA,"CAS: 18465-19-5; PubChem: 4192; ChEBI: 16769 30882; 3DMET: B00205; NIKKAJI: J39.559E","cpd:C00940; cpd:C05572",5,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H8O4N1","C5H6O4N1",145.0375077,146.0453327,144.0296827
"cpd:C01042","N-Acetyl-L-aspartate;","C6H9NO5","N-Acetyl-L-aspartate; N-Acetyl-L-aspartic acid","R00487 R00488 R10678 R10679 R10687","Alanine, aspartate and glutamate metabolism; Metabolic pathways","2.3.1.17; 3.4.17.21; 3.5.1.15; 6.3.2.41; 6.3.2.42",NA,NA,"CAS: 997-55-7; PubChem: 4284; ChEBI: 16953 21547; ChEMBL: CHEMBL1162494; 3DMET: B00227; NIKKAJI: J62.824G","cpd:C01042; cpd:C01045; cpd:C05520",6,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H10O5N1","C6H8O5N1",175.0480724,176.0558974,174.0402474
"cpd:C02362","2-Oxosuccinamate;","C4H5NO4","2-Oxosuccinamate; 2-Oxosuccinamic acid; gamma-Aminooxaloacetate; Oxaloacetamide","R00348 R01346","Alanine, aspartate and glutamate metabolism","2.6.1.14; 3.5.1.3",NA,NA,"PubChem: 5407; ChEBI: 16327; 3DMET: B01568; NIKKAJI: J2.362.002B","cpd:C02362; cpd:C05840; cpd:C13058",4,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H6O4N1","C4H4O4N1",131.0218576,132.0296827,130.0140326
"cpd:C03912","(S)-1-Pyrroline-5-carboxylate;","C5H7NO2","(S)-1-Pyrroline-5-carboxylate; L-1-Pyrroline-5-carboxylate; 1-Pyrroline-5-carboxylate","R00707 R00708 R01248 R01251 R01253 R03314 R09785 R10082; R10485 R10507","Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Carbapenem biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.2.1.88; 1.5.1.2; 1.5.5.2; 1.5.-.-; 1.14.11.34; 2.3.1.226","Proline biosynthesis, glutamate => proline; Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate",NA,"PubChem: 6642; ChEBI: 17388 371; KNApSAcK: C00007606; 3DMET: B01698; NIKKAJI: J654.872E","cpd:C03564; cpd:C03912; cpd:C04322; cpd:C04445; cpd:C07275; cpd:C20317",5,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H8O2N1","C5H6O2N1",113.0476785,114.0555035,112.0398534
"cpd:C12270","N-Acetylaspartylglutamate;","C11H16N2O8","N-Acetylaspartylglutamate; NAAG; Isospaglumic acid; N-Acetyl-L-aspartyl-L-glutamate","R10678 R10687 R10688 R10693","Alanine, aspartate and glutamate metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction","3.4.17.21; 6.3.2.41; 6.3.2.42",NA,NA,"CAS: 3106-85-2; PubChem: 14415; ChEBI: 73688; ChEMBL: CHEMBL376326 CHEMBL94282; NIKKAJI: J22.752H","cpd:C12270",11,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H17O8N2","C11H15O8N2",304.0906655,305.0984905,303.0828404
"cpd:C20775","beta-Citryl-L-glutamate;","C11H15NO10","beta-Citryl-L-glutamate; beta-Citrylglutamate","R10677","Alanine, aspartate and glutamate metabolism; Metabolic pathways","6.3.1.17",NA,NA,"PubChem: 254741242; PDB-CCD: BC8","cpd:C20775",11,15,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H16O10N1","C11H14O10N1",321.0695957,322.0774207,320.0617707
"cpd:C20776","N-Acetylaspartylglutamylglutamate;","C16H23N3O11","N-Acetylaspartylglutamylglutamate; N-Acetyl-L-aspartyl-L-glutamyl-L-glutamate; NAAG2","R10679 R10688 R10693","Alanine, aspartate and glutamate metabolism; Metabolic pathways","3.4.17.21; 6.3.2.42",NA,NA,"PubChem: 254741243","cpd:C20776",16,23,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H24O11N3","C16H22O11N3",433.1332586,434.1410836,432.1254335
"cpd:C02811","Anhydrotetracycline","C22H22N2O7","Anhydrotetracycline","R04060 R09191 R11521","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.14.13.38; 2.1.1.335","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C02811  Anhydrotetracycline","PubChem: 5761; ChEBI: 17146; ChEMBL: CHEMBL1214599; PDB-CCD: TDC; 3DMET: B01603; NIKKAJI: J114.616E","cpd:C02811",22,22,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H23O7N2","C22H21O7N2",426.1427011,427.1505261,425.134876
"cpd:C03206","5a,11a-Dehydrotetracycline;","C22H22N2O8","5a,11a-Dehydrotetracycline; 12-Dehydrotetracycline","R04060 R05459 R09198","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.3.98.4; 1.14.13.38; 1.14.13.234","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C03206  12-Dehydrotetracycline","PubChem: 6082; ChEBI: 15808; 3DMET: B01639; NIKKAJI: J2.741.332C","cpd:C03206; cpd:C07654; cpd:C08029",22,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H23O8N2","C22H21O8N2",442.1376157,443.1454407,441.1297906
"cpd:C06570","Tetracycline","C22H24N2O8","Tetracycline","R05459 R11449 R11478","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics; Bile secretion","1.3.98.4; 1.14.13.231; 1.14.19.49","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Tetracyclines;     C06570  Tetracycline; Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06570  Tetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB13 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA04 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA07 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA09 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA08 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;    S03A ANTIINFECTIVES;     S03AA Antiinfectives;      S03AA02 Tetracycline;       D00201  Tetracycline (JAN/USP/INN); USP drug classification [BR:br08302];  Antibacterials;   Tetracyclines;    Tetracycline;     D00201  Tetracycline (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Tetracycline;     D00201  Tetracycline (JAN/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Tetracycline;       D00201  Tetracycline (JAN/USP/INN)","CAS: 60-54-8; PubChem: 8799; ChEBI: 27902; ChEMBL: CHEMBL1440 CHEMBL1485984 CHEMBL198; PDB-CCD: TAC; 3DMET: B02074; NIKKAJI: J209.316B","cpd:C06570; cpd:C06973",22,24,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H25O8N2","C22H23O8N2",444.1532657,445.1610908,443.1454407
"cpd:C06571","Chlortetracycline;","C22H23ClN2O8","Chlortetracycline; 7-Chlorotetracycline; Aureomycin","R09194 R11478 R11526","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.14.13.231; 1.14.19.49","Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Tetracyclines;     C06571  Chlortetracycline; Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06571  Chlortetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB21 Chlortetracycline;       D07689  Chlortetracycline (INN);  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA02 Chlortetracycline;       D07689  Chlortetracycline (INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA03 Chlortetracycline;       D07689  Chlortetracycline (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA02 Chlortetracycline;       D07689  Chlortetracycline (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Chlortetracycline;       D07689  Chlortetracycline (INN)","CAS: 57-62-5; PubChem: 8800; ChEBI: 27644; LIPIDMAPS: LMPK07000004; PDB-CCD: CTC; NIKKAJI: J4.583G","cpd:C06571",22,23,8,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"C22H24O8N2Cl1","C22H22O8N2Cl1",478.1142934,479.1221184,477.1064684
"cpd:C06624","Oxytetracycline;","C22H24N2O9","Oxytetracycline; Oxytetracycline anhydrous","R09192 R11525","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.3.98.4; 1.14.13.231","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06624  Oxytetracycline; Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C06624  Oxytetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA03 Oxytetracycline;       C06624  Oxytetracycline;  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AA Antibiotics;      G01AA07 Oxytetracycline;       C06624  Oxytetracycline;  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA06 Oxytetracycline;       C06624  Oxytetracycline;  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA04 Oxytetracycline;       C06624  Oxytetracycline; Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Oxytetracycline;       C06624  Oxytetracycline","CAS: 79-57-2; PubChem: 8850; ChEBI: 27701; ChEMBL: CHEMBL1517; LIPIDMAPS: LMPK07000005; PDB-CCD: OTC; 3DMET: B02077; NIKKAJI: J3.847D","cpd:C06624; cpd:C13055; cpd:C21391",22,24,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H25O9N2","C22H23O9N2",460.1481804,461.1560054,459.1403553
"cpd:C06627","4-Keto-anhydrotetracycline;","C20H15NO8","4-Keto-anhydrotetracycline; 4-Ketoanhydrotetracycline; 4-Keto-ATC; 4-Dedimethylamino-4-oxo-anhydrotetracycline; 4-De(dimethylamino)-4-oxoanhydrotetracycline; (4aR,12aS)-3,10,11,12a-Tetrahydroxy-6-methyl-1,4,12-trioxo-4a,5-dihydrotetracene-2-carboxamide","R05456 R05462 R09190 R09197","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.14.13.232; 1.14.13.233; 1.14.14.-","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06627  4-Dedimethylamino-4-oxo-anhydrotetracycline","PubChem: 8853; ChEBI: 28408; LIPIDMAPS: LMPK07000007; 3DMET: B05217; NIKKAJI: J2.762.510J","cpd:C06627",20,15,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H16O8N1","C20H14O8N1",397.0797664,398.0875915,396.0719414
"cpd:C06628","4-Hydroxy-6-methylpretetramide;","C20H15NO7","4-Hydroxy-6-methylpretetramide; 1,3,4,10,11,12-Hexahydroxy-6-methyltetracene-2-carboxamide","R05462 R05463","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.14.13.232; 1.14.13.233","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,"PubChem: 8854; ChEBI: 28464; 3DMET: B01003; NIKKAJI: J147.317D","cpd:C06628",20,15,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H16O7N1","C20H14O7N1",381.0848518,382.0926769,380.0770268
"cpd:C06629","6-Methylpretetramide;","C20H15NO6","6-Methylpretetramide; 1,3,10,11,12-Pentahydroxy-6-methyltetracene-2-carboxamide","R05463 R09189 R09190","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.14.13.232; 1.14.13.233; 2.1.1.-","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,"PubChem: 8855; ChEBI: 27879; 3DMET: B01004; NIKKAJI: J2.622.010F","cpd:C06629",20,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H16O6N1","C20H14O6N1",365.0899372,366.0977622,364.0821122
"cpd:C06654","4-Amino-anhydrotetracycline;","C20H18N2O7","4-Amino-anhydrotetracycline; 4-Amino-ATC; 4-Dedimethyl-6-dehydro-anhydrotetracycline; 4-Amino-4-de(dimethylamino)anhydrotetracycline","R09191 R09197 R11520","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","2.1.1.335","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06654  4-Dedimethyl-6-dehydro-anhydrotetracycline","PubChem: 8879; ChEBI: 28461; LIPIDMAPS: LMPK07000008; 3DMET: B05221; NIKKAJI: J2.763.320J","cpd:C06654",20,18,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H19O7N2","C20H17O7N2",398.1114009,399.119226,397.1035759
"cpd:C18295","Pretetramid;","C19H13NO6","Pretetramid; Pretetramide","R09189 R09196","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","2.1.1.-","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,"PubChem: 103061477; ChEBI: 81646","cpd:C18295",19,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H14O6N1","C19H12O6N1",351.0742871,352.0821122,350.0664621
"cpd:C18296","5a,11a-Dehydrooxytetracycline","C22H22N2O9","5a,11a-Dehydrooxytetracycline","R09192 R09198","Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics","1.3.98.4; 1.14.13.234","Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline",NA,"PubChem: 103061478; ChEBI: 134368","cpd:C18296",22,22,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H23O9N2","C22H21O9N2",458.1325303,459.1403553,457.1247053
"cpd:C21391","11a-Hydroxytetracycline","C22H24N2O9","11a-Hydroxytetracycline","R11449","Tetracycline biosynthesis; Biosynthesis of antibiotics","1.14.13.231",NA,NA,"PubChem: 328082934","cpd:C06624; cpd:C13055; cpd:C21391",22,24,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H25O9N2","C22H23O9N2",460.1481804,461.1560054,459.1403553
"cpd:C21438","11a-Hydroxyoxytetracycline","C22H24N2O10","11a-Hydroxyoxytetracycline","R11525","Tetracycline biosynthesis; Biosynthesis of antibiotics","1.14.13.231",NA,NA,"PubChem: 329728061","cpd:C21438",22,24,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C22H25O10N2","C22H23O10N2",476.143095,477.15092,475.1352699
"cpd:C21439","11a-Hydroxy-7-chlortetracycline","C22H23ClN2O9","11a-Hydroxy-7-chlortetracycline","R11526","Tetracycline biosynthesis; Biosynthesis of antibiotics","1.14.13.231",NA,NA,"PubChem: 329728062","cpd:C21439",22,23,9,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"C22H24O9N2Cl1","C22H22O9N2Cl1",494.109208,495.117033,493.101383
"cpd:C00961","Sterigmatocystin","C18H12O6","Sterigmatocystin","R03111 R03112","Aflatoxin biosynthesis","2.1.1.109; 2.1.1.110",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C00961  Sterigmatocystin; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00961  Sterigmatocystin; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Others;     C00961  Sterigmatocystin","CAS: 10048-13-2; PubChem: 4212; ChEBI: 18227; ChEMBL: CHEMBL524291; LIPIDMAPS: LMPK10000001; KNApSAcK: C00000563; 3DMET: B01360; NIKKAJI: J9.276B","cpd:C00961",18,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H13O6","C18H11O6",324.0633881,325.0712131,323.0555631
"cpd:C03683","6-Demethylsterigmatocystin","C17H10O6","6-Demethylsterigmatocystin","R03112 R10481","Aflatoxin biosynthesis","2.1.1.109",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03683  6-Demethylsterigmatocystin","PubChem: 6458; ChEBI: 18236; LIPIDMAPS: LMPK10000002; 3DMET: B00622; NIKKAJI: J75.542G","cpd:C03683",17,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H11O6","C17H9O6",310.047738,311.0555631,309.039913
"cpd:C03686","O-Methylsterigmatocystin;","C19H14O6","O-Methylsterigmatocystin; 8-O-Methylsterigmatocystin","R03111 R10319 R10483","Aflatoxin biosynthesis","1.14.13.175; 2.1.1.110",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03686  7-O-Methylsterigmatocystin","CAS: 17878-69-2; PubChem: 6461; ChEBI: 18171; LIPIDMAPS: LMPK10000003; KNApSAcK: C00023634; 3DMET: B00623; NIKKAJI: J86.123E","cpd:C03686; cpd:C12402; cpd:C18294; cpd:C19979",19,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H15O6","C19H13O6",338.0790382,339.0868632,337.0712131
"cpd:C03944","Dihydro-O-methylsterigmatocystin;","C19H16O6","Dihydro-O-methylsterigmatocystin; DHOMST; Dihydromethylsterigmatocystin; 8-O-Methyldihydrosterigmatocystin","R10307 R10320 R10482","Aflatoxin biosynthesis","1.14.13.175; 2.1.1.110",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03944  Dihydromethylsterigmatocystin","PubChem: 6668; ChEBI: 4572; LIPIDMAPS: LMPK10000004; 3DMET: B01703; NIKKAJI: J2.744.788K","cpd:C03944; cpd:C10090; cpd:C17473",19,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H17O6","C19H15O6",340.0946882,341.1025133,339.0868632
"cpd:C06800","Aflatoxin B1","C17H12O6","Aflatoxin B1","R09404 R09405 R09407 R09408 R10319","Aflatoxin biosynthesis; Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis","1.14.13.175; 1.14.13.-; 1.14.14.1",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C06800  Aflatoxin B1; Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06800  Aflatoxin B1; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C06800  Aflatoxin B1","CAS: 1162-65-8; PubChem: 9019; ChEBI: 2504; LIPIDMAPS: LMPK10000006; KNApSAcK: C00000546; 3DMET: B05231; NIKKAJI: J5.139J","cpd:C02007; cpd:C06800; cpd:C10201; cpd:C20444",17,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H13O6","C17H11O6",312.0633881,313.0712131,311.0555631
"cpd:C16753","Aflatoxin B2","C17H14O6","Aflatoxin B2","R10320","Aflatoxin biosynthesis","1.14.13.175",NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16753  Aflatoxin B2; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16753  Aflatoxin B2","CAS: 7220-81-7; PubChem: 96023277; ChEBI: 48209; KNApSAcK: C00023617; NIKKAJI: J37.504G","cpd:C10407; cpd:C10471; cpd:C10516; cpd:C15100; cpd:C16418; cpd:C16753; cpd:C17784; cpd:C17785; cpd:C19584",17,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H15O6","C17H13O6",314.0790382,315.0868632,313.0712131
"cpd:C16754","Aflatoxin G2","C17H14O7","Aflatoxin G2","R10482","Aflatoxin biosynthesis",NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16754  Aflatoxin G2; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16754  Aflatoxin G2","CAS: 7241-98-7; PubChem: 96023278; ChEBI: 80705; KNApSAcK: C00023619; NIKKAJI: J9.341F","cpd:C01265; cpd:C03036; cpd:C03040; cpd:C10033; cpd:C10193; cpd:C10424; cpd:C12478; cpd:C13702; cpd:C16754; cpd:C17670",17,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H15O7","C17H13O7",330.0739528,331.0817778,329.0661278
"cpd:C16755","Aflatoxin G1","C17H12O7","Aflatoxin G1","R10483","Aflatoxin biosynthesis",NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16755  Aflatoxin G1; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16755  Aflatoxin G1","CAS: 1165-39-5; PubChem: 96023279; ChEBI: 80706; KNApSAcK: C00023618; NIKKAJI: J9.339D","cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595",17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H13O7","C17H11O7",328.0583027,329.0661278,327.0504777
"cpd:C20444","Dihydrodemethylsterigmatocystin;","C17H12O6","Dihydrodemethylsterigmatocystin; DHDMST","R10403 R10480","Aflatoxin biosynthesis","2.1.1.109",NA,NA,"PubChem: 163312181","cpd:C02007; cpd:C06800; cpd:C10201; cpd:C20444",17,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C17H13O6","C17H11O6",312.0633881,313.0712131,311.0555631
"cpd:C20445","Dihydrosterigmatocystin;","C18H14O6","Dihydrosterigmatocystin; DHST","R10307 R10403","Aflatoxin biosynthesis","2.1.1.109; 2.1.1.110",NA,NA,"PubChem: 163312182","cpd:C10074; cpd:C17471; cpd:C20445",18,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H15O6","C18H13O6",326.0790382,327.0868632,325.0712131
"cpd:C20452","Norsolorinic acid;","C20H18O7","Norsolorinic acid; Norsolorinate; 2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone","R10224 R10309","Aflatoxin biosynthesis","1.1.1.349; 1.13.12.20",NA,NA,"CAS: 10254-99-6; PubChem: 163312189","cpd:C06654; cpd:C10887; cpd:C20452",20,18,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H19O7","C20H17O7",370.1052529,371.1130779,369.0974279
"cpd:C20453","Norsolorinic acid anthrone;","C20H20O6","Norsolorinic acid anthrone; Noranthrone; 2-Hexanoyl-1,3,6,8-tetrahydroxyanthracen-9(10H)-one","R10224 R10239","Aflatoxin biosynthesis","1.13.12.20; 2.3.1.221",NA,NA,"PubChem: 163312190","cpd:C01590; cpd:C09166; cpd:C10549; cpd:C17855; cpd:C18024; cpd:C20453; cpd:C21191",20,20,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H21O6","C20H19O6",356.1259884,357.1338134,355.1181633
"cpd:C20499","(1'S)-Averantin;","C20H20O7","(1'S)-Averantin; 1,3,6,8-Tetrahydroxy-[(1S)-2-hydroxyhexyl]-9,10-anthraquinone","R10309 R10317 R10318","Aflatoxin biosynthesis","1.1.1.349; 1.14.13.174",NA,NA,"PubChem: 172232248","cpd:C10186; cpd:C10190; cpd:C10883; cpd:C20499",20,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H21O7","C20H19O7",372.120903,373.128728,371.1130779
"cpd:C20500","(1'S,5'S)-5'-Hydroxyaverantin;","C20H20O8","(1'S,5'S)-5'-Hydroxyaverantin; (1'S,5'S)-Hydroxyaverantin","R10310 R10317","Aflatoxin biosynthesis","1.1.1.352; 1.14.13.174",NA,NA,"PubChem: 172232249","cpd:C20500; cpd:C20501",20,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H21O8","C20H19O8",388.1158176,389.1236426,387.1079926
"cpd:C20501","(1'S,5'R)-5'-Hydroxyaverantin;","C20H20O8","(1'S,5'R)-5'-Hydroxyaverantin; (1'S,5'R)-Hydroxyaverantin","R10311 R10318","Aflatoxin biosynthesis","1.1.1.352; 1.14.13.174",NA,NA,"PubChem: 172232250","cpd:C20500; cpd:C20501",20,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H21O8","C20H19O8",388.1158176,389.1236426,387.1079926
"cpd:C20502","5'-Oxoaverantin;","C20H18O8","5'-Oxoaverantin; 1,3,6,8-Tetrahydroxy-2-[(1S)-1-hydroxy-5-oxohexyl]anthracene-9,10-dione","R10310 R10311 R10475","Aflatoxin biosynthesis","1.1.1.352; 4.2.1.142",NA,NA,"PubChem: 172232251","cpd:C03503; cpd:C09922; cpd:C09924; cpd:C10446; cpd:C17958; cpd:C20502; cpd:C20504",20,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H19O8","C20H17O8",386.1001675,387.1079926,385.0923425
"cpd:C20503","1'-Hydroxyversicolorone;","C20H16O8","1'-Hydroxyversicolorone; Hydroxyversicolorone","R09756 R10476 R10477","Aflatoxin biosynthesis","1.1.1.353",NA,NA,"CAS: 111975-78-1; PubChem: 172232252","cpd:C12366; cpd:C18709; cpd:C20503",20,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H17O8","C20H15O8",384.0845175,385.0923425,383.0766924
"cpd:C20504","Versicolorone","C20H18O8","Versicolorone","R09756 R10478","Aflatoxin biosynthesis","1.1.1.353",NA,NA,"PubChem: 172232253","cpd:C03503; cpd:C09922; cpd:C09924; cpd:C10446; cpd:C17958; cpd:C20502; cpd:C20504",20,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H19O8","C20H17O8",386.1001675,387.1079926,385.0923425
"cpd:C20505","Versiconal hemiacetal acetate","C20H16O9","Versiconal hemiacetal acetate","R10399 R10401 R10477","Aflatoxin biosynthesis","1.1.1.353; 3.1.1.94",NA,NA,"PubChem: 172232254","cpd:C12382; cpd:C20505",20,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H17O9","C20H15O9",400.0794321,401.0872571,399.0716071
"cpd:C20506","Versiconol acetate","C20H18O9","Versiconol acetate","R10398 R10399 R10478","Aflatoxin biosynthesis","1.1.1.353; 3.1.1.94",NA,NA,"CAS: 70979-72-5; PubChem: 172232255","cpd:C04719; cpd:C10349; cpd:C20506",20,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H19O9","C20H17O9",402.0950822,403.1029072,401.0872571
"cpd:C20507","Versiconal","C18H14O8","Versiconal","R10400 R10401 R10402","Aflatoxin biosynthesis","1.1.1.353; 3.1.1.94; 4.2.1.143",NA,NA,"PubChem: 172232256","cpd:C20507",18,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H15O8","C18H13O8",358.0688674,359.0766924,357.0610424
"cpd:C20508","Versiconol","C18H16O8","Versiconol","R10398 R10400","Aflatoxin biosynthesis","1.1.1.353; 3.1.1.94",NA,NA,"CAS: 22268-13-9; PubChem: 172232257","cpd:C01850; cpd:C04552; cpd:C08105; cpd:C08539; cpd:C09764; cpd:C09982; cpd:C10031; cpd:C10115; cpd:C10116; cpd:C10191; cpd:C17753; cpd:C17787; cpd:C17957; cpd:C20508",18,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H17O8","C18H15O8",360.0845175,361.0923425,359.0766924
"cpd:C20574","(1'S,5'S)-Averufin","C20H16O7","(1'S,5'S)-Averufin","R10475 R10476","Aflatoxin biosynthesis","4.2.1.142",NA,NA,"PubChem: 172232311","cpd:C10194; cpd:C12401; cpd:C18629; cpd:C20574",20,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H17O7","C20H15O7",368.0896029,369.0974279,367.0817778
"cpd:C20575","Versicolorin B","C18H12O7","Versicolorin B","R10402 R10479 R10480","Aflatoxin biosynthesis","4.2.1.143",NA,NA,"CAS: 4331-22-0; PubChem: 172232312","cpd:C20575",18,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H13O7","C18H11O7",340.0583027,341.0661278,339.0504777
"cpd:C20583","Versicolorin A","C18H10O7","Versicolorin A","R10479 R10481","Aflatoxin biosynthesis",NA,NA,NA,"CAS: 6807-96-1; PubChem: 172232320","cpd:C20583",18,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C18H11O7","C18H9O7",338.0426527,339.0504777,337.0348276
"cpd:C00065","L-Serine;","C3H7NO3","L-Serine; L-2-Amino-3-hydroxypropionic acid; L-3-Hydroxy-alanine; Serine","R00220 R00581 R00582 R00584 R00585 R00586 R00588 R00589; R00590 R00674 R00891 R00945 R01281 R01289 R01290 R01800; R02378 R02563 R02722 R02817 R03662 R03923 R04350 R04942; R06126 R07376 R07377 R07644 R08218 R09099 R10255 R10441; R10880 R10984 R10985 R10986","Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Cyanoamino acid metabolism; Sphingolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Sulfur metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Sphingolipid signaling pathway; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.1.1.276; 1.1.1.387; 1.4.1.7; 2.1.2.1; 2.3.1.30; 2.3.1.50; 2.6.1.45; 2.6.1.51; 2.7.1.80; 2.7.8.4; 2.7.8.8; 2.7.8.29; 2.7.8.38; 2.8.1.4; 3.1.3.3; 3.1.4.13; 3.5.1.61; 4.2.1.20; 4.2.1.22; 4.2.1.50; 4.2.1.122; 4.3.1.17; 4.3.1.19; 5.1.1.10; 5.1.1.18; 6.1.1.11; 6.3.2.14","Serine biosynthesis, glycerate-3P => serine; Cysteine biosynthesis, serine => cysteine; Methionine degradation; Ceramide biosynthesis; Cysteine biosynthesis, homocysteine + serine => cysteine; Formaldehyde assimilation, serine pathway; Photorespiration; Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A; Cycloserine biosynthesis, arginine/serine => cycloserine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00065  Serine (Ser); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00016  L-Serine","CAS: 56-45-1; PubChem: 3365; ChEBI: 17115; ChEMBL: CHEMBL11298; KNApSAcK: C00001393; PDB-CCD: SER; 3DMET: B01145; NIKKAJI: J1.195I","cpd:C00065; cpd:C00716; cpd:C00740",3,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O3N1","C3H6O3N1",105.0425931,106.0504181,104.0347681
"cpd:C00078","L-Tryptophan;","C11H12N2O2","L-Tryptophan; Tryptophan; (S)-alpha-Amino-beta-(3-indolyl)-propionic acid","R00673 R00674 R00675 R00676 R00677 R00678 R00679 R00681; R00682 R00683 R00684 R00685 R01376 R01657 R01814 R02722; R03664 R05317 R07213 R08160 R08547 R09570 R09583 R09638; R10180 R10661 R11119 R11328","Glycine, serine and threonine metabolism; Tryptophan metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Staurosporine biosynthesis; Indole alkaloid biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Serotonergic synapse; Protein digestion and absorption; Mineral absorption; African trypanosomiasis; Central carbon metabolism in cancer","1.3.3.10; 1.4.1.19; 1.4.3.2; 1.4.3.-; 1.13.11.11; 1.13.11.52; 1.13.12.3; 1.13.99.3; 1.14.13.125; 1.14.16.4; 1.14.19.9; 2.1.1.106; 2.5.1.34; 2.5.1.80; 2.6.1.27; 2.6.1.28; 2.6.1.99; 3.5.1.57; 4.1.1.28; 4.1.99.1; 4.2.1.20; 4.2.1.122; 4.3.1.31; 6.1.1.2","Tryptophan biosynthesis, chorismate => tryptophan; Melatonin biosynthesis, tryptophan => serotonin => melatonin; Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate; Glucosinolate biosynthesis, tryptophan => glucobrassicin; Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A; Rebeccamycin biosynthesis, tryptophan => rebeccamycin; Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin; Staurosporine biosynthesis, tryptophan => staurosporine; Violacein biosynthesis, tryptophan => violacein","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00078  Tryptophan (Trp); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06A ANTIDEPRESSANTS;     N06AX Other antidepressants;      N06AX02 Tryptophan;       D00020  Tryptophan (USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Tryptophan;     D00020  Tryptophan (USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00020  L-Tryptophan","CAS: 73-22-3; PubChem: 3378; ChEBI: 16828; ChEMBL: CHEMBL54976; KNApSAcK: C00001396; PDB-CCD: TRP; 3DMET: B01150; NIKKAJI: J9.181B","cpd:C00078; cpd:C00525; cpd:C00806; cpd:C07839; cpd:C10743; cpd:C10968; cpd:C14916",11,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H13O2N2","C11H11O2N2",204.0898776,205.0977027,203.0820526
"cpd:C00097","L-Cysteine;","C3H7NO2S","L-Cysteine; L-2-Amino-3-mercaptopropionic acid","R00782 R00891 R00892 R00893 R00894 R00895 R00896 R00897; R00899 R00900 R00901 R00903 R01001 R01113 R02409 R02508; R02743 R03217 R03260 R03524 R03650 R03923 R04230 R04231; R04859 R04870 R07274 R07360 R07460 R08168 R08608 R08632; R08653 R08659 R08666 R08685 R08848 R09562 R09591 R10409; R10670 R10672 R10736 R11014 R11015 R11524 R11528","Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Penicillin and cephalosporin biosynthesis; Carbapenem biosynthesis; Taurine and hypotaurine metabolism; Cyanoamino acid metabolism; Glutathione metabolism; Thiamine metabolism; Pantothenate and CoA biosynthesis; Sulfur metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Sulfur relay system; Protein digestion and absorption; Central carbon metabolism in cancer","1.8.1.6; 1.8.1.9; 1.8.1.10; 1.8.3.5; 1.8.3.6; 1.8.4.3; 1.8.4.4; 1.13.11.20; 1.14.99.51; 1.14.99.52; 1.14.-.-; 2.3.2.4; 2.5.1.47; 2.5.1.48; 2.5.1.49; 2.5.1.65; 2.6.1.1; 2.6.1.3; 2.8.1.4; 2.8.1.7; 3.4.11.1; 3.4.11.2; 3.4.11.23; 3.4.13.-; 3.4.17.-; 4.2.1.22; 4.4.1.1; 4.4.1.8; 4.4.1.9; 4.4.1.10; 4.4.1.28; 5.1.1.10; 6.1.1.16; 6.3.1.13; 6.3.2.2; 6.3.2.5; 6.3.2.26","Cysteine biosynthesis, serine => cysteine; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00097  Cysteine (Cys); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D00026  L-Cysteine (JP17); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   45 Protein and amino acid based drugs;    D00026  L-Cysteine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Cysteine;     D00026  L-Cysteine (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00026  [003614] L-Cysteine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00026  L-Cysteine","CAS: 52-90-4; PubChem: 3397; ChEBI: 17561; ChEMBL: CHEMBL863; KNApSAcK: C00001351; PDB-CCD: CYS; 3DMET: B01159; NIKKAJI: J9.167G","cpd:C00097; cpd:C00736; cpd:C00793",3,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1S1","C3H6O2N1S1",121.0197496,122.0275747,120.0119246
"cpd:C00101","Tetrahydrofolate;","C19H23N7O6","Tetrahydrofolate; 5,6,7,8-Tetrahydrofolate; Tetrahydrofolic acid; THF; (6S)-Tetrahydrofolate; (6S)-Tetrahydrofolic acid; (6S)-THFA","R00936 R00937 R00939 R00940 R00941 R00942 R00943 R00944; R00945 R00946 R01221 R01225 R01226 R01669 R02287 R02289; R02573 R02729 R02912 R03189 R03704 R03940 R04125 R04242; R04325 R04326 R04560 R06613 R07660 R08701 R09093 R09270; R09271 R10136 R10243 R10333","Glycine, serine and threonine metabolism; One carbon pool by folate; Methane metabolism; Carbon fixation pathways in prokaryotes; Folate biosynthesis; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance","1.4.4.2; 1.5.1.3; 1.5.1.6; 1.8.1.4; 2.1.1.13; 2.1.1.19; 2.1.1.74; 2.1.1.148; 2.1.1.258; 2.1.1.269; 2.1.1.-; 2.1.2.1; 2.1.2.2; 2.1.2.3; 2.1.2.4; 2.1.2.5; 2.1.2.7; 2.1.2.8; 2.1.2.9; 2.1.2.10; 2.1.2.11; 2.1.2.13; 2.3.1.169; 3.4.19.9; 3.5.1.10; 6.3.2.17; 6.3.4.3","Tetrahydrofolate biosynthesis, GTP => THF; C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00101  THF","CAS: 135-16-0; PubChem: 3401; ChEBI: 15635 20506; KNApSAcK: C00007249; PDB-CCD: THG; 3DMET: B04633; NIKKAJI: J184.393A","cpd:C00101",19,23,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H24O6N7","C19H22O6N7",445.1709815,446.1788065,444.1631565
"cpd:C00109","2-Oxobutanoate;","C4H6O3","2-Oxobutanoate; 2-Ketobutyric acid; 2-Oxobutyric acid; 2-Oxobutyrate; 2-Oxobutanoic acid; alpha-Ketobutyric acid; alpha-Ketobutyrate","R00654 R00993 R00994 R00995 R00996 R00997 R00998 R00999; R01000 R01001 R01199 R01283 R04673 R04770 R04930 R05840; R06987 R08637 R08648 R10991 R10992 R10996 R11098","Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Valine, leucine and isoleucine biosynthesis; Propanoate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.27; 1.1.1.85; 1.2.3.-; 1.2.4.4; 1.2.7.1; 2.2.1.6; 2.3.1.54; 2.3.3.6; 2.5.1.48; 2.6.1.42; 2.6.1.44; 3.5.99.7; 3.5.99.10; 4.1.1.3; 4.3.1.19; 4.4.1.1; 4.4.1.2; 4.4.1.11","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, pyruvate => 2-oxobutanoate; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00109  2-Oxobutanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C00109  2-Oxobutanoic acid","CAS: 600-18-0; PubChem: 3409; ChEBI: 16763 30831; ChEMBL: CHEMBL171246; LIPIDMAPS: LMFA01060002; LipidBank: DFA0386; KNApSAcK: C00019675; PDB-CCD: 2KT; 3DMET: B00028; NIKKAJI: J2.726J","cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172",4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3","C4H5O3",102.0316941,103.0395191,101.023869
"cpd:C00114","Choline;","C5H14NO","Choline; Bilineurine","R01021 R01022 R01023 R01025 R01026 R01027 R01028 R01029; R01030 R01310 R02381 R02542 R03075 R05739 R05794 R06871; R07377 R07386 R07409 R08212 R08557 R08558 R10285","Glycine, serine and threonine metabolism; Glycerophospholipid metabolism; Metabolic pathways; ABC transporters; Cholinergic synapse; Bile secretion; Choline metabolism in cancer","1.1.1.1; 1.1.3.17; 1.1.99.1; 1.14.15.7; 2.3.1.6; 2.3.1.91; 2.6.-.-; 2.7.1.32; 2.7.8.24; 2.8.2.6; 3.1.1.7; 3.1.1.8; 3.1.1.49; 3.1.3.75; 3.1.4.2; 3.1.4.4; 3.1.4.41; 3.1.4.46; 3.1.6.6; 4.3.99.4","Phosphatidylcholine (PC) biosynthesis, choline => PC; Betaine biosynthesis, choline => betaine","Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Others;     C00114  Choline; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Choline;     C00114  Choline","CAS: 62-49-7; PubChem: 3414; ChEBI: 15354; ChEMBL: CHEMBL920; KNApSAcK: C00007298; PDB-CCD: CHT; 3DMET: B00031; NIKKAJI: J4.822D","cpd:C00114",5,14,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H15O1N1","C5H13O1N1",104.1075391,105.1153641,103.099714
"cpd:C00143","5,10-Methylenetetrahydrofolate;","C20H23N7O6","5,10-Methylenetetrahydrofolate; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-THF","R00945 R01217 R01218 R01220 R01221 R01224 R01225 R01226; R01669 R01670 R02101 R03704 R04125 R06613 R07168 R09093","Glycine, serine and threonine metabolism; One carbon pool by folate; Methane metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance","1.4.4.2; 1.5.1.5; 1.5.1.15; 1.5.1.20; 1.5.7.1; 1.8.1.4; 2.1.1.45; 2.1.1.54; 2.1.1.74; 2.1.1.148; 2.1.2.1; 2.1.2.7; 2.1.2.8; 2.1.2.10; 2.1.2.11","C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)",NA,"CAS: 3432-99-3; PubChem: 3443; ChEBI: 1989; KNApSAcK: C00007250; PDB-CCD: MEF MHF; 3DMET: B04640; NIKKAJI: J356.347B","cpd:C00143",20,23,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C20H24O6N7","C20H22O6N7",457.1709815,458.1788065,456.1631565
"cpd:C00168","Hydroxypyruvate;","C3H4O4","Hydroxypyruvate; Hydroxypyruvic acid; 3-Hydroxypyruvate; 3-Hydroxypyruvic acid","R00581 R00585 R00588 R01388 R01390 R01392 R01393 R01394","Glycine, serine and threonine metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","1.1.1.26; 1.1.1.29; 1.1.1.79; 1.1.1.81; 1.4.1.7; 2.6.1.45; 2.6.1.51; 4.1.1.40; 5.3.1.22","Formaldehyde assimilation, serine pathway; Photorespiration",NA,"CAS: 1113-60-6; PubChem: 3468; ChEBI: 17180 30841; KNApSAcK: C00007563; PDB-CCD: 3PY; 3DMET: B00049; NIKKAJI: J515.825G","cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146",3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O4","C3H3O4",104.0109586,105.0187836,103.0031336
"cpd:C00188","L-Threonine;","C4H9NO3","L-Threonine; 2-Amino-3-hydroxybutyric acid","R00751 R00996 R01465 R01466 R01467 R03663 R06531 R07247; R08323 R10463 R10888 R10891 R10892","Glycine, serine and threonine metabolism; Monobactam biosynthesis; Valine, leucine and isoleucine biosynthesis; Porphyrin and chlorophyll metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption","1.1.1.103; 2.2.1.8; 2.7.1.177; 2.7.7.87; 3.4.-.-; 4.1.2.5; 4.1.2.48; 4.2.3.1; 4.3.1.19; 5.1.1.6; 6.1.1.3; 6.3.2.-","Threonine biosynthesis, aspartate => homoserine => threonine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00188  Threonine (Thr); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Threonine;     D00041  Threonine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00041  L-Threonine","CAS: 72-19-5; PubChem: 3488; ChEBI: 16857; ChEMBL: CHEMBL291747; KNApSAcK: C00001394; PDB-CCD: THR; 3DMET: B01182; NIKKAJI: J21.883I","cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905",4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O3N1","C4H8O3N1",119.0582432,120.0660682,118.0504181
"cpd:C00213","Sarcosine;","C3H7NO2","Sarcosine; N-Methylglycine","R00367 R00610 R00611 R01563 R01564 R01565 R01566 R05862; R07227 R07243 R10061","Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways","1.4.3.19; 1.5.3.1; 1.5.3.10; 1.5.8.3; 1.5.8.4; 1.21.4.3; 2.1.1.20; 2.1.1.156; 2.1.1.157; 2.1.1.162; 3.5.1.59; 3.5.3.3",NA,NA,"CAS: 107-97-1; PubChem: 3513; ChEBI: 15611; ChEMBL: CHEMBL304383; PDB-CCD: SAR; 3DMET: B01190; NIKKAJI: J5.067I","cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488",3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1","C3H6O2N1",89.04767847,90.0555035,88.03985344
"cpd:C00263","L-Homoserine;","C4H9NO3","L-Homoserine; 2-Amino-4-hydroxybutyric acid","R00175 R01771 R01773 R01775 R01776 R01777","Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Lysine biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.1.1.3; 2.3.1.31; 2.3.1.46; 2.7.1.39; 3.3.1.2","Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00263  L-Homoserine","CAS: 672-15-1; PubChem: 3561; ChEBI: 15699; ChEMBL: CHEMBL11722; KNApSAcK: C00001366; PDB-CCD: HSE; 3DMET: B01202; NIKKAJI: J9.199E","cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905",4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O3N1","C4H8O3N1",119.0582432,120.0660682,118.0504181
"cpd:C00300","Creatine;","C4H9N3O2","Creatine; alpha-Methylguanidino acetic acid; Methylglycocyamine","R01566 R01881 R01882 R01883 R01884","Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways","2.1.1.2; 2.7.3.2; 3.5.2.10; 3.5.3.3; 3.9.1.1","Creatine pathway",NA,"CAS: 57-00-1; PubChem: 3594; ChEBI: 16919; ChEMBL: CHEMBL283800; PDB-CCD: CRN; 3DMET: B00084; NIKKAJI: J9.321A","cpd:C00300; cpd:C03065",4,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N3","C4H8O2N3",131.0694765,132.0773016,130.0616515
"cpd:C00430","5-Aminolevulinate;","C5H9NO3","5-Aminolevulinate; 5-Amino-4-oxopentanoate; 5-Amino-4-oxovaleric acid","R00036 R00830 R02271 R02272","Glycine, serine and threonine metabolism; Porphyrin and chlorophyll metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; ABC transporters","2.3.1.37; 2.6.1.43; 4.2.1.24; 5.4.3.8","Heme biosynthesis, glutamate => protoheme/siroheme","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XD Sensitizers used in photodynamic/radiation therapy;      L01XD04 Aminolevulinic acid;       D07567  Aminolevulinic acid","CAS: 106-60-5; PubChem: 3719; ChEBI: 17549; ChEMBL: CHEMBL601; LIPIDMAPS: LMFA01100055; KNApSAcK: C00007378; 3DMET: B00110; NIKKAJI: J38.537I","cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706",5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H10O3N1","C5H8O3N1",131.0582432,132.0660682,130.0504181
"cpd:C00441","L-Aspartate 4-semialdehyde;","C4H7NO3","L-Aspartate 4-semialdehyde; Aspartate beta-semialdehyde; L-Aspartic 4-semialdehyde","R01773 R01775 R02291 R02293 R06977 R08568 R08650 R09079; R09080 R09805 R10147 R10673","Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Arginine and proline metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.3; 1.2.1.11; 1.2.1.-; 1.5.1.43; 2.2.1.10; 2.6.1.46; 2.6.1.76; 4.1.2.56; 4.3.3.7","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Ectoine biosynthesis, aspartate => ectoine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"PubChem: 3730; ChEBI: 13086 18051; ChEMBL: CHEMBL404100; KNApSAcK: C00007469; 3DMET: B00117; NIKKAJI: J457.019G","cpd:C00441; cpd:C03214; cpd:C03508; cpd:C20250",4,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H8O3N1","C4H6O3N1",117.0425931,118.0504181,116.0347681
"cpd:C00546","Methylglyoxal;","C3H4O2","Methylglyoxal; Pyruvaldehyde; Pyruvic aldehyde; 2-Ketopropionaldehyde; 2-Oxopropanal","R00203 R00205 R01016 R02260 R02527 R02528 R02529 R02530; R02531 R07183 R09796 R10049 R10050 R10715 R10718 R11352","Glycine, serine and threonine metabolism; Pyruvate metabolism; Propanoate metabolism; Microbial metabolism in diverse environments","1.1.1.6; 1.1.1.21; 1.1.1.78; 1.1.1.79; 1.1.1.283; 1.1.1.-; 1.2.1.22; 1.2.1.23; 1.2.1.49; 1.2.3.15; 1.4.3.4; 1.4.3.21; 1.13.11.50; 2.2.1.11; 4.2.1.130; 4.2.3.3; 4.4.1.5",NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00546  Methylglyoxal","CAS: 78-98-8; PubChem: 3827; ChEBI: 17158; ChEMBL: CHEMBL170721; KNApSAcK: C00007562; 3DMET: B00127; NIKKAJI: J1.489C","cpd:C00511; cpd:C00546; cpd:C01271; cpd:C03129; cpd:C05146; cpd:C05197; cpd:C08734; cpd:C18600; cpd:C19246; cpd:C19297; cpd:C19440; cpd:C19501; cpd:C21430",3,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O2","C3H3O2",72.02112937,73.0289544,71.01330434
"cpd:C00576","Betaine aldehyde","C5H12NO","Betaine aldehyde","R01022 R01025 R02565 R02566 R07409 R08211 R08557 R08558","Glycine, serine and threonine metabolism; Metabolic pathways","1.1.1.1; 1.1.3.17; 1.1.99.1; 1.2.1.8; 1.14.15.7","Betaine biosynthesis, choline => betaine",NA,"CAS: 7418-61-3; PubChem: 3855; ChEBI: 15710; ChEMBL: CHEMBL1231491; PDB-CCD: BTL; 3DMET: B00136; NIKKAJI: J413.989E","cpd:C00576",5,12,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H13O1N1","C5H11O1N1",102.091889,103.099714,101.084064
"cpd:C00581","Guanidinoacetate;","C3H7N3O2","Guanidinoacetate; Guanidinoacetic acid; Glycocyamine; N-Amidinoglycine; Guanidoacetic acid","R00565 R00775 R01883 R02575","Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways","2.1.1.2; 2.1.4.1; 2.7.3.1; 3.5.3.2","Creatine pathway",NA,"CAS: 352-97-6; PubChem: 3860; ChEBI: 16344; ChEMBL: CHEMBL281593; PDB-CCD: NMG; 3DMET: B00139; NIKKAJI: J4.504G","cpd:C00581; cpd:C19178",3,7,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N3","C3H6O2N3",117.0538265,118.0616515,116.0460014
"cpd:C00719","Betaine;","C5H11NO2","Betaine; Trimethylaminoacetate; Glycine betaine; N,N,N-Trimethylglycine; Trimethylammonioacetate","R02565 R02566 R02821 R07228 R07244 R08211 R08212 R10061; R10062","Glycine, serine and threonine metabolism; Metabolic pathways; ABC transporters","1.1.3.17; 1.2.1.8; 1.21.4.4; 2.1.1.5; 2.1.1.157; 2.1.1.161; 2.1.1.162","Betaine biosynthesis, choline => betaine","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA06 Betaine;       D07523  Betaine (JAN); USP drug classification [BR:br08302];  Enzyme Replacement/Modifiers;   Betaine;    D07523  Betaine (JAN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D07523  Betaine (JAN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Betaine;     D07523  Betaine (JAN); New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D07523; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D07523; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D07523; Major components of natural products [BR:br08323];  Crude drugs;   Lycium fruit;    C00719  Betaine","CAS: 107-43-7; PubChem: 3985; ChEBI: 17750; ChEMBL: CHEMBL95889; KNApSAcK: C00007291; PDB-CCD: BET; 3DMET: B01318; NIKKAJI: J5.058J","cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436",5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O2N1","C5H10O2N1",117.0789786,118.0868036,116.0711536
"cpd:C00740","D-Serine","C3H7NO3","D-Serine","R00221 R00589 R02853 R02854 R09595","Glycine, serine and threonine metabolism; Metabolic pathways; Vancomycin resistance; Taste transduction","3.1.3.3; 4.3.1.18; 5.1.1.10; 5.1.1.18; 6.3.2.35",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00740  D-Serine","CAS: 312-84-5; PubChem: 4003; ChEBI: 16523; ChEMBL: CHEMBL285123; PDB-CCD: DSN; 3DMET: B00163; NIKKAJI: J1.196G","cpd:C00065; cpd:C00716; cpd:C00740",3,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O3N1","C3H6O3N1",105.0425931,106.0504181,104.0347681
"cpd:C00986","1,3-Diaminopropane;","C3H10N2","1,3-Diaminopropane; Trimethylenediamine; 1,3-Propanediamine; Propane-1,3-diamine","R01914 R01915 R01919 R03139 R03271 R05329 R07479 R07650; R09075 R09080","Glycine, serine and threonine metabolism; Arginine and proline metabolism; beta-Alanine metabolism; Microbial metabolism in diverse environments","1.4.3.21; 1.4.3.22; 1.5.1.43; 1.5.3.14; 1.5.3.15; 1.5.99.6; 2.5.1.23; 2.5.1.44; 2.5.1.45; 2.5.1.46; 4.1.1.86",NA,NA,"CAS: 109-76-2; PubChem: 4233; ChEBI: 15725; ChEMBL: CHEMBL174324; KNApSAcK: C00007404; PDB-CCD: 13D; 3DMET: B00214; NIKKAJI: J1.969K","cpd:C00986",3,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H11N2","C3H9N2",74.08439833,75.09222336,73.0765733
"cpd:C01005","O-Phospho-L-serine;","C3H8NO6P","O-Phospho-L-serine; L-O-Phosphoserine; 3-Phosphoserine; Dexfosfoserine","R00582 R00584 R04173 R07274 R08576 R09530 R10610","Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Methane metabolism; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","2.5.1.65; 2.5.1.76; 2.5.1.113; 2.6.1.52; 2.7.1.80; 3.1.3.3; 6.1.1.27","Serine biosynthesis, glycerate-3P => serine",NA,"CAS: 407-41-0; PubChem: 4251; ChEBI: 15811; ChEMBL: CHEMBL284377; KNApSAcK: C00007287; PDB-CCD: SEP; 3DMET: B01366; NIKKAJI: J136.545B","cpd:C01005; cpd:C02532",3,8,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H9O6N1P1","C3H7O6N1P1",185.008924,186.016749,184.0010989
"cpd:C01026","N,N-Dimethylglycine;","C4H9NO2","N,N-Dimethylglycine; Dimethylglycine","R01564 R01565 R02821 R07243 R07244 R10060","Glycine, serine and threonine metabolism; Metabolic pathways","1.5.3.10; 1.5.8.4; 2.1.1.5; 2.1.1.156; 2.1.1.157; 2.1.1.161; 2.1.1.162",NA,NA,"CAS: 1118-68-9; PubChem: 4271; ChEBI: 17724; PDB-CCD: DMG; 3DMET: B00224; NIKKAJI: J135.420E","cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514",4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1","C4H8O2N1",103.0633285,104.0711536,102.0555035
"cpd:C01102","O-Phospho-L-homoserine","C4H10NO6P","O-Phospho-L-homoserine","R01466 R01771","Glycine, serine and threonine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of amino acids","2.7.1.39; 4.2.3.1","Threonine biosynthesis, aspartate => homoserine => threonine",NA,"PubChem: 4336; ChEBI: 15961; KNApSAcK: C00007385; 3DMET: B01380; NIKKAJI: J2.731.281K","cpd:C01102; cpd:C05702; cpd:C12147; cpd:C12215",4,10,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H11O6N1P1","C4H9O6N1P1",199.024574,200.0323991,198.016749
"cpd:C01726","D-Lombricine","C6H15N4O6P","D-Lombricine","R02854 R03691","Glycine, serine and threonine metabolism","2.7.3.5",NA,NA,"PubChem: 4863; ChEBI: 32969; 3DMET: B01489; NIKKAJI: J2.733.996D","cpd:C01726; cpd:C14177",6,15,6,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H16O6N4P1","C6H14O6N4P1",270.0729212,271.0807462,269.0650962
"cpd:C01888","Aminoacetone;","C3H7NO","Aminoacetone; 1-Amino-2-propanone","R02529 R03758 R03759 R10852","Glycine, serine and threonine metabolism","1.1.1.75; 1.1.1.381; 1.4.3.4; 1.4.3.21",NA,NA,"CAS: 298-08-8; PubChem: 5001; ChEBI: 17906; 3DMET: B00367; NIKKAJI: J38.126H","cpd:C01888; cpd:C01995; cpd:C03134; cpd:C05665",3,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O1N1","C3H6O1N1",73.05276385,74.06058888,72.04493882
"cpd:C02291","L-Cystathionine","C7H14N2O4S","L-Cystathionine","R01001 R01286 R01290 R03217 R03260 R08632 R10305","Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","2.5.1.48; 2.5.1.134; 4.2.1.22; 4.4.1.1; 4.4.1.8","Methionine biosynthesis, apartate => homoserine => methionine; Methionine degradation; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine",NA,"CAS: 56-88-2; PubChem: 5347; ChEBI: 17482; KNApSAcK: C00007498; 3DMET: B01559; NIKKAJI: J4.574H","cpd:C00542; cpd:C02291; cpd:C18646; cpd:C18906",7,14,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C7H15O4N2S1","C7H13O4N2S1",222.0674281,223.0752531,221.0596031
"cpd:C02855","N-Phospho-D-lombricine","C6H16N4O9P2","N-Phospho-D-lombricine","R03691","Glycine, serine and threonine metabolism","2.7.3.5",NA,NA,"PubChem: 5793; ChEBI: 35265; 3DMET: B01606; NIKKAJI: J2.740.230E","cpd:C02855; cpd:C14178",6,16,9,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H17O9N4P2","C6H15O9N4P2",350.0392521,351.0470771,349.0314271
"cpd:C03082","4-Phospho-L-aspartate;","C4H8NO7P","4-Phospho-L-aspartate; L-4-Aspartyl phosphate","R00480 R02291","Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.2.1.11; 2.7.2.4","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Ectoine biosynthesis, aspartate => ectoine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"CAS: 22138-53-0; PubChem: 5980; ChEBI: 15836; KNApSAcK: C00007471; PDB-CCD: PHD; 3DMET: B01629; NIKKAJI: J37.493H","cpd:C03082; cpd:C07335",4,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O7N1P1","C4H7O7N1P1",213.0038386,214.0116636,211.9960136
"cpd:C03194","(R)-1-Aminopropan-2-ol;","C3H9NO","(R)-1-Aminopropan-2-ol; (R)-1-Amino-2-propanol","R03759 R05226 R07302","Glycine, serine and threonine metabolism; Porphyrin and chlorophyll metabolism","1.1.1.75; 3.5.1.90; 6.3.1.10",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C03194  Aminopropanol","CAS: 2799-16-8; PubChem: 6071; ChEBI: 15675; PDB-CCD: FOP; 3DMET: B00555; NIKKAJI: J9.255J","cpd:C01104; cpd:C03194; cpd:C05771",3,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H10O1N1","C3H8O1N1",75.06841391,76.07623895,74.06058888
"cpd:C03232","3-Phosphonooxypyruvate;","C3H5O7P","3-Phosphonooxypyruvate; 3-Phosphonooxypyruvic acid; 3-Phosphohydroxypyruvate; 3-Phosphohydroxypyruvic acid","R01513 R04173","Glycine, serine and threonine metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids","1.1.1.95; 2.6.1.52","Serine biosynthesis, glycerate-3P => serine",NA,"PubChem: 6103; ChEBI: 18110 30933; KNApSAcK: C00019657; PDB-CCD: HPV; 3DMET: B00565; NIKKAJI: J2.180.747H","cpd:C03232",3,5,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6O7P1","C3H4O7P1",183.9772895,184.9851145,182.9694645
"cpd:C03283","L-2,4-Diaminobutanoate;","C4H10N2O2","L-2,4-Diaminobutanoate; alpha,gamma-Diaminobutyrate; L-2,4-Diaminobutyrate","R02293 R06977 R06978 R07650 R09801","Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.3.1.178; 2.6.1.46; 2.6.1.76; 3.5.1.-; 4.1.1.86","Ectoine biosynthesis, aspartate => ectoine",NA,"CAS: 1758-80-1; PubChem: 6142; ChEBI: 48950; ChEMBL: CHEMBL321357; KNApSAcK: C00001353 C00034868; PDB-CCD: DAB; 3DMET: B00574; NIKKAJI: J80.310C","cpd:C03283; cpd:C08291",4,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H11O2N2","C4H9O2N2",118.0742276,119.0820526,117.0664025
"cpd:C03508","L-2-Amino-3-oxobutanoic acid;","C4H7NO3","L-2-Amino-3-oxobutanoic acid; L-2-Amino-3-oxobutanoate; L-2-Amino-acetoacetate; (S)-2-Amino-3-oxobutanoic acid","R00371 R01465 R03758 R10851","Glycine, serine and threonine metabolism","1.1.1.103; 1.1.1.381; 2.3.1.29",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C03508  L-2-Amino-3-oxobutanoic acid","PubChem: 6318; ChEBI: 16944 40673; LIPIDMAPS: LMFA01060172; PDB-CCD: AKB; 3DMET: B00594; NIKKAJI: J2.359.951A","cpd:C00441; cpd:C03214; cpd:C03508; cpd:C20250",4,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H8O3N1","C4H6O3N1",117.0425931,118.0504181,116.0347681
"cpd:C05519","L-Allothreonine;","C4H9NO3","L-Allothreonine; L-allo-Threonine","R06171 R10851 R10852","Glycine, serine and threonine metabolism; Metabolic pathways","1.1.1.381; 4.1.2.48; 4.1.2.49",NA,NA,"CAS: 28954-12-3; PubChem: 7864; ChEBI: 28718; ChEMBL: CHEMBL1734340 CHEMBL59238; PDB-CCD: ALO; 3DMET: B01870; NIKKAJI: J1.327G","cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905",4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O3N1","C4H8O3N1",119.0582432,120.0660682,118.0504181
"cpd:C06231","Ectoine;","C6H10N2O2","Ectoine; L-Ectoine","R06979 R08050 R09800","Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.14.11.-; 4.2.1.108","Ectoine biosynthesis, aspartate => ectoine",NA,"CAS: 96702-03-3; PubChem: 8474; ChEBI: 27592; PDB-CCD: 4CS; 3DMET: B05179; NIKKAJI: J648.947H","cpd:C03023; cpd:C05205; cpd:C06231; cpd:C21377",6,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O2N2","C6H9O2N2",142.0742276,143.0820526,141.0664025
"cpd:C06442","N(gamma)-Acetyldiaminobutyrate;","C6H12N2O3","N(gamma)-Acetyldiaminobutyrate; N4-Acetyl-L-2,4-diaminobutyrate; N4-Acetyl-L-2,4-diaminobutanoate","R06978 R06979","Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments","2.3.1.178; 4.2.1.108","Ectoine biosynthesis, aspartate => ectoine",NA,"PubChem: 8676; ChEBI: 7351; 3DMET: B02029; NIKKAJI: J80.071F","cpd:C00993; cpd:C03153; cpd:C03922; cpd:C06442; cpd:C10996; cpd:C19929",6,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O3N2","C6H11O3N2",160.0847923,161.0926173,159.0769672
"cpd:C16432","5-Hydroxyectoine","C6H10N2O3","5-Hydroxyectoine","R08050","Glycine, serine and threonine metabolism; Microbial metabolism in diverse environments","1.14.11.-",NA,NA,"PubChem: 47205729; ChEBI: 49432; PDB-CCD: 6CS; NIKKAJI: J2.662.228J","cpd:C01109; cpd:C03625; cpd:C03895; cpd:C15653; cpd:C16432; cpd:C21378",6,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O3N2","C6H9O3N2",158.0691422,159.0769672,157.0613172
"cpd:C19929","N-alpha-Acetyl-L-2,4-diaminobutyrate","C6H12N2O3","N-alpha-Acetyl-L-2,4-diaminobutyrate","R09800 R09801","Glycine, serine and threonine metabolism; Metabolic pathways","3.5.1.-",NA,NA,"PubChem: 135626395","cpd:C00993; cpd:C03153; cpd:C03922; cpd:C06442; cpd:C10996; cpd:C19929",6,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O3N2","C6H11O3N2",160.0847923,161.0926173,159.0769672
"cpd:C00019","S-Adenosyl-L-methionine;","C15H22N6O5S","S-Adenosyl-L-methionine; S-Adenosylmethionine; AdoMet; SAM","R00075 R00175 R00177 R00178 R00179 R00180 R00367 R00380; R00594 R00595 R00596 R00597 R00598 R00599 R00600 R00601; R00649 R00650 R00683 R00827 R00984 R01078 R01153 R01159; R01169 R01188 R01189 R01190 R01235 R01239 R01269 R01320; R01349 R01721 R01883 R01942 R01972 R01973 R02037 R02056; R02144 R02155 R02157 R02174 R02175 R02379 R02384 R02533; R02534 R02572 R02623 R02627 R02667 R02671 R02808 R02858; R02859 R02862 R02882 R02910 R02917 R02920 R02931 R02961; R02982 R03003 R03019 R03072 R03111 R03112 R03130 R03194; R03229 R03231 R03304 R03366 R03410 R03411 R03424 R03456; R03472 R03554 R03571 R03587 R03623 R03633 R03701 R03721; R03725 R03726 R03731 R03746 R03788 R03805 R03832 R03835; R03875 R03922 R03934 R03938 R03943 R03948 R03950 R03955; R04013 R04033 R04062 R04077 R04145 R04169 R04190 R04237; R04301 R04332 R04396 R04398 R04421 R04427 R04436 R04481; R04496 R04505 R04691 R04692 R04705 R04707 R04710 R04711; R04713 R04714 R04715 R04716 R04717 R04718 R04719 R04762; R04763 R04764 R04772 R04858 R04866 R04867 R04881 R04887; R04905 R04931 R04981 R04983 R04988 R04990 R04993 R04994; R05035 R05122 R05123 R05149 R05162 R05179 R05180 R05181; R05182 R05211 R05212 R05213 R05214 R05216 R05219 R05303; R05323 R05520 R05532 R05614 R05673 R05674 R05676 R05754; R05755 R05756 R05757 R05759 R05760 R05763 R05764 R05776; R05808 R05809 R05810 R05811 R05813 R05834 R05881 R05885; R06268 R06269 R06270 R06427 R06439 R06456 R06476 R06477; R06478 R06479 R06564 R06574 R06575 R06576 R06577 R06578; R06627 R06675 R06680 R06687 R06693 R06703 R06713 R06715; R06719 R06767 R06771 R06774 R06778 R06794 R06807 R06815; R06816 R06824 R06859 R06868 R06869 R06895 R06998 R07232; R07233 R07234 R07235 R07236 R07237 R07238 R07239 R07240; R07241 R07242 R07243 R07244 R07251 R07330 R07375 R07481; R07501 R07504 R07521 R07524 R07527 R07529 R07533 R07535; R07722 R07724 R07750 R07767 R07768 R07773 R07774 R07775; R07917 R07919 R07920 R07921 R07922 R08147 R08151 R08236; R08239 R08246 R08410 R08437 R08441 R08446 R08449 R08455; R08465 R08467 R08468 R08469 R08479 R08537 R08538 R08547; R08583 R08588 R08769 R08771 R08774 R08781 R08787 R08788; R08789 R08791 R08794 R08803 R08804 R08862 R08873 R08875; R08893 R08932 R08933 R08939 R08940 R08973 R08987 R09063; R09072 R09073 R09177 R09189 R09191 R09200 R09369 R09370; R09371 R09394 R09396 R09523 R09543 R09569 R09611 R09612; R09613 R09637 R09639 R09678 R09679 R09736 R09737 R09791; R09792 R09821 R09822 R09823 R09856 R09870 R09871 R09872; R09939 R09940 R10060 R10061 R10062 R10166 R10167 R10168; R10169 R10195 R10196 R10197 R10198 R10199 R10204 R10246; R10250 R10251 R10252 R10306 R10307 R10403 R10404 R10431; R10447 R10448 R10449 R10450 R10451 R10452 R10454 R10455; R10472 R10491 R10492 R10495 R10497 R10498 R10523 R10524; R10526 R10529 R10552 R10586 R10587 R10588 R10605 R10606; R10611 R10645 R10646 R10647 R10649 R10650 R10651 R10652; R10653 R10654 R10658 R10667 R10680 R10709 R10710 R10716; R10806 R10812 R10824 R10881 R10956 R10957 R10958 R10959; R10962 R10963 R10964 R11020 R11041 R11045 R11112 R11165; R11191 R11192 R11193 R11216 R11217 R11218 R11219 R11220; R11221 R11230 R11274 R11275 R11292 R11293 R11294 R11371; R11413 R11416 R11445 R11452 R11453 R11469 R11476 R11484; R11494 R11507 R11508 R11509 R11520 R11521 R11533 R11534; R11545 R11546","Monobactam biosynthesis; Cysteine and methionine metabolism; Arginine and proline metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids; Sulfur relay system","1.1.99.38; 1.3.98.3; 1.16.1.8; 1.17.98.2; 1.21.98.1; 1.21.98.3; 1.97.1.4; 2.1.1.1; 2.1.1.2; 2.1.1.4; 2.1.1.6; 2.1.1.7; 2.1.1.8; 2.1.1.9; 2.1.1.10; 2.1.1.11; 2.1.1.12; 2.1.1.15; 2.1.1.16; 2.1.1.17; 2.1.1.18; 2.1.1.20; 2.1.1.22; 2.1.1.25; 2.1.1.26; 2.1.1.27; 2.1.1.28; 2.1.1.33; 2.1.1.34; 2.1.1.35; 2.1.1.37; 2.1.1.38; 2.1.1.39; 2.1.1.40; 2.1.1.41; 2.1.1.42; 2.1.1.43; 2.1.1.44; 2.1.1.47; 2.1.1.49; 2.1.1.50; 2.1.1.53; 2.1.1.55; 2.1.1.56; 2.1.1.57; 2.1.1.59; 2.1.1.60; 2.1.1.61; 2.1.1.62; 2.1.1.64; 2.1.1.65; 2.1.1.67; 2.1.1.68; 2.1.1.69; 2.1.1.70; 2.1.1.71; 2.1.1.72; 2.1.1.75; 2.1.1.76; 2.1.1.77; 2.1.1.78; 2.1.1.79; 2.1.1.80; 2.1.1.82; 2.1.1.83; 2.1.1.84; 2.1.1.85; 2.1.1.87; 2.1.1.88; 2.1.1.89; 2.1.1.91; 2.1.1.94; 2.1.1.95; 2.1.1.96; 2.1.1.97; 2.1.1.98; 2.1.1.99; 2.1.1.100; 2.1.1.101; 2.1.1.102; 2.1.1.103; 2.1.1.104; 2.1.1.105; 2.1.1.106; 2.1.1.107; 2.1.1.108; 2.1.1.109; 2.1.1.110; 2.1.1.111; 2.1.1.112; 2.1.1.113; 2.1.1.114; 2.1.1.115; 2.1.1.116; 2.1.1.117; 2.1.1.118; 2.1.1.119; 2.1.1.120; 2.1.1.121; 2.1.1.122; 2.1.1.123; 2.1.1.127; 2.1.1.128; 2.1.1.129; 2.1.1.130; 2.1.1.131; 2.1.1.132; 2.1.1.133; 2.1.1.136; 2.1.1.137; 2.1.1.139; 2.1.1.140; 2.1.1.141; 2.1.1.142; 2.1.1.143; 2.1.1.144; 2.1.1.145; 2.1.1.146; 2.1.1.147; 2.1.1.150; 2.1.1.151; 2.1.1.152; 2.1.1.153; 2.1.1.154; 2.1.1.155; 2.1.1.156; 2.1.1.157; 2.1.1.158; 2.1.1.159; 2.1.1.160; 2.1.1.161; 2.1.1.162; 2.1.1.163; 2.1.1.164; 2.1.1.165; 2.1.1.169; 2.1.1.171; 2.1.1.172; 2.1.1.173; 2.1.1.174; 2.1.1.175; 2.1.1.181; 2.1.1.182; 2.1.1.183; 2.1.1.184; 2.1.1.187; 2.1.1.188; 2.1.1.195; 2.1.1.196; 2.1.1.197; 2.1.1.201; 2.1.1.202; 2.1.1.203; 2.1.1.204; 2.1.1.210; 2.1.1.212; 2.1.1.222; 2.1.1.228; 2.1.1.231; 2.1.1.232; 2.1.1.234; 2.1.1.235; 2.1.1.236; 2.1.1.237; 2.1.1.238; 2.1.1.239; 2.1.1.240; 2.1.1.241; 2.1.1.243; 2.1.1.254; 2.1.1.255; 2.1.1.261; 2.1.1.262; 2.1.1.263; 2.1.1.267; 2.1.1.270; 2.1.1.271; 2.1.1.273; 2.1.1.274; 2.1.1.275; 2.1.1.276; 2.1.1.277; 2.1.1.278; 2.1.1.279; 2.1.1.281; 2.1.1.282; 2.1.1.283; 2.1.1.284; 2.1.1.285; 2.1.1.286; 2.1.1.287; 2.1.1.288; 2.1.1.289; 2.1.1.290; 2.1.1.291; 2.1.1.292; 2.1.1.293; 2.1.1.294; 2.1.1.295; 2.1.1.296; 2.1.1.297; 2.1.1.298; 2.1.1.300; 2.1.1.302; 2.1.1.303; 2.1.1.304; 2.1.1.305; 2.1.1.306; 2.1.1.307; 2.1.1.308; 2.1.1.314; 2.1.1.315; 2.1.1.316; 2.1.1.317; 2.1.1.319; 2.1.1.320; 2.1.1.321; 2.1.1.322; 2.1.1.323; 2.1.1.324; 2.1.1.325; 2.1.1.326; 2.1.1.327; 2.1.1.328; 2.1.1.329; 2.1.1.330; 2.1.1.331; 2.1.1.332; 2.1.1.333; 2.1.1.334; 2.1.1.335; 2.1.1.336; 2.1.1.-; 2.3.1.161; 2.3.1.184; 2.3.1.228; 2.3.1.229; 2.3.1.231; 2.3.1.244; 2.5.1.4; 2.5.1.6; 2.5.1.24; 2.5.1.25; 2.5.1.38; 2.5.1.43; 2.5.1.63; 2.5.1.77; 2.5.1.94; 2.5.1.108; 2.5.1.114; 2.5.1.120; 2.6.1.62; 2.8.1.6; 2.8.1.8; 2.8.4.3; 2.8.4.4; 2.8.4.5; 2.-.-.-; 3.3.1.2; 4.1.1.50; 4.1.3.44; 4.1.99.17; 4.1.99.19; 4.1.99.22; 4.3.1.30; 4.4.1.14; 4.7.1.1; 6.3.2.40","Methionine salvage pathway; Methionine degradation; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine; Ethylene biosynthesis, methionine => ethylene; Cysteine biosynthesis, methionine => cysteine","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00019  SAM","CAS: 29908-03-0; PubChem: 3321; ChEBI: 15414 67040; ChEMBL: CHEMBL1088977 CHEMBL1235831 CHEMBL224120; KNApSAcK: C00007347; PDB-CCD: SAM; 3DMET: B04620; NIKKAJI: J23.293I","cpd:C00019",15,22,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C15H23O5N6S1","C15H21O5N6S1",398.137239,399.145064,397.129414
"cpd:C00927","Isonocardicin A;","C23H24N4O9","Isonocardicin A; 1-Azetidineacetic acid","R03072 R03073","Monobactam biosynthesis; Biosynthesis of antibiotics","2.5.1.38; 5.1.1.14","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,"PubChem: 4180; ChEBI: 16483; NIKKAJI: J2.731.006K","cpd:C00927; cpd:C01941; cpd:C17350",23,24,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H25O9N4","C23H23O9N4",500.1543284,501.1621534,499.1465033
"cpd:C01739","Nocardicin E","C19H17N3O7","Nocardicin E","R03072 R10903","Monobactam biosynthesis; Biosynthesis of antibiotics","2.5.1.38","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,"CAS: 63555-59-9; PubChem: 4874; ChEBI: 29091; NIKKAJI: J19.574J","cpd:C01739; cpd:C17354",19,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H18O7N3","C19H16O7N3",399.1066499,400.1144749,398.0988249
"cpd:C01941","Nocardicin A","C23H24N4O9","Nocardicin A","R03073 R10882","Monobactam biosynthesis; Biosynthesis of antibiotics; Cephalosporins - parenteral agents","1.14.13.-; 5.1.1.14","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A","Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Monobactams;     C01941  Nocardicin A","CAS: 39391-39-4; PubChem: 5045; ChEBI: 17711; KNApSAcK: C00018088; NIKKAJI: J17.397E","cpd:C00927; cpd:C01941; cpd:C17350",23,24,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H25O9N4","C23H23O9N4",500.1543284,501.1621534,499.1465033
"cpd:C03198","(S)-4-Hydroxymandelate;","C8H8O4","(S)-4-Hydroxymandelate; (S)-2-Hydroxy-2-(4-hydroxyphenyl)acetate; L-4-Hydroxymandelate; L-p-Hydroxymandelate","R02673 R03794 R04160 R04161 R06632 R06633","Monobactam biosynthesis; Aminobenzoate degradation; Biosynthesis of vancomycin group antibiotics; Microbial metabolism in diverse environments; Biosynthesis of antibiotics","1.1.3.19; 1.1.3.46; 1.1.99.31; 1.13.11.46; 1.14.16.6; 5.1.2.2",NA,NA,"PubChem: 6075; ChEBI: 17210 32802; PDB-CCD: HHH; 3DMET: B00557; NIKKAJI: J74.174D","cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272",8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H9O4","C8H7O4",168.0422587,169.0500838,167.0344337
"cpd:C03590","4-Hydroxyphenylglyoxylate;","C8H6O4","4-Hydroxyphenylglyoxylate; 4-Hydroxybenzoylformate; 4-Hydroxyphenylglyoxylic acid; 2-(4-Hydroxyphenyl)-2-oxoacetate","R02672 R04160 R04234 R06626 R06633","Monobactam biosynthesis; Aminobenzoate degradation; Biosynthesis of vancomycin group antibiotics; Microbial metabolism in diverse environments; Biosynthesis of antibiotics","1.1.3.46; 1.1.99.31; 2.6.1.72; 2.6.1.103; 4.1.1.7",NA,NA,"CAS: 15573-67-8; PubChem: 6381; ChEBI: 28719; ChEMBL: CHEMBL129918; 3DMET: B00609; NIKKAJI: J410.258D","cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240",8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H7O4","C8H5O4",166.0266087,167.0344337,165.0187836
"cpd:C03972","2,3,4,5-Tetrahydrodipicolinate;","C7H9NO4","2,3,4,5-Tetrahydrodipicolinate; Delta1-Piperidine-2,6-dicarboxylate; L-2,3,4,5-Tetrahydrodipicolinate; (S)-2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate","R04198 R04199 R04336 R04364 R04365 R07613","Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.17.1.8; 2.3.1.89; 2.3.1.117; 2.3.1.-; 2.6.1.83","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"PubChem: 6692; ChEBI: 16845 864; KNApSAcK: C00007502; 3DMET: B01707; NIKKAJI: J603.133A","cpd:C03972; cpd:C12108; cpd:C17356; cpd:C21249",7,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H10O4N1","C7H8O4N1",171.0531578,172.0609828,170.0453327
"cpd:C05539","N-Acetyl-L-2-amino-6-oxopimelate;","C9H13NO6","N-Acetyl-L-2-amino-6-oxopimelate; L-2-Acetamido-6-oxoheptanedioate; L-2-Acetamido-6-oxopimelate","R04364 R04467 R10884","Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","2.3.1.89; 2.3.1.-; 2.6.1.-","Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine",NA,"PubChem: 7878; ChEBI: 17355; 3DMET: B00788; NIKKAJI: J788.070G","cpd:C05539; cpd:C05932",9,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H14O6N1","C9H12O6N1",231.0742871,232.0821122,230.0664621
"cpd:C12323","L-4-Hydroxyphenylglycine","C8H9NO3","L-4-Hydroxyphenylglycine","R06626 R10880","Monobactam biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics","2.6.1.103","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A","Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    carnitine palmitoyltransferase (CPT) 1;     Oxfenicine;      D05292  Oxfenicine (USAN/INN)","CAS: 32462-30-9; PubChem: 582713; ChEBI: 31755; PDB-CCD: D4P; 3DMET: B04451; NIKKAJI: J17.730J","cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821",8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H10O3N1","C8H8O3N1",167.0582432,168.0660682,166.0504181
"cpd:C16842","SQ 26180","C6H10N2O6S","SQ 26180",NA,"Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 96023366; ChEBI: 80766; ChEMBL: CHEMBL1205337; NIKKAJI: J39.232D","cpd:C16842",6,10,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O6N2S1","C6H9O6N2S1",238.0259572,239.0337823,237.0181322
"cpd:C17351","Nocardicin C","C23H26N4O8","Nocardicin C","R10882 R10883","Monobactam biosynthesis; Biosynthesis of antibiotics","1.14.13.-; 5.1.1.14","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,"CAS: 59511-12-5; PubChem: 96023704; ChEBI: 81021; NIKKAJI: J12.900C","cpd:C17351; cpd:C17352",23,26,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H27O8N4","C23H25O8N4",486.1750638,487.1828888,485.1672388
"cpd:C17352","Isonocardicin C","C23H26N4O8","Isonocardicin C","R10881 R10883","Monobactam biosynthesis; Biosynthesis of antibiotics","2.5.1.38; 5.1.1.14","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,"PubChem: 96023705; ChEBI: 81022; NIKKAJI: J2.806.282F","cpd:C17351; cpd:C17352",23,26,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C23H27O8N4","C23H25O8N4",486.1750638,487.1828888,485.1672388
"cpd:C17355","Nocardicin G","C19H19N3O6","Nocardicin G","R10880 R10881 R10903","Monobactam biosynthesis; Biosynthesis of antibiotics","2.5.1.38","Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,"CAS: 65309-11-7; PubChem: 96023708; ChEBI: 81024; NIKKAJI: J19.575H","cpd:C17355",19,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C19H20O6N3","C19H18O6N3",385.1273853,386.1352104,384.1195603
"cpd:C20258","(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate;","C7H9NO5","(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate; (2S,4S)-4-Hydroxy-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate; HTPA","R04198 R04199 R10147","Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.17.1.8; 4.3.3.7","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"PubChem: 163311998; ChEMBL: CHEMBL1668237","cpd:C01215; cpd:C20258",7,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H10O5N1","C7H8O5N1",187.0480724,188.0558974,186.0402474
"cpd:C20911","C20911;","C10H13NO8","C20911; Tabtoxin biosynthesis intermediate 1","R10884 R10885","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741374","cpd:C11107; cpd:C20911",10,13,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H14O8N1","C10H12O8N1",275.0641164,276.0719414,274.0562913
"cpd:C20912","C20912;","C10H16N2O7","C20912; Tabtoxin biosynthesis intermediate 2","R10885 R10886","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741375","cpd:C01425; cpd:C05282; cpd:C20912",10,16,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O7N2","C10H15O7N2",276.0957509,277.1035759,275.0879258
"cpd:C20913","C20913;","C8H14N2O6","C20913; Tabtoxin biosynthesis intermediate 3","R10886 R10887","Monobactam biosynthesis; Biosynthesis of antibiotics","4.1.1.-",NA,NA,"PubChem: 254741376","cpd:C20913; cpd:C21396",8,14,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H15O6N2","C8H13O6N2",234.0851862,235.0930112,233.0773611
"cpd:C20914","C20914;","C7H14N2O4","C20914; Tabtoxin biosynthesis intermediate 4","R10887 R10888","Monobactam biosynthesis; Biosynthesis of antibiotics","4.1.1.-",NA,NA,"PubChem: 254741377","cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914",7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H15O4N2","C7H13O4N2",190.0953569,191.103182,189.0875319
"cpd:C20915","C20915;","C11H21N3O6","C20915; Tabtoxin biosynthesis intermediate 5","R10888 R10889","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741378","cpd:C20915",11,21,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H22O6N3","C11H20O6N3",291.1430354,292.1508604,290.1352104
"cpd:C20916","C20916;","C11H19N3O5","C20916; Tabtoxin biosynthesis intermediate 6","R10889 R10890","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741379","cpd:C20916",11,19,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H20O5N3","C11H18O5N3",273.1324707,274.1402958,272.1246457
"cpd:C20917","Tabtoxin;","C11H19N3O6","Tabtoxin; beta-Tabtoxin","R10890 R10891 R10892 R10895","Monobactam biosynthesis; Biosynthesis of antibiotics","3.4.-.-; 6.3.2.-",NA,NA,"PubChem: 254741380","cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016",11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H20O6N3","C11H18O6N3",289.1273853,290.1352104,288.1195603
"cpd:C20918","Tabtoxinine-beta-lactam","C7H12N2O4","Tabtoxinine-beta-lactam","R10891 R10892 R10893 R10894","Monobactam biosynthesis; Biosynthesis of antibiotics","2.3.1.-; 3.4.-.-; 6.3.2.-",NA,NA,"PubChem: 254741381","cpd:C11490; cpd:C20918; cpd:C20920",7,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O4N2","C7H11O4N2",188.0797069,189.0875319,187.0718818
"cpd:C20919","Isotabtoxin;","C11H19N3O6","Isotabtoxin; delta-Tabtoxin","R10895","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741382","cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016",11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H20O6N3","C11H18O6N3",289.1273853,290.1352104,288.1195603
"cpd:C20920","Tabtoxinine-delta-lactam","C7H12N2O4","Tabtoxinine-delta-lactam","R10894","Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"PubChem: 254741383","cpd:C11490; cpd:C20918; cpd:C20920",7,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O4N2","C7H11O4N2",188.0797069,189.0875319,187.0718818
"cpd:C20921","N1-Acetyl-tabtoxinine-beta-lactam","C9H14N2O5","N1-Acetyl-tabtoxinine-beta-lactam","R10893","Monobactam biosynthesis; Biosynthesis of antibiotics","2.3.1.-",NA,NA,"PubChem: 254741384","cpd:C20921",9,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H15O5N2","C9H13O5N2",230.0902716,231.0980966,229.0824465
"cpd:C20927","Sulfazecin;","C12H20N4O9S","Sulfazecin; SQ 26445",NA,"Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"CAS: 77912-79-9; PubChem: 254741390","cpd:C20927",12,20,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C12H21O9N4S1","C12H19O9N4S1",396.0950994,397.1029244,395.0872744
"cpd:C20928","MM 42842","C13H22N4O9S","MM 42842",NA,"Monobactam biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,"CAS: 113784-28-4; PubChem: 254741391","cpd:C20928",13,22,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C13H23O9N4S1","C13H21O9N4S1",410.1107495,411.1185745,409.1029244
"cpd:C00021","S-Adenosyl-L-homocysteine;","C14H20N6O5S","S-Adenosyl-L-homocysteine; S-Adenosylhomocysteine","R00192 R00193 R00194 R00367 R00380 R00594 R00595 R00596; R00597 R00598 R00599 R00600 R00601 R00649 R00650 R00683; R00827 R00984 R01153 R01159 R01169 R01188 R01189 R01190; R01235 R01239 R01269 R01320 R01349 R01721 R01883 R01942; R01972 R01973 R02037 R02056 R02144 R02155 R02157 R02174; R02175 R02379 R02384 R02533 R02534 R02572 R02623 R02627; R02667 R02671 R02808 R02858 R02859 R02862 R02882 R02910; R02917 R02920 R02931 R02961 R02982 R03003 R03111 R03112; R03130 R03194 R03229 R03304 R03366 R03410 R03411 R03424; R03456 R03554 R03571 R03587 R03623 R03633 R03701 R03721; R03725 R03731 R03746 R03788 R03805 R03832 R03835 R03875; R03922 R03934 R03938 R03943 R03948 R03950 R03955 R04013; R04033 R04062 R04077 R04145 R04169 R04190 R04237 R04301; R04332 R04396 R04398 R04421 R04427 R04436 R04481 R04496; R04505 R04691 R04692 R04705 R04707 R04711 R04713 R04714; R04715 R04716 R04717 R04718 R04719 R04762 R04763 R04764; R04772 R04858 R04866 R04867 R04881 R04887 R04905 R04931; R04981 R04983 R04988 R04990 R04993 R04994 R05035 R05122; R05123 R05149 R05162 R05179 R05180 R05181 R05182 R05211; R05212 R05213 R05214 R05216 R05219 R05303 R05323 R05520; R05532 R05614 R05673 R05674 R05676 R05754 R05755 R05756; R05757 R05759 R05760 R05763 R05764 R05776 R05808 R05809; R05810 R05811 R05813 R05834 R05881 R05885 R06427 R06439; R06456 R06476 R06477 R06478 R06479 R06564 R06574 R06575; R06576 R06577 R06578 R06627 R06675 R06680 R06687 R06693; R06703 R06713 R06715 R06719 R06767 R06771 R06774 R06778; R06794 R06807 R06815 R06816 R06824 R06859 R06868 R06869; R06998 R07232 R07233 R07234 R07235 R07236 R07237 R07238; R07239 R07240 R07241 R07242 R07243 R07244 R07251 R07330; R07375 R07481 R07501 R07504 R07521 R07524 R07527 R07529; R07533 R07535 R07722 R07724 R07750 R07773 R07774 R07775; R07917 R07919 R07920 R07921 R07922 R08147 R08151 R08236; R08239 R08246 R08410 R08437 R08441 R08446 R08449 R08455; R08465 R08467 R08468 R08469 R08479 R08537 R08538 R08547; R08769 R08771 R08774 R08781 R08787 R08788 R08789 R08791; R08794 R08803 R08804 R08932 R08933 R08973 R08987 R09063; R09073 R09177 R09189 R09191 R09200 R09369 R09370 R09371; R09523 R09543 R09569 R09611 R09612 R09613 R09678 R09679; R09736 R09737 R09791 R09792 R09821 R09822 R09823 R09856; R09870 R09871 R09872 R09939 R09940 R10060 R10061 R10062; R10166 R10167 R10168 R10169 R10195 R10196 R10197 R10198; R10199 R10250 R10251 R10252 R10306 R10307 R10403 R10404; R10431 R10447 R10448 R10449 R10450 R10451 R10452 R10454; R10472 R10491 R10492 R10495 R10497 R10498 R10523 R10524; R10586 R10587 R10588 R10605 R10606 R10645 R10647 R10649; R10651 R10652 R10654 R10658 R10680 R10709 R10710 R10716; R10806 R10812 R10824 R10956 R10957 R10958 R10959 R10962; R10963 R10964 R11020 R11041 R11045 R11165 R11191 R11192; R11193 R11216 R11217 R11218 R11219 R11220 R11221 R11230; R11292 R11371 R11413 R11416 R11445 R11452 R11453 R11469; R11476 R11507 R11508 R11509 R11520 R11521 R11533 R11534; R11545 R11546","Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of amino acids","1.16.1.8; 2.1.1.1; 2.1.1.2; 2.1.1.4; 2.1.1.6; 2.1.1.7; 2.1.1.8; 2.1.1.9; 2.1.1.10; 2.1.1.11; 2.1.1.12; 2.1.1.15; 2.1.1.16; 2.1.1.17; 2.1.1.18; 2.1.1.20; 2.1.1.22; 2.1.1.25; 2.1.1.26; 2.1.1.27; 2.1.1.28; 2.1.1.33; 2.1.1.34; 2.1.1.35; 2.1.1.37; 2.1.1.38; 2.1.1.39; 2.1.1.40; 2.1.1.41; 2.1.1.42; 2.1.1.43; 2.1.1.44; 2.1.1.47; 2.1.1.49; 2.1.1.50; 2.1.1.53; 2.1.1.55; 2.1.1.56; 2.1.1.57; 2.1.1.59; 2.1.1.60; 2.1.1.61; 2.1.1.62; 2.1.1.64; 2.1.1.65; 2.1.1.67; 2.1.1.68; 2.1.1.69; 2.1.1.70; 2.1.1.71; 2.1.1.72; 2.1.1.75; 2.1.1.76; 2.1.1.77; 2.1.1.78; 2.1.1.79; 2.1.1.80; 2.1.1.82; 2.1.1.83; 2.1.1.84; 2.1.1.85; 2.1.1.87; 2.1.1.88; 2.1.1.89; 2.1.1.91; 2.1.1.94; 2.1.1.95; 2.1.1.96; 2.1.1.97; 2.1.1.98; 2.1.1.99; 2.1.1.100; 2.1.1.101; 2.1.1.102; 2.1.1.103; 2.1.1.104; 2.1.1.105; 2.1.1.106; 2.1.1.107; 2.1.1.108; 2.1.1.109; 2.1.1.110; 2.1.1.111; 2.1.1.112; 2.1.1.113; 2.1.1.114; 2.1.1.115; 2.1.1.116; 2.1.1.117; 2.1.1.118; 2.1.1.119; 2.1.1.120; 2.1.1.121; 2.1.1.122; 2.1.1.123; 2.1.1.127; 2.1.1.128; 2.1.1.129; 2.1.1.130; 2.1.1.131; 2.1.1.132; 2.1.1.133; 2.1.1.136; 2.1.1.137; 2.1.1.139; 2.1.1.140; 2.1.1.141; 2.1.1.142; 2.1.1.143; 2.1.1.144; 2.1.1.145; 2.1.1.146; 2.1.1.147; 2.1.1.150; 2.1.1.151; 2.1.1.152; 2.1.1.153; 2.1.1.154; 2.1.1.155; 2.1.1.156; 2.1.1.157; 2.1.1.158; 2.1.1.159; 2.1.1.160; 2.1.1.161; 2.1.1.162; 2.1.1.163; 2.1.1.164; 2.1.1.165; 2.1.1.169; 2.1.1.171; 2.1.1.172; 2.1.1.173; 2.1.1.174; 2.1.1.175; 2.1.1.181; 2.1.1.182; 2.1.1.183; 2.1.1.184; 2.1.1.187; 2.1.1.188; 2.1.1.195; 2.1.1.196; 2.1.1.197; 2.1.1.201; 2.1.1.202; 2.1.1.203; 2.1.1.204; 2.1.1.210; 2.1.1.212; 2.1.1.222; 2.1.1.228; 2.1.1.231; 2.1.1.232; 2.1.1.234; 2.1.1.235; 2.1.1.236; 2.1.1.237; 2.1.1.238; 2.1.1.239; 2.1.1.240; 2.1.1.241; 2.1.1.243; 2.1.1.254; 2.1.1.255; 2.1.1.261; 2.1.1.262; 2.1.1.263; 2.1.1.267; 2.1.1.270; 2.1.1.271; 2.1.1.273; 2.1.1.274; 2.1.1.275; 2.1.1.276; 2.1.1.277; 2.1.1.278; 2.1.1.279; 2.1.1.281; 2.1.1.282; 2.1.1.283; 2.1.1.284; 2.1.1.285; 2.1.1.286; 2.1.1.287; 2.1.1.288; 2.1.1.289; 2.1.1.290; 2.1.1.291; 2.1.1.292; 2.1.1.293; 2.1.1.294; 2.1.1.295; 2.1.1.296; 2.1.1.297; 2.1.1.298; 2.1.1.300; 2.1.1.302; 2.1.1.303; 2.1.1.304; 2.1.1.305; 2.1.1.306; 2.1.1.307; 2.1.1.314; 2.1.1.315; 2.1.1.316; 2.1.1.317; 2.1.1.319; 2.1.1.320; 2.1.1.321; 2.1.1.322; 2.1.1.323; 2.1.1.324; 2.1.1.325; 2.1.1.327; 2.1.1.328; 2.1.1.329; 2.1.1.330; 2.1.1.331; 2.1.1.332; 2.1.1.333; 2.1.1.334; 2.1.1.335; 2.1.1.336; 2.1.1.-; 2.3.1.161; 2.3.1.231; 2.3.1.244; 2.8.4.3; 2.8.4.4; 2.8.4.5; 2.-.-.-; 3.2.2.9; 3.3.1.1; 3.5.4.28; 6.3.2.40","Methionine degradation; Cysteine biosynthesis, methionine => cysteine",NA,"CAS: 979-92-0; PubChem: 3323; ChEBI: 16680; ChEMBL: CHEMBL142828 CHEMBL418052; KNApSAcK: C00007230; PDB-CCD: SAH SAO; 3DMET: B01134; NIKKAJI: J14.397I","cpd:C00021",14,20,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C14H21O5N6S1","C14H19O5N6S1",384.1215889,385.129414,383.1137639
"cpd:C00051","Glutathione;","C10H17N3O6S","Glutathione; 5-L-Glutamyl-L-cysteinylglycine; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; gamma-L-Glutamyl-L-cysteinyl-glycine; GSH; Reduced glutathione","R00094 R00115 R00120 R00274 R00494 R00497 R00499 R00527; R00547 R00900 R01108 R01109 R01110 R01111 R01113 R01262; R01292 R01736 R01875 R01917 R01918 R02530 R02824 R03059; R03082 R03167 R03522 R03822 R03915 R03956 R03984 R04039; R04090 R04860 R05267 R05269 R05402 R05403 R05714 R05717; R05748 R06982 R07002 R07003 R07004 R07023 R07024 R07025; R07026 R07034 R07035 R07069 R07070 R07083 R07084 R07091; R07092 R07093 R07094 R07100 R07113 R07116 R07124 R08280; R08350 R08351 R08352 R08353 R08354 R08355 R08511 R08512; R08677 R08678 R09338 R09367 R09368 R09409 R11411","Cysteine and methionine metabolism; Glutathione metabolism; Metabolic pathways; ABC transporters; Thyroid hormone synthesis; Bile secretion","1.5.4.1; 1.8.1.7; 1.8.1.9; 1.8.1.10; 1.8.3.3; 1.8.4.1; 1.8.4.2; 1.8.4.3; 1.8.4.4; 1.8.4.7; 1.8.4.9; 1.8.5.1; 1.11.1.9; 1.11.1.12; 1.13.11.18; 1.20.4.2; 2.3.2.2; 2.3.2.15; 2.5.1.18; 2.5.1.-; 2.8.1.3; 3.1.2.6; 3.1.2.7; 3.1.2.12; 3.1.2.13; 3.4.19.13; 3.5.1.78; 3.5.1.-; 4.4.1.5; 4.4.1.20; 4.4.1.22; 4.4.1.34; 6.3.1.8; 6.3.1.9; 6.3.2.3","Glutathione biosynthesis, glutamate => glutathione","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00051  Glutathione; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB32 Glutathione;       D00014  Glutathione (JP17); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00014  Glutathione (JP17);  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    392  Antidotes;     3922  Glutathiones;      D00014  Glutathione (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00014  Glutathione; Endocrine and hormonal agents [br08373.html];  Other gynecological agents;   D00014; Dermatological agents [br08370.html];  Non-steroidal injection;   D00014; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   967  Agents for liver disease and antidotes;    9676  Other amino acid and preparations;     C00051  Glutathione","CAS: 70-18-8; PubChem: 3353; ChEBI: 16856; ChEMBL: CHEMBL1514919 CHEMBL1543 CHEMBL31464; KNApSAcK: C00001518; PDB-CCD: GSH; 3DMET: B01138; NIKKAJI: J10.686K","cpd:C00051; cpd:C02755; cpd:C18871",10,17,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C10H18O6N3S1","C10H16O6N3S1",307.0838065,308.0916315,306.0759814
"cpd:C00073","L-Methionine;","C5H11NO2S","L-Methionine; Methionine; L-2-Amino-4methylthiobutyric acid","R00177 R00648 R00649 R00650 R00651 R00652 R00653 R00654; R00655 R00656 R00657 R00946 R01078 R02025 R02821 R03472; R03659 R04153 R04405 R04710 R06268 R06269 R06270 R06895; R07396 R07606 R07608 R07767 R07768 R08583 R08588 R08618; R08635 R08862 R08873 R08875 R08893 R09373 R09394 R09396; R09637 R09639 R10204 R10246 R10430 R10552 R10645 R10646; R10649 R10650 R10652 R10653 R10667 R11063 R11112 R11274; R11275 R11293 R11294 R11484","Cysteine and methionine metabolism; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Antifolate resistance; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.1.99.38; 1.3.98.3; 1.4.3.2; 1.8.4.11; 1.8.4.13; 1.8.4.14; 1.17.98.2; 1.21.98.1; 1.21.98.3; 1.97.1.4; 2.1.1.3; 2.1.1.5; 2.1.1.10; 2.1.1.12; 2.1.1.13; 2.1.1.14; 2.1.1.280; 2.1.1.308; 2.1.1.326; 2.1.1.-; 2.5.1.6; 2.5.1.49; 2.5.1.63; 2.5.1.77; 2.5.1.94; 2.5.1.120; 2.6.1.5; 2.6.1.57; 2.6.1.73; 2.6.1.88; 2.6.1.-; 2.8.1.6; 2.8.1.8; 2.8.4.3; 2.8.4.4; 2.8.4.5; 3.4.13.12; 3.5.1.31; 4.1.1.57; 4.1.3.44; 4.1.99.17; 4.1.99.19; 4.1.99.22; 4.3.1.30; 4.4.1.11; 4.7.1.1; 5.1.1.2; 6.1.1.10","Methionine biosynthesis, apartate => homoserine => methionine; Methionine salvage pathway; Methionine degradation; Ethylene biosynthesis, methionine => ethylene; Cysteine biosynthesis, methionine => cysteine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00073  Methionine (Met); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB26 Methionine;       D00019  Methionine (USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    392  Antidotes;     3929  Others;      D00019  Methionine (USP); L-Methionine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Methionine;     D00019  Methionine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00019  [001621] L-Methionine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00019  L-Methionine","CAS: 63-68-3; PubChem: 3373; ChEBI: 16643; ChEMBL: CHEMBL42336; KNApSAcK: C00001379; PDB-CCD: MET; 3DMET: B01148; NIKKAJI: J9.174J","cpd:C00073; cpd:C00855; cpd:C01733; cpd:C07418",5,11,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O2N1S1","C5H10O2N1S1",149.0510498,150.0588748,148.0432247
"cpd:C00155","L-Homocysteine;","C4H9NO2S","L-Homocysteine; L-2-Amino-4-mercaptobutyric acid; Homocysteine","R00192 R00650 R00946 R01283 R01286 R01287 R01288 R01289; R01290 R01291 R01292 R02026 R02821 R04153 R04405 R08633; R10305 R11063","Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids; Antifolate resistance; NOD-like receptor signaling pathway","1.8.4.1; 2.1.1.3; 2.1.1.5; 2.1.1.10; 2.1.1.13; 2.1.1.14; 2.5.1.48; 2.5.1.49; 2.5.1.134; 2.5.1.-; 3.3.1.1; 4.2.1.22; 4.4.1.2; 4.4.1.8; 4.4.1.21","Methionine biosynthesis, apartate => homoserine => methionine; Methionine degradation; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00155  L-Homocysteine","CAS: 6027-13-0; PubChem: 3455; ChEBI: 17588; ChEMBL: CHEMBL469662; KNApSAcK: C00001365; PDB-CCD: HCS; 3DMET: B01174; NIKKAJI: J228C","cpd:C00155; cpd:C05330",4,9,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1S1","C4H8O2N1S1",135.0353997,136.0432247,134.0275747
"cpd:C00170","5'-Methylthioadenosine;","C11H15N5O3S","5'-Methylthioadenosine; Methylthioadenosine; S-Methyl-5'-thioadenosine; 5-Methylthioadenosine; 5'-Deoxy-5'-(methylthio)adenosine; Thiomethyladenosine; MTA","R00075 R00175 R00179 R00180 R01401 R01402 R01920 R02869; R03019 R03072 R03271 R03726 R08359 R08939 R08940 R09072; R09531 R09660 R10338 R10455 R10526 R10529 R10611 R10881; R11088 R11089 R11154 R11159 R11160","Cysteine and methionine metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways","2.3.1.184; 2.3.1.228; 2.3.1.229; 2.4.2.28; 2.5.1.4; 2.5.1.16; 2.5.1.22; 2.5.1.23; 2.5.1.24; 2.5.1.25; 2.5.1.38; 2.5.1.43; 2.5.1.79; 2.5.1.104; 2.5.1.108; 2.5.1.114; 2.5.1.126; 2.5.1.127; 2.5.1.128; 3.2.2.9; 3.2.2.16; 3.3.1.2; 3.5.4.31; 4.4.1.14","Methionine salvage pathway",NA,"CAS: 2457-80-9; PubChem: 3470; ChEBI: 17509; ChEMBL: CHEMBL277041 CHEMBL603295; PDB-CCD: MTA; 3DMET: B01178; NIKKAJI: J22.737D","cpd:C00170",11,15,3,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C11H16O3N5S1","C11H14O3N5S1",297.0895605,298.0973856,296.0817355
"cpd:C00409","Methanethiol;","CH4S","Methanethiol; Methylmercaptan","R00651 R00654 R01851 R08635 R09786 R09997 R10001 R10936; R10946 R11546","Cysteine and methionine metabolism; Sulfur metabolism","1.8.3.4; 1.14.13.131; 2.1.1.251; 2.1.1.334; 2.5.1.49; 4.2.1.155; 4.4.1.11",NA,NA,"CAS: 74-93-1; PubChem: 3699; ChEBI: 16007; KNApSAcK: C00001258; PDB-CCD: MEE; 3DMET: B00105; NIKKAJI: J1.432J","cpd:C00409; cpd:C02704; cpd:C08087; cpd:C08091; cpd:C11145; cpd:C12560; cpd:C13167; cpd:C13168; cpd:C13524; cpd:C14053; cpd:C14054; cpd:C14055; cpd:C14415; cpd:C18361; cpd:C19432; cpd:C21398",1,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C1H5S1","C1H3S1",48.0033713,49.01119634,46.99554627
"cpd:C00491","L-Cystine;","C6H12N2O4S2","L-Cystine; L-Dicysteine; L-alpha-Diamino-beta-dithiolactic acid","R00892 R01113 R02408 R02409","Cysteine and methionine metabolism; ABC transporters; Protein digestion and absorption","1.8.1.6; 1.8.4.3; 1.8.4.4; 4.4.1.1; 4.4.1.8",NA,"Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Cystine;     D03636  Cystine (USAN/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D03636  [103758] L-Cystine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D03636  L-Cystine","CAS: 56-89-3; PubChem: 3774; ChEBI: 16283; ChEMBL: CHEMBL590540; KNApSAcK: C00001352; 3DMET: B01265; NIKKAJI: J9.172C","cpd:C00491; cpd:C01420",6,12,4,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O4N2S2","C6H11O4N2S2",240.0238492,241.0316743,239.0160242
"cpd:C00506","L-Cysteate;","C3H7NO5S","L-Cysteate; L-Cysteic acid; 3-Sulfoalanine; 2-Amino-3-sulfopropionic acid","R00901 R01682 R02433 R02434 R07634 R08699 R09530","Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction","2.5.1.76; 2.6.1.1; 4.1.1.15; 4.1.1.29; 4.4.1.10; 4.4.1.25",NA,NA,"CAS: 13100-82-8; PubChem: 3789; ChEBI: 17285; PDB-CCD: OCS; 3DMET: B01274; NIKKAJI: J8.084E","cpd:C00506",3,7,5,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O5N1S1","C3H6O5N1S1",169.0044935,170.0123185,167.9966685
"cpd:C00606","3-Sulfino-L-alanine;","C3H7NO4S","3-Sulfino-L-alanine; L-Cysteinesulfinic acid; 3-Sulphino-L-alanine; 3-Sulfinoalanine","R00863 R00893 R02434 R02466 R02618 R02619","Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Metabolic pathways","1.4.1.-; 1.13.11.20; 2.6.1.1; 4.1.1.12; 4.1.1.15; 4.1.1.29",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00606  3-Sulfino-L-alanine","CAS: 1115-65-7; PubChem: 3881; ChEBI: 16345; ChEMBL: CHEMBL1160508; PDB-CCD: CSD; 3DMET: B01293; NIKKAJI: J36.785K","cpd:C00606",3,7,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O4N1S1","C3H6O4N1S1",153.0095789,154.0174039,152.0017539
"cpd:C00793","D-Cysteine;","C3H7NO2S","D-Cysteine; D-Amino-3-mercaptopropionic acid","R00903 R01874","Cysteine and methionine metabolism","4.4.1.15; 5.1.1.10",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00793  D-Cysteine","CAS: 921-01-7; PubChem: 4051; ChEBI: 16375; ChEMBL: CHEMBL171281; KNApSAcK: C00007323; PDB-CCD: DCY; 3DMET: B01332; NIKKAJI: J9.202I","cpd:C00097; cpd:C00736; cpd:C00793",3,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1S1","C3H6O2N1S1",121.0197496,122.0275747,120.0119246
"cpd:C00957","Mercaptopyruvate;","C3H4O3S","Mercaptopyruvate; 3-Mercaptopyruvic acid; 3-Mercaptopyruvate","R00895 R00896 R03104 R03105 R03106","Cysteine and methionine metabolism; Metabolic pathways","1.1.1.27; 2.6.1.1; 2.6.1.3; 2.8.1.2",NA,NA,"CAS: 2464-23-5; PubChem: 4208; ChEBI: 16208; KNApSAcK: C00007464; 3DMET: B00208; NIKKAJI: J72.997C","cpd:C00957; cpd:C18618",3,4,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O3S1","C3H3O3S1",119.9881152,120.9959402,118.9802901
"cpd:C00979","O-Acetyl-L-serine;","C5H9NO4","O-Acetyl-L-serine; O3-Acetyl-L-serine","R00586 R00897 R03131 R03132 R03133 R03134 R03601 R04091; R04859 R10305 R10461 R10839 R10840","Cysteine and methionine metabolism; Zeatin biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Sulfur relay system","2.3.1.30; 2.5.1.47; 2.5.1.49; 2.5.1.50; 2.5.1.51; 2.5.1.52; 2.5.1.53; 2.5.1.65; 2.5.1.118; 2.5.1.119; 2.5.1.134; 2.6.99.3","Cysteine biosynthesis, serine => cysteine; Cycloserine biosynthesis, arginine/serine => cycloserine",NA,"CAS: 5147-00-2; PubChem: 4228; ChEBI: 17981; KNApSAcK: C00007459; PDB-CCD: OAS; 3DMET: B00213; NIKKAJI: J37.500D","cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269",5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H10O4N1","C5H8O4N1",147.0531578,148.0609828,146.0453327
"cpd:C01077","O-Acetyl-L-homoserine;","C6H11NO4","O-Acetyl-L-homoserine; O-Acetylhomoserine","R00651 R01287 R01776 R02026 R03217 R04945","Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of antibiotics","2.3.1.31; 2.5.1.48; 2.5.1.49",NA,NA,"CAS: 7540-67-2; PubChem: 4315; ChEBI: 16288; KNApSAcK: C00019570; 3DMET: B01374; NIKKAJI: J37.499G","cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694",6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O4N1","C6H10O4N1",161.0688078,162.0766329,160.0609828
"cpd:C01118","O-Succinyl-L-homoserine;","C8H13NO6","O-Succinyl-L-homoserine; O4-Succinyl-L-homoserine; O-Succinylhomoserine","R00999 R01288 R01777 R02508 R03260 R04946","Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids","2.3.1.46; 2.5.1.48; 2.5.1.-","Methionine biosynthesis, apartate => homoserine => methionine",NA,"CAS: 1492-23-5; PubChem: 4349; ChEBI: 16160; KNApSAcK: C00019621; 3DMET: B01386; NIKKAJI: J1.770.210F","cpd:C01118; cpd:C03776",8,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C8H14O6N1","C8H12O6N1",219.0742871,220.0821122,218.0664621
"cpd:C01137","S-Adenosylmethioninamine;","C14H23N6O3S","S-Adenosylmethioninamine; (5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium; (5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium cation; S-Adenosyl-(5')-3-methylthiopropylamine; S-Adenosyl 3-(methylthio)propylamine; Decarboxy-AdoMet","R00178 R01920 R02869 R03271 R08359 R09531 R10338 R11088; R11089 R11154 R11159 R11160","Cysteine and methionine metabolism; Arginine and proline metabolism; Metabolic pathways","2.5.1.16; 2.5.1.22; 2.5.1.23; 2.5.1.79; 2.5.1.104; 2.5.1.126; 2.5.1.127; 2.5.1.128; 4.1.1.50","Methionine salvage pathway; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine","Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C01137  S-Adenosylmethioninamine","PubChem: 4368; ChEBI: 15625; 3DMET: B04775; NIKKAJI: J39.567F","cpd:C01137",14,23,3,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C14H24O3N6S1","C14H22O3N6S1",355.1552348,356.1630598,354.1474098
"cpd:C01180","4-Methylthio-2-oxobutanoic acid;","C5H8O3S","4-Methylthio-2-oxobutanoic acid; 4-Methylthio-2-oxobutanoate; 2-Keto-4-methylthiobutyric acid; 2-Oxo-4-methylthiobutanoate; 2-Oxo-4-methylthiobutanoic acid","R00648 R00652 R03001 R07364 R07396 R08618 R08619 R09373","Cysteine and methionine metabolism; Glucosinolate biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism","1.4.3.2; 1.13.11.54; 2.3.3.17; 2.6.1.5; 2.6.1.41; 2.6.1.57; 2.6.1.73; 2.6.1.88; 2.6.1.-","Methionine salvage pathway","Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C01180  2-Oxo-4-methylthiobutanoic acid","CAS: 583-92-6; PubChem: 4407; ChEBI: 16723 33574; LIPIDMAPS: LMFA01060170; KNApSAcK: C00007474; PDB-CCD: KMT; 3DMET: B00255; NIKKAJI: J39.561G","cpd:C01180; cpd:C05727; cpd:C18006",5,8,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O3S1","C5H7O3S1",148.0194153,149.0272403,147.0115903
"cpd:C01234","1-Aminocyclopropane-1-carboxylate;","C4H7NO2","1-Aminocyclopropane-1-carboxylate; 1-Aminocyclopropane-1-carboxylic acid","R00179 R00997 R07214","Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites","1.14.17.4; 3.5.99.7; 4.4.1.14","Ethylene biosynthesis, methionine => ethylene",NA,"CAS: 22059-21-8; PubChem: 4455; ChEBI: 18053 30526; ChEMBL: CHEMBL265325; KNApSAcK: C00007566; PDB-CCD: 1AC; 3DMET: B00262; NIKKAJI: J83.133F","cpd:C01234; cpd:C02926; cpd:C07509; cpd:C08267; cpd:C11106; cpd:C17234; cpd:C19456; cpd:C19777; cpd:C20905",4,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H8O2N1","C4H6O2N1",101.0476785,102.0555035,100.0398534
"cpd:C01817","L-Homocystine;","C8H16N2O4S2","L-Homocystine; Homocystine","R01292","Cysteine and methionine metabolism","1.8.4.1",NA,NA,"CAS: 626-72-2; PubChem: 4941; ChEBI: 17485; ChEMBL: CHEMBL212056; 3DMET: B01502; NIKKAJI: J5.770C","cpd:C01817; cpd:C20788",8,16,4,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,"C8H17O4N2S2","C8H15O4N2S2",268.0551494,269.0629744,267.0473243
"cpd:C01962","Thiocysteine;","C3H7NO2S2","Thiocysteine; S-Mercapto-L-cysteine","R02408","Cysteine and methionine metabolism","4.4.1.1; 4.4.1.8",NA,NA,"CAS: 5652-32-4; PubChem: 5063; ChEBI: 28839; PDB-CCD: CSS; 3DMET: B00374; NIKKAJI: J2.365.199H","cpd:C01962",3,7,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O2N1S2","C3H6O2N1S2",152.9918208,153.9996459,151.9839958
"cpd:C02218","Dehydroalanine;","C3H5NO2","Dehydroalanine; 2-Aminoacrylate; 2-Aminoprop-2-enoate","R00590 R03208 R03901 R03953 R08698 R08699 R11100","Cysteine and methionine metabolism","1.11.1.8; 4.3.1.17; 4.4.1.4",NA,NA,"CAS: 1948-56-7; PubChem: 5284; ChEBI: 17123; PDB-CCD: DHA; 3DMET: B00405; NIKKAJI: J80.352I","cpd:C02218; cpd:C04313; cpd:C06695; cpd:C20253; cpd:C20904",3,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C3H6O2N1","C3H4O2N1",87.0320284,88.03985344,86.02420337
"cpd:C02356","(S)-2-Aminobutanoate;","C4H9NO2","(S)-2-Aminobutanoate; (S)-2-Aminobutanoic acid; (S)-2-Aminobutyric acid","R10991 R10992 R10993","Cysteine and methionine metabolism; Metabolic pathways","2.6.1.42; 2.6.1.44; 6.3.2.2",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C02356  (S)-2-Aminobutanoic acid","PubChem: 5403; ChEBI: 28340 35619 74359; ChEMBL: CHEMBL1230782; LIPIDMAPS: LMFA01100034; PDB-CCD: ABA UNK; 3DMET: B01567; NIKKAJI: J7.749F","cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514",4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1","C4H8O2N1",103.0633285,104.0711536,102.0555035
"cpd:C02989","L-Methionine S-oxide","C5H11NO3S","L-Methionine S-oxide","R02025","Cysteine and methionine metabolism","1.8.4.13; 1.8.4.14",NA,NA,"CAS: 3226-65-1; PubChem: 5898; ChEBI: 17016; ChEMBL: CHEMBL445753; PDB-CCD: MHO SME; 3DMET: B04873; NIKKAJI: J231.856C","cpd:C02989; cpd:C15998; cpd:C15999",5,11,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O3N1S1","C5H10O3N1S1",165.0459644,166.0537894,164.0381394
"cpd:C03089","5-Methylthio-D-ribose;","C6H12O4S","5-Methylthio-D-ribose; S-Methyl-5-thio-D-ribose","R01401 R04143","Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways","2.7.1.100; 3.2.2.9; 3.2.2.16","Methionine salvage pathway",NA,"PubChem: 5987; ChEBI: 78440; PDB-CCD: SR1; 3DMET: B01630; NIKKAJI: J1.615.621C","cpd:C03089",6,12,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O4S1","C6H11O4S1",180.04563,181.0534551,179.037805
"cpd:C03145","N-Formylmethionine;","C6H11NO3S","N-Formylmethionine; N-Formyl-L-methionine","R00653","Cysteine and methionine metabolism","3.5.1.31",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C03145  N-Formylmethionine","CAS: 4289-98-9; PubChem: 6033; ChEBI: 16552; PDB-CCD: FME; 3DMET: B01634; NIKKAJI: J208.507K","cpd:C03145; cpd:C08265; cpd:C08295",6,11,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O3N1S1","C6H10O3N1S1",177.0459644,178.0537894,176.0381394
"cpd:C03539","S-Ribosyl-L-homocysteine;","C9H17NO6S","S-Ribosyl-L-homocysteine; S-D-Ribosyl-L-homocysteine; Ribose-5-S-homocysteine; S-Ribosylhomocysteine; S-(5-Deoxy-D-ribos-5-yl)-L-homocysteine","R00194 R01291","Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of amino acids","3.2.2.9; 4.4.1.21","Cysteine biosynthesis, methionine => cysteine",NA,"PubChem: 6343; ChEMBL: CHEMBL593446; PDB-CCD: 2WP RHC; 3DMET: B01667; NIKKAJI: J1.589.202A","cpd:C03539",9,17,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C9H18O6N1S1","C9H16O6N1S1",267.0776584,268.0854835,266.0698334
"cpd:C04188","S-Methyl-5-thio-D-ribose 1-phosphate;","C6H13O7PS","S-Methyl-5-thio-D-ribose 1-phosphate; S-Methyl-5-thio-alpha-D-ribose 1-phosphate; S-Methyl-5-thio-5-deoxy-D-ribose 1-phosphate","R01402 R04143 R04420 R09668","Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways","2.4.2.28; 2.4.2.44; 2.7.1.100; 5.3.1.23","Methionine salvage pathway",NA,"PubChem: 6864; ChEBI: 27859; 3DMET: B01722; NIKKAJI: J2.401.247F","cpd:C04188; cpd:C04582",6,13,7,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O7P1S1","C6H12O7P1S1",260.0119609,261.019786,259.0041359
"cpd:C04582","S-Methyl-5-thio-D-ribulose 1-phosphate","C6H13O7PS","S-Methyl-5-thio-D-ribulose 1-phosphate","R04420 R07392","Cysteine and methionine metabolism; Metabolic pathways","4.2.1.109; 5.3.1.23","Methionine salvage pathway",NA,"PubChem: 7183; ChEBI: 28096; PDB-CCD: MRU; 3DMET: B04948; NIKKAJI: J2.752.046D","cpd:C04188; cpd:C04582",6,13,7,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O7P1S1","C6H12O7P1S1",260.0119609,261.019786,259.0041359
"cpd:C05526","S-Glutathionyl-L-cysteine","C13H22N4O8S2","S-Glutathionyl-L-cysteine","R00900 R04860","Cysteine and methionine metabolism","1.8.1.9; 1.8.1.10; 1.8.4.3",NA,NA,"PubChem: 7869; ChEBI: 21264 8959; NIKKAJI: J2.756.162D","cpd:C05526",13,22,8,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,"C13H23O8N4S2","C13H21O8N4S2",426.087906,427.0957311,425.080081
"cpd:C05527","3-Sulfinylpyruvate;","C3H4O5S","3-Sulfinylpyruvate; 3-Sulfinopyruvate","R02618 R02619 R04861","Cysteine and methionine metabolism; Metabolic pathways","1.4.1.-; 2.6.1.1",NA,NA,"PubChem: 7870; ChEBI: 1665; 3DMET: B00785; NIKKAJI: J2.365.114I","cpd:C05527; cpd:C20929",3,4,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O5S1","C3H3O5S1",151.9779444,152.9857694,150.9701194
"cpd:C05528","3-Sulfopyruvate;","C3H4O6S","3-Sulfopyruvate; 3-Sulfopyruvic acid","R02433 R05693 R05694 R05774 R07136 R07137 R08590","Cysteine and methionine metabolism; Methane metabolism; Microbial metabolism in diverse environments","1.1.1.37; 1.1.1.310; 1.1.1.337; 1.1.1.338; 2.6.1.1; 4.1.1.79","Coenzyme M biosynthesis",NA,"PubChem: 7871; ChEBI: 16894; KNApSAcK: C00000764; PDB-CCD: SPV; 3DMET: B00786; NIKKAJI: J1.837.369F","cpd:C05528",3,4,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H5O6S1","C3H3O6S1",167.972859,168.9806841,166.965034
"cpd:C05823","3-Mercaptolactate;","C3H6O3S","3-Mercaptolactate; L-3-Mercaptolactate; (R)-3-Mercaptolactate","R03104","Cysteine and methionine metabolism","1.1.1.27",NA,NA,"PubChem: 8118; ChEBI: 28580; 3DMET: B05120; NIKKAJI: J397.550I","cpd:C03726; cpd:C05823; cpd:C19296",3,6,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O3S1","C3H5O3S1",122.0037652,123.0115903,120.9959402
"cpd:C05824","S-Sulfo-L-cysteine","C3H7NO5S2","S-Sulfo-L-cysteine","R02409 R03132 R04860 R10409","Cysteine and methionine metabolism; Biosynthesis of amino acids","1.8.4.3; 2.5.1.47",NA,NA,"CAS: 1637-71-4; PubChem: 8119; ChEBI: 27891; ChEMBL: CHEMBL457665; PDB-CCD: CSU; 3DMET: B01899; NIKKAJI: J832.997D","cpd:C05824",3,7,5,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,"C3H8O5N1S2","C3H6O5N1S2",200.9765647,201.9843897,199.9687396
"cpd:C06547","Ethylene","C2H4","Ethylene","R05444 R05496 R05498 R07214 R09784","Cysteine and methionine metabolism; Chloroalkane and chloroalkene degradation; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Plant hormone signal transduction; Chemical carcinogenesis","1.13.12.19; 1.14.13.69; 1.14.17.4; 1.18.6.1; 1.97.1.-","Ethylene biosynthesis, methionine => ethylene","Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06547  Ethylene","CAS: 74-85-1; PubChem: 8777; ChEBI: 18153; ChEMBL: CHEMBL117822; KNApSAcK: C00000175; 3DMET: B00966; NIKKAJI: J1.939I","cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00084; cpd:C00098; cpd:C00151; cpd:C00160; cpd:C00266; cpd:C00405; cpd:C00593; cpd:C00980; cpd:C01010; cpd:C01857; cpd:C02086; cpd:C02896; cpd:C02903; cpd:C02998; cpd:C03129; cpd:C05167; cpd:C05234; cpd:C05710; cpd:C06547; cpd:C06548; cpd:C06752; cpd:C07165; cpd:C08382; cpd:C11088; cpd:C11261; cpd:C11317; cpd:C11623; cpd:C11624; cpd:C11625; cpd:C13301; cpd:C13400; cpd:C13724; cpd:C14179; cpd:C14860; cpd:C18091; cpd:C18247; cpd:C18372; cpd:C18424; cpd:C18568; cpd:C18675; cpd:C18723; cpd:C18940; cpd:C19158; cpd:C19419; cpd:C19503; cpd:C20305; cpd:C20794",2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C2H5","C2H3",28.03130013,29.03912516,27.0234751
"cpd:C08276","3-(Methylthio)propanoate;","C4H8O2S","3-(Methylthio)propanoate; 3-(Methylthio)propionic acid; 3-Methylthiopropionate","R07363 R10333 R10820","Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways","1.13.11.53; 2.1.1.269; 6.2.1.44",NA,NA,"CAS: 646-01-5; PubChem: 10474; ChEBI: 1438; ChEMBL: CHEMBL116212; LIPIDMAPS: LMFA01130006; KNApSAcK: C00001194; 3DMET: B02154; NIKKAJI: J22.485E","cpd:C08276",4,8,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O2S1","C4H7O2S1",120.0245007,121.0323257,119.0166756
"cpd:C11499","(S)-3-Sulfolactate;","C3H6O6S","(S)-3-Sulfolactate; (2S)-3-Sulfolactate","R05693 R05694","Cysteine and methionine metabolism","1.1.1.310",NA,NA,"PubChem: 13669; ChEBI: 16712 61289; NIKKAJI: J2.774.742F","cpd:C02543; cpd:C02914; cpd:C11499; cpd:C11537; cpd:C16069; cpd:C17205",3,6,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O6S1","C3H5O6S1",169.9885091,170.9963341,168.9806841
"cpd:C11537","(2R)-3-Sulfolactate;","C3H6O6S","(2R)-3-Sulfolactate; (R)-3-Sulfolactate","R05789 R07136 R07137 R09545","Cysteine and methionine metabolism; Methane metabolism; Microbial metabolism in diverse environments","1.1.1.37; 1.1.1.308; 1.1.1.337; 1.1.1.338; 3.1.3.71","Coenzyme M biosynthesis",NA,"PubChem: 13704; ChEBI: 48291; PDB-CCD: 3SL; NIKKAJI: J2.774.884H","cpd:C02543; cpd:C02914; cpd:C11499; cpd:C11537; cpd:C16069; cpd:C17205",3,6,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C3H7O6S1","C3H5O6S1",169.9885091,170.9963341,168.9806841
"cpd:C15606","1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one","C6H10O3S","1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one","R07363 R07364 R07394 R07395","Cysteine and methionine metabolism; Metabolic pathways","1.13.11.53; 1.13.11.54; 3.1.3.77; 3.1.3.87","Methionine salvage pathway",NA,"PubChem: 17396598; ChEBI: 49252; NIKKAJI: J1.779.751D","cpd:C03895; cpd:C05535; cpd:C15606; cpd:C15653; cpd:C17211; cpd:C21378",6,10,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O3S1","C6H9O3S1",162.0350654,163.0428904,161.0272403
"cpd:C15650","2,3-Diketo-5-methylthiopentyl-1-phosphate;","C6H11O6PS","2,3-Diketo-5-methylthiopentyl-1-phosphate; 5-(Methylthio)-2,3-dioxopentyl phosphate","R07392 R07393 R07395","Cysteine and methionine metabolism; Metabolic pathways","3.1.3.77; 4.2.1.109; 5.3.2.5","Methionine salvage pathway",NA,"PubChem: 17396640; ChEBI: 50604; NIKKAJI: J2.178.133I","cpd:C15650; cpd:C15651",6,11,6,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O6P1S1","C6H10O6P1S1",242.0013962,243.0092213,240.9935712
"cpd:C15651","2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate;","C6H11O6PS","2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate; 2-Hydroxy-5-(methylthio)-3-oxopent-1-enyl phosphate","R07393 R07394","Cysteine and methionine metabolism; Metabolic pathways","3.1.3.77; 3.1.3.87; 5.3.2.5","Methionine salvage pathway",NA,"PubChem: 17396641; ChEBI: 50605; NIKKAJI: J1.971.656B","cpd:C15650; cpd:C15651",6,11,6,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O6P1S1","C6H10O6P1S1",242.0013962,243.0092213,240.9935712
"cpd:C19787","5'-S-Methyl-5'-thioinosine;","C11H14N4O4S","5'-S-Methyl-5'-thioinosine; 5'-Deoxy-5'-methylthioinosine; S-Methyl-5'-thioinosine","R09660 R09668","Cysteine and methionine metabolism; Metabolic pathways","2.4.2.44; 3.5.4.31",NA,NA,"CAS: 17298-58-7; PubChem: 135626254","cpd:C19787",11,14,4,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"C11H15O4N4S1","C11H13O4N4S1",298.0735761,299.0814012,297.0657511
"cpd:C21015","gamma-L-Glutamyl-L-2-aminobutyrate","C9H16N2O5","gamma-L-Glutamyl-L-2-aminobutyrate","R10993 R10994","Cysteine and methionine metabolism; Metabolic pathways","6.3.2.2; 6.3.2.3",NA,NA,"PubChem: 254741469","cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015",9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H17O5N2","C9H15O5N2",232.1059216,233.1137467,231.0980966
"cpd:C21016","Ophthalmate;","C11H19N3O6","Ophthalmate; gamma-L-Glutamyl-L-2-aminobutyrylglycine","R10994","Cysteine and methionine metabolism; Metabolic pathways","6.3.2.3",NA,NA,"PubChem: 254741470","cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016",11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H20O6N3","C11H18O6N3",289.1273853,290.1352104,288.1195603
"cpd:C00100","Propanoyl-CoA;","C24H40N7O17P3S","Propanoyl-CoA; Propionyl-CoA; Propionyl coenzyme A","R00918 R00919 R00920 R00921 R00922 R00923 R00924 R00925; R00926 R00927 R00928 R00930 R00931 R00932 R00934 R00935; R01199 R01449 R01859 R03719 R04432 R04546 R04811 R05330; R05373 R06414 R06644 R06987 R09097 R10161 R10974 R10998","Valine, leucine and isoleucine degradation; beta-Alanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Xylene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of type II polyketide backbone; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds","1.2.1.27; 1.2.1.87; 1.2.7.1; 1.3.1.84; 1.3.1.95; 1.3.1.-; 1.3.8.7; 2.1.3.1; 2.3.1.8; 2.3.1.9; 2.3.1.16; 2.3.1.54; 2.3.1.94; 2.3.1.168; 2.3.1.176; 2.3.1.222; 2.3.1.-; 2.3.3.5; 2.3.3.11; 2.8.3.1; 3.13.1.4; 4.1.1.9; 4.1.1.41; 4.1.3.24; 6.2.1.1; 6.2.1.13; 6.2.1.17; 6.4.1.3","Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA; Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,"CAS: 317-66-8; PubChem: 3400; ChEBI: 15539; PDB-CCD: 1VU; 3DMET: B04632; NIKKAJI: J1.695.704F","cpd:C00100",24,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C24H41O17N7P3S1","C24H39O17N7P3S1",823.141425,824.1492501,822.1336
"cpd:C00123","L-Leucine;","C6H13NO2","L-Leucine; 2-Amino-4-methylvaleric acid; (2S)-alpha-2-Amino-4-methylvaleric acid; (2S)-alpha-Leucine","R01088 R01089 R01090 R01091 R02552 R03657 R08411 R08664; R10944","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; mTOR signaling pathway; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.9; 1.14.13.-; 2.3.1.66; 2.6.1.6; 2.6.1.42; 2.6.1.67; 3.5.1.64; 5.4.3.7; 6.1.1.4; 6.3.2.47","Leucine degradation, leucine => acetoacetate + acetyl-CoA","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00123  Leucine (Leu); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Leucine;     D00030  Leucine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00030  [003619] L-Leucine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00030  L-Leucine","CAS: 61-90-5; PubChem: 3423; ChEBI: 15603; ChEMBL: CHEMBL291962; KNApSAcK: C00001377; PDB-CCD: LEU; 3DMET: B00034; NIKKAJI: J1.167C","cpd:C00123; cpd:C00407; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02378; cpd:C02486; cpd:C06418; cpd:C08263; cpd:C11227; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C17213; cpd:C20988; cpd:C21092; cpd:C21096",6,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O2N1","C6H12O2N1",131.0946287,132.1024537,130.0868036
"cpd:C00141","3-Methyl-2-oxobutanoic acid;","C5H8O3","3-Methyl-2-oxobutanoic acid; 3-Methyl-2-oxobutyric acid; 3-Methyl-2-oxobutanoate; 2-Oxo-3-methylbutanoate; 2-Oxoisovalerate; 2-Oxoisopentanoate; alpha-Ketovaline; 2-Ketovaline; 2-Keto-3-methylbutyric acid","R01209 R01210 R01211 R01212 R01213 R01214 R01215 R01216; R01226 R01434 R01701 R02200 R04441 R07160 R07599","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Pantothenate and CoA biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.84; 1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.8; 1.4.1.9; 1.4.1.23; 2.1.2.11; 2.3.3.13; 2.6.1.6; 2.6.1.32; 2.6.1.42; 2.6.1.66; 4.1.2.12; 4.2.1.9","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00141  2-Oxoisovalerate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C00141  3-Methyl-2-oxobutanoic acid","CAS: 759-05-7; PubChem: 3441; ChEBI: 11851 16530; ChEMBL: CHEMBL146554; LIPIDMAPS: LMFA01020274; LipidBank: DFA0388; KNApSAcK: C00007623; PDB-CCD: KIV; 3DMET: B00039; NIKKAJI: J39.558G","cpd:C00141; cpd:C01180; cpd:C02233; cpd:C02707; cpd:C03273; cpd:C05727; cpd:C06255; cpd:C07764; cpd:C18006; cpd:C19485; cpd:C19803",5,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O3","C5H7O3",116.0473441,117.0551691,115.0395191
"cpd:C00183","L-Valine;","C5H11NO2","L-Valine; 2-Amino-3-methylbutyric acid","R01212 R01214 R01215 R01434 R01437 R02200 R03665 R04870; R08663 R10031 R10941 R10942","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Penicillin and cephalosporin biosynthesis; Cyanoamino acid metabolism; Pantothenate and CoA biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.8; 1.4.1.9; 1.4.1.23; 1.14.13.117; 1.14.13.118; 2.6.1.6; 2.6.1.32; 2.6.1.42; 2.6.1.66; 4.1.1.14; 6.1.1.9; 6.3.2.26; 6.3.2.47","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00183  Valine (Val); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Valine;     D00039  Valine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00039  L-Valine","CAS: 72-18-4; PubChem: 3483; ChEBI: 16414; ChEMBL: CHEMBL43068; KNApSAcK: C00001398; PDB-CCD: VAL; 3DMET: B00054; NIKKAJI: J9.179K","cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436",5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O2N1","C5H10O2N1",117.0789786,118.0868036,116.0711536
"cpd:C00233","4-Methyl-2-oxopentanoate;","C6H10O3","4-Methyl-2-oxopentanoate; 2-Oxoisocaproate","R01088 R01090 R01651 R01652 R01702 R07601 R08566 R10052","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.85; 1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.9; 2.6.1.6; 2.6.1.42; 2.6.1.67","Leucine degradation, leucine => acetoacetate + acetyl-CoA; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00233  2-Oxoisocaproate","CAS: 816-66-0; PubChem: 3532; ChEBI: 17865 48430; ChEMBL: CHEMBL445647; KNApSAcK: C00019677; PDB-CCD: COI; 3DMET: B00066; NIKKAJI: J39.557I","cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378",6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O3","C6H9O3",130.0629942,131.0708192,129.0551691
"cpd:C00349","2-Methyl-3-oxopropanoate;","C4H6O3","2-Methyl-3-oxopropanoate; 3-Oxo-2-methylpropanoate; Methylmalonate semialdehyde","R00922 R02047 R02050","Valine, leucine and isoleucine degradation","1.1.1.31; 1.2.1.27; 2.6.1.40",NA,NA,"PubChem: 3642; ChEBI: 16256; LIPIDMAPS: LMFA01060193; NIKKAJI: J707.628B","cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172",4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3","C4H5O3",102.0316941,103.0395191,101.023869
"cpd:C00407","L-Isoleucine;","C6H13NO2","L-Isoleucine; 2-Amino-3-methylvaleric acid","R02196 R02197 R02199 R02200 R03656 R06726 R09344 R09403; R10027 R10723 R10943 R11078","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Cyanoamino acid metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer","1.4.1.9; 1.4.3.2; 1.14.11.45; 1.14.13.117; 1.14.13.118; 2.6.1.32; 2.6.1.42; 5.1.1.21; 6.1.1.5; 6.3.2.47","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00407  Isoleucine (Ile); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Isoleucine;     D00065  Isoleucine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00065  L-Isoleucine","CAS: 73-32-5; PubChem: 3697; ChEBI: 17191; ChEMBL: CHEMBL1233584 CHEMBL1869615; LIPIDMAPS: LMFA01100047; KNApSAcK: C00001374; PDB-CCD: ILE; 3DMET: B01236; NIKKAJI: J2.818E","cpd:C00123; cpd:C00407; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02378; cpd:C02486; cpd:C06418; cpd:C08263; cpd:C11227; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C17213; cpd:C20988; cpd:C21092; cpd:C21096",6,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H14O2N1","C6H12O2N1",131.0946287,132.1024537,130.0868036
"cpd:C00630","2-Methylpropanoyl-CoA;","C25H42N7O17P3S","2-Methylpropanoyl-CoA; 2-Methylpropionyl-CoA; Isobutyryl-CoA","R01181 R01210 R02661 R02662 R02663 R06482 R06483 R07160; R09090 R09854","Valine, leucine and isoleucine degradation; Phenylalanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.2.1.25; 1.2.7.7; 1.3.8.1; 1.3.8.7; 1.3.99.12; 1.3.99.-; 2.3.1.168; 5.4.99.13","Capsaicin biosynthesis, L-Phenylalanine => Capsaicin; Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,"PubChem: 3903; ChEBI: 15479; PDB-CCD: CO6; 3DMET: B04708; NIKKAJI: J721.070A","cpd:C00136; cpd:C00630",25,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H43O17N7P3S1","C25H41O17N7P3S1",837.1570751,838.1649001,836.1492501
"cpd:C00671","(S)-3-Methyl-2-oxopentanoic acid;","C6H10O3","(S)-3-Methyl-2-oxopentanoic acid; (S)-3-Methyl-2-oxopentanoate; (3S)-3-Methyl-2-oxopentanoic acid; (3S)-3-Methyl-2-oxopentanoate","R02196 R02197 R02199 R02200 R03171 R03894 R04225 R05070; R07603 R08567","Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.9; 1.4.3.2; 2.6.1.32; 2.6.1.42; 4.1.1.72; 4.2.1.9","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00671  (S)-3-Methyl-2-oxopentanoic acid; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C00671  (S)-3-Methyl-2-oxopentanoic acid","PubChem: 3940; ChEBI: 15614 35146; LIPIDMAPS: LMFA01020275; PDB-CCD: 1QQ; 3DMET: B01307; NIKKAJI: J264.814H","cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378",6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O3","C6H9O3",130.0629942,131.0708192,129.0551691
"cpd:C00683","(S)-Methylmalonyl-CoA;","C25H40N7O19P3S","(S)-Methylmalonyl-CoA; (S)-Methylmalonyl-coenzyme A; (2S)-Methylmalonyl-CoA; D-Methylmalonyl-CoA","R00918 R00923 R00930 R01859 R02764 R02765 R06458 R06459","Valine, leucine and isoleucine degradation; Biosynthesis of 12-, 14- and 16-membered macrolides; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism","2.1.3.1; 2.3.1.94; 2.3.1.239; 2.3.1.240; 3.1.2.17; 4.1.1.41; 5.1.99.1; 6.4.1.3","Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA; Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B; Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",NA,"PubChem: 3952; ChEBI: 15466; 3DMET: B04716; NIKKAJI: J921.435F","cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557",25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O19N7P3S1","C25H39O19N7P3S1",867.1312543,868.1390793,866.1234292
"cpd:C01213","(R)-Methylmalonyl-CoA;","C25H40N7O19P3S","(R)-Methylmalonyl-CoA; L-Methylmalonyl-CoA","R00833 R02765 R03381 R03383","Valine, leucine and isoleucine degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism","1.2.1.-; 5.1.99.1; 5.4.99.2; 6.2.1.-","Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",NA,"PubChem: 4435; ChEBI: 15465; PDB-CCD: MCA; 3DMET: B04783; NIKKAJI: J890.616E","cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557",25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O19N7P3S1","C25H39O19N7P3S1",867.1312543,868.1390793,866.1234292
"cpd:C02939","3-Methylbutanoyl-CoA;","C26H44N7O17P3S","3-Methylbutanoyl-CoA; Isovaleryl-CoA","R01651 R04095 R04096 R04097 R04098 R05331 R08566 R10526","Valine, leucine and isoleucine degradation; Metabolic pathways","1.2.1.25; 1.2.7.7; 1.3.8.4; 1.3.8.7; 2.3.1.156; 2.3.1.168; 2.3.1.228","Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,"PubChem: 5858; ChEBI: 15487; PDB-CCD: IVC; 3DMET: B04869; NIKKAJI: J675.058C","cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980",26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H45O17N7P3S1","C26H43O17N7P3S1",851.1727252,852.1805502,850.1649001
"cpd:C03069","3-Methylcrotonyl-CoA;","C26H42N7O17P3S","3-Methylcrotonyl-CoA; 3-Methylbut-2-enoyl-CoA; 3-Methylcrotonoyl-CoA; Dimethylacryloyl-CoA","R04095 R04096 R04137 R04138 R08095","Valine, leucine and isoleucine degradation; Geraniol degradation; Metabolic pathways","1.3.8.4; 1.3.8.7; 2.3.1.16; 4.2.1.17; 6.4.1.4","Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,"PubChem: 5969; ChEBI: 15486; 3DMET: B04879; NIKKAJI: J1.710.034C","cpd:C02451; cpd:C03069; cpd:C03345; cpd:C03466",26,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H43O17N7P3S1","C26H41O17N7P3S1",849.1570751,850.1649001,848.1492501
"cpd:C03231","3-Methylglutaconyl-CoA;","C27H42N7O19P3S","3-Methylglutaconyl-CoA; trans-3-Methylglutaconyl-CoA; (E)-3-Methylglutaconyl-1-CoA","R02085 R04138","Valine, leucine and isoleucine degradation; Metabolic pathways","4.2.1.18; 6.4.1.4","Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,"PubChem: 6102; ChEBI: 15488; 3DMET: B04886; NIKKAJI: J2.741.395A","cpd:C03231; cpd:C14144; cpd:C19682",27,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C27H43O19N7P3S1","C27H41O19N7P3S1",893.1469043,894.1547294,892.1390793
"cpd:C03284","L-3-Aminoisobutanoate;","C4H9NO2","L-3-Aminoisobutanoate; (S)-3-Aminoisobutyrate; L-3-Aminoisobutyrate; (S)-3-Aminoisobutanoate; (S)-3-Amino-2-methylpropanoate; (S)-beta-Aminoisobutyrate","R04187 R04188","Valine, leucine and isoleucine degradation","2.6.1.18; 2.6.1.22",NA,NA,"PubChem: 6143; ChEBI: 18188 33094; LIPIDMAPS: LMFA01100050; PDB-CCD: 62H BIB; 3DMET: B01645; NIKKAJI: J52.799H","cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514",4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H10O2N1","C4H8O2N1",103.0633285,104.0711536,102.0555035
"cpd:C03344","2-Methylacetoacetyl-CoA;","C26H42N7O18P3S","2-Methylacetoacetyl-CoA; 2-Methyl-3-acetoacetyl-CoA","R00927 R04203","Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.1.1.35; 1.1.1.178; 2.3.1.9; 2.3.1.16",NA,NA,"PubChem: 6187; ChEBI: 15476; 3DMET: B04890; NIKKAJI: J2.741.588A","cpd:C03344",26,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H43O18N7P3S1","C26H41O18N7P3S1",865.1519897,866.1598147,864.1441647
"cpd:C03345","2-Methylbut-2-enoyl-CoA;","C26H42N7O17P3S","2-Methylbut-2-enoyl-CoA; trans-2-Methylbut-2-enoyl-CoA; Tiglyl-CoA; (E)-2-Methylcrotonoyl-CoA; Methylcrotonoyl-CoA; Methylcrotonyl-CoA; Tigloyl-CoA; 2-Methylcrotanoyl-CoA","R03169 R03172 R03173 R04204 R04205","Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.3.8.1; 1.3.8.5; 1.3.8.7; 1.3.99.12; 2.3.1.93; 4.2.1.17",NA,NA,"PubChem: 6188; ChEBI: 15478; 3DMET: B04891","cpd:C02451; cpd:C03069; cpd:C03345; cpd:C03466",26,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H43O17N7P3S1","C26H41O17N7P3S1",849.1570751,850.1649001,848.1492501
"cpd:C03460","2-Methylprop-2-enoyl-CoA;","C25H40N7O17P3S","2-Methylprop-2-enoyl-CoA; Methacrylyl-CoA; Methylacrylyl-CoA","R02661 R04224","Valine, leucine and isoleucine degradation; Metabolic pathways","1.3.8.1; 1.3.8.7; 1.3.99.12; 1.3.99.-; 4.2.1.17",NA,NA,"PubChem: 6280; ChEBI: 27754; PDB-CCD: 2MC; 3DMET: B04898; NIKKAJI: J2.076.063J","cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268",25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H41O17N7P3S1","C25H39O17N7P3S1",835.141425,836.1492501,834.1336
"cpd:C04405","(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA;","C26H44N7O18P3S","(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA; (S)-3-Hydroxy-2-methylbutyryl-CoA","R04203 R04204","Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.1.1.35; 1.1.1.178; 4.2.1.17",NA,NA,"PubChem: 7041; ChEBI: 15449; PDB-CCD: T1G; 3DMET: B04940; NIKKAJI: J2.750.522H","cpd:C03237; cpd:C04405; cpd:C05998",26,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H45O18N7P3S1","C26H43O18N7P3S1",867.1676398,868.1754648,866.1598147
"cpd:C05998","3-Hydroxyisovaleryl-CoA;","C26H44N7O18P3S","3-Hydroxyisovaleryl-CoA; 3-Hydroxyisovaleryl coenzyme A","R04137 R10759","Valine, leucine and isoleucine degradation","4.2.1.17",NA,NA,"PubChem: 8272; ChEBI: 28291; 3DMET: B05143; NIKKAJI: J2.760.860D","cpd:C03237; cpd:C04405; cpd:C05998",26,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H45O18N7P3S1","C26H43O18N7P3S1",867.1676398,868.1754648,866.1598147
"cpd:C06000","(S)-3-Hydroxyisobutyryl-CoA","C25H42N7O18P3S","(S)-3-Hydroxyisobutyryl-CoA","R04224 R05064","Valine, leucine and isoleucine degradation; Metabolic pathways","3.1.2.4; 4.2.1.17",NA,NA,"PubChem: 8274; ChEBI: 28259; 3DMET: B05145; NIKKAJI: J2.760.861B","cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287",25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C25H43O18N7P3S1","C25H41O18N7P3S1",853.1519897,854.1598147,852.1441647
"cpd:C06001","(S)-3-Hydroxyisobutyrate","C4H8O3","(S)-3-Hydroxyisobutyrate","R05064 R05066","Valine, leucine and isoleucine degradation; Metabolic pathways","1.1.1.31; 1.1.1.35; 3.1.2.4",NA,NA,"PubChem: 8275; ChEBI: 37373 62638; 3DMET: B01946; NIKKAJI: J61.903E","cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297",4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H9O3","C4H7O3",104.0473441,105.0551691,103.0395191
"cpd:C06002","(S)-Methylmalonate semialdehyde","C4H6O3","(S)-Methylmalonate semialdehyde","R00935 R03381 R03869 R03871 R03872 R04187 R04188 R05066; R09238 R11028","Valine, leucine and isoleucine degradation; Nitrotoluene degradation; Propanoate metabolism; Metabolic pathways; Microbial metabolism in diverse environments","1.1.1.31; 1.1.1.35; 1.2.1.3; 1.2.1.27; 1.2.1.-; 1.2.3.1; 2.6.1.18; 2.6.1.22; 3.7.1.-",NA,NA,"PubChem: 8276; ChEBI: 27821; LIPIDMAPS: LMFA01060190; 3DMET: B01947; NIKKAJI: J2.359.609A","cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172",4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C4H7O3","C4H5O3",102.0316941,103.0395191,101.023869
"cpd:C15974","3-Methyl-1-hydroxybutyl-ThPP;","C17H29N4O8P2S","3-Methyl-1-hydroxybutyl-ThPP; 3-Methyl-1-hydroxybutyl-TPP","R07601 R07602","Valine, leucine and isoleucine degradation","1.2.4.4",NA,NA,"PubChem: 47205287; ChEBI: 80220; NIKKAJI: J2.799.840B","cpd:C15974; cpd:C15978",17,29,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C17H30O8N4P2S1","C17H28O8N4P2S1",511.1181341,512.1259591,510.110309
"cpd:C15976","2-Methyl-1-hydroxypropyl-ThPP;","C16H27N4O8P2S","2-Methyl-1-hydroxypropyl-ThPP; 2-Methyl-1-hydroxypropyl-TPP","R07599 R07600","Valine, leucine and isoleucine degradation","1.2.4.4",NA,NA,"PubChem: 47205289; ChEBI: 48522; NIKKAJI: J2.799.841K","cpd:C15976",16,27,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C16H28O8N4P2S1","C16H26O8N4P2S1",497.102484,498.110309,496.094659
"cpd:C15978","2-Methyl-1-hydroxybutyl-ThPP;","C17H29N4O8P2S","2-Methyl-1-hydroxybutyl-ThPP; 2-Methyl-1-hydroxybutyl-TPP","R07603 R07604","Valine, leucine and isoleucine degradation","1.2.4.4",NA,NA,"PubChem: 47205291; ChEBI: 80223; NIKKAJI: J2.799.847J","cpd:C15974; cpd:C15978",17,29,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,"C17H30O8N4P2S1","C17H28O8N4P2S1",511.1181341,512.1259591,510.110309
"cpd:C15980","(S)-2-Methylbutanoyl-CoA","C26H44N7O17P3S","(S)-2-Methylbutanoyl-CoA","R03171 R03172 R03174 R03175 R08567","Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.2.1.25; 1.2.7.7; 1.3.8.1; 1.3.8.7; 1.3.99.12; 2.3.1.168",NA,NA,"PubChem: 47205293; ChEBI: 90222; NIKKAJI: J971.426J","cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980",26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C26H45O17N7P3S1","C26H43O17N7P3S1",851.1727252,852.1805502,850.1649001
"cpd:C20827","3-Hydroxyisovalerate;","C5H10O3","3-Hydroxyisovalerate; 3-Hydroxy-3-methylbutyrate","R10759","Valine, leucine and isoleucine degradation",NA,NA,NA,"PubChem: 254741293","cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C02804; cpd:C05100; cpd:C16673; cpd:C20827; cpd:C21029",5,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O3","C5H9O3",118.0629942,119.0708192,117.0551691
"cpd:C01291","3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA;","C32H50N7O19P3S","3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA; Isohexenyl-glutaconyl-CoA","R03493 R03494","Geraniol degradation","4.2.1.57; 6.4.1.5",NA,NA,"PubChem: 4510; ChEBI: 15480; NIKKAJI: J2.732.417G","cpd:C01291",32,50,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C32H51O19N7P3S1","C32H49O19N7P3S1",961.2095046,962.2173296,960.2016796
"cpd:C01499","Geranial;","C10H16O","Geranial; trans-Citral","R03581 R08086 R08099 R08398 R10308","Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.1.1.183; 1.1.1.347; 1.2.1.86",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C01499  Geranial; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C01499  Geranial; Major components of natural products [BR:br08323];  Medicinal herbs;   Lemon grass;    C01499  Geranial","CAS: 141-27-5 5392-40-5; PubChem: 4668; ChEBI: 16980; ChEMBL: CHEMBL1080997; LIPIDMAPS: LMPR0102010003; KNApSAcK: C00003035 C00035822; 3DMET: B00306; NIKKAJI: J2.026E J3.073B","cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943",10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O1","C10H15O1",152.1201151,153.1279402,151.1122901
"cpd:C01500","Geraniol","C10H18O","Geraniol","R03581 R08396 R08501 R08502 R08785 R09708 R10308 R11552","Geraniol degradation; Monoterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics","1.1.1.183; 1.1.1.347; 1.14.13.152; 3.1.7.3; 3.1.7.11; 5.4.4.4",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C01500  Geraniol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C01500  Geraniol; Pharmaceutical additives [BR:br08316];  Base;   C01500  [102490] Geraniol;  Algefacient;   C01500  [102490] Geraniol;  Favoring agent, Fragrance;   C01500  [102490] Geraniol;  Solubilization agent;   C01500  [102490] Geraniol; Major components of natural products [BR:br08323];  Essential oils;   Palmarosa oil (India);    C01500  Geraniol","CAS: 106-24-1; PubChem: 4669; ChEBI: 17447; ChEMBL: CHEMBL25719; LipidBank: IIP0004; KNApSAcK: C00000845; PDB-CCD: 64Z; 3DMET: B00307; NIKKAJI: J3.240I","cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261",10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O1","C10H17O1",154.1357652,155.1435902,153.1279402
"cpd:C01920","Geranoyl-CoA;","C31H50N7O17P3S","Geranoyl-CoA; cis-Geranyl-CoA","R03494 R08089 R08098","Geraniol degradation","1.3.99.-; 5.2.1.-; 6.4.1.5",NA,NA,"PubChem: 5026; ChEBI: 15523; NIKKAJI: J2.609.446A","cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465",31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H51O17N7P3S1","C31H49O17N7P3S1",917.2196753,918.2275004,916.2118503
"cpd:C04675","3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA;","C32H52N7O20P3S","3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA; 3-Hydroxy-3-isohexeneylglutaryl-CoA","R03493 R08090","Geraniol degradation","4.1.3.4; 4.1.3.26; 4.2.1.57",NA,NA,"PubChem: 7256; ChEBI: 15483; NIKKAJI: J2.752.858I","cpd:C04675",32,52,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C32H53O20N7P3S1","C32H51O20N7P3S1",979.2200693,980.2278943,978.2122442
"cpd:C09847","cis-Citral;","C10H16O","cis-Citral; Neral","R08083 R08099 R08394","Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites","1.1.1.183",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09847  Neral; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09847  cis-Citral; Major components of natural products [BR:br08323];  Medicinal herbs;   Lemon grass;    C09847  cis-Citral","CAS: 106-26-3; PubChem: 12034; ChEBI: 29020; LIPIDMAPS: LMPR0102010006; KNApSAcK: C00003036; 3DMET: B03319; NIKKAJI: J3.242E","cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943",10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O1","C10H15O1",152.1201151,153.1279402,151.1122901
"cpd:C09848","(R)-(+)-Citronellal","C10H18O","(R)-(+)-Citronellal","R08084 R08087 R08399 R10125","Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites","1.1.1.183; 1.1.1.-; 1.2.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09848  (R)-(+)-Citronellal; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09848  (R)-(+)-Citronellal","CAS: 2385-77-5; PubChem: 12035; ChEBI: 299; ChEMBL: CHEMBL1081721; LIPIDMAPS: LMPR0102010007; KNApSAcK: C00003037; 3DMET: B03320; NIKKAJI: J3.239E J43.580E","cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261",10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O1","C10H17O1",154.1357652,155.1435902,153.1279402
"cpd:C09849","beta-Citronellol;","C10H20O","beta-Citronellol; (R)-(+)-Citronellol","R08084 R08397 R10125","Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites","1.1.1.183; 1.1.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09849  beta-Citronellol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09849  beta-Citronellol; Major components of natural products [BR:br08323];  Essential oils;   Rose oil;    C09849  beta-Citronellol;   Geranium oil;    C09849  beta-Citronellol","CAS: 106-22-9 1117-61-9; PubChem: 12036; ChEBI: 10360; ChEMBL: CHEMBL1907993; LIPIDMAPS: LMPR0102010008; KNApSAcK: C00000844 C00003038; 3DMET: B03321; NIKKAJI: J3.238G J67.959C","cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307",10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H21O1","C10H19O1",156.1514153,157.1592403,155.1435902
"cpd:C09871","Nerol;","C10H18O","Nerol; (Z)-3,7-Dimethylocta-2,6-dien-1-ol","R08083 R08393","Geraniol degradation; Biosynthesis of terpenoids and steroids","1.1.1.183",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09871  Nerol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09871  Nerol","CAS: 106-25-2; PubChem: 12057; ChEBI: 29452; ChEMBL: CHEMBL452683; LIPIDMAPS: LMPR0102010010; KNApSAcK: C00000855; 3DMET: B03338; NIKKAJI: J3.241G","cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261",10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O1","C10H17O1",154.1357652,155.1435902,153.1279402
"cpd:C11384","(S)-(-)-Citronellal;","C10H18O","(S)-(-)-Citronellal; (S)-3,7-Dimethyloct-6-enal","R08085 R08096 R10126","Geraniol degradation","1.1.1.183; 1.1.1.-; 1.2.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11384  (S)-(-)-Citronellal; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11384  (S)-(-)-Citronellal","CAS: 5949-05-3; PubChem: 13558; ChEBI: 368; LIPIDMAPS: LMPR0102010011; KNApSAcK: C00010309; 3DMET: B04233; NIKKAJI: J66.806K","cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261",10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O1","C10H17O1",154.1357652,155.1435902,153.1279402
"cpd:C11386","(-)-Citronellol","C10H20O","(-)-Citronellol","R08085 R10126","Geraniol degradation","1.1.1.183; 1.1.1.-",NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11386  (-)-Citronellol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11386  (-)-Citronellol; Major components of natural products [BR:br08323];  Essential oils;   Rose oil;    C11386  (-)-Citronellol;   Geranium oil;    C11386  (-)-Citronellol","CAS: 7540-51-4; PubChem: 13560; ChEBI: 88; ChEMBL: CHEMBL1907995; LIPIDMAPS: LMPR0102010012; KNApSAcK: C00000844; 3DMET: B04234; NIKKAJI: J67.958E","cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307",10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H21O1","C10H19O1",156.1514153,157.1592403,155.1435902
"cpd:C16461","Geranic acid;","C10H16O2","Geranic acid; 3,7-Dimethylocta-2,6-dienoate; Geranate","R08086 R08097","Geraniol degradation; Biosynthesis of antibiotics","1.2.1.86; 2.8.3.-",NA,NA,"CAS: 459-80-3; PubChem: 47205757; ChEBI: 67264; ChEMBL: CHEMBL170190; LIPIDMAPS: LMFA01030784; PDB-CCD: 58X; NIKKAJI: J400F","cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323",10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H17O2","C10H15O2",168.1150298,169.1228548,167.1072047
"cpd:C16462","Citronellate;","C10H18O2","Citronellate; Citronellic acid; 3,7-Dimethyl-6-octenoic acid","R08087 R08088 R08096","Geraniol degradation","1.2.1.-; 6.2.1.-",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16462  3,7-Dimethyl-6-octenoic acid","CAS: 502-47-6; PubChem: 47205758; ChEBI: 80507; LIPIDMAPS: LMFA01020104; NIKKAJI: J11.776E","cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139",10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C10H19O2","C10H17O2",170.1306798,171.1385049,169.1228548
"cpd:C16464","Citronellyl-CoA","C31H52N7O17P3S","Citronellyl-CoA","R08088 R08089","Geraniol degradation","1.3.99.-; 6.2.1.-",NA,NA,"PubChem: 47205760; ChEBI: 80508; NIKKAJI: J2.802.630G","cpd:C05275; cpd:C16464",31,52,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H53O17N7P3S1","C31H51O17N7P3S1",919.2353254,920.2431504,918.2275004
"cpd:C16465","trans-Geranyl-CoA","C31H50N7O17P3S","trans-Geranyl-CoA","R08097 R08098","Geraniol degradation","2.8.3.-; 5.2.1.-",NA,NA,"PubChem: 47205761; ChEBI: 80509; NIKKAJI: J2.802.631E","cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465",31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C31H51O17N7P3S1","C31H49O17N7P3S1",917.2196753,918.2275004,916.2118503
"cpd:C16466","7-Methyl-3-oxo-6-octenoyl-CoA","C30H48N7O18P3S","7-Methyl-3-oxo-6-octenoyl-CoA","R08090 R08091","Geraniol degradation","2.3.1.16; 4.1.3.4; 4.1.3.26",NA,NA,"PubChem: 47205762; ChEBI: 52043; NIKKAJI: J2.802.632C","cpd:C16466",30,48,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C30H49O18N7P3S1","C30H47O18N7P3S1",919.1989399,920.2067649,918.1911149
"cpd:C16468","(2E)-5-Methylhexa-2,4-dienoyl-CoA","C28H44N7O17P3S","(2E)-5-Methylhexa-2,4-dienoyl-CoA","R08092 R08093","Geraniol degradation","1.3.99.-; 4.2.1.17",NA,NA,"PubChem: 47205764; ChEBI: 80511; NIKKAJI: J2.802.633A","cpd:C09811; cpd:C16468",28,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O17N7P3S1","C28H43O17N7P3S1",875.1727252,876.1805502,874.1649001
"cpd:C16469","3-Hydroxy-5-methylhex-4-enoyl-CoA","C28H46N7O18P3S","3-Hydroxy-5-methylhex-4-enoyl-CoA","R08093 R08094","Geraniol degradation","1.1.1.35; 4.2.1.17",NA,NA,"PubChem: 47205765; ChEBI: 80512; NIKKAJI: J2.802.634J","cpd:C09812; cpd:C16469",28,46,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O18N7P3S1","C28H45O18N7P3S1",893.1832898,894.1911149,892.1754648
"cpd:C16470","5-Methylhex-4-enoyl-CoA","C28H46N7O17P3S","5-Methylhex-4-enoyl-CoA","R08091 R08092","Geraniol degradation","1.3.99.-; 2.3.1.16",NA,NA,"PubChem: 47205766; ChEBI: 80513; NIKKAJI: J2.802.635H","cpd:C09823; cpd:C11949; cpd:C16470",28,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C28H47O17N7P3S1","C28H45O17N7P3S1",877.1883752,878.1962002,876.1805502
"cpd:C16471","5-Methyl-3-oxo-4-hexenoyl-CoA","C28H44N7O18P3S","5-Methyl-3-oxo-4-hexenoyl-CoA","R08094 R08095","Geraniol degradation","1.1.1.35; 2.3.1.16",NA,NA,"PubChem: 47205767; ChEBI: 80514; NIKKAJI: J2.802.636F","cpd:C06749; cpd:C09813; cpd:C16471",28,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,"C28H45O18N7P3S1","C28H43O18N7P3S1",891.1676398,892.1754648,890.1598147
"cpd:C02226","2-Methylmaleate;","C5H6O4","2-Methylmaleate; Citraconate; Citraconic acid; Methylmaleic acid","R03896 R03897 R03898","Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism","4.2.1.35","Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,"CAS: 498-23-7; PubChem: 5291; ChEBI: 17626 30719; LIPIDMAPS: LMFA01170099; PDB-CCD: CIZ; 3DMET: B00408; NIKKAJI: J6.106I","cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757",5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H7O4","C5H5O4",130.0266087,131.0344337,129.0187836
"cpd:C02504","alpha-Isopropylmalate;","C7H12O5","alpha-Isopropylmalate; (2S)-2-Isopropylmalate; (2S)-2-Hydroxy-2-isopropylsuccinic acid; 2-Isopropylmalic acid; 3-Carboxy-3-hydroxy-4-methylpentanoate; 3-Carboxy-3-hydroxyisocaproate","R01213 R03968 R10170","Valine, leucine and isoleucine biosynthesis; Pyruvate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.3.3.13; 4.2.1.33","Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,"PubChem: 5516; ChEBI: 1178 35128; LIPIDMAPS: LMFA01170083; KNApSAcK: C00019690; PDB-CCD: VPM; 3DMET: B01581; NIKKAJI: J319.987H","cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371",7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O5","C7H11O5",176.0684735,177.0762985,175.0606485
"cpd:C02612","(R)-2-Methylmalate;","C5H8O5","(R)-2-Methylmalate; (R)-2-Methylmalic acid; (R)-Citramalate; (R)-Citramalic acid; (R)-alpha-Hydroxypyrotartaric acid; D-Citramalate; D-Citramalic acid; D-alpha-Hydroxypyrotartaric acid; (2R)-2-Hydroxy-2-methylbutanedioate","R03896 R03995 R07399 R10640","Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.3.1.182; 2.8.3.20; 4.2.1.35","Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,"PubChem: 5597; ChEBI: 15586 30934; 3DMET: B00465; NIKKAJI: J73.970G","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C02631","2-Isopropylmaleate;","C7H10O4","2-Isopropylmaleate; beta-Isopropylmaleate","R03968 R04001","Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism","4.2.1.33",NA,NA,"PubChem: 5611; ChEBI: 17275; 3DMET: B00468; NIKKAJI: J867.346B","cpd:C02631; cpd:C04142; cpd:C04670; cpd:C04815; cpd:C05126; cpd:C13672; cpd:C21468",7,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H11O4","C7H9O4",158.0579088,159.0657338,157.0500838
"cpd:C04181","3-Hydroxy-3-methyl-2-oxobutanoic acid;","C5H8O4","3-Hydroxy-3-methyl-2-oxobutanoic acid; 3-Hydroxy-3-methyl-2-oxobutanoate; 2-Oxo-3-hydroxyisovalerate","R03052 R04440 R05071","Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism","1.1.1.86; 5.4.99.3","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine","Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C04181  3-Hydroxy-3-methyl-2-oxobutanoic acid","PubChem: 6858; ChEBI: 11812 17667; LIPIDMAPS: LMFA01020277; 3DMET: B00686; NIKKAJI: J2.362.068E","cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177",5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O4","C5H7O4",132.0422587,133.0500838,131.0344337
"cpd:C04236","(2S)-2-Isopropyl-3-oxosuccinate;","C7H10O5","(2S)-2-Isopropyl-3-oxosuccinate; 3-Carboxy-4-methyl-2-oxopentanoate; 2-Oxo-4-methyl-3-carboxypentanoate","R01652 R04426","Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism","1.1.1.85",NA,NA,"PubChem: 6905; ChEBI: 1467; 3DMET: B01725; NIKKAJI: J2.747.832H","cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281",7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H11O5","C7H9O5",174.0528234,175.0606485,173.0449984
"cpd:C04272","(R)-2,3-Dihydroxy-3-methylbutanoate;","C5H10O4","(R)-2,3-Dihydroxy-3-methylbutanoate; (R)-2,3-Dihydroxy-isovalerate; (R)-2,3-Dihydroxy-isovaleric acid; (2R)-2,3-Dihydroxy-3-methylbutanoate","R04439 R04440 R04441 R10916","Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.86; 1.1.1.382; 1.1.1.383; 4.2.1.9","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine",NA,"PubChem: 6935; ChEBI: 15684 49072; 3DMET: B01729; NIKKAJI: J57.649B","cpd:C01801; cpd:C02783; cpd:C04039; cpd:C04272; cpd:C06257; cpd:C08347; cpd:C11497",5,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H11O4","C5H9O4",134.0579088,135.0657338,133.0500838
"cpd:C04411","(2R,3S)-3-Isopropylmalate;","C7H12O5","(2R,3S)-3-Isopropylmalate; 3-Isopropylmalate; 3-Carboxy-2-hydroxy-4-methylpentanoate; 2-D-threo-Hydroxy-3-carboxy-isocaproate","R04001 R04426 R10052 R10170","Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.85; 4.2.1.33","Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,"PubChem: 7045; ChEBI: 35121 43468; ChEMBL: CHEMBL376564; KNApSAcK: C00019691; PDB-CCD: IPM; 3DMET: B01741; NIKKAJI: J1.641.400J","cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371",7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H13O5","C7H11O5",176.0684735,177.0762985,175.0606485
"cpd:C06006","(S)-2-Aceto-2-hydroxybutanoate;","C6H10O4","(S)-2-Aceto-2-hydroxybutanoate; (S)-2-Hydroxy-2-ethyl-3-oxobutanoate","R04673 R05069 R08648","Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.86; 2.2.1.6; 5.4.99.3","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,"PubChem: 8279; ChEBI: 27681 49256; LIPIDMAPS: LMFA01050383; 3DMET: B01948; NIKKAJI: J372.593F","cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465",6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O4","C6H9O4",146.0579088,147.0657338,145.0500838
"cpd:C06007","(R)-2,3-Dihydroxy-3-methylpentanoate;","C6H12O4","(R)-2,3-Dihydroxy-3-methylpentanoate; (R)-2,3-Dihydroxy-3-methylvalerate; (2R,3R)-2,3-Dihydroxy-3-methylpentanoate","R05068 R05070","Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.86; 4.2.1.9","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,"PubChem: 8280; ChEBI: 27512 49258; PDB-CCD: DMV; 3DMET: B05146; NIKKAJI: J2.760.883C","cpd:C00418; cpd:C00491; cpd:C00522; cpd:C01100; cpd:C01420; cpd:C02104; cpd:C03089; cpd:C03348; cpd:C04104; cpd:C05704; cpd:C06007; cpd:C06471; cpd:C13522; cpd:C14445; cpd:C18988; cpd:C19719; cpd:C21045; cpd:C21054; cpd:C21055; cpd:C21062; cpd:C21397",6,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H13O4","C6H11O4",148.0735589,149.0813839,147.0657338
"cpd:C06010","(S)-2-Acetolactate;","C5H8O4","(S)-2-Acetolactate; (S)-2-Hydroxy-2-methyl-3-oxobutanoate; (2S)-2-Hydroxy-2-methyl-3-oxobutanoate","R00226 R02948 R04439 R04672 R05071 R10506 R10916","Valine, leucine and isoleucine biosynthesis; Butanoate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.86; 1.1.1.382; 1.1.1.383; 2.2.1.6; 4.1.1.5; 5.4.99.3","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine",NA,"PubChem: 8282; ChEBI: 18409; PDB-CCD: X2X; 3DMET: B01949; NIKKAJI: J2.362.063D","cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177",5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O4","C5H7O4",132.0422587,133.0500838,131.0344337
"cpd:C06032","D-erythro-3-Methylmalate;","C5H8O5","D-erythro-3-Methylmalate; (2R,3S)-3-Methylmalate","R00994 R03898","Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.85; 4.2.1.35","Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,"PubChem: 8304; ChEBI: 27394; ChEMBL: CHEMBL226414; 3DMET: B01955; NIKKAJI: J883.007J","cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031",5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H9O5","C5H7O5",148.0371734,149.0449984,147.0293483
"cpd:C14463","(R)-3-Hydroxy-3-methyl-2-oxopentanoate","C6H10O4","(R)-3-Hydroxy-3-methyl-2-oxopentanoate","R05068 R05069","Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism","1.1.1.86; 5.4.99.3","Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,"PubChem: 17395463; ChEBI: 34008 49257; NIKKAJI: J2.788.388E","cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465",6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H11O4","C6H9O4",146.0579088,147.0657338,145.0500838
"cpd:C00047","L-Lysine;","C6H14N2O2","L-Lysine; Lysine acid; 2,6-Diaminohexanoic acid","R00445 R00446 R00447 R00448 R00449 R00451 R00452 R00453; R00454 R00457 R00458 R00459 R00460 R00461 R00462 R00463; R00545 R00612 R00715 R00716 R00910 R00911 R01077 R01396; R01620 R02786 R03095 R03658 R07598 R07646 R08125 R09597; R09779 R10010 R10011 R10054 R10277 R10699 R11190","Lysine biosynthesis; Lysine degradation; Biotin metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption","1.4.1.15; 1.4.1.18; 1.4.3.14; 1.4.3.20; 1.5.1.7; 1.5.1.8; 1.5.1.16; 1.5.3.4; 1.13.12.2; 1.14.13.59; 2.1.3.8; 2.3.1.32; 2.3.1.-; 2.6.1.36; 2.6.1.71; 2.6.1.105; 3.4.13.4; 3.4.14.13; 3.5.1.12; 3.5.1.17; 3.5.1.-; 3.5.2.11; 3.5.-.-; 4.1.1.18; 4.1.1.20; 4.3.1.28; 5.1.1.5; 5.1.1.9; 5.4.3.2; 5.4.99.58; 6.1.1.6; 6.3.2.7; 6.3.2.11; 6.3.2.20; 6.3.4.19","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00047  Lysine (Lys); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05X I.V. SOLUTION ADDITIVES;     B05XB Amino acids;      B05XB03 Lysine;       D02304  Lysine (USAN/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Lysine;     D02304  Lysine (USAN/INN)","CAS: 56-87-1; PubChem: 3349; ChEBI: 18019; ChEMBL: CHEMBL8085; KNApSAcK: C00001378; PDB-CCD: LYS; 3DMET: B00013; NIKKAJI: J9.176F","cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277",6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O2N2","C6H13O2N2",146.1055277,147.1133527,145.0977027
"cpd:C00322","2-Oxoadipate;","C6H8O5","2-Oxoadipate; 2-Oxoadipic acid","R01932 R01933 R01934 R01936 R01937 R01938 R01939 R01940; R08331","Lysine biosynthesis; Lysine degradation; Tryptophan metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.87; 1.1.1.172; 1.1.1.286; 1.2.4.2; 1.5.1.-; 1.8.1.4; 2.3.1.61; 2.3.3.-; 2.6.1.39","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00322  2-Oxoadipate","CAS: 3184-35-8; PubChem: 3616; ChEBI: 15753; LIPIDMAPS: LMFA01170121; KNApSAcK: C00000770; PDB-CCD: OOG; 3DMET: B00088; NIKKAJI: J39.063A","cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781",6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H9O5","C6H7O5",160.0371734,161.0449984,159.0293483
"cpd:C00449","N6-(L-1,3-Dicarboxypropyl)-L-lysine;","C11H20N2O6","N6-(L-1,3-Dicarboxypropyl)-L-lysine; Saccharopine; L-Saccharopine; N-[(S)-5-Amino-5-carboxypentyl]-L-glutamic acid","R00715 R00716 R02313 R02315 R09495","Lysine biosynthesis; Lysine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.5.1.7; 1.5.1.8; 1.5.1.9; 1.5.1.10; 1.5.3.18","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,"CAS: 997-68-2; PubChem: 3737; ChEBI: 16927; KNApSAcK: C00007227; PDB-CCD: SHR; 3DMET: B01246; NIKKAJI: J7.215J","cpd:C00449",11,20,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H21O6N2","C11H19O6N2",276.1321364,277.1399614,275.1243113
"cpd:C00666","LL-2,6-Diaminoheptanedioate;","C7H14N2O4","LL-2,6-Diaminoheptanedioate; LL-2,6-Diaminopimelate; LL-2,6-Diaminopimelic acid","R02733 R02734 R02735 R07613","Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids","2.6.1.83; 3.5.1.18; 3.5.1.47; 5.1.1.7","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"PubChem: 3935; ChEBI: 16026 47031; LIPIDMAPS: LMFA01170102; KNApSAcK: C00007596; 3DMET: B01303; NIKKAJI: J81.742B","cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914",7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H15O4N2","C7H13O4N2",190.0953569,191.103182,189.0875319
"cpd:C00680","meso-2,6-Diaminoheptanedioate;","C7H14N2O4","meso-2,6-Diaminoheptanedioate; meso-2,6-Diaminopimelate; meso-2,6-Diaminopimelic acid; meso-Diaminoheptanedioate","R00451 R02735 R02755 R02788","Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.4.1.16; 4.1.1.20; 5.1.1.7; 6.3.2.13","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,"PubChem: 3949; ChEBI: 16488 30308; ChEMBL: CHEMBL415306; KNApSAcK: C00007595; PDB-CCD: 6CL API; 3DMET: B01309; NIKKAJI: J407.120D","cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914",7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H15O4N2","C7H13O4N2",190.0953569,191.103182,189.0875319
"cpd:C00956","L-2-Aminoadipate;","C6H11NO4","L-2-Aminoadipate; L-alpha-Aminoadipate; L-alpha-Aminoadipic acid; L-2-Aminoadipic acid; L-2-Aminohexanedioate","R01939 R03098 R03102 R03103 R04868 R04870 R06361 R09775; R11231 R11232","Lysine biosynthesis; Lysine degradation; Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.2.1.31; 2.3.1.164; 2.6.1.39; 6.3.2.26; 6.3.2.43","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,"CAS: 542-32-5; PubChem: 4207; ChEBI: 37023; ChEMBL: CHEMBL88804; KNApSAcK: C00007393; PDB-CCD: UN1; 3DMET: B01358; NIKKAJI: J38.125J","cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694",6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O4N1","C6H10O4N1",161.0688078,162.0766329,160.0609828
"cpd:C01251","(R)-2-Hydroxybutane-1,2,4-tricarboxylate;","C7H10O7","(R)-2-Hydroxybutane-1,2,4-tricarboxylate; Homocitrate; Homocitric acid; 3-Hydroxy-3-carboxyadipic acid; (R)-2-Hydroxy-1,2,4-butanetricarboxylic acid","R00271 R03444 R09720","Lysine biosynthesis; Pyruvate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","2.3.3.14; 4.2.1.114; 4.2.1.-","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,"PubChem: 4471; ChEBI: 17852 36457 52222; PDB-CCD: HCA; 3DMET: B01423; NIKKAJI: J593.429J","cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662",7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H11O7","C7H9O7",206.0426527,207.0504777,205.0348276
"cpd:C03871","L-2-Amino-6-oxoheptanedioate;","C7H11NO5","L-2-Amino-6-oxoheptanedioate; L-2-Amino-6-oxopimelate","R02755 R04336","Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids","1.4.1.16","Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine",NA,"PubChem: 6605; ChEBI: 28245; PDB-CCD: 26P; 3DMET: B00648; NIKKAJI: J1.813.077G","cpd:C00624; cpd:C03871; cpd:C12109",7,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H12O5N1","C7H10O5N1",189.0637225,190.0715475,188.0558974
"cpd:C04002","(Z)-But-1-ene-1,2,4-tricarboxylate;","C7H8O6","(Z)-But-1-ene-1,2,4-tricarboxylate; Homo-cis-aconitate; cis-Homoaconitate; (Z)-1,2,4-But-1-enetricarboxylic acid","R03444 R04371","Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","4.2.1.36; 4.2.1.114; 4.2.1.-","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,"PubChem: 6715; ChEBI: 17516; 3DMET: B00663; NIKKAJI: J181.759K","cpd:C04002; cpd:C04225; cpd:C06246; cpd:C11514; cpd:C11515; cpd:C16579; cpd:C21250",7,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H9O6","C7H7O6",188.032088,189.039913,187.0242629
"cpd:C04076","L-2-Aminoadipate 6-semialdehyde;","C6H11NO3","L-2-Aminoadipate 6-semialdehyde; 2-Aminoadipate 6-semialdehyde; L-Allysine; Allysine; (S)-2-Amino-6-oxohexanoate","R00446 R00453 R00457 R02313 R02315 R02317 R03102 R03103; R04390 R07598 R09495 R10270 R10699","Lysine biosynthesis; Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids","1.2.1.31; 1.4.1.18; 1.4.3.20; 1.5.1.9; 1.5.1.10; 1.5.3.18; 2.6.1.36; 2.6.1.71; 2.6.1.105; 4.2.3.134","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,"PubChem: 6771; ChEBI: 17917; 3DMET: B00675; NIKKAJI: J1.136.598A","cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295",6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O3N1","C6H10O3N1",145.0738932,146.0817182,144.0660682
"cpd:C04390","N6-Acetyl-LL-2,6-diaminoheptanedioate;","C9H16N2O5","N6-Acetyl-LL-2,6-diaminoheptanedioate; N2-Acetyl-LL-2,6-diaminoheptanedioate; N6-Acetyl-LL-2,6-diaminopimelate; N2-Acetyl-LL-2,6-diaminopimelate; N6-Acetyl-L-2,6-diaminoheptanedioate; N6-Acetyl-L-2,6-diaminopimelate; N-Acetyl-LL-2,6-diaminoheptanedioate","R02733 R04467","Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids","2.6.1.-; 3.5.1.47","Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine",NA,"PubChem: 7030; ChEBI: 18317 49004; 3DMET: B01738; NIKKAJI: J2.358.308I","cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015",9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C9H17O5N2","C9H15O5N2",232.1059216,233.1137467,231.0980966
"cpd:C04421","N-Succinyl-LL-2,6-diaminoheptanedioate;","C11H18N2O7","N-Succinyl-LL-2,6-diaminoheptanedioate; N-Succinyl-LL-2,6-diaminopimelate; N-Succinyl-L-2,6-diaminoheptanedioate; N-Succinyl-L-2,6-diaminopimelate","R02734 R04475","Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids","2.6.1.17; 3.5.1.18","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine",NA,"PubChem: 7053; ChEBI: 17279; KNApSAcK: C00007597; 3DMET: B01743; NIKKAJI: J978.287G","cpd:C04421",11,18,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H19O7N2","C11H17O7N2",290.1114009,291.119226,289.1035759
"cpd:C04462","N-Succinyl-2-L-amino-6-oxoheptanedioate;","C11H15NO8","N-Succinyl-2-L-amino-6-oxoheptanedioate; N-Succinyl-L-2-amino-6-oxoheptanedioate; N-Succinyl-L-2-amino-6-oxopimelate; N-Succinyl-2-amino-6-oxo-L-pimelic acid; N-Succinyl-epsilon-keto-L-aminopimelic acid; (S)-2-(Succinylamino)-6-oxoheptanedioate","R04365 R04475","Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids","2.3.1.117; 2.6.1.17","Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine",NA,"PubChem: 7087; ChEBI: 15685 35266; ChEMBL: CHEMBL175209; KNApSAcK: C00007598; 3DMET: B00719; NIKKAJI: J788.069C","cpd:C04462; cpd:C05537",11,15,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C11H16O8N1","C11H14O8N1",289.0797664,290.0875915,288.0719414
"cpd:C04877","UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate;","C35H55N7O26P2","UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate; UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate; UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimelate; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diamino-heptanedioate","R02788 R04617 R10901","Lysine biosynthesis; Peptidoglycan biosynthesis","6.3.2.10; 6.3.2.13; 6.3.2.45",NA,NA,"PubChem: 7429; ChEBI: 84805; 3DMET: B04971; NIKKAJI: J2.757.188C","cpd:C04877; cpd:C20886",35,55,26,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C35H56O26N7P2","C35H54O26N7P2",1051.267199,1052.275024,1050.259374
"cpd:C04882","UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine;","C41H65N9O28P2","UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine","R04617 R05630 R08850","Lysine biosynthesis; Peptidoglycan biosynthesis","2.7.8.13; 3.4.17.8; 6.3.2.10",NA,NA,"PubChem: 7434; ChEBI: 18199; 3DMET: B04972; NIKKAJI: J2.754.729J","cpd:C04882",41,65,28,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,"C41H66O28N9P2","C41H64O28N9P2",1193.341426,1194.349252,1192.333601
"cpd:C05560","L-2-Aminoadipate adenylate;","C16H23N6O10P","L-2-Aminoadipate adenylate; 5-Adenylyl-2-aminoadipate; alpha-Aminoadipoyl-C6-AMP","R03098 R04863","Lysine biosynthesis","1.2.1.31","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine",NA,"PubChem: 7891; ChEBI: 20536 6163; 3DMET: B01874; NIKKAJI: J2.756.232I","cpd:C05560",16,23,10,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"C16H24O10N6P1","C16H22O10N6P1",490.121328,491.129153,489.1135029
"cpd:C05662","Homoisocitrate;","C7H10O7","Homoisocitrate; 3-Carboxy-2-hydroxyadipate; (-)-1-Hydroxy-1,2,4-butanetricarboxylate; (1R,2S)-1-Hydroxybutane-1,2,4-tricarboxylate; (-)-threo-Homoisocitrate","R01934 R04371 R04862 R09720","Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids","1.1.1.87; 1.1.1.286; 4.2.1.36; 4.2.1.114","Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,"PubChem: 7972; ChEBI: 15404 30903 30904; ChEMBL: CHEMBL375897; PDB-CCD: 48Y; 3DMET: B01881; NIKKAJI: J2.204.427C","cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662",7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H11O7","C7H9O7",206.0426527,207.0504777,205.0348276
"cpd:C16138","L-Pyrrolysine;","C12H21N3O3","L-Pyrrolysine; Pyrrolysine","R08578 R10013","Lysine biosynthesis; Aminoacyl-tRNA biosynthesis; Microbial metabolism in diverse environments; Protein digestion and absorption","6.1.1.26",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C16138  Pyrrolysine (Pyl)","CAS: 448235-52-7; PubChem: 47205448; ChEBI: 21860; PDB-CCD: PYL; NIKKAJI: J1.888.988I","cpd:C16138",12,21,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H22O3N3","C12H20O3N3",255.1582915,256.1661166,254.1504665
"cpd:C20277","(2R,3R)-3-Methylornithine;","C6H14N2O2","(2R,3R)-3-Methylornithine; (3R)-3-Methyl-D-ornithine","R10010 R10011","Lysine biosynthesis; Microbial metabolism in diverse environments","5.4.99.58",NA,NA,"PubChem: 163312017; PDB-CCD: MD0","cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277",6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O2N2","C6H13O2N2",146.1055277,147.1133527,145.0977027
"cpd:C20278","(2R,3R)-3-Methylornithinyl-N6-lysine","C12H26N4O3","(2R,3R)-3-Methylornithinyl-N6-lysine","R10011 R10012","Lysine biosynthesis; Microbial metabolism in diverse environments",NA,NA,NA,"PubChem: 163312018","cpd:C20278",12,26,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H27O3N4","C12H25O3N4",274.2004907,275.2083157,273.1926657
"cpd:C20279","(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine","C12H23N3O4","(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine","R10012 R10013","Lysine biosynthesis; Microbial metabolism in diverse environments",NA,NA,NA,"PubChem: 163312019","cpd:C20279",12,23,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C12H24O4N3","C12H22O4N3",273.1688562,274.1766813,272.1610312
"cpd:C00408","L-Pipecolate;","C6H11NO2","L-Pipecolate; Pipecolinic acid; Pipecolic acid; 2-Piperidinecarboxylic acid; (S)-Piperidine-2-carboxylic acid","R00459 R02201 R02203 R02204 R02205 R02206 R08414 R08415; R09680 R10277","Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites","1.5.1.1; 1.5.1.21; 1.5.3.7; 1.5.99.3; 3.5.1.101; 4.3.1.28",NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C00408  L-Pipecolate","CAS: 3105-95-1; PubChem: 3698; ChEBI: 30633 30913; ChEMBL: CHEMBL322883; KNApSAcK: C00000210 C00001387; PDB-CCD: YCP; 3DMET: B01237; NIKKAJI: J215.717I","cpd:C00408; cpd:C03969; cpd:C05936; cpd:C07500; cpd:C13696; cpd:C16759; cpd:C20204",6,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H12O2N1","C6H10O2N1",129.0789786,130.0868036,128.0711536
"cpd:C00431","5-Aminopentanoate;","C5H11NO2","5-Aminopentanoate; 5-Aminopentanoic acid; 5-Aminovaleric acid","R02273 R02274 R02276 R02825","Lysine degradation; Arginine and proline metabolism","1.4.1.12; 1.21.4.1; 2.6.1.48; 3.5.1.30; 3.5.1.63",NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C00431  5-Aminopentanoic acid","CAS: 660-88-8; PubChem: 3720; ChEBI: 15887; ChEMBL: CHEMBL284116; LIPIDMAPS: LMFA01100040; PDB-CCD: DAV; 3DMET: B00111; NIKKAJI: J38.132B","cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436",5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C5H12O2N1","C5H10O2N1",117.0789786,118.0868036,116.0711536
"cpd:C00450","(S)-2,3,4,5-Tetrahydropyridine-2-carboxylate;","C6H9NO2","(S)-2,3,4,5-Tetrahydropyridine-2-carboxylate; Delta1-Piperideine-6-L-carboxylate","R02204 R02205 R02206 R02317 R08414 R10054 R11231 R11232","Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites","1.2.1.31; 1.4.1.18; 1.5.3.7; 1.5.99.3",NA,NA,"PubChem: 3738; ChEBI: 49014 58769; 3DMET: B04684; NIKKAJI: J762.515D","cpd:C00450; cpd:C04092; cpd:C08268; cpd:C08292; cpd:C10149; cpd:C13694",6,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H10O2N1","C6H8O2N1",127.0633285,128.0711536,126.0555035
"cpd:C00487","Carnitine;","C7H16NO3","Carnitine; gamma-Trimethyl-hydroxybutyrobetaine; 3-Hydroxy-4-trimethylammoniobutanoate","R02395 R02396 R02397 R02398","Lysine degradation; ABC transporters","1.1.1.108; 1.14.11.1; 2.3.1.7; 4.1.1.42",NA,"Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Carnitine;     C00487  Carnitine","CAS: 406-76-8; PubChem: 3770; ChEBI: 17126 3424; ChEMBL: CHEMBL1620698; 3DMET: B04687; NIKKAJI: J334.275A","cpd:C00487",7,16,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C7H17O3N1","C7H15O3N1",162.1130184,163.1208434,161.1051933
"cpd:C00739","D-Lysine;","C6H14N2O2","D-Lysine; D-2,6-Diaminohexanoic acid","R00460 R02851 R02852 R09596","Lysine degradation","2.6.1.21; 5.1.1.5; 5.1.1.9; 5.4.3.4; 6.3.2.37",NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00739  D-Lysine","CAS: 923-27-3; PubChem: 4002; ChEBI: 16855; ChEMBL: CHEMBL319497; PDB-CCD: DLY; 3DMET: B01320; NIKKAJI: J9.203G","cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277",6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"C6H15O2N2","C6H13O2N2",146.1055277,147.1133527,145.0977027
